{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "from datetime import datetime"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"../data/drug-ndc-0001-of-0001.json\") as f:\n",
    "    data = json.load(f)\n",
    "    "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "I am checking how many items is in the file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "138449"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(data[\"results\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'product_ndc': '71335-1974',\n",
       "  'generic_name': 'Fluvoxamine Maleate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Fluvoxamine Maleate',\n",
       "  'active_ingredients': [{'name': 'FLUVOXAMINE MALEATE',\n",
       "    'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-1974-1',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-1974-1)',\n",
       "    'marketing_start_date': '20220214',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1974-2',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-1974-2)',\n",
       "    'marketing_start_date': '20211014',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['903891'],\n",
       "   'spl_set_id': ['47daea9e-545d-4a67-b2b2-d12c3c98734b'],\n",
       "   'unii': ['5LGN83G74V']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'ee35b0d2-a375-4176-be7d-23783cf8eb22',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20010710',\n",
       "  'product_id': '71335-1974_ee35b0d2-a375-4176-be7d-23783cf8eb22',\n",
       "  'application_number': 'ANDA075902',\n",
       "  'brand_name_base': 'Fluvoxamine Maleate',\n",
       "  'pharm_class': ['Serotonin Reuptake Inhibitor [EPC]',\n",
       "   'Serotonin Uptake Inhibitors [MoA]']},\n",
       " {'product_ndc': '71335-1975',\n",
       "  'generic_name': 'Desvenlafaxine',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Desvenlafaxine',\n",
       "  'active_ingredients': [{'name': 'DESVENLAFAXINE SUCCINATE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-1975-1',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1975-1)',\n",
       "    'marketing_start_date': '20211014',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1975-2',\n",
       "    'description': '60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1975-2)',\n",
       "    'marketing_start_date': '20211014',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1975-3',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1975-3)',\n",
       "    'marketing_start_date': '20240718',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1975-4',\n",
       "    'description': '120 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1975-4)',\n",
       "    'marketing_start_date': '20240718',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1607617'],\n",
       "   'spl_set_id': ['1d8889c9-9403-4b4b-8abd-7dc9a9fc1816'],\n",
       "   'unii': ['ZB22ENF0XR']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': 'ac9d9fae-eba2-468f-9bc3-66ee222ce3ce',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210105',\n",
       "  'product_id': '71335-1975_ac9d9fae-eba2-468f-9bc3-66ee222ce3ce',\n",
       "  'application_number': 'ANDA210014',\n",
       "  'brand_name_base': 'Desvenlafaxine',\n",
       "  'pharm_class': ['Cytochrome P450 2D6 Inhibitors [MoA]',\n",
       "   'Norepinephrine Uptake Inhibitors [MoA]',\n",
       "   'Serotonin Uptake Inhibitors [MoA]',\n",
       "   'Serotonin and Norepinephrine Reuptake Inhibitor [EPC]']},\n",
       " {'product_ndc': '71335-1989',\n",
       "  'generic_name': 'hydrocortisone',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'HYDROCORTISONE',\n",
       "  'active_ingredients': [{'name': 'HYDROCORTISONE', 'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-1989-1',\n",
       "    'description': '30 TABLET in 1 BOTTLE, PLASTIC (71335-1989-1)',\n",
       "    'marketing_start_date': '20240718',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1989-2',\n",
       "    'description': '90 TABLET in 1 BOTTLE, PLASTIC (71335-1989-2)',\n",
       "    'marketing_start_date': '20240718',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1989-3',\n",
       "    'description': '58 TABLET in 1 BOTTLE, PLASTIC (71335-1989-3)',\n",
       "    'marketing_start_date': '20240718',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1989-4',\n",
       "    'description': '28 TABLET in 1 BOTTLE, PLASTIC (71335-1989-4)',\n",
       "    'marketing_start_date': '20240718',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1989-5',\n",
       "    'description': '60 TABLET in 1 BOTTLE, PLASTIC (71335-1989-5)',\n",
       "    'marketing_start_date': '20211111',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1989-6',\n",
       "    'description': '100 TABLET in 1 BOTTLE, PLASTIC (71335-1989-6)',\n",
       "    'marketing_start_date': '20240718',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197787'],\n",
       "   'spl_set_id': ['47bfae62-bf25-413e-93fc-3c72c901f1a5'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['WI4X0X7BPJ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '54e94095-73b5-4dfc-a0f7-1b97ea861f37',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20070330',\n",
       "  'product_id': '71335-1989_54e94095-73b5-4dfc-a0f7-1b97ea861f37',\n",
       "  'application_number': 'ANDA040646',\n",
       "  'brand_name_base': 'HYDROCORTISONE',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '71335-1999',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-1999-1',\n",
       "    'description': '10 CAPSULE in 1 BOTTLE (71335-1999-1)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-2',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71335-1999-2)',\n",
       "    'marketing_start_date': '20211123',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-3',\n",
       "    'description': '7 CAPSULE in 1 BOTTLE (71335-1999-3)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-4',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71335-1999-4)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-5',\n",
       "    'description': '20 CAPSULE in 1 BOTTLE (71335-1999-5)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-6',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (71335-1999-6)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-7',\n",
       "    'description': '180 CAPSULE in 1 BOTTLE (71335-1999-7)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-8',\n",
       "    'description': '28 CAPSULE in 1 BOTTLE (71335-1999-8)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198108'],\n",
       "   'spl_set_id': ['99351f77-46b8-4741-9193-1a6d6a7b0b18'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'a3dbc27d-e958-4092-abee-2b77950b342c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170801',\n",
       "  'product_id': '71335-1999_a3dbc27d-e958-4092-abee-2b77950b342c',\n",
       "  'application_number': 'ANDA208340',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '71335-2008',\n",
       "  'generic_name': 'Fluvoxamine Maleate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Fluvoxamine Maleate',\n",
       "  'active_ingredients': [{'name': 'FLUVOXAMINE MALEATE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2008-1',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2008-1)',\n",
       "    'marketing_start_date': '20220117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2008-2',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2008-2)',\n",
       "    'marketing_start_date': '20220217',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2008-3',\n",
       "    'description': '18 TABLET in 1 BOTTLE (71335-2008-3)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2008-4',\n",
       "    'description': '28 TABLET in 1 BOTTLE (71335-2008-4)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2008-5',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71335-2008-5)',\n",
       "    'marketing_start_date': '20230913',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['903884'],\n",
       "   'spl_set_id': ['4239fc32-e5cb-4393-b90c-742db42b5d07'],\n",
       "   'unii': ['5LGN83G74V']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'd6d75403-b70e-48da-b36a-3e808554dcec',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20010710',\n",
       "  'product_id': '71335-2008_d6d75403-b70e-48da-b36a-3e808554dcec',\n",
       "  'application_number': 'ANDA075902',\n",
       "  'brand_name_base': 'Fluvoxamine Maleate',\n",
       "  'pharm_class': ['Serotonin Reuptake Inhibitor [EPC]',\n",
       "   'Serotonin Uptake Inhibitors [MoA]']},\n",
       " {'product_ndc': '71335-2040',\n",
       "  'generic_name': 'Esomeprazole Magnesium',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Esomeprazole Magnesium',\n",
       "  'active_ingredients': [{'name': 'ESOMEPRAZOLE MAGNESIUM',\n",
       "    'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2040-1',\n",
       "    'description': '90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-2040-1)',\n",
       "    'marketing_start_date': '20220303',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2040-2',\n",
       "    'description': '30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-2040-2)',\n",
       "    'marketing_start_date': '20220420',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2040-3',\n",
       "    'description': '60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-2040-3)',\n",
       "    'marketing_start_date': '20220222',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2040-4',\n",
       "    'description': '10 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-2040-4)',\n",
       "    'marketing_start_date': '20240812',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2040-5',\n",
       "    'description': '20 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-2040-5)',\n",
       "    'marketing_start_date': '20230713',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2040-6',\n",
       "    'description': '120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-2040-6)',\n",
       "    'marketing_start_date': '20240812',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2040-7',\n",
       "    'description': '180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-2040-7)',\n",
       "    'marketing_start_date': '20230126',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['606730'],\n",
       "   'spl_set_id': ['61cc0020-aab8-42a3-b0a6-93062f382c87'],\n",
       "   'unii': ['R6DXU4WAY9']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, DELAYED RELEASE',\n",
       "  'spl_id': '3688c82f-b564-4f5c-b916-617310c93f70',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200602',\n",
       "  'product_id': '71335-2040_3688c82f-b564-4f5c-b916-617310c93f70',\n",
       "  'application_number': 'ANDA211977',\n",
       "  'brand_name_base': 'Esomeprazole Magnesium',\n",
       "  'pharm_class': ['Cytochrome P450 2C19 Inhibitors [MoA]',\n",
       "   'Proton Pump Inhibitor [EPC]',\n",
       "   'Proton Pump Inhibitors [MoA]']},\n",
       " {'product_ndc': '71335-2045',\n",
       "  'generic_name': 'Potassium Chloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'POTASSIUM CHLORIDE',\n",
       "  'active_ingredients': [{'name': 'POTASSIUM CHLORIDE',\n",
       "    'strength': '1500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2045-1',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2045-1)',\n",
       "    'marketing_start_date': '20220218',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2045-2',\n",
       "    'description': '60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2045-2)',\n",
       "    'marketing_start_date': '20220210',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2045-3',\n",
       "    'description': '100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2045-3)',\n",
       "    'marketing_start_date': '20220317',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2045-4',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2045-4)',\n",
       "    'marketing_start_date': '20220218',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2045-5',\n",
       "    'description': '15 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2045-5)',\n",
       "    'marketing_start_date': '20220218',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2045-6',\n",
       "    'description': '7 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2045-6)',\n",
       "    'marketing_start_date': '20220317',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2045-7',\n",
       "    'description': '10 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2045-7)',\n",
       "    'marketing_start_date': '20220317',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1801294'],\n",
       "   'spl_set_id': ['d396477a-6b15-4782-9c85-b9663b83c484'],\n",
       "   'unii': ['660YQ98I10']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': 'a54d2cd4-3479-41bb-920f-6d5ba2bf9811',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210120',\n",
       "  'product_id': '71335-2045_a54d2cd4-3479-41bb-920f-6d5ba2bf9811',\n",
       "  'application_number': 'ANDA214422',\n",
       "  'brand_name_base': 'POTASSIUM CHLORIDE',\n",
       "  'pharm_class': ['Increased Large Intestinal Motility [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Potassium Compounds [CS]',\n",
       "   'Potassium Salt [EPC]']},\n",
       " {'product_ndc': '0517-0791',\n",
       "  'generic_name': 'Betamethasone Sodium Phosphate and Betamethasone Acetate',\n",
       "  'labeler_name': 'American Regent, Inc.',\n",
       "  'brand_name': 'Betamethasone Sodium Phosphate and Betamethasone Acetate',\n",
       "  'active_ingredients': [{'name': 'BETAMETHASONE ACETATE',\n",
       "    'strength': '3 mg/mL'},\n",
       "   {'name': 'BETAMETHASONE SODIUM PHOSPHATE', 'strength': '3 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0517-0791-01',\n",
       "    'description': '1 VIAL, MULTI-DOSE in 1 CARTON (0517-0791-01)  / 5 mL in 1 VIAL, MULTI-DOSE',\n",
       "    'marketing_start_date': '20191101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['American Regent, Inc.'],\n",
       "   'rxcui': ['578803'],\n",
       "   'spl_set_id': ['335f17e7-069d-456c-8507-26253692f2ee'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['TI05AO53L7', '7BK02SCL3W']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SUSPENSION',\n",
       "  'spl_id': '963c2f51-4a65-43f7-99a6-9dffc301d875',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRA-ARTICULAR', 'INTRALESIONAL', 'INTRAMUSCULAR'],\n",
       "  'marketing_start_date': '20191101',\n",
       "  'product_id': '0517-0791_963c2f51-4a65-43f7-99a6-9dffc301d875',\n",
       "  'application_number': 'ANDA090747',\n",
       "  'brand_name_base': 'Betamethasone Sodium Phosphate and Betamethasone Acetate',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '71335-2057',\n",
       "  'generic_name': 'Labetalol Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Labetalol Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'LABETALOL', 'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2057-1',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71335-2057-1)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2057-2',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71335-2057-2)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2057-3',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71335-2057-3)',\n",
       "    'marketing_start_date': '20220303',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['896762'],\n",
       "   'spl_set_id': ['6f919513-500e-4a05-935e-b6fc1615368a'],\n",
       "   'nui': ['N0000000161', 'N0000175556'],\n",
       "   'pharm_class_moa': ['Adrenergic beta-Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['beta-Adrenergic Blocker [EPC]'],\n",
       "   'unii': ['R5H8897N95']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '3f08b857-efe9-4fee-91a8-dfd95c137b0a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20191122',\n",
       "  'product_id': '71335-2057_3f08b857-efe9-4fee-91a8-dfd95c137b0a',\n",
       "  'application_number': 'ANDA075215',\n",
       "  'brand_name_base': 'Labetalol Hydrochloride',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '71335-2068',\n",
       "  'generic_name': 'Ibuprofen',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'ibuprofen',\n",
       "  'active_ingredients': [{'name': 'IBUPROFEN', 'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2068-0',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71335-2068-0)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2068-1',\n",
       "    'description': '20 TABLET, FILM COATED in 1 BOTTLE (71335-2068-1)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2068-2',\n",
       "    'description': '15 TABLET, FILM COATED in 1 BOTTLE (71335-2068-2)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2068-3',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71335-2068-3)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2068-4',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (71335-2068-4)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2068-5',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71335-2068-5)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2068-6',\n",
       "    'description': '50 TABLET, FILM COATED in 1 BOTTLE (71335-2068-6)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2068-7',\n",
       "    'description': '40 TABLET, FILM COATED in 1 BOTTLE (71335-2068-7)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2068-8',\n",
       "    'description': '10 TABLET, FILM COATED in 1 BOTTLE (71335-2068-8)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2068-9',\n",
       "    'description': '56 TABLET, FILM COATED in 1 BOTTLE (71335-2068-9)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['310965'],\n",
       "   'spl_set_id': ['230fd746-92e0-40b6-9a90-595812bd8a18'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['WK2XYI10QM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '9ad350ec-4ed1-415a-afb6-5f611e7d8f77',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19940816',\n",
       "  'product_id': '71335-2068_9ad350ec-4ed1-415a-afb6-5f611e7d8f77',\n",
       "  'application_number': 'ANDA072096',\n",
       "  'brand_name_base': 'ibuprofen',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '71335-2104',\n",
       "  'generic_name': 'Hydrocodone Bitartrate and Acetaminophen',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Hydrocodone Bitartrate and Acetaminophen',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '325 mg/1'},\n",
       "   {'name': 'HYDROCODONE BITARTRATE', 'strength': '7.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2104-1',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2104-1)',\n",
       "    'marketing_start_date': '20220606',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2104-2',\n",
       "    'description': '15 TABLET in 1 BOTTLE (71335-2104-2)',\n",
       "    'marketing_start_date': '20220606',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2104-3',\n",
       "    'description': '28 TABLET in 1 BOTTLE (71335-2104-3)',\n",
       "    'marketing_start_date': '20220606',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2104-4',\n",
       "    'description': '56 TABLET in 1 BOTTLE (71335-2104-4)',\n",
       "    'marketing_start_date': '20220606',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2104-5',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-2104-5)',\n",
       "    'marketing_start_date': '20220606',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2104-6',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2104-6)',\n",
       "    'marketing_start_date': '20220606',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2104-7',\n",
       "    'description': '120 TABLET in 1 BOTTLE (71335-2104-7)',\n",
       "    'marketing_start_date': '20220606',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['857005'],\n",
       "   'spl_set_id': ['96a84a12-da15-410a-9c70-af125f2fcacc'],\n",
       "   'unii': ['362O9ITL9D', 'NO70W886KK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'b0ea909c-4c4a-4fcf-8c22-dfba2e3d2994',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181108',\n",
       "  'product_id': '71335-2104_b0ea909c-4c4a-4fcf-8c22-dfba2e3d2994',\n",
       "  'application_number': 'ANDA211487',\n",
       "  'brand_name_base': 'Hydrocodone Bitartrate and Acetaminophen',\n",
       "  'pharm_class': ['Opioid Agonist [EPC]', 'Opioid Agonists [MoA]']},\n",
       " {'product_ndc': '71335-2111',\n",
       "  'generic_name': 'Loperamide Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Loperamide Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'LOPERAMIDE HYDROCHLORIDE',\n",
       "    'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2111-0',\n",
       "    'description': '50 CAPSULE in 1 BOTTLE (71335-2111-0)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2111-1',\n",
       "    'description': '15 CAPSULE in 1 BOTTLE (71335-2111-1)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2111-2',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71335-2111-2)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2111-3',\n",
       "    'description': '20 CAPSULE in 1 BOTTLE (71335-2111-3)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2111-4',\n",
       "    'description': '12 CAPSULE in 1 BOTTLE (71335-2111-4)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2111-5',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71335-2111-5)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2111-6',\n",
       "    'description': '24 CAPSULE in 1 BOTTLE (71335-2111-6)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2111-7',\n",
       "    'description': '14 CAPSULE in 1 BOTTLE (71335-2111-7)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2111-8',\n",
       "    'description': '9 CAPSULE in 1 BOTTLE (71335-2111-8)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2111-9',\n",
       "    'description': '5 CAPSULE in 1 BOTTLE (71335-2111-9)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['978006'],\n",
       "   'spl_set_id': ['1e9dfe71-28a9-4b54-a0e1-7c0d82fec0d7'],\n",
       "   'unii': ['77TI35393C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'fc76d7e3-6f71-d6c2-e053-6394a90a2f73',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200925',\n",
       "  'product_id': '71335-2111_fc76d7e3-6f71-d6c2-e053-6394a90a2f73',\n",
       "  'application_number': 'ANDA215001',\n",
       "  'brand_name_base': 'Loperamide Hydrochloride',\n",
       "  'pharm_class': ['Opioid Agonist [EPC]', 'Opioid Agonists [MoA]']},\n",
       " {'product_ndc': '71335-2121',\n",
       "  'generic_name': 'Oxybutynin Chloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Oxybutynin Chloride Extended Release',\n",
       "  'brand_name_suffix': 'Extended Release',\n",
       "  'active_ingredients': [{'name': 'OXYBUTYNIN CHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2121-1',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2121-1)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2121-2',\n",
       "    'description': '18 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2121-2)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2121-3',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2121-3)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2121-4',\n",
       "    'description': '60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2121-4)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['863619'],\n",
       "   'spl_set_id': ['169d6d58-8887-4bdd-95bd-873d1f049eaa'],\n",
       "   'unii': ['L9F3D9RENQ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '9b4a7465-5a1a-4474-b2d3-9befee70bc1c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20160927',\n",
       "  'product_id': '71335-2121_9b4a7465-5a1a-4474-b2d3-9befee70bc1c',\n",
       "  'application_number': 'ANDA206121',\n",
       "  'brand_name_base': 'Oxybutynin Chloride',\n",
       "  'pharm_class': ['Cholinergic Muscarinic Antagonist [EPC]',\n",
       "   'Cholinergic Muscarinic Antagonists [MoA]']},\n",
       " {'product_ndc': '0517-1020',\n",
       "  'generic_name': 'Vasopressin',\n",
       "  'labeler_name': 'American Regent, Inc.',\n",
       "  'brand_name': 'Vasopressin',\n",
       "  'active_ingredients': [{'name': 'VASOPRESSIN', 'strength': \"20 [USP'U]/mL\"}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0517-1020-25',\n",
       "    'description': '25 VIAL, SINGLE-DOSE in 1 CARTON (0517-1020-25)  / 1 mL in 1 VIAL, SINGLE-DOSE (0517-1020-01)',\n",
       "    'marketing_start_date': '20220203',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['American Regent, Inc.'],\n",
       "   'rxcui': ['313578', '2103182'],\n",
       "   'spl_set_id': ['0ab267f4-9ec9-44fd-8521-f975074667d9'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305171030017'],\n",
       "   'nui': ['M0022562', 'N0000009908', 'N0000175360'],\n",
       "   'pharm_class_cs': ['Vasopressins [CS]'],\n",
       "   'pharm_class_pe': ['Vasoconstriction [PE]', 'Decreased Diuresis [PE]'],\n",
       "   'unii': ['Y4907O6MFD']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '36148e09-1c3c-4878-a194-8e10291972ff',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20220203',\n",
       "  'product_id': '0517-1020_36148e09-1c3c-4878-a194-8e10291972ff',\n",
       "  'application_number': 'NDA212593',\n",
       "  'brand_name_base': 'Vasopressin',\n",
       "  'pharm_class': ['Decreased Diuresis [PE]',\n",
       "   'Vasoconstriction [PE]',\n",
       "   'Vasopressins [CS]']},\n",
       " {'product_ndc': '71335-2122',\n",
       "  'generic_name': 'PREDNISONE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'prednisone',\n",
       "  'active_ingredients': [{'name': 'PREDNISONE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2122-1',\n",
       "    'description': '5 TABLET in 1 BOTTLE (71335-2122-1)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2122-2',\n",
       "    'description': '54 TABLET in 1 BOTTLE (71335-2122-2)',\n",
       "    'marketing_start_date': '20220617',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2122-3',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2122-3)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198145'],\n",
       "   'spl_set_id': ['ecc48869-3812-4440-a398-749b28062059'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['VB0R961HZT']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '6a544b39-8e2f-43af-812c-25f804093603',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210901',\n",
       "  'product_id': '71335-2122_6a544b39-8e2f-43af-812c-25f804093603',\n",
       "  'application_number': 'ANDA208412',\n",
       "  'brand_name_base': 'prednisone',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '71335-2126',\n",
       "  'generic_name': 'Oxycodone Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Oxycodone Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'OXYCODONE HYDROCHLORIDE',\n",
       "    'strength': '30 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2126-1',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-2126-1)',\n",
       "    'marketing_start_date': '20220718',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2126-2',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2126-2)',\n",
       "    'marketing_start_date': '20220718',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2126-3',\n",
       "    'description': '120 TABLET in 1 BOTTLE (71335-2126-3)',\n",
       "    'marketing_start_date': '20220718',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2126-4',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2126-4)',\n",
       "    'marketing_start_date': '20220718',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2126-5',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71335-2126-5)',\n",
       "    'marketing_start_date': '20220718',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2126-6',\n",
       "    'description': '40 TABLET in 1 BOTTLE (71335-2126-6)',\n",
       "    'marketing_start_date': '20220718',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2126-7',\n",
       "    'description': '18 TABLET in 1 BOTTLE (71335-2126-7)',\n",
       "    'marketing_start_date': '20220718',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2126-8',\n",
       "    'description': '28 TABLET in 1 BOTTLE (71335-2126-8)',\n",
       "    'marketing_start_date': '20220718',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1049618'],\n",
       "   'spl_set_id': ['27124cdf-a3e8-474c-9c1e-6fa48f6ddc05'],\n",
       "   'unii': ['C1ENJ2TE6C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '1aa823c3-7615-481c-ae22-3432032ed3ee',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170808',\n",
       "  'product_id': '71335-2126_1aa823c3-7615-481c-ae22-3432032ed3ee',\n",
       "  'application_number': 'ANDA207418',\n",
       "  'brand_name_base': 'Oxycodone Hydrochloride',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '71335-2132',\n",
       "  'generic_name': 'nifedipine',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Nifedipine',\n",
       "  'active_ingredients': [{'name': 'NIFEDIPINE', 'strength': '90 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2132-1',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2132-1)',\n",
       "    'marketing_start_date': '20220727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2132-2',\n",
       "    'description': '60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2132-2)',\n",
       "    'marketing_start_date': '20220727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2132-3',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2132-3)',\n",
       "    'marketing_start_date': '20220727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2132-4',\n",
       "    'description': '180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2132-4)',\n",
       "    'marketing_start_date': '20220727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2132-5',\n",
       "    'description': '100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2132-5)',\n",
       "    'marketing_start_date': '20220727',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1812015'],\n",
       "   'spl_set_id': ['71a4e00b-8386-4da1-8515-a0e7e8db104d'],\n",
       "   'nui': ['N0000000069', 'N0000175421', 'M0006414'],\n",
       "   'pharm_class_moa': ['Calcium Channel Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Dihydropyridine Calcium Channel Blocker [EPC]'],\n",
       "   'pharm_class_cs': ['Dihydropyridines [CS]'],\n",
       "   'unii': ['I9ZF7L6G2L']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '5cb5ba49-d959-4e98-8c12-efff26869287',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190312',\n",
       "  'product_id': '71335-2132_5cb5ba49-d959-4e98-8c12-efff26869287',\n",
       "  'application_number': 'ANDA210614',\n",
       "  'brand_name_base': 'Nifedipine',\n",
       "  'pharm_class': ['Calcium Channel Antagonists [MoA]',\n",
       "   'Dihydropyridine Calcium Channel Blocker [EPC]',\n",
       "   'Dihydropyridines [CS]']},\n",
       " {'product_ndc': '71335-2135',\n",
       "  'generic_name': 'Phendimetrazine Tartrate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CIII',\n",
       "  'brand_name': 'Phendimetrazine Tartrate',\n",
       "  'active_ingredients': [{'name': 'PHENDIMETRAZINE TARTRATE',\n",
       "    'strength': '35 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2135-0',\n",
       "    'description': '120 TABLET in 1 BOTTLE (71335-2135-0)',\n",
       "    'marketing_start_date': '20220802',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2135-1',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2135-1)',\n",
       "    'marketing_start_date': '20220802',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2135-2',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2135-2)',\n",
       "    'marketing_start_date': '20220802',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2135-3',\n",
       "    'description': '15 TABLET in 1 BOTTLE (71335-2135-3)',\n",
       "    'marketing_start_date': '20220802',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2135-4',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-2135-4)',\n",
       "    'marketing_start_date': '20220802',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2135-5',\n",
       "    'description': '7 TABLET in 1 BOTTLE (71335-2135-5)',\n",
       "    'marketing_start_date': '20220802',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2135-6',\n",
       "    'description': '21 TABLET in 1 BOTTLE (71335-2135-6)',\n",
       "    'marketing_start_date': '20220802',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2135-7',\n",
       "    'description': '42 TABLET in 1 BOTTLE (71335-2135-7)',\n",
       "    'marketing_start_date': '20220802',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2135-8',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71335-2135-8)',\n",
       "    'marketing_start_date': '20220802',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2135-9',\n",
       "    'description': '28 TABLET in 1 BOTTLE (71335-2135-9)',\n",
       "    'marketing_start_date': '20220802',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['979549'],\n",
       "   'spl_set_id': ['2a6b6fd3-4c92-4dad-a7bb-d6078dbe0f7f'],\n",
       "   'unii': ['6985IP0T80']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'c0dc9359-2790-4457-bb4d-e4eefc9d00dc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20100915',\n",
       "  'product_id': '71335-2135_c0dc9359-2790-4457-bb4d-e4eefc9d00dc',\n",
       "  'application_number': 'ANDA091042',\n",
       "  'brand_name_base': 'Phendimetrazine Tartrate',\n",
       "  'pharm_class': ['Appetite Suppression [PE]',\n",
       "   'Increased Sympathetic Activity [PE]',\n",
       "   'Sympathomimetic Amine Anorectic [EPC]']},\n",
       " {'product_ndc': '71335-2141',\n",
       "  'generic_name': 'Tetracycline Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Tetracycline Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'TETRACYCLINE HYDROCHLORIDE',\n",
       "    'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2141-1',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2141-2',\n",
       "    'description': '40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2141-3',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3)',\n",
       "    'marketing_start_date': '20220729',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2141-4',\n",
       "    'description': '56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2141-5',\n",
       "    'description': '28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2141-6',\n",
       "    'description': '20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2141-7',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2141-8',\n",
       "    'description': '45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198252'],\n",
       "   'spl_set_id': ['2c9208db-5f4f-4382-854f-6786b1e458db'],\n",
       "   'unii': ['P6R62377KV']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'dbd18052-a245-4b01-8654-0505c06cfb26',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190118',\n",
       "  'product_id': '71335-2141_dbd18052-a245-4b01-8654-0505c06cfb26',\n",
       "  'application_number': 'ANDA210662',\n",
       "  'brand_name_base': 'Tetracycline Hydrochloride',\n",
       "  'pharm_class': ['Tetracycline-class Antimicrobial [EPC]',\n",
       "   'Tetracyclines [CS]']},\n",
       " {'product_ndc': '71335-2146',\n",
       "  'generic_name': 'Alfuzosin Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Alfuzosin Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'ALFUZOSIN HYDROCHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2146-1',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2146-1)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2146-2',\n",
       "    'description': '60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2146-2)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2146-3',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2146-3)',\n",
       "    'marketing_start_date': '20230130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2146-4',\n",
       "    'description': '120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2146-4)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2146-5',\n",
       "    'description': '100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2146-5)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['861132'],\n",
       "   'spl_set_id': ['98fa10c2-7c12-44aa-9112-e2fd6fa71d06'],\n",
       "   'unii': ['75046A1XTN']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '20858b72-0778-46d6-be98-37d913c425b0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20111122',\n",
       "  'product_id': '71335-2146_20858b72-0778-46d6-be98-37d913c425b0',\n",
       "  'application_number': 'ANDA079057',\n",
       "  'brand_name_base': 'Alfuzosin Hydrochloride',\n",
       "  'pharm_class': ['Adrenergic alpha-Antagonists [MoA]',\n",
       "   'alpha-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '71335-2151',\n",
       "  'generic_name': 'Valsartan',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Valsartan',\n",
       "  'active_ingredients': [{'name': 'VALSARTAN', 'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2151-1',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71335-2151-1)',\n",
       "    'marketing_start_date': '20220822',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2151-2',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71335-2151-2)',\n",
       "    'marketing_start_date': '20220822',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['349483'],\n",
       "   'spl_set_id': ['b3880f58-ce15-4701-84aa-8eb185cf43e2'],\n",
       "   'nui': ['N0000000070', 'N0000175561'],\n",
       "   'pharm_class_moa': ['Angiotensin 2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Angiotensin 2 Receptor Blocker [EPC]'],\n",
       "   'unii': ['80M03YXJ7I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'c42a9457-c2f1-4b0b-a954-f67f2ccd1032',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210623',\n",
       "  'product_id': '71335-2151_c42a9457-c2f1-4b0b-a954-f67f2ccd1032',\n",
       "  'application_number': 'ANDA203311',\n",
       "  'brand_name_base': 'Valsartan',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]']},\n",
       " {'product_ndc': '71335-2162',\n",
       "  'generic_name': 'Atomoxetine',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Atomoxetine',\n",
       "  'active_ingredients': [{'name': 'ATOMOXETINE HYDROCHLORIDE',\n",
       "    'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2162-1',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71335-2162-1)',\n",
       "    'marketing_start_date': '20220907',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['349594'],\n",
       "   'spl_set_id': ['d4fe9217-1853-4f8b-9a93-77e511554ca1'],\n",
       "   'unii': ['57WVB6I2W0']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'ba0c6820-c922-4431-a10b-5f5a75e0603f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170530',\n",
       "  'product_id': '71335-2162_ba0c6820-c922-4431-a10b-5f5a75e0603f',\n",
       "  'application_number': 'ANDA079016',\n",
       "  'brand_name_base': 'Atomoxetine',\n",
       "  'pharm_class': ['Norepinephrine Reuptake Inhibitor [EPC]',\n",
       "   'Norepinephrine Uptake Inhibitors [MoA]']},\n",
       " {'product_ndc': '71335-2165',\n",
       "  'generic_name': 'fexofenadine hcl',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'fexofenadine hcl',\n",
       "  'active_ingredients': [{'name': 'FEXOFENADINE HYDROCHLORIDE',\n",
       "    'strength': '60 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2165-1',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71335-2165-1)',\n",
       "    'marketing_start_date': '20220829',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2165-2',\n",
       "    'description': '10 TABLET, FILM COATED in 1 BOTTLE (71335-2165-2)',\n",
       "    'marketing_start_date': '20220829',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2165-3',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71335-2165-3)',\n",
       "    'marketing_start_date': '20220829',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2165-4',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71335-2165-4)',\n",
       "    'marketing_start_date': '20220829',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2165-5',\n",
       "    'description': '14 TABLET, FILM COATED in 1 BOTTLE (71335-2165-5)',\n",
       "    'marketing_start_date': '20220829',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2165-6',\n",
       "    'description': '20 TABLET, FILM COATED in 1 BOTTLE (71335-2165-6)',\n",
       "    'marketing_start_date': '20220829',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'a96608c4-5ec4-4d19-8401-f3d0b36282a2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210826',\n",
       "  'product_id': '71335-2165_a96608c4-5ec4-4d19-8401-f3d0b36282a2',\n",
       "  'application_number': 'ANDA204507',\n",
       "  'brand_name_base': 'fexofenadine hcl',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '71335-2168',\n",
       "  'generic_name': 'Irbesartan',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Irbesartan',\n",
       "  'active_ingredients': [{'name': 'IRBESARTAN', 'strength': '150 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2168-1',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2168-1)',\n",
       "    'marketing_start_date': '20220906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2168-2',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-2168-2)',\n",
       "    'marketing_start_date': '20220906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2168-3',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2168-3)',\n",
       "    'marketing_start_date': '20220906',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['200095'],\n",
       "   'spl_set_id': ['1ab1ff46-d0b1-4762-9ebf-3e07dde8b048'],\n",
       "   'nui': ['N0000000070', 'N0000175561'],\n",
       "   'pharm_class_moa': ['Angiotensin 2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Angiotensin 2 Receptor Blocker [EPC]'],\n",
       "   'unii': ['J0E2756Z7N']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'f8e0d3a4-3293-4db6-861a-238dd17c9d45',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20160613',\n",
       "  'product_id': '71335-2168_f8e0d3a4-3293-4db6-861a-238dd17c9d45',\n",
       "  'application_number': 'ANDA203071',\n",
       "  'brand_name_base': 'Irbesartan',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]']},\n",
       " {'product_ndc': '71335-2172',\n",
       "  'generic_name': 'Flecainide Acetate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Flecainide Acetate',\n",
       "  'active_ingredients': [{'name': 'FLECAINIDE ACETATE',\n",
       "    'strength': '150 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2172-1',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2172-1)',\n",
       "    'marketing_start_date': '20221003',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2172-2',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2172-2)',\n",
       "    'marketing_start_date': '20221003',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2172-3',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-2172-3)',\n",
       "    'marketing_start_date': '20221003',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2172-4',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71335-2172-4)',\n",
       "    'marketing_start_date': '20221003',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['886671'],\n",
       "   'spl_set_id': ['6b73e32f-851b-4503-8296-e5db3a584b75'],\n",
       "   'unii': ['M8U465Q1WQ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'd2b04520-2e5c-4986-949a-7ec3919022d2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20150708',\n",
       "  'product_id': '71335-2172_d2b04520-2e5c-4986-949a-7ec3919022d2',\n",
       "  'application_number': 'ANDA202821',\n",
       "  'brand_name_base': 'Flecainide Acetate',\n",
       "  'pharm_class': ['Antiarrhythmic [EPC]']},\n",
       " {'product_ndc': '71335-2173',\n",
       "  'generic_name': 'Telmisartan',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Telmisartan',\n",
       "  'active_ingredients': [{'name': 'TELMISARTAN', 'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2173-1',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2173-1)',\n",
       "    'marketing_start_date': '20221010',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2173-2',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2173-2)',\n",
       "    'marketing_start_date': '20221010',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['205304'],\n",
       "   'spl_set_id': ['a5ded796-3555-4476-8b37-0cdc88d7594a'],\n",
       "   'nui': ['N0000000070', 'N0000175561'],\n",
       "   'pharm_class_moa': ['Angiotensin 2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Angiotensin 2 Receptor Blocker [EPC]'],\n",
       "   'unii': ['U5SYW473RQ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'dd8babb8-8394-4d19-acde-91af5e661fc0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170820',\n",
       "  'product_id': '71335-2173_dd8babb8-8394-4d19-acde-91af5e661fc0',\n",
       "  'application_number': 'ANDA207882',\n",
       "  'brand_name_base': 'Telmisartan',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]']},\n",
       " {'product_ndc': '71335-2207',\n",
       "  'generic_name': 'SPIRONOLACTONE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'SPIRONOLACTONE',\n",
       "  'active_ingredients': [{'name': 'SPIRONOLACTONE', 'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2207-1',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71335-2207-1)',\n",
       "    'marketing_start_date': '20230804',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198223'],\n",
       "   'spl_set_id': ['813d199a-9004-4102-8ade-cf877caedafb'],\n",
       "   'nui': ['N0000175557', 'N0000011310'],\n",
       "   'pharm_class_epc': ['Aldosterone Antagonist [EPC]'],\n",
       "   'pharm_class_moa': ['Aldosterone Antagonists [MoA]'],\n",
       "   'unii': ['27O7W4T232']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '1bac88dc-588e-4051-b1d5-516ac21ae839',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19860723',\n",
       "  'product_id': '71335-2207_1bac88dc-588e-4051-b1d5-516ac21ae839',\n",
       "  'application_number': 'ANDA089424',\n",
       "  'brand_name_base': 'SPIRONOLACTONE',\n",
       "  'pharm_class': ['Aldosterone Antagonist [EPC]',\n",
       "   'Aldosterone Antagonists [MoA]']},\n",
       " {'product_ndc': '71335-2208',\n",
       "  'generic_name': 'Tizanidne Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Tizanidne hydrochloride',\n",
       "  'active_ingredients': [{'name': 'TIZANIDINE HYDROCHLORIDE',\n",
       "    'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2208-1',\n",
       "    'description': '150 CAPSULE in 1 BOTTLE (71335-2208-1)',\n",
       "    'marketing_start_date': '20230804',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['485486'],\n",
       "   'spl_set_id': ['226b506f-6f85-48e8-b8e5-86442d74d951'],\n",
       "   'unii': ['B53E3NMY5C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '48236fde-4fc5-4d1c-8120-e34e873c0069',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190329',\n",
       "  'product_id': '71335-2208_48236fde-4fc5-4d1c-8120-e34e873c0069',\n",
       "  'application_number': 'ANDA212196',\n",
       "  'brand_name_base': 'Tizanidne hydrochloride',\n",
       "  'pharm_class': ['Adrenergic alpha2-Agonists [MoA]',\n",
       "   'Central alpha-2 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '71335-2225',\n",
       "  'generic_name': 'Atorvastatin Calcium',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Atorvastatin Calcium',\n",
       "  'active_ingredients': [{'name': 'ATORVASTATIN CALCIUM TRIHYDRATE',\n",
       "    'strength': '80 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2225-1',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2225-1)',\n",
       "    'marketing_start_date': '20231009',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2225-2',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-2225-2)',\n",
       "    'marketing_start_date': '20240716',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2225-3',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2225-3)',\n",
       "    'marketing_start_date': '20230929',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2225-4',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71335-2225-4)',\n",
       "    'marketing_start_date': '20240716',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['259255'],\n",
       "   'spl_set_id': ['9c435528-4c44-44c6-bb10-049a72533c2f'],\n",
       "   'unii': ['48A5M73Z4Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '98a82149-92c6-4667-94e4-63487201823a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220829',\n",
       "  'product_id': '71335-2225_98a82149-92c6-4667-94e4-63487201823a',\n",
       "  'application_number': 'ANDA214659',\n",
       "  'brand_name_base': 'Atorvastatin Calcium',\n",
       "  'pharm_class': ['HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71335-2231',\n",
       "  'generic_name': 'Phenazopyridine Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Phenazopyridine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PHENAZOPYRIDINE HYDROCHLORIDE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2231-1',\n",
       "    'description': '20 TABLET in 1 BOTTLE (71335-2231-1)',\n",
       "    'marketing_start_date': '20230828',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2231-2',\n",
       "    'description': '12 TABLET in 1 BOTTLE (71335-2231-2)',\n",
       "    'marketing_start_date': '20230828',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2231-3',\n",
       "    'description': '9 TABLET in 1 BOTTLE (71335-2231-3)',\n",
       "    'marketing_start_date': '20230828',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2231-4',\n",
       "    'description': '10 TABLET in 1 BOTTLE (71335-2231-4)',\n",
       "    'marketing_start_date': '20230828',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2231-5',\n",
       "    'description': '15 TABLET in 1 BOTTLE (71335-2231-5)',\n",
       "    'marketing_start_date': '20230828',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2231-6',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71335-2231-6)',\n",
       "    'marketing_start_date': '20230828',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2231-7',\n",
       "    'description': '6 TABLET in 1 BOTTLE (71335-2231-7)',\n",
       "    'marketing_start_date': '20230828',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2231-8',\n",
       "    'description': '21 TABLET in 1 BOTTLE (71335-2231-8)',\n",
       "    'marketing_start_date': '20230828',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2231-9',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2231-9)',\n",
       "    'marketing_start_date': '20230828',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1094107'],\n",
       "   'spl_set_id': ['9acd0528-822c-49a7-9c86-fa13b60ef030'],\n",
       "   'unii': ['0EWG668W17']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '0017b1e3-75e7-4d07-bc93-fabfc1d06aef',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230508',\n",
       "  'product_id': '71335-2231_0017b1e3-75e7-4d07-bc93-fabfc1d06aef',\n",
       "  'brand_name_base': 'Phenazopyridine Hydrochloride'},\n",
       " {'product_ndc': '71335-2234',\n",
       "  'generic_name': 'Phenazopyridine Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Phenazopyridine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PHENAZOPYRIDINE HYDROCHLORIDE',\n",
       "    'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2234-1',\n",
       "    'description': '9 TABLET in 1 BOTTLE (71335-2234-1)',\n",
       "    'marketing_start_date': '20230907',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2234-2',\n",
       "    'description': '20 TABLET in 1 BOTTLE (71335-2234-2)',\n",
       "    'marketing_start_date': '20230907',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2234-3',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2234-3)',\n",
       "    'marketing_start_date': '20230907',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2234-4',\n",
       "    'description': '10 TABLET in 1 BOTTLE (71335-2234-4)',\n",
       "    'marketing_start_date': '20230907',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2234-5',\n",
       "    'description': '15 TABLET in 1 BOTTLE (71335-2234-5)',\n",
       "    'marketing_start_date': '20230907',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2234-6',\n",
       "    'description': '6 TABLET in 1 BOTTLE (71335-2234-6)',\n",
       "    'marketing_start_date': '20230907',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2234-7',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2234-7)',\n",
       "    'marketing_start_date': '20230907',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2234-8',\n",
       "    'description': '12 TABLET in 1 BOTTLE (71335-2234-8)',\n",
       "    'marketing_start_date': '20230907',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2234-9',\n",
       "    'description': '18 TABLET in 1 BOTTLE (71335-2234-9)',\n",
       "    'marketing_start_date': '20230907',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1094104'],\n",
       "   'spl_set_id': ['44b37241-e984-40f6-8775-f822e1c77ad3'],\n",
       "   'unii': ['0EWG668W17']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'b1096355-2ea6-4116-889d-2c755a4484b8',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230508',\n",
       "  'product_id': '71335-2234_b1096355-2ea6-4116-889d-2c755a4484b8',\n",
       "  'brand_name_base': 'Phenazopyridine Hydrochloride'},\n",
       " {'product_ndc': '71335-2269',\n",
       "  'generic_name': 'Chlorthalidone',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'CHLORTHALIDONE',\n",
       "  'active_ingredients': [{'name': 'CHLORTHALIDONE', 'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2269-1',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2269-1)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2269-2',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2269-2)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2269-3',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-2269-3)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2269-4',\n",
       "    'description': '8 TABLET in 1 BOTTLE (71335-2269-4)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2269-5',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71335-2269-5)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197499'],\n",
       "   'spl_set_id': ['1ba595d4-b105-4d52-90dd-0fb8bda1fe1b'],\n",
       "   'nui': ['N0000175359', 'N0000175420'],\n",
       "   'pharm_class_pe': ['Increased Diuresis [PE]'],\n",
       "   'pharm_class_epc': ['Thiazide-like Diuretic [EPC]'],\n",
       "   'unii': ['Q0MQD1073Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '8887b3a4-0310-4537-8427-1cc963160c15',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210331',\n",
       "  'product_id': '71335-2269_8887b3a4-0310-4537-8427-1cc963160c15',\n",
       "  'application_number': 'ANDA211320',\n",
       "  'brand_name_base': 'CHLORTHALIDONE',\n",
       "  'pharm_class': ['Increased Diuresis [PE]', 'Thiazide-like Diuretic [EPC]']},\n",
       " {'product_ndc': '71335-2288',\n",
       "  'generic_name': 'levothyroxine sodium',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'levothyroxine sodium',\n",
       "  'active_ingredients': [{'name': 'LEVOTHYROXINE SODIUM',\n",
       "    'strength': '50 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2288-1',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (71335-2288-1)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['966221'],\n",
       "   'spl_set_id': ['c1b0fbad-5816-4152-ab59-05079e8c2148'],\n",
       "   'unii': ['9J765S329G']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'a52127dc-e9a5-4599-a3e0-fdf89f7a3d73',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190507',\n",
       "  'product_id': '71335-2288_a52127dc-e9a5-4599-a3e0-fdf89f7a3d73',\n",
       "  'application_number': 'NDA021116',\n",
       "  'brand_name_base': 'levothyroxine sodium',\n",
       "  'pharm_class': ['Thyroxine [CS]', 'l-Thyroxine [EPC]']},\n",
       " {'product_ndc': '71335-2296',\n",
       "  'generic_name': 'phentermine hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Phentermine hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PHENTERMINE HYDROCHLORIDE',\n",
       "    'strength': '37.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2296-1',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (71335-2296-1)',\n",
       "    'marketing_start_date': '20231201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['803348'],\n",
       "   'spl_set_id': ['70f68311-8d1f-4b8e-b8a7-13bc4c17727e'],\n",
       "   'unii': ['0K2I505OTV']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'deaf90cf-41e5-4173-9914-b564152077be',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170124',\n",
       "  'product_id': '71335-2296_deaf90cf-41e5-4173-9914-b564152077be',\n",
       "  'application_number': 'ANDA205017',\n",
       "  'brand_name_base': 'Phentermine hydrochloride',\n",
       "  'pharm_class': ['Appetite Suppression [PE]',\n",
       "   'Increased Sympathetic Activity [PE]',\n",
       "   'Sympathomimetic Amine Anorectic [EPC]']},\n",
       " {'product_ndc': '71335-2315',\n",
       "  'generic_name': 'propranolol hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'propranolol hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PROPRANOLOL HYDROCHLORIDE',\n",
       "    'strength': '80 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2315-1',\n",
       "    'description': '100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-2315-1)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['856569'],\n",
       "   'spl_set_id': ['4803b5bf-8ca4-4a8b-bd24-1f3ff7d93d7e'],\n",
       "   'unii': ['F8A3652H1V']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, EXTENDED RELEASE',\n",
       "  'spl_id': 'de221ce6-f5cb-4690-acfb-6311364a6638',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20130311',\n",
       "  'product_id': '71335-2315_de221ce6-f5cb-4690-acfb-6311364a6638',\n",
       "  'application_number': 'ANDA078703',\n",
       "  'brand_name_base': 'propranolol hydrochloride',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '71335-2340',\n",
       "  'generic_name': 'Hydroxyzine hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Hydroxyzine hydrochloride',\n",
       "  'active_ingredients': [{'name': 'HYDROXYZINE DIHYDROCHLORIDE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2340-1',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2340-1)',\n",
       "    'marketing_start_date': '20240502',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2340-2',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-2340-2)',\n",
       "    'marketing_start_date': '20240502',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2340-3',\n",
       "    'description': '20 TABLET in 1 BOTTLE (71335-2340-3)',\n",
       "    'marketing_start_date': '20240502',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2340-4',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71335-2340-4)',\n",
       "    'marketing_start_date': '20240502',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2340-5',\n",
       "    'description': '15 TABLET in 1 BOTTLE (71335-2340-5)',\n",
       "    'marketing_start_date': '20240502',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2340-6',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2340-6)',\n",
       "    'marketing_start_date': '20240502',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2340-7',\n",
       "    'description': '19 TABLET in 1 BOTTLE (71335-2340-7)',\n",
       "    'marketing_start_date': '20240502',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2340-8',\n",
       "    'description': '10 TABLET in 1 BOTTLE (71335-2340-8)',\n",
       "    'marketing_start_date': '20240502',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['995258'],\n",
       "   'spl_set_id': ['e4c60e14-28c7-46e2-9fdc-b1a1ce54f3c2'],\n",
       "   'unii': ['76755771U3']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'd75eb8b5-5460-415b-8f71-55c10f3bb7b0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20140820',\n",
       "  'product_id': '71335-2340_d75eb8b5-5460-415b-8f71-55c10f3bb7b0',\n",
       "  'application_number': 'ANDA204279',\n",
       "  'brand_name_base': 'Hydroxyzine hydrochloride',\n",
       "  'pharm_class': ['Antihistamine [EPC]',\n",
       "   'Histamine Receptor Antagonists [MoA]']},\n",
       " {'product_ndc': '71335-2363',\n",
       "  'generic_name': 'tadalafil',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'TADALAFIL',\n",
       "  'active_ingredients': [{'name': 'TADALAFIL', 'strength': '2.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2363-1',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2363-1)',\n",
       "    'marketing_start_date': '20240430',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2363-2',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2363-2)',\n",
       "    'marketing_start_date': '20240430',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2363-3',\n",
       "    'description': '10 TABLET in 1 BOTTLE (71335-2363-3)',\n",
       "    'marketing_start_date': '20240430',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2363-4',\n",
       "    'description': '20 TABLET in 1 BOTTLE (71335-2363-4)',\n",
       "    'marketing_start_date': '20240430',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['757707'],\n",
       "   'spl_set_id': ['b3a58c17-f260-4125-abd1-27da00bb0719'],\n",
       "   'nui': ['N0000175599', 'N0000020026'],\n",
       "   'pharm_class_epc': ['Phosphodiesterase 5 Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Phosphodiesterase 5 Inhibitors [MoA]'],\n",
       "   'unii': ['742SXX0ICT']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '6f71e600-ca1c-4d61-9e9f-859eef56f665',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220118',\n",
       "  'product_id': '71335-2363_6f71e600-ca1c-4d61-9e9f-859eef56f665',\n",
       "  'application_number': 'ANDA210609',\n",
       "  'brand_name_base': 'TADALAFIL',\n",
       "  'pharm_class': ['Phosphodiesterase 5 Inhibitor [EPC]',\n",
       "   'Phosphodiesterase 5 Inhibitors [MoA]']},\n",
       " {'product_ndc': '71335-2373',\n",
       "  'generic_name': 'Diltiazem hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Diltiazem Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'DILTIAZEM HYDROCHLORIDE',\n",
       "    'strength': '30 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2373-1',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2373-1)',\n",
       "    'marketing_start_date': '20240523',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['833217'],\n",
       "   'spl_set_id': ['76e04232-b3da-48e8-a944-5f4f97a508df'],\n",
       "   'unii': ['OLH94387TE']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'ce93c85d-fd72-4fb7-94ee-9338518e1f45',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220926',\n",
       "  'product_id': '71335-2373_ce93c85d-fd72-4fb7-94ee-9338518e1f45',\n",
       "  'application_number': 'ANDA216521',\n",
       "  'brand_name_base': 'Diltiazem Hydrochloride',\n",
       "  'pharm_class': ['Calcium Channel Antagonists [MoA]',\n",
       "   'Calcium Channel Blocker [EPC]',\n",
       "   'Cytochrome P450 3A4 Inhibitors [MoA]']},\n",
       " {'product_ndc': '71335-2376',\n",
       "  'generic_name': 'Olmesartan Medoxomil',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Olmesartan Medoxomil',\n",
       "  'active_ingredients': [{'name': 'OLMESARTAN MEDOXOMIL',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2376-1',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71335-2376-1)',\n",
       "    'marketing_start_date': '20240523',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['349373'],\n",
       "   'spl_set_id': ['57dc737b-01e2-4b22-991f-d4710950dcf3'],\n",
       "   'unii': ['6M97XTV3HD']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '90e7b0d8-5a1e-4ba2-8313-39ba6381ab7c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170525',\n",
       "  'product_id': '71335-2376_90e7b0d8-5a1e-4ba2-8313-39ba6381ab7c',\n",
       "  'application_number': 'ANDA203281',\n",
       "  'brand_name_base': 'Olmesartan Medoxomil',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]']},\n",
       " {'product_ndc': '71335-2377',\n",
       "  'generic_name': 'Nitrofurantoin (monohydrate/macrocrystals)',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Nitrofurantoin (monohydrate/macrocrystals)',\n",
       "  'active_ingredients': [{'name': 'NITROFURANTOIN', 'strength': '25 mg/1'},\n",
       "   {'name': 'NITROFURANTOIN MONOHYDRATE', 'strength': '75 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2377-0',\n",
       "    'description': '6 CAPSULE in 1 BOTTLE (71335-2377-0)',\n",
       "    'marketing_start_date': '20240529',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2377-1',\n",
       "    'description': '20 CAPSULE in 1 BOTTLE (71335-2377-1)',\n",
       "    'marketing_start_date': '20240529',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2377-2',\n",
       "    'description': '14 CAPSULE in 1 BOTTLE (71335-2377-2)',\n",
       "    'marketing_start_date': '20240529',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2377-3',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71335-2377-3)',\n",
       "    'marketing_start_date': '20240529',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2377-4',\n",
       "    'description': '28 CAPSULE in 1 BOTTLE (71335-2377-4)',\n",
       "    'marketing_start_date': '20240529',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2377-5',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71335-2377-5)',\n",
       "    'marketing_start_date': '20240529',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2377-6',\n",
       "    'description': '10 CAPSULE in 1 BOTTLE (71335-2377-6)',\n",
       "    'marketing_start_date': '20240529',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2377-7',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (71335-2377-7)',\n",
       "    'marketing_start_date': '20240529',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2377-8',\n",
       "    'description': '21 CAPSULE in 1 BOTTLE (71335-2377-8)',\n",
       "    'marketing_start_date': '20240529',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2377-9',\n",
       "    'description': '8 CAPSULE in 1 BOTTLE (71335-2377-9)',\n",
       "    'marketing_start_date': '20240529',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1648755'],\n",
       "   'spl_set_id': ['63a4b367-bf4b-4b5f-b3e9-394ba307886d'],\n",
       "   'nui': ['N0000175494', 'M0014892'],\n",
       "   'pharm_class_epc': ['Nitrofuran Antibacterial [EPC]'],\n",
       "   'pharm_class_cs': ['Nitrofurans [CS]'],\n",
       "   'unii': ['927AH8112L', 'E1QI2CQQ1I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '74eb23e7-d977-44bb-a79d-4ab088ef42aa',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230914',\n",
       "  'product_id': '71335-2377_74eb23e7-d977-44bb-a79d-4ab088ef42aa',\n",
       "  'application_number': 'ANDA217357',\n",
       "  'brand_name_base': 'Nitrofurantoin (monohydrate/macrocrystals)',\n",
       "  'pharm_class': ['Nitrofuran Antibacterial [EPC]',\n",
       "   'Nitrofuran Antibacterial [EPC]',\n",
       "   'Nitrofurans [CS]',\n",
       "   'Nitrofurans [CS]']},\n",
       " {'product_ndc': '71335-2379',\n",
       "  'generic_name': 'GUANFACINE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'GUANFACINE',\n",
       "  'active_ingredients': [{'name': 'GUANFACINE HYDROCHLORIDE',\n",
       "    'strength': '1 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2379-1',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2379-1)',\n",
       "    'marketing_start_date': '20240529',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['862006'],\n",
       "   'spl_set_id': ['7db29f50-df23-49b1-ad92-05c42fda4ccd'],\n",
       "   'unii': ['PML56A160O']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': 'd9782545-77a2-4b3b-b910-d6900c418e2d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230808',\n",
       "  'product_id': '71335-2379_d9782545-77a2-4b3b-b910-d6900c418e2d',\n",
       "  'application_number': 'ANDA217269',\n",
       "  'brand_name_base': 'GUANFACINE',\n",
       "  'pharm_class': ['Adrenergic alpha2-Agonists [MoA]',\n",
       "   'Central alpha-2 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '0517-4602',\n",
       "  'generic_name': 'Glycopyrrolate',\n",
       "  'labeler_name': 'American Regent, Inc.',\n",
       "  'brand_name': 'Glycopyrrolate',\n",
       "  'active_ingredients': [{'name': 'GLYCOPYRROLATE', 'strength': '.2 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0517-4602-25',\n",
       "    'description': '25 VIAL, SINGLE-DOSE in 1 TRAY (0517-4602-25)  / 2 mL in 1 VIAL, SINGLE-DOSE',\n",
       "    'marketing_start_date': '19900930',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['American Regent, Inc.'],\n",
       "   'rxcui': ['238212', '1731582', '1731590'],\n",
       "   'spl_set_id': ['62267afe-1a73-4623-984e-646db590ec5b'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305174601252', '0305174605250', '0305174602259', '0305174620253'],\n",
       "   'unii': ['V92SO9WP2I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'ad03d273-8f44-48f2-bc0e-4dd8dbf08507',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS'],\n",
       "  'marketing_start_date': '19900930',\n",
       "  'product_id': '0517-4602_ad03d273-8f44-48f2-bc0e-4dd8dbf08507',\n",
       "  'application_number': 'ANDA089335',\n",
       "  'brand_name_base': 'Glycopyrrolate',\n",
       "  'pharm_class': ['Anticholinergic [EPC]',\n",
       "   'Cholinergic Antagonists [MoA]',\n",
       "   'Cholinergic Muscarinic Antagonist [EPC]',\n",
       "   'Cholinergic Muscarinic Antagonists [MoA]']},\n",
       " {'product_ndc': '71335-2409',\n",
       "  'generic_name': 'Glimepiride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Glimepiride',\n",
       "  'active_ingredients': [{'name': 'GLIMEPIRIDE', 'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2409-1',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2409-1)',\n",
       "    'marketing_start_date': '20240611',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2409-2',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-2409-2)',\n",
       "    'marketing_start_date': '20240611',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2409-3',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2409-3)',\n",
       "    'marketing_start_date': '20240611',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2409-4',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71335-2409-4)',\n",
       "    'marketing_start_date': '20240611',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2409-5',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71335-2409-5)',\n",
       "    'marketing_start_date': '20240611',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['199247'],\n",
       "   'spl_set_id': ['0b12d4ab-fa0c-44d5-888c-265dbb661561'],\n",
       "   'nui': ['N0000175608', 'M0020795'],\n",
       "   'pharm_class_epc': ['Sulfonylurea [EPC]'],\n",
       "   'pharm_class_cs': ['Sulfonylurea Compounds [CS]'],\n",
       "   'unii': ['6KY687524K']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '5f8f3cde-9b59-4f0a-8363-2a645e3b904d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230731',\n",
       "  'product_id': '71335-2409_5f8f3cde-9b59-4f0a-8363-2a645e3b904d',\n",
       "  'application_number': 'ANDA202112',\n",
       "  'brand_name_base': 'Glimepiride',\n",
       "  'pharm_class': ['Sulfonylurea Compounds [CS]', 'Sulfonylurea [EPC]']},\n",
       " {'product_ndc': '71335-2416',\n",
       "  'generic_name': 'Allopurinol',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Allopurinol',\n",
       "  'active_ingredients': [{'name': 'ALLOPURINOL', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2416-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71335-2416-1)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2416-2',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2416-2)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2416-3',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-2416-3)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2416-4',\n",
       "    'description': '120 TABLET in 1 BOTTLE (71335-2416-4)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2416-5',\n",
       "    'description': '20 TABLET in 1 BOTTLE (71335-2416-5)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2416-6',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2416-6)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197319'],\n",
       "   'spl_set_id': ['b943dbb1-7f54-434c-9439-8ce768d94ff4'],\n",
       "   'nui': ['N0000175698', 'N0000000206'],\n",
       "   'pharm_class_epc': ['Xanthine Oxidase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Xanthine Oxidase Inhibitors [MoA]'],\n",
       "   'unii': ['63CZ7GJN5I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '4fa6aecc-c8db-4829-847c-ee4c4fb51197',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231031',\n",
       "  'product_id': '71335-2416_4fa6aecc-c8db-4829-847c-ee4c4fb51197',\n",
       "  'application_number': 'ANDA204467',\n",
       "  'brand_name_base': 'Allopurinol',\n",
       "  'pharm_class': ['Xanthine Oxidase Inhibitor [EPC]',\n",
       "   'Xanthine Oxidase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71335-2417',\n",
       "  'generic_name': 'doxycycline',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Doxycycline',\n",
       "  'active_ingredients': [{'name': 'DOXYCYCLINE', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2417-0',\n",
       "    'description': '2 CAPSULE in 1 BOTTLE (71335-2417-0)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2417-1',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71335-2417-1)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2417-2',\n",
       "    'description': '14 CAPSULE in 1 BOTTLE (71335-2417-2)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2417-3',\n",
       "    'description': '20 CAPSULE in 1 BOTTLE (71335-2417-3)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2417-4',\n",
       "    'description': '12 CAPSULE in 1 BOTTLE (71335-2417-4)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2417-5',\n",
       "    'description': '40 CAPSULE in 1 BOTTLE (71335-2417-5)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2417-6',\n",
       "    'description': '10 CAPSULE in 1 BOTTLE (71335-2417-6)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2417-7',\n",
       "    'description': '50 CAPSULE in 1 BOTTLE (71335-2417-7)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2417-8',\n",
       "    'description': '21 CAPSULE in 1 BOTTLE (71335-2417-8)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2417-9',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71335-2417-9)',\n",
       "    'marketing_start_date': '20241112',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1649990'],\n",
       "   'spl_set_id': ['04de98f3-33a2-48ba-85b5-9fac867524b7'],\n",
       "   'nui': ['N0000175882', 'N0000007948'],\n",
       "   'pharm_class_epc': ['Tetracycline-class Drug [EPC]'],\n",
       "   'pharm_class_cs': ['Tetracyclines [Chemical/Ingredient]'],\n",
       "   'unii': ['N12000U13O']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '90a89990-d767-4844-af36-275c3cec0d91',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220801',\n",
       "  'product_id': '71335-2417_90a89990-d767-4844-af36-275c3cec0d91',\n",
       "  'application_number': 'ANDA065055',\n",
       "  'brand_name_base': 'Doxycycline',\n",
       "  'pharm_class': ['Tetracycline-class Drug [EPC]', 'Tetracyclines [CS]']},\n",
       " {'product_ndc': '71335-2453',\n",
       "  'generic_name': 'CYPROHEPTADINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'CYPROHEPTADINE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'CYPROHEPTADINE HYDROCHLORIDE',\n",
       "    'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2453-1',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2453-1)',\n",
       "    'marketing_start_date': '20240820',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2453-2',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-2453-2)',\n",
       "    'marketing_start_date': '20240820',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2453-3',\n",
       "    'description': '28 TABLET in 1 BOTTLE (71335-2453-3)',\n",
       "    'marketing_start_date': '20240820',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2453-4',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71335-2453-4)',\n",
       "    'marketing_start_date': '20240820',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2453-5',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2453-5)',\n",
       "    'marketing_start_date': '20240820',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['866144'],\n",
       "   'spl_set_id': ['5d0db096-f35d-4065-bff1-2fd7ef5a1a6f'],\n",
       "   'unii': ['NJ82J0F8QC']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'eb9db456-0185-416b-a9c7-875b5694be5e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210224',\n",
       "  'product_id': '71335-2453_eb9db456-0185-416b-a9c7-875b5694be5e',\n",
       "  'application_number': 'ANDA212491',\n",
       "  'brand_name_base': 'CYPROHEPTADINE HYDROCHLORIDE'},\n",
       " {'product_ndc': '71335-2458',\n",
       "  'generic_name': 'Buspirone Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Buspirone Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'BUSPIRONE HYDROCHLORIDE',\n",
       "    'strength': '30 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2458-1',\n",
       "    'description': '60 TABLET in 1 BOTTLE, PLASTIC (71335-2458-1)',\n",
       "    'marketing_start_date': '20240820',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2458-2',\n",
       "    'description': '30 TABLET in 1 BOTTLE, PLASTIC (71335-2458-2)',\n",
       "    'marketing_start_date': '20240820',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2458-3',\n",
       "    'description': '56 TABLET in 1 BOTTLE, PLASTIC (71335-2458-3)',\n",
       "    'marketing_start_date': '20240820',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2458-4',\n",
       "    'description': '90 TABLET in 1 BOTTLE, PLASTIC (71335-2458-4)',\n",
       "    'marketing_start_date': '20240820',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2458-5',\n",
       "    'description': '180 TABLET in 1 BOTTLE, PLASTIC (71335-2458-5)',\n",
       "    'marketing_start_date': '20240820',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2458-6',\n",
       "    'description': '15 TABLET in 1 BOTTLE, PLASTIC (71335-2458-6)',\n",
       "    'marketing_start_date': '20240820',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2458-7',\n",
       "    'description': '120 TABLET in 1 BOTTLE, PLASTIC (71335-2458-7)',\n",
       "    'marketing_start_date': '20240820',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['866090'],\n",
       "   'spl_set_id': ['38faa7cb-d858-4481-8649-35d228acbd38'],\n",
       "   'unii': ['207LT9J9OC']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '1fb03366-6bc1-49fa-80f4-f2afeaac9d01',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231017',\n",
       "  'product_id': '71335-2458_1fb03366-6bc1-49fa-80f4-f2afeaac9d01',\n",
       "  'application_number': 'ANDA210907',\n",
       "  'brand_name_base': 'Buspirone Hydrochloride'},\n",
       " {'product_ndc': '71335-2464',\n",
       "  'generic_name': 'Digoxin',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Digoxin',\n",
       "  'active_ingredients': [{'name': 'DIGOXIN', 'strength': '250 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2464-1',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (71335-2464-1)',\n",
       "    'marketing_start_date': '20240904',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2464-2',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71335-2464-2)',\n",
       "    'marketing_start_date': '20240904',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197606'],\n",
       "   'spl_set_id': ['03612934-62f4-4002-85af-6c66cd172acb'],\n",
       "   'nui': ['N0000175568', 'M0003451'],\n",
       "   'pharm_class_epc': ['Cardiac Glycoside [EPC]'],\n",
       "   'pharm_class_cs': ['Cardiac Glycosides [CS]'],\n",
       "   'unii': ['73K4184T59']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '20347bf0-6858-4d38-b1f6-8ec210d2bb1a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220901',\n",
       "  'product_id': '71335-2464_20347bf0-6858-4d38-b1f6-8ec210d2bb1a',\n",
       "  'application_number': 'ANDA076268',\n",
       "  'brand_name_base': 'Digoxin',\n",
       "  'pharm_class': ['Cardiac Glycoside [EPC]', 'Cardiac Glycosides [CS]']},\n",
       " {'product_ndc': '71335-2478',\n",
       "  'generic_name': 'Gabapentin',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Gabapentin',\n",
       "  'active_ingredients': [{'name': 'GABAPENTIN', 'strength': '400 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2478-0',\n",
       "    'description': '180 CAPSULE in 1 BOTTLE (71335-2478-0)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2478-1',\n",
       "    'description': '20 CAPSULE in 1 BOTTLE (71335-2478-1)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2478-2',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (71335-2478-2)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2478-3',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71335-2478-3)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2478-4',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71335-2478-4)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2478-5',\n",
       "    'description': '120 CAPSULE in 1 BOTTLE (71335-2478-5)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2478-6',\n",
       "    'description': '21 CAPSULE in 1 BOTTLE (71335-2478-6)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2478-7',\n",
       "    'description': '84 CAPSULE in 1 BOTTLE (71335-2478-7)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2478-8',\n",
       "    'description': '112 CAPSULE in 1 BOTTLE (71335-2478-8)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2478-9',\n",
       "    'description': '28 CAPSULE in 1 BOTTLE (71335-2478-9)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['310432'],\n",
       "   'spl_set_id': ['2dad630a-09d8-4f40-bdad-24e877a9ee38'],\n",
       "   'nui': ['N0000008486'],\n",
       "   'pharm_class_pe': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]'],\n",
       "   'unii': ['6CW7F3G59X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '2973d72c-9629-418f-8443-47ca3a54d352',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210503',\n",
       "  'product_id': '71335-2478_2973d72c-9629-418f-8443-47ca3a54d352',\n",
       "  'application_number': 'ANDA213603',\n",
       "  'brand_name_base': 'Gabapentin',\n",
       "  'pharm_class': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]']},\n",
       " {'product_ndc': '71335-2497',\n",
       "  'generic_name': 'BACLOFEN',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'BACLOFEN',\n",
       "  'active_ingredients': [{'name': 'BACLOFEN', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2497-0',\n",
       "    'description': '120 TABLET in 1 BOTTLE (71335-2497-0)',\n",
       "    'marketing_start_date': '20240916',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2497-1',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2497-1)',\n",
       "    'marketing_start_date': '20240916',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2497-2',\n",
       "    'description': '20 TABLET in 1 BOTTLE (71335-2497-2)',\n",
       "    'marketing_start_date': '20240916',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2497-3',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-2497-3)',\n",
       "    'marketing_start_date': '20240916',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2497-4',\n",
       "    'description': '45 TABLET in 1 BOTTLE (71335-2497-4)',\n",
       "    'marketing_start_date': '20240916',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2497-5',\n",
       "    'description': '112 TABLET in 1 BOTTLE (71335-2497-5)',\n",
       "    'marketing_start_date': '20240916',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2497-6',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2497-6)',\n",
       "    'marketing_start_date': '20240916',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2497-7',\n",
       "    'description': '56 TABLET in 1 BOTTLE (71335-2497-7)',\n",
       "    'marketing_start_date': '20240916',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2497-8',\n",
       "    'description': '15 TABLET in 1 BOTTLE (71335-2497-8)',\n",
       "    'marketing_start_date': '20240916',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2497-9',\n",
       "    'description': '84 TABLET in 1 BOTTLE (71335-2497-9)',\n",
       "    'marketing_start_date': '20240916',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197392'],\n",
       "   'spl_set_id': ['f9c6d75a-a956-47b6-a5a2-deaf9797e2b2'],\n",
       "   'nui': ['N0000000196', 'N0000000116', 'N0000175759'],\n",
       "   'pharm_class_moa': ['GABA A Agonists [MoA]', 'GABA B Agonists [MoA]'],\n",
       "   'pharm_class_epc': ['gamma-Aminobutyric Acid-ergic Agonist [EPC]'],\n",
       "   'unii': ['H789N3FKE8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '3677e29b-ef5f-459f-a9f0-b74a91b32924',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240301',\n",
       "  'product_id': '71335-2497_3677e29b-ef5f-459f-a9f0-b74a91b32924',\n",
       "  'application_number': 'ANDA214374',\n",
       "  'brand_name_base': 'BACLOFEN',\n",
       "  'pharm_class': ['GABA A Agonists [MoA]',\n",
       "   'GABA B Agonists [MoA]',\n",
       "   'gamma-Aminobutyric Acid-ergic Agonist [EPC]']},\n",
       " {'product_ndc': '71335-2498',\n",
       "  'generic_name': 'Rosuvastatin',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Rosuvastatin',\n",
       "  'active_ingredients': [{'name': 'ROSUVASTATIN', 'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2498-1',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71335-2498-1)',\n",
       "    'marketing_start_date': '20241014',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2498-2',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71335-2498-2)',\n",
       "    'marketing_start_date': '20241014',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2498-3',\n",
       "    'description': '28 TABLET, FILM COATED in 1 BOTTLE (71335-2498-3)',\n",
       "    'marketing_start_date': '20241101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2498-4',\n",
       "    'description': '10 TABLET, FILM COATED in 1 BOTTLE (71335-2498-4)',\n",
       "    'marketing_start_date': '20241101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2498-5',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71335-2498-5)',\n",
       "    'marketing_start_date': '20241101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['859419'],\n",
       "   'spl_set_id': ['e4f6f29b-9d44-4389-9aa8-01000f94775e'],\n",
       "   'nui': ['N0000175589', 'N0000000121'],\n",
       "   'pharm_class_epc': ['HMG-CoA Reductase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]'],\n",
       "   'unii': ['413KH5ZJ73']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '029a4920-fc8c-466d-a283-2ec641d445ce',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190424',\n",
       "  'product_id': '71335-2498_029a4920-fc8c-466d-a283-2ec641d445ce',\n",
       "  'application_number': 'ANDA206381',\n",
       "  'brand_name_base': 'Rosuvastatin',\n",
       "  'pharm_class': ['HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71335-2518',\n",
       "  'generic_name': 'tramadol hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'tramadol hydrochloride',\n",
       "  'active_ingredients': [{'name': 'TRAMADOL HYDROCHLORIDE',\n",
       "    'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2518-0',\n",
       "    'description': '50 TABLET in 1 BOTTLE (71335-2518-0)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2518-1',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-2518-1)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2518-2',\n",
       "    'description': '20 TABLET in 1 BOTTLE (71335-2518-2)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2518-3',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-2518-3)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2518-4',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-2518-4)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2518-5',\n",
       "    'description': '120 TABLET in 1 BOTTLE (71335-2518-5)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2518-6',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71335-2518-6)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2518-7',\n",
       "    'description': '40 TABLET in 1 BOTTLE (71335-2518-7)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2518-8',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71335-2518-8)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2518-9',\n",
       "    'description': '15 TABLET in 1 BOTTLE (71335-2518-9)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['835603'],\n",
       "   'spl_set_id': ['6ebc5864-c222-4400-a9b2-f66fd6fb0da6'],\n",
       "   'unii': ['9N7R477WCK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'e37a5865-f78e-41d4-9d0a-b7ec7bcd0807',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180301',\n",
       "  'product_id': '71335-2518_e37a5865-f78e-41d4-9d0a-b7ec7bcd0807',\n",
       "  'application_number': 'ANDA202075',\n",
       "  'brand_name_base': 'tramadol hydrochloride',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '71335-2532',\n",
       "  'generic_name': 'Isosorbide Mononitrate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Isosorbide Mononitrate',\n",
       "  'active_ingredients': [{'name': 'ISOSORBIDE MONONITRATE',\n",
       "    'strength': '60 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2532-1',\n",
       "    'description': '100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2532-1)',\n",
       "    'marketing_start_date': '20241126',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2532-2',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2532-2)',\n",
       "    'marketing_start_date': '20241126',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2532-3',\n",
       "    'description': '60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2532-3)',\n",
       "    'marketing_start_date': '20241126',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2532-4',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2532-4)',\n",
       "    'marketing_start_date': '20241126',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2532-5',\n",
       "    'description': '10 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2532-5)',\n",
       "    'marketing_start_date': '20241126',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['353538'],\n",
       "   'spl_set_id': ['cd60ded0-01d9-4a51-a8ad-cdfeb27d88fb'],\n",
       "   'nui': ['N0000175415', 'M0014874', 'N0000009909'],\n",
       "   'pharm_class_epc': ['Nitrate Vasodilator [EPC]'],\n",
       "   'pharm_class_cs': ['Nitrates [CS]'],\n",
       "   'pharm_class_pe': ['Vasodilation [PE]'],\n",
       "   'unii': ['LX1OH63030']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': 'a0fc33f6-0f34-4fa8-b4df-33f4b74c6bca',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20100607',\n",
       "  'product_id': '71335-2532_a0fc33f6-0f34-4fa8-b4df-33f4b74c6bca',\n",
       "  'application_number': 'ANDA075522',\n",
       "  'brand_name_base': 'Isosorbide Mononitrate',\n",
       "  'pharm_class': ['Nitrate Vasodilator [EPC]',\n",
       "   'Nitrates [CS]',\n",
       "   'Vasodilation [PE]']},\n",
       " {'product_ndc': '71335-9613',\n",
       "  'generic_name': 'carisoprodol',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'carisoprodol',\n",
       "  'active_ingredients': [{'name': 'CARISOPRODOL', 'strength': '350 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-9613-0',\n",
       "    'description': '56 TABLET in 1 BOTTLE (71335-9613-0)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9613-1',\n",
       "    'description': '14 TABLET in 1 BOTTLE (71335-9613-1)',\n",
       "    'marketing_start_date': '20240301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9613-2',\n",
       "    'description': '28 TABLET in 1 BOTTLE (71335-9613-2)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9613-3',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-9613-3)',\n",
       "    'marketing_start_date': '20230814',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9613-4',\n",
       "    'description': '20 TABLET in 1 BOTTLE (71335-9613-4)',\n",
       "    'marketing_start_date': '20230424',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9613-5',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-9613-5)',\n",
       "    'marketing_start_date': '20230106',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9613-6',\n",
       "    'description': '84 TABLET in 1 BOTTLE (71335-9613-6)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9613-7',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-9613-7)',\n",
       "    'marketing_start_date': '20221222',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9613-8',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71335-9613-8)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9613-9',\n",
       "    'description': '120 TABLET in 1 BOTTLE (71335-9613-9)',\n",
       "    'marketing_start_date': '20230526',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197446'],\n",
       "   'spl_set_id': ['b72ac75b-8c7c-4ec4-a7fa-b9c1a18f644c'],\n",
       "   'nui': ['N0000175730', 'N0000175737'],\n",
       "   'pharm_class_pe': ['Centrally-mediated Muscle Relaxation [PE]'],\n",
       "   'pharm_class_epc': ['Muscle Relaxant [EPC]'],\n",
       "   'unii': ['21925K482H']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '59d75529-83e0-47de-8688-707bb4a2339f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20090806',\n",
       "  'product_id': '71335-9613_59d75529-83e0-47de-8688-707bb4a2339f',\n",
       "  'application_number': 'ANDA040792',\n",
       "  'brand_name_base': 'carisoprodol',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '0517-7510',\n",
       "  'generic_name': 'acetylcysteine',\n",
       "  'labeler_name': 'American Regent, Inc.',\n",
       "  'brand_name': 'Acetylcysteine',\n",
       "  'active_ingredients': [{'name': 'ACETYLCYSTEINE', 'strength': '100 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0517-7510-03',\n",
       "    'description': '3 VIAL, GLASS in 1 BOX (0517-7510-03)  / 10 mL in 1 VIAL, GLASS',\n",
       "    'marketing_start_date': '19951001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['American Regent, Inc.'],\n",
       "   'rxcui': ['307718', '307719'],\n",
       "   'spl_set_id': ['f56b4087-db48-4fd7-84ec-9c927962b805'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305177510032', '0305177604250', '0305177504253', '0305177610039'],\n",
       "   'nui': ['N0000175429',\n",
       "    'N0000175961',\n",
       "    'N0000008867',\n",
       "    'N0000175960',\n",
       "    'N0000175776',\n",
       "    'N0000175547'],\n",
       "   'pharm_class_epc': ['Antidote [EPC]',\n",
       "    'Antidote for Acetaminophen Overdose [EPC]',\n",
       "    'Mucolytic [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "    'Increased Glutathione Concentration [PE]'],\n",
       "   'pharm_class_moa': ['Reduction Activity [MoA]'],\n",
       "   'unii': ['WYQ7N0BPYC']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INHALANT',\n",
       "  'spl_id': '2bcb9dd3-17f8-439e-a395-aa081c5cc4bf',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['RESPIRATORY (INHALATION)'],\n",
       "  'marketing_start_date': '19951001',\n",
       "  'product_id': '0517-7510_2bcb9dd3-17f8-439e-a395-aa081c5cc4bf',\n",
       "  'application_number': 'ANDA072489',\n",
       "  'brand_name_base': 'Acetylcysteine',\n",
       "  'pharm_class': ['Antidote [EPC]',\n",
       "   'Antidote for Acetaminophen Overdose [EPC]',\n",
       "   'Decreased Respiratory Secretion Viscosity [PE]',\n",
       "   'Increased Glutathione Concentration [PE]',\n",
       "   'Mucolytic [EPC]',\n",
       "   'Reduction Activity [MoA]']},\n",
       " {'product_ndc': '71335-9636',\n",
       "  'generic_name': 'SIMVASTATIN',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'SIMVASTATIN',\n",
       "  'active_ingredients': [{'name': 'SIMVASTATIN', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-9636-1',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71335-9636-1)',\n",
       "    'marketing_start_date': '20230313',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9636-2',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71335-9636-2)',\n",
       "    'marketing_start_date': '20230303',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9636-3',\n",
       "    'description': '120 TABLET, FILM COATED in 1 BOTTLE (71335-9636-3)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9636-4',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (71335-9636-4)',\n",
       "    'marketing_start_date': '20231019',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9636-5',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71335-9636-5)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9636-6',\n",
       "    'description': '28 TABLET, FILM COATED in 1 BOTTLE (71335-9636-6)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9636-7',\n",
       "    'description': '10 TABLET, FILM COATED in 1 BOTTLE (71335-9636-7)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['314231'],\n",
       "   'spl_set_id': ['76ea62f3-4efb-4649-829d-3f0c28d5dae7'],\n",
       "   'nui': ['N0000175589', 'N0000000121'],\n",
       "   'pharm_class_epc': ['HMG-CoA Reductase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]'],\n",
       "   'unii': ['AGG2FN16EV']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'd5c4817c-fce5-4b4c-adaa-7ae947b8457f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20070612',\n",
       "  'product_id': '71335-9636_d5c4817c-fce5-4b4c-adaa-7ae947b8457f',\n",
       "  'application_number': 'ANDA078103',\n",
       "  'brand_name_base': 'SIMVASTATIN',\n",
       "  'pharm_class': ['HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71335-9650',\n",
       "  'generic_name': 'paroxetine hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'paroxetine hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PAROXETINE HYDROCHLORIDE HEMIHYDRATE',\n",
       "    'strength': '30 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-9650-1',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71335-9650-1)',\n",
       "    'marketing_start_date': '20230328',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9650-2',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71335-9650-2)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9650-3',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71335-9650-3)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9650-4',\n",
       "    'description': '180 TABLET, FILM COATED in 1 BOTTLE (71335-9650-4)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1738503'],\n",
       "   'spl_set_id': ['c3c204df-6b7d-42fb-8794-4f38064ed963'],\n",
       "   'unii': ['X2ELS050D8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '52e74299-f193-408d-9d0d-e48398a1734a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20221114',\n",
       "  'product_id': '71335-9650_52e74299-f193-408d-9d0d-e48398a1734a',\n",
       "  'application_number': 'ANDA076968',\n",
       "  'brand_name_base': 'paroxetine hydrochloride',\n",
       "  'pharm_class': ['Serotonin Reuptake Inhibitor [EPC]',\n",
       "   'Serotonin Uptake Inhibitors [MoA]']},\n",
       " {'product_ndc': '71335-9670',\n",
       "  'generic_name': 'TRAMADOL HYDROCHLORIDE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'TRAMADOL HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'TRAMADOL HYDROCHLORIDE',\n",
       "    'strength': '300 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-9670-1',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9670-1)',\n",
       "    'marketing_start_date': '20230324',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9670-2',\n",
       "    'description': '60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9670-2)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9670-3',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9670-3)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9670-4',\n",
       "    'description': '120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9670-4)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['833713'],\n",
       "   'spl_set_id': ['acd5d8e0-a4cc-4654-ae04-faff347a60ca'],\n",
       "   'unii': ['9N7R477WCK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '14c82d58-57d2-4128-894c-01f65528d5af',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20140819',\n",
       "  'product_id': '71335-9670_14c82d58-57d2-4128-894c-01f65528d5af',\n",
       "  'application_number': 'ANDA200503',\n",
       "  'brand_name_base': 'TRAMADOL HYDROCHLORIDE',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '71335-9672',\n",
       "  'generic_name': 'Doxazosin Mesylate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Doxazosin',\n",
       "  'active_ingredients': [{'name': 'DOXAZOSIN MESYLATE', 'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-9672-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71335-9672-1)',\n",
       "    'marketing_start_date': '20230403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9672-2',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71335-9672-2)',\n",
       "    'marketing_start_date': '20230403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9672-3',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71335-9672-3)',\n",
       "    'marketing_start_date': '20230403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9672-4',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71335-9672-4)',\n",
       "    'marketing_start_date': '20230403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197627'],\n",
       "   'spl_set_id': ['277c3278-4fe2-47ac-9115-15b417325ffd'],\n",
       "   'unii': ['86P6PQK0MU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'fc8c4c3a-f16e-b270-e053-6394a90ad28b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180417',\n",
       "  'product_id': '71335-9672_fc8c4c3a-f16e-b270-e053-6394a90ad28b',\n",
       "  'application_number': 'ANDA209013',\n",
       "  'brand_name_base': 'Doxazosin',\n",
       "  'pharm_class': ['Adrenergic alpha-Antagonists [MoA]',\n",
       "   'alpha-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '71335-9683',\n",
       "  'generic_name': 'METFORMIN HYDROCHLORIDE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'METFORMIN HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'METFORMIN HYDROCHLORIDE',\n",
       "    'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-9683-1',\n",
       "    'description': '60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9683-1)',\n",
       "    'marketing_start_date': '20230411',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9683-2',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9683-2)',\n",
       "    'marketing_start_date': '20230411',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9683-3',\n",
       "    'description': '100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9683-3)',\n",
       "    'marketing_start_date': '20230411',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9683-4',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9683-4)',\n",
       "    'marketing_start_date': '20230411',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9683-5',\n",
       "    'description': '120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9683-5)',\n",
       "    'marketing_start_date': '20230411',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9683-6',\n",
       "    'description': '15 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9683-6)',\n",
       "    'marketing_start_date': '20230411',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9683-7',\n",
       "    'description': '45 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9683-7)',\n",
       "    'marketing_start_date': '20230411',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9683-8',\n",
       "    'description': '180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9683-8)',\n",
       "    'marketing_start_date': '20230411',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9683-9',\n",
       "    'description': '20 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-9683-9)',\n",
       "    'marketing_start_date': '20230411',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['860975'],\n",
       "   'spl_set_id': ['86627ff4-da1c-429d-991b-88e97f6967d6'],\n",
       "   'unii': ['786Z46389E']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '4e6e3035-562a-4663-bf3d-cb2f755702bb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200806',\n",
       "  'product_id': '71335-9683_4e6e3035-562a-4663-bf3d-cb2f755702bb',\n",
       "  'application_number': 'ANDA076756',\n",
       "  'brand_name_base': 'METFORMIN HYDROCHLORIDE',\n",
       "  'pharm_class': ['Biguanide [EPC]', 'Biguanides [CS]']},\n",
       " {'product_ndc': '71335-9707',\n",
       "  'generic_name': 'Carvedilol Phosphate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Carvedilol Phosphate',\n",
       "  'active_ingredients': [{'name': 'CARVEDILOL PHOSPHATE',\n",
       "    'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-9707-1',\n",
       "    'description': '30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-9707-1)',\n",
       "    'marketing_start_date': '20230505',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9707-2',\n",
       "    'description': '90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-9707-2)',\n",
       "    'marketing_start_date': '20230505',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['860516'],\n",
       "   'spl_set_id': ['ce9623f8-6cea-45e0-a15c-2dd78690f2a7'],\n",
       "   'unii': ['EQT531S367']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, EXTENDED RELEASE',\n",
       "  'spl_id': 'ce9623f8-6cea-45e0-a15c-2dd78690f2a7',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171108',\n",
       "  'product_id': '71335-9707_ce9623f8-6cea-45e0-a15c-2dd78690f2a7',\n",
       "  'application_number': 'ANDA090132',\n",
       "  'brand_name_base': 'Carvedilol Phosphate',\n",
       "  'pharm_class': ['Adrenergic alpha-Antagonists [MoA]',\n",
       "   'Adrenergic beta1-Antagonists [MoA]',\n",
       "   'Adrenergic beta2-Antagonists [MoA]',\n",
       "   'alpha-Adrenergic Blocker [EPC]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '71335-9721',\n",
       "  'generic_name': 'Acyclovir',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Acyclovir',\n",
       "  'active_ingredients': [{'name': 'ACYCLOVIR', 'strength': '800 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-9721-0',\n",
       "    'description': '500 TABLET in 1 BOTTLE, PLASTIC (71335-9721-0)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9721-1',\n",
       "    'description': '25 TABLET in 1 BOTTLE, PLASTIC (71335-9721-1)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9721-2',\n",
       "    'description': '35 TABLET in 1 BOTTLE, PLASTIC (71335-9721-2)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9721-3',\n",
       "    'description': '30 TABLET in 1 BOTTLE, PLASTIC (71335-9721-3)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9721-4',\n",
       "    'description': '60 TABLET in 1 BOTTLE, PLASTIC (71335-9721-4)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9721-5',\n",
       "    'description': '50 TABLET in 1 BOTTLE, PLASTIC (71335-9721-5)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9721-6',\n",
       "    'description': '10 TABLET in 1 BOTTLE, PLASTIC (71335-9721-6)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9721-7',\n",
       "    'description': '40 TABLET in 1 BOTTLE, PLASTIC (71335-9721-7)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9721-8',\n",
       "    'description': '21 TABLET in 1 BOTTLE, PLASTIC (71335-9721-8)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9721-9',\n",
       "    'description': '90 TABLET in 1 BOTTLE, PLASTIC (71335-9721-9)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197313'],\n",
       "   'spl_set_id': ['e0f17e6f-63c7-4828-8585-91fc582df30b'],\n",
       "   'nui': ['N0000020060',\n",
       "    'N0000180187',\n",
       "    'N0000180188',\n",
       "    'N0000175468',\n",
       "    'N0000175459'],\n",
       "   'pharm_class_moa': ['DNA Polymerase Inhibitors [MoA]'],\n",
       "   'pharm_class_epc': ['Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "    'Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "    'Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]'],\n",
       "   'unii': ['X4HES1O11F']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '637f4303-bd11-4934-b45d-d353b402cffd',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20091022',\n",
       "  'product_id': '71335-9721_637f4303-bd11-4934-b45d-d353b402cffd',\n",
       "  'application_number': 'ANDA075382',\n",
       "  'brand_name_base': 'Acyclovir',\n",
       "  'pharm_class': ['DNA Polymerase Inhibitors [MoA]',\n",
       "   'Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "   'Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "   'Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "   'Nucleoside Analog [EXT]']},\n",
       " {'product_ndc': '71335-9732',\n",
       "  'generic_name': 'Doxepin hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Doxepin hydrochloride',\n",
       "  'active_ingredients': [{'name': 'DOXEPIN HYDROCHLORIDE',\n",
       "    'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-9732-1',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71335-9732-1)',\n",
       "    'marketing_start_date': '20230630',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9732-2',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71335-9732-2)',\n",
       "    'marketing_start_date': '20230630',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9732-3',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (71335-9732-3)',\n",
       "    'marketing_start_date': '20230630',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9732-4',\n",
       "    'description': '120 CAPSULE in 1 BOTTLE (71335-9732-4)',\n",
       "    'marketing_start_date': '20230630',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1000076'],\n",
       "   'spl_set_id': ['41046d94-1443-4bbd-96d0-8463604ae459'],\n",
       "   'unii': ['3U9A0FE9N5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'cfc63853-77b0-4c21-981e-ddea13fcc09c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20191220',\n",
       "  'product_id': '71335-9732_cfc63853-77b0-4c21-981e-ddea13fcc09c',\n",
       "  'application_number': 'ANDA212624',\n",
       "  'brand_name_base': 'Doxepin hydrochloride',\n",
       "  'pharm_class': ['Tricyclic Antidepressant [EPC]']},\n",
       " {'product_ndc': '71335-9736',\n",
       "  'generic_name': 'Hydrocodone Bitartrate and Acetaminophen',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Hydrocodone Bitartrate and Acetaminophen',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '325 mg/1'},\n",
       "   {'name': 'HYDROCODONE BITARTRATE', 'strength': '7.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-9736-0',\n",
       "    'description': '8 TABLET in 1 BOTTLE, PLASTIC (71335-9736-0)',\n",
       "    'marketing_start_date': '20240405',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9736-1',\n",
       "    'description': '120 TABLET in 1 BOTTLE, PLASTIC (71335-9736-1)',\n",
       "    'marketing_start_date': '20231128',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9736-2',\n",
       "    'description': '15 TABLET in 1 BOTTLE, PLASTIC (71335-9736-2)',\n",
       "    'marketing_start_date': '20231017',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9736-3',\n",
       "    'description': '20 TABLET in 1 BOTTLE, PLASTIC (71335-9736-3)',\n",
       "    'marketing_start_date': '20230628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9736-4',\n",
       "    'description': '28 TABLET in 1 BOTTLE, PLASTIC (71335-9736-4)',\n",
       "    'marketing_start_date': '20240405',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9736-5',\n",
       "    'description': '30 TABLET in 1 BOTTLE, PLASTIC (71335-9736-5)',\n",
       "    'marketing_start_date': '20230906',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9736-6',\n",
       "    'description': '40 TABLET in 1 BOTTLE, PLASTIC (71335-9736-6)',\n",
       "    'marketing_start_date': '20240405',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9736-7',\n",
       "    'description': '56 TABLET in 1 BOTTLE, PLASTIC (71335-9736-7)',\n",
       "    'marketing_start_date': '20240405',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9736-8',\n",
       "    'description': '60 TABLET in 1 BOTTLE, PLASTIC (71335-9736-8)',\n",
       "    'marketing_start_date': '20231205',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9736-9',\n",
       "    'description': '90 TABLET in 1 BOTTLE, PLASTIC (71335-9736-9)',\n",
       "    'marketing_start_date': '20231215',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['857005'],\n",
       "   'spl_set_id': ['d3b7f2b3-28c4-4ba5-961f-48e838600be2'],\n",
       "   'unii': ['362O9ITL9D', 'NO70W886KK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'd72c1058-94a6-4a3c-b92f-de81cb23083e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20141006',\n",
       "  'product_id': '71335-9736_d72c1058-94a6-4a3c-b92f-de81cb23083e',\n",
       "  'application_number': 'ANDA202214',\n",
       "  'brand_name_base': 'Hydrocodone Bitartrate and Acetaminophen',\n",
       "  'pharm_class': ['Opioid Agonist [EPC]', 'Opioid Agonists [MoA]']},\n",
       " {'product_ndc': '71335-9741',\n",
       "  'generic_name': 'Temazepam',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Temazepam',\n",
       "  'active_ingredients': [{'name': 'TEMAZEPAM', 'strength': '15 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-9741-1',\n",
       "    'description': '20 CAPSULE in 1 BOTTLE (71335-9741-1)',\n",
       "    'marketing_start_date': '20230710',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9741-2',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71335-9741-2)',\n",
       "    'marketing_start_date': '20230710',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9741-3',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71335-9741-3)',\n",
       "    'marketing_start_date': '20230710',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9741-4',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (71335-9741-4)',\n",
       "    'marketing_start_date': '20230710',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9741-5',\n",
       "    'description': '28 CAPSULE in 1 BOTTLE (71335-9741-5)',\n",
       "    'marketing_start_date': '20230710',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9741-6',\n",
       "    'description': '120 CAPSULE in 1 BOTTLE (71335-9741-6)',\n",
       "    'marketing_start_date': '20230710',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9741-7',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (71335-9741-7)',\n",
       "    'marketing_start_date': '20230710',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198241'],\n",
       "   'spl_set_id': ['44461dcc-5c1e-4852-92d3-854ac0849e3d'],\n",
       "   'nui': ['N0000175694', 'M0002356'],\n",
       "   'pharm_class_epc': ['Benzodiazepine [EPC]'],\n",
       "   'pharm_class_cs': ['Benzodiazepines [CS]'],\n",
       "   'unii': ['CHB1QD2QSS']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '5fb01933-af3d-4abe-b7d0-8f410a0a6d39',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181127',\n",
       "  'product_id': '71335-9741_5fb01933-af3d-4abe-b7d0-8f410a0a6d39',\n",
       "  'application_number': 'ANDA211542',\n",
       "  'brand_name_base': 'Temazepam',\n",
       "  'pharm_class': ['Benzodiazepine [EPC]', 'Benzodiazepines [CS]']},\n",
       " {'product_ndc': '71335-9748',\n",
       "  'generic_name': 'FAMOTIDINE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'FAMOTIDINE',\n",
       "  'active_ingredients': [{'name': 'FAMOTIDINE', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-9748-1',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71335-9748-1)',\n",
       "    'marketing_start_date': '20230914',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9748-2',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71335-9748-2)',\n",
       "    'marketing_start_date': '20231003',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9748-3',\n",
       "    'description': '20 TABLET, FILM COATED in 1 BOTTLE (71335-9748-3)',\n",
       "    'marketing_start_date': '20230918',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9748-4',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71335-9748-4)',\n",
       "    'marketing_start_date': '20230905',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9748-5',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (71335-9748-5)',\n",
       "    'marketing_start_date': '20231117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9748-6',\n",
       "    'description': '10 TABLET, FILM COATED in 1 BOTTLE (71335-9748-6)',\n",
       "    'marketing_start_date': '20240405',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9748-7',\n",
       "    'description': '120 TABLET, FILM COATED in 1 BOTTLE (71335-9748-7)',\n",
       "    'marketing_start_date': '20240326',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9748-8',\n",
       "    'description': '50 TABLET, FILM COATED in 1 BOTTLE (71335-9748-8)',\n",
       "    'marketing_start_date': '20240405',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9748-9',\n",
       "    'description': '14 TABLET, FILM COATED in 1 BOTTLE (71335-9748-9)',\n",
       "    'marketing_start_date': '20240405',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['310273'],\n",
       "   'spl_set_id': ['a24e8f45-6ace-4a81-8005-c23a55dadd9a'],\n",
       "   'nui': ['N0000000151', 'N0000175784'],\n",
       "   'pharm_class_moa': ['Histamine H2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Histamine-2 Receptor Antagonist [EPC]'],\n",
       "   'unii': ['5QZO15J2Z8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '4f0eae9b-c81a-4343-bfbe-a2ff619e8498',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220708',\n",
       "  'product_id': '71335-9748_4f0eae9b-c81a-4343-bfbe-a2ff619e8498',\n",
       "  'application_number': 'ANDA215630',\n",
       "  'brand_name_base': 'FAMOTIDINE',\n",
       "  'pharm_class': ['Histamine H2 Receptor Antagonists [MoA]',\n",
       "   'Histamine-2 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '71338-123',\n",
       "  'generic_name': 'Benzaalkonium chloride, Lidocaine HCl',\n",
       "  'labeler_name': 'ECOLAB Food Safety Specialties, Inc.',\n",
       "  'brand_name': 'ECOLAB Burn Cream',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '1.3 mg/g'},\n",
       "   {'name': 'LIDOCAINE HYDROCHLORIDE', 'strength': '5 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71338-123-73',\n",
       "    'description': '25 PACKET in 1 BOX (71338-123-73)  / .9 g in 1 PACKET',\n",
       "    'marketing_start_date': '20170320',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['ECOLAB Food Safety Specialties, Inc.'],\n",
       "   'rxcui': ['1012100'],\n",
       "   'spl_set_id': ['4b2a7da9-c0e9-61c5-e054-00144ff8d46c'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7', 'V13007Z41A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '27306cc1-6846-1a58-e063-6394a90a1b46',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20170320',\n",
       "  'product_id': '71338-123_27306cc1-6846-1a58-e063-6394a90a1b46',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'ECOLAB Burn Cream',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '71338-312',\n",
       "  'generic_name': 'Benzalkonium Chloride',\n",
       "  'labeler_name': 'Ecolab Food Safety Specialties, Inc.',\n",
       "  'brand_name': 'ECOLAB Antiseptic',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '1.3 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71338-312-71',\n",
       "    'description': '20 PACKET in 1 BOX (71338-312-71)  / 1.4 mL in 1 PACKET',\n",
       "    'marketing_start_date': '20191101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Ecolab Food Safety Specialties, Inc.'],\n",
       "   'spl_set_id': ['246e53bc-7a65-876c-e063-6294a90aab6d'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '2652f664-5f59-a0e3-e063-6394a90a00d3',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20191101',\n",
       "  'product_id': '71338-312_2652f664-5f59-a0e3-e063-6394a90a00d3',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'ECOLAB Antiseptic'},\n",
       " {'product_ndc': '71347-102',\n",
       "  'generic_name': 'Benzocaine',\n",
       "  'labeler_name': 'The Atlanta Dental Supply Company DBA Advanced Dental Products',\n",
       "  'brand_name': 'Advance Topical Anesthetic Gel',\n",
       "  'active_ingredients': [{'name': 'BENZOCAINE', 'strength': '200 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71347-102-30',\n",
       "    'description': '30 g in 1 JAR (71347-102-30)',\n",
       "    'marketing_start_date': '20180601',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['The Atlanta Dental Supply Company DBA Advanced Dental Products'],\n",
       "   'rxcui': ['238910'],\n",
       "   'spl_set_id': ['c385cc66-7d08-4b63-bfba-a133b5275c6d'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185508', 'N0000175629', 'N0000184306', 'M0000728'],\n",
       "   'pharm_class_epc': ['Standardized Chemical Allergen [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]'],\n",
       "   'unii': ['U3RSY48JW5']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'd6589afb-2d2b-9804-e053-2995a90abf14',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['DENTAL'],\n",
       "  'marketing_start_date': '20170301',\n",
       "  'product_id': '71347-102_d6589afb-2d2b-9804-e053-2995a90abf14',\n",
       "  'application_number': 'part356',\n",
       "  'brand_name_base': 'Advance Topical Anesthetic Gel',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Standardized Chemical Allergen [EPC]']},\n",
       " {'product_ndc': '71347-210',\n",
       "  'generic_name': 'Lidocaine Hydrochloride and Epinephrine Bitartrate',\n",
       "  'labeler_name': 'The Atlanta Dental Supply Company DBA Advanced Dental Products',\n",
       "  'brand_name': 'Lidocaine',\n",
       "  'active_ingredients': [{'name': 'EPINEPHRINE BITARTRATE',\n",
       "    'strength': '.01 mg/mL'},\n",
       "   {'name': 'LIDOCAINE HYDROCHLORIDE', 'strength': '20 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71347-210-50',\n",
       "    'description': '50 CARTRIDGE in 1 CARTON (71347-210-50)  / 1.7 mL in 1 CARTRIDGE',\n",
       "    'marketing_start_date': '20190318',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['The Atlanta Dental Supply Company DBA Advanced Dental Products'],\n",
       "   'rxcui': ['1293648'],\n",
       "   'spl_set_id': ['55030c51-250b-4fc2-ba3c-ac38dab7cc8e'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['30Q7KI53AK', 'V13007Z41A']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '992100ab-d1e7-4657-b600-11fd0f3e96c5',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBMUCOSAL'],\n",
       "  'marketing_start_date': '20190318',\n",
       "  'product_id': '71347-210_992100ab-d1e7-4657-b600-11fd0f3e96c5',\n",
       "  'application_number': 'ANDA088390',\n",
       "  'brand_name_base': 'Lidocaine',\n",
       "  'pharm_class': ['Adrenergic alpha-Agonists [MoA]',\n",
       "   'Adrenergic beta-Agonists [MoA]',\n",
       "   'Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Catecholamine [EPC]',\n",
       "   'Catecholamines [CS]',\n",
       "   'Local Anesthesia [PE]',\n",
       "   'alpha-Adrenergic Agonist [EPC]',\n",
       "   'beta-Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '71355-219',\n",
       "  'generic_name': 'ZINC OXIDE',\n",
       "  'labeler_name': 'Pure Haven, LLC',\n",
       "  'brand_name': 'PURE HAVEN Face Sunscreen SPF-30',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '140 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71355-219-00',\n",
       "    'description': '30 mL in 1 JAR (71355-219-00)',\n",
       "    'marketing_start_date': '20210901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Pure Haven, LLC'],\n",
       "   'spl_set_id': ['1fff88a0-4d23-4cd7-872e-1a0b8c680342'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '09db4f55-0153-f22c-e063-6294a90ac06a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210901',\n",
       "  'product_id': '71355-219_09db4f55-0153-f22c-e063-6294a90ac06a',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'PURE HAVEN Face Sunscreen SPF-30',\n",
       "  'pharm_class': ['Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]']},\n",
       " {'product_ndc': '0527-0764',\n",
       "  'generic_name': 'Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate',\n",
       "  'active_ingredients': [{'name': 'AMPHETAMINE ASPARTATE MONOHYDRATE',\n",
       "    'strength': '3.75 mg/1'},\n",
       "   {'name': 'AMPHETAMINE SULFATE', 'strength': '3.75 mg/1'},\n",
       "   {'name': 'DEXTROAMPHETAMINE SACCHARATE', 'strength': '3.75 mg/1'},\n",
       "   {'name': 'DEXTROAMPHETAMINE SULFATE', 'strength': '3.75 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-0764-37',\n",
       "    'description': '100 TABLET in 1 BOTTLE (0527-0764-37)',\n",
       "    'marketing_start_date': '20220708',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['541363',\n",
       "    '541878',\n",
       "    '541892',\n",
       "    '577957',\n",
       "    '577961',\n",
       "    '687043',\n",
       "    '1009145'],\n",
       "   'spl_set_id': ['f92497b5-baea-4760-b615-45a0b6184402'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['G83415V073', 'O1ZPV620O4', 'JJ768O327N', '6DPV8NK46S']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'e0804f43-4685-4017-b839-3212d1167362',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220708',\n",
       "  'product_id': '0527-0764_e0804f43-4685-4017-b839-3212d1167362',\n",
       "  'application_number': 'ANDA215565',\n",
       "  'brand_name_base': 'Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate',\n",
       "  'pharm_class': ['Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Central Nervous System Stimulation [PE]']},\n",
       " {'product_ndc': '71355-819',\n",
       "  'generic_name': 'TITANIUM DIOXIDE, ZINC OXIDE',\n",
       "  'labeler_name': 'Pure Haven LLC',\n",
       "  'brand_name': 'Pure Haven Essentials',\n",
       "  'active_ingredients': [{'name': 'TITANIUM DIOXIDE', 'strength': '60 mg/mL'},\n",
       "   {'name': 'ZINC OXIDE', 'strength': '60 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71355-819-03',\n",
       "    'description': '90 mL in 1 TUBE (71355-819-03)',\n",
       "    'marketing_start_date': '20170328',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Pure Haven LLC'],\n",
       "   'spl_set_id': ['4bccc017-266d-11ce-e054-00144ff8d46c'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['15FIX9V2JP', 'SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '09db5696-960c-d689-e063-6394a90aeb01',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20170328',\n",
       "  'product_id': '71355-819_09db5696-960c-d689-e063-6394a90aeb01',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Pure Haven Essentials',\n",
       "  'pharm_class': ['Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]']},\n",
       " {'product_ndc': '71363-100',\n",
       "  'generic_name': 'Benzocaine',\n",
       "  'labeler_name': 'Zag Usa Inc',\n",
       "  'brand_name': 'Astra-dent Topical Anesthetic Gel',\n",
       "  'active_ingredients': [{'name': 'BENZOCAINE', 'strength': '200 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71363-100-30',\n",
       "    'description': '28 g in 1 JAR (71363-100-30)',\n",
       "    'marketing_start_date': '20180801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Zag Usa Inc'],\n",
       "   'rxcui': ['238910'],\n",
       "   'spl_set_id': ['37e2d51d-8526-4766-9f15-0ef4bc1f1155'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185508', 'N0000175629', 'N0000184306', 'M0000728'],\n",
       "   'pharm_class_epc': ['Standardized Chemical Allergen [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]'],\n",
       "   'unii': ['U3RSY48JW5']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'd658afd2-ce50-2e82-e053-2a95a90a54f1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['DENTAL'],\n",
       "  'marketing_start_date': '20160701',\n",
       "  'product_id': '71363-100_d658afd2-ce50-2e82-e053-2a95a90a54f1',\n",
       "  'application_number': 'part356',\n",
       "  'brand_name_base': 'Astra-dent Topical Anesthetic Gel',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Standardized Chemical Allergen [EPC]']},\n",
       " {'product_ndc': '0527-0791',\n",
       "  'generic_name': 'Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate',\n",
       "  'active_ingredients': [{'name': 'AMPHETAMINE ASPARTATE MONOHYDRATE',\n",
       "    'strength': '2.5 mg/1'},\n",
       "   {'name': 'AMPHETAMINE SULFATE', 'strength': '2.5 mg/1'},\n",
       "   {'name': 'DEXTROAMPHETAMINE SACCHARATE', 'strength': '2.5 mg/1'},\n",
       "   {'name': 'DEXTROAMPHETAMINE SULFATE', 'strength': '2.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-0791-37',\n",
       "    'description': '100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-0791-37)',\n",
       "    'marketing_start_date': '20211126',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['861221', '861223', '861225', '861227', '861232', '861237'],\n",
       "   'spl_set_id': ['e95bdaf9-007a-4088-b969-fee38a97a475'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305270791376', '0305870193310', '0305270790379', '0305270794377'],\n",
       "   'unii': ['G83415V073', 'O1ZPV620O4', 'JJ768O327N', '6DPV8NK46S']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, EXTENDED RELEASE',\n",
       "  'spl_id': 'bcd83dbd-5f90-45d7-b85d-6e4cbd62e1e9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20211126',\n",
       "  'product_id': '0527-0791_bcd83dbd-5f90-45d7-b85d-6e4cbd62e1e9',\n",
       "  'application_number': 'ANDA214403',\n",
       "  'brand_name_base': 'Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate',\n",
       "  'pharm_class': ['Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Central Nervous System Stimulation [PE]']},\n",
       " {'product_ndc': '71399-0054',\n",
       "  'generic_name': 'Guaifenesin',\n",
       "  'labeler_name': 'Akron Pharma Inc.',\n",
       "  'brand_name': 'MAX Tussin Mucus and Chest Congestion',\n",
       "  'active_ingredients': [{'name': 'GUAIFENESIN', 'strength': '200 mg/10mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71399-0054-8',\n",
       "    'description': '1 BOTTLE in 1 PACKAGE (71399-0054-8)  / 236 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20231103',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Akron Pharma Inc.'],\n",
       "   'rxcui': ['310604'],\n",
       "   'spl_set_id': ['ac874a31-5556-4669-937f-dcb52aaecd8a'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000193956', 'N0000008867', 'N0000009560'],\n",
       "   'pharm_class_epc': ['Expectorant [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "    'Increased Respiratory Secretions [PE]'],\n",
       "   'unii': ['495W7451VQ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'f1b38b6f-7def-48bd-905a-7f03bf9db4f9',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231103',\n",
       "  'product_id': '71399-0054_f1b38b6f-7def-48bd-905a-7f03bf9db4f9',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'MAX Tussin Mucus and Chest Congestion',\n",
       "  'pharm_class': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "   'Expectorant [EPC]',\n",
       "   'Increased Respiratory Secretions [PE]']},\n",
       " {'product_ndc': '0527-1231',\n",
       "  'generic_name': 'Primidone',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'brand_name': 'Primidone',\n",
       "  'active_ingredients': [{'name': 'PRIMIDONE', 'strength': '250 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-1231-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (0527-1231-01)',\n",
       "    'marketing_start_date': '19781201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0527-1231-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (0527-1231-05)',\n",
       "    'marketing_start_date': '19781201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0527-1231-10',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (0527-1231-10)',\n",
       "    'marketing_start_date': '19781201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['96304', '198150'],\n",
       "   'spl_set_id': ['a1a817f7-c190-4825-94eb-442f477187e3'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305871231011'],\n",
       "   'nui': ['N0000175753', 'N0000008486'],\n",
       "   'pharm_class_epc': ['Anti-epileptic Agent [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]'],\n",
       "   'unii': ['13AFD7670Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '99bd0a67-2742-43dd-9ddc-430b9141c3b1',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19781201',\n",
       "  'product_id': '0527-1231_99bd0a67-2742-43dd-9ddc-430b9141c3b1',\n",
       "  'application_number': 'ANDA084903',\n",
       "  'brand_name_base': 'Primidone',\n",
       "  'pharm_class': ['Anti-epileptic Agent [EPC]',\n",
       "   'Decreased Central Nervous System Disorganized Electrical Activity [PE]']},\n",
       " {'product_ndc': '71409-311',\n",
       "  'generic_name': 'Sore Throat Relief',\n",
       "  'labeler_name': 'Clineva Urgent Care',\n",
       "  'brand_name': 'Sore Throat Relief',\n",
       "  'active_ingredients': [{'name': 'ACONITUM NAPELLUS',\n",
       "    'strength': '10 [hp_X]/1'},\n",
       "   {'name': 'APIS MELLIFERA', 'strength': '10 [hp_X]/1'},\n",
       "   {'name': 'ATROPA BELLADONNA', 'strength': '10 [hp_X]/1'},\n",
       "   {'name': 'MERCURIUS SOLUBILIS', 'strength': '10 [hp_X]/1'},\n",
       "   {'name': 'PHYTOLACCA AMERICANA ROOT', 'strength': '8 [hp_X]/1'},\n",
       "   {'name': 'SOLANUM DULCAMARA WHOLE', 'strength': '8 [hp_X]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71409-311-80',\n",
       "    'description': '80 PELLET in 1 VIAL, DISPENSING (71409-311-80)',\n",
       "    'marketing_start_date': '20170718',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Clineva Urgent Care'],\n",
       "   'spl_set_id': ['549d9cc4-13df-57ad-e054-00144ff8d46c'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185021',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'N0000185001',\n",
       "    'M0000728',\n",
       "    'M0002274'],\n",
       "   'pharm_class_epc': ['Standardized Insect Venom Allergenic Extract [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]',\n",
       "    'Increased IgG Production [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]', 'Bee Venoms [CS]'],\n",
       "   'unii': ['U0NQ8555JD',\n",
       "    '7S82P3R43Z',\n",
       "    'WQZ3G9PF0H',\n",
       "    '324Y4038G2',\n",
       "    '11E6VI8VEG',\n",
       "    'G72JA9DHK5']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'PELLET',\n",
       "  'spl_id': '620e0d1d-b067-2a86-e053-2a91aa0a9bef',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL', 'SUBLINGUAL'],\n",
       "  'marketing_start_date': '20170718',\n",
       "  'product_id': '71409-311_620e0d1d-b067-2a86-e053-2a91aa0a9bef',\n",
       "  'brand_name_base': 'Sore Throat Relief',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Bee Venoms [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Increased IgG Production [PE]',\n",
       "   'Standardized Insect Venom Allergenic Extract [EPC]']},\n",
       " {'product_ndc': '71435-8202',\n",
       "  'generic_name': 'Avobenzone, Octinoxate, Octocrylene, and Oxybenzone',\n",
       "  'labeler_name': 'The Milani Group, Inc.',\n",
       "  'brand_name': 'Milani Prime Protect SPF 30 Face Primer',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '30 mg/mL'},\n",
       "   {'name': 'OCTINOXATE', 'strength': '73 mg/mL'},\n",
       "   {'name': 'OCTOCRYLENE', 'strength': '30 mg/mL'},\n",
       "   {'name': 'OXYBENZONE', 'strength': '20 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71435-8202-6',\n",
       "    'description': '1 TUBE in 1 CARTON (71435-8202-6)  / 30 mL in 1 TUBE',\n",
       "    'marketing_start_date': '20171125',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['The Milani Group, Inc.'],\n",
       "   'spl_set_id': ['d557d554-5161-482c-bd78-7721c7dc9a6e'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['G63QQF2NOX', '4Y5P7MUD51', '5A68WGF6WM', '95OOS7VE0Y']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '2874ab15-80ca-c108-e063-6294a90a43a0',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20171125',\n",
       "  'product_id': '71435-8202_2874ab15-80ca-c108-e063-6294a90a43a0',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Milani Prime Protect SPF 30 Face Primer'},\n",
       " {'product_ndc': '71436-3571',\n",
       "  'generic_name': 'Lidocaine and Menthol',\n",
       "  'labeler_name': 'ARI BRANDS, LLC',\n",
       "  'brand_name': 'LM Plus Relief',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '490 mg/1'},\n",
       "   {'name': 'MENTHOL', 'strength': '980 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71436-3571-5',\n",
       "    'description': '3 POUCH in 1 CARTON (71436-3571-5)  / 5 PATCH in 1 POUCH',\n",
       "    'marketing_start_date': '20230901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['ARI BRANDS, LLC'],\n",
       "   'rxcui': ['2199672'],\n",
       "   'spl_set_id': ['e9b52074-b4ca-43e9-9f2e-2afcdb5efdc7'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175682', 'M0000897', 'N0000175426', 'N0000175976'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]', 'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'unii': ['98PI200987', 'L7T10EIP3A']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'PATCH',\n",
       "  'spl_id': '27fac912-0cb1-4cbd-b500-ce1a224cd965',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230901',\n",
       "  'product_id': '71436-3571_27fac912-0cb1-4cbd-b500-ce1a224cd965',\n",
       "  'brand_name_base': 'LM Plus Relief',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '0527-1301',\n",
       "  'generic_name': 'Primidone',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'brand_name': 'Primidone',\n",
       "  'active_ingredients': [{'name': 'PRIMIDONE', 'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-1301-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (0527-1301-01)',\n",
       "    'marketing_start_date': '20010524',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0527-1301-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (0527-1301-05)',\n",
       "    'marketing_start_date': '20010524',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0527-1301-10',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (0527-1301-10)',\n",
       "    'marketing_start_date': '20010524',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['96304', '198150'],\n",
       "   'spl_set_id': ['a1a817f7-c190-4825-94eb-442f477187e3'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305871231011'],\n",
       "   'nui': ['N0000175753', 'N0000008486'],\n",
       "   'pharm_class_epc': ['Anti-epileptic Agent [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]'],\n",
       "   'unii': ['13AFD7670Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '99bd0a67-2742-43dd-9ddc-430b9141c3b1',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20010524',\n",
       "  'product_id': '0527-1301_99bd0a67-2742-43dd-9ddc-430b9141c3b1',\n",
       "  'application_number': 'ANDA084903',\n",
       "  'brand_name_base': 'Primidone',\n",
       "  'pharm_class': ['Anti-epileptic Agent [EPC]',\n",
       "   'Decreased Central Nervous System Disorganized Electrical Activity [PE]']},\n",
       " {'product_ndc': '71447-006',\n",
       "  'generic_name': 'Salicylic Acid',\n",
       "  'labeler_name': 'LABORATOIRES DRUIDE INC',\n",
       "  'brand_name': 'NELLY DEVUYST SERUM BIOACNE',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '2 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71447-006-00',\n",
       "    'description': '2 g in 1 BOTTLE, GLASS (71447-006-00)',\n",
       "    'marketing_start_date': '20180423',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['LABORATOIRES DRUIDE INC'],\n",
       "   'rxcui': ['251577'],\n",
       "   'spl_set_id': ['6a21c767-1242-ac58-e053-2a91aa0a1530'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0829852194312'],\n",
       "   'unii': ['O414PZ4LPZ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'c790ed12-fe9e-6619-e053-2a95a90aa45a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180420',\n",
       "  'product_id': '71447-006_c790ed12-fe9e-6619-e053-2a95a90aa45a',\n",
       "  'application_number': 'part333D',\n",
       "  'brand_name_base': 'NELLY DEVUYST SERUM BIOACNE'},\n",
       " {'product_ndc': '71447-008',\n",
       "  'generic_name': 'SALICYLIC ACID',\n",
       "  'labeler_name': 'LABORATOIRES DRUIDE INC',\n",
       "  'brand_name': 'NELLY DEVUYST MICELLAR FOAM BIOACNE',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '.5 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71447-008-00',\n",
       "    'description': '1 BOTTLE, PUMP in 1 CARTON (71447-008-00)  / 150 mL in 1 BOTTLE, PUMP',\n",
       "    'marketing_start_date': '20180425',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['LABORATOIRES DRUIDE INC'],\n",
       "   'rxcui': ['865105'],\n",
       "   'spl_set_id': ['6a3cc545-29b9-1a75-e053-2a91aa0a8f8c'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0829852192110'],\n",
       "   'unii': ['O414PZ4LPZ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'c791089f-f86f-f1d4-e053-2995a90ad844',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180425',\n",
       "  'product_id': '71447-008_c791089f-f86f-f1d4-e053-2995a90ad844',\n",
       "  'application_number': 'part333D',\n",
       "  'brand_name_base': 'NELLY DEVUYST MICELLAR FOAM BIOACNE'},\n",
       " {'product_ndc': '71447-100',\n",
       "  'generic_name': 'TITANIUM DIOXIDE, ZINC OXIDE',\n",
       "  'labeler_name': 'LABORATOIRES DRUIDE INC',\n",
       "  'brand_name': 'NELLY DEVUYST ORGANIC TRANSPARENT MINERAL SUNSCREEN SPF30',\n",
       "  'brand_name_suffix': 'SPF30',\n",
       "  'active_ingredients': [{'name': 'TITANIUM DIOXIDE', 'strength': '2 g/100g'},\n",
       "   {'name': 'ZINC OXIDE', 'strength': '18.4 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71447-100-01',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 BOX (71447-100-01)  / 100 g in 1 BOTTLE, PLASTIC (71447-100-00)',\n",
       "    'marketing_start_date': '20191001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['LABORATOIRES DRUIDE INC'],\n",
       "   'spl_set_id': ['9535f56d-a976-fc33-e053-2995a90a09f6'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0829852196118'],\n",
       "   'unii': ['15FIX9V2JP', 'SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': 'c781ee12-6676-81dc-e053-2995a90adf93',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20191001',\n",
       "  'product_id': '71447-100_c781ee12-6676-81dc-e053-2995a90adf93',\n",
       "  'application_number': 'part352',\n",
       "  'brand_name_base': 'NELLY DEVUYST ORGANIC TRANSPARENT MINERAL SUNSCREEN'},\n",
       " {'product_ndc': '71481-009',\n",
       "  'generic_name': 'CALCIUM CARBONATE',\n",
       "  'labeler_name': 'BioV Health Inc',\n",
       "  'brand_name': 'Bio V Antacid Wintergreen 96ct',\n",
       "  'active_ingredients': [{'name': 'CALCIUM CARBONATE',\n",
       "    'strength': '750 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71481-009-01',\n",
       "    'description': '96 TABLET in 1 BOTTLE (71481-009-01)',\n",
       "    'marketing_start_date': '20220228',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['BioV Health Inc'],\n",
       "   'rxcui': ['308915'],\n",
       "   'spl_set_id': ['1db86834-459e-4ba5-80f5-d889763714d5'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['H0G9379FGK']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '1549b8d2-50d4-4e42-e063-6394a90a7aec',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220228',\n",
       "  'product_id': '71481-009_1549b8d2-50d4-4e42-e063-6394a90a7aec',\n",
       "  'application_number': 'M001',\n",
       "  'brand_name_base': 'Bio V Antacid Wintergreen 96ct'},\n",
       " {'product_ndc': '71481-012',\n",
       "  'generic_name': 'CALCIUM CARBONATE',\n",
       "  'labeler_name': 'BioV Health Inc',\n",
       "  'brand_name': 'DGH Antacid 1000 Tropical Fruit, 72ct',\n",
       "  'active_ingredients': [{'name': 'CALCIUM CARBONATE',\n",
       "    'strength': '1000 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71481-012-01',\n",
       "    'description': '72 TABLET, CHEWABLE in 1 BOTTLE (71481-012-01)',\n",
       "    'marketing_start_date': '20230308',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['BioV Health Inc'],\n",
       "   'rxcui': ['308892'],\n",
       "   'spl_set_id': ['527a3686-fbc6-418b-892e-ead28fd48c3a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['H0G9379FGK']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'TABLET, CHEWABLE',\n",
       "  'spl_id': 'f663921b-abeb-bf81-e053-2a95a90a2e1e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230308',\n",
       "  'product_id': '71481-012_f663921b-abeb-bf81-e053-2a95a90a2e1e',\n",
       "  'application_number': 'part331',\n",
       "  'brand_name_base': 'DGH Antacid 1000 Tropical Fruit, 72ct'},\n",
       " {'product_ndc': '71494-103',\n",
       "  'generic_name': 'Salicylic Acid',\n",
       "  'labeler_name': 'Peace Out LLC',\n",
       "  'brand_name': 'Peace Out Acne Cleanser',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '20 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71494-103-01',\n",
       "    'description': '1 TUBE in 1 CARTON (71494-103-01)  / 118 mL in 1 TUBE',\n",
       "    'marketing_start_date': '20240301',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Peace Out LLC'],\n",
       "   'rxcui': ['562600'],\n",
       "   'spl_set_id': ['0a8897b0-cb8f-ba50-e063-6394a90a7f34'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['O414PZ4LPZ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '0e107a4a-a96e-d03c-e063-6394a90af89b',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240301',\n",
       "  'product_id': '71494-103_0e107a4a-a96e-d03c-e063-6394a90af89b',\n",
       "  'application_number': 'M006',\n",
       "  'brand_name_base': 'Peace Out Acne Cleanser'},\n",
       " {'product_ndc': '71499-220',\n",
       "  'generic_name': 'AVOBENZONE, HOMOSALATE, OCTISALATE',\n",
       "  'labeler_name': 'KENDO HOLDINGS INC',\n",
       "  'brand_name': 'FENTY SKIN HYDRA VIZOR SPF 30',\n",
       "  'brand_name_suffix': 'SPF 30',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '3 g/100mL'},\n",
       "   {'name': 'HOMOSALATE', 'strength': '9 g/100mL'},\n",
       "   {'name': 'OCTISALATE', 'strength': '4.5 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71499-220-01',\n",
       "    'description': '7 mL in 1 TUBE (71499-220-01)',\n",
       "    'marketing_start_date': '20200823',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71499-220-02',\n",
       "    'description': '30 mL in 1 TUBE (71499-220-02)',\n",
       "    'marketing_start_date': '20200823',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71499-220-03',\n",
       "    'description': '50 mL in 1 BOTTLE (71499-220-03)',\n",
       "    'marketing_start_date': '20200823',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['KENDO HOLDINGS INC'],\n",
       "   'spl_set_id': ['1d26bfb0-3c05-4a0c-9d4b-810359222730'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['G63QQF2NOX', 'V06SV4M95S', '4X49Y0596W']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '09d12237-9b5f-f8e4-e063-6294a90ae278',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200823',\n",
       "  'product_id': '71499-220_09d12237-9b5f-f8e4-e063-6294a90ae278',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'FENTY SKIN HYDRA VIZOR'},\n",
       " {'product_ndc': '71501-1903',\n",
       "  'generic_name': 'Zinc Oxide',\n",
       "  'labeler_name': 'Dr. Loretta, LLC',\n",
       "  'brand_name': 'Universal Glow Daily Defense SPF 40',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '170 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71501-1903-1',\n",
       "    'description': '50 mL in 1 TUBE (71501-1903-1)',\n",
       "    'marketing_start_date': '20230501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Dr. Loretta, LLC'],\n",
       "   'spl_set_id': ['fae21e0a-5e41-bffb-e053-6294a90afb9d'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['O414PZ4LPZ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': 'fae21e0a-5e42-bffb-e053-6294a90afb9d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230501',\n",
       "  'product_id': '71501-1903_fae21e0a-5e42-bffb-e053-6294a90afb9d',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Universal Glow Daily Defense SPF 40'},\n",
       " {'product_ndc': '71511-701',\n",
       "  'generic_name': 'Naproxen',\n",
       "  'labeler_name': 'Athena Bioscience, LLC',\n",
       "  'brand_name': 'Naprosyn',\n",
       "  'active_ingredients': [{'name': 'NAPROXEN', 'strength': '125 mg/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71511-701-16',\n",
       "    'description': '473 mL in 1 BOTTLE, PLASTIC (71511-701-16)',\n",
       "    'marketing_start_date': '20180101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Athena Bioscience, LLC'],\n",
       "   'rxcui': ['207093', '311913'],\n",
       "   'spl_set_id': ['f9b4173d-7836-4d7d-b149-1d96f9377ad0'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['57Y76R9ATQ']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'SUSPENSION',\n",
       "  'spl_id': '8ae1c41c-a532-4878-bc44-814b2061fdd3',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180101',\n",
       "  'product_id': '71511-701_8ae1c41c-a532-4878-bc44-814b2061fdd3',\n",
       "  'application_number': 'NDA018965',\n",
       "  'brand_name_base': 'Naprosyn',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '71516-342',\n",
       "  'generic_name': 'HYDROCORTISONE',\n",
       "  'labeler_name': 'DR. MARDER SKINCARE, LLC',\n",
       "  'brand_name': 'TOTAL RELIEF',\n",
       "  'active_ingredients': [{'name': 'HYDROCORTISONE', 'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71516-342-00',\n",
       "    'description': '180 mL in 1 TUBE (71516-342-00)',\n",
       "    'marketing_start_date': '20220725',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['DR. MARDER SKINCARE, LLC'],\n",
       "   'rxcui': ['1926571'],\n",
       "   'spl_set_id': ['2c05459c-5a2c-45ab-b534-87f966b41681'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['WI4X0X7BPJ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SHAMPOO',\n",
       "  'spl_id': '09db4f55-0162-f22c-e063-6294a90ac06a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220725',\n",
       "  'product_id': '71516-342_09db4f55-0162-f22c-e063-6294a90ac06a',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'TOTAL RELIEF',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '71521-026',\n",
       "  'generic_name': 'Colloidal Oatmeal',\n",
       "  'labeler_name': 'Lavior Pharma Inc',\n",
       "  'brand_name': 'Diabetic Itch Relief Cream',\n",
       "  'active_ingredients': [{'name': 'OATMEAL', 'strength': '1 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71521-026-15',\n",
       "    'description': '15 g in 1 TUBE (71521-026-15)',\n",
       "    'marketing_start_date': '20220317',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71521-026-50',\n",
       "    'description': '50 g in 1 BOTTLE, PUMP (71521-026-50)',\n",
       "    'marketing_start_date': '20210331',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lavior Pharma Inc'],\n",
       "   'rxcui': ['240651'],\n",
       "   'spl_set_id': ['bdcfe9f9-60a6-be70-e053-2995a90aaa20'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0869330000407'],\n",
       "   'nui': ['N0000185371',\n",
       "    'N0000185375',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'M0000728',\n",
       "    'M0006342',\n",
       "    'M0016962',\n",
       "    'N0000185016'],\n",
       "   'pharm_class_epc': ['Non-Standardized Food Allergenic Extract [EPC]',\n",
       "    'Non-Standardized Plant Allergenic Extract [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]',\n",
       "    'Dietary Proteins [CS]',\n",
       "    'Plant Proteins [CS]'],\n",
       "   'unii': ['8PI54V663Y']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '25159403-7b87-358b-e063-6394a90ab987',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210331',\n",
       "  'product_id': '71521-026_25159403-7b87-358b-e063-6394a90ab987',\n",
       "  'application_number': 'M016',\n",
       "  'brand_name_base': 'Diabetic Itch Relief Cream',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Grain Proteins [EXT]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]']},\n",
       " {'product_ndc': '71569-602',\n",
       "  'generic_name': 'Magnesium Sulfate',\n",
       "  'labeler_name': 'Jubilant, LLC',\n",
       "  'brand_name': 'Epsom Salt',\n",
       "  'active_ingredients': [{'name': 'MAGNESIUM SULFATE HEPTAHYDRATE',\n",
       "    'strength': '1 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71569-602-80',\n",
       "    'description': '3630 g in 1 POUCH (71569-602-80)',\n",
       "    'marketing_start_date': '20171001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Jubilant, LLC'],\n",
       "   'rxcui': ['1053346'],\n",
       "   'spl_set_id': ['0a5b4db5-a410-49e8-87ae-db9ab43ff464'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SK47B8698T']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GRANULE, FOR SOLUTION',\n",
       "  'spl_id': '231d7ca7-8eb4-5eac-e063-6394a90a7f72',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL', 'TOPICAL'],\n",
       "  'marketing_start_date': '20171001',\n",
       "  'product_id': '71569-602_231d7ca7-8eb4-5eac-e063-6394a90a7f72',\n",
       "  'application_number': 'M007',\n",
       "  'brand_name_base': 'Epsom Salt',\n",
       "  'pharm_class': ['Calculi Dissolution Agent [EPC]',\n",
       "   'Increased Large Intestinal Motility [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Magnesium Ion Exchange Activity [MoA]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]']},\n",
       " {'product_ndc': '71569-664',\n",
       "  'generic_name': 'Eucalyptol, menthol, methyl salicylate, thymol',\n",
       "  'labeler_name': 'Jubilant, LLC',\n",
       "  'brand_name': 'Antispetic',\n",
       "  'active_ingredients': [{'name': 'EUCALYPTOL', 'strength': '.92 mg/mL'},\n",
       "   {'name': 'MENTHOL', 'strength': '.42 mg/mL'},\n",
       "   {'name': 'METHYL SALICYLATE', 'strength': '.6 mg/mL'},\n",
       "   {'name': 'THYMOL', 'strength': '.64 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71569-664-12',\n",
       "    'description': '1500 mL in 1 BOTTLE, PLASTIC (71569-664-12)',\n",
       "    'marketing_start_date': '20170403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71569-664-86',\n",
       "    'description': '1000 mL in 1 BOTTLE, PLASTIC (71569-664-86)',\n",
       "    'marketing_start_date': '20170403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Jubilant, LLC'],\n",
       "   'rxcui': ['1043619'],\n",
       "   'spl_set_id': ['193a8edb-0d5d-48a8-95a8-bd0d7de9418f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['RV6J6604TK', 'L7T10EIP3A', 'LAV5U5022Y', '3J50XA376E']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'MOUTHWASH',\n",
       "  'spl_id': '231d7ca7-8ec4-5eac-e063-6394a90a7f72',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170403',\n",
       "  'product_id': '71569-664_231d7ca7-8ec4-5eac-e063-6394a90a7f72',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Antispetic'},\n",
       " {'product_ndc': '71574-601',\n",
       "  'generic_name': 'MENTHOL, CAPSAICIN',\n",
       "  'labeler_name': 'Village Pharma LLC',\n",
       "  'brand_name': 'Menthozen Hydrogel',\n",
       "  'active_ingredients': [{'name': 'CAPSAICIN', 'strength': '.3 mg/g'},\n",
       "   {'name': 'MENTHOL', 'strength': '40 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71574-601-05',\n",
       "    'description': '5 PATCH in 1 POUCH (71574-601-05)  / 1 g in 1 PATCH',\n",
       "    'marketing_start_date': '20190701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Village Pharma LLC'],\n",
       "   'rxcui': ['2178283'],\n",
       "   'spl_set_id': ['4c979a71-7c8f-4dff-abae-bf4cdf8f67b4'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0371574601055'],\n",
       "   'unii': ['S07O44R1ZM', 'L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'PATCH',\n",
       "  'spl_id': '0b8196c9-4d7e-996e-e063-6294a90a62a0',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190701',\n",
       "  'product_id': '71574-601_0b8196c9-4d7e-996e-e063-6294a90a62a0',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Menthozen Hydrogel'},\n",
       " {'product_ndc': '71585-138',\n",
       "  'generic_name': 'ZINC OXIDE',\n",
       "  'labeler_name': 'Salt and Stone LLC',\n",
       "  'brand_name': 'Salt and Stone Tinted Sunscreen SPF 50',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '.2405 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71585-138-00',\n",
       "    'description': '15 g in 1 APPLICATOR (71585-138-00)',\n",
       "    'marketing_start_date': '20201101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Salt and Stone LLC'],\n",
       "   'spl_set_id': ['b554b787-a7d1-0993-e053-2995a90ade1b'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0860003937518'],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'STICK',\n",
       "  'spl_id': '08c19c7c-b466-761c-e063-6294a90a0279',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20201101',\n",
       "  'product_id': '71585-138_08c19c7c-b466-761c-e063-6294a90a0279',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Salt and Stone Tinted Sunscreen SPF 50',\n",
       "  'pharm_class': ['Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]']},\n",
       " {'product_ndc': '71585-144',\n",
       "  'generic_name': 'ZINC OXIDE',\n",
       "  'labeler_name': 'SALT & STONE, INC.',\n",
       "  'brand_name': 'Salt and Stone Lightweight Sheer Mineral Sunscreen SPF30',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '157 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71585-144-00',\n",
       "    'description': '1 TUBE in 1 BOX (71585-144-00)  / 60 mL in 1 TUBE',\n",
       "    'marketing_start_date': '20230901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['SALT & STONE, INC.'],\n",
       "   'spl_set_id': ['479921da-94d1-46e9-a15e-ced8746b9b72'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0711221983743'],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '08c196b2-7262-778c-e063-6294a90a2bd3',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230901',\n",
       "  'product_id': '71585-144_08c196b2-7262-778c-e063-6294a90a2bd3',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Salt and Stone Lightweight Sheer Mineral Sunscreen SPF30',\n",
       "  'pharm_class': ['Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]']},\n",
       " {'product_ndc': '71593-101',\n",
       "  'generic_name': 'DIMETHICONE',\n",
       "  'labeler_name': 'ARG LABORATORIES INC',\n",
       "  'brand_name': 'NIGHTLY FACE TREATMENT - DIMETHICONE',\n",
       "  'active_ingredients': [{'name': 'DIMETHICONE', 'strength': '1.5 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71593-101-51',\n",
       "    'description': '1 BOTTLE in 1 BOX (71593-101-51)  / 30 mL in 1 BOTTLE (71593-101-11)',\n",
       "    'marketing_start_date': '20171206',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['ARG LABORATORIES INC'],\n",
       "   'rxcui': ['309917'],\n",
       "   'spl_set_id': ['c9fcd080-1d06-4026-bd09-1fc6cd7f72c2'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0850171007199'],\n",
       "   'nui': ['N0000010282'],\n",
       "   'pharm_class_pe': ['Skin Barrier Activity [PE]'],\n",
       "   'unii': ['92RU3N3Y1O']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': 'f1dd2cd5-417b-06c5-e053-2995a90aed79',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20171206',\n",
       "  'product_id': '71593-101_f1dd2cd5-417b-06c5-e053-2995a90aed79',\n",
       "  'application_number': 'part347',\n",
       "  'brand_name_base': 'NIGHTLY FACE TREATMENT - DIMETHICONE',\n",
       "  'pharm_class': ['Skin Barrier Activity [PE]']},\n",
       " {'product_ndc': '71610-015',\n",
       "  'generic_name': 'Hydrochlorothiazide',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Hydrochlorothiazide',\n",
       "  'active_ingredients': [{'name': 'HYDROCHLOROTHIAZIDE',\n",
       "    'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-015-45',\n",
       "    'description': '45 TABLET in 1 BOTTLE (71610-015-45)',\n",
       "    'marketing_start_date': '20180123',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-015-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-015-60)',\n",
       "    'marketing_start_date': '20171201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197770', '310798'],\n",
       "   'spl_set_id': ['27e9e65d-d6f5-40e6-899e-cb033a171291'],\n",
       "   'nui': ['N0000175359', 'N0000175419', 'M0471776'],\n",
       "   'pharm_class_pe': ['Increased Diuresis [PE]'],\n",
       "   'pharm_class_epc': ['Thiazide Diuretic [EPC]'],\n",
       "   'pharm_class_cs': ['Thiazides [CS]'],\n",
       "   'unii': ['0J48LPH2TH']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '2c278b34-9004-4bae-a43d-ee454d87b9ba',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170608',\n",
       "  'product_id': '71610-015_2c278b34-9004-4bae-a43d-ee454d87b9ba',\n",
       "  'application_number': 'ANDA083177',\n",
       "  'brand_name_base': 'Hydrochlorothiazide',\n",
       "  'pharm_class': ['Increased Diuresis [PE]',\n",
       "   'Thiazide Diuretic [EPC]',\n",
       "   'Thiazides [CS]']},\n",
       " {'product_ndc': '71610-016',\n",
       "  'generic_name': 'Cyclobenzaprine Hydrochloride',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Cyclobenzaprine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'CYCLOBENZAPRINE HYDROCHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-016-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71610-016-30)',\n",
       "    'marketing_start_date': '20200408',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-016-45',\n",
       "    'description': '45 TABLET, FILM COATED in 1 BOTTLE (71610-016-45)',\n",
       "    'marketing_start_date': '20171207',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-016-53',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71610-016-53)',\n",
       "    'marketing_start_date': '20200505',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-016-70',\n",
       "    'description': '120 TABLET, FILM COATED in 1 BOTTLE (71610-016-70)',\n",
       "    'marketing_start_date': '20200505',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-016-92',\n",
       "    'description': '270 TABLET, FILM COATED in 1 BOTTLE (71610-016-92)',\n",
       "    'marketing_start_date': '20171227',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['828348'],\n",
       "   'spl_set_id': ['bb23383c-087a-4fb1-8917-edecd1ec4527'],\n",
       "   'unii': ['0VE05JYS2P']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'a35560e7-0593-4c49-87b1-8971ff6df820',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20140731',\n",
       "  'product_id': '71610-016_a35560e7-0593-4c49-87b1-8971ff6df820',\n",
       "  'application_number': 'ANDA078048',\n",
       "  'brand_name_base': 'Cyclobenzaprine Hydrochloride',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '71610-031',\n",
       "  'generic_name': 'Divalproex Sodium',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Divalproex Sodium',\n",
       "  'active_ingredients': [{'name': 'DIVALPROEX SODIUM',\n",
       "    'strength': '250 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-031-60',\n",
       "    'description': '90 TABLET, DELAYED RELEASE in 1 BOTTLE (71610-031-60)',\n",
       "    'marketing_start_date': '20180119',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['1099678'],\n",
       "   'spl_set_id': ['b74adc5e-e92d-46a7-afdc-a6464a440bde'],\n",
       "   'unii': ['644VL95AO6']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, DELAYED RELEASE',\n",
       "  'spl_id': '0f33ee94-fff3-4ae7-92fc-16f72a983d21',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20140321',\n",
       "  'product_id': '71610-031_0f33ee94-fff3-4ae7-92fc-16f72a983d21',\n",
       "  'application_number': 'ANDA078182',\n",
       "  'brand_name_base': 'Divalproex Sodium',\n",
       "  'pharm_class': ['Anti-epileptic Agent [EPC]',\n",
       "   'Decreased Central Nervous System Disorganized Electrical Activity [PE]',\n",
       "   'Mood Stabilizer [EPC]']},\n",
       " {'product_ndc': '71610-032',\n",
       "  'generic_name': 'Divalproex Sodium',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Divalproex Sodium',\n",
       "  'active_ingredients': [{'name': 'DIVALPROEX SODIUM',\n",
       "    'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-032-53',\n",
       "    'description': '60 TABLET, DELAYED RELEASE in 1 BOTTLE (71610-032-53)',\n",
       "    'marketing_start_date': '20180119',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-032-60',\n",
       "    'description': '90 TABLET, DELAYED RELEASE in 1 BOTTLE (71610-032-60)',\n",
       "    'marketing_start_date': '20180119',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['1099870'],\n",
       "   'spl_set_id': ['9cfdcb58-d6d7-43bb-b6e1-17172b143296'],\n",
       "   'unii': ['644VL95AO6']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, DELAYED RELEASE',\n",
       "  'spl_id': 'a117c85f-4dfb-46da-99aa-4c4146e78865',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20140321',\n",
       "  'product_id': '71610-032_a117c85f-4dfb-46da-99aa-4c4146e78865',\n",
       "  'application_number': 'ANDA078182',\n",
       "  'brand_name_base': 'Divalproex Sodium',\n",
       "  'pharm_class': ['Anti-epileptic Agent [EPC]',\n",
       "   'Decreased Central Nervous System Disorganized Electrical Activity [PE]',\n",
       "   'Mood Stabilizer [EPC]']},\n",
       " {'product_ndc': '0527-1407',\n",
       "  'generic_name': 'Pilocarpine Hydrochloride',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'brand_name': 'Pilocarpine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PILOCARPINE HYDROCHLORIDE',\n",
       "    'strength': '7.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-1407-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (0527-1407-01)',\n",
       "    'marketing_start_date': '20051014',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['1000913', '1001004'],\n",
       "   'spl_set_id': ['8db0db4f-55ad-46b2-af50-e71b4a763aaa'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305271313010', '0305271407016'],\n",
       "   'unii': ['0WW6D218XJ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '3062d101-0b98-4101-8f53-13ae694873fe',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20051014',\n",
       "  'product_id': '0527-1407_3062d101-0b98-4101-8f53-13ae694873fe',\n",
       "  'application_number': 'ANDA077220',\n",
       "  'brand_name_base': 'Pilocarpine Hydrochloride',\n",
       "  'pharm_class': ['Cholinergic Agonists [MoA]',\n",
       "   'Cholinergic Muscarinic Agonists [MoA]',\n",
       "   'Cholinergic Receptor Agonist [EPC]']},\n",
       " {'product_ndc': '71610-054',\n",
       "  'generic_name': 'SENNA',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'SENNA',\n",
       "  'active_ingredients': [{'name': 'SENNOSIDES A AND B',\n",
       "    'strength': '8.6 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-054-65',\n",
       "    'description': '100 TABLET, COATED in 1 BOTTLE, PLASTIC (71610-054-65)',\n",
       "    'marketing_start_date': '20180426',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['312935'],\n",
       "   'spl_set_id': ['fb426ee8-b582-405f-9ded-71aea6bf2640'],\n",
       "   'unii': ['1B5FPI42EN']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': 'de9c808c-32de-497e-95ce-3c93fa4f3cf1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20150609',\n",
       "  'product_id': '71610-054_de9c808c-32de-497e-95ce-3c93fa4f3cf1',\n",
       "  'application_number': 'part334',\n",
       "  'brand_name_base': 'SENNA'},\n",
       " {'product_ndc': '71610-092',\n",
       "  'generic_name': 'CITALOPRAM',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'CITALOPRAM HYDROBROMIDE',\n",
       "  'active_ingredients': [{'name': 'CITALOPRAM HYDROBROMIDE',\n",
       "    'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-092-15',\n",
       "    'description': '15 TABLET in 1 BOTTLE (71610-092-15)',\n",
       "    'marketing_start_date': '20180626',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-092-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71610-092-30)',\n",
       "    'marketing_start_date': '20180626',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-092-45',\n",
       "    'description': '45 TABLET in 1 BOTTLE (71610-092-45)',\n",
       "    'marketing_start_date': '20180626',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-092-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-092-60)',\n",
       "    'marketing_start_date': '20180626',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['200371'],\n",
       "   'spl_set_id': ['d05f4e71-95f3-4f22-8b01-b21e5c19e0f2'],\n",
       "   'unii': ['I1E9D14F36']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'd05f4e71-95f3-4f22-8b01-b21e5c19e0f2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171110',\n",
       "  'product_id': '71610-092_d05f4e71-95f3-4f22-8b01-b21e5c19e0f2',\n",
       "  'application_number': 'ANDA077534',\n",
       "  'brand_name_base': 'CITALOPRAM HYDROBROMIDE',\n",
       "  'pharm_class': ['Serotonin Reuptake Inhibitor [EPC]',\n",
       "   'Serotonin Uptake Inhibitors [MoA]']},\n",
       " {'product_ndc': '71610-095',\n",
       "  'generic_name': 'Hydroxyzine Pamoate',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Hydroxyzine Pamoate',\n",
       "  'active_ingredients': [{'name': 'HYDROXYZINE PAMOATE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-095-60',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE, PLASTIC (71610-095-60)',\n",
       "    'marketing_start_date': '20180713',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['995253'],\n",
       "   'spl_set_id': ['cac660eb-d125-4651-95cf-d44e267abadf'],\n",
       "   'unii': ['M20215MUFR']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'cd7fa91d-c679-4050-a1b7-3e68b7c49658',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180412',\n",
       "  'product_id': '71610-095_cd7fa91d-c679-4050-a1b7-3e68b7c49658',\n",
       "  'application_number': 'ANDA040156',\n",
       "  'brand_name_base': 'Hydroxyzine Pamoate',\n",
       "  'pharm_class': ['Antihistamine [EPC]',\n",
       "   'Histamine Receptor Antagonists [MoA]']},\n",
       " {'product_ndc': '71610-101',\n",
       "  'generic_name': 'temazepam',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'temazepam',\n",
       "  'active_ingredients': [{'name': 'TEMAZEPAM', 'strength': '30 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-101-15',\n",
       "    'description': '15 CAPSULE in 1 BOTTLE, PLASTIC (71610-101-15)',\n",
       "    'marketing_start_date': '20180726',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-101-20',\n",
       "    'description': '20 CAPSULE in 1 BOTTLE, PLASTIC (71610-101-20)',\n",
       "    'marketing_start_date': '20180726',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-101-28',\n",
       "    'description': '28 CAPSULE in 1 BOTTLE, PLASTIC (71610-101-28)',\n",
       "    'marketing_start_date': '20180726',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-101-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE, PLASTIC (71610-101-30)',\n",
       "    'marketing_start_date': '20180726',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-101-53',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE, PLASTIC (71610-101-53)',\n",
       "    'marketing_start_date': '20180726',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-101-59',\n",
       "    'description': '22 CAPSULE in 1 BOTTLE, PLASTIC (71610-101-59)',\n",
       "    'marketing_start_date': '20180726',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-101-60',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE, PLASTIC (71610-101-60)',\n",
       "    'marketing_start_date': '20180726',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['198242'],\n",
       "   'spl_set_id': ['0f996a27-a07a-4d76-a130-33bab4a7ce96'],\n",
       "   'nui': ['N0000175694', 'M0002356'],\n",
       "   'pharm_class_epc': ['Benzodiazepine [EPC]'],\n",
       "   'pharm_class_cs': ['Benzodiazepines [CS]'],\n",
       "   'unii': ['CHB1QD2QSS']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'a5b51b65-39a0-4c0f-97c2-8c91700b5f08',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19870421',\n",
       "  'product_id': '71610-101_a5b51b65-39a0-4c0f-97c2-8c91700b5f08',\n",
       "  'application_number': 'ANDA071457',\n",
       "  'brand_name_base': 'temazepam',\n",
       "  'pharm_class': ['Benzodiazepine [EPC]', 'Benzodiazepines [CS]']},\n",
       " {'product_ndc': '71610-105',\n",
       "  'generic_name': 'Glipizide',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Glipizide',\n",
       "  'active_ingredients': [{'name': 'GLIPIZIDE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-105-53',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71610-105-53)',\n",
       "    'marketing_start_date': '20180727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-105-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-105-60)',\n",
       "    'marketing_start_date': '20180727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-105-70',\n",
       "    'description': '120 TABLET in 1 BOTTLE (71610-105-70)',\n",
       "    'marketing_start_date': '20180727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-105-80',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71610-105-80)',\n",
       "    'marketing_start_date': '20180727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-105-92',\n",
       "    'description': '270 TABLET in 1 BOTTLE (71610-105-92)',\n",
       "    'marketing_start_date': '20180727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-105-94',\n",
       "    'description': '360 TABLET in 1 BOTTLE (71610-105-94)',\n",
       "    'marketing_start_date': '20180815',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['310488'],\n",
       "   'spl_set_id': ['9f7f880a-1060-431a-a155-884e8cfbdf22'],\n",
       "   'nui': ['N0000175608', 'M0020795'],\n",
       "   'pharm_class_epc': ['Sulfonylurea [EPC]'],\n",
       "   'pharm_class_cs': ['Sulfonylurea Compounds [CS]'],\n",
       "   'unii': ['X7WDT95N5C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'cb4966b5-fc0b-416e-a3d3-9153957afd38',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20020925',\n",
       "  'product_id': '71610-105_cb4966b5-fc0b-416e-a3d3-9153957afd38',\n",
       "  'application_number': 'ANDA075795',\n",
       "  'brand_name_base': 'Glipizide',\n",
       "  'pharm_class': ['Sulfonylurea Compounds [CS]', 'Sulfonylurea [EPC]']},\n",
       " {'product_ndc': '71610-119',\n",
       "  'generic_name': 'Ondansetron Hydrochloride',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Ondansetron Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'ONDANSETRON HYDROCHLORIDE',\n",
       "    'strength': '8 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-119-88',\n",
       "    'description': '900 TABLET, FILM COATED in 1 BOTTLE (71610-119-88)',\n",
       "    'marketing_start_date': '20180815',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['312086'],\n",
       "   'spl_set_id': ['08db5ce7-4dcf-4581-a0bf-f405cc22b48d'],\n",
       "   'unii': ['NMH84OZK2B']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '864f5aaf-0819-42bb-8bc6-7878a5378986',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20070731',\n",
       "  'product_id': '71610-119_864f5aaf-0819-42bb-8bc6-7878a5378986',\n",
       "  'application_number': 'ANDA078539',\n",
       "  'brand_name_base': 'Ondansetron Hydrochloride',\n",
       "  'pharm_class': ['Serotonin 3 Receptor Antagonists [MoA]',\n",
       "   'Serotonin-3 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '71610-121',\n",
       "  'generic_name': 'Mirtazapine',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Mirtazapine',\n",
       "  'active_ingredients': [{'name': 'MIRTAZAPINE', 'strength': '15 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-121-09',\n",
       "    'description': '9000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-121-09)',\n",
       "    'marketing_start_date': '20180815',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['311725'],\n",
       "   'spl_set_id': ['dee6139c-4102-4b25-84c0-29390db7a8f7'],\n",
       "   'unii': ['A051Q2099Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '658b4bb3-7feb-4cd0-85e5-7d6096e601e1',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20030619',\n",
       "  'product_id': '71610-121_658b4bb3-7feb-4cd0-85e5-7d6096e601e1',\n",
       "  'application_number': 'ANDA076312',\n",
       "  'brand_name_base': 'Mirtazapine'},\n",
       " {'product_ndc': '71610-157',\n",
       "  'generic_name': 'Divalproex sodium',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Divalproex sodium',\n",
       "  'active_ingredients': [{'name': 'DIVALPROEX SODIUM',\n",
       "    'strength': '250 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-157-60',\n",
       "    'description': '90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-157-60)',\n",
       "    'marketing_start_date': '20180920',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-157-75',\n",
       "    'description': '150 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-157-75)',\n",
       "    'marketing_start_date': '20180920',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['1099563'],\n",
       "   'spl_set_id': ['ad5e8bd8-c923-40f0-a106-55620c4247d7'],\n",
       "   'unii': ['644VL95AO6']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED, EXTENDED RELEASE',\n",
       "  'spl_id': '33511714-8ded-46ee-ae1d-03a536728d31',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20140602',\n",
       "  'product_id': '71610-157_33511714-8ded-46ee-ae1d-03a536728d31',\n",
       "  'application_number': 'ANDA202419',\n",
       "  'brand_name_base': 'Divalproex sodium',\n",
       "  'pharm_class': ['Anti-epileptic Agent [EPC]',\n",
       "   'Decreased Central Nervous System Disorganized Electrical Activity [PE]',\n",
       "   'Mood Stabilizer [EPC]']},\n",
       " {'product_ndc': '71610-159',\n",
       "  'generic_name': 'Ciprofloxacin Hydrochloride',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Ciprofloxacin',\n",
       "  'active_ingredients': [{'name': 'CIPROFLOXACIN HYDROCHLORIDE',\n",
       "    'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-159-83',\n",
       "    'description': '3600 TABLET, FILM COATED in 1 BOTTLE (71610-159-83)',\n",
       "    'marketing_start_date': '20180920',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['309309'],\n",
       "   'spl_set_id': ['4e74496f-4dca-4471-be32-c0a14bc62750'],\n",
       "   'unii': ['4BA73M5E37']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'ed26d6d8-3eab-470a-80ce-d18fabbdfb3a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20070426',\n",
       "  'product_id': '71610-159_ed26d6d8-3eab-470a-80ce-d18fabbdfb3a',\n",
       "  'application_number': 'ANDA077859',\n",
       "  'brand_name_base': 'Ciprofloxacin',\n",
       "  'pharm_class': ['Quinolone Antimicrobial [EPC]', 'Quinolones [CS]']},\n",
       " {'product_ndc': '71610-160',\n",
       "  'generic_name': 'Doxazosin',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Doxazosin',\n",
       "  'active_ingredients': [{'name': 'DOXAZOSIN MESYLATE', 'strength': '8 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-160-16',\n",
       "    'description': '6000 TABLET in 1 BOTTLE (71610-160-16)',\n",
       "    'marketing_start_date': '20180920',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-160-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-160-60)',\n",
       "    'marketing_start_date': '20211123',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197626', '197628'],\n",
       "   'spl_set_id': ['f1dc70f6-4329-46da-8990-7bd6eec9d37d'],\n",
       "   'unii': ['86P6PQK0MU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'c783db8d-05dc-4b11-9f6a-bcb821b73cac',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20150409',\n",
       "  'product_id': '71610-160_c783db8d-05dc-4b11-9f6a-bcb821b73cac',\n",
       "  'application_number': 'ANDA075580',\n",
       "  'brand_name_base': 'Doxazosin',\n",
       "  'pharm_class': ['Adrenergic alpha-Antagonists [MoA]',\n",
       "   'alpha-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '71610-165',\n",
       "  'generic_name': 'Buspirone Hydrochloride',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Buspirone Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'BUSPIRONE HYDROCHLORIDE',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-165-53',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71610-165-53)',\n",
       "    'marketing_start_date': '20180928',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-165-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-165-60)',\n",
       "    'marketing_start_date': '20180928',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-165-80',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71610-165-80)',\n",
       "    'marketing_start_date': '20180928',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['866094'],\n",
       "   'spl_set_id': ['8b6e7ae6-5b83-4a5a-ab45-cf4be4287d78'],\n",
       "   'unii': ['207LT9J9OC']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'a80c0ae3-f047-4f97-bddd-0de411fd19ce',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20161215',\n",
       "  'product_id': '71610-165_a80c0ae3-f047-4f97-bddd-0de411fd19ce',\n",
       "  'application_number': 'ANDA202557',\n",
       "  'brand_name_base': 'Buspirone Hydrochloride'},\n",
       " {'product_ndc': '71610-168',\n",
       "  'generic_name': 'ATORVASTATIN CALCIUM',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'ATORVASTATIN CALCIUM',\n",
       "  'active_ingredients': [{'name': 'ATORVASTATIN CALCIUM TRIHYDRATE',\n",
       "    'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-168-15',\n",
       "    'description': '15 TABLET, FILM COATED in 1 BOTTLE (71610-168-15)',\n",
       "    'marketing_start_date': '20220628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-168-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71610-168-30)',\n",
       "    'marketing_start_date': '20220628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-168-45',\n",
       "    'description': '45 TABLET, FILM COATED in 1 BOTTLE (71610-168-45)',\n",
       "    'marketing_start_date': '20181005',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-168-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71610-168-60)',\n",
       "    'marketing_start_date': '20220628',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['259255', '617311', '617312'],\n",
       "   'spl_set_id': ['82203824-c0aa-41dd-8dd1-13cd5063917f'],\n",
       "   'unii': ['48A5M73Z4Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '2cff8a5e-1a3e-4a4f-b916-520ce1c15a4d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20160519',\n",
       "  'product_id': '71610-168_2cff8a5e-1a3e-4a4f-b916-520ce1c15a4d',\n",
       "  'application_number': 'ANDA205519',\n",
       "  'brand_name_base': 'ATORVASTATIN CALCIUM',\n",
       "  'pharm_class': ['HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71610-180',\n",
       "  'generic_name': 'ATORVASTATIN CALCIUM',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'ATORVASTATIN CALCIUM',\n",
       "  'active_ingredients': [{'name': 'ATORVASTATIN CALCIUM TRIHYDRATE',\n",
       "    'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-180-15',\n",
       "    'description': '15 TABLET, FILM COATED in 1 BOTTLE (71610-180-15)',\n",
       "    'marketing_start_date': '20220628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-180-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71610-180-30)',\n",
       "    'marketing_start_date': '20220628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-180-45',\n",
       "    'description': '45 TABLET, FILM COATED in 1 BOTTLE (71610-180-45)',\n",
       "    'marketing_start_date': '20181028',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-180-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71610-180-60)',\n",
       "    'marketing_start_date': '20181028',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['617310'],\n",
       "   'spl_set_id': ['acca55df-591b-4122-ac67-a1ee193e9424'],\n",
       "   'unii': ['48A5M73Z4Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '0be8396c-e02e-46f8-9528-dcfe9f7ab28a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20160519',\n",
       "  'product_id': '71610-180_0be8396c-e02e-46f8-9528-dcfe9f7ab28a',\n",
       "  'application_number': 'ANDA205519',\n",
       "  'brand_name_base': 'ATORVASTATIN CALCIUM',\n",
       "  'pharm_class': ['HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '0527-1535',\n",
       "  'generic_name': 'Doxycycline',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'brand_name': 'Doxycycline',\n",
       "  'active_ingredients': [{'name': 'DOXYCYCLINE', 'strength': '75 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-1535-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-1535-01)',\n",
       "    'marketing_start_date': '20080825',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['1649429', '1650142', '1650444', '1652673'],\n",
       "   'spl_set_id': ['4999bbd9-44ed-4749-9730-be2337bdf490'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305271537300', '0305271535016'],\n",
       "   'nui': ['N0000175882', 'N0000007948'],\n",
       "   'pharm_class_epc': ['Tetracycline-class Drug [EPC]'],\n",
       "   'pharm_class_cs': ['Tetracyclines [Chemical/Ingredient]'],\n",
       "   'unii': ['N12000U13O']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'dc960a6c-1b09-4049-a1e9-0109576b1d30',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20080825',\n",
       "  'product_id': '0527-1535_dc960a6c-1b09-4049-a1e9-0109576b1d30',\n",
       "  'application_number': 'ANDA065285',\n",
       "  'brand_name_base': 'Doxycycline',\n",
       "  'pharm_class': ['Tetracycline-class Drug [EPC]', 'Tetracyclines [CS]']},\n",
       " {'product_ndc': '71610-194',\n",
       "  'generic_name': 'Allopurinol',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Allopurinol',\n",
       "  'active_ingredients': [{'name': 'ALLOPURINOL', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-194-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71610-194-30)',\n",
       "    'marketing_start_date': '20210609',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-194-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-194-60)',\n",
       "    'marketing_start_date': '20181116',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-194-80',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71610-194-80)',\n",
       "    'marketing_start_date': '20190108',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197319'],\n",
       "   'spl_set_id': ['3dc4980c-8062-4239-a860-63888cabee46'],\n",
       "   'nui': ['N0000175698', 'N0000000206'],\n",
       "   'pharm_class_epc': ['Xanthine Oxidase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Xanthine Oxidase Inhibitors [MoA]'],\n",
       "   'unii': ['63CZ7GJN5I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'f91cc234-c1d7-4d08-bfca-4966770a3339',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20091001',\n",
       "  'product_id': '71610-194_f91cc234-c1d7-4d08-bfca-4966770a3339',\n",
       "  'application_number': 'ANDA071586',\n",
       "  'brand_name_base': 'Allopurinol',\n",
       "  'pharm_class': ['Xanthine Oxidase Inhibitor [EPC]',\n",
       "   'Xanthine Oxidase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71610-197',\n",
       "  'generic_name': 'Allopurinol',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Allopurinol',\n",
       "  'active_ingredients': [{'name': 'ALLOPURINOL', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-197-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE, PLASTIC (71610-197-60)',\n",
       "    'marketing_start_date': '20181127',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-197-80',\n",
       "    'description': '180 TABLET in 1 BOTTLE, PLASTIC (71610-197-80)',\n",
       "    'marketing_start_date': '20181127',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197319'],\n",
       "   'spl_set_id': ['3f5905f1-243e-4880-ad1c-d34064f17356'],\n",
       "   'nui': ['N0000175698', 'N0000000206'],\n",
       "   'pharm_class_epc': ['Xanthine Oxidase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Xanthine Oxidase Inhibitors [MoA]'],\n",
       "   'unii': ['63CZ7GJN5I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '17bbed36-cb0a-4e46-8a4c-234817505566',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19870109',\n",
       "  'product_id': '71610-197_17bbed36-cb0a-4e46-8a4c-234817505566',\n",
       "  'application_number': 'ANDA071450',\n",
       "  'brand_name_base': 'Allopurinol',\n",
       "  'pharm_class': ['Xanthine Oxidase Inhibitor [EPC]',\n",
       "   'Xanthine Oxidase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71610-201',\n",
       "  'generic_name': 'DIVALPROEX SODIUM',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Divalproex Sodium',\n",
       "  'active_ingredients': [{'name': 'DIVALPROEX SODIUM',\n",
       "    'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-201-53',\n",
       "    'description': '60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-201-53)',\n",
       "    'marketing_start_date': '20181203',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-201-60',\n",
       "    'description': '90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-201-60)',\n",
       "    'marketing_start_date': '20181203',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-201-70',\n",
       "    'description': '120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-201-70)',\n",
       "    'marketing_start_date': '20181203',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['1099569'],\n",
       "   'spl_set_id': ['5d82d8bb-fb03-4922-937f-f53594bbcc05'],\n",
       "   'unii': ['644VL95AO6']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED, EXTENDED RELEASE',\n",
       "  'spl_id': '463f25a7-5120-4ca4-b572-502598615a09',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20090804',\n",
       "  'product_id': '71610-201_463f25a7-5120-4ca4-b572-502598615a09',\n",
       "  'application_number': 'ANDA078791',\n",
       "  'brand_name_base': 'Divalproex Sodium',\n",
       "  'pharm_class': ['Anti-epileptic Agent [EPC]',\n",
       "   'Decreased Central Nervous System Disorganized Electrical Activity [PE]',\n",
       "   'Mood Stabilizer [EPC]']},\n",
       " {'product_ndc': '71610-223',\n",
       "  'generic_name': 'Methocarbamol',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Methocarbamol',\n",
       "  'active_ingredients': [{'name': 'METHOCARBAMOL', 'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-223-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71610-223-30)',\n",
       "    'marketing_start_date': '20190116',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-223-53',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71610-223-53)',\n",
       "    'marketing_start_date': '20190116',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-223-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71610-223-60)',\n",
       "    'marketing_start_date': '20190116',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-223-70',\n",
       "    'description': '120 TABLET, FILM COATED in 1 BOTTLE (71610-223-70)',\n",
       "    'marketing_start_date': '20190116',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-223-80',\n",
       "    'description': '180 TABLET, FILM COATED in 1 BOTTLE (71610-223-80)',\n",
       "    'marketing_start_date': '20190116',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-223-90',\n",
       "    'description': '240 TABLET, FILM COATED in 1 BOTTLE (71610-223-90)',\n",
       "    'marketing_start_date': '20190116',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-223-92',\n",
       "    'description': '270 TABLET, FILM COATED in 1 BOTTLE (71610-223-92)',\n",
       "    'marketing_start_date': '20190116',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197943'],\n",
       "   'spl_set_id': ['54f95c9f-df3d-49db-be1c-17e1eb060bf7'],\n",
       "   'nui': ['N0000175730', 'N0000175737'],\n",
       "   'pharm_class_pe': ['Centrally-mediated Muscle Relaxation [PE]'],\n",
       "   'pharm_class_epc': ['Muscle Relaxant [EPC]'],\n",
       "   'unii': ['125OD7737X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '516b1961-a47b-4474-a1c1-507ee9d670c0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181001',\n",
       "  'product_id': '71610-223_516b1961-a47b-4474-a1c1-507ee9d670c0',\n",
       "  'application_number': 'ANDA208507',\n",
       "  'brand_name_base': 'Methocarbamol',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '71610-228',\n",
       "  'generic_name': 'Tizanidine',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Tizanidine',\n",
       "  'active_ingredients': [{'name': 'TIZANIDINE HYDROCHLORIDE',\n",
       "    'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-228-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE, PLASTIC (71610-228-30)',\n",
       "    'marketing_start_date': '20190131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-228-53',\n",
       "    'description': '60 TABLET in 1 BOTTLE, PLASTIC (71610-228-53)',\n",
       "    'marketing_start_date': '20190131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-228-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE, PLASTIC (71610-228-60)',\n",
       "    'marketing_start_date': '20190131',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['313413'],\n",
       "   'spl_set_id': ['ea242c7d-b101-4197-8e65-b2b079e3b2b6'],\n",
       "   'unii': ['B53E3NMY5C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'fb129009-348e-4512-a39f-e36fbf805c86',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20130401',\n",
       "  'product_id': '71610-228_fb129009-348e-4512-a39f-e36fbf805c86',\n",
       "  'application_number': 'ANDA091283',\n",
       "  'brand_name_base': 'Tizanidine',\n",
       "  'pharm_class': ['Adrenergic alpha2-Agonists [MoA]',\n",
       "   'Central alpha-2 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '71610-236',\n",
       "  'generic_name': 'Glimepiride',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Glimepiride',\n",
       "  'active_ingredients': [{'name': 'GLIMEPIRIDE', 'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-236-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-236-60)',\n",
       "    'marketing_start_date': '20190213',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-236-80',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71610-236-80)',\n",
       "    'marketing_start_date': '20190213',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['199247'],\n",
       "   'spl_set_id': ['00b9e312-921e-41e6-ad27-0a6ce87f8298'],\n",
       "   'nui': ['N0000175608', 'M0020795'],\n",
       "   'pharm_class_epc': ['Sulfonylurea [EPC]'],\n",
       "   'pharm_class_cs': ['Sulfonylurea Compounds [CS]'],\n",
       "   'unii': ['6KY687524K']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '51de9fdb-99a3-41a6-a7ef-ec6c5f819088',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20090817',\n",
       "  'product_id': '71610-236_51de9fdb-99a3-41a6-a7ef-ec6c5f819088',\n",
       "  'application_number': 'ANDA077911',\n",
       "  'brand_name_base': 'Glimepiride',\n",
       "  'pharm_class': ['Sulfonylurea Compounds [CS]', 'Sulfonylurea [EPC]']},\n",
       " {'product_ndc': '71610-242',\n",
       "  'generic_name': 'Methocarbamol',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Methocarbamol',\n",
       "  'active_ingredients': [{'name': 'METHOCARBAMOL', 'strength': '750 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-242-53',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71610-242-53)',\n",
       "    'marketing_start_date': '20190222',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-242-70',\n",
       "    'description': '120 TABLET, FILM COATED in 1 BOTTLE (71610-242-70)',\n",
       "    'marketing_start_date': '20190222',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-242-80',\n",
       "    'description': '180 TABLET, FILM COATED in 1 BOTTLE (71610-242-80)',\n",
       "    'marketing_start_date': '20190222',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197944'],\n",
       "   'spl_set_id': ['3043ecba-d66c-4287-b519-5f9955ac1b18'],\n",
       "   'nui': ['N0000175730', 'N0000175737'],\n",
       "   'pharm_class_pe': ['Centrally-mediated Muscle Relaxation [PE]'],\n",
       "   'pharm_class_epc': ['Muscle Relaxant [EPC]'],\n",
       "   'unii': ['125OD7737X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '53b25c9f-5a70-4294-9d8a-abcef0b12211',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181001',\n",
       "  'product_id': '71610-242_53b25c9f-5a70-4294-9d8a-abcef0b12211',\n",
       "  'application_number': 'ANDA208507',\n",
       "  'brand_name_base': 'Methocarbamol',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '71610-257',\n",
       "  'generic_name': 'Buspirone Hydrochloride',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Buspirone Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'BUSPIRONE HYDROCHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-257-53',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71610-257-53)',\n",
       "    'marketing_start_date': '20190329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-257-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-257-60)',\n",
       "    'marketing_start_date': '20190329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-257-80',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71610-257-80)',\n",
       "    'marketing_start_date': '20190329',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['866083'],\n",
       "   'spl_set_id': ['093b701d-4a43-4871-b726-c5820fa3ab95'],\n",
       "   'unii': ['207LT9J9OC']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '66ae500b-25d1-41af-a30c-e6f21a906eb9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20150630',\n",
       "  'product_id': '71610-257_66ae500b-25d1-41af-a30c-e6f21a906eb9',\n",
       "  'application_number': 'ANDA202330',\n",
       "  'brand_name_base': 'Buspirone Hydrochloride'},\n",
       " {'product_ndc': '71610-285',\n",
       "  'generic_name': 'Metolazone',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Metolazone',\n",
       "  'active_ingredients': [{'name': 'METOLAZONE', 'strength': '2.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-285-09',\n",
       "    'description': '9000 TABLET in 1 BOTTLE (71610-285-09)',\n",
       "    'marketing_start_date': '20190531',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197979', '311671'],\n",
       "   'spl_set_id': ['71f86ee1-9e43-482b-9ad8-ec5d5576f360'],\n",
       "   'nui': ['N0000175359', 'N0000175420'],\n",
       "   'pharm_class_pe': ['Increased Diuresis [PE]'],\n",
       "   'pharm_class_epc': ['Thiazide-like Diuretic [EPC]'],\n",
       "   'unii': ['TZ7V40X7VX']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '875c85ff-ca13-41b1-bc4e-ca871c3d2cd1',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20031219',\n",
       "  'product_id': '71610-285_875c85ff-ca13-41b1-bc4e-ca871c3d2cd1',\n",
       "  'application_number': 'ANDA076732',\n",
       "  'brand_name_base': 'Metolazone',\n",
       "  'pharm_class': ['Increased Diuresis [PE]', 'Thiazide-like Diuretic [EPC]']},\n",
       " {'product_ndc': '71610-300',\n",
       "  'generic_name': 'Alogliptin',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Alogliptin',\n",
       "  'active_ingredients': [{'name': 'ALOGLIPTIN BENZOATE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-300-09',\n",
       "    'description': '9000 TABLET, FILM COATED in 1 BOTTLE (71610-300-09)',\n",
       "    'marketing_start_date': '20190703',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-300-18',\n",
       "    'description': '3000 TABLET, FILM COATED in 1 BOTTLE (71610-300-18)',\n",
       "    'marketing_start_date': '20220125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-300-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71610-300-60)',\n",
       "    'marketing_start_date': '20230202',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['1368006'],\n",
       "   'spl_set_id': ['4b007011-547a-498e-b8f6-34ea4ea00eb4'],\n",
       "   'unii': ['EEN99869SC']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'a8ff5402-3a49-4f04-9868-f8b2dff3aa99',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20160408',\n",
       "  'product_id': '71610-300_a8ff5402-3a49-4f04-9868-f8b2dff3aa99',\n",
       "  'application_number': 'NDA022271',\n",
       "  'brand_name_base': 'Alogliptin',\n",
       "  'pharm_class': ['Dipeptidyl Peptidase 4 Inhibitor [EPC]',\n",
       "   'Dipeptidyl Peptidase 4 Inhibitors [MoA]']},\n",
       " {'product_ndc': '0527-1818',\n",
       "  'generic_name': 'Sumatriptan',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'brand_name': 'Sumatriptan',\n",
       "  'active_ingredients': [{'name': 'SUMATRIPTAN', 'strength': '5 mg/.1mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-1818-43',\n",
       "    'description': '6 BLISTER PACK in 1 CARTON (0527-1818-43)  / .1 mL in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20160219',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['313159', '314227'],\n",
       "   'spl_set_id': ['64efe12a-cc43-47e6-b3dc-21dab6ddae06'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305271818430', '0305271859433'],\n",
       "   'nui': ['N0000175763', 'N0000175764', 'N0000175765'],\n",
       "   'pharm_class_moa': ['Serotonin 1b Receptor Agonists [MoA]',\n",
       "    'Serotonin 1d Receptor Agonists [MoA]'],\n",
       "   'pharm_class_epc': ['Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]'],\n",
       "   'unii': ['8R78F6L9VO']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '1fca524e-6cf5-4782-b5d5-b37b101cd93a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['NASAL'],\n",
       "  'marketing_start_date': '20160219',\n",
       "  'product_id': '0527-1818_1fca524e-6cf5-4782-b5d5-b37b101cd93a',\n",
       "  'application_number': 'ANDA204841',\n",
       "  'brand_name_base': 'Sumatriptan',\n",
       "  'pharm_class': ['Serotonin 1b Receptor Agonists [MoA]',\n",
       "   'Serotonin 1d Receptor Agonists [MoA]',\n",
       "   'Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]']},\n",
       " {'product_ndc': '71610-370',\n",
       "  'generic_name': 'LOSARTAN POTASSIUM',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'LOSARTAN POTASSIUM',\n",
       "  'active_ingredients': [{'name': 'LOSARTAN POTASSIUM',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-370-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71610-370-30)',\n",
       "    'marketing_start_date': '20200810',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-370-45',\n",
       "    'description': '45 TABLET in 1 BOTTLE (71610-370-45)',\n",
       "    'marketing_start_date': '20191126',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['979485'],\n",
       "   'spl_set_id': ['5086631c-fa62-49c7-9290-5e3b7023e2d1'],\n",
       "   'unii': ['3ST302B24A']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '206438fc-a53c-4d5e-afcb-0c85d2be2534',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20101006',\n",
       "  'product_id': '71610-370_206438fc-a53c-4d5e-afcb-0c85d2be2534',\n",
       "  'application_number': 'ANDA090083',\n",
       "  'brand_name_base': 'LOSARTAN POTASSIUM',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]']},\n",
       " {'product_ndc': '0002-8149',\n",
       "  'generic_name': 'Somatropin',\n",
       "  'labeler_name': 'Eli Lilly and Company',\n",
       "  'brand_name': 'HUMATROPE',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0002-8149-01',\n",
       "    'description': '1 TRAY in 1 CARTON (0002-8149-01)  / 1 KIT in 1 TRAY *  2.88 mL in 1 CARTRIDGE (0002-7556-01)  *  2.88 mL in 1 SYRINGE (0002-7619-01)',\n",
       "    'marketing_start_date': '20060127',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Eli Lilly and Company'],\n",
       "   'spl_set_id': ['a774e1ae-3997-49ee-8b0e-99a2b315d409'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': '62a4fe00-f5d5-412f-b3eb-0dbcea81fbd0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20060127',\n",
       "  'product_id': '0002-8149_62a4fe00-f5d5-412f-b3eb-0dbcea81fbd0',\n",
       "  'application_number': 'BLA019640',\n",
       "  'brand_name_base': 'HUMATROPE'},\n",
       " {'product_ndc': '71610-411',\n",
       "  'generic_name': 'Febuxostat',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Febuxostat',\n",
       "  'active_ingredients': [{'name': 'FEBUXOSTAT', 'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-411-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71610-411-60)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['834235'],\n",
       "   'spl_set_id': ['bf4d29c8-4731-42bc-887a-d8302add9ca9'],\n",
       "   'nui': ['N0000175698', 'N0000000206'],\n",
       "   'pharm_class_epc': ['Xanthine Oxidase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Xanthine Oxidase Inhibitors [MoA]'],\n",
       "   'unii': ['101V0R1N2E']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '528f271b-fb68-4d6a-b115-607aaabefd0c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20191230',\n",
       "  'product_id': '71610-411_528f271b-fb68-4d6a-b115-607aaabefd0c',\n",
       "  'application_number': 'ANDA210461',\n",
       "  'brand_name_base': 'Febuxostat',\n",
       "  'pharm_class': ['Xanthine Oxidase Inhibitor [EPC]',\n",
       "   'Xanthine Oxidase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71610-439',\n",
       "  'generic_name': 'LOSARTAN POTASSIUM',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'LOSARTAN POTASSIUM',\n",
       "  'active_ingredients': [{'name': 'LOSARTAN POTASSIUM',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-439-15',\n",
       "    'description': '15 TABLET, FILM COATED in 1 BOTTLE (71610-439-15)',\n",
       "    'marketing_start_date': '20210427',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-439-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71610-439-30)',\n",
       "    'marketing_start_date': '20200624',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-439-45',\n",
       "    'description': '45 TABLET, FILM COATED in 1 BOTTLE (71610-439-45)',\n",
       "    'marketing_start_date': '20210315',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-439-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71610-439-60)',\n",
       "    'marketing_start_date': '20221017',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['979485', '979492'],\n",
       "   'spl_set_id': ['8015c22c-d944-4a49-8721-70d0c1b98526'],\n",
       "   'unii': ['3ST302B24A']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'ac858720-a7ec-4205-a13b-596c948cde60',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200313',\n",
       "  'product_id': '71610-439_ac858720-a7ec-4205-a13b-596c948cde60',\n",
       "  'application_number': 'ANDA203835',\n",
       "  'brand_name_base': 'LOSARTAN POTASSIUM',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]']},\n",
       " {'product_ndc': '71610-443',\n",
       "  'generic_name': 'Metoprolol tartrate',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Metoprolol tartrate',\n",
       "  'active_ingredients': [{'name': 'METOPROLOL TARTRATE',\n",
       "    'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-443-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-443-60)',\n",
       "    'marketing_start_date': '20200707',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-443-70',\n",
       "    'description': '120 TABLET in 1 BOTTLE (71610-443-70)',\n",
       "    'marketing_start_date': '20200106',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-443-80',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71610-443-80)',\n",
       "    'marketing_start_date': '20200707',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-443-92',\n",
       "    'description': '270 TABLET in 1 BOTTLE (71610-443-92)',\n",
       "    'marketing_start_date': '20200707',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-443-94',\n",
       "    'description': '360 TABLET in 1 BOTTLE (71610-443-94)',\n",
       "    'marketing_start_date': '20210212',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['866514'],\n",
       "   'spl_set_id': ['89b427c4-f479-4758-97b8-6214021d587e'],\n",
       "   'unii': ['W5S57Y3A5L']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'e8e90401-c593-4009-8954-89cb927d1430',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20150629',\n",
       "  'product_id': '71610-443_e8e90401-c593-4009-8954-89cb927d1430',\n",
       "  'application_number': 'ANDA074644',\n",
       "  'brand_name_base': 'Metoprolol tartrate',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '71610-456',\n",
       "  'generic_name': 'ibuprofen',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'ibuprofen',\n",
       "  'active_ingredients': [{'name': 'IBUPROFEN', 'strength': '800 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-456-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-456-60)',\n",
       "    'marketing_start_date': '20200827',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-456-80',\n",
       "    'description': '180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-456-80)',\n",
       "    'marketing_start_date': '20200827',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-456-92',\n",
       "    'description': '270 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-456-92)',\n",
       "    'marketing_start_date': '20200827',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197807'],\n",
       "   'spl_set_id': ['c9ba5c17-12a8-426d-ad06-2acb344793bb'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['WK2XYI10QM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'b1e690f9-663d-40c1-9803-143678bd96bc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20161123',\n",
       "  'product_id': '71610-456_b1e690f9-663d-40c1-9803-143678bd96bc',\n",
       "  'application_number': 'ANDA202413',\n",
       "  'brand_name_base': 'ibuprofen',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '71610-457',\n",
       "  'generic_name': 'metformin hydrochloride',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'METFORMIN HYDROCHLORIDE ER',\n",
       "  'brand_name_suffix': 'ER',\n",
       "  'active_ingredients': [{'name': 'METFORMIN HYDROCHLORIDE',\n",
       "    'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-457-30',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-457-30)',\n",
       "    'marketing_start_date': '20200911',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-457-53',\n",
       "    'description': '60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-457-53)',\n",
       "    'marketing_start_date': '20200902',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-457-60',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-457-60)',\n",
       "    'marketing_start_date': '20200827',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-457-70',\n",
       "    'description': '120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-457-70)',\n",
       "    'marketing_start_date': '20200827',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-457-80',\n",
       "    'description': '180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-457-80)',\n",
       "    'marketing_start_date': '20200827',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-457-92',\n",
       "    'description': '270 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-457-92)',\n",
       "    'marketing_start_date': '20200827',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-457-94',\n",
       "    'description': '360 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-457-94)',\n",
       "    'marketing_start_date': '20200911',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['860975'],\n",
       "   'spl_set_id': ['f0371d2a-276b-4acb-80f8-e24fb8ceae19'],\n",
       "   'unii': ['786Z46389E']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '26802a69-e56c-4a63-add0-178b560cce98',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20131101',\n",
       "  'product_id': '71610-457_26802a69-e56c-4a63-add0-178b560cce98',\n",
       "  'application_number': 'ANDA201991',\n",
       "  'brand_name_base': 'METFORMIN HYDROCHLORIDE',\n",
       "  'pharm_class': ['Biguanide [EPC]', 'Biguanides [CS]']},\n",
       " {'product_ndc': '0527-1947',\n",
       "  'generic_name': 'Lopinavir-Ritonavir',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'brand_name': 'Lopinavir-Ritonavir',\n",
       "  'active_ingredients': [{'name': 'LOPINAVIR', 'strength': '80 mg/mL'},\n",
       "   {'name': 'RITONAVIR', 'strength': '20 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-1947-48',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (0527-1947-48)  / 160 mL in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20161227',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['311369'],\n",
       "   'spl_set_id': ['4b1caefa-e6a2-42f3-9194-6dc1dd9e6d85'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000246',\n",
       "    'N0000175889',\n",
       "    'N0000185503',\n",
       "    'N0000190114',\n",
       "    'N0000190107',\n",
       "    'N0000191001',\n",
       "    'N0000182137',\n",
       "    'N0000185607',\n",
       "    'N0000190118',\n",
       "    'N0000190113',\n",
       "    'N0000182141',\n",
       "    'N0000191266',\n",
       "    'N0000185507',\n",
       "    'N0000187064',\n",
       "    'N0000190117'],\n",
       "   'pharm_class_moa': ['HIV Protease Inhibitors [MoA]',\n",
       "    'P-Glycoprotein Inhibitors [MoA]',\n",
       "    'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "    'Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]',\n",
       "    'Cytochrome P450 2D6 Inhibitors [MoA]',\n",
       "    'Cytochrome P450 2C19 Inducers [MoA]',\n",
       "    'Cytochrome P450 3A Inducers [MoA]',\n",
       "    'Breast Cancer Resistance Protein Inhibitors [MoA]',\n",
       "    'Cytochrome P450 3A4 Inhibitors [MoA]',\n",
       "    'Cytochrome P450 1A2 Inducers [MoA]',\n",
       "    'Cytochrome P450 2C9 Inducers [MoA]',\n",
       "    'Cytochrome P450 2B6 Inducers [MoA]',\n",
       "    'UDP Glucuronosyltransferases Inducers [MoA]'],\n",
       "   'pharm_class_epc': ['Protease Inhibitor [EPC]',\n",
       "    'Cytochrome P450 3A Inhibitor [EPC]'],\n",
       "   'unii': ['2494G1JF75', 'O3J8G9O825']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '751545a0-3b8c-4486-821d-94eb6383dc52',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20161227',\n",
       "  'product_id': '0527-1947_751545a0-3b8c-4486-821d-94eb6383dc52',\n",
       "  'application_number': 'ANDA207407',\n",
       "  'brand_name_base': 'Lopinavir-Ritonavir',\n",
       "  'pharm_class': ['Breast Cancer Resistance Protein Inhibitors [MoA]',\n",
       "   'Cytochrome P450 1A2 Inducers [MoA]',\n",
       "   'Cytochrome P450 2B6 Inducers [MoA]',\n",
       "   'Cytochrome P450 2C19 Inducers [MoA]',\n",
       "   'Cytochrome P450 2C9 Inducers [MoA]',\n",
       "   'Cytochrome P450 2D6 Inhibitors [MoA]',\n",
       "   'Cytochrome P450 3A Inducers [MoA]',\n",
       "   'Cytochrome P450 3A Inhibitor [EPC]',\n",
       "   'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "   'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "   'Cytochrome P450 3A4 Inhibitors [MoA]',\n",
       "   'HIV Protease Inhibitors [MoA]',\n",
       "   'HIV Protease Inhibitors [MoA]',\n",
       "   'Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]',\n",
       "   'P-Glycoprotein Inhibitors [MoA]',\n",
       "   'P-Glycoprotein Inhibitors [MoA]',\n",
       "   'Protease Inhibitor [EPC]',\n",
       "   'Protease Inhibitor [EPC]',\n",
       "   'UDP Glucuronosyltransferases Inducers [MoA]']},\n",
       " {'product_ndc': '71610-470',\n",
       "  'generic_name': 'Famotidine',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Famotidine',\n",
       "  'active_ingredients': [{'name': 'FAMOTIDINE', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-470-53',\n",
       "    'description': '60 TABLET in 1 BOTTLE, PLASTIC (71610-470-53)',\n",
       "    'marketing_start_date': '20210407',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-470-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE, PLASTIC (71610-470-60)',\n",
       "    'marketing_start_date': '20201009',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-470-80',\n",
       "    'description': '180 TABLET in 1 BOTTLE, PLASTIC (71610-470-80)',\n",
       "    'marketing_start_date': '20201009',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['310273'],\n",
       "   'spl_set_id': ['46c6d243-eefc-40ca-8bd4-4c89456f635f'],\n",
       "   'nui': ['N0000000151', 'N0000175784'],\n",
       "   'pharm_class_moa': ['Histamine H2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Histamine-2 Receptor Antagonist [EPC]'],\n",
       "   'unii': ['5QZO15J2Z8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'cd18c7ed-b8ed-45a8-accb-f1baa08f0a5b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20010416',\n",
       "  'product_id': '71610-470_cd18c7ed-b8ed-45a8-accb-f1baa08f0a5b',\n",
       "  'application_number': 'ANDA075805',\n",
       "  'brand_name_base': 'Famotidine',\n",
       "  'pharm_class': ['Histamine H2 Receptor Antagonists [MoA]',\n",
       "   'Histamine-2 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '71610-482',\n",
       "  'generic_name': 'Doxazosin Mesylate',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Doxazosin',\n",
       "  'active_ingredients': [{'name': 'DOXAZOSIN MESYLATE', 'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-482-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-482-60)',\n",
       "    'marketing_start_date': '20201110',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197626'],\n",
       "   'spl_set_id': ['6b74b18f-b89a-4109-a29e-c4fa65a3c5ee'],\n",
       "   'unii': ['86P6PQK0MU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '5d499a9f-8647-4ede-bb94-ad6f2302d14f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180417',\n",
       "  'product_id': '71610-482_5d499a9f-8647-4ede-bb94-ad6f2302d14f',\n",
       "  'application_number': 'ANDA209013',\n",
       "  'brand_name_base': 'Doxazosin',\n",
       "  'pharm_class': ['Adrenergic alpha-Antagonists [MoA]',\n",
       "   'alpha-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '71610-484',\n",
       "  'generic_name': 'Metoprolol succinate',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'METOPROLOL SUCCINATE',\n",
       "  'active_ingredients': [{'name': 'METOPROLOL SUCCINATE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-484-45',\n",
       "    'description': '45 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-484-45)',\n",
       "    'marketing_start_date': '20201110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-484-60',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-484-60)',\n",
       "    'marketing_start_date': '20201110',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['866412', '866427'],\n",
       "   'spl_set_id': ['1b926135-a67f-4386-a2ba-de5d9fd5a7c5'],\n",
       "   'unii': ['TH25PD4CCB']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '8d71968c-b273-4b5e-9afd-4f04e10c45cc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180101',\n",
       "  'product_id': '71610-484_8d71968c-b273-4b5e-9afd-4f04e10c45cc',\n",
       "  'application_number': 'NDA019962',\n",
       "  'brand_name_base': 'METOPROLOL SUCCINATE',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '71610-522',\n",
       "  'generic_name': 'Pioglitazone Hydrochloride',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Pioglitazone Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PIOGLITAZONE HYDROCHLORIDE',\n",
       "    'strength': '15 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-522-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71610-522-30)',\n",
       "    'marketing_start_date': '20210203',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['317573'],\n",
       "   'spl_set_id': ['42ca8fbc-1512-47d2-8b2c-2ce012a3f973'],\n",
       "   'unii': ['JQT35NPK6C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'dc443031-f5ad-43b3-bc5c-8e7f5a5c0e16',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20130213',\n",
       "  'product_id': '71610-522_dc443031-f5ad-43b3-bc5c-8e7f5a5c0e16',\n",
       "  'application_number': 'ANDA200268',\n",
       "  'brand_name_base': 'Pioglitazone Hydrochloride',\n",
       "  'pharm_class': ['PPAR alpha [CS]',\n",
       "   'PPAR gamma [CS]',\n",
       "   'Peroxisome Proliferator Receptor alpha Agonist [EPC]',\n",
       "   'Peroxisome Proliferator Receptor gamma Agonist [EPC]',\n",
       "   'Peroxisome Proliferator-activated Receptor Activity [MoA]',\n",
       "   'Thiazolidinedione [EPC]',\n",
       "   'Thiazolidinediones [CS]']},\n",
       " {'product_ndc': '71610-532',\n",
       "  'generic_name': 'IBUPROFEN',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'IBUPROFEN',\n",
       "  'active_ingredients': [{'name': 'IBUPROFEN', 'strength': '600 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-532-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71610-532-60)',\n",
       "    'marketing_start_date': '20210309',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-532-80',\n",
       "    'description': '180 TABLET, FILM COATED in 1 BOTTLE (71610-532-80)',\n",
       "    'marketing_start_date': '20210309',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-532-92',\n",
       "    'description': '270 TABLET, FILM COATED in 1 BOTTLE (71610-532-92)',\n",
       "    'marketing_start_date': '20210309',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197806'],\n",
       "   'spl_set_id': ['77adb094-869c-44b4-8a4e-b739ac9cd701'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['WK2XYI10QM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'afa576a9-24b6-40ee-99f6-9126eb884bed',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20151230',\n",
       "  'product_id': '71610-532_afa576a9-24b6-40ee-99f6-9126eb884bed',\n",
       "  'application_number': 'ANDA090796',\n",
       "  'brand_name_base': 'IBUPROFEN',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '71610-544',\n",
       "  'generic_name': 'Meloxicam',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Meloxicam',\n",
       "  'active_ingredients': [{'name': 'MELOXICAM', 'strength': '15 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-544-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71610-544-30)',\n",
       "    'marketing_start_date': '20210513',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-544-53',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71610-544-53)',\n",
       "    'marketing_start_date': '20210726',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-544-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-544-60)',\n",
       "    'marketing_start_date': '20210415',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['152695'],\n",
       "   'spl_set_id': ['9392df66-a152-40e6-b43b-44dc46a23496'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['VG2QF83CGL']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'dbe2faa6-75ee-4c6d-9bd9-c91b63851a25',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200217',\n",
       "  'product_id': '71610-544_dbe2faa6-75ee-4c6d-9bd9-c91b63851a25',\n",
       "  'application_number': 'ANDA077927',\n",
       "  'brand_name_base': 'Meloxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '71610-547',\n",
       "  'generic_name': 'Ibuprofen',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'IBU',\n",
       "  'active_ingredients': [{'name': 'IBUPROFEN', 'strength': '600 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-547-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-547-60)',\n",
       "    'marketing_start_date': '20210430',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-547-80',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71610-547-80)',\n",
       "    'marketing_start_date': '20210430',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-547-92',\n",
       "    'description': '270 TABLET in 1 BOTTLE (71610-547-92)',\n",
       "    'marketing_start_date': '20210430',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'spl_set_id': ['b0f03994-b744-4d66-95b7-8c86217882bc'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['WK2XYI10QM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '19cc7ade-51b3-44f2-9bb1-a7a22909af97',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20011114',\n",
       "  'product_id': '71610-547_19cc7ade-51b3-44f2-9bb1-a7a22909af97',\n",
       "  'application_number': 'ANDA075682',\n",
       "  'brand_name_base': 'IBU',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '71610-611',\n",
       "  'generic_name': 'Simvastatin',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Simvastatin',\n",
       "  'active_ingredients': [{'name': 'SIMVASTATIN', 'strength': '80 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-611-45',\n",
       "    'description': '45 TABLET, FILM COATED in 1 BOTTLE (71610-611-45)',\n",
       "    'marketing_start_date': '20211025',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['198211', '200345', '312961'],\n",
       "   'spl_set_id': ['c0a303c5-6277-47ce-bb8a-bd5400fd8261'],\n",
       "   'nui': ['N0000175589', 'N0000000121'],\n",
       "   'pharm_class_epc': ['HMG-CoA Reductase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]'],\n",
       "   'unii': ['AGG2FN16EV']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'ed131a35-eda8-4cdb-a6f0-eae48ea1c59e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20151217',\n",
       "  'product_id': '71610-611_ed131a35-eda8-4cdb-a6f0-eae48ea1c59e',\n",
       "  'application_number': 'ANDA078034',\n",
       "  'brand_name_base': 'Simvastatin',\n",
       "  'pharm_class': ['HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71610-617',\n",
       "  'generic_name': 'Carisoprodol',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Carisoprodol',\n",
       "  'active_ingredients': [{'name': 'CARISOPRODOL', 'strength': '350 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-617-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE, PLASTIC (71610-617-30)',\n",
       "    'marketing_start_date': '20211124',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-617-53',\n",
       "    'description': '60 TABLET in 1 BOTTLE, PLASTIC (71610-617-53)',\n",
       "    'marketing_start_date': '20211124',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-617-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE, PLASTIC (71610-617-60)',\n",
       "    'marketing_start_date': '20211124',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-617-70',\n",
       "    'description': '120 TABLET in 1 BOTTLE, PLASTIC (71610-617-70)',\n",
       "    'marketing_start_date': '20211124',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197446'],\n",
       "   'spl_set_id': ['2179f18b-df15-4bf6-a7c7-6d9960f49a42'],\n",
       "   'nui': ['N0000175730', 'N0000175737'],\n",
       "   'pharm_class_pe': ['Centrally-mediated Muscle Relaxation [PE]'],\n",
       "   'pharm_class_epc': ['Muscle Relaxant [EPC]'],\n",
       "   'unii': ['21925K482H']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '71d51e86-d125-48bc-8c1a-0f08ed9d547e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200120',\n",
       "  'product_id': '71610-617_71d51e86-d125-48bc-8c1a-0f08ed9d547e',\n",
       "  'application_number': 'ANDA040188',\n",
       "  'brand_name_base': 'Carisoprodol',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '71610-623',\n",
       "  'generic_name': 'Simvastatin',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Simvastatin',\n",
       "  'active_ingredients': [{'name': 'SIMVASTATIN', 'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-623-15',\n",
       "    'description': '15 TABLET, FILM COATED in 1 BOTTLE (71610-623-15)',\n",
       "    'marketing_start_date': '20211206',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-623-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71610-623-30)',\n",
       "    'marketing_start_date': '20211206',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-623-45',\n",
       "    'description': '45 TABLET, FILM COATED in 1 BOTTLE (71610-623-45)',\n",
       "    'marketing_start_date': '20211206',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-623-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71610-623-60)',\n",
       "    'marketing_start_date': '20211206',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['198211', '312961'],\n",
       "   'spl_set_id': ['a753846e-4cd5-4ddc-a4f2-c45da571c883'],\n",
       "   'nui': ['N0000175589', 'N0000000121'],\n",
       "   'pharm_class_epc': ['HMG-CoA Reductase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]'],\n",
       "   'unii': ['AGG2FN16EV']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '86b78fe2-ccb5-45de-8746-f8bcbcead975',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20151217',\n",
       "  'product_id': '71610-623_86b78fe2-ccb5-45de-8746-f8bcbcead975',\n",
       "  'application_number': 'ANDA078034',\n",
       "  'brand_name_base': 'Simvastatin',\n",
       "  'pharm_class': ['HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71610-631',\n",
       "  'generic_name': 'Gabapentin',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Gabapentin',\n",
       "  'active_ingredients': [{'name': 'GABAPENTIN', 'strength': '400 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-631-53',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE, PLASTIC (71610-631-53)',\n",
       "    'marketing_start_date': '20220131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-631-60',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE, PLASTIC (71610-631-60)',\n",
       "    'marketing_start_date': '20220131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-631-80',\n",
       "    'description': '180 CAPSULE in 1 BOTTLE, PLASTIC (71610-631-80)',\n",
       "    'marketing_start_date': '20220131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-631-92',\n",
       "    'description': '270 CAPSULE in 1 BOTTLE, PLASTIC (71610-631-92)',\n",
       "    'marketing_start_date': '20220131',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['310432'],\n",
       "   'spl_set_id': ['95757436-2093-41cf-a9a9-ef2f28ac096f'],\n",
       "   'nui': ['N0000008486'],\n",
       "   'pharm_class_pe': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]'],\n",
       "   'unii': ['6CW7F3G59X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'c5c95e4f-541c-478d-9a40-28813a12969a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20160218',\n",
       "  'product_id': '71610-631_c5c95e4f-541c-478d-9a40-28813a12969a',\n",
       "  'application_number': 'ANDA204989',\n",
       "  'brand_name_base': 'Gabapentin',\n",
       "  'pharm_class': ['Anti-epileptic Agent [EPC]',\n",
       "   'Decreased Central Nervous System Disorganized Electrical Activity [PE]']},\n",
       " {'product_ndc': '71610-645',\n",
       "  'generic_name': 'Ibuprofen',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Ibuprofen',\n",
       "  'active_ingredients': [{'name': 'IBUPROFEN', 'strength': '600 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-645-53',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71610-645-53)',\n",
       "    'marketing_start_date': '20241030',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-645-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71610-645-60)',\n",
       "    'marketing_start_date': '20220628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-645-80',\n",
       "    'description': '180 TABLET, FILM COATED in 1 BOTTLE (71610-645-80)',\n",
       "    'marketing_start_date': '20220628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-645-92',\n",
       "    'description': '270 TABLET, FILM COATED in 1 BOTTLE (71610-645-92)',\n",
       "    'marketing_start_date': '20220628',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197805', '197806', '197807'],\n",
       "   'spl_set_id': ['018feb6f-3936-4322-a6e4-035bc302e3ac'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['WK2XYI10QM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'faea710b-5dca-4f7f-8e72-a2d5e328c6df',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220310',\n",
       "  'product_id': '71610-645_faea710b-5dca-4f7f-8e72-a2d5e328c6df',\n",
       "  'application_number': 'ANDA091625',\n",
       "  'brand_name_base': 'Ibuprofen',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '71610-646',\n",
       "  'generic_name': 'Ibuprofen',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Ibuprofen',\n",
       "  'active_ingredients': [{'name': 'IBUPROFEN', 'strength': '800 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-646-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71610-646-60)',\n",
       "    'marketing_start_date': '20220628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-646-80',\n",
       "    'description': '180 TABLET, FILM COATED in 1 BOTTLE (71610-646-80)',\n",
       "    'marketing_start_date': '20220628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-646-92',\n",
       "    'description': '270 TABLET, FILM COATED in 1 BOTTLE (71610-646-92)',\n",
       "    'marketing_start_date': '20220628',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197805', '197806', '197807'],\n",
       "   'spl_set_id': ['018feb6f-3936-4322-a6e4-035bc302e3ac'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['WK2XYI10QM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'faea710b-5dca-4f7f-8e72-a2d5e328c6df',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220310',\n",
       "  'product_id': '71610-646_faea710b-5dca-4f7f-8e72-a2d5e328c6df',\n",
       "  'application_number': 'ANDA091625',\n",
       "  'brand_name_base': 'Ibuprofen',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '71610-650',\n",
       "  'generic_name': 'Simethicone',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Antiflatulent',\n",
       "  'active_ingredients': [{'name': 'DIMETHICONE', 'strength': '80 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-650-04',\n",
       "    'description': '4 TABLET, CHEWABLE in 1 BOTTLE (71610-650-04)',\n",
       "    'marketing_start_date': '20220519',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['314216'],\n",
       "   'spl_set_id': ['dd2ca97e-89eb-4940-ac6e-abf1f9e1c6ea'],\n",
       "   'nui': ['N0000010282'],\n",
       "   'pharm_class_pe': ['Skin Barrier Activity [PE]'],\n",
       "   'unii': ['92RU3N3Y1O']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'TABLET, CHEWABLE',\n",
       "  'spl_id': 'f65851fe-74aa-46e7-b72e-fe8d7f78deae',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20211004',\n",
       "  'product_id': '71610-650_f65851fe-74aa-46e7-b72e-fe8d7f78deae',\n",
       "  'application_number': 'part332',\n",
       "  'brand_name_base': 'Antiflatulent',\n",
       "  'pharm_class': ['Skin Barrier Activity [PE]']},\n",
       " {'product_ndc': '71610-651',\n",
       "  'generic_name': 'SERTRALINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'SERTRALINE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'SERTRALINE HYDROCHLORIDE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-651-15',\n",
       "    'description': '15 TABLET, FILM COATED in 1 BOTTLE (71610-651-15)',\n",
       "    'marketing_start_date': '20220623',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-651-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71610-651-30)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-651-45',\n",
       "    'description': '45 TABLET, FILM COATED in 1 BOTTLE (71610-651-45)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-651-53',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71610-651-53)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-651-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71610-651-60)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-651-73',\n",
       "    'description': '135 TABLET, FILM COATED in 1 BOTTLE (71610-651-73)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-651-80',\n",
       "    'description': '180 TABLET, FILM COATED in 1 BOTTLE (71610-651-80)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['312938'],\n",
       "   'spl_set_id': ['68c94fb4-3018-44af-b982-2b4b6d461e6f'],\n",
       "   'unii': ['UTI8907Y6X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'a189f92d-a14a-45be-8f55-4b81fe2dce92',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170209',\n",
       "  'product_id': '71610-651_a189f92d-a14a-45be-8f55-4b81fe2dce92',\n",
       "  'application_number': 'ANDA202825',\n",
       "  'brand_name_base': 'SERTRALINE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Cytochrome P450 2D6 Inhibitors [MoA]',\n",
       "   'Serotonin Reuptake Inhibitor [EPC]',\n",
       "   'Serotonin Uptake Inhibitors [MoA]']},\n",
       " {'product_ndc': '71610-656',\n",
       "  'generic_name': 'folic acid',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'FOLIC ACID',\n",
       "  'active_ingredients': [{'name': 'FOLIC ACID', 'strength': '1 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-656-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71610-656-30)',\n",
       "    'marketing_start_date': '20220811',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-656-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-656-60)',\n",
       "    'marketing_start_date': '20220811',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['310410'],\n",
       "   'spl_set_id': ['dc4d097d-6e7e-4229-9853-04c31444d703'],\n",
       "   'unii': ['935E97BOY8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '017f87a0-dedf-4942-923b-2bc510e9aafa',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20150804',\n",
       "  'product_id': '71610-656_017f87a0-dedf-4942-923b-2bc510e9aafa',\n",
       "  'application_number': 'ANDA204418',\n",
       "  'brand_name_base': 'FOLIC ACID'},\n",
       " {'product_ndc': '71610-662',\n",
       "  'generic_name': 'apixaban',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'ELIQUIS',\n",
       "  'active_ingredients': [{'name': 'APIXABAN', 'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-662-09',\n",
       "    'description': '9000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-662-09)',\n",
       "    'marketing_start_date': '20220908',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-662-18',\n",
       "    'description': '3000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-662-18)',\n",
       "    'marketing_start_date': '20221017',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-662-80',\n",
       "    'description': '180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-662-80)',\n",
       "    'marketing_start_date': '20230201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['1364445', '1364447'],\n",
       "   'spl_set_id': ['41a133ef-e461-48ad-8221-b735bdd0ec25'],\n",
       "   'nui': ['N0000175637', 'N0000175635'],\n",
       "   'pharm_class_epc': ['Factor Xa Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Factor Xa Inhibitors [MoA]'],\n",
       "   'unii': ['3Z9Y7UWC1J']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'c42aeca0-6ad0-4382-8d81-077fe3a44ccb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20121228',\n",
       "  'product_id': '71610-662_c42aeca0-6ad0-4382-8d81-077fe3a44ccb',\n",
       "  'application_number': 'NDA202155',\n",
       "  'brand_name_base': 'ELIQUIS',\n",
       "  'pharm_class': ['Factor Xa Inhibitor [EPC]', 'Factor Xa Inhibitors [MoA]']},\n",
       " {'product_ndc': '71610-668',\n",
       "  'generic_name': 'Glipizide',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Glipizide',\n",
       "  'active_ingredients': [{'name': 'GLIPIZIDE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-668-53',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71610-668-53)',\n",
       "    'marketing_start_date': '20221010',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-668-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-668-60)',\n",
       "    'marketing_start_date': '20221010',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-668-70',\n",
       "    'description': '120 TABLET in 1 BOTTLE (71610-668-70)',\n",
       "    'marketing_start_date': '20221010',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-668-80',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71610-668-80)',\n",
       "    'marketing_start_date': '20221010',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-668-92',\n",
       "    'description': '270 TABLET in 1 BOTTLE (71610-668-92)',\n",
       "    'marketing_start_date': '20221010',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-668-94',\n",
       "    'description': '360 TABLET in 1 BOTTLE (71610-668-94)',\n",
       "    'marketing_start_date': '20221010',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['310488', '310490'],\n",
       "   'spl_set_id': ['64c2a82f-014c-47d7-b303-23531e6bb723'],\n",
       "   'nui': ['N0000175608', 'M0020795'],\n",
       "   'pharm_class_epc': ['Sulfonylurea [EPC]'],\n",
       "   'pharm_class_cs': ['Sulfonylurea Compounds [CS]'],\n",
       "   'unii': ['X7WDT95N5C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '737c6102-3cac-4ef5-812b-13e0298c7210',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19950831',\n",
       "  'product_id': '71610-668_737c6102-3cac-4ef5-812b-13e0298c7210',\n",
       "  'application_number': 'ANDA074497',\n",
       "  'brand_name_base': 'Glipizide',\n",
       "  'pharm_class': ['Sulfonylurea Compounds [CS]', 'Sulfonylurea [EPC]']},\n",
       " {'product_ndc': '71610-681',\n",
       "  'generic_name': 'Allopurinol',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Allopurinol',\n",
       "  'active_ingredients': [{'name': 'ALLOPURINOL', 'strength': '300 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-681-45',\n",
       "    'description': '45 TABLET in 1 BOTTLE (71610-681-45)',\n",
       "    'marketing_start_date': '20221213',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-681-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-681-60)',\n",
       "    'marketing_start_date': '20221213',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197320'],\n",
       "   'spl_set_id': ['a5c35283-09d2-4bb4-bdd1-055035fa272b'],\n",
       "   'nui': ['N0000175698', 'N0000000206'],\n",
       "   'pharm_class_epc': ['Xanthine Oxidase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Xanthine Oxidase Inhibitors [MoA]'],\n",
       "   'unii': ['63CZ7GJN5I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'fe21f4f9-59eb-4885-90b5-c2859a714516',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220301',\n",
       "  'product_id': '71610-681_fe21f4f9-59eb-4885-90b5-c2859a714516',\n",
       "  'application_number': 'ANDA204467',\n",
       "  'brand_name_base': 'Allopurinol',\n",
       "  'pharm_class': ['Xanthine Oxidase Inhibitor [EPC]',\n",
       "   'Xanthine Oxidase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71610-687',\n",
       "  'generic_name': 'AMLODIPINE BESYLATE',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'AMLODIPINE BESYLATE 5 mg',\n",
       "  'brand_name_suffix': '5 mg',\n",
       "  'active_ingredients': [{'name': 'AMLODIPINE BESYLATE',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-687-15',\n",
       "    'description': '15 TABLET in 1 BOTTLE, PLASTIC (71610-687-15)',\n",
       "    'marketing_start_date': '20230119',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-687-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE, PLASTIC (71610-687-30)',\n",
       "    'marketing_start_date': '20230119',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-687-45',\n",
       "    'description': '45 TABLET in 1 BOTTLE, PLASTIC (71610-687-45)',\n",
       "    'marketing_start_date': '20230119',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-687-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE, PLASTIC (71610-687-60)',\n",
       "    'marketing_start_date': '20230418',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197361'],\n",
       "   'spl_set_id': ['b597d1e1-aba1-4272-bed7-4c95e8150d58'],\n",
       "   'unii': ['864V2Q084H']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'a4b2d571-c110-49fb-8eff-688308608ae3',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20211001',\n",
       "  'product_id': '71610-687_a4b2d571-c110-49fb-8eff-688308608ae3',\n",
       "  'application_number': 'ANDA078414',\n",
       "  'brand_name_base': 'AMLODIPINE BESYLATE',\n",
       "  'pharm_class': ['Calcium Channel Antagonists [MoA]',\n",
       "   'Calcium Channel Blocker [EPC]',\n",
       "   'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "   'Dihydropyridine Calcium Channel Blocker [EPC]',\n",
       "   'Dihydropyridines [CS]']},\n",
       " {'product_ndc': '71610-700',\n",
       "  'generic_name': 'Bisacodyl',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Bisacodyl',\n",
       "  'active_ingredients': [{'name': 'BISACODYL', 'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-700-02',\n",
       "    'description': '2 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (71610-700-02)',\n",
       "    'marketing_start_date': '20230403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-700-03',\n",
       "    'description': '3 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (71610-700-03)',\n",
       "    'marketing_start_date': '20230403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-700-04',\n",
       "    'description': '4 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (71610-700-04)',\n",
       "    'marketing_start_date': '20230403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-700-06',\n",
       "    'description': '6 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (71610-700-06)',\n",
       "    'marketing_start_date': '20230403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-700-08',\n",
       "    'description': '8 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (71610-700-08)',\n",
       "    'marketing_start_date': '20230403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-700-20',\n",
       "    'description': '20 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (71610-700-20)',\n",
       "    'marketing_start_date': '20230403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['308753'],\n",
       "   'spl_set_id': ['ca67d5e8-d67d-44ce-adf7-cf9b2eed89d2'],\n",
       "   'nui': ['N0000009371', 'N0000175812', 'N0000009871'],\n",
       "   'pharm_class_pe': ['Increased Large Intestinal Motility [PE]',\n",
       "    'Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]'],\n",
       "   'pharm_class_epc': ['Stimulant Laxative [EPC]'],\n",
       "   'unii': ['10X0709Y6I']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'TABLET, DELAYED RELEASE',\n",
       "  'spl_id': '23fad7c7-8db8-44c2-9df4-26a05c74c157',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181201',\n",
       "  'product_id': '71610-700_23fad7c7-8db8-44c2-9df4-26a05c74c157',\n",
       "  'application_number': 'part334',\n",
       "  'brand_name_base': 'Bisacodyl',\n",
       "  'pharm_class': ['Increased Large Intestinal Motility [PE]',\n",
       "   'Stimulant Laxative [EPC]',\n",
       "   'Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]']},\n",
       " {'product_ndc': '0527-2801',\n",
       "  'generic_name': 'Vardenafil Hydrochloride',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'brand_name': 'Vardenafil Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'VARDENAFIL HYDROCHLORIDE',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-2801-32',\n",
       "    'description': '30 TABLET in 1 BOTTLE (0527-2801-32)',\n",
       "    'marketing_start_date': '20181101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['349478', '349479', '349480', '402273'],\n",
       "   'spl_set_id': ['2782efed-6198-47b9-81ac-3e255e2ab7f6'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305272802322'],\n",
       "   'unii': ['5M8S2CU0TS']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '56c68926-da9d-4f55-b4f0-a10b294f2de8',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181101',\n",
       "  'product_id': '0527-2801_56c68926-da9d-4f55-b4f0-a10b294f2de8',\n",
       "  'application_number': 'ANDA209057',\n",
       "  'brand_name_base': 'Vardenafil Hydrochloride',\n",
       "  'pharm_class': ['Phosphodiesterase 5 Inhibitor [EPC]',\n",
       "   'Phosphodiesterase 5 Inhibitors [MoA]']},\n",
       " {'product_ndc': '0527-2802',\n",
       "  'generic_name': 'Vardenafil Hydrochloride',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'brand_name': 'Vardenafil Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'VARDENAFIL HYDROCHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-2802-32',\n",
       "    'description': '30 TABLET in 1 BOTTLE (0527-2802-32)',\n",
       "    'marketing_start_date': '20181101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['349478', '349479', '349480', '402273'],\n",
       "   'spl_set_id': ['2782efed-6198-47b9-81ac-3e255e2ab7f6'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305272802322'],\n",
       "   'unii': ['5M8S2CU0TS']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '56c68926-da9d-4f55-b4f0-a10b294f2de8',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181101',\n",
       "  'product_id': '0527-2802_56c68926-da9d-4f55-b4f0-a10b294f2de8',\n",
       "  'application_number': 'ANDA209057',\n",
       "  'brand_name_base': 'Vardenafil Hydrochloride',\n",
       "  'pharm_class': ['Phosphodiesterase 5 Inhibitor [EPC]',\n",
       "   'Phosphodiesterase 5 Inhibitors [MoA]']},\n",
       " {'product_ndc': '0527-2803',\n",
       "  'generic_name': 'Vardenafil Hydrochloride',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'brand_name': 'Vardenafil Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'VARDENAFIL HYDROCHLORIDE',\n",
       "    'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-2803-32',\n",
       "    'description': '30 TABLET in 1 BOTTLE (0527-2803-32)',\n",
       "    'marketing_start_date': '20181101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['349478', '349479', '349480', '402273'],\n",
       "   'spl_set_id': ['2782efed-6198-47b9-81ac-3e255e2ab7f6'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305272802322'],\n",
       "   'unii': ['5M8S2CU0TS']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '56c68926-da9d-4f55-b4f0-a10b294f2de8',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181101',\n",
       "  'product_id': '0527-2803_56c68926-da9d-4f55-b4f0-a10b294f2de8',\n",
       "  'application_number': 'ANDA209057',\n",
       "  'brand_name_base': 'Vardenafil Hydrochloride',\n",
       "  'pharm_class': ['Phosphodiesterase 5 Inhibitor [EPC]',\n",
       "   'Phosphodiesterase 5 Inhibitors [MoA]']},\n",
       " {'product_ndc': '0065-0431',\n",
       "  'generic_name': 'polyethylene glycol and propylene glycol',\n",
       "  'labeler_name': 'Alcon Research Ltd',\n",
       "  'brand_name': 'Systane',\n",
       "  'active_ingredients': [{'name': 'POLYETHYLENE GLYCOL 400',\n",
       "    'strength': '4 mg/mL'},\n",
       "   {'name': 'PROPYLENE GLYCOL', 'strength': '3 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0065-0431-33',\n",
       "    'description': '30 VIAL in 1 CARTON (0065-0431-33)  / .7 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20151030',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Alcon Research Ltd'],\n",
       "   'rxcui': ['477589'],\n",
       "   'spl_set_id': ['14916d2c-a63d-491e-bd91-a61f300af38a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['B697894SGQ', '6DC9Q167V3']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOLUTION/ DROPS',\n",
       "  'spl_id': '5c7432b0-b4b8-49a1-89b7-6e3befa25917',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20151030',\n",
       "  'product_id': '0065-0431_5c7432b0-b4b8-49a1-89b7-6e3befa25917',\n",
       "  'application_number': 'M018',\n",
       "  'brand_name_base': 'Systane'},\n",
       " {'product_ndc': '71610-751',\n",
       "  'generic_name': 'Amitriptyline Hydrochloride',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Amitriptyline Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'AMITRIPTYLINE HYDROCHLORIDE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-751-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-751-30)',\n",
       "    'marketing_start_date': '20231113',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-751-53',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-751-53)',\n",
       "    'marketing_start_date': '20231113',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-751-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-751-60)',\n",
       "    'marketing_start_date': '20231113',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-751-80',\n",
       "    'description': '180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-751-80)',\n",
       "    'marketing_start_date': '20231113',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['856783', '856834', '856845'],\n",
       "   'spl_set_id': ['25832051-837b-4682-8548-5ab9a1b7cdac'],\n",
       "   'unii': ['26LUD4JO9K']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'b68d1558-fe35-4440-9225-d0a5556a04b9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19870714',\n",
       "  'product_id': '71610-751_b68d1558-fe35-4440-9225-d0a5556a04b9',\n",
       "  'application_number': 'ANDA089399',\n",
       "  'brand_name_base': 'Amitriptyline Hydrochloride',\n",
       "  'pharm_class': ['Tricyclic Antidepressant [EPC]']},\n",
       " {'product_ndc': '71610-752',\n",
       "  'generic_name': 'Amitriptyline Hydrochloride',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Amitriptyline Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'AMITRIPTYLINE HYDROCHLORIDE',\n",
       "    'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-752-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-752-30)',\n",
       "    'marketing_start_date': '20231113',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-752-53',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-752-53)',\n",
       "    'marketing_start_date': '20231113',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-752-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-752-60)',\n",
       "    'marketing_start_date': '20231113',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-752-80',\n",
       "    'description': '180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-752-80)',\n",
       "    'marketing_start_date': '20231113',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['856783', '856834', '856845'],\n",
       "   'spl_set_id': ['25832051-837b-4682-8548-5ab9a1b7cdac'],\n",
       "   'unii': ['26LUD4JO9K']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'b68d1558-fe35-4440-9225-d0a5556a04b9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19870714',\n",
       "  'product_id': '71610-752_b68d1558-fe35-4440-9225-d0a5556a04b9',\n",
       "  'application_number': 'ANDA089399',\n",
       "  'brand_name_base': 'Amitriptyline Hydrochloride',\n",
       "  'pharm_class': ['Tricyclic Antidepressant [EPC]']},\n",
       " {'product_ndc': '71610-759',\n",
       "  'generic_name': 'Pregabalin',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'dea_schedule': 'CV',\n",
       "  'brand_name': 'Pregabalin',\n",
       "  'active_ingredients': [{'name': 'PREGABALIN', 'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-759-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71610-759-30)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-759-46',\n",
       "    'description': '56 CAPSULE in 1 BOTTLE (71610-759-46)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-759-53',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71610-759-53)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-759-60',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (71610-759-60)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-759-80',\n",
       "    'description': '180 CAPSULE in 1 BOTTLE (71610-759-80)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['483446', '483450', '577127'],\n",
       "   'spl_set_id': ['d2a98872-1a52-47e1-b4bd-0ff7d6272a92'],\n",
       "   'unii': ['55JG375S6M']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '43388205-9926-420f-99ca-4882e24a9fad',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190719',\n",
       "  'product_id': '71610-759_43388205-9926-420f-99ca-4882e24a9fad',\n",
       "  'application_number': 'ANDA209357',\n",
       "  'brand_name_base': 'Pregabalin'},\n",
       " {'product_ndc': '71610-768',\n",
       "  'generic_name': 'Lorazepam',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Lorazepam',\n",
       "  'active_ingredients': [{'name': 'LORAZEPAM', 'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-768-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71610-768-30)',\n",
       "    'marketing_start_date': '20240205',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-768-53',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71610-768-53)',\n",
       "    'marketing_start_date': '20240109',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-768-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-768-60)',\n",
       "    'marketing_start_date': '20240205',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-768-70',\n",
       "    'description': '120 TABLET in 1 BOTTLE (71610-768-70)',\n",
       "    'marketing_start_date': '20240109',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197902'],\n",
       "   'spl_set_id': ['82f79757-69f0-4a37-93a6-55b66ae86ad7'],\n",
       "   'nui': ['N0000175694', 'M0002356'],\n",
       "   'pharm_class_epc': ['Benzodiazepine [EPC]'],\n",
       "   'pharm_class_cs': ['Benzodiazepines [CS]'],\n",
       "   'unii': ['O26FZP769L']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '0ce251c7-bba3-45c9-aa24-6b7c6007b13a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230625',\n",
       "  'product_id': '71610-768_0ce251c7-bba3-45c9-aa24-6b7c6007b13a',\n",
       "  'application_number': 'ANDA076045',\n",
       "  'brand_name_base': 'Lorazepam',\n",
       "  'pharm_class': ['Benzodiazepine [EPC]', 'Benzodiazepines [CS]']},\n",
       " {'product_ndc': '71610-772',\n",
       "  'generic_name': 'Isosorbide Mononitrate',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Isosorbide Mononitrate',\n",
       "  'active_ingredients': [{'name': 'ISOSORBIDE MONONITRATE',\n",
       "    'strength': '60 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-772-30',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-772-30)',\n",
       "    'marketing_start_date': '20240122',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-772-45',\n",
       "    'description': '45 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-772-45)',\n",
       "    'marketing_start_date': '20240122',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-772-60',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-772-60)',\n",
       "    'marketing_start_date': '20240125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-772-80',\n",
       "    'description': '180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-772-80)',\n",
       "    'marketing_start_date': '20240122',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['353538'],\n",
       "   'spl_set_id': ['0af6c67f-919d-4515-8074-f6c3aaa835b5'],\n",
       "   'nui': ['N0000175415', 'M0014874', 'N0000009909'],\n",
       "   'pharm_class_epc': ['Nitrate Vasodilator [EPC]'],\n",
       "   'pharm_class_cs': ['Nitrates [CS]'],\n",
       "   'pharm_class_pe': ['Vasodilation [PE]'],\n",
       "   'unii': ['LX1OH63030']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '10f2e7b3-b561-443d-9bfd-6c3420a9edb7',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181105',\n",
       "  'product_id': '71610-772_10f2e7b3-b561-443d-9bfd-6c3420a9edb7',\n",
       "  'application_number': 'ANDA210918',\n",
       "  'brand_name_base': 'Isosorbide Mononitrate',\n",
       "  'pharm_class': ['Nitrate Vasodilator [EPC]',\n",
       "   'Nitrates [CS]',\n",
       "   'Vasodilation [PE]']},\n",
       " {'product_ndc': '71610-776',\n",
       "  'generic_name': 'tizanidine',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'tizanidine',\n",
       "  'active_ingredients': [{'name': 'TIZANIDINE HYDROCHLORIDE',\n",
       "    'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-776-16',\n",
       "    'description': '6000 TABLET in 1 BOTTLE (71610-776-16)',\n",
       "    'marketing_start_date': '20240125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-776-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71610-776-30)',\n",
       "    'marketing_start_date': '20240122',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-776-53',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71610-776-53)',\n",
       "    'marketing_start_date': '20240125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-776-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-776-60)',\n",
       "    'marketing_start_date': '20240125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-776-75',\n",
       "    'description': '7500 TABLET in 1 BOTTLE (71610-776-75)',\n",
       "    'marketing_start_date': '20240401',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['313413'],\n",
       "   'spl_set_id': ['ef7673f4-e0c1-4d79-af36-2f2ed2cc28f7'],\n",
       "   'unii': ['B53E3NMY5C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '1524f17c-bf89-57f4-e063-6394a90a83ff',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20040116',\n",
       "  'product_id': '71610-776_1524f17c-bf89-57f4-e063-6394a90a83ff',\n",
       "  'application_number': 'ANDA076533',\n",
       "  'brand_name_base': 'tizanidine',\n",
       "  'pharm_class': ['Adrenergic alpha2-Agonists [MoA]',\n",
       "   'Central alpha-2 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '71610-798',\n",
       "  'generic_name': 'Rosuvastatin',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Rosuvastatin',\n",
       "  'active_ingredients': [{'name': 'ROSUVASTATIN', 'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-798-15',\n",
       "    'description': '15 TABLET, FILM COATED in 1 BOTTLE (71610-798-15)',\n",
       "    'marketing_start_date': '20240216',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-798-16',\n",
       "    'description': '6000 TABLET, FILM COATED in 1 BOTTLE (71610-798-16)',\n",
       "    'marketing_start_date': '20240626',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-798-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71610-798-30)',\n",
       "    'marketing_start_date': '20240216',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-798-45',\n",
       "    'description': '45 TABLET, FILM COATED in 1 BOTTLE (71610-798-45)',\n",
       "    'marketing_start_date': '20240216',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-798-53',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71610-798-53)',\n",
       "    'marketing_start_date': '20240216',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-798-60',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (71610-798-60)',\n",
       "    'marketing_start_date': '20240216',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['859419'],\n",
       "   'spl_set_id': ['1185b112-f59d-8762-e063-6394a90a120d'],\n",
       "   'nui': ['N0000175589', 'N0000000121'],\n",
       "   'pharm_class_epc': ['HMG-CoA Reductase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]'],\n",
       "   'unii': ['413KH5ZJ73']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '20253fa4-28cf-2a97-e063-6294a90af9c4',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190424',\n",
       "  'product_id': '71610-798_20253fa4-28cf-2a97-e063-6294a90af9c4',\n",
       "  'application_number': 'ANDA206381',\n",
       "  'brand_name_base': 'Rosuvastatin',\n",
       "  'pharm_class': ['HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71610-836',\n",
       "  'generic_name': 'Meclizine Hydrochloride',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Meclizine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'MECLIZINE HYDROCHLORIDE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-836-30',\n",
       "    'description': '30 TABLET, CHEWABLE in 1 BOTTLE (71610-836-30)',\n",
       "    'marketing_start_date': '20240524',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-836-53',\n",
       "    'description': '60 TABLET, CHEWABLE in 1 BOTTLE (71610-836-53)',\n",
       "    'marketing_start_date': '20240524',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-836-60',\n",
       "    'description': '90 TABLET, CHEWABLE in 1 BOTTLE (71610-836-60)',\n",
       "    'marketing_start_date': '20240524',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-836-80',\n",
       "    'description': '180 TABLET, CHEWABLE in 1 BOTTLE (71610-836-80)',\n",
       "    'marketing_start_date': '20240524',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['995632'],\n",
       "   'spl_set_id': ['199ae195-4556-ee88-e063-6394a90a40d4'],\n",
       "   'unii': ['HDP7W44CIO']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, CHEWABLE',\n",
       "  'spl_id': '1a8bdae4-1b42-0a1c-e063-6294a90a49aa',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201030',\n",
       "  'product_id': '71610-836_1a8bdae4-1b42-0a1c-e063-6294a90a49aa',\n",
       "  'application_number': 'M009',\n",
       "  'brand_name_base': 'Meclizine Hydrochloride',\n",
       "  'pharm_class': ['Antiemetic [EPC]', 'Emesis Suppression [PE]']},\n",
       " {'product_ndc': '71610-837',\n",
       "  'generic_name': 'metformin hydrochloride',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'METFORMIN HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'METFORMIN HYDROCHLORIDE',\n",
       "    'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-837-30',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-837-30)',\n",
       "    'marketing_start_date': '20240531',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-837-53',\n",
       "    'description': '60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-837-53)',\n",
       "    'marketing_start_date': '20240531',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-837-60',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-837-60)',\n",
       "    'marketing_start_date': '20240531',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-837-70',\n",
       "    'description': '120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-837-70)',\n",
       "    'marketing_start_date': '20240531',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-837-80',\n",
       "    'description': '180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-837-80)',\n",
       "    'marketing_start_date': '20240531',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-837-94',\n",
       "    'description': '360 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-837-94)',\n",
       "    'marketing_start_date': '20240531',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['860975'],\n",
       "   'spl_set_id': ['1a047fc0-196e-79af-e063-6394a90a1e0d'],\n",
       "   'unii': ['786Z46389E']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '1a0499c1-6f4c-d51b-e063-6294a90a72fb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20130301',\n",
       "  'product_id': '71610-837_1a0499c1-6f4c-d51b-e063-6294a90a72fb',\n",
       "  'application_number': 'ANDA201991',\n",
       "  'brand_name_base': 'METFORMIN HYDROCHLORIDE',\n",
       "  'pharm_class': ['Biguanide [EPC]', 'Biguanides [CS]']},\n",
       " {'product_ndc': '0527-3236',\n",
       "  'generic_name': 'Levorphanol Tartrate',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Levorphanol Tartrate',\n",
       "  'active_ingredients': [{'name': 'LEVORPHANOL TARTRATE',\n",
       "    'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-3236-37',\n",
       "    'description': '100 TABLET in 1 BOTTLE (0527-3236-37)',\n",
       "    'marketing_start_date': '20190520',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['197873', '2058845'],\n",
       "   'spl_set_id': ['a50debe1-90b3-4931-9ec0-67e88dd21b04'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305273236379', '0305273237376'],\n",
       "   'unii': ['04WQU6T9QI']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'ec424bc5-a1d0-4153-8782-12711cc7ffe7',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190520',\n",
       "  'product_id': '0527-3236_ec424bc5-a1d0-4153-8782-12711cc7ffe7',\n",
       "  'application_number': 'ANDA213479',\n",
       "  'brand_name_base': 'Levorphanol Tartrate',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '71610-843',\n",
       "  'generic_name': 'Furosemide',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Furosemide',\n",
       "  'active_ingredients': [{'name': 'FUROSEMIDE', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-843-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71610-843-30)',\n",
       "    'marketing_start_date': '20240626',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-843-53',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71610-843-53)',\n",
       "    'marketing_start_date': '20240626',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-843-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-843-60)',\n",
       "    'marketing_start_date': '20240626',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-843-80',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71610-843-80)',\n",
       "    'marketing_start_date': '20240626',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['310429'],\n",
       "   'spl_set_id': ['307c3b89-f37f-45ee-8ec7-d402008cf2fa'],\n",
       "   'nui': ['N0000175366', 'N0000175590'],\n",
       "   'pharm_class_pe': ['Increased Diuresis at Loop of Henle [PE]'],\n",
       "   'pharm_class_epc': ['Loop Diuretic [EPC]'],\n",
       "   'unii': ['7LXU5N7ZO5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'dbc10744-27d9-46ad-9071-d5a049596b1c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20060201',\n",
       "  'product_id': '71610-843_dbc10744-27d9-46ad-9071-d5a049596b1c',\n",
       "  'application_number': 'ANDA077293',\n",
       "  'brand_name_base': 'Furosemide',\n",
       "  'pharm_class': ['Increased Diuresis at Loop of Henle [PE]',\n",
       "   'Loop Diuretic [EPC]']},\n",
       " {'product_ndc': '71610-845',\n",
       "  'generic_name': 'Pregabalin',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'dea_schedule': 'CV',\n",
       "  'brand_name': 'Pregabalin',\n",
       "  'active_ingredients': [{'name': 'PREGABALIN', 'strength': '150 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-845-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71610-845-30)',\n",
       "    'marketing_start_date': '20240716',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-845-46',\n",
       "    'description': '56 CAPSULE in 1 BOTTLE (71610-845-46)',\n",
       "    'marketing_start_date': '20240716',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-845-53',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71610-845-53)',\n",
       "    'marketing_start_date': '20240716',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-845-54',\n",
       "    'description': '84 CAPSULE in 1 BOTTLE (71610-845-54)',\n",
       "    'marketing_start_date': '20240716',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-845-70',\n",
       "    'description': '120 CAPSULE in 1 BOTTLE (71610-845-70)',\n",
       "    'marketing_start_date': '20240716',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['483440'],\n",
       "   'spl_set_id': ['8bb9495e-1354-4a70-baa5-9b80eb3518c8'],\n",
       "   'unii': ['55JG375S6M']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '076a2ad0-6afe-43d8-a6fe-7058acc4ea92',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190719',\n",
       "  'product_id': '71610-845_076a2ad0-6afe-43d8-a6fe-7058acc4ea92',\n",
       "  'application_number': 'ANDA209357',\n",
       "  'brand_name_base': 'Pregabalin'},\n",
       " {'product_ndc': '71610-850',\n",
       "  'generic_name': 'Etodolac',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Etodolac',\n",
       "  'active_ingredients': [{'name': 'ETODOLAC', 'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-850-53',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (71610-850-53)',\n",
       "    'marketing_start_date': '20240821',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['199390'],\n",
       "   'spl_set_id': ['20b2c2c3-02ab-6377-e063-6294a90a7b23'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['2M36281008']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '20b2b175-ce56-fa94-e063-6294a90a068e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210801',\n",
       "  'product_id': '71610-850_20b2b175-ce56-fa94-e063-6294a90a068e',\n",
       "  'application_number': 'ANDA210704',\n",
       "  'brand_name_base': 'Etodolac',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '71610-854',\n",
       "  'generic_name': 'Terazosin Hydrochloride',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'brand_name': 'Terazosin Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'TERAZOSIN HYDROCHLORIDE',\n",
       "    'strength': '1 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-854-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71610-854-30)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-854-53',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71610-854-53)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-854-60',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (71610-854-60)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-854-80',\n",
       "    'description': '180 CAPSULE in 1 BOTTLE (71610-854-80)',\n",
       "    'marketing_start_date': '20240903',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['313215'],\n",
       "   'spl_set_id': ['214d9b06-8d23-3ee8-e063-6394a90a1521'],\n",
       "   'unii': ['D32S14F082']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '214d9180-c434-330d-e063-6394a90a795c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200630',\n",
       "  'product_id': '71610-854_214d9180-c434-330d-e063-6394a90a795c',\n",
       "  'application_number': 'ANDA074823',\n",
       "  'brand_name_base': 'Terazosin Hydrochloride',\n",
       "  'pharm_class': ['Adrenergic alpha-Antagonists [MoA]',\n",
       "   'alpha-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '71610-863',\n",
       "  'generic_name': 'clonazepam',\n",
       "  'labeler_name': 'Aphena Pharma Solutions - Tennessee, LLC',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Clonazepam',\n",
       "  'active_ingredients': [{'name': 'CLONAZEPAM', 'strength': '.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71610-863-10',\n",
       "    'description': '10 TABLET in 1 BOTTLE (71610-863-10)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-863-15',\n",
       "    'description': '15 TABLET in 1 BOTTLE (71610-863-15)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-863-20',\n",
       "    'description': '20 TABLET in 1 BOTTLE (71610-863-20)',\n",
       "    'marketing_start_date': '20241113',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-863-28',\n",
       "    'description': '28 TABLET in 1 BOTTLE (71610-863-28)',\n",
       "    'marketing_start_date': '20241113',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-863-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71610-863-30)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-863-45',\n",
       "    'description': '45 TABLET in 1 BOTTLE (71610-863-45)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-863-46',\n",
       "    'description': '56 TABLET in 1 BOTTLE (71610-863-46)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-863-53',\n",
       "    'description': '60 TABLET in 1 BOTTLE (71610-863-53)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-863-54',\n",
       "    'description': '84 TABLET in 1 BOTTLE (71610-863-54)',\n",
       "    'marketing_start_date': '20241113',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-863-55',\n",
       "    'description': '75 TABLET in 1 BOTTLE (71610-863-55)',\n",
       "    'marketing_start_date': '20241113',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-863-60',\n",
       "    'description': '90 TABLET in 1 BOTTLE (71610-863-60)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-863-70',\n",
       "    'description': '120 TABLET in 1 BOTTLE (71610-863-70)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71610-863-80',\n",
       "    'description': '180 TABLET in 1 BOTTLE (71610-863-80)',\n",
       "    'marketing_start_date': '20241104',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aphena Pharma Solutions - Tennessee, LLC'],\n",
       "   'rxcui': ['197527'],\n",
       "   'spl_set_id': ['263f99eb-9744-5601-e063-6394a90a47b1'],\n",
       "   'nui': ['N0000175694', 'M0002356'],\n",
       "   'pharm_class_epc': ['Benzodiazepine [EPC]'],\n",
       "   'pharm_class_cs': ['Benzodiazepines [CS]'],\n",
       "   'unii': ['5PE9FDE8GB']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '26e544ba-44b8-cc65-e063-6394a90a2d64',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180215',\n",
       "  'product_id': '71610-863_26e544ba-44b8-cc65-e063-6394a90a2d64',\n",
       "  'application_number': 'ANDA077856',\n",
       "  'brand_name_base': 'Clonazepam',\n",
       "  'pharm_class': ['Benzodiazepine [EPC]', 'Benzodiazepines [CS]']},\n",
       " {'product_ndc': '71611-093',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'CLICK PRODUCTS LLC',\n",
       "  'brand_name': 'WISH HAND SANITIZER WHITE JSAMINE',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '70 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71611-093-01',\n",
       "    'description': '1 BOTTLE in 1 BAG (71611-093-01)  / 35 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20240628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71611-093-02',\n",
       "    'description': '35 mL in 1 BOTTLE (71611-093-02)',\n",
       "    'marketing_start_date': '20240628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71611-093-03',\n",
       "    'description': '1 BOTTLE in 1 BAG (71611-093-03)  / 45 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20240628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71611-093-04',\n",
       "    'description': '45 mL in 1 BOTTLE (71611-093-04)',\n",
       "    'marketing_start_date': '20240628',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['CLICK PRODUCTS LLC'],\n",
       "   'rxcui': ['581662'],\n",
       "   'spl_set_id': ['1bda6912-ee4a-6054-e063-6394a90a79df'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0191554603530', '0191554603516', '0191554603509'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '1bda6912-ee4b-6054-e063-6394a90a79df',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240628',\n",
       "  'product_id': '71611-093_1bda6912-ee4b-6054-e063-6394a90a79df',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'WISH HAND SANITIZER WHITE JSAMINE'},\n",
       " {'product_ndc': '71626-101',\n",
       "  'generic_name': 'Zolmitriptan',\n",
       "  'labeler_name': 'Medstone Pharma LLC',\n",
       "  'brand_name': 'Zolmitriptan',\n",
       "  'active_ingredients': [{'name': 'ZOLMITRIPTAN', 'strength': '2.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71626-101-06',\n",
       "    'description': '6 BLISTER PACK in 1 CARTON (71626-101-06)  / 1 TABLET, FILM COATED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20180530',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Medstone Pharma LLC'],\n",
       "   'rxcui': ['200193', '200194'],\n",
       "   'spl_set_id': ['c970dd17-abdb-4fac-8de8-984e388b498c'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0371626102035'],\n",
       "   'nui': ['N0000175763', 'N0000175764', 'N0000175765'],\n",
       "   'pharm_class_moa': ['Serotonin 1b Receptor Agonists [MoA]',\n",
       "    'Serotonin 1d Receptor Agonists [MoA]'],\n",
       "   'pharm_class_epc': ['Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]'],\n",
       "   'unii': ['2FS66TH3YW']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'f538eaaa-1f19-4f02-b744-4749e899b54d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180530',\n",
       "  'product_id': '71626-101_f538eaaa-1f19-4f02-b744-4749e899b54d',\n",
       "  'application_number': 'ANDA207867',\n",
       "  'brand_name_base': 'Zolmitriptan',\n",
       "  'pharm_class': ['Serotonin 1b Receptor Agonists [MoA]',\n",
       "   'Serotonin 1d Receptor Agonists [MoA]',\n",
       "   'Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]']},\n",
       " {'product_ndc': '71655-103',\n",
       "  'generic_name': 'raxibacumab',\n",
       "  'labeler_name': 'Emergent Manufacturing Operations Baltimore LLC',\n",
       "  'brand_name': 'Raxibacumab',\n",
       "  'active_ingredients': [{'name': 'RAXIBACUMAB', 'strength': '50 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71655-103-01',\n",
       "    'description': '1 VIAL, SINGLE-USE in 1 CARTON (71655-103-01)  / 34 mL in 1 VIAL, SINGLE-USE',\n",
       "    'marketing_start_date': '20121214',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Emergent Manufacturing Operations Baltimore LLC'],\n",
       "   'rxcui': ['1366571'],\n",
       "   'spl_set_id': ['f6927e91-bb46-47b3-ab66-f9d8a9d7b12a'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000192703', 'N0000192702'],\n",
       "   'pharm_class_epc': ['Anthrax Protective Antigen-directed Antibody [EPC]'],\n",
       "   'pharm_class_moa': ['Anthrax Protective Antigen-directed Antibody Interactions [MoA]'],\n",
       "   'unii': ['794PGL549S']},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': '8bdc1b76-3c74-4a6a-8a82-86a6a09f6c1d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20121214',\n",
       "  'product_id': '71655-103_8bdc1b76-3c74-4a6a-8a82-86a6a09f6c1d',\n",
       "  'application_number': 'BLA125349',\n",
       "  'brand_name_base': 'Raxibacumab',\n",
       "  'pharm_class': ['Anthrax Protective Antigen-directed Antibody Interactions [MoA]',\n",
       "   'Anthrax Protective Antigen-directed Antibody [EPC]']},\n",
       " {'product_ndc': '71679-110',\n",
       "  'generic_name': 'Diphenhydramine HCl 25 mg',\n",
       "  'labeler_name': 'Health Pharma USA LLC',\n",
       "  'brand_name': 'Nighttime Sleep Aid',\n",
       "  'active_ingredients': [{'name': 'DIPHENHYDRAMINE HYDROCHLORIDE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71679-110-03',\n",
       "    'description': '300 TABLET, COATED in 1 BOTTLE (71679-110-03)',\n",
       "    'marketing_start_date': '20220101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71679-110-06',\n",
       "    'description': '600 TABLET, COATED in 1 BOTTLE (71679-110-06)',\n",
       "    'marketing_start_date': '20220101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71679-110-10',\n",
       "    'description': '1000 TABLET, COATED in 1 BOTTLE (71679-110-10)',\n",
       "    'marketing_start_date': '20220101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Health Pharma USA LLC'],\n",
       "   'rxcui': ['1049630'],\n",
       "   'spl_set_id': ['d659f747-9790-8bd6-e053-2995a90ae793'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0371679110032'],\n",
       "   'unii': ['TC2D6JAD40']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '08da137b-bf5c-886c-e063-6294a90a1da3',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220101',\n",
       "  'product_id': '71679-110_08da137b-bf5c-886c-e063-6294a90a1da3',\n",
       "  'application_number': 'M010',\n",
       "  'brand_name_base': 'Nighttime Sleep Aid',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '71687-3006',\n",
       "  'generic_name': 'Acetaminophen and Aspirin and Caffeine',\n",
       "  'labeler_name': 'Focus Consumer Healthcare, LLC',\n",
       "  'brand_name': 'Pamprin Max Menstrual Pain Relief',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '250 mg/1'},\n",
       "   {'name': 'ASPIRIN', 'strength': '250 mg/1'},\n",
       "   {'name': 'CAFFEINE', 'strength': '65 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71687-3006-6',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (71687-3006-6)  / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20171018',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Focus Consumer Healthcare, LLC'],\n",
       "   'rxcui': ['308297', '1052416'],\n",
       "   'spl_set_id': ['5bd4b935-f003-7df8-e053-2a91aa0a5d79'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000160',\n",
       "    'N0000008836',\n",
       "    'M0001335',\n",
       "    'N0000175722',\n",
       "    'N0000175578',\n",
       "    'N0000008832',\n",
       "    'N0000175739',\n",
       "    'N0000175729',\n",
       "    'N0000175790',\n",
       "    'M0023046'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_pe': ['Decreased Prostaglandin Production [PE]',\n",
       "    'Decreased Platelet Aggregation [PE]',\n",
       "    'Central Nervous System Stimulation [PE]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]',\n",
       "    'Xanthines [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]',\n",
       "    'Platelet Aggregation Inhibitor [EPC]',\n",
       "    'Central Nervous System Stimulant [EPC]',\n",
       "    'Methylxanthine [EPC]'],\n",
       "   'unii': ['362O9ITL9D', 'R16CO5Y76E', '3G6A5W338E']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '0c509c36-ea0d-7db3-e063-6394a90a6f58',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171018',\n",
       "  'product_id': '71687-3006_0c509c36-ea0d-7db3-e063-6394a90a6f58',\n",
       "  'application_number': 'M013',\n",
       "  'brand_name_base': 'Pamprin Max Menstrual Pain Relief',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Decreased Platelet Aggregation [PE]',\n",
       "   'Decreased Prostaglandin Production [PE]',\n",
       "   'Methylxanthine [EPC]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]',\n",
       "   'Platelet Aggregation Inhibitor [EPC]',\n",
       "   'Xanthines [CS]']},\n",
       " {'product_ndc': '71699-100',\n",
       "  'generic_name': 'cenobamate',\n",
       "  'labeler_name': 'SK Life Science, Inc.',\n",
       "  'dea_schedule': 'CV',\n",
       "  'brand_name': 'Xcopri',\n",
       "  'active_ingredients': [{'name': 'CENOBAMATE', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71699-100-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71699-100-30)',\n",
       "    'marketing_start_date': '20200312',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '1eb45542-1e48-4a07-92d6-db2284f81921',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200312',\n",
       "  'product_id': '71699-100_1eb45542-1e48-4a07-92d6-db2284f81921',\n",
       "  'application_number': 'NDA212839',\n",
       "  'brand_name_base': 'Xcopri',\n",
       "  'pharm_class': ['Cytochrome P450 2B6 Inducers [MoA]',\n",
       "   'Cytochrome P450 2B6 Inhibitors [MoA]',\n",
       "   'Cytochrome P450 2C19 Inhibitors [MoA]',\n",
       "   'Cytochrome P450 2C8 Inducers [MoA]',\n",
       "   'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "   'Cytochrome P450 3A4 Inducers [MoA]',\n",
       "   'GABA A Receptor Positive Modulators [MoA]',\n",
       "   'Sodium Channel Antagonists [MoA]']},\n",
       " {'product_ndc': '71699-104',\n",
       "  'generic_name': 'cenobamate',\n",
       "  'labeler_name': 'SK Life Science, Inc.',\n",
       "  'brand_name': 'Xcopri Maintenance Pack',\n",
       "  'brand_name_suffix': 'Maintenance Pack',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71699-104-56',\n",
       "    'description': '1 KIT in 1 CARTON (71699-104-56)  *  1 TABLET, FILM COATED in 1 BLISTER PACK *  1 TABLET, FILM COATED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20210430',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': '1eb45542-1e48-4a07-92d6-db2284f81921',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210430',\n",
       "  'product_id': '71699-104_1eb45542-1e48-4a07-92d6-db2284f81921',\n",
       "  'application_number': 'NDA212839',\n",
       "  'brand_name_base': 'Xcopri'},\n",
       " {'product_ndc': '71699-150',\n",
       "  'generic_name': 'cenobamate',\n",
       "  'labeler_name': 'SK Life Science, Inc.',\n",
       "  'dea_schedule': 'CV',\n",
       "  'brand_name': 'Xcopri',\n",
       "  'active_ingredients': [{'name': 'CENOBAMATE', 'strength': '150 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71699-150-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (71699-150-30)',\n",
       "    'marketing_start_date': '20200312',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '1eb45542-1e48-4a07-92d6-db2284f81921',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200312',\n",
       "  'product_id': '71699-150_1eb45542-1e48-4a07-92d6-db2284f81921',\n",
       "  'application_number': 'NDA212839',\n",
       "  'brand_name_base': 'Xcopri',\n",
       "  'pharm_class': ['Cytochrome P450 2B6 Inducers [MoA]',\n",
       "   'Cytochrome P450 2B6 Inhibitors [MoA]',\n",
       "   'Cytochrome P450 2C19 Inhibitors [MoA]',\n",
       "   'Cytochrome P450 2C8 Inducers [MoA]',\n",
       "   'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "   'Cytochrome P450 3A4 Inducers [MoA]',\n",
       "   'GABA A Receptor Positive Modulators [MoA]',\n",
       "   'Sodium Channel Antagonists [MoA]']},\n",
       " {'product_ndc': '71709-112',\n",
       "  'generic_name': 'Metformin Hydrochloride',\n",
       "  'labeler_name': 'Metcure Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Metformin Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'METFORMIN HYDROCHLORIDE',\n",
       "    'strength': '1000 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71709-112-06',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (71709-112-06)',\n",
       "    'marketing_start_date': '20171114',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71709-112-07',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (71709-112-07)',\n",
       "    'marketing_start_date': '20171114',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Metcure Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['861004', '861007', '861010'],\n",
       "   'spl_set_id': ['5df6adc9-79fd-66ef-e053-2991aa0a75ce'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0371709110063', '0371709111060'],\n",
       "   'unii': ['786Z46389E']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '63699815-ee85-645d-e053-2a91aa0a7c4f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171114',\n",
       "  'product_id': '71709-112_63699815-ee85-645d-e053-2a91aa0a7c4f',\n",
       "  'application_number': 'ANDA090564',\n",
       "  'brand_name_base': 'Metformin Hydrochloride',\n",
       "  'pharm_class': ['Biguanide [EPC]', 'Biguanides [CS]']},\n",
       " {'product_ndc': '71730-129',\n",
       "  'generic_name': 'Minoxidil',\n",
       "  'labeler_name': 'Hims Inc',\n",
       "  'brand_name': 'hers hair regrowth treatment',\n",
       "  'active_ingredients': [{'name': 'MINOXIDIL', 'strength': '50 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71730-129-01',\n",
       "    'description': '1 CAN in 1 CARTON (71730-129-01)  / 60 g in 1 CAN',\n",
       "    'marketing_start_date': '20210518',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Hims Inc'],\n",
       "   'rxcui': ['645146'],\n",
       "   'spl_set_id': ['77b917ec-65ea-4c7c-941e-fc37f598294b'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175379', 'N0000175564'],\n",
       "   'pharm_class_pe': ['Arteriolar Vasodilation [PE]'],\n",
       "   'pharm_class_epc': ['Arteriolar Vasodilator [EPC]'],\n",
       "   'unii': ['5965120SH1']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'AEROSOL, FOAM',\n",
       "  'spl_id': '93ad4c26-56ca-4f8e-b87a-b20c2fbe61e1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210518',\n",
       "  'product_id': '71730-129_93ad4c26-56ca-4f8e-b87a-b20c2fbe61e1',\n",
       "  'application_number': 'ANDA091344',\n",
       "  'brand_name_base': 'hers hair regrowth treatment',\n",
       "  'pharm_class': ['Arteriolar Vasodilation [PE]',\n",
       "   'Arteriolar Vasodilator [EPC]']},\n",
       " {'product_ndc': '0527-4108',\n",
       "  'generic_name': 'Mexiletine Hydrochloride',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'brand_name': 'Mexiletine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'MEXILETINE HYDROCHLORIDE',\n",
       "    'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-4108-37',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (0527-4108-37)',\n",
       "    'marketing_start_date': '20200723',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['1362706', '1362712', '1362720'],\n",
       "   'spl_set_id': ['4cf19b14-050e-4083-8f1e-6618310e02f1'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305274107371', '0305274108378', '0305274109375'],\n",
       "   'unii': ['606D60IS38']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '328667a9-1180-4924-aef5-c23c738af939',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200723',\n",
       "  'product_id': '0527-4108_328667a9-1180-4924-aef5-c23c738af939',\n",
       "  'application_number': 'ANDA213500',\n",
       "  'brand_name_base': 'Mexiletine Hydrochloride',\n",
       "  'pharm_class': ['Antiarrhythmic [EPC]']},\n",
       " {'product_ndc': '71734-204',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.',\n",
       "  'brand_name': 'KidzStuff Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '62 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71734-204-01',\n",
       "    'description': '2 g in 1 BOTTLE (71734-204-01)',\n",
       "    'marketing_start_date': '20180117',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.'],\n",
       "   'rxcui': ['247835'],\n",
       "   'spl_set_id': ['7ecf92e5-0ad6-41f0-bd02-2f79acb2b722'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '7b66fbd8-0469-4370-b7d0-126ab69d4d49',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180117',\n",
       "  'product_id': '71734-204_7b66fbd8-0469-4370-b7d0-126ab69d4d49',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'KidzStuff Hand Sanitizer'},\n",
       " {'product_ndc': '71734-313',\n",
       "  'generic_name': 'benzalkonium chloride',\n",
       "  'labeler_name': 'JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.',\n",
       "  'brand_name': 'Bactro Disinfecting wipe',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '.13 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71734-313-01',\n",
       "    'description': '3.7 g in 1 PACKAGE (71734-313-01)',\n",
       "    'marketing_start_date': '20200710',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.'],\n",
       "   'rxcui': ['1038558'],\n",
       "   'spl_set_id': ['5d6e6b4f-f0af-4068-9bda-736cbb54d931'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'SWAB',\n",
       "  'spl_id': '3fd806a5-e179-4fa0-a07e-32a690ab9011',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200710',\n",
       "  'product_id': '71734-313_3fd806a5-e179-4fa0-a07e-32a690ab9011',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'Bactro Disinfecting wipe'},\n",
       " {'product_ndc': '71734-322',\n",
       "  'generic_name': 'benzalkonium chloride',\n",
       "  'labeler_name': 'JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.',\n",
       "  'brand_name': 'Mykro Max Multi Purpose Disinfecting wipe',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '.13 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71734-322-01',\n",
       "    'description': '100 PACKAGE in 1 CANISTER (71734-322-01)  / 3.5 g in 1 PACKAGE',\n",
       "    'marketing_start_date': '20200731',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.'],\n",
       "   'rxcui': ['1038558'],\n",
       "   'spl_set_id': ['341ce3c1-7ec6-44b1-af1d-d705786ba202'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'SWAB',\n",
       "  'spl_id': '616e9779-64a4-4e81-99bd-eda059909577',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200731',\n",
       "  'product_id': '71734-322_616e9779-64a4-4e81-99bd-eda059909577',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'Mykro Max Multi Purpose Disinfecting wipe'},\n",
       " {'product_ndc': '71734-324',\n",
       "  'generic_name': 'benzalkonium chloride',\n",
       "  'labeler_name': 'JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.',\n",
       "  'brand_name': 'Sanitize Those Hands 40 Antibacterial Wipes',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '.13 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71734-324-01',\n",
       "    'description': '40 POUCH in 1 BAG (71734-324-01)  / 3.5 g in 1 POUCH',\n",
       "    'marketing_start_date': '20200819',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.'],\n",
       "   'rxcui': ['1038558'],\n",
       "   'spl_set_id': ['cda09196-1105-4993-ab44-dac2c69c7a24'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0850018852029'],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'SWAB',\n",
       "  'spl_id': '0ef811c4-e335-4d0d-b7b8-693a97ced210',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200819',\n",
       "  'product_id': '71734-324_0ef811c4-e335-4d0d-b7b8-693a97ced210',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'Sanitize Those Hands 40 Antibacterial Wipes'},\n",
       " {'product_ndc': '71734-327',\n",
       "  'generic_name': 'Alcohol',\n",
       "  'labeler_name': 'JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.',\n",
       "  'brand_name': 'Purenique Hygiene Solutions Alcohol Wipes',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '75 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71734-327-01',\n",
       "    'description': '2 g in 1 POUCH (71734-327-01)',\n",
       "    'marketing_start_date': '20200925',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.'],\n",
       "   'rxcui': ['1307051'],\n",
       "   'spl_set_id': ['6ba87272-0272-4d30-b958-652a96e0b24b'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'SWAB',\n",
       "  'spl_id': '28ca2771-933b-4b12-84bd-93bf3d0bc815',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200925',\n",
       "  'product_id': '71734-327_28ca2771-933b-4b12-84bd-93bf3d0bc815',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'Purenique Hygiene Solutions Alcohol Wipes'},\n",
       " {'product_ndc': '71734-343',\n",
       "  'generic_name': 'benzalkonium chloride',\n",
       "  'labeler_name': 'JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.',\n",
       "  'brand_name': 'Keep Going Non Sting Cleaning Wipe',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '.13 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71734-343-01',\n",
       "    'description': '2 g in 1 PACKAGE (71734-343-01)',\n",
       "    'marketing_start_date': '20240809',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.'],\n",
       "   'rxcui': ['1038558'],\n",
       "   'spl_set_id': ['6b7400d5-d4b8-4b68-b048-c1917cdf3ce3'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SWAB',\n",
       "  'spl_id': '1f3796ed-6fff-14d1-e063-6394a90a4eaa',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240809',\n",
       "  'product_id': '71734-343_1f3796ed-6fff-14d1-e063-6394a90a4eaa',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'Keep Going Non Sting Cleaning Wipe'},\n",
       " {'product_ndc': '0527-4119',\n",
       "  'generic_name': 'propranolol hydrochloride',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'brand_name': 'Propranolol Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PROPRANOLOL HYDROCHLORIDE',\n",
       "    'strength': '160 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-4119-37',\n",
       "    'description': '100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-4119-37)',\n",
       "    'marketing_start_date': '20200106',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0527-4119-41',\n",
       "    'description': '500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-4119-41)',\n",
       "    'marketing_start_date': '20200106',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['856460', '856481', '856535', '856569'],\n",
       "   'spl_set_id': ['5229b561-287b-463c-8679-cda4c34f440b'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305274116373'],\n",
       "   'unii': ['F8A3652H1V']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, EXTENDED RELEASE',\n",
       "  'spl_id': 'ceeffec9-095b-4081-b268-7869b0685921',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200106',\n",
       "  'product_id': '0527-4119_ceeffec9-095b-4081-b268-7869b0685921',\n",
       "  'application_number': 'ANDA212026',\n",
       "  'brand_name_base': 'Propranolol Hydrochloride',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '71740-112',\n",
       "  'generic_name': 'Potassium Iodide',\n",
       "  'labeler_name': 'Avondale Pharmaceuticals, LLC',\n",
       "  'brand_name': 'SSKI',\n",
       "  'active_ingredients': [{'name': 'POTASSIUM IODIDE', 'strength': '1 g/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71740-112-30',\n",
       "    'description': '1 BOTTLE, WITH APPLICATOR in 1 CARTON (71740-112-30)  / 30 mL in 1 BOTTLE, WITH APPLICATOR',\n",
       "    'marketing_start_date': '20171113',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Avondale Pharmaceuticals, LLC'],\n",
       "   'rxcui': ['312541', '544597'],\n",
       "   'spl_set_id': ['ca1d3449-ea29-49a4-8863-365ec95f1553'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0371740112309'],\n",
       "   'unii': ['1C4QK22F9J']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '8ef3bbab-b537-441b-a81f-3ad59cdd6b5f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171113',\n",
       "  'product_id': '71740-112_8ef3bbab-b537-441b-a81f-3ad59cdd6b5f',\n",
       "  'brand_name_base': 'SSKI'},\n",
       " {'product_ndc': '71742-0001',\n",
       "  'generic_name': 'Gaba, L-Dopa, Norepinephrine, Serotonin, Adrenocorticotrophin, Anacardium Orientale, Arsenicum Album, Baryta Carbonica, Calcarea Carbonica, Calcarea Phosphorica, Hyoscyamus Niger, Lycopodium Clavatum, Stramonium',\n",
       "  'labeler_name': 'Guangzhou Renuma Medical Systems Co., Ltd',\n",
       "  'brand_name': 'Neuro-Pro T007',\n",
       "  'brand_name_suffix': 'T007',\n",
       "  'active_ingredients': [{'name': '.GAMMA.-AMINOBUTYRIC ACID',\n",
       "    'strength': '6 [hp_X]/mL'},\n",
       "   {'name': 'ANACARDIUM OCCIDENTALE FRUIT', 'strength': '30 [hp_C]/mL'},\n",
       "   {'name': 'ARSENIC TRIOXIDE', 'strength': '30 [hp_C]/mL'},\n",
       "   {'name': 'BARIUM CARBONATE', 'strength': '30 [hp_C]/mL'},\n",
       "   {'name': 'CORTICOTROPIN', 'strength': '8 [hp_X]/mL'},\n",
       "   {'name': 'DATURA STRAMONIUM', 'strength': '30 [hp_C]/mL'},\n",
       "   {'name': 'HYOSCYAMUS NIGER', 'strength': '30 [hp_C]/mL'},\n",
       "   {'name': 'LEVODOPA', 'strength': '6 [hp_X]/mL'},\n",
       "   {'name': 'LYCOPODIUM CLAVATUM SPORE', 'strength': '30 [hp_C]/mL'},\n",
       "   {'name': 'NOREPINEPHRINE', 'strength': '6 [hp_X]/mL'},\n",
       "   {'name': 'OYSTER SHELL CALCIUM CARBONATE, CRUDE',\n",
       "    'strength': '30 [hp_C]/mL'},\n",
       "   {'name': 'SEROTONIN HYDROCHLORIDE', 'strength': '6 [hp_X]/mL'},\n",
       "   {'name': 'TRIBASIC CALCIUM PHOSPHATE', 'strength': '30 [hp_C]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71742-0001-1',\n",
       "    'description': '59 mL in 1 BOTTLE, DROPPER (71742-0001-1)',\n",
       "    'marketing_start_date': '20171018',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Renuma Medical Systems Co., Ltd'],\n",
       "   'spl_set_id': ['7e02ab0c-9bc2-4ffe-926c-5b388a07f7b2'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['M0000499',\n",
       "    'N0000175941',\n",
       "    'N0000193220',\n",
       "    'M0370111',\n",
       "    'N0000175570',\n",
       "    'M0003647'],\n",
       "   'pharm_class_cs': ['Adrenocorticotropic Hormone [CS]',\n",
       "    'Amino Acids, Aromatic [CS]',\n",
       "    'Catecholamines [CS]'],\n",
       "   'pharm_class_epc': ['Adrenocorticotropic Hormone [EPC]',\n",
       "    'Aromatic Amino Acid [EPC]',\n",
       "    'Catecholamine [EPC]'],\n",
       "   'unii': ['2ACZ6IPC6I',\n",
       "    '4A10JR4E7E',\n",
       "    'S7V92P67HO',\n",
       "    '6P669D8HQ8',\n",
       "    'K0U68Q2TXA',\n",
       "    'G6W4F0V8Z3',\n",
       "    '4WRK2153H3',\n",
       "    '46627O600J',\n",
       "    'C88X29Y479',\n",
       "    'X4W3ENH1CV',\n",
       "    '2E32821G6I',\n",
       "    'GKN429M9VS',\n",
       "    '91D9GV0Z28']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '33bf81ec-4693-464f-ab65-61cce5756124',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171018',\n",
       "  'product_id': '71742-0001_33bf81ec-4693-464f-ab65-61cce5756124',\n",
       "  'brand_name_base': 'Neuro-Pro',\n",
       "  'pharm_class': ['Adrenocorticotropic Hormone [CS]',\n",
       "   'Adrenocorticotropic Hormone [EPC]',\n",
       "   'Amino Acids',\n",
       "   'Aromatic [CS]',\n",
       "   'Aromatic Amino Acid [EPC]',\n",
       "   'Blood Coagulation Factor [EPC]',\n",
       "   'Calcium [CS]',\n",
       "   'Catecholamine [EPC]',\n",
       "   'Catecholamines [CS]',\n",
       "   'Cations',\n",
       "   'Divalent [CS]',\n",
       "   'Increased Coagulation Factor Activity [PE]']},\n",
       " {'product_ndc': '71742-0009',\n",
       "  'generic_name': 'Syzygium Jambolanum, Glandula Suprarenalis Suis, Hydrastis Canadensis, Hypophysis Suis, Pancreas Suis, Phaseolus, Aceticum Acidum, Lacticum Acidum, Phosphoricum Acidum, Phosphorus, Uranium Nitricum',\n",
       "  'labeler_name': 'Guangzhou Renuma Medical Systems Co., Ltd',\n",
       "  'brand_name': 'Glucose Control T015',\n",
       "  'brand_name_suffix': 'T015',\n",
       "  'active_ingredients': [{'name': 'ACETIC ACID', 'strength': '12 [hp_X]/mL'},\n",
       "   {'name': 'GOLDENSEAL', 'strength': '6 [hp_X]/mL'},\n",
       "   {'name': 'KIDNEY BEAN', 'strength': '9 [hp_X]/mL'},\n",
       "   {'name': 'LACTIC ACID', 'strength': '12 [hp_X]/mL'},\n",
       "   {'name': 'PHOSPHORIC ACID', 'strength': '12 [hp_X]/mL'},\n",
       "   {'name': 'PHOSPHORUS', 'strength': '12 [hp_X]/mL'},\n",
       "   {'name': 'SUS SCROFA ADRENAL GLAND', 'strength': '6 [hp_X]/mL'},\n",
       "   {'name': 'SUS SCROFA PANCREAS', 'strength': '6 [hp_X]/mL'},\n",
       "   {'name': 'SUS SCROFA PITUITARY GLAND', 'strength': '6 [hp_X]/mL'},\n",
       "   {'name': 'SYZYGIUM CUMINI SEED', 'strength': '3 [hp_X]/mL'},\n",
       "   {'name': 'URANYL NITRATE HEXAHYDRATE', 'strength': '12 [hp_X]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71742-0009-1',\n",
       "    'description': '59 mL in 1 BOTTLE, DROPPER (71742-0009-1)',\n",
       "    'marketing_start_date': '20171026',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Renuma Medical Systems Co., Ltd'],\n",
       "   'spl_set_id': ['3fd02c0a-5cf1-4f35-86d0-d5d09e63f39b'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185375',\n",
       "    'N0000185371',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'M0000728',\n",
       "    'M0006342',\n",
       "    'M0016962',\n",
       "    'M0022575'],\n",
       "   'pharm_class_epc': ['Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "    'Non-Standardized Food Allergenic Extract [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]',\n",
       "    'Dietary Proteins [CS]',\n",
       "    'Plant Proteins [CS]',\n",
       "    'Vegetable Proteins [CS]'],\n",
       "   'unii': ['Q40Q9N063P',\n",
       "    'ZW3Z11D0JV',\n",
       "    'M98C8416QO',\n",
       "    '33X04XA5AT',\n",
       "    'E4GA8884NN',\n",
       "    '27YLU75U4W',\n",
       "    '398IYQ16YV',\n",
       "    '9Y3J3362RY',\n",
       "    'L0PFEMQ1DT',\n",
       "    '820LSF646I',\n",
       "    '3V057702FY']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '5e65d625-8b6c-48af-84c6-f91fdf8cf01d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171026',\n",
       "  'product_id': '71742-0009_5e65d625-8b6c-48af-84c6-f91fdf8cf01d',\n",
       "  'brand_name_base': 'Glucose Control',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]',\n",
       "   'Vegetable Proteins [CS]']},\n",
       " {'product_ndc': '71753-1450',\n",
       "  'marketing_end_date': '20251125',\n",
       "  'generic_name': 'Influenzinum (2020-2021)',\n",
       "  'labeler_name': 'Ratis, LLC',\n",
       "  'brand_name': 'Influenzinum',\n",
       "  'active_ingredients': [{'name': 'INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'strength': '10 [hp_C]/mL'},\n",
       "   {'name': 'INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'strength': '10 [hp_C]/mL'},\n",
       "   {'name': 'INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'strength': '10 [hp_C]/mL'},\n",
       "   {'name': 'INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'strength': '10 [hp_C]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71753-1450-1',\n",
       "    'description': '30 mL in 1 BOTTLE, SPRAY (71753-1450-1)',\n",
       "    'marketing_start_date': '20201109',\n",
       "    'marketing_end_date': '20251125',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Ratis, LLC'],\n",
       "   'spl_set_id': ['529143bd-4181-437b-8fb6-ba0f73fa2b93'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0371753145011'],\n",
       "   'unii': ['NY1FF92M1E', 'P8ORN3UOM6', 'B93BQX9789', 'VEH9U90EHX']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '0472a0c4-cd8f-4e11-809b-a5d43205c583',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201109',\n",
       "  'product_id': '71753-1450_0472a0c4-cd8f-4e11-809b-a5d43205c583',\n",
       "  'brand_name_base': 'Influenzinum'},\n",
       " {'product_ndc': '71777-390',\n",
       "  'generic_name': 'LAROTRECTINIB',\n",
       "  'labeler_name': 'Loxo Oncology, Inc.',\n",
       "  'brand_name': 'VITRAKVI',\n",
       "  'active_ingredients': [{'name': 'LAROTRECTINIB', 'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71777-390-01',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71777-390-01)',\n",
       "    'marketing_start_date': '20181126',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Loxo Oncology, Inc.'],\n",
       "   'rxcui': ['2105633', '2105645', '2105649', '2105653', '2105655', '2105657'],\n",
       "   'spl_set_id': ['9525f887-a055-4e33-8e92-898d42828cd1'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175605', 'N0000193859'],\n",
       "   'pharm_class_epc': ['Kinase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Tropomyosin Receptor Kinases Inhibitors [MoA]'],\n",
       "   'unii': ['PF9462I9HX']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '5b9e7961-f843-49d8-94b5-a2ce2c9efa46',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181126',\n",
       "  'product_id': '71777-390_5b9e7961-f843-49d8-94b5-a2ce2c9efa46',\n",
       "  'application_number': 'NDA210861',\n",
       "  'brand_name_base': 'VITRAKVI',\n",
       "  'pharm_class': ['Kinase Inhibitor [EPC]',\n",
       "   'Tropomyosin Receptor Kinases Inhibitors [MoA]']},\n",
       " {'product_ndc': '71777-391',\n",
       "  'generic_name': 'LAROTRECTINIB',\n",
       "  'labeler_name': 'Loxo Oncology, Inc.',\n",
       "  'brand_name': 'VITRAKVI',\n",
       "  'active_ingredients': [{'name': 'LAROTRECTINIB', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71777-391-01',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71777-391-01)',\n",
       "    'marketing_start_date': '20181126',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Loxo Oncology, Inc.'],\n",
       "   'rxcui': ['2105633', '2105645', '2105649', '2105653', '2105655', '2105657'],\n",
       "   'spl_set_id': ['9525f887-a055-4e33-8e92-898d42828cd1'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175605', 'N0000193859'],\n",
       "   'pharm_class_epc': ['Kinase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Tropomyosin Receptor Kinases Inhibitors [MoA]'],\n",
       "   'unii': ['PF9462I9HX']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '5b9e7961-f843-49d8-94b5-a2ce2c9efa46',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181126',\n",
       "  'product_id': '71777-391_5b9e7961-f843-49d8-94b5-a2ce2c9efa46',\n",
       "  'application_number': 'NDA210861',\n",
       "  'brand_name_base': 'VITRAKVI',\n",
       "  'pharm_class': ['Kinase Inhibitor [EPC]',\n",
       "   'Tropomyosin Receptor Kinases Inhibitors [MoA]']},\n",
       " {'product_ndc': '71782-601',\n",
       "  'generic_name': 'octinoxate, octisalate, octocrylene, avobenzone',\n",
       "  'labeler_name': 'DUKE CANNON SUPPLY CO.',\n",
       "  'brand_name': 'Winter Rescue Kit',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71782-601-01',\n",
       "    'description': '1 KIT in 1 CARTON (71782-601-01)  *  85 g in 1 TUBE *  17 g in 1 TUBE (71782-115-01)  *  42.5 g in 1 JAR',\n",
       "    'marketing_start_date': '20241101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['DUKE CANNON SUPPLY CO.'],\n",
       "   'spl_set_id': ['24356548-348d-2cd2-e063-6294a90ab352'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0854410004406']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': '24356548-348e-2cd2-e063-6294a90ab352',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'marketing_start_date': '20241101',\n",
       "  'product_id': '71782-601_24356548-348e-2cd2-e063-6294a90ab352',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Winter Rescue Kit'},\n",
       " {'product_ndc': '71804-531',\n",
       "  'generic_name': 'BENZOYL PEROXIDE',\n",
       "  'labeler_name': 'MDAlgorithms Inc',\n",
       "  'brand_name': 'MDacne Customized Acne Treatment Benzoyl Peroxide',\n",
       "  'active_ingredients': [{'name': 'BENZOYL PEROXIDE', 'strength': '25 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71804-531-00',\n",
       "    'description': '1 TUBE in 1 BOX (71804-531-00)  / 15 mL in 1 TUBE',\n",
       "    'marketing_start_date': '20240912',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['MDAlgorithms Inc'],\n",
       "   'rxcui': ['308688'],\n",
       "   'spl_set_id': ['a1f38604-9a42-400d-851e-148d0dc9c86b'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0850026819281'],\n",
       "   'unii': ['W9WZN9A0GM']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '2275c6c5-5ad4-a323-e063-6394a90a54bc',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240912',\n",
       "  'product_id': '71804-531_2275c6c5-5ad4-a323-e063-6394a90a54bc',\n",
       "  'application_number': 'M006',\n",
       "  'brand_name_base': 'MDacne Customized Acne Treatment Benzoyl Peroxide'},\n",
       " {'product_ndc': '71811-003',\n",
       "  'generic_name': 'Lidocaine',\n",
       "  'labeler_name': 'InterMed Laboratories Private Limited',\n",
       "  'brand_name': 'Pain Relieving Lidocaine Patch',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71811-003-30',\n",
       "    'description': '30 POUCH in 1 CARTON (71811-003-30)  / 1 PATCH in 1 POUCH',\n",
       "    'marketing_start_date': '20200917',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71811-003-40',\n",
       "    'description': '40 POUCH in 1 CARTON (71811-003-40)  / 1 PATCH in 1 POUCH',\n",
       "    'marketing_start_date': '20200917',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['InterMed Laboratories Private Limited'],\n",
       "   'rxcui': ['1737778'],\n",
       "   'spl_set_id': ['01d3b2bb-3944-083e-e063-6394a90a7816'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175682', 'M0000897', 'N0000175426', 'N0000175976'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]', 'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'unii': ['98PI200987']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'PATCH',\n",
       "  'spl_id': '27c03a04-63cd-3245-e063-6394a90a0147',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200917',\n",
       "  'product_id': '71811-003_27c03a04-63cd-3245-e063-6394a90a0147',\n",
       "  'brand_name_base': 'Pain Relieving Lidocaine Patch',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '71819-006',\n",
       "  'generic_name': 'Salicylic Acid, Sulfur',\n",
       "  'labeler_name': 'D3 Development, Inc.',\n",
       "  'brand_name': 'Dermaharmony Sulfur and Salicylic Acid',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '2 g/100mL'},\n",
       "   {'name': 'SULFUR', 'strength': '5 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71819-006-04',\n",
       "    'description': '118 mL in 1 BOTTLE, PLASTIC (71819-006-04)',\n",
       "    'marketing_start_date': '20200327',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71819-006-10',\n",
       "    'description': '296 mL in 1 BOTTLE, PLASTIC (71819-006-10)',\n",
       "    'marketing_start_date': '20200327',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71819-006-12',\n",
       "    'description': '355 mL in 1 BOTTLE, PLASTIC (71819-006-12)',\n",
       "    'marketing_start_date': '20200327',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71819-006-64',\n",
       "    'description': '1893 mL in 1 BOTTLE, PLASTIC (71819-006-64)',\n",
       "    'marketing_start_date': '20200327',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71819-006-99',\n",
       "    'description': '3785 mL in 1 BOTTLE, PLASTIC (71819-006-99)',\n",
       "    'marketing_start_date': '20200327',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['D3 Development, Inc.'],\n",
       "   'rxcui': ['2286294'],\n",
       "   'spl_set_id': ['a1c61da2-7e7a-430a-e053-2995a90ad594'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['O414PZ4LPZ', '70FD1KFU70']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'a1c61da2-7e7b-430a-e053-2995a90ad594',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200327',\n",
       "  'product_id': '71819-006_a1c61da2-7e7b-430a-e053-2995a90ad594',\n",
       "  'application_number': 'part358H',\n",
       "  'brand_name_base': 'Dermaharmony Sulfur and Salicylic Acid'},\n",
       " {'product_ndc': '71819-010',\n",
       "  'generic_name': 'Pyrithione Zinc',\n",
       "  'labeler_name': 'D3 Development, Inc.',\n",
       "  'brand_name': 'Dermaharmony 1% Pyrithione Zinc',\n",
       "  'active_ingredients': [{'name': 'PYRITHIONE ZINC', 'strength': '1 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71819-010-04',\n",
       "    'description': '113 g in 1 CELLO PACK (71819-010-04)',\n",
       "    'marketing_start_date': '20210127',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['D3 Development, Inc.'],\n",
       "   'rxcui': ['251632'],\n",
       "   'spl_set_id': ['b9e765eb-f55f-f38a-e053-2a95a90aafd1'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['R953O2RHZ5']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'SOAP',\n",
       "  'spl_id': 'b9e765eb-f560-f38a-e053-2a95a90aafd1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210127',\n",
       "  'product_id': '71819-010_b9e765eb-f560-f38a-e053-2a95a90aafd1',\n",
       "  'application_number': 'part358H',\n",
       "  'brand_name_base': 'Dermaharmony 1% Pyrithione Zinc'},\n",
       " {'product_ndc': '71824-1700',\n",
       "  'generic_name': 'Ethyl Alcohol',\n",
       "  'labeler_name': 'Prima Fleur Botanicals, Inc.',\n",
       "  'brand_name': 'Prima Fleur Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL',\n",
       "    'strength': '2649.787 mL/3785.41mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71824-1700-1',\n",
       "    'description': '1 mL in 1 BOTTLE, PUMP (71824-1700-1)',\n",
       "    'marketing_start_date': '20200811',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Prima Fleur Botanicals, Inc.'],\n",
       "   'rxcui': ['581662'],\n",
       "   'spl_set_id': ['aca372a3-9b44-5816-e053-2995a90a2d6b'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '10570edd-49ad-857a-e063-6294a90aa09b',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['CUTANEOUS'],\n",
       "  'marketing_start_date': '20200811',\n",
       "  'product_id': '71824-1700_10570edd-49ad-857a-e063-6294a90aa09b',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Prima Fleur Hand Sanitizer'},\n",
       " {'product_ndc': '71824-7916',\n",
       "  'generic_name': 'Ethyl Alcohol Hand Sanitizer',\n",
       "  'labeler_name': 'Prima Fleur Botanicals, Inc.',\n",
       "  'brand_name': 'Workforce Personal Care Hand Sanitizer Lemon Tea Tree',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL',\n",
       "    'strength': '331.2232 mL/473.176mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71824-7916-1',\n",
       "    'description': '1 mL in 1 BOTTLE, PLASTIC (71824-7916-1)',\n",
       "    'marketing_start_date': '20200521',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Prima Fleur Botanicals, Inc.'],\n",
       "   'rxcui': ['581662'],\n",
       "   'spl_set_id': ['a62b0662-e328-4a8e-e053-2995a90a267d'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '10572058-e928-9236-e063-6294a90a2ac2',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['CUTANEOUS'],\n",
       "  'marketing_start_date': '20200521',\n",
       "  'product_id': '71824-7916_10572058-e928-9236-e063-6294a90a2ac2',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Workforce Personal Care Hand Sanitizer Lemon Tea Tree'},\n",
       " {'product_ndc': '71831-004',\n",
       "  'generic_name': 'GLYCERIN, KAOLIN, CALAMINE, MENTHOL',\n",
       "  'labeler_name': 'PRANICURA GROUP LLC',\n",
       "  'brand_name': 'Pranicura 5',\n",
       "  'active_ingredients': [{'name': 'GLYCERIN', 'strength': '25 g/100g'},\n",
       "   {'name': 'KAOLIN', 'strength': '12.5 g/100g'},\n",
       "   {'name': 'MENTHOL', 'strength': '1 g/100g'},\n",
       "   {'name': 'ZINC OXIDE', 'strength': '12.5 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71831-004-01',\n",
       "    'description': '60 g in 1 JAR (71831-004-01)',\n",
       "    'marketing_start_date': '20211018',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PRANICURA GROUP LLC'],\n",
       "   'spl_set_id': ['af520a58-3f3c-4d28-a41f-3ed8f74da095'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185370',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'N0000185001',\n",
       "    'M0000728',\n",
       "    'M0009417'],\n",
       "   'pharm_class_epc': ['Non-Standardized Chemical Allergen [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]',\n",
       "    'Increased IgG Production [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]', 'Glycerol [CS]'],\n",
       "   'unii': ['PDC6A3C0OX', '24H4NWX5CO', 'L7T10EIP3A', 'SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '427f7534-740c-4fb1-ac94-df4c937fd3ea',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20211018',\n",
       "  'product_id': '71831-004_427f7534-740c-4fb1-ac94-df4c937fd3ea',\n",
       "  'application_number': 'M015',\n",
       "  'brand_name_base': 'Pranicura 5',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]',\n",
       "   'Glycerol [CS]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Increased IgG Production [PE]',\n",
       "   'Non-Standardized Chemical Allergen [EPC]']},\n",
       " {'product_ndc': '71831-005',\n",
       "  'generic_name': 'GLYCERIN, KAOLIN, CALAMINE, MENTHOL',\n",
       "  'labeler_name': 'PRANICURA GROUP LLC',\n",
       "  'brand_name': 'No More Products',\n",
       "  'active_ingredients': [{'name': 'GLYCERIN', 'strength': '25 g/100g'},\n",
       "   {'name': 'KAOLIN', 'strength': '12.5 g/100g'},\n",
       "   {'name': 'MENTHOL', 'strength': '1 g/100g'},\n",
       "   {'name': 'ZINC OXIDE', 'strength': '12.5 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71831-005-01',\n",
       "    'description': '1 TUBE in 1 BOX (71831-005-01)  / 35 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71831-005-02',\n",
       "    'description': '1 TUBE in 1 BOX (71831-005-02)  / 35 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71831-005-03',\n",
       "    'description': '1 TUBE in 1 BOX (71831-005-03)  / 35 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230301',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['PRANICURA GROUP LLC'],\n",
       "   'spl_set_id': ['2cc9fb86-50dc-4c2e-b83d-f96826ffd9ab'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185370',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'N0000185001',\n",
       "    'M0000728',\n",
       "    'M0009417'],\n",
       "   'pharm_class_epc': ['Non-Standardized Chemical Allergen [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]',\n",
       "    'Increased IgG Production [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]', 'Glycerol [CS]'],\n",
       "   'unii': ['PDC6A3C0OX', '24H4NWX5CO', 'L7T10EIP3A', 'SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '8a8a50c0-b8db-423b-9b79-aa3ae73818db',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230301',\n",
       "  'product_id': '71831-005_8a8a50c0-b8db-423b-9b79-aa3ae73818db',\n",
       "  'application_number': 'M015',\n",
       "  'brand_name_base': 'No More Products',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]',\n",
       "   'Glycerol [CS]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Increased IgG Production [PE]',\n",
       "   'Non-Standardized Chemical Allergen [EPC]']},\n",
       " {'product_ndc': '71839-126',\n",
       "  'generic_name': 'glycopyrrolate',\n",
       "  'labeler_name': 'BE Pharmaceuticals Inc.',\n",
       "  'brand_name': 'glycopyrrolate',\n",
       "  'active_ingredients': [{'name': 'GLYCOPYRROLATE', 'strength': '4 mg/20mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71839-126-25',\n",
       "    'description': '25 VIAL, MULTI-DOSE in 1 CARTON (71839-126-25)  / 20 mL in 1 VIAL, MULTI-DOSE (71839-126-01)',\n",
       "    'marketing_start_date': '20220310',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['BE Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['238212', '1731582', '1731590'],\n",
       "   'spl_set_id': ['d9df3900-a8c2-438b-8971-ba11ff91f90b'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0371839126019'],\n",
       "   'unii': ['V92SO9WP2I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'd9df3900-a8c2-438b-8971-ba11ff91f90b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS'],\n",
       "  'marketing_start_date': '20220310',\n",
       "  'product_id': '71839-126_d9df3900-a8c2-438b-8971-ba11ff91f90b',\n",
       "  'application_number': 'ANDA211705',\n",
       "  'brand_name_base': 'glycopyrrolate',\n",
       "  'pharm_class': ['Anticholinergic [EPC]', 'Cholinergic Antagonists [MoA]']},\n",
       " {'product_ndc': '71839-142',\n",
       "  'generic_name': 'rocuronium bromide',\n",
       "  'labeler_name': 'BE Pharmaceuticals Inc.',\n",
       "  'brand_name': 'Rocuronium Bromide',\n",
       "  'active_ingredients': [{'name': 'ROCURONIUM BROMIDE',\n",
       "    'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71839-142-10',\n",
       "    'description': '10 VIAL, MULTI-DOSE in 1 CARTON (71839-142-10)  / 10 mL in 1 VIAL, MULTI-DOSE (71839-142-01)',\n",
       "    'marketing_start_date': '20230712',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['BE Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['1234995'],\n",
       "   'spl_set_id': ['1543ea2b-54ab-4088-a72a-5d71854a2dce'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0371839142019', '0371839141012'],\n",
       "   'unii': ['I65MW4OFHZ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '1543ea2b-54ab-4088-a72a-5d71854a2dce',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20230712',\n",
       "  'product_id': '71839-142_1543ea2b-54ab-4088-a72a-5d71854a2dce',\n",
       "  'application_number': 'ANDA216234',\n",
       "  'brand_name_base': 'Rocuronium Bromide',\n",
       "  'pharm_class': ['Neuromuscular Nondepolarizing Blockade [PE]',\n",
       "   'Nondepolarizing Neuromuscular Blocker [EPC]']},\n",
       " {'product_ndc': '71839-143',\n",
       "  'generic_name': 'norepinephrine bitartrate',\n",
       "  'labeler_name': 'BE Pharmaceuticals Inc.',\n",
       "  'brand_name': 'Norepinephrine Bitartrate',\n",
       "  'active_ingredients': [{'name': 'NOREPINEPHRINE BITARTRATE',\n",
       "    'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71839-143-10',\n",
       "    'description': '10 VIAL, SINGLE-DOSE in 1 CARTON (71839-143-10)  / 4 mL in 1 VIAL, SINGLE-DOSE (71839-143-01)',\n",
       "    'marketing_start_date': '20231230',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71839-143-25',\n",
       "    'description': '25 VIAL, SINGLE-DOSE in 1 CARTON (71839-143-25)  / 4 mL in 1 VIAL, SINGLE-DOSE (71839-143-01)',\n",
       "    'marketing_start_date': '20231230',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['BE Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['242969'],\n",
       "   'spl_set_id': ['c42d425a-094e-4390-b4f9-4bb4b0fbc7d0'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0371839143252', '0371839143016', '0371839143108'],\n",
       "   'unii': ['IFY5PE3ZRW']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'c42d425a-094e-4390-b4f9-4bb4b0fbc7d0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20231230',\n",
       "  'product_id': '71839-143_c42d425a-094e-4390-b4f9-4bb4b0fbc7d0',\n",
       "  'application_number': 'ANDA217575',\n",
       "  'brand_name_base': 'Norepinephrine Bitartrate',\n",
       "  'pharm_class': ['Catecholamine [EPC]', 'Catecholamines [CS]']},\n",
       " {'product_ndc': '71852-334',\n",
       "  'generic_name': 'OCTINOXATE, OCTISALATE, AVOBENZONE',\n",
       "  'labeler_name': 'Product Management, LLC',\n",
       "  'brand_name': 'NO BS Moisturizer SPF20',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '30 mg/mL'},\n",
       "   {'name': 'OCTINOXATE', 'strength': '50 mg/mL'},\n",
       "   {'name': 'OCTISALATE', 'strength': '30 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71852-334-00',\n",
       "    'description': '1 BOTTLE in 1 BOX (71852-334-00)  / 50 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20180601',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Product Management, LLC'],\n",
       "   'spl_set_id': ['142f3610-85da-408d-8fa5-3773167ffc9f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['G63QQF2NOX', '4Y5P7MUD51', '4X49Y0596W']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '097483fe-a26b-b6fc-e063-6394a90a44dd',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180601',\n",
       "  'product_id': '71852-334_097483fe-a26b-b6fc-e063-6394a90a44dd',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'NO BS Moisturizer SPF20'},\n",
       " {'product_ndc': '71853-007',\n",
       "  'generic_name': 'BENZALKONIUM CHLORIDE',\n",
       "  'labeler_name': 'Bryson Industries Inc.',\n",
       "  'brand_name': 'ElimiShield Alcohol Free Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '1.3 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71853-007-01',\n",
       "    'description': '500 mL in 1 BOTTLE (71853-007-01)',\n",
       "    'marketing_start_date': '20200901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Bryson Industries Inc.'],\n",
       "   'rxcui': ['1049254'],\n",
       "   'spl_set_id': ['b0002a22-118e-0ef9-e053-2a95a90ac1c2'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '09c2dbb9-bc5c-b54b-e063-6294a90a9c25',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200901',\n",
       "  'product_id': '71853-007_09c2dbb9-bc5c-b54b-e063-6294a90a9c25',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'ElimiShield Alcohol Free Hand Sanitizer'},\n",
       " {'product_ndc': '0527-4952',\n",
       "  'marketing_end_date': '20250930',\n",
       "  'generic_name': 'levothyroxine sodium',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'brand_name': 'Levothyroxine Sodium',\n",
       "  'active_ingredients': [{'name': 'LEVOTHYROXINE SODIUM',\n",
       "    'strength': '25 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-4952-32',\n",
       "    'description': '3 BLISTER PACK in 1 CARTON (0527-4952-32)  / 10 CAPSULE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20201102',\n",
       "    'marketing_end_date': '20250930',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['905451',\n",
       "    '905455',\n",
       "    '905458',\n",
       "    '905462',\n",
       "    '966404',\n",
       "    '966405',\n",
       "    '966406',\n",
       "    '966407',\n",
       "    '966412',\n",
       "    '966413',\n",
       "    '1923047',\n",
       "    '1923050'],\n",
       "   'spl_set_id': ['686ba2cf-7651-44de-9b4d-eeaaf2a0e364'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305274951325',\n",
       "    '0305274952322',\n",
       "    '0305274955323',\n",
       "    '0305274958324',\n",
       "    '0305274959321',\n",
       "    '0305274954326',\n",
       "    '0305274956320',\n",
       "    '0305274962321',\n",
       "    '0305274957327',\n",
       "    '0305274960327'],\n",
       "   'unii': ['9J765S329G']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '19314c06-6be2-6e6e-e063-6394a90ac159',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201102',\n",
       "  'product_id': '0527-4952_19314c06-6be2-6e6e-e063-6394a90ac159',\n",
       "  'application_number': 'NDA021924',\n",
       "  'brand_name_base': 'Levothyroxine Sodium',\n",
       "  'pharm_class': ['Thyroxine [CS]', 'l-Thyroxine [EPC]']},\n",
       " {'product_ndc': '71858-0012',\n",
       "  'generic_name': 'levothyroxine sodium',\n",
       "  'labeler_name': 'IBSA Pharma Inc.',\n",
       "  'brand_name': 'Tirosint',\n",
       "  'active_ingredients': [{'name': 'LEVOTHYROXINE SODIUM',\n",
       "    'strength': '37.5 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71858-0012-1',\n",
       "    'description': '1 BLISTER PACK in 1 CARTON (71858-0012-1)  / 10 CAPSULE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20230301',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '71858-0012-4',\n",
       "    'description': '3 BLISTER PACK in 1 CARTON (71858-0012-4)  / 10 CAPSULE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20230301',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['IBSA Pharma Inc.'],\n",
       "   'rxcui': ['905451',\n",
       "    '905453',\n",
       "    '905455',\n",
       "    '905457',\n",
       "    '905458',\n",
       "    '905460',\n",
       "    '905462',\n",
       "    '905464',\n",
       "    '966404',\n",
       "    '966405',\n",
       "    '966406',\n",
       "    '966407',\n",
       "    '966412',\n",
       "    '966413',\n",
       "    '966415',\n",
       "    '966417',\n",
       "    '966420',\n",
       "    '966423',\n",
       "    '966426',\n",
       "    '966434',\n",
       "    '1923047',\n",
       "    '1923049',\n",
       "    '1923050',\n",
       "    '1923052',\n",
       "    '2630738',\n",
       "    '2630740',\n",
       "    '2630742',\n",
       "    '2630744',\n",
       "    '2630746',\n",
       "    '2630748'],\n",
       "   'spl_set_id': ['7a7ade79-0165-4e31-b84e-667416c00c7e'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0371858001540',\n",
       "    '0371858006040',\n",
       "    '0371858003049',\n",
       "    '0371858004541',\n",
       "    '0371858001045',\n",
       "    '0371858004046',\n",
       "    '0371858001243',\n",
       "    '0371858001748',\n",
       "    '0371858002042',\n",
       "    '0371858003544',\n",
       "    '0371858001342',\n",
       "    '0371858005043'],\n",
       "   'unii': ['9J765S329G']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '254d1ae9-8aae-f4b6-e063-6394a90a39d0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230301',\n",
       "  'product_id': '71858-0012_254d1ae9-8aae-f4b6-e063-6394a90a39d0',\n",
       "  'application_number': 'NDA021924',\n",
       "  'brand_name_base': 'Tirosint',\n",
       "  'pharm_class': ['Thyroxine [CS]', 'l-Thyroxine [EPC]']},\n",
       " {'product_ndc': '71858-0025',\n",
       "  'generic_name': 'levothyroxine sodium',\n",
       "  'labeler_name': 'IBSA Pharma Inc.',\n",
       "  'brand_name': 'Tirosint',\n",
       "  'active_ingredients': [{'name': 'LEVOTHYROXINE SODIUM',\n",
       "    'strength': '88 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71858-0025-1',\n",
       "    'description': '1 BLISTER PACK in 1 CARTON (71858-0025-1)  / 10 CAPSULE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20181201',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '71858-0025-4',\n",
       "    'description': '3 BLISTER PACK in 1 CARTON (71858-0025-4)  / 10 CAPSULE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20181201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['IBSA Pharma Inc.'],\n",
       "   'rxcui': ['905451',\n",
       "    '905453',\n",
       "    '905455',\n",
       "    '905457',\n",
       "    '905458',\n",
       "    '905460',\n",
       "    '905462',\n",
       "    '905464',\n",
       "    '966404',\n",
       "    '966405',\n",
       "    '966406',\n",
       "    '966407',\n",
       "    '966412',\n",
       "    '966413',\n",
       "    '966415',\n",
       "    '966417',\n",
       "    '966420',\n",
       "    '966423',\n",
       "    '966426',\n",
       "    '966434',\n",
       "    '1923047',\n",
       "    '1923049',\n",
       "    '1923050',\n",
       "    '1923052',\n",
       "    '2630738',\n",
       "    '2630740',\n",
       "    '2630742',\n",
       "    '2630744',\n",
       "    '2630746',\n",
       "    '2630748'],\n",
       "   'spl_set_id': ['7a7ade79-0165-4e31-b84e-667416c00c7e'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0371858001540',\n",
       "    '0371858006040',\n",
       "    '0371858003049',\n",
       "    '0371858004541',\n",
       "    '0371858001045',\n",
       "    '0371858004046',\n",
       "    '0371858001243',\n",
       "    '0371858001748',\n",
       "    '0371858002042',\n",
       "    '0371858003544',\n",
       "    '0371858001342',\n",
       "    '0371858005043'],\n",
       "   'unii': ['9J765S329G']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '254d1ae9-8aae-f4b6-e063-6394a90a39d0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181201',\n",
       "  'product_id': '71858-0025_254d1ae9-8aae-f4b6-e063-6394a90a39d0',\n",
       "  'application_number': 'NDA021924',\n",
       "  'brand_name_base': 'Tirosint',\n",
       "  'pharm_class': ['Thyroxine [CS]', 'l-Thyroxine [EPC]']},\n",
       " {'product_ndc': '71858-0113',\n",
       "  'generic_name': 'Levothyroxine Sodium',\n",
       "  'labeler_name': 'IBSA Pharma Inc.',\n",
       "  'brand_name': 'Tirosint SOL',\n",
       "  'brand_name_suffix': 'SOL',\n",
       "  'active_ingredients': [{'name': 'LEVOTHYROXINE SODIUM',\n",
       "    'strength': '44 ug/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71858-0113-1',\n",
       "    'description': '2 POUCH in 1 CARTON (71858-0113-1)  / 5 AMPULE in 1 POUCH (71858-0113-4)  / 1 mL in 1 AMPULE (71858-0113-6)',\n",
       "    'marketing_start_date': '20210701',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '71858-0113-5',\n",
       "    'description': '6 POUCH in 1 CARTON (71858-0113-5)  / 5 AMPULE in 1 POUCH (71858-0113-4)  / 1 mL in 1 AMPULE (71858-0113-6)',\n",
       "    'marketing_start_date': '20210701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['IBSA Pharma Inc.'],\n",
       "   'rxcui': ['2056462',\n",
       "    '2056466',\n",
       "    '2056468',\n",
       "    '2056470',\n",
       "    '2056472',\n",
       "    '2056474',\n",
       "    '2056476',\n",
       "    '2056478',\n",
       "    '2056480',\n",
       "    '2056482',\n",
       "    '2056484',\n",
       "    '2056486',\n",
       "    '2056488',\n",
       "    '2056490',\n",
       "    '2056492',\n",
       "    '2056494',\n",
       "    '2056496',\n",
       "    '2056498',\n",
       "    '2056500',\n",
       "    '2056502',\n",
       "    '2056504',\n",
       "    '2056506',\n",
       "    '2056508',\n",
       "    '2056510',\n",
       "    '2566608',\n",
       "    '2566610',\n",
       "    '2566613',\n",
       "    '2566615',\n",
       "    '2566617',\n",
       "    '2566619'],\n",
       "   'spl_set_id': ['5d378add-f13d-40f2-99dc-0f2340ab44b7'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['9J765S329G']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '25224536-09f7-ca7c-e063-6394a90a3bf9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210701',\n",
       "  'product_id': '71858-0113_25224536-09f7-ca7c-e063-6394a90a3bf9',\n",
       "  'application_number': 'NDA206977',\n",
       "  'brand_name_base': 'Tirosint',\n",
       "  'pharm_class': ['Thyroxine [CS]', 'l-Thyroxine [EPC]']},\n",
       " {'product_ndc': '71858-0155',\n",
       "  'generic_name': 'Levothyroxine Sodium',\n",
       "  'labeler_name': 'IBSA Pharma Inc.',\n",
       "  'brand_name': 'Tirosint SOL',\n",
       "  'brand_name_suffix': 'SOL',\n",
       "  'active_ingredients': [{'name': 'LEVOTHYROXINE SODIUM',\n",
       "    'strength': '175 ug/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71858-0155-1',\n",
       "    'description': '2 POUCH in 1 CARTON (71858-0155-1)  / 5 AMPULE in 1 POUCH (71858-0155-4)  / 1 mL in 1 AMPULE (71858-0155-6)',\n",
       "    'marketing_start_date': '20190301',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '71858-0155-5',\n",
       "    'description': '6 POUCH in 1 CARTON (71858-0155-5)  / 5 AMPULE in 1 POUCH (71858-0155-4)  / 1 mL in 1 AMPULE (71858-0155-6)',\n",
       "    'marketing_start_date': '20190301',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['IBSA Pharma Inc.'],\n",
       "   'rxcui': ['2056462',\n",
       "    '2056466',\n",
       "    '2056468',\n",
       "    '2056470',\n",
       "    '2056472',\n",
       "    '2056474',\n",
       "    '2056476',\n",
       "    '2056478',\n",
       "    '2056480',\n",
       "    '2056482',\n",
       "    '2056484',\n",
       "    '2056486',\n",
       "    '2056488',\n",
       "    '2056490',\n",
       "    '2056492',\n",
       "    '2056494',\n",
       "    '2056496',\n",
       "    '2056498',\n",
       "    '2056500',\n",
       "    '2056502',\n",
       "    '2056504',\n",
       "    '2056506',\n",
       "    '2056508',\n",
       "    '2056510',\n",
       "    '2566608',\n",
       "    '2566610',\n",
       "    '2566613',\n",
       "    '2566615',\n",
       "    '2566617',\n",
       "    '2566619'],\n",
       "   'spl_set_id': ['5d378add-f13d-40f2-99dc-0f2340ab44b7'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['9J765S329G']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '25224536-09f7-ca7c-e063-6394a90a3bf9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190301',\n",
       "  'product_id': '71858-0155_25224536-09f7-ca7c-e063-6394a90a3bf9',\n",
       "  'application_number': 'NDA206977',\n",
       "  'brand_name_base': 'Tirosint',\n",
       "  'pharm_class': ['Thyroxine [CS]', 'l-Thyroxine [EPC]']},\n",
       " {'product_ndc': '71858-0405',\n",
       "  'generic_name': 'diclofenac epolamine',\n",
       "  'labeler_name': 'IBSA Pharma Inc.',\n",
       "  'brand_name': 'FLECTOR',\n",
       "  'active_ingredients': [{'name': 'DICLOFENAC EPOLAMINE',\n",
       "    'strength': '.013 g/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71858-0405-2',\n",
       "    'description': '1 POUCH in 1 CARTON (71858-0405-2)  / 2 SYSTEM in 1 POUCH (71858-0405-1)',\n",
       "    'marketing_start_date': '20201101',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '71858-0405-5',\n",
       "    'description': '6 POUCH in 1 CARTON (71858-0405-5)  / 5 SYSTEM in 1 POUCH (71858-0405-4)',\n",
       "    'marketing_start_date': '20201101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['IBSA Pharma Inc.'],\n",
       "   'rxcui': ['855626', '855628'],\n",
       "   'spl_set_id': ['1f19a016-c4fc-43c5-9990-e5f2e2776a82'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['X5F8EKL9ZG']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'SYSTEM',\n",
       "  'spl_id': '27fa4fb3-84b8-41c9-e063-6394a90a2443',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20201101',\n",
       "  'product_id': '71858-0405_27fa4fb3-84b8-41c9-e063-6394a90a2443',\n",
       "  'application_number': 'NDA021234',\n",
       "  'brand_name_base': 'FLECTOR',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Decreased Prostaglandin Production [PE]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '71872-7002',\n",
       "  'generic_name': 'ATROPINE SULFATE',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Atropine Sulfate',\n",
       "  'active_ingredients': [{'name': 'ATROPINE SULFATE', 'strength': '.1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7002-1',\n",
       "    'description': '10 CARTON in 1 BAG (71872-7002-1)  / 1 SYRINGE, PLASTIC in 1 CARTON / 10 mL in 1 SYRINGE, PLASTIC',\n",
       "    'marketing_start_date': '20180228',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['1190546'],\n",
       "   'spl_set_id': ['66710a22-2eaa-6dbd-e053-2a91aa0a900d'],\n",
       "   'unii': ['03J5ZE7KA5']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'eaee9ea4-7c4b-26ce-e053-2995a90acdd9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ENDOTRACHEAL', 'INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20060119',\n",
       "  'product_id': '71872-7002_eaee9ea4-7c4b-26ce-e053-2995a90acdd9',\n",
       "  'application_number': 'NDA021146',\n",
       "  'brand_name_base': 'Atropine Sulfate',\n",
       "  'pharm_class': ['Anticholinergic [EPC]',\n",
       "   'Cholinergic Antagonists [MoA]',\n",
       "   'Cholinergic Muscarinic Antagonist [EPC]',\n",
       "   'Cholinergic Muscarinic Antagonists [MoA]']},\n",
       " {'product_ndc': '71872-7016',\n",
       "  'generic_name': 'NEOSTIGMINE METHYLSULFATE',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'NEOSTIGMINE METHYLSULFATE',\n",
       "  'active_ingredients': [{'name': 'NEOSTIGMINE METHYLSULFATE',\n",
       "    'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7016-1',\n",
       "    'description': '1 VIAL, MULTI-DOSE in 1 BAG (71872-7016-1)  / 10 mL in 1 VIAL, MULTI-DOSE',\n",
       "    'marketing_start_date': '20180319',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['311936'],\n",
       "   'spl_set_id': ['6b541714-9850-bdbd-e053-2991aa0ab244'],\n",
       "   'upc': ['0371872701617'],\n",
       "   'unii': ['98IMH7M386']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'fd1a2aa4-0b7f-eee6-e053-6294a90ac4ea',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20170426',\n",
       "  'product_id': '71872-7016_fd1a2aa4-0b7f-eee6-e053-6294a90ac4ea',\n",
       "  'application_number': 'ANDA208405',\n",
       "  'brand_name_base': 'NEOSTIGMINE METHYLSULFATE',\n",
       "  'pharm_class': ['Cholinesterase Inhibitor [EPC]',\n",
       "   'Cholinesterase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71872-7064',\n",
       "  'generic_name': 'LIDOCAINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'LIDOCAINE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE HYDROCHLORIDE',\n",
       "    'strength': '20 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7064-1',\n",
       "    'description': '1 CARTON in 1 BAG (71872-7064-1)  / 1 SYRINGE, PLASTIC in 1 CARTON / 5 mL in 1 SYRINGE, PLASTIC',\n",
       "    'marketing_start_date': '20180214',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['1012068'],\n",
       "   'spl_set_id': ['6bcdbee5-014e-6b4c-e053-2a91aa0aecd2'],\n",
       "   'unii': ['V13007Z41A']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'fcea4371-f2f1-724b-e053-6394a90a6e50',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20051209',\n",
       "  'product_id': '71872-7064_fcea4371-f2f1-724b-e053-6394a90a6e50',\n",
       "  'application_number': 'ANDA040302',\n",
       "  'brand_name_base': 'LIDOCAINE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '71872-7066',\n",
       "  'generic_name': 'Dopamine Hydrochloride',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'DOPamine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'DOPAMINE HYDROCHLORIDE',\n",
       "    'strength': '40 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7066-1',\n",
       "    'description': '1 VIAL, SINGLE-DOSE in 1 BAG (71872-7066-1)  / 5 mL in 1 VIAL, SINGLE-DOSE',\n",
       "    'marketing_start_date': '20200917',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['1743941'],\n",
       "   'spl_set_id': ['b61fffd0-7bc8-09e2-e053-2995a90ae0e4'],\n",
       "   'unii': ['7L3E358N9L']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION, CONCENTRATE',\n",
       "  'spl_id': 'fcea4214-2952-5502-e053-6294a90a7252',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20050825',\n",
       "  'product_id': '71872-7066_fcea4214-2952-5502-e053-6294a90a7252',\n",
       "  'application_number': 'NDA018132',\n",
       "  'brand_name_base': 'DOPamine Hydrochloride',\n",
       "  'pharm_class': ['Catecholamine [EPC]', 'Catecholamines [CS]']},\n",
       " {'product_ndc': '71872-7114',\n",
       "  'generic_name': 'NALBUPHINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Nalbuphine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'NALBUPHINE HYDROCHLORIDE',\n",
       "    'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7114-1',\n",
       "    'description': '1 VIAL, MULTI-DOSE in 1 BAG (71872-7114-1)  / 10 mL in 1 VIAL, MULTI-DOSE',\n",
       "    'marketing_start_date': '20180503',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['904415'],\n",
       "   'spl_set_id': ['6bde2184-5643-3ec6-e053-2991aa0a115f'],\n",
       "   'unii': ['ZU4275277R']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'fc5e0914-3e38-0be4-e053-6394a90aee7d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20050719',\n",
       "  'product_id': '71872-7114_fc5e0914-3e38-0be4-e053-6394a90aee7d',\n",
       "  'application_number': 'ANDA070915',\n",
       "  'brand_name_base': 'Nalbuphine Hydrochloride',\n",
       "  'pharm_class': ['Competitive Opioid Antagonists [MoA]',\n",
       "   'Opioid Agonist/Antagonist [EPC]',\n",
       "   'Partial Opioid Agonists [MoA]']},\n",
       " {'product_ndc': '71872-7126',\n",
       "  'generic_name': 'Lidocaine Hydrochloride',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Lidocaine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE HYDROCHLORIDE',\n",
       "    'strength': '20 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7126-1',\n",
       "    'description': '1 CARTON in 1 BAG (71872-7126-1)  / 1 SYRINGE in 1 CARTON / 5 mL in 1 SYRINGE',\n",
       "    'marketing_start_date': '20180330',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['1012068'],\n",
       "   'spl_set_id': ['6947af02-f4e0-7f9c-e053-2a91aa0a45cd'],\n",
       "   'unii': ['V13007Z41A']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'fc50b26b-fbe2-1776-e053-6294a90a5129',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20010601',\n",
       "  'product_id': '71872-7126_fc50b26b-fbe2-1776-e053-6294a90a5129',\n",
       "  'application_number': 'ANDA083173',\n",
       "  'brand_name_base': 'Lidocaine Hydrochloride',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '71872-7155',\n",
       "  'generic_name': 'metoprolol tartrate',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Metoprolol',\n",
       "  'active_ingredients': [{'name': 'METOPROLOL TARTRATE',\n",
       "    'strength': '5 mg/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7155-1',\n",
       "    'description': '1 VIAL in 1 BAG (71872-7155-1)  / 5 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20190226',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['866508'],\n",
       "   'spl_set_id': ['86081f3b-40e8-3f06-e053-2991aa0aeb4c'],\n",
       "   'unii': ['W5S57Y3A5L']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'fbd11419-4512-10d7-e053-6394a90ac82b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20120925',\n",
       "  'product_id': '71872-7155_fbd11419-4512-10d7-e053-6394a90ac82b',\n",
       "  'application_number': 'ANDA078950',\n",
       "  'brand_name_base': 'Metoprolol',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '71872-7166',\n",
       "  'generic_name': 'SUCCINYLCHOLINE CHLORIDE',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'SUCCINYLCHOLINE CHLORIDE',\n",
       "  'active_ingredients': [{'name': 'SUCCINYLCHOLINE CHLORIDE',\n",
       "    'strength': '20 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7166-1',\n",
       "    'description': '1 VIAL, MULTI-DOSE in 1 BAG (71872-7166-1)  / 10 mL in 1 VIAL, MULTI-DOSE',\n",
       "    'marketing_start_date': '20190513',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['1594589'],\n",
       "   'spl_set_id': ['896a4238-667d-45b0-e053-2a95a90a60dd'],\n",
       "   'unii': ['I9L0DDD30I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'fbbf1c9f-000b-1ef4-e053-6294a90abf53',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS'],\n",
       "  'marketing_start_date': '20181120',\n",
       "  'product_id': '71872-7166_fbbf1c9f-000b-1ef4-e053-6294a90abf53',\n",
       "  'application_number': 'ANDA211432',\n",
       "  'brand_name_base': 'SUCCINYLCHOLINE CHLORIDE',\n",
       "  'pharm_class': ['Depolarizing Neuromuscular Blocker [EPC]',\n",
       "   'Neuromuscular Depolarizing Blockade [PE]']},\n",
       " {'product_ndc': '71872-7169',\n",
       "  'generic_name': 'ampicillin sodium',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Ampicillin',\n",
       "  'active_ingredients': [{'name': 'AMPICILLIN SODIUM', 'strength': '2 g/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7169-1',\n",
       "    'description': '1 VIAL in 1 BAG (71872-7169-1)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL',\n",
       "    'marketing_start_date': '20190523',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['1721476'],\n",
       "   'spl_set_id': ['8a0e1d98-b473-1b29-e053-2995a90a82ae'],\n",
       "   'unii': ['JFN36L5S8K']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, FOR SOLUTION',\n",
       "  'spl_id': 'fbbddf4e-0ab7-44ab-e053-6294a90ae4eb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20180801',\n",
       "  'product_id': '71872-7169_fbbddf4e-0ab7-44ab-e053-6294a90ae4eb',\n",
       "  'application_number': 'ANDA090354',\n",
       "  'brand_name_base': 'Ampicillin',\n",
       "  'pharm_class': ['Penicillin-class Antibacterial [EPC]', 'Penicillins [CS]']},\n",
       " {'product_ndc': '0002-8207',\n",
       "  'generic_name': 'Insulin lispro-aabc',\n",
       "  'labeler_name': 'Eli Lilly and Company',\n",
       "  'brand_name': 'LYUMJEV KwikPen',\n",
       "  'brand_name_suffix': 'KwikPen',\n",
       "  'active_ingredients': [{'name': 'INSULIN LISPRO',\n",
       "    'strength': '100 [iU]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0002-8207-05',\n",
       "    'description': '5 SYRINGE in 1 CARTON (0002-8207-05)  / 3 mL in 1 SYRINGE (0002-8207-01)',\n",
       "    'marketing_start_date': '20200615',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0002-8207-61',\n",
       "    'description': '1 SYRINGE in 1 CARTON (0002-8207-61)  / 3 mL in 1 SYRINGE',\n",
       "    'marketing_start_date': '20200615',\n",
       "    'sample': True}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Eli Lilly and Company'],\n",
       "   'rxcui': ['2380231',\n",
       "    '2380236',\n",
       "    '2380248',\n",
       "    '2380250',\n",
       "    '2380254',\n",
       "    '2380256',\n",
       "    '2380259',\n",
       "    '2380260',\n",
       "    '2380265',\n",
       "    '2380266',\n",
       "    '2380267',\n",
       "    '2380268'],\n",
       "   'spl_set_id': ['c5a056e2-b568-4ca6-9ed8-79c010942d00'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0300027728018'],\n",
       "   'nui': ['N0000004931', 'N0000175453'],\n",
       "   'pharm_class_cs': ['Insulin [Chemical/Ingredient]'],\n",
       "   'pharm_class_epc': ['Insulin Analog [EPC]'],\n",
       "   'unii': ['GFX7QIS1II']},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '280961ff-5a2a-4713-a315-995e6f0b7771',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20200615',\n",
       "  'product_id': '0002-8207_280961ff-5a2a-4713-a315-995e6f0b7771',\n",
       "  'application_number': 'BLA761109',\n",
       "  'brand_name_base': 'LYUMJEV',\n",
       "  'pharm_class': ['Insulin Analog [EPC]', 'Insulin [Chemical/Ingredient]']},\n",
       " {'product_ndc': '0527-5406',\n",
       "  'generic_name': 'Prednisolone',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'brand_name': 'PrednisoLONE',\n",
       "  'active_ingredients': [{'name': 'PREDNISOLONE', 'strength': '15 mg/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-5406-68',\n",
       "    'description': '240 mL in 1 BOTTLE (0527-5406-68)',\n",
       "    'marketing_start_date': '20070921',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0527-5406-70',\n",
       "    'description': '480 mL in 1 BOTTLE (0527-5406-70)',\n",
       "    'marketing_start_date': '20070921',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['283077'],\n",
       "   'spl_set_id': ['86652e2d-664a-4388-a611-c2a9aa4a4bc8'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['9PHQ9Y1OLM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SYRUP',\n",
       "  'spl_id': '5122ba73-5783-49f0-9b9c-a03d59d8899c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20070921',\n",
       "  'product_id': '0527-5406_5122ba73-5783-49f0-9b9c-a03d59d8899c',\n",
       "  'application_number': 'ANDA040775',\n",
       "  'brand_name_base': 'PrednisoLONE',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '71872-7183',\n",
       "  'generic_name': 'Verapamil Hydrochloride',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Verapamil Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'VERAPAMIL HYDROCHLORIDE',\n",
       "    'strength': '2.5 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7183-1',\n",
       "    'description': '1 VIAL in 1 BAG (71872-7183-1)  / 2 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20191118',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['1665057'],\n",
       "   'spl_set_id': ['9e04440f-4cee-990b-e053-2995a90a09e1'],\n",
       "   'unii': ['V3888OEY5R']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'fb5c8bd7-70e5-d657-e053-6394a90a0b58',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20190304',\n",
       "  'product_id': '71872-7183_fb5c8bd7-70e5-d657-e053-6394a90a0b58',\n",
       "  'application_number': 'ANDA211370',\n",
       "  'brand_name_base': 'Verapamil Hydrochloride',\n",
       "  'pharm_class': ['Calcium Channel Antagonists [MoA]',\n",
       "   'Calcium Channel Blocker [EPC]',\n",
       "   'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "   'Cytochrome P450 3A4 Inhibitors [MoA]',\n",
       "   'P-Glycoprotein Inhibitors [MoA]']},\n",
       " {'product_ndc': '71872-7192',\n",
       "  'generic_name': 'Clindamycin Phosphate',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Clindamycin',\n",
       "  'active_ingredients': [{'name': 'CLINDAMYCIN PHOSPHATE',\n",
       "    'strength': '150 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7192-1',\n",
       "    'description': '1 VIAL in 1 BAG (71872-7192-1)  / 4 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20200108',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['1737578'],\n",
       "   'spl_set_id': ['9e500a08-0339-eb6b-e053-2a95a90a130c'],\n",
       "   'unii': ['EH6D7113I8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'fb582ad8-1754-2041-e053-6294a90a6592',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS'],\n",
       "  'marketing_start_date': '20120515',\n",
       "  'product_id': '71872-7192_fb582ad8-1754-2041-e053-6294a90a6592',\n",
       "  'application_number': 'ANDA090108',\n",
       "  'brand_name_base': 'Clindamycin',\n",
       "  'pharm_class': ['Decreased Sebaceous Gland Activity [PE]',\n",
       "   'Lincosamide Antibacterial [EPC]',\n",
       "   'Lincosamides [CS]',\n",
       "   'Neuromuscular Blockade [PE]']},\n",
       " {'product_ndc': '71872-7197',\n",
       "  'generic_name': 'clindamycin phosphate',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Cleocin Phosphate',\n",
       "  'active_ingredients': [{'name': 'CLINDAMYCIN PHOSPHATE',\n",
       "    'strength': '150 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7197-1',\n",
       "    'description': '1 VIAL in 1 BAG (71872-7197-1)  / 4 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20200123',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['1737578', '1737579'],\n",
       "   'spl_set_id': ['9e5365a0-dd47-264a-e053-2a95a90a7fb8'],\n",
       "   'unii': ['EH6D7113I8']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'fb4af179-57f4-296b-e053-6294a90a7a82',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS'],\n",
       "  'marketing_start_date': '19721002',\n",
       "  'product_id': '71872-7197_fb4af179-57f4-296b-e053-6294a90a7a82',\n",
       "  'application_number': 'NDA050441',\n",
       "  'brand_name_base': 'Cleocin Phosphate',\n",
       "  'pharm_class': ['Decreased Sebaceous Gland Activity [PE]',\n",
       "   'Lincosamide Antibacterial [EPC]',\n",
       "   'Lincosamides [CS]',\n",
       "   'Neuromuscular Blockade [PE]']},\n",
       " {'product_ndc': '71872-7231',\n",
       "  'generic_name': 'Phenylephrine hydrochloride',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Phenylephrine hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PHENYLEPHRINE HYDROCHLORIDE',\n",
       "    'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7231-1',\n",
       "    'description': '1 VIAL in 1 BAG (71872-7231-1)  / 1 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20201117',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['1232651'],\n",
       "   'spl_set_id': ['b6358e7a-ecd5-dad5-e053-2995a90aac3f'],\n",
       "   'unii': ['04JA59TNSJ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'fae6cee0-57a1-f879-e053-6394a90a1d57',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20200812',\n",
       "  'product_id': '71872-7231_fae6cee0-57a1-f879-e053-6394a90a1d57',\n",
       "  'application_number': 'ANDA211081',\n",
       "  'brand_name_base': 'Phenylephrine hydrochloride',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '71872-7235',\n",
       "  'generic_name': 'Famotidine',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Famotidine',\n",
       "  'active_ingredients': [{'name': 'FAMOTIDINE', 'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7235-1',\n",
       "    'description': '1 VIAL in 1 BAG (71872-7235-1)  / 2 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20201215',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['1743833'],\n",
       "   'spl_set_id': ['bbeffa0a-2bc7-fea4-e053-2a95a90ac511'],\n",
       "   'nui': ['N0000000151', 'N0000175784'],\n",
       "   'pharm_class_moa': ['Histamine H2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Histamine-2 Receptor Antagonist [EPC]'],\n",
       "   'unii': ['5QZO15J2Z8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'fb339cb7-08a5-d926-e053-6394a90a6c7f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20010416',\n",
       "  'product_id': '71872-7235_fb339cb7-08a5-d926-e053-6394a90a6c7f',\n",
       "  'application_number': 'ANDA075486',\n",
       "  'brand_name_base': 'Famotidine',\n",
       "  'pharm_class': ['Histamine H2 Receptor Antagonists [MoA]',\n",
       "   'Histamine-2 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '71872-7243',\n",
       "  'generic_name': 'Verapamil Hydrochloride',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Verapamil Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'VERAPAMIL HYDROCHLORIDE',\n",
       "    'strength': '2.5 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7243-1',\n",
       "    'description': '1 VIAL in 1 BAG (71872-7243-1)  / 2 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20210312',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['1665057'],\n",
       "   'spl_set_id': ['bfc7fa37-1ee3-5eb2-e053-2995a90a5622'],\n",
       "   'unii': ['V3888OEY5R']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'fa596101-01ec-c228-e053-6394a90aa48b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20180618',\n",
       "  'product_id': '71872-7243_fa596101-01ec-c228-e053-6394a90aa48b',\n",
       "  'application_number': 'ANDA211015',\n",
       "  'brand_name_base': 'Verapamil Hydrochloride',\n",
       "  'pharm_class': ['Calcium Channel Antagonists [MoA]',\n",
       "   'Calcium Channel Blocker [EPC]',\n",
       "   'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "   'Cytochrome P450 3A4 Inhibitors [MoA]',\n",
       "   'P-Glycoprotein Inhibitors [MoA]']},\n",
       " {'product_ndc': '71872-7245',\n",
       "  'generic_name': 'ATROPINE SULFATE',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Atropine Sulfate',\n",
       "  'active_ingredients': [{'name': 'ATROPINE SULFATE', 'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7245-1',\n",
       "    'description': '1 VIAL, SINGLE-DOSE in 1 BAG (71872-7245-1)  / 1 mL in 1 VIAL, SINGLE-DOSE',\n",
       "    'marketing_start_date': '20210330',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'rxcui': ['1190795'],\n",
       "   'spl_set_id': ['bfc8a727-0cb8-3152-e053-2995a90a28ba'],\n",
       "   'unii': ['03J5ZE7KA5']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'eaef17bc-bf14-6157-e053-2a95a90a3910',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20210111',\n",
       "  'product_id': '71872-7245_eaef17bc-bf14-6157-e053-2a95a90a3910',\n",
       "  'application_number': 'NDA214652',\n",
       "  'brand_name_base': 'Atropine Sulfate',\n",
       "  'pharm_class': ['Anticholinergic [EPC]',\n",
       "   'Cholinergic Antagonists [MoA]',\n",
       "   'Cholinergic Muscarinic Antagonist [EPC]',\n",
       "   'Cholinergic Muscarinic Antagonists [MoA]']},\n",
       " {'product_ndc': '0527-8108',\n",
       "  'generic_name': 'dexmethylphenidate hydrochloride',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Dexmethylphenidate Hydrochloride Extended-Release',\n",
       "  'brand_name_suffix': 'Extended-Release',\n",
       "  'active_ingredients': [{'name': 'DEXMETHYLPHENIDATE HYDROCHLORIDE',\n",
       "    'strength': '15 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-8108-37',\n",
       "    'description': '100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-8108-37)',\n",
       "    'marketing_start_date': '20181009',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['899439',\n",
       "    '899461',\n",
       "    '899485',\n",
       "    '899495',\n",
       "    '899511',\n",
       "    '1006608',\n",
       "    '1101926',\n",
       "    '1101932'],\n",
       "   'spl_set_id': ['edad7c67-a872-41ad-a8bd-169278693cc2'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305278113378',\n",
       "    '0305278106370',\n",
       "    '0305278107377',\n",
       "    '0305278108374',\n",
       "    '0305278109371',\n",
       "    '0305278110377',\n",
       "    '0305278111374',\n",
       "    '0305278112371'],\n",
       "   'unii': ['1678OK0E08']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, EXTENDED RELEASE',\n",
       "  'spl_id': 'e4c11747-213b-4b92-9490-c33f4e3a2721',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181009',\n",
       "  'product_id': '0527-8108_e4c11747-213b-4b92-9490-c33f4e3a2721',\n",
       "  'application_number': 'ANDA210279',\n",
       "  'brand_name_base': 'Dexmethylphenidate Hydrochloride',\n",
       "  'pharm_class': ['Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulation [PE]']},\n",
       " {'product_ndc': '0527-8110',\n",
       "  'generic_name': 'dexmethylphenidate hydrochloride',\n",
       "  'labeler_name': 'Lannett Company, Inc.',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Dexmethylphenidate Hydrochloride Extended-Release',\n",
       "  'brand_name_suffix': 'Extended-Release',\n",
       "  'active_ingredients': [{'name': 'DEXMETHYLPHENIDATE HYDROCHLORIDE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0527-8110-37',\n",
       "    'description': '100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-8110-37)',\n",
       "    'marketing_start_date': '20181009',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Lannett Company, Inc.'],\n",
       "   'rxcui': ['899439',\n",
       "    '899461',\n",
       "    '899485',\n",
       "    '899495',\n",
       "    '899511',\n",
       "    '1006608',\n",
       "    '1101926',\n",
       "    '1101932'],\n",
       "   'spl_set_id': ['edad7c67-a872-41ad-a8bd-169278693cc2'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305278113378',\n",
       "    '0305278106370',\n",
       "    '0305278107377',\n",
       "    '0305278108374',\n",
       "    '0305278109371',\n",
       "    '0305278110377',\n",
       "    '0305278111374',\n",
       "    '0305278112371'],\n",
       "   'unii': ['1678OK0E08']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, EXTENDED RELEASE',\n",
       "  'spl_id': 'e4c11747-213b-4b92-9490-c33f4e3a2721',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181009',\n",
       "  'product_id': '0527-8110_e4c11747-213b-4b92-9490-c33f4e3a2721',\n",
       "  'application_number': 'ANDA210279',\n",
       "  'brand_name_base': 'Dexmethylphenidate Hydrochloride',\n",
       "  'pharm_class': ['Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulation [PE]']},\n",
       " {'product_ndc': '71872-7313',\n",
       "  'generic_name': 'Cosyntropin',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Cosyntropin',\n",
       "  'active_ingredients': [{'name': 'COSYNTROPIN', 'strength': '.25 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7313-1',\n",
       "    'description': '1 VIAL in 1 BAG (71872-7313-1)  / 1 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20231006',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'spl_set_id': ['09441f78-7350-0cb3-e063-6394a90a46ab'],\n",
       "   'nui': ['M0000499', 'N0000175941'],\n",
       "   'pharm_class_cs': ['Adrenocorticotropic Hormone [CS]'],\n",
       "   'pharm_class_epc': ['Adrenocorticotropic Hormone [EPC]'],\n",
       "   'unii': ['72YY86EA29']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION',\n",
       "  'spl_id': '094426f5-3a15-37e5-e063-6394a90aa985',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20120629',\n",
       "  'product_id': '71872-7313_094426f5-3a15-37e5-e063-6394a90aa985',\n",
       "  'application_number': 'ANDA202147',\n",
       "  'brand_name_base': 'Cosyntropin',\n",
       "  'pharm_class': ['Adrenocorticotropic Hormone [CS]',\n",
       "   'Adrenocorticotropic Hormone [EPC]']},\n",
       " {'product_ndc': '71872-7318',\n",
       "  'generic_name': 'Cosyntropin',\n",
       "  'labeler_name': 'Medical Purchasing Solutions, LLC',\n",
       "  'brand_name': 'Cortrosyn',\n",
       "  'active_ingredients': [{'name': 'COSYNTROPIN', 'strength': '.25 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71872-7318-1',\n",
       "    'description': '1 VIAL in 1 BAG (71872-7318-1)  / 1 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20240101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Medical Purchasing Solutions, LLC'],\n",
       "   'spl_set_id': ['15eaaab2-d656-7310-e063-6394a90ae59f'],\n",
       "   'nui': ['M0000499', 'N0000175941'],\n",
       "   'pharm_class_cs': ['Adrenocorticotropic Hormone [CS]'],\n",
       "   'pharm_class_epc': ['Adrenocorticotropic Hormone [EPC]'],\n",
       "   'unii': ['72YY86EA29']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION',\n",
       "  'spl_id': '15eaa42c-d1e7-5c08-e063-6394a90ae469',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS'],\n",
       "  'marketing_start_date': '20030801',\n",
       "  'product_id': '71872-7318_15eaa42c-d1e7-5c08-e063-6394a90ae469',\n",
       "  'application_number': 'NDA016750',\n",
       "  'brand_name_base': 'Cortrosyn',\n",
       "  'pharm_class': ['Adrenocorticotropic Hormone [CS]',\n",
       "   'Adrenocorticotropic Hormone [EPC]']},\n",
       " {'product_ndc': '71881-107',\n",
       "  'generic_name': 'Peanut',\n",
       "  'labeler_name': 'Aimmune Therapeutics',\n",
       "  'brand_name': 'PALFORZIA (Level 7)',\n",
       "  'brand_name_suffix': '(Level 7)',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71881-107-30',\n",
       "    'description': '15 BLISTER PACK in 1 PACKAGE (71881-107-30)  / 1 KIT in 1 BLISTER PACK *  1 POWDER in 1 CAPSULE (71881-124-01)  *  1 POWDER in 1 CAPSULE (71881-125-01)',\n",
       "    'marketing_start_date': '20200131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71881-107-99',\n",
       "    'description': '12 BLISTER PACK in 1 CARTON (71881-107-99)  / 1 KIT in 1 BLISTER PACK (71881-107-09)  *  1 POWDER in 1 CAPSULE (71881-124-01)  *  1 POWDER in 1 CAPSULE (71881-125-01)',\n",
       "    'marketing_start_date': '20200131',\n",
       "    'sample': True}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Aimmune Therapeutics'],\n",
       "   'rxcui': ['2279407',\n",
       "    '2279409',\n",
       "    '2279410',\n",
       "    '2279416',\n",
       "    '2279418',\n",
       "    '2279419',\n",
       "    '2279421',\n",
       "    '2279422',\n",
       "    '2279424',\n",
       "    '2279425',\n",
       "    '2279426',\n",
       "    '2279427',\n",
       "    '2279428',\n",
       "    '2279429',\n",
       "    '2279431',\n",
       "    '2279432',\n",
       "    '2279434',\n",
       "    '2279435',\n",
       "    '2279436',\n",
       "    '2279437',\n",
       "    '2279438',\n",
       "    '2279439',\n",
       "    '2279441',\n",
       "    '2279442',\n",
       "    '2279444',\n",
       "    '2279445',\n",
       "    '2279446',\n",
       "    '2279447',\n",
       "    '2279448',\n",
       "    '2279449',\n",
       "    '2279450',\n",
       "    '2279451',\n",
       "    '2279453',\n",
       "    '2279454',\n",
       "    '2279456',\n",
       "    '2279457'],\n",
       "   'spl_set_id': ['17f5be03-6705-4ac9-b8f3-bc4993ebc0eb'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185371',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'M0000728',\n",
       "    'M0006342',\n",
       "    'N0000185019'],\n",
       "   'pharm_class_epc': ['Non-Standardized Food Allergenic Extract [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]', 'Dietary Proteins [CS]'],\n",
       "   'unii': ['QE1QX6B99R']},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': 'f724158a-5c2e-fa1e-e053-6394a90a5519',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'marketing_start_date': '20200131',\n",
       "  'product_id': '71881-107_f724158a-5c2e-fa1e-e053-6394a90a5519',\n",
       "  'application_number': 'BLA125696',\n",
       "  'brand_name_base': 'PALFORZIA'},\n",
       " {'product_ndc': '71883-050',\n",
       "  'generic_name': 'Homosalate, Octyl salicylate, Titanium dioxide, Zinc oxide',\n",
       "  'labeler_name': 'Oracle Cosmetic Co., Ltd.',\n",
       "  'brand_name': 'Dr.Oracle AIR FIT DEFENSE SOOTHING SUNSCREEN',\n",
       "  'active_ingredients': [{'name': 'HOMOSALATE', 'strength': '3.75 g/50mL'},\n",
       "   {'name': 'OCTISALATE', 'strength': '2.25 g/50mL'},\n",
       "   {'name': 'TITANIUM DIOXIDE', 'strength': '1.1 g/50mL'},\n",
       "   {'name': 'ZINC OXIDE', 'strength': '6.35 g/50mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71883-050-02',\n",
       "    'description': '1 TUBE in 1 BOX (71883-050-02)  / 50 mL in 1 TUBE (71883-050-01)',\n",
       "    'marketing_start_date': '20240926',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Oracle Cosmetic Co., Ltd.'],\n",
       "   'spl_set_id': ['21424f78-f8d5-6a9b-e063-6294a90ab7dc'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['8809408733303'],\n",
       "   'unii': ['V06SV4M95S', '4X49Y0596W', '15FIX9V2JP', 'SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '21424f78-f8d6-6a9b-e063-6294a90ab7dc',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240926',\n",
       "  'product_id': '71883-050_21424f78-f8d6-6a9b-e063-6294a90ab7dc',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Dr.Oracle AIR FIT DEFENSE SOOTHING SUNSCREEN'},\n",
       " {'product_ndc': '71894-126',\n",
       "  'generic_name': 'onasemnogene abeparvovec-xioi',\n",
       "  'labeler_name': 'Novartis Gene Therapies, Inc.',\n",
       "  'brand_name': 'Zolgensma',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71894-126-04',\n",
       "    'description': '1 KIT in 1 CARTON (71894-126-04)  *  8.3 mL in 1 VIAL (71894-115-01)  *  1 mL in 1 POUCH',\n",
       "    'marketing_start_date': '20190524',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novartis Gene Therapies, Inc.'],\n",
       "   'rxcui': ['797544',\n",
       "    '2170239',\n",
       "    '2170241',\n",
       "    '2170244',\n",
       "    '2170245',\n",
       "    '2170246',\n",
       "    '2170247',\n",
       "    '2170248',\n",
       "    '2170249',\n",
       "    '2170250',\n",
       "    '2170251',\n",
       "    '2170252',\n",
       "    '2170253',\n",
       "    '2170254',\n",
       "    '2170255',\n",
       "    '2170256',\n",
       "    '2170257',\n",
       "    '2170258',\n",
       "    '2170259',\n",
       "    '2170260',\n",
       "    '2170261',\n",
       "    '2170262',\n",
       "    '2170263',\n",
       "    '2170264',\n",
       "    '2170265',\n",
       "    '2170266',\n",
       "    '2170267',\n",
       "    '2170270',\n",
       "    '2170272',\n",
       "    '2170273',\n",
       "    '2170274',\n",
       "    '2170275',\n",
       "    '2170276',\n",
       "    '2170278',\n",
       "    '2170279',\n",
       "    '2170281',\n",
       "    '2170282',\n",
       "    '2170283',\n",
       "    '2170284',\n",
       "    '2170288',\n",
       "    '2170289',\n",
       "    '2170290',\n",
       "    '2170291',\n",
       "    '2170292',\n",
       "    '2170293',\n",
       "    '2170294',\n",
       "    '2170295',\n",
       "    '2170296',\n",
       "    '2170297',\n",
       "    '2630761',\n",
       "    '2630763',\n",
       "    '2630765',\n",
       "    '2630767',\n",
       "    '2630769',\n",
       "    '2630771',\n",
       "    '2630773',\n",
       "    '2630775',\n",
       "    '2630777',\n",
       "    '2630779',\n",
       "    '2630781',\n",
       "    '2630783',\n",
       "    '2630785',\n",
       "    '2630787',\n",
       "    '2630790',\n",
       "    '2630832',\n",
       "    '2630833',\n",
       "    '2630839',\n",
       "    '2630840',\n",
       "    '2630855',\n",
       "    '2630856',\n",
       "    '2630857',\n",
       "    '2630858',\n",
       "    '2630859',\n",
       "    '2630860',\n",
       "    '2630861',\n",
       "    '2630862',\n",
       "    '2630863',\n",
       "    '2630864',\n",
       "    '2630865'],\n",
       "   'spl_set_id': ['68cd4f06-70e1-40d8-bedb-609ec0afa471'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': 'cbe2deea-e33b-47bc-8dac-2587bea0fa32',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'marketing_start_date': '20190524',\n",
       "  'product_id': '71894-126_cbe2deea-e33b-47bc-8dac-2587bea0fa32',\n",
       "  'application_number': 'BLA125694',\n",
       "  'brand_name_base': 'Zolgensma'},\n",
       " {'product_ndc': '0536-1010',\n",
       "  'marketing_end_date': '20250430',\n",
       "  'generic_name': 'Diphenhydramine HCl',\n",
       "  'labeler_name': 'Rugby Laboratories',\n",
       "  'brand_name': 'Diphenhist',\n",
       "  'active_ingredients': [{'name': 'DIPHENHYDRAMINE HYDROCHLORIDE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1010-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (0536-1010-01)',\n",
       "    'marketing_start_date': '20140317',\n",
       "    'marketing_end_date': '20250430',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Rugby Laboratories'],\n",
       "   'rxcui': ['1049909', '1092447'],\n",
       "   'spl_set_id': ['f7da0c1b-b471-48ee-99c7-e957eae31b9c'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305361010010'],\n",
       "   'unii': ['TC2D6JAD40']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '0eaf12c0-ca13-1396-e063-6294a90aa5c8',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20140317',\n",
       "  'product_id': '0536-1010_0eaf12c0-ca13-1396-e063-6294a90aa5c8',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'Diphenhist',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '71894-146',\n",
       "  'generic_name': 'onasemnogene abeparvovec-xioi',\n",
       "  'labeler_name': 'Novartis Gene Therapies, Inc.',\n",
       "  'brand_name': 'Zolgensma',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71894-146-11',\n",
       "    'description': '1 KIT in 1 CARTON (71894-146-11)  *  1 mL in 1 POUCH *  5.5 mL in 1 VIAL (71894-110-01)  *  8.3 mL in 1 VIAL (71894-115-01)',\n",
       "    'marketing_start_date': '20230216',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novartis Gene Therapies, Inc.'],\n",
       "   'rxcui': ['797544',\n",
       "    '2170239',\n",
       "    '2170241',\n",
       "    '2170244',\n",
       "    '2170245',\n",
       "    '2170246',\n",
       "    '2170247',\n",
       "    '2170248',\n",
       "    '2170249',\n",
       "    '2170250',\n",
       "    '2170251',\n",
       "    '2170252',\n",
       "    '2170253',\n",
       "    '2170254',\n",
       "    '2170255',\n",
       "    '2170256',\n",
       "    '2170257',\n",
       "    '2170258',\n",
       "    '2170259',\n",
       "    '2170260',\n",
       "    '2170261',\n",
       "    '2170262',\n",
       "    '2170263',\n",
       "    '2170264',\n",
       "    '2170265',\n",
       "    '2170266',\n",
       "    '2170267',\n",
       "    '2170270',\n",
       "    '2170272',\n",
       "    '2170273',\n",
       "    '2170274',\n",
       "    '2170275',\n",
       "    '2170276',\n",
       "    '2170278',\n",
       "    '2170279',\n",
       "    '2170281',\n",
       "    '2170282',\n",
       "    '2170283',\n",
       "    '2170284',\n",
       "    '2170288',\n",
       "    '2170289',\n",
       "    '2170290',\n",
       "    '2170291',\n",
       "    '2170292',\n",
       "    '2170293',\n",
       "    '2170294',\n",
       "    '2170295',\n",
       "    '2170296',\n",
       "    '2170297',\n",
       "    '2630761',\n",
       "    '2630763',\n",
       "    '2630765',\n",
       "    '2630767',\n",
       "    '2630769',\n",
       "    '2630771',\n",
       "    '2630773',\n",
       "    '2630775',\n",
       "    '2630777',\n",
       "    '2630779',\n",
       "    '2630781',\n",
       "    '2630783',\n",
       "    '2630785',\n",
       "    '2630787',\n",
       "    '2630790',\n",
       "    '2630832',\n",
       "    '2630833',\n",
       "    '2630839',\n",
       "    '2630840',\n",
       "    '2630855',\n",
       "    '2630856',\n",
       "    '2630857',\n",
       "    '2630858',\n",
       "    '2630859',\n",
       "    '2630860',\n",
       "    '2630861',\n",
       "    '2630862',\n",
       "    '2630863',\n",
       "    '2630864',\n",
       "    '2630865'],\n",
       "   'spl_set_id': ['68cd4f06-70e1-40d8-bedb-609ec0afa471'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': 'cbe2deea-e33b-47bc-8dac-2587bea0fa32',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'marketing_start_date': '20190524',\n",
       "  'product_id': '71894-146_cbe2deea-e33b-47bc-8dac-2587bea0fa32',\n",
       "  'application_number': 'BLA125694',\n",
       "  'brand_name_base': 'Zolgensma'},\n",
       " {'product_ndc': '71894-156',\n",
       "  'generic_name': 'onasemnogene abeparvovec-xioi',\n",
       "  'labeler_name': 'Novartis Gene Therapies, Inc.',\n",
       "  'brand_name': 'Zolgensma',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71894-156-14',\n",
       "    'description': '1 KIT in 1 CARTON (71894-156-14)  *  8.3 mL in 1 VIAL (71894-115-01)  *  1 mL in 1 POUCH',\n",
       "    'marketing_start_date': '20230216',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novartis Gene Therapies, Inc.'],\n",
       "   'rxcui': ['797544',\n",
       "    '2170239',\n",
       "    '2170241',\n",
       "    '2170244',\n",
       "    '2170245',\n",
       "    '2170246',\n",
       "    '2170247',\n",
       "    '2170248',\n",
       "    '2170249',\n",
       "    '2170250',\n",
       "    '2170251',\n",
       "    '2170252',\n",
       "    '2170253',\n",
       "    '2170254',\n",
       "    '2170255',\n",
       "    '2170256',\n",
       "    '2170257',\n",
       "    '2170258',\n",
       "    '2170259',\n",
       "    '2170260',\n",
       "    '2170261',\n",
       "    '2170262',\n",
       "    '2170263',\n",
       "    '2170264',\n",
       "    '2170265',\n",
       "    '2170266',\n",
       "    '2170267',\n",
       "    '2170270',\n",
       "    '2170272',\n",
       "    '2170273',\n",
       "    '2170274',\n",
       "    '2170275',\n",
       "    '2170276',\n",
       "    '2170278',\n",
       "    '2170279',\n",
       "    '2170281',\n",
       "    '2170282',\n",
       "    '2170283',\n",
       "    '2170284',\n",
       "    '2170288',\n",
       "    '2170289',\n",
       "    '2170290',\n",
       "    '2170291',\n",
       "    '2170292',\n",
       "    '2170293',\n",
       "    '2170294',\n",
       "    '2170295',\n",
       "    '2170296',\n",
       "    '2170297',\n",
       "    '2630761',\n",
       "    '2630763',\n",
       "    '2630765',\n",
       "    '2630767',\n",
       "    '2630769',\n",
       "    '2630771',\n",
       "    '2630773',\n",
       "    '2630775',\n",
       "    '2630777',\n",
       "    '2630779',\n",
       "    '2630781',\n",
       "    '2630783',\n",
       "    '2630785',\n",
       "    '2630787',\n",
       "    '2630790',\n",
       "    '2630832',\n",
       "    '2630833',\n",
       "    '2630839',\n",
       "    '2630840',\n",
       "    '2630855',\n",
       "    '2630856',\n",
       "    '2630857',\n",
       "    '2630858',\n",
       "    '2630859',\n",
       "    '2630860',\n",
       "    '2630861',\n",
       "    '2630862',\n",
       "    '2630863',\n",
       "    '2630864',\n",
       "    '2630865'],\n",
       "   'spl_set_id': ['68cd4f06-70e1-40d8-bedb-609ec0afa471'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': 'cbe2deea-e33b-47bc-8dac-2587bea0fa32',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'marketing_start_date': '20190524',\n",
       "  'product_id': '71894-156_cbe2deea-e33b-47bc-8dac-2587bea0fa32',\n",
       "  'application_number': 'BLA125694',\n",
       "  'brand_name_base': 'Zolgensma'},\n",
       " {'product_ndc': '71906-051',\n",
       "  'generic_name': 'Chloroxylenol',\n",
       "  'labeler_name': 'Essendant Co.',\n",
       "  'brand_name': 'BOARDWALK Antibacterial Ltion So ap',\n",
       "  'active_ingredients': [{'name': 'CHLOROXYLENOL', 'strength': '.003 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71906-051-27',\n",
       "    'description': '800 mL in 1 PACKAGE (71906-051-27)',\n",
       "    'marketing_start_date': '20030315',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Essendant Co.'],\n",
       "   'spl_set_id': ['f312250b-e3d3-4fa8-b8e9-324a7d13873a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['0F32U78V2Q']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '90a2e701-55e6-4755-a8ae-0eb053cd5eb1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20030315',\n",
       "  'product_id': '71906-051_90a2e701-55e6-4755-a8ae-0eb053cd5eb1',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'BOARDWALK Antibacterial Ltion So ap'},\n",
       " {'product_ndc': '71907-701',\n",
       "  'generic_name': 'PCMX',\n",
       "  'labeler_name': 'Dade Paper & Bag, LLC',\n",
       "  'brand_name': 'Victoria Bay Soft Touch Antibacterial',\n",
       "  'active_ingredients': [{'name': 'CHLOROXYLENOL', 'strength': '1 g/L'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71907-701-41',\n",
       "    'description': '3.78 L in 1 BOTTLE, PLASTIC (71907-701-41)',\n",
       "    'marketing_start_date': '20210630',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Dade Paper & Bag, LLC'],\n",
       "   'rxcui': ['1941461'],\n",
       "   'spl_set_id': ['c60227da-a4b3-3a05-e053-2995a90a1ee8'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['0F32U78V2Q']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOAP',\n",
       "  'spl_id': '217571ee-77b9-6aa0-e063-6294a90a1472',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210630',\n",
       "  'product_id': '71907-701_217571ee-77b9-6aa0-e063-6294a90a1472',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Victoria Bay Soft Touch Antibacterial'},\n",
       " {'product_ndc': '71919-034',\n",
       "  'generic_name': 'ALUMINUM OXIDE',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'Alumina',\n",
       "  'active_ingredients': [{'name': 'ALUMINUM OXIDE',\n",
       "    'strength': '30 [hp_C]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-034-07',\n",
       "    'description': '15 mL in 1 VIAL, GLASS (71919-034-07)',\n",
       "    'marketing_start_date': '20100429',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-034-08',\n",
       "    'description': '30 mL in 1 VIAL, GLASS (71919-034-08)',\n",
       "    'marketing_start_date': '20100429',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-034-09',\n",
       "    'description': '50 mL in 1 BOTTLE, GLASS (71919-034-09)',\n",
       "    'marketing_start_date': '20100429',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-034-10',\n",
       "    'description': '100 mL in 1 BOTTLE, GLASS (71919-034-10)',\n",
       "    'marketing_start_date': '20100429',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['c6adfa5b-7011-4838-8a60-960f9c9da8e0'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0740640212035'],\n",
       "   'unii': ['LMI26O6933']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'ecf7b735-9258-4039-82d3-ee1ae9c5ba9f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20100429',\n",
       "  'product_id': '71919-034_ecf7b735-9258-4039-82d3-ee1ae9c5ba9f',\n",
       "  'brand_name_base': 'Alumina'},\n",
       " {'product_ndc': '71919-596',\n",
       "  'generic_name': 'SCHOENOCAULON OFFICINALE SEED',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'Sabadilla',\n",
       "  'active_ingredients': [{'name': 'SCHOENOCAULON OFFICINALE SEED',\n",
       "    'strength': '30 [hp_C]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-596-07',\n",
       "    'description': '15 mL in 1 VIAL, GLASS (71919-596-07)',\n",
       "    'marketing_start_date': '20100112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-596-08',\n",
       "    'description': '30 mL in 1 VIAL, GLASS (71919-596-08)',\n",
       "    'marketing_start_date': '20100112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-596-09',\n",
       "    'description': '50 mL in 1 BOTTLE, GLASS (71919-596-09)',\n",
       "    'marketing_start_date': '20100112',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-596-10',\n",
       "    'description': '100 mL in 1 BOTTLE, GLASS (71919-596-10)',\n",
       "    'marketing_start_date': '20100112',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['4ab9ce30-c199-4efa-bb26-1e34b17cbef7'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0740640452486'],\n",
       "   'unii': ['6NAF1689IO']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '0acbe15c-5af6-4ba3-99ac-fd4f69fc2ca0',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20100112',\n",
       "  'product_id': '71919-596_0acbe15c-5af6-4ba3-99ac-fd4f69fc2ca0',\n",
       "  'brand_name_base': 'Sabadilla'},\n",
       " {'product_ndc': '71919-597',\n",
       "  'generic_name': 'SAW PALMETTO',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'Sabal serrulata',\n",
       "  'active_ingredients': [{'name': 'SAW PALMETTO', 'strength': '30 [hp_C]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-597-07',\n",
       "    'description': '15 mL in 1 VIAL, GLASS (71919-597-07)',\n",
       "    'marketing_start_date': '20100514',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-597-08',\n",
       "    'description': '30 mL in 1 VIAL, GLASS (71919-597-08)',\n",
       "    'marketing_start_date': '20100514',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-597-09',\n",
       "    'description': '50 mL in 1 BOTTLE, GLASS (71919-597-09)',\n",
       "    'marketing_start_date': '20100514',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-597-10',\n",
       "    'description': '100 mL in 1 BOTTLE, GLASS (71919-597-10)',\n",
       "    'marketing_start_date': '20100514',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['ce69e1c3-45d4-4a80-adfb-db456c02b2ea'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0740640453322'],\n",
       "   'unii': ['J7WWH9M8QS']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '42b543d0-478f-4d13-aab2-3b79d088301c',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20100514',\n",
       "  'product_id': '71919-597_42b543d0-478f-4d13-aab2-3b79d088301c',\n",
       "  'brand_name_base': 'Sabal serrulata'},\n",
       " {'product_ndc': '71919-603',\n",
       "  'generic_name': 'SALIX NIGRA BARK',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'Salix nigra',\n",
       "  'active_ingredients': [{'name': 'SALIX NIGRA BARK',\n",
       "    'strength': '30 [hp_C]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-603-07',\n",
       "    'description': '15 mL in 1 VIAL, GLASS (71919-603-07)',\n",
       "    'marketing_start_date': '20101007',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-603-08',\n",
       "    'description': '30 mL in 1 VIAL, GLASS (71919-603-08)',\n",
       "    'marketing_start_date': '20101007',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-603-09',\n",
       "    'description': '50 mL in 1 BOTTLE, GLASS (71919-603-09)',\n",
       "    'marketing_start_date': '20101007',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-603-10',\n",
       "    'description': '100 mL in 1 BOTTLE, GLASS (71919-603-10)',\n",
       "    'marketing_start_date': '20101007',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['d7d19f36-1e05-4e4e-a3f1-0f4e731309eb'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0740640455425'],\n",
       "   'unii': ['QU52J3A5B3']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'a12fdd29-c66b-4b14-8cc1-9f00c6160993',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20101007',\n",
       "  'product_id': '71919-603_a12fdd29-c66b-4b14-8cc1-9f00c6160993',\n",
       "  'brand_name_base': 'Salix nigra'},\n",
       " {'product_ndc': '71919-623',\n",
       "  'generic_name': 'PACKERA AUREA',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'Senecio aureus',\n",
       "  'active_ingredients': [{'name': 'PACKERA AUREA',\n",
       "    'strength': '30 [hp_C]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-623-07',\n",
       "    'description': '15 mL in 1 VIAL, GLASS (71919-623-07)',\n",
       "    'marketing_start_date': '20100203',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-623-08',\n",
       "    'description': '30 mL in 1 VIAL, GLASS (71919-623-08)',\n",
       "    'marketing_start_date': '20100203',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-623-09',\n",
       "    'description': '50 mL in 1 BOTTLE, GLASS (71919-623-09)',\n",
       "    'marketing_start_date': '20100203',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71919-623-10',\n",
       "    'description': '100 mL in 1 BOTTLE, GLASS (71919-623-10)',\n",
       "    'marketing_start_date': '20100203',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['3301a8ae-9c1b-4eef-94a5-0dbc8534149a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0740640465080'],\n",
       "   'unii': ['5WS1632J8W']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'f7b72fad-5612-41ca-b784-e48d6a407c07',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20100203',\n",
       "  'product_id': '71919-623_f7b72fad-5612-41ca-b784-e48d6a407c07',\n",
       "  'brand_name_base': 'Senecio aureus'},\n",
       " {'product_ndc': '71919-759',\n",
       "  'generic_name': 'HORSE CHESTNUT',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'Aesculus Hipp Kit Refill',\n",
       "  'active_ingredients': [{'name': 'HORSE CHESTNUT',\n",
       "    'strength': '200 [hp_C]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-759-01',\n",
       "    'description': '350 PELLET in 1 VIAL, GLASS (71919-759-01)',\n",
       "    'marketing_start_date': '20220505',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['de49ce14-eb8f-4c00-e053-2995a90a2f9f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3C18L6RJAZ']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'PELLET',\n",
       "  'spl_id': 'de49cd4b-cc15-89dc-e053-2995a90a6a13',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220505',\n",
       "  'product_id': '71919-759_de49cd4b-cc15-89dc-e053-2995a90a6a13',\n",
       "  'brand_name_base': 'Aesculus Hipp Kit Refill'},\n",
       " {'product_ndc': '71919-761',\n",
       "  'generic_name': 'DROSERA ROTUNDIFOLIA',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'Drosera Rotundifolia Kit Refill',\n",
       "  'active_ingredients': [{'name': 'DROSERA ROTUNDIFOLIA',\n",
       "    'strength': '200 [hp_C]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-761-01',\n",
       "    'description': '350 PELLET in 1 VIAL, GLASS (71919-761-01)',\n",
       "    'marketing_start_date': '20220510',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['deaaf6b3-0cc2-4813-e053-2995a90ac5d6'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['QR44N9XPJQ']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'PELLET',\n",
       "  'spl_id': 'deaad1e2-cdd3-c952-e053-2a95a90a3383',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220510',\n",
       "  'product_id': '71919-761_deaad1e2-cdd3-c952-e053-2a95a90a3383',\n",
       "  'brand_name_base': 'Drosera Rotundifolia Kit Refill'},\n",
       " {'product_ndc': '71919-762',\n",
       "  'generic_name': 'BERBERIS VULGARIS ROOT BARK',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'Berberis Vulgaris Kit Refill',\n",
       "  'active_ingredients': [{'name': 'BERBERIS VULGARIS ROOT BARK',\n",
       "    'strength': '200 [hp_C]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-762-01',\n",
       "    'description': '350 PELLET in 1 VIAL, GLASS (71919-762-01)',\n",
       "    'marketing_start_date': '20220510',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['deab1d3e-75a1-480e-e053-2995a90a0a75'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['1TH8Q20J0U']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'PELLET',\n",
       "  'spl_id': 'deab272a-6e6f-26b4-e053-2995a90aa410',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220510',\n",
       "  'product_id': '71919-762_deab272a-6e6f-26b4-e053-2995a90aa410',\n",
       "  'brand_name_base': 'Berberis Vulgaris Kit Refill'},\n",
       " {'product_ndc': '71919-769',\n",
       "  'generic_name': 'POTASSIUM CARBONATE',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'Kali Carbonicum Kit Refill',\n",
       "  'active_ingredients': [{'name': 'POTASSIUM CARBONATE',\n",
       "    'strength': '200 [hp_C]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-769-01',\n",
       "    'description': '350 PELLET in 1 VIAL, GLASS (71919-769-01)',\n",
       "    'marketing_start_date': '20220525',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['dfdb7ca2-8b15-683b-e053-2995a90a3f61'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['BQN1B9B9HA']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'PELLET',\n",
       "  'spl_id': 'dfdb7bfb-40c5-87c4-e053-2995a90a46d2',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220525',\n",
       "  'product_id': '71919-769_dfdb7bfb-40c5-87c4-e053-2995a90a46d2',\n",
       "  'brand_name_base': 'Kali Carbonicum Kit Refill'},\n",
       " {'product_ndc': '71919-773',\n",
       "  'generic_name': 'BELLIS PERENNIS',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'Bellis Perennis Kit Refill',\n",
       "  'active_ingredients': [{'name': 'BELLIS PERENNIS',\n",
       "    'strength': '200 [hp_C]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-773-01',\n",
       "    'description': '350 PELLET in 1 VIAL, GLASS (71919-773-01)',\n",
       "    'marketing_start_date': '20220610',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['e11a653d-42d4-1b82-e053-2a95a90a3b58'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['2HU33I03UY']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'PELLET',\n",
       "  'spl_id': 'e11a6519-07a5-6c08-e053-2a95a90a3526',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220610',\n",
       "  'product_id': '71919-773_e11a6519-07a5-6c08-e053-2a95a90a3526',\n",
       "  'brand_name_base': 'Bellis Perennis Kit Refill'},\n",
       " {'product_ndc': '71919-799',\n",
       "  'generic_name': 'CAMPHORA',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'Camphora Kit Refill',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (NATURAL)',\n",
       "    'strength': '200 [hp_C]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-799-01',\n",
       "    'description': '750 PELLET in 1 VIAL, GLASS (71919-799-01)',\n",
       "    'marketing_start_date': '20230914',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['0551d3f7-bb16-2339-e063-6394a90a48ce'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['N20HL7Q941']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'PELLET',\n",
       "  'spl_id': '0551bc2c-6e0d-99d1-e063-6294a90aa3af',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230914',\n",
       "  'product_id': '71919-799_0551bc2c-6e0d-99d1-e063-6294a90aa3af',\n",
       "  'brand_name_base': 'Camphora Kit Refill'},\n",
       " {'product_ndc': '71919-806',\n",
       "  'generic_name': 'KEROSENE - SULFUR - THUJA OCCIDENTALIS LEAFY',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'WHP Fungus',\n",
       "  'active_ingredients': [{'name': 'KEROSENE', 'strength': '6 [hp_C]/1'},\n",
       "   {'name': 'SULFUR', 'strength': '6 [hp_C]/1'},\n",
       "   {'name': 'THUJA OCCIDENTALIS LEAFY TWIG', 'strength': '6 [hp_C]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-806-14',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 BOX (71919-806-14)  / 1 PELLET in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20231003',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['06d446a8-2fc0-fea1-e063-6394a90a835e'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['1C89KKC04E', '70FD1KFU70', '1NT28V9397']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'PELLET',\n",
       "  'spl_id': '06d446a8-2fc1-fea1-e063-6394a90a835e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231003',\n",
       "  'product_id': '71919-806_06d446a8-2fc1-fea1-e063-6394a90a835e',\n",
       "  'brand_name_base': 'WHP Fungus'},\n",
       " {'product_ndc': '71919-814',\n",
       "  'generic_name': 'PHOSPHORIC ACID',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'Phosphoricum Acidum Kit Refill',\n",
       "  'active_ingredients': [{'name': 'PHOSPHORIC ACID',\n",
       "    'strength': '200 [hp_C]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-814-01',\n",
       "    'description': '750 PELLET in 1 VIAL, GLASS (71919-814-01)',\n",
       "    'marketing_start_date': '20231107',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['099254bb-7923-8887-e063-6294a90a2f2e'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['E4GA8884NN']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'PELLET',\n",
       "  'spl_id': '099251f6-be56-e136-e063-6394a90a94c7',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231107',\n",
       "  'product_id': '71919-814_099251f6-be56-e136-e063-6394a90a94c7',\n",
       "  'brand_name_base': 'Phosphoricum Acidum Kit Refill'},\n",
       " {'product_ndc': '71919-818',\n",
       "  'generic_name': 'HELLEBORUS NIGER ROOT',\n",
       "  'labeler_name': 'Washington Homeopathic Products',\n",
       "  'brand_name': 'Helleborus niger',\n",
       "  'active_ingredients': [{'name': 'HELLEBORUS NIGER ROOT',\n",
       "    'strength': '200 [hp_C]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71919-818-01',\n",
       "    'description': '350 PELLET in 1 VIAL, GLASS (71919-818-01)',\n",
       "    'marketing_start_date': '20231107',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Washington Homeopathic Products'],\n",
       "   'spl_set_id': ['0996cbde-0212-ee6b-e063-6394a90a4820'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['608DGJ6815']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'PELLET',\n",
       "  'spl_id': '0996d446-1c36-f98f-e063-6394a90af8b8',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231107',\n",
       "  'product_id': '71919-818_0996d446-1c36-f98f-e063-6394a90af8b8',\n",
       "  'brand_name_base': 'Helleborus niger'},\n",
       " {'product_ndc': '71921-242',\n",
       "  'generic_name': 'Allopurinol',\n",
       "  'labeler_name': 'Florida Pharmaceutical Products, LLC',\n",
       "  'brand_name': 'Allopurinol',\n",
       "  'active_ingredients': [{'name': 'ALLOPURINOL', 'strength': '300 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71921-242-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (71921-242-01)',\n",
       "    'marketing_start_date': '20231031',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71921-242-50',\n",
       "    'description': '500 TABLET in 1 BOTTLE (71921-242-50)',\n",
       "    'marketing_start_date': '20231031',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Florida Pharmaceutical Products, LLC'],\n",
       "   'rxcui': ['197319', '197320'],\n",
       "   'spl_set_id': ['815af471-5985-4819-936d-1f5f3d871ef8'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0371921240609',\n",
       "    '0371921240333',\n",
       "    '0371921240012',\n",
       "    '0371921240500',\n",
       "    '0371921242504',\n",
       "    '0371921242016'],\n",
       "   'nui': ['N0000175698', 'N0000000206'],\n",
       "   'pharm_class_epc': ['Xanthine Oxidase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Xanthine Oxidase Inhibitors [MoA]'],\n",
       "   'unii': ['63CZ7GJN5I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '3dcd374e-562b-4788-bc2a-cccc72a95d8b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231031',\n",
       "  'product_id': '71921-242_3dcd374e-562b-4788-bc2a-cccc72a95d8b',\n",
       "  'application_number': 'ANDA204467',\n",
       "  'brand_name_base': 'Allopurinol',\n",
       "  'pharm_class': ['Xanthine Oxidase Inhibitor [EPC]',\n",
       "   'Xanthine Oxidase Inhibitors [MoA]']},\n",
       " {'product_ndc': '71922-100',\n",
       "  'generic_name': 'Benzocaine',\n",
       "  'labeler_name': 'American Medical & Hospital Supply Co., Inc.',\n",
       "  'brand_name': 'Candee Caine Topical Anesthetic',\n",
       "  'active_ingredients': [{'name': 'BENZOCAINE', 'strength': '200 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71922-100-30',\n",
       "    'description': '30 g in 1 JAR (71922-100-30)',\n",
       "    'marketing_start_date': '20180801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['American Medical & Hospital Supply Co., Inc.'],\n",
       "   'rxcui': ['238910', '1992043'],\n",
       "   'spl_set_id': ['edcb8451-6fa7-4bc2-95f6-2a0806f7f3da'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185508', 'N0000175629', 'N0000184306', 'M0000728'],\n",
       "   'pharm_class_epc': ['Standardized Chemical Allergen [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]'],\n",
       "   'unii': ['U3RSY48JW5']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'd691da56-baa8-c47a-e053-2995a90a2ba2',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['DENTAL'],\n",
       "  'marketing_start_date': '20130701',\n",
       "  'product_id': '71922-100_d691da56-baa8-c47a-e053-2995a90a2ba2',\n",
       "  'application_number': 'part356',\n",
       "  'brand_name_base': 'Candee Caine Topical Anesthetic',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Standardized Chemical Allergen [EPC]']},\n",
       " {'product_ndc': '0536-1103',\n",
       "  'generic_name': 'ISOPROPYL ALCOHOL',\n",
       "  'labeler_name': 'Rugby Laboratories',\n",
       "  'brand_name': 'Alcohol Prep Pad',\n",
       "  'active_ingredients': [{'name': 'ISOPROPYL ALCOHOL',\n",
       "    'strength': '.7 mL/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1103-01',\n",
       "    'description': '.4 mL in 1 POUCH (0536-1103-01)',\n",
       "    'marketing_start_date': '20170405',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Rugby Laboratories'],\n",
       "   'rxcui': ['797544'],\n",
       "   'spl_set_id': ['ea28b27a-456e-4042-b769-f06072759933'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['ND2M416302']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SWAB',\n",
       "  'spl_id': '24a703fe-efb2-d6de-e063-6394a90aee6c',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20170405',\n",
       "  'product_id': '0536-1103_24a703fe-efb2-d6de-e063-6394a90aee6c',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'Alcohol Prep Pad'},\n",
       " {'product_ndc': '0536-1106',\n",
       "  'generic_name': 'Nicotine',\n",
       "  'labeler_name': 'Rugby Laboratories',\n",
       "  'brand_name': 'Nicotine transdermal system step 3',\n",
       "  'brand_name_suffix': 'transdermal system step 3',\n",
       "  'active_ingredients': [{'name': 'NICOTINE', 'strength': '7 mg/24h'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1106-88',\n",
       "    'description': '14 PATCH in 1 CARTON (0536-1106-88)  / 24 h in 1 PATCH',\n",
       "    'marketing_start_date': '20160401',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Rugby Laboratories'],\n",
       "   'rxcui': ['198029', '198030', '198031'],\n",
       "   'spl_set_id': ['ae406389-0f83-d5c8-bd2f-56075e57453a'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175706', 'M0014836'],\n",
       "   'pharm_class_epc': ['Cholinergic Nicotinic Agonist [EPC]'],\n",
       "   'pharm_class_cs': ['Nicotine [CS]'],\n",
       "   'unii': ['6M3C89ZY6R']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'PATCH, EXTENDED RELEASE',\n",
       "  'spl_id': '83002453-670f-7a2c-a003-0bd6ee464b24',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TRANSDERMAL'],\n",
       "  'marketing_start_date': '20160401',\n",
       "  'product_id': '0536-1106_83002453-670f-7a2c-a003-0bd6ee464b24',\n",
       "  'application_number': 'NDA020076',\n",
       "  'brand_name_base': 'Nicotine',\n",
       "  'pharm_class': ['Cholinergic Nicotinic Agonist [EPC]', 'Nicotine [CS]']},\n",
       " {'product_ndc': '71927-014',\n",
       "  'generic_name': 'Isopropyl Alcohol',\n",
       "  'labeler_name': 'Orazen Inc',\n",
       "  'brand_name': 'American Safety First Aid Antispetic',\n",
       "  'active_ingredients': [{'name': 'ISOPROPYL ALCOHOL',\n",
       "    'strength': '700 mg/1000mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71927-014-01',\n",
       "    'description': '59.1 mL in 1 BOTTLE, SPRAY (71927-014-01)',\n",
       "    'marketing_start_date': '20221003',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Orazen Inc'],\n",
       "   'rxcui': ['1014638'],\n",
       "   'spl_set_id': ['ea302ba4-a63d-e713-e053-2995a90a3fc4'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['ND2M416302']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '0efffe89-b8f0-b1c2-e063-6394a90aaa67',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20221003',\n",
       "  'product_id': '71927-014_0efffe89-b8f0-b1c2-e063-6394a90aaa67',\n",
       "  'application_number': 'M004',\n",
       "  'brand_name_base': 'American Safety First Aid Antispetic'},\n",
       " {'product_ndc': '71971-6002',\n",
       "  'generic_name': 'Chamomila, Coffea Cruda, Eriodictyon californicum, Histaminum, Ipecacuanha, Lobelia inflata, Sambucus nigra, Solidago virgaurea',\n",
       "  'labeler_name': 'Homeolab International (Canada) inc',\n",
       "  'brand_name': 'Real Relief',\n",
       "  'active_ingredients': [{'name': 'ARABICA COFFEE BEAN',\n",
       "    'strength': '8 [hp_X]/1'},\n",
       "   {'name': 'ERIODICTYON CALIFORNICUM LEAF', 'strength': '8 [hp_X]/1'},\n",
       "   {'name': 'HISTAMINE DIHYDROCHLORIDE', 'strength': '8 [hp_X]/1'},\n",
       "   {'name': 'IPECAC', 'strength': '8 [hp_X]/1'},\n",
       "   {'name': 'LOBELIA INFLATA', 'strength': '8 [hp_X]/1'},\n",
       "   {'name': 'MATRICARIA CHAMOMILLA', 'strength': '8 [hp_X]/1'},\n",
       "   {'name': 'SAMBUCUS NIGRA FLOWERING TOP', 'strength': '8 [hp_X]/1'},\n",
       "   {'name': 'SOLIDAGO VIRGAUREA FLOWERING TOP', 'strength': '8 [hp_X]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71971-6002-0',\n",
       "    'description': '1 BOTTLE in 1 CARTON (71971-6002-0)  / 90 TABLET in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71971-6002-5',\n",
       "    'description': '30 TABLET in 1 BOTTLE (71971-6002-5)',\n",
       "    'marketing_start_date': '20200101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71971-6002-8',\n",
       "    'description': '1 BOTTLE in 1 CARTON (71971-6002-8)  / 60 TABLET in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '0da99696-b23d-4565-be15-d92a3fe6d439',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200101',\n",
       "  'product_id': '71971-6002_0da99696-b23d-4565-be15-d92a3fe6d439',\n",
       "  'brand_name_base': 'Real Relief',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]',\n",
       "   'Seed Storage Proteins [CS]']},\n",
       " {'product_ndc': '71971-9083',\n",
       "  'generic_name': 'COLOCYNTHIS, MAGNESIA PHOSPHORICA, CHAMOMILLA, DIOSCOREA VILLOSA',\n",
       "  'labeler_name': 'Homeolab International (Canada) inc',\n",
       "  'brand_name': 'Kids Relief',\n",
       "  'active_ingredients': [{'name': 'CITRULLUS COLOCYNTHIS FRUIT PULP',\n",
       "    'strength': '6 [hp_X]/25mL'},\n",
       "   {'name': 'DIOSCOREA VILLOSA TUBER', 'strength': '6 [hp_X]/25mL'},\n",
       "   {'name': 'MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE',\n",
       "    'strength': '6 [hp_X]/25mL'},\n",
       "   {'name': 'MATRICARIA CHAMOMILLA', 'strength': '6 [hp_X]/25mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71971-9083-8',\n",
       "    'description': '1 BOTTLE in 1 CARTON (71971-9083-8)  / 25 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20170303',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Homeolab International (Canada) inc'],\n",
       "   'spl_set_id': ['df8e8995-3106-4b21-acc4-24eeefd109fc'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['23H32AOH17', 'IWY3IWX2G8', 'HF539G9L3Q', 'G0R4UBI2ZZ']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '3c6169c7-d8f8-4cbe-adf3-efedd55bc0ee',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170303',\n",
       "  'product_id': '71971-9083_3c6169c7-d8f8-4cbe-adf3-efedd55bc0ee',\n",
       "  'brand_name_base': 'Kids Relief',\n",
       "  'pharm_class': ['Calculi Dissolution Agent [EPC]',\n",
       "   'Increased Large Intestinal Motility [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Magnesium Ion Exchange Activity [MoA]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]']},\n",
       " {'product_ndc': '0536-1142',\n",
       "  'generic_name': 'Levonorgestrel',\n",
       "  'labeler_name': 'Rugby Laboratories',\n",
       "  'brand_name': 'Levonorgestrel',\n",
       "  'active_ingredients': [{'name': 'LEVONORGESTREL', 'strength': '1.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1142-63',\n",
       "    'description': '1 BLISTER PACK in 1 CARTON (0536-1142-63)  / 1 TABLET in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20171101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Rugby Laboratories'],\n",
       "   'rxcui': ['483325'],\n",
       "   'spl_set_id': ['bea85d01-936e-46f6-8037-b60d0e39dd05'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0064674000087'],\n",
       "   'nui': ['N0000175830', 'M0447349', 'N0000175602', 'N0000175832'],\n",
       "   'pharm_class_pe': ['Inhibit Ovum Fertilization [PE]'],\n",
       "   'pharm_class_cs': ['Progesterone Congeners [CS]'],\n",
       "   'pharm_class_epc': ['Progestin [EPC]',\n",
       "    'Progestin-containing Intrauterine System [EPC]'],\n",
       "   'unii': ['5W7SIA7YZW']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'bea85d01-936e-46f6-8037-b60d0e39dd05',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171101',\n",
       "  'product_id': '0536-1142_bea85d01-936e-46f6-8037-b60d0e39dd05',\n",
       "  'application_number': 'ANDA202635',\n",
       "  'brand_name_base': 'Levonorgestrel',\n",
       "  'pharm_class': ['Inhibit Ovum Fertilization [PE]',\n",
       "   'Progesterone Congeners [CS]',\n",
       "   'Progesterone Congeners [CS]',\n",
       "   'Progestin [EPC]',\n",
       "   'Progestin-containing Intrauterine Device [EPC]']},\n",
       " {'product_ndc': '72030-002',\n",
       "  'generic_name': 'ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE',\n",
       "  'labeler_name': 'ANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD.',\n",
       "  'brand_name': 'GANMAOLING',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '60 mg/1'},\n",
       "   {'name': 'CHLORPHENIRAMINE MALEATE', 'strength': '.667 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72030-002-01',\n",
       "    'description': '1 BOTTLE in 1 BOX (72030-002-01)  / 120 TABLET in 1 BOTTLE',\n",
       "    'marketing_start_date': '20181126',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['ANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD.'],\n",
       "   'rxcui': ['1599133'],\n",
       "   'spl_set_id': ['c757a03e-59ea-469c-970d-4bc62e73f36f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['362O9ITL9D', 'V1Q0O9OJ9Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '992db9b6-e8a8-4efa-a19f-8a76cccda813',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181126',\n",
       "  'product_id': '72030-002_992db9b6-e8a8-4efa-a19f-8a76cccda813',\n",
       "  'application_number': 'part341',\n",
       "  'brand_name_base': 'GANMAOLING',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72033-120',\n",
       "  'marketing_end_date': '20250730',\n",
       "  'generic_name': 'Alcohol',\n",
       "  'labeler_name': 'Touchland LLC',\n",
       "  'brand_name': 'Touchland BlackPink Blue Sandalwood Power Mist',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '.7 mL/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72033-120-01',\n",
       "    'description': '30 mL in 1 BOTTLE, SPRAY (72033-120-01)',\n",
       "    'marketing_start_date': '20230608',\n",
       "    'marketing_end_date': '20250730',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Touchland LLC'],\n",
       "   'rxcui': ['1041849'],\n",
       "   'spl_set_id': ['fda132e6-193b-9d87-e053-6394a90a910f'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0850028448359'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '2884a5bd-0bbb-bc81-e063-6394a90a9467',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230608',\n",
       "  'product_id': '72033-120_2884a5bd-0bbb-bc81-e063-6394a90a9467',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Touchland BlackPink Blue Sandalwood Power Mist'},\n",
       " {'product_ndc': '72033-142',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'TOUCHLAND LLC',\n",
       "  'brand_name': 'Touchland Power Mist Spiced Pumpkin tini Scented Hydrating Hand sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '70 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72033-142-00',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72033-142-00)  / 30 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20240801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['TOUCHLAND LLC'],\n",
       "   'rxcui': ['1041849'],\n",
       "   'spl_set_id': ['6f2e53ca-f2f5-494f-a192-16a7b932e615'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0850028448496'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '1c3338ad-e54f-38dc-e063-6294a90abe15',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240801',\n",
       "  'product_id': '72033-142_1c3338ad-e54f-38dc-e063-6294a90abe15',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Touchland Power Mist Spiced Pumpkin tini Scented Hydrating Hand sanitizer'},\n",
       " {'product_ndc': '0536-1168',\n",
       "  'marketing_end_date': '20251130',\n",
       "  'generic_name': 'Sennosides',\n",
       "  'labeler_name': 'Rugby Laboratories',\n",
       "  'brand_name': 'Sennosides',\n",
       "  'active_ingredients': [{'name': 'SENNOSIDES', 'strength': '8.6 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1168-01',\n",
       "    'description': '1 BOTTLE in 1 CARTON (0536-1168-01)  / 100 TABLET, FILM COATED in 1 BOTTLE',\n",
       "    'marketing_start_date': '20190123',\n",
       "    'marketing_end_date': '20251130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0536-1168-10',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (0536-1168-10)',\n",
       "    'marketing_start_date': '20190214',\n",
       "    'marketing_end_date': '20250930',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Rugby Laboratories'],\n",
       "   'rxcui': ['312935'],\n",
       "   'spl_set_id': ['78fc2b97-ea53-0538-e053-2991aa0a9099'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305361168100'],\n",
       "   'unii': ['3FYP5M0IJX']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '0eafc535-7f23-7eab-e063-6294a90a07c8',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190123',\n",
       "  'product_id': '0536-1168_0eafc535-7f23-7eab-e063-6294a90a07c8',\n",
       "  'application_number': 'M007',\n",
       "  'brand_name_base': 'Sennosides'},\n",
       " {'product_ndc': '72036-092',\n",
       "  'generic_name': 'Acetaminophen',\n",
       "  'labeler_name': 'HARRIS TEETER',\n",
       "  'brand_name': 'Acetaminophen',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72036-092-01',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (72036-092-01)  / 100 TABLET, COATED in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20130601',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72036-092-03',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (72036-092-03)  / 50 TABLET, COATED in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20111201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['HARRIS TEETER'],\n",
       "   'rxcui': ['198440'],\n",
       "   'spl_set_id': ['a60f6439-2033-4bd2-b78c-6c083414a12b'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0072036707734'],\n",
       "   'unii': ['362O9ITL9D']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '2512a7c7-7679-63a8-e063-6394a90a3976',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20111201',\n",
       "  'product_id': '72036-092_2512a7c7-7679-63a8-e063-6394a90a3976',\n",
       "  'application_number': 'M013',\n",
       "  'brand_name_base': 'Acetaminophen'},\n",
       " {'product_ndc': '0536-1172',\n",
       "  'generic_name': 'Acetaminophen',\n",
       "  'labeler_name': 'Rugby Laboratories',\n",
       "  'brand_name': 'Acetaminophen',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1172-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (0536-1172-01)',\n",
       "    'marketing_start_date': '20181001',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0536-1172-10',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (0536-1172-10)',\n",
       "    'marketing_start_date': '20181001',\n",
       "    'marketing_end_date': '20251130',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Rugby Laboratories'],\n",
       "   'rxcui': ['198440'],\n",
       "   'spl_set_id': ['76f10ee2-1d6a-097c-e053-2991aa0af526'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305361172015'],\n",
       "   'unii': ['362O9ITL9D']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '0eaf3569-5e07-f353-e063-6294a90a4150',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181001',\n",
       "  'product_id': '0536-1172_0eaf3569-5e07-f353-e063-6294a90a4150',\n",
       "  'application_number': 'M013',\n",
       "  'brand_name_base': 'Acetaminophen'},\n",
       " {'product_ndc': '72036-146',\n",
       "  'generic_name': 'ASPIRIN',\n",
       "  'labeler_name': 'Harris Teeter',\n",
       "  'brand_name': 'Aspirin',\n",
       "  'active_ingredients': [{'name': 'ASPIRIN', 'strength': '81 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72036-146-01',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (72036-146-01)  / 180 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20111006',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Harris Teeter'],\n",
       "   'rxcui': ['308416'],\n",
       "   'spl_set_id': ['8df9ad9a-72ec-486e-a381-54c2bce27da7'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0072036987402'],\n",
       "   'nui': ['N0000000160',\n",
       "    'N0000008836',\n",
       "    'M0001335',\n",
       "    'N0000175722',\n",
       "    'N0000175578',\n",
       "    'N0000008832'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_pe': ['Decreased Prostaglandin Production [PE]',\n",
       "    'Decreased Platelet Aggregation [PE]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]',\n",
       "    'Platelet Aggregation Inhibitor [EPC]'],\n",
       "   'unii': ['R16CO5Y76E']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, DELAYED RELEASE',\n",
       "  'spl_id': '2514d576-c097-6b54-e063-6394a90a17fb',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20111006',\n",
       "  'product_id': '72036-146_2514d576-c097-6b54-e063-6394a90a17fb',\n",
       "  'application_number': 'M013',\n",
       "  'brand_name_base': 'Aspirin',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Decreased Platelet Aggregation [PE]',\n",
       "   'Decreased Prostaglandin Production [PE]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]',\n",
       "   'Platelet Aggregation Inhibitor [EPC]']},\n",
       " {'product_ndc': '72036-205',\n",
       "  'generic_name': 'ASPIRIN',\n",
       "  'labeler_name': 'HARRIS TEETER',\n",
       "  'brand_name': 'Chewable Aspirin',\n",
       "  'active_ingredients': [{'name': 'ASPIRIN', 'strength': '81 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72036-205-01',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (72036-205-01)  / 36 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20210906',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['HARRIS TEETER'],\n",
       "   'rxcui': ['318272'],\n",
       "   'spl_set_id': ['c6a28c83-60c9-3304-e053-2a95a90aa06c'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0072036987372'],\n",
       "   'nui': ['N0000000160',\n",
       "    'N0000008836',\n",
       "    'M0001335',\n",
       "    'N0000175722',\n",
       "    'N0000175578',\n",
       "    'N0000008832'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_pe': ['Decreased Prostaglandin Production [PE]',\n",
       "    'Decreased Platelet Aggregation [PE]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]',\n",
       "    'Platelet Aggregation Inhibitor [EPC]'],\n",
       "   'unii': ['R16CO5Y76E']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, CHEWABLE',\n",
       "  'spl_id': '25130304-cc12-e122-e063-6394a90a90a4',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210906',\n",
       "  'product_id': '72036-205_25130304-cc12-e122-e063-6394a90a90a4',\n",
       "  'application_number': 'M013',\n",
       "  'brand_name_base': 'Chewable Aspirin',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Decreased Platelet Aggregation [PE]',\n",
       "   'Decreased Prostaglandin Production [PE]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]',\n",
       "   'Platelet Aggregation Inhibitor [EPC]']},\n",
       " {'product_ndc': '72036-211',\n",
       "  'generic_name': 'Ibuprofen',\n",
       "  'labeler_name': 'Harris Teeter',\n",
       "  'brand_name': 'Ibuprofen',\n",
       "  'active_ingredients': [{'name': 'IBUPROFEN', 'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72036-211-02',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (72036-211-02)  / 50 TABLET, COATED in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20191213',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72036-211-03',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (72036-211-03)  / 100 TABLET, COATED in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20191213',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Harris Teeter'],\n",
       "   'rxcui': ['310965'],\n",
       "   'spl_set_id': ['14515409-736f-4119-b6a0-cb19ee2e948e'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0072036705518'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['WK2XYI10QM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': 'd07104c9-e97c-69f7-e053-2a95a90a0723',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20191213',\n",
       "  'product_id': '72036-211_d07104c9-e97c-69f7-e053-2a95a90a0723',\n",
       "  'application_number': 'ANDA202312',\n",
       "  'brand_name_base': 'Ibuprofen',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72036-602',\n",
       "  'generic_name': 'Magnesium Sulfate',\n",
       "  'labeler_name': 'HARRIS TEETER',\n",
       "  'brand_name': 'Epsom Salt',\n",
       "  'active_ingredients': [{'name': 'MAGNESIUM SULFATE HEPTAHYDRATE',\n",
       "    'strength': '1 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72036-602-01',\n",
       "    'description': '1814 g in 1 POUCH (72036-602-01)',\n",
       "    'marketing_start_date': '20241203',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['HARRIS TEETER'],\n",
       "   'rxcui': ['1053346'],\n",
       "   'spl_set_id': ['73065a04-b7cd-437d-9624-f845f5ec93bf'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SK47B8698T']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GRANULE, FOR SOLUTION',\n",
       "  'spl_id': '28657181-be60-ac1b-e063-6394a90ae388',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL', 'TOPICAL'],\n",
       "  'marketing_start_date': '20241203',\n",
       "  'product_id': '72036-602_28657181-be60-ac1b-e063-6394a90ae388',\n",
       "  'application_number': 'M007',\n",
       "  'brand_name_base': 'Epsom Salt',\n",
       "  'pharm_class': ['Calculi Dissolution Agent [EPC]',\n",
       "   'Increased Large Intestinal Motility [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Magnesium Ion Exchange Activity [MoA]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]']},\n",
       " {'product_ndc': '72036-664',\n",
       "  'generic_name': 'Eucalyptol, menthol, methyl salicylate, thymol',\n",
       "  'labeler_name': 'HARRIS TEETER',\n",
       "  'brand_name': 'Antispetic',\n",
       "  'active_ingredients': [{'name': 'EUCALYPTOL', 'strength': '.92 mg/mL'},\n",
       "   {'name': 'MENTHOL', 'strength': '.42 mg/mL'},\n",
       "   {'name': 'METHYL SALICYLATE', 'strength': '.6 mg/mL'},\n",
       "   {'name': 'THYMOL', 'strength': '.64 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72036-664-69',\n",
       "    'description': '250 mL in 1 BOTTLE, PLASTIC (72036-664-69)',\n",
       "    'marketing_start_date': '19921001',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72036-664-77',\n",
       "    'description': '500 mL in 1 BOTTLE, PLASTIC (72036-664-77)',\n",
       "    'marketing_start_date': '19921001',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72036-664-86',\n",
       "    'description': '1000 mL in 1 BOTTLE, PLASTIC (72036-664-86)',\n",
       "    'marketing_start_date': '19921001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['HARRIS TEETER'],\n",
       "   'rxcui': ['1043619'],\n",
       "   'spl_set_id': ['98728688-32f6-44f1-9cc9-cd72c3a039ad'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['RV6J6604TK', 'L7T10EIP3A', 'LAV5U5022Y', '3J50XA376E']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'MOUTHWASH',\n",
       "  'spl_id': '2255933c-c99f-b7f8-e063-6394a90aa88a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19921001',\n",
       "  'product_id': '72036-664_2255933c-c99f-b7f8-e063-6394a90aa88a',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Antispetic'},\n",
       " {'product_ndc': '72036-804',\n",
       "  'generic_name': 'Isopropyl Alcohol',\n",
       "  'labeler_name': 'HARRIS TEETER',\n",
       "  'brand_name': 'Isopropyl Alcohol',\n",
       "  'active_ingredients': [{'name': 'ISOPROPYL ALCOHOL',\n",
       "    'strength': '91 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72036-804-43',\n",
       "    'description': '473 mL in 1 BOTTLE, PLASTIC (72036-804-43)',\n",
       "    'marketing_start_date': '20231213',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['HARRIS TEETER'],\n",
       "   'rxcui': ['582901'],\n",
       "   'spl_set_id': ['c4e816c7-a8a2-404c-9354-eaaed6dbf0f5'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['ND2M416302']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '22559bf9-bc01-9107-e063-6294a90a68bd',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20231213',\n",
       "  'product_id': '72036-804_22559bf9-bc01-9107-e063-6294a90a68bd',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'Isopropyl Alcohol'},\n",
       " {'product_ndc': '72043-2578',\n",
       "  'generic_name': 'zinc oxide and titanium dioxide sunscrreen',\n",
       "  'labeler_name': 'CP Skin Health Group, Inc.',\n",
       "  'brand_name': 'EltaMD UV Physical SPF41',\n",
       "  'active_ingredients': [{'name': 'TITANIUM DIOXIDE',\n",
       "    'strength': '70 g/1000g'},\n",
       "   {'name': 'ZINC OXIDE', 'strength': '90 g/1000g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72043-2578-2',\n",
       "    'description': '2 g in 1 PACKET (72043-2578-2)',\n",
       "    'marketing_start_date': '20220706',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72043-2578-3',\n",
       "    'description': '85 g in 1 TUBE (72043-2578-3)',\n",
       "    'marketing_start_date': '20180110',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['CP Skin Health Group, Inc.'],\n",
       "   'spl_set_id': ['2900b117-ff98-42e6-a2fc-2cd89d14ee6e'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0390205025787'],\n",
       "   'unii': ['15FIX9V2JP', 'SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '6e5791ac-2a4b-458c-bd5e-e34dc048c801',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180110',\n",
       "  'product_id': '72043-2578_6e5791ac-2a4b-458c-bd5e-e34dc048c801',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'EltaMD UV Physical SPF41',\n",
       "  'pharm_class': ['Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]']},\n",
       " {'product_ndc': '72043-2582',\n",
       "  'generic_name': 'zinc oxide and titanium dioxide sunscreen',\n",
       "  'labeler_name': 'CP Skin Health Group, Inc.',\n",
       "  'brand_name': 'EltaMD UV Pure SPF47',\n",
       "  'active_ingredients': [{'name': 'TITANIUM DIOXIDE',\n",
       "    'strength': '55 g/1000g'},\n",
       "   {'name': 'ZINC OXIDE', 'strength': '100 g/1000g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72043-2582-2',\n",
       "    'description': '2 g in 1 PACKET (72043-2582-2)',\n",
       "    'marketing_start_date': '20220706',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72043-2582-4',\n",
       "    'description': '114 g in 1 BOTTLE (72043-2582-4)',\n",
       "    'marketing_start_date': '20180110',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['CP Skin Health Group, Inc.'],\n",
       "   'spl_set_id': ['9afe900b-4186-4189-a871-ad6f26fc26e4'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0390205025824'],\n",
       "   'unii': ['15FIX9V2JP', 'SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '6f7bbffb-97bc-4a8e-aba3-dbd9bd1ef381',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180110',\n",
       "  'product_id': '72043-2582_6f7bbffb-97bc-4a8e-aba3-dbd9bd1ef381',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'EltaMD UV Pure SPF47',\n",
       "  'pharm_class': ['Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]']},\n",
       " {'product_ndc': '72053-000',\n",
       "  'generic_name': 'TETRACYCLINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Patient Focused Tele-Health, LLC',\n",
       "  'brand_name': 'Tetracycline 3 percent a First Aid Antibiotic',\n",
       "  'active_ingredients': [{'name': 'TETRACYCLINE HYDROCHLORIDE',\n",
       "    'strength': '30 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72053-000-00',\n",
       "    'description': '1 BOTTLE, DROPPER in 1 BOX (72053-000-00)  / 3 g in 1 BOTTLE, DROPPER',\n",
       "    'marketing_start_date': '20180401',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Patient Focused Tele-Health, LLC'],\n",
       "   'rxcui': ['1542813'],\n",
       "   'spl_set_id': ['647918a1-f49f-ef01-e053-2a91aa0a11fb'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['P6R62377KV']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': '0b6dc9f9-4461-e765-e063-6394a90ac6c8',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180401',\n",
       "  'product_id': '72053-000_0b6dc9f9-4461-e765-e063-6394a90ac6c8',\n",
       "  'application_number': 'M004',\n",
       "  'brand_name_base': 'Tetracycline 3 percent a First Aid Antibiotic',\n",
       "  'pharm_class': ['Tetracycline-class Antimicrobial [EPC]',\n",
       "   'Tetracyclines [CS]']},\n",
       " {'product_ndc': '72064-110',\n",
       "  'generic_name': 'avapritinib',\n",
       "  'labeler_name': 'Blueprint Medicines Corporation',\n",
       "  'brand_name': 'Ayvakit',\n",
       "  'active_ingredients': [{'name': 'AVAPRITINIB', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72064-110-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72064-110-30)',\n",
       "    'marketing_start_date': '20200109',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Blueprint Medicines Corporation'],\n",
       "   'rxcui': ['2272112',\n",
       "    '2272118',\n",
       "    '2272120',\n",
       "    '2272122',\n",
       "    '2272124',\n",
       "    '2272126',\n",
       "    '2559723',\n",
       "    '2559725',\n",
       "    '2559727',\n",
       "    '2559729'],\n",
       "   'spl_set_id': ['645c887c-8cd4-4623-8da9-ac223d71a8b9'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372064125303', '0372064150305', '0372064110309', '0372064130307'],\n",
       "   'nui': ['N0000175605',\n",
       "    'N0000020001',\n",
       "    'N0000185504',\n",
       "    'N0000185503',\n",
       "    'N0000190113',\n",
       "    'N0000191423',\n",
       "    'N0000193932',\n",
       "    'N0000193845'],\n",
       "   'pharm_class_epc': ['Kinase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Tyrosine Kinase Inhibitors [MoA]',\n",
       "    'Cytochrome P450 2C9 Inhibitors [MoA]',\n",
       "    'P-Glycoprotein Inhibitors [MoA]',\n",
       "    'Breast Cancer Resistance Protein Inhibitors [MoA]',\n",
       "    'Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]',\n",
       "    'Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]',\n",
       "    'Bile Salt Export Pump Inhibitors [MoA]'],\n",
       "   'unii': ['513P80B4YJ']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '04b549f4-4d67-4915-9ed4-737c3e68e444',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200109',\n",
       "  'product_id': '72064-110_04b549f4-4d67-4915-9ed4-737c3e68e444',\n",
       "  'application_number': 'NDA212608',\n",
       "  'brand_name_base': 'Ayvakit',\n",
       "  'pharm_class': ['Bile Salt Export Pump Inhibitors [MoA]',\n",
       "   'Breast Cancer Resistance Protein Inhibitors [MoA]',\n",
       "   'Cytochrome P450 2C9 Inhibitors [MoA]',\n",
       "   'Kinase Inhibitor [EPC]',\n",
       "   'Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]',\n",
       "   'Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]',\n",
       "   'P-Glycoprotein Inhibitors [MoA]',\n",
       "   'Tyrosine Kinase Inhibitors [MoA]']},\n",
       " {'product_ndc': '72078-035',\n",
       "  'generic_name': 'Remifentanil Hydrochloride',\n",
       "  'labeler_name': 'Mylan Institutional LLC',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Ultiva',\n",
       "  'active_ingredients': [{'name': 'REMIFENTANIL HYDROCHLORIDE',\n",
       "    'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72078-035-02',\n",
       "    'description': '10 VIAL, GLASS in 1 CARTON (72078-035-02)  / 5 mL in 1 VIAL, GLASS (72078-035-00)',\n",
       "    'marketing_start_date': '20230918',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Mylan Institutional LLC'],\n",
       "   'rxcui': ['1729578', '1729581', '1729584', '1729586', '1729710', '1729712'],\n",
       "   'spl_set_id': ['8b4c8696-e23e-4c51-a4d2-babab5bd945a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['5V444H5WIC']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION',\n",
       "  'spl_id': 'c10cf43f-066a-43ff-9166-242cbb7754af',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20230918',\n",
       "  'product_id': '72078-035_c10cf43f-066a-43ff-9166-242cbb7754af',\n",
       "  'application_number': 'NDA020630',\n",
       "  'brand_name_base': 'Ultiva',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '72078-065',\n",
       "  'generic_name': 'Vancomycin Hydrochloride',\n",
       "  'labeler_name': 'Mylan Institutional LLC',\n",
       "  'brand_name': 'Vancomycin Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'VANCOMYCIN HYDROCHLORIDE',\n",
       "    'strength': '1.75 g/35mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72078-065-99',\n",
       "    'description': '10 VIAL, SINGLE-DOSE in 1 CARTON (72078-065-99)  / 50 mL in 1 VIAL, SINGLE-DOSE',\n",
       "    'marketing_start_date': '20240723',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Mylan Institutional LLC'],\n",
       "   'rxcui': ['2688632', '2688634'],\n",
       "   'spl_set_id': ['40a88420-5fcb-4715-abc5-595a18fd08d0'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372078065503', '0372078066500'],\n",
       "   'unii': ['71WO621TJD']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION',\n",
       "  'spl_id': '40a88420-5fcb-4715-abc5-595a18fd08d0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20240723',\n",
       "  'product_id': '72078-065_40a88420-5fcb-4715-abc5-595a18fd08d0',\n",
       "  'application_number': 'NDA209481',\n",
       "  'brand_name_base': 'Vancomycin Hydrochloride',\n",
       "  'pharm_class': ['Glycopeptide Antibacterial [EPC]', 'Glycopeptides [CS]']},\n",
       " {'product_ndc': '72086-010',\n",
       "  'generic_name': 'LANOLIN, PETROLATUM',\n",
       "  'labeler_name': 'Apipharma d.o.o',\n",
       "  'brand_name': 'Hemopropin Hemorrhoidal',\n",
       "  'active_ingredients': [{'name': 'LANOLIN', 'strength': '17.76 g/100g'},\n",
       "   {'name': 'PETROLATUM', 'strength': '71.2 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72086-010-00',\n",
       "    'description': '1 TUBE in 1 BOX (72086-010-00)  / 20 g in 1 TUBE',\n",
       "    'marketing_start_date': '20180701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Apipharma d.o.o'],\n",
       "   'rxcui': ['2048952'],\n",
       "   'spl_set_id': ['a90725fd-e203-48ca-a159-ce105ef72f66'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['3858882101318'],\n",
       "   'unii': ['7EV65EAW6H', '4T6H12BN9U']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': '086354ef-915b-ef86-e063-6294a90a3ecd',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180701',\n",
       "  'product_id': '72086-010_086354ef-915b-ef86-e063-6294a90a3ecd',\n",
       "  'application_number': 'M015',\n",
       "  'brand_name_base': 'Hemopropin Hemorrhoidal'},\n",
       " {'product_ndc': '0065-1432',\n",
       "  'generic_name': 'polyethylene glycol 400 and propylene glycol',\n",
       "  'labeler_name': 'Alcon Laboratories, Inc.',\n",
       "  'brand_name': 'Systane ULTRA',\n",
       "  'brand_name_suffix': 'ULTRA',\n",
       "  'active_ingredients': [{'name': 'POLYETHYLENE GLYCOL 400',\n",
       "    'strength': '4 mg/mL'},\n",
       "   {'name': 'PROPYLENE GLYCOL', 'strength': '3 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0065-1432-04',\n",
       "    'description': '5 VIAL in 1 CARTON (0065-1432-04)  / .7 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20090727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0065-1432-05',\n",
       "    'description': '60 VIAL in 1 CARTON (0065-1432-05)  / .7 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20090727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0065-1432-06',\n",
       "    'description': '25 VIAL in 1 CARTON (0065-1432-06)  / .7 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20090727',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Alcon Laboratories, Inc.'],\n",
       "   'rxcui': ['477589'],\n",
       "   'spl_set_id': ['a5c1c194-3db5-4f18-9cd1-97f7f84c3cff'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['B697894SGQ', '6DC9Q167V3']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOLUTION/ DROPS',\n",
       "  'spl_id': 'cce3e663-58ef-4ece-a6d2-c49ecc7ea9cb',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20090727',\n",
       "  'product_id': '0065-1432_cce3e663-58ef-4ece-a6d2-c49ecc7ea9cb',\n",
       "  'application_number': 'M018',\n",
       "  'brand_name_base': 'Systane'},\n",
       " {'product_ndc': '72090-008',\n",
       "  'generic_name': 'ACETAMINOPHEN',\n",
       "  'labeler_name': 'Pioneer Life Sciences, LLC',\n",
       "  'brand_name': 'ACETAMINOPHEN 500 MG',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72090-008-30',\n",
       "    'description': '300 TABLET in 1 BOTTLE (72090-008-30)',\n",
       "    'marketing_start_date': '20230511',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Pioneer Life Sciences, LLC'],\n",
       "   'rxcui': ['198440'],\n",
       "   'spl_set_id': ['11e6ec2a-5171-4496-a15f-6ff744bd1f2f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['362O9ITL9D']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'bab336df-6e26-44d5-8f0a-aa433cd6c3d1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230511',\n",
       "  'product_id': '72090-008_bab336df-6e26-44d5-8f0a-aa433cd6c3d1',\n",
       "  'application_number': 'M013',\n",
       "  'brand_name_base': 'ACETAMINOPHEN 500 MG'},\n",
       " {'product_ndc': '72090-010',\n",
       "  'generic_name': 'FEXOFENADINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Pioneer Life Sciences, LLC',\n",
       "  'brand_name': 'FEXOFENADINE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'FEXOFENADINE HYDROCHLORIDE',\n",
       "    'strength': '180 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72090-010-02',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72090-010-02)',\n",
       "    'marketing_start_date': '20241029',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72090-010-03',\n",
       "    'description': '50 TABLET in 1 BOTTLE (72090-010-03)',\n",
       "    'marketing_start_date': '20241003',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72090-010-04',\n",
       "    'description': '150 TABLET in 1 BOTTLE (72090-010-04)',\n",
       "    'marketing_start_date': '20241003',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Pioneer Life Sciences, LLC'],\n",
       "   'rxcui': ['997420'],\n",
       "   'spl_set_id': ['0a4f4178-bea5-4995-99dc-96980cccdc8a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372090002999', '0372090002968'],\n",
       "   'unii': ['2S068B75ZU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '9b744eda-9e25-46f7-9431-ae2711592a8d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20241003',\n",
       "  'product_id': '72090-010_9b744eda-9e25-46f7-9431-ae2711592a8d',\n",
       "  'application_number': 'ANDA210137',\n",
       "  'brand_name_base': 'FEXOFENADINE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72090-023',\n",
       "  'generic_name': 'Diphenhydramine Hydrochloride',\n",
       "  'labeler_name': 'PIONEER LIFE SCIENCES, LLC',\n",
       "  'brand_name': 'SleepAid Softgels',\n",
       "  'active_ingredients': [{'name': 'DIPHENHYDRAMINE HYDROCHLORIDE',\n",
       "    'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72090-023-01',\n",
       "    'description': '180 CAPSULE, LIQUID FILLED in 1 BOTTLE (72090-023-01)',\n",
       "    'marketing_start_date': '20240425',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PIONEER LIFE SCIENCES, LLC'],\n",
       "   'rxcui': ['1020477'],\n",
       "   'spl_set_id': ['9d6b5ec1-3aa4-4a19-936e-c44b04b2f3fa'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['TC2D6JAD40']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CAPSULE, LIQUID FILLED',\n",
       "  'spl_id': 'beb4f62f-7197-4a97-bcf1-601c9edb3432',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240425',\n",
       "  'product_id': '72090-023_beb4f62f-7197-4a97-bcf1-601c9edb3432',\n",
       "  'application_number': 'M010',\n",
       "  'brand_name_base': 'SleepAid Softgels',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72090-027',\n",
       "  'generic_name': 'Dextromethorphan HBr 20mg Guaifenesin 400mg',\n",
       "  'labeler_name': 'Pioneer Life Sciences, LLC',\n",
       "  'brand_name': 'Mucus Relief DM',\n",
       "  'active_ingredients': [{'name': 'DEXTROMETHORPHAN HYDROBROMIDE',\n",
       "    'strength': '20 mg/1'},\n",
       "   {'name': 'GUAIFENESIN', 'strength': '400 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72090-027-01',\n",
       "    'description': '150 TABLET in 1 BOTTLE (72090-027-01)',\n",
       "    'marketing_start_date': '20241004',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Pioneer Life Sciences, LLC'],\n",
       "   'rxcui': ['1147685'],\n",
       "   'spl_set_id': ['3ce0f096-906e-47eb-8061-0ac1e9d8ea55'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372090001640'],\n",
       "   'nui': ['N0000193956', 'N0000008867', 'N0000009560'],\n",
       "   'pharm_class_epc': ['Expectorant [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "    'Increased Respiratory Secretions [PE]'],\n",
       "   'unii': ['9D2RTI9KYH', '495W7451VQ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'f9a8bdfe-5b3b-4451-881c-a4808aa260b4',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20241004',\n",
       "  'product_id': '72090-027_f9a8bdfe-5b3b-4451-881c-a4808aa260b4',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'Mucus Relief DM',\n",
       "  'pharm_class': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "   'Expectorant [EPC]',\n",
       "   'Increased Respiratory Secretions [PE]',\n",
       "   'Sigma-1 Agonist [EPC]',\n",
       "   'Sigma-1 Receptor Agonists [MoA]',\n",
       "   'Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]',\n",
       "   'Uncompetitive NMDA Receptor Antagonists [MoA]']},\n",
       " {'product_ndc': '72119-003',\n",
       "  'generic_name': 'Alcohol',\n",
       "  'labeler_name': 'BLUE SEA AEROSOL & DAILY CARE CO., LTD',\n",
       "  'brand_name': 'BLUESEA INSTANT HAND SANITIZER',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '70 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72119-003-01',\n",
       "    'description': '60 mL in 1 BOTTLE (72119-003-01)',\n",
       "    'marketing_start_date': '20200608',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72119-003-02',\n",
       "    'description': '100 mL in 1 BOTTLE (72119-003-02)',\n",
       "    'marketing_start_date': '20200608',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72119-003-03',\n",
       "    'description': '237 mL in 1 BOTTLE (72119-003-03)',\n",
       "    'marketing_start_date': '20200608',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72119-003-04',\n",
       "    'description': '300 mL in 1 BOTTLE (72119-003-04)',\n",
       "    'marketing_start_date': '20200608',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72119-003-05',\n",
       "    'description': '500 mL in 1 BOTTLE (72119-003-05)',\n",
       "    'marketing_start_date': '20200608',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['BLUE SEA AEROSOL & DAILY CARE CO., LTD'],\n",
       "   'rxcui': ['582753'],\n",
       "   'spl_set_id': ['e6b5ce49-d6d6-4b24-8b40-bfb1fb7005bd'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '289f17c4-dca7-a52e-e063-6394a90a41b0',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200608',\n",
       "  'product_id': '72119-003_289f17c4-dca7-a52e-e063-6394a90a41b0',\n",
       "  'application_number': 'M005',\n",
       "  'brand_name_base': 'BLUESEA INSTANT HAND SANITIZER'},\n",
       " {'product_ndc': '72119-006',\n",
       "  'generic_name': 'Aluminum Chlorohydrate',\n",
       "  'labeler_name': 'BLUE SEA AEROSOL & DAILY CARE CO., LTD.',\n",
       "  'brand_name': 'Dry Original Fresh 3.5oz',\n",
       "  'active_ingredients': [{'name': 'ALUMINUM CHLOROHYDRATE',\n",
       "    'strength': '20.2 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72119-006-01',\n",
       "    'description': '99 g in 1 CAN (72119-006-01)',\n",
       "    'marketing_start_date': '20231213',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['BLUE SEA AEROSOL & DAILY CARE CO., LTD.'],\n",
       "   'spl_set_id': ['0c5f5bd8-6fa0-bb44-e063-6294a90ae830'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['HPN8MZW13M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'AEROSOL, SPRAY',\n",
       "  'spl_id': '0c5f5bd8-6fa1-bb44-e063-6294a90ae830',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20231213',\n",
       "  'product_id': '72119-006_0c5f5bd8-6fa1-bb44-e063-6294a90ae830',\n",
       "  'application_number': 'M019',\n",
       "  'brand_name_base': 'Dry Original Fresh 3.5oz'},\n",
       " {'product_ndc': '72119-008',\n",
       "  'generic_name': 'Aluminum Chlorohydrate',\n",
       "  'labeler_name': 'BLUE SEA AEROSOL & DAILY CARE CO., LTD',\n",
       "  'brand_name': 'Dry Orignal Fresh 3.5oz',\n",
       "  'active_ingredients': [{'name': 'ALUMINUM CHLOROHYDRATE',\n",
       "    'strength': '20.2 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72119-008-01',\n",
       "    'description': '99 g in 1 CAN (72119-008-01)',\n",
       "    'marketing_start_date': '20231212',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['BLUE SEA AEROSOL & DAILY CARE CO., LTD'],\n",
       "   'spl_set_id': ['0c726342-1a74-cfa0-e063-6294a90a2885'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0849607074706'],\n",
       "   'unii': ['HPN8MZW13M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'AEROSOL, SPRAY',\n",
       "  'spl_id': '0c729c2b-47c5-09d9-e063-6294a90afb01',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20231212',\n",
       "  'product_id': '72119-008_0c729c2b-47c5-09d9-e063-6294a90afb01',\n",
       "  'application_number': 'M019',\n",
       "  'brand_name_base': 'Dry Orignal Fresh 3.5oz'},\n",
       " {'product_ndc': '72146-028',\n",
       "  'generic_name': 'BENZALKONIUM CHLORIDE',\n",
       "  'labeler_name': 'TARGET PRICE, INC',\n",
       "  'brand_name': 'GLOBAL CARE ANTIBACTERIAL HAND CUCUMBER MELON',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '.13 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72146-028-01',\n",
       "    'description': '221 mL in 1 BOTTLE, PUMP (72146-028-01)',\n",
       "    'marketing_start_date': '20200801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['TARGET PRICE, INC'],\n",
       "   'rxcui': ['1046593'],\n",
       "   'spl_set_id': ['aeca6aae-23b5-7df5-e053-2995a90acedb'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0870373013071'],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'bba7da88-9fed-6270-e053-2a95a90a4fe3',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200801',\n",
       "  'product_id': '72146-028_bba7da88-9fed-6270-e053-2a95a90a4fe3',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'GLOBAL CARE ANTIBACTERIAL HAND CUCUMBER MELON'},\n",
       " {'product_ndc': '72162-1076',\n",
       "  'generic_name': 'POTASSIUM CHLORIDE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'POTASSIUM CHLORIDE',\n",
       "  'active_ingredients': [{'name': 'POTASSIUM CHLORIDE',\n",
       "    'strength': '600 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1076-1',\n",
       "    'description': '100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72162-1076-1)',\n",
       "    'marketing_start_date': '20240405',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1076-2',\n",
       "    'description': '90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72162-1076-2)',\n",
       "    'marketing_start_date': '20240405',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1076-3',\n",
       "    'description': '360 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72162-1076-3)',\n",
       "    'marketing_start_date': '20240405',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['315183'],\n",
       "   'spl_set_id': ['65e30d1a-50e9-4b84-ad4d-daaea91eab4b'],\n",
       "   'unii': ['660YQ98I10']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, EXTENDED RELEASE',\n",
       "  'spl_id': 'ede9d98b-a627-4a32-80fe-11769d5f945a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200102',\n",
       "  'product_id': '72162-1076_ede9d98b-a627-4a32-80fe-11769d5f945a',\n",
       "  'application_number': 'ANDA208864',\n",
       "  'brand_name_base': 'POTASSIUM CHLORIDE',\n",
       "  'pharm_class': ['Increased Large Intestinal Motility [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Potassium Compounds [CS]',\n",
       "   'Potassium Salt [EPC]']},\n",
       " {'product_ndc': '0536-1248',\n",
       "  'generic_name': 'Docusate Sodium 50 mg and Sennosides 8.6 mg',\n",
       "  'labeler_name': 'RUGBY LABORATORIES',\n",
       "  'brand_name': 'Stimulant Laxative Plus Stool Softener',\n",
       "  'active_ingredients': [{'name': 'DOCUSATE SODIUM', 'strength': '50 mg/1'},\n",
       "   {'name': 'SENNOSIDES', 'strength': '8.6 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1248-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0536-1248-01)',\n",
       "    'marketing_start_date': '20191022',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0536-1248-10',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0536-1248-10)',\n",
       "    'marketing_start_date': '20191022',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['RUGBY LABORATORIES'],\n",
       "   'rxcui': ['998740'],\n",
       "   'spl_set_id': ['f5afd8eb-d35d-44ab-897d-1d41c98ca138'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F05Q2T2JA0', '3FYP5M0IJX']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '46553c5e-85d5-491a-8e23-0cd9b7451bb8',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20191022',\n",
       "  'product_id': '0536-1248_46553c5e-85d5-491a-8e23-0cd9b7451bb8',\n",
       "  'application_number': 'part334',\n",
       "  'brand_name_base': 'Stimulant Laxative Plus Stool Softener'},\n",
       " {'product_ndc': '72162-1083',\n",
       "  'generic_name': 'Metaxalone',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Metaxalone',\n",
       "  'active_ingredients': [{'name': 'METAXALONE', 'strength': '800 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1083-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1083-1)',\n",
       "    'marketing_start_date': '20241113',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['351254'],\n",
       "   'spl_set_id': ['a12304b7-6477-4518-8db5-898879c62caf'],\n",
       "   'nui': ['N0000175730', 'N0000175737'],\n",
       "   'pharm_class_pe': ['Centrally-mediated Muscle Relaxation [PE]'],\n",
       "   'pharm_class_epc': ['Muscle Relaxant [EPC]'],\n",
       "   'unii': ['1NMA9J598Y']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'd6b5c3d1-07f5-48a7-b942-ae3895d65986',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20161122',\n",
       "  'product_id': '72162-1083_d6b5c3d1-07f5-48a7-b942-ae3895d65986',\n",
       "  'application_number': 'ANDA204770',\n",
       "  'brand_name_base': 'Metaxalone',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '72162-1086',\n",
       "  'generic_name': 'Diclofenac Sodium',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Diclofenac Sodium',\n",
       "  'active_ingredients': [{'name': 'DICLOFENAC SODIUM',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1086-8',\n",
       "    'description': '21 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72162-1086-8)',\n",
       "    'marketing_start_date': '20230508',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['855657'],\n",
       "   'spl_set_id': ['9f7824cf-c0c2-46d9-958e-21fabde0299e'],\n",
       "   'unii': ['QTG126297Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': 'b48907d5-f288-41f3-b160-ed26c05290aa',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20021106',\n",
       "  'product_id': '72162-1086_b48907d5-f288-41f3-b160-ed26c05290aa',\n",
       "  'application_number': 'ANDA076201',\n",
       "  'brand_name_base': 'Diclofenac Sodium',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Decreased Prostaglandin Production [PE]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '0536-1252',\n",
       "  'generic_name': 'Ketotifen Fumarate',\n",
       "  'labeler_name': 'Rugby Laboratories',\n",
       "  'brand_name': 'Ketotifen Fumarate',\n",
       "  'active_ingredients': [{'name': 'KETOTIFEN FUMARATE',\n",
       "    'strength': '.25 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1252-40',\n",
       "    'description': '1 BOTTLE, DROPPER in 1 CARTON (0536-1252-40)  / 5 mL in 1 BOTTLE, DROPPER',\n",
       "    'marketing_start_date': '20200918',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Rugby Laboratories'],\n",
       "   'rxcui': ['311237'],\n",
       "   'spl_set_id': ['8aa81ae9-112a-49fa-a0cb-ed0217a40de5'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305361252403'],\n",
       "   'unii': ['HBD503WORO']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'SOLUTION/ DROPS',\n",
       "  'spl_id': 'd4082ec4-f5c5-4f0d-be97-89f44f6aa52c',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20200918',\n",
       "  'product_id': '0536-1252_d4082ec4-f5c5-4f0d-be97-89f44f6aa52c',\n",
       "  'application_number': 'NDA021996',\n",
       "  'brand_name_base': 'Ketotifen Fumarate',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Inhibitor [EPC]']},\n",
       " {'product_ndc': '72162-1094',\n",
       "  'generic_name': 'Levothyroxine Sodium',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Levothyroxine Sodium',\n",
       "  'active_ingredients': [{'name': 'LEVOTHYROXINE SODIUM',\n",
       "    'strength': '200 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1094-0',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72162-1094-0)',\n",
       "    'marketing_start_date': '20200803',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['892251'],\n",
       "   'spl_set_id': ['0b9d21d8-9b49-4fd2-b516-b25bc6a6b671'],\n",
       "   'unii': ['9J765S329G']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '0b9d21d8-9b49-4fd2-b516-b25bc6a6b671',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200803',\n",
       "  'product_id': '72162-1094_0b9d21d8-9b49-4fd2-b516-b25bc6a6b671',\n",
       "  'application_number': 'NDA021342',\n",
       "  'brand_name_base': 'Levothyroxine Sodium',\n",
       "  'pharm_class': ['Thyroxine [CS]', 'l-Thyroxine [EPC]']},\n",
       " {'product_ndc': '72162-1176',\n",
       "  'generic_name': 'propranolol hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Propranolol Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PROPRANOLOL HYDROCHLORIDE',\n",
       "    'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1176-0',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72162-1176-0)',\n",
       "    'marketing_start_date': '20241004',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1176-1',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72162-1176-1)',\n",
       "    'marketing_start_date': '20241004',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1176-3',\n",
       "    'description': '60 TABLET in 1 BOTTLE (72162-1176-3)',\n",
       "    'marketing_start_date': '20230710',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1176-8',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1176-8)',\n",
       "    'marketing_start_date': '20241004',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['856457'],\n",
       "   'spl_set_id': ['8b3f61f9-2efc-40c1-9c80-11aa145b3484'],\n",
       "   'unii': ['F8A3652H1V']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'cbd04603-1490-42c3-97f6-3fc4ce9aadc9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20100621',\n",
       "  'product_id': '72162-1176_cbd04603-1490-42c3-97f6-3fc4ce9aadc9',\n",
       "  'application_number': 'ANDA070221',\n",
       "  'brand_name_base': 'Propranolol Hydrochloride',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72162-1267',\n",
       "  'generic_name': 'Phenobarbital',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Phenobarbital',\n",
       "  'active_ingredients': [{'name': 'PHENOBARBITAL', 'strength': '16.2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1267-0',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72162-1267-0)',\n",
       "    'marketing_start_date': '20231006',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1267-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1267-1)',\n",
       "    'marketing_start_date': '20231006',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198086'],\n",
       "   'spl_set_id': ['2c238b77-6806-44af-9a66-fd871eaddfc0'],\n",
       "   'unii': ['YQE403BP4D']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '7c1c85c9-6581-42f8-8e33-2cc4722934a7',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201101',\n",
       "  'product_id': '72162-1267_7c1c85c9-6581-42f8-8e33-2cc4722934a7',\n",
       "  'brand_name_base': 'Phenobarbital'},\n",
       " {'product_ndc': '72162-1273',\n",
       "  'generic_name': 'Clobetasol Propionate Ointment USP, 0.05%',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Clobetasol Propionate',\n",
       "  'active_ingredients': [{'name': 'CLOBETASOL PROPIONATE',\n",
       "    'strength': '.5 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1273-2',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1273-2)  / 45 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230926',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1273-3',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1273-3)  / 30 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230926',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1273-4',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1273-4)  / 15 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230926',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1273-6',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1273-6)  / 60 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230926',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['861448'],\n",
       "   'spl_set_id': ['60f65ee3-b972-4e58-97fe-0c0ab14b9b48'],\n",
       "   'unii': ['779619577M']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': 'dc442b04-d693-4c18-94e9-7165d59cb839',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20191118',\n",
       "  'product_id': '72162-1273_dc442b04-d693-4c18-94e9-7165d59cb839',\n",
       "  'application_number': 'ANDA211295',\n",
       "  'brand_name_base': 'Clobetasol Propionate',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72162-1275',\n",
       "  'generic_name': 'Nystatin and Triamcinolone Acetonide',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Nystatin and Triamcinolone Acetonide',\n",
       "  'active_ingredients': [{'name': 'NYSTATIN', 'strength': \"100000 [USP'U]/g\"},\n",
       "   {'name': 'TRIAMCINOLONE ACETONIDE', 'strength': '1 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1275-2',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1275-2)  / 15 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230926',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1275-3',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1275-3)  / 30 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230926',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1275-6',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1275-6)  / 60 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230926',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1053697'],\n",
       "   'spl_set_id': ['ec28a12b-96f8-44ff-a440-8cff34ac2095'],\n",
       "   'nui': ['N0000175498', 'M0017172', 'N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Polyene Antifungal [EPC]', 'Corticosteroid [EPC]'],\n",
       "   'pharm_class_cs': ['Polyenes [CS]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['BDF1O1C72E', 'F446C597KA']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': '4a91b2a9-37da-4e28-bd32-10d414ea3241',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190928',\n",
       "  'product_id': '72162-1275_4a91b2a9-37da-4e28-bd32-10d414ea3241',\n",
       "  'application_number': 'ANDA207741',\n",
       "  'brand_name_base': 'Nystatin and Triamcinolone Acetonide',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]',\n",
       "   'Polyene Antifungal [EPC]',\n",
       "   'Polyenes [CS]']},\n",
       " {'product_ndc': '72162-1316',\n",
       "  'generic_name': 'Benzonatate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Benzonatate',\n",
       "  'active_ingredients': [{'name': 'BENZONATATE', 'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1316-1',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (72162-1316-1)',\n",
       "    'marketing_start_date': '20230829',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['283417'],\n",
       "   'spl_set_id': ['da093b5e-83a7-467e-9716-bc5827a18c20'],\n",
       "   'nui': ['N0000009010', 'N0000175796'],\n",
       "   'pharm_class_pe': ['Decreased Tracheobronchial Stretch Receptor Activity [PE]'],\n",
       "   'pharm_class_epc': ['Non-narcotic Antitussive [EPC]'],\n",
       "   'unii': ['5P4DHS6ENR']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '01c4f415-1f2d-413b-8696-85aec7791fac',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190222',\n",
       "  'product_id': '72162-1316_01c4f415-1f2d-413b-8696-85aec7791fac',\n",
       "  'application_number': 'ANDA211518',\n",
       "  'brand_name_base': 'Benzonatate',\n",
       "  'pharm_class': ['Decreased Tracheobronchial Stretch Receptor Activity [PE]',\n",
       "   'Non-narcotic Antitussive [EPC]']},\n",
       " {'product_ndc': '72162-1337',\n",
       "  'generic_name': 'Oxycodone Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Oxycodone Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'OXYCODONE HYDROCHLORIDE',\n",
       "    'strength': '30 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1337-3',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72162-1337-3)',\n",
       "    'marketing_start_date': '20240408',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1337-6',\n",
       "    'description': '60 TABLET in 1 BOTTLE (72162-1337-6)',\n",
       "    'marketing_start_date': '20240408',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1337-9',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72162-1337-9)',\n",
       "    'marketing_start_date': '20240408',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1049618'],\n",
       "   'spl_set_id': ['22f9eeaa-8aad-44f6-8258-e41edb60f876'],\n",
       "   'unii': ['C1ENJ2TE6C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '10c5dede-e7d3-48aa-a9e7-2c7e0d07a20c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20140908',\n",
       "  'product_id': '72162-1337_10c5dede-e7d3-48aa-a9e7-2c7e0d07a20c',\n",
       "  'application_number': 'ANDA091490',\n",
       "  'brand_name_base': 'Oxycodone Hydrochloride',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '72162-1360',\n",
       "  'generic_name': 'furosemide',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Furosemide',\n",
       "  'active_ingredients': [{'name': 'FUROSEMIDE', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1360-0',\n",
       "    'description': '1000 TABLET in 1 BOTTLE, PLASTIC (72162-1360-0)',\n",
       "    'marketing_start_date': '20240202',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1360-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE, PLASTIC (72162-1360-1)',\n",
       "    'marketing_start_date': '20240202',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['310429'],\n",
       "   'spl_set_id': ['d07ff11c-c1ab-41e6-a455-f2b89340106e'],\n",
       "   'nui': ['N0000175366', 'N0000175590'],\n",
       "   'pharm_class_pe': ['Increased Diuresis at Loop of Henle [PE]'],\n",
       "   'pharm_class_epc': ['Loop Diuretic [EPC]'],\n",
       "   'unii': ['7LXU5N7ZO5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '22202f87-ad58-420f-a081-22d646c8e7a8',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20040326',\n",
       "  'product_id': '72162-1360_22202f87-ad58-420f-a081-22d646c8e7a8',\n",
       "  'application_number': 'ANDA076796',\n",
       "  'brand_name_base': 'Furosemide',\n",
       "  'pharm_class': ['Increased Diuresis at Loop of Henle [PE]',\n",
       "   'Loop Diuretic [EPC]']},\n",
       " {'product_ndc': '0536-1268',\n",
       "  'generic_name': 'Camphor, Menthol',\n",
       "  'labeler_name': 'RUGBY LABORATORIES',\n",
       "  'brand_name': 'Rugby Anti-Itch',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (SYNTHETIC)',\n",
       "    'strength': '.5 g/100g'},\n",
       "   {'name': 'MENTHOL', 'strength': '.5 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1268-12',\n",
       "    'description': '212 g in 1 BOTTLE, PUMP (0536-1268-12)',\n",
       "    'marketing_start_date': '20191220',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['RUGBY LABORATORIES'],\n",
       "   'rxcui': ['200176'],\n",
       "   'spl_set_id': ['99d8ad9e-46ec-15fc-e053-2995a90a0d17'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['5TJD82A1ET', 'L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '99d8a53f-8b88-033d-e053-2995a90ad4b0',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20191216',\n",
       "  'product_id': '0536-1268_99d8a53f-8b88-033d-e053-2995a90ad4b0',\n",
       "  'application_number': 'part348',\n",
       "  'brand_name_base': 'Rugby Anti-Itch'},\n",
       " {'product_ndc': '72162-1363',\n",
       "  'generic_name': 'Methocarbamol',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Methocarbamol',\n",
       "  'active_ingredients': [{'name': 'METHOCARBAMOL', 'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1363-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1363-1)',\n",
       "    'marketing_start_date': '20240205',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1363-5',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72162-1363-5)',\n",
       "    'marketing_start_date': '20240205',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197943'],\n",
       "   'spl_set_id': ['8cf27774-82ed-4ed1-a55d-41bf476745db'],\n",
       "   'nui': ['N0000175730', 'N0000175737'],\n",
       "   'pharm_class_pe': ['Centrally-mediated Muscle Relaxation [PE]'],\n",
       "   'pharm_class_epc': ['Muscle Relaxant [EPC]'],\n",
       "   'unii': ['125OD7737X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '51c6c6b0-3cfb-445a-bde4-0fedf48c18b3',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171215',\n",
       "  'product_id': '72162-1363_51c6c6b0-3cfb-445a-bde4-0fedf48c18b3',\n",
       "  'application_number': 'ANDA086989',\n",
       "  'brand_name_base': 'Methocarbamol',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '72162-1382',\n",
       "  'generic_name': 'Hydrocortisone',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Hydrocortisone',\n",
       "  'active_ingredients': [{'name': 'HYDROCORTISONE', 'strength': '25 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1382-2',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1382-2)  / 28 g in 1 TUBE',\n",
       "    'marketing_start_date': '20240312',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1382-4',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1382-4)  / 20 g in 1 TUBE',\n",
       "    'marketing_start_date': '20240312',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['310891'],\n",
       "   'spl_set_id': ['2352bb58-a624-4c5e-8966-f68817c30470'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['WI4X0X7BPJ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '9660d0c5-90f7-44dc-9328-e7e434be3a57',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20060331',\n",
       "  'product_id': '72162-1382_9660d0c5-90f7-44dc-9328-e7e434be3a57',\n",
       "  'application_number': 'ANDA085025',\n",
       "  'brand_name_base': 'Hydrocortisone',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72162-1388',\n",
       "  'generic_name': 'azelastine hydrochloride, fluticasone propionate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE',\n",
       "  'active_ingredients': [{'name': 'AZELASTINE HYDROCHLORIDE',\n",
       "    'strength': '137 ug/1'},\n",
       "   {'name': 'FLUTICASONE PROPIONATE', 'strength': '50 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1388-2',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72162-1388-2)  / 120 SPRAY, METERED in 1 BOTTLE',\n",
       "    'marketing_start_date': '20240208',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1797847'],\n",
       "   'spl_set_id': ['e95227ff-5747-4a35-a1b8-b1019fe1e61c'],\n",
       "   'unii': ['0L591QR10I', 'O2GMZ0LF5W']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SPRAY, METERED',\n",
       "  'spl_id': '111448bd-70c3-43e7-b280-aa5e631708d5',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['NASAL'],\n",
       "  'marketing_start_date': '20210301',\n",
       "  'product_id': '72162-1388_111448bd-70c3-43e7-b280-aa5e631708d5',\n",
       "  'application_number': 'ANDA208111',\n",
       "  'brand_name_base': 'AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]',\n",
       "   'Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72162-1396',\n",
       "  'generic_name': 'Halobetasol Propionate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Halobetasol Propionate',\n",
       "  'active_ingredients': [{'name': 'HALOBETASOL PROPIONATE',\n",
       "    'strength': '.5 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1396-2',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1396-2)  / 15 g in 1 TUBE',\n",
       "    'marketing_start_date': '20240311',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1396-4',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1396-4)  / 50 g in 1 TUBE',\n",
       "    'marketing_start_date': '20240311',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['977978'],\n",
       "   'spl_set_id': ['be683823-9c07-498c-8357-71cbb3a3964c'],\n",
       "   'unii': ['91A0K1TY3Z']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': 'cc8e6b0e-a56b-4523-9876-fba77118cd1b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20090205',\n",
       "  'product_id': '72162-1396_cc8e6b0e-a56b-4523-9876-fba77118cd1b',\n",
       "  'application_number': 'ANDA076872',\n",
       "  'brand_name_base': 'Halobetasol Propionate',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72162-1421',\n",
       "  'generic_name': 'testosterone',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CIII',\n",
       "  'brand_name': 'testosterone',\n",
       "  'active_ingredients': [{'name': 'TESTOSTERONE', 'strength': '30 mg/1.5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1421-2',\n",
       "    'description': '1 BOTTLE, PUMP in 1 CARTON (72162-1421-2)  / 110 mL in 1 BOTTLE, PUMP',\n",
       "    'marketing_start_date': '20240111',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1599949'],\n",
       "   'spl_set_id': ['5be74193-de73-436d-a9a1-35a857bc8e0c'],\n",
       "   'nui': ['N0000175824', 'N0000000146', 'M0001109'],\n",
       "   'pharm_class_epc': ['Androgen [EPC]'],\n",
       "   'pharm_class_moa': ['Androgen Receptor Agonists [MoA]'],\n",
       "   'pharm_class_cs': ['Androstanes [CS]'],\n",
       "   'unii': ['3XMK78S47O']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '78ca5df2-0a66-41fe-9f28-4ba270cfce81',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20170628',\n",
       "  'product_id': '72162-1421_78ca5df2-0a66-41fe-9f28-4ba270cfce81',\n",
       "  'application_number': 'ANDA204255',\n",
       "  'brand_name_base': 'testosterone',\n",
       "  'pharm_class': ['Androgen Receptor Agonists [MoA]',\n",
       "   'Androgen [EPC]',\n",
       "   'Androstanes [CS]']},\n",
       " {'product_ndc': '0536-1277',\n",
       "  'generic_name': 'HYDROCORTISONE',\n",
       "  'labeler_name': 'RUGBY',\n",
       "  'brand_name': 'RUGBY HYDROCORTISONE WITH ALOE',\n",
       "  'active_ingredients': [{'name': 'HYDROCORTISONE', 'strength': '.01 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1277-80',\n",
       "    'description': '1 TUBE in 1 CARTON (0536-1277-80)  / 28 g in 1 TUBE',\n",
       "    'marketing_start_date': '20200114',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['RUGBY'],\n",
       "   'rxcui': ['106258'],\n",
       "   'spl_set_id': ['796e792b-20c4-4a43-b7a2-55d31ee04092'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['WI4X0X7BPJ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '8f428539-3797-4a6a-8a11-d6f26a2019dc',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200114',\n",
       "  'product_id': '0536-1277_8f428539-3797-4a6a-8a11-d6f26a2019dc',\n",
       "  'application_number': 'part348',\n",
       "  'brand_name_base': 'RUGBY HYDROCORTISONE WITH ALOE',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72162-1434',\n",
       "  'generic_name': 'fluocinolone acetonide',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'fluocinolone acetonide',\n",
       "  'active_ingredients': [{'name': 'FLUOCINOLONE ACETONIDE',\n",
       "    'strength': '.01 mg/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1434-2',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72162-1434-2)  / 118.28 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20240312',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'spl_set_id': ['4790bdfa-c964-4c3e-9d01-c2fb23a0172e'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['0CD5FD6S2M']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'OIL',\n",
       "  'spl_id': '82b1df95-c858-4e19-b6d5-08eeb32bf0e2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20170614',\n",
       "  'product_id': '72162-1434_82b1df95-c858-4e19-b6d5-08eeb32bf0e2',\n",
       "  'application_number': 'ANDA202847',\n",
       "  'brand_name_base': 'fluocinolone acetonide',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72162-1444',\n",
       "  'generic_name': 'Erythromycin',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Erythromycin',\n",
       "  'active_ingredients': [{'name': 'ERYTHROMYCIN', 'strength': '20 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1444-3',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1444-3)  / 30 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230816',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1444-6',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1444-6)  / 60 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230816',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['310152'],\n",
       "   'spl_set_id': ['b7d11564-c92d-4eed-bdd9-8fc355e7dfc7'],\n",
       "   'nui': ['N0000009982', 'N0000175877', 'N0000175935', 'M0028311'],\n",
       "   'pharm_class_pe': ['Decreased Sebaceous Gland Activity [PE]'],\n",
       "   'pharm_class_epc': ['Macrolide [EPC]', 'Macrolide Antimicrobial [EPC]'],\n",
       "   'pharm_class_cs': ['Macrolides [CS]'],\n",
       "   'unii': ['63937KV33D']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '04a760c9-4888-4649-8162-9767d06d8a43',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20080612',\n",
       "  'product_id': '72162-1444_04a760c9-4888-4649-8162-9767d06d8a43',\n",
       "  'application_number': 'ANDA063211',\n",
       "  'brand_name_base': 'Erythromycin',\n",
       "  'pharm_class': ['Decreased Sebaceous Gland Activity [PE]',\n",
       "   'Macrolide Antimicrobial [EPC]',\n",
       "   'Macrolide [EPC]',\n",
       "   'Macrolides [CS]']},\n",
       " {'product_ndc': '0065-1502',\n",
       "  'generic_name': 'Polyethylene Glycol 400, Propylene Glycol 0.3%',\n",
       "  'labeler_name': 'Alcon Laboratories, Inc.',\n",
       "  'brand_name': 'Systane Day and Night Value Pack',\n",
       "  'finished': True,\n",
       "  'packaging': [],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Alcon Laboratories, Inc.'],\n",
       "   'rxcui': ['477589', '895753', '1989901'],\n",
       "   'spl_set_id': ['df13ca6f-7ce1-455a-ae13-9bbc5e9d2e07'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': '90134f50-ea64-4651-a2c0-afa48e09f129',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'marketing_start_date': '20171024',\n",
       "  'product_id': '0065-1502_90134f50-ea64-4651-a2c0-afa48e09f129',\n",
       "  'application_number': 'M018',\n",
       "  'brand_name_base': 'Systane Day and Night Value Pack'},\n",
       " {'product_ndc': '72162-1470',\n",
       "  'generic_name': 'ASPIRIN',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'LOW DOSE ASPIRIN',\n",
       "  'active_ingredients': [{'name': 'ASPIRIN', 'strength': '81 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1470-3',\n",
       "    'description': '30 TABLET, COATED in 1 BOTTLE (72162-1470-3)',\n",
       "    'marketing_start_date': '20241018',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['308416'],\n",
       "   'spl_set_id': ['6b4b7f72-dac8-4b59-a58c-7c59d4b1ef32'],\n",
       "   'nui': ['N0000000160',\n",
       "    'N0000008836',\n",
       "    'M0001335',\n",
       "    'N0000175722',\n",
       "    'N0000175578',\n",
       "    'N0000008832'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_pe': ['Decreased Prostaglandin Production [PE]',\n",
       "    'Decreased Platelet Aggregation [PE]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]',\n",
       "    'Platelet Aggregation Inhibitor [EPC]'],\n",
       "   'unii': ['R16CO5Y76E']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '4f4965a7-2367-4246-8de9-8efae65ffc59',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20150619',\n",
       "  'product_id': '72162-1470_4f4965a7-2367-4246-8de9-8efae65ffc59',\n",
       "  'application_number': 'M013',\n",
       "  'brand_name_base': 'LOW DOSE ASPIRIN',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Decreased Platelet Aggregation [PE]',\n",
       "   'Decreased Prostaglandin Production [PE]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]',\n",
       "   'Platelet Aggregation Inhibitor [EPC]']},\n",
       " {'product_ndc': '72162-1477',\n",
       "  'generic_name': 'glycopyrrolate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Glycopyrrolate',\n",
       "  'active_ingredients': [{'name': 'GLYCOPYRROLATE', 'strength': '1 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1477-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1477-1)',\n",
       "    'marketing_start_date': '20241004',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197738'],\n",
       "   'spl_set_id': ['d93a9b2b-708d-4db5-8aae-45fd3a7ca65c'],\n",
       "   'unii': ['V92SO9WP2I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'ed633567-f685-499b-9e0f-58a89e7ce562',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20060926',\n",
       "  'product_id': '72162-1477_ed633567-f685-499b-9e0f-58a89e7ce562',\n",
       "  'application_number': 'ANDA040653',\n",
       "  'brand_name_base': 'Glycopyrrolate',\n",
       "  'pharm_class': ['Anticholinergic [EPC]',\n",
       "   'Cholinergic Antagonists [MoA]',\n",
       "   'Cholinergic Muscarinic Antagonist [EPC]',\n",
       "   'Cholinergic Muscarinic Antagonists [MoA]']},\n",
       " {'product_ndc': '72162-1485',\n",
       "  'generic_name': 'Doxylamine Succinate and Pyridoxine Hydrochloride, Delayed release Tablets 10 mg/10 mg',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Doxylamine Succinate and Pyridoxine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'DOXYLAMINE SUCCINATE',\n",
       "    'strength': '10 mg/1'},\n",
       "   {'name': 'PYRIDOXINE HYDROCHLORIDE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1485-1',\n",
       "    'description': '100 TABLET, DELAYED RELEASE in 1 BOTTLE (72162-1485-1)',\n",
       "    'marketing_start_date': '20230830',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1375948'],\n",
       "   'spl_set_id': ['172f1b4f-4b9f-4ba4-97f6-769cfec6e0d7'],\n",
       "   'unii': ['V9BI9B5YI2', '68Y4CF58BV']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, DELAYED RELEASE',\n",
       "  'spl_id': 'cc985325-f831-4f1a-8111-2ce9fce02a96',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20191219',\n",
       "  'product_id': '72162-1485_cc985325-f831-4f1a-8111-2ce9fce02a96',\n",
       "  'application_number': 'ANDA208518',\n",
       "  'brand_name_base': 'Doxylamine Succinate and Pyridoxine Hydrochloride',\n",
       "  'pharm_class': ['Analogs/Derivatives [Chemical/Ingredient]',\n",
       "   'Antihistamine [EPC]',\n",
       "   'Histamine Receptor Antagonists [MoA]',\n",
       "   'Vitamin B 6 [Chemical/Ingredient]',\n",
       "   'Vitamin B6 Analog [EPC]']},\n",
       " {'product_ndc': '72162-1505',\n",
       "  'generic_name': 'cholestyramine',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Cholestyramine',\n",
       "  'active_ingredients': [{'name': 'CHOLESTYRAMINE', 'strength': '4 g/5g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1505-2',\n",
       "    'description': '210 g in 1 CAN (72162-1505-2)',\n",
       "    'marketing_start_date': '20240315',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1801279'],\n",
       "   'spl_set_id': ['c58d6bd9-0273-4c16-8533-495170413d8c'],\n",
       "   'nui': ['N0000180292', 'N0000175365'],\n",
       "   'pharm_class_epc': ['Bile Acid Sequestrant [EPC]'],\n",
       "   'pharm_class_moa': ['Bile-acid Binding Activity [MoA]'],\n",
       "   'unii': ['4B33BGI082']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'POWDER, FOR SUSPENSION',\n",
       "  'spl_id': 'fa6509db-b5e2-4210-873b-f0ff4ddc010a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20050915',\n",
       "  'product_id': '72162-1505_fa6509db-b5e2-4210-873b-f0ff4ddc010a',\n",
       "  'application_number': 'ANDA077203',\n",
       "  'brand_name_base': 'Cholestyramine',\n",
       "  'pharm_class': ['Bile Acid Sequestrant [EPC]',\n",
       "   'Bile-acid Binding Activity [MoA]']},\n",
       " {'product_ndc': '72162-1506',\n",
       "  'generic_name': 'Fluoxetine',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Fluoxetine',\n",
       "  'active_ingredients': [{'name': 'FLUOXETINE HYDROCHLORIDE',\n",
       "    'strength': '60 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1506-3',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72162-1506-3)',\n",
       "    'marketing_start_date': '20240408',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1190110'],\n",
       "   'spl_set_id': ['dced86a0-fc08-465c-897c-f8899e6206d5'],\n",
       "   'unii': ['I9W7N6B1KJ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'cf0b39d7-583f-43cc-9737-e28c00ff392c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171116',\n",
       "  'product_id': '72162-1506_cf0b39d7-583f-43cc-9737-e28c00ff392c',\n",
       "  'application_number': 'ANDA209419',\n",
       "  'brand_name_base': 'Fluoxetine',\n",
       "  'pharm_class': ['Serotonin Reuptake Inhibitor [EPC]',\n",
       "   'Serotonin Uptake Inhibitors [MoA]']},\n",
       " {'product_ndc': '72162-1510',\n",
       "  'generic_name': 'Candesartan cilexetil',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Candesartan cilexetil',\n",
       "  'active_ingredients': [{'name': 'CANDESARTAN CILEXETIL',\n",
       "    'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1510-9',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72162-1510-9)',\n",
       "    'marketing_start_date': '20230829',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['153822'],\n",
       "   'spl_set_id': ['a096f782-482c-41ef-a72c-58253fc12146'],\n",
       "   'unii': ['R85M2X0D68']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '061d25d1-2ade-44ab-aa27-7cb4c3fab99f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20130521',\n",
       "  'product_id': '72162-1510_061d25d1-2ade-44ab-aa27-7cb4c3fab99f',\n",
       "  'application_number': 'NDA020838',\n",
       "  'brand_name_base': 'Candesartan cilexetil',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]']},\n",
       " {'product_ndc': '72162-1546',\n",
       "  'generic_name': 'PREGABALIN',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CV',\n",
       "  'brand_name': 'Pregabalin',\n",
       "  'active_ingredients': [{'name': 'PREGABALIN', 'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1546-9',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (72162-1546-9)',\n",
       "    'marketing_start_date': '20240812',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['483446'],\n",
       "   'spl_set_id': ['df382975-73f1-4957-8959-177848f796f7'],\n",
       "   'unii': ['55JG375S6M']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '10289a92-4b55-4b22-9e2b-56b6d42d4161',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190719',\n",
       "  'product_id': '72162-1546_10289a92-4b55-4b22-9e2b-56b6d42d4161',\n",
       "  'application_number': 'ANDA208677',\n",
       "  'brand_name_base': 'Pregabalin'},\n",
       " {'product_ndc': '72162-1574',\n",
       "  'generic_name': 'phenobarbital',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Phenobarbital',\n",
       "  'active_ingredients': [{'name': 'PHENOBARBITAL', 'strength': '97.2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1574-0',\n",
       "    'description': '1000 TABLET in 1 BOTTLE, PLASTIC (72162-1574-0)',\n",
       "    'marketing_start_date': '20230913',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1574-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE, PLASTIC (72162-1574-1)',\n",
       "    'marketing_start_date': '20230913',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['199164'],\n",
       "   'spl_set_id': ['7411c46a-a472-4147-b119-3a1db2069dc6'],\n",
       "   'unii': ['YQE403BP4D']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '655af772-ea90-47d5-9ad3-d8dfe08a4974',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20141124',\n",
       "  'product_id': '72162-1574_655af772-ea90-47d5-9ad3-d8dfe08a4974',\n",
       "  'brand_name_base': 'Phenobarbital'},\n",
       " {'product_ndc': '72162-1595',\n",
       "  'generic_name': 'Terbinafine Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Terbinafine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'TERBINAFINE HYDROCHLORIDE',\n",
       "    'strength': '250 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1595-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1595-1)',\n",
       "    'marketing_start_date': '20240207',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['313222'],\n",
       "   'spl_set_id': ['e2ecf7a5-1c84-4977-8a87-d1bfb9658668'],\n",
       "   'unii': ['012C11ZU6G']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'b60519c3-48a2-4f7b-8315-86644b94be2e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20101227',\n",
       "  'product_id': '72162-1595_b60519c3-48a2-4f7b-8315-86644b94be2e',\n",
       "  'application_number': 'ANDA077714',\n",
       "  'brand_name_base': 'Terbinafine Hydrochloride',\n",
       "  'pharm_class': ['Allylamine Antifungal [EPC]', 'Allylamine [CS]']},\n",
       " {'product_ndc': '72162-1599',\n",
       "  'generic_name': 'DULOXETINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Duloxetine Delayed-Release',\n",
       "  'brand_name_suffix': 'Delayed-Release',\n",
       "  'active_ingredients': [{'name': 'DULOXETINE HYDROCHLORIDE',\n",
       "    'strength': '60 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1599-1',\n",
       "    'description': '100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (72162-1599-1)',\n",
       "    'marketing_start_date': '20240205',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1599-9',\n",
       "    'description': '90 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (72162-1599-9)',\n",
       "    'marketing_start_date': '20240205',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['596934'],\n",
       "   'spl_set_id': ['a23e79b3-7bd3-4b83-beb0-dc23d4830e9e'],\n",
       "   'unii': ['9044SC542W']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, DELAYED RELEASE PELLETS',\n",
       "  'spl_id': 'f350d543-666b-4acd-845d-18c26692da18',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20140611',\n",
       "  'product_id': '72162-1599_f350d543-666b-4acd-845d-18c26692da18',\n",
       "  'application_number': 'ANDA203088',\n",
       "  'brand_name_base': 'Duloxetine',\n",
       "  'pharm_class': ['Norepinephrine Uptake Inhibitors [MoA]',\n",
       "   'Serotonin Uptake Inhibitors [MoA]',\n",
       "   'Serotonin and Norepinephrine Reuptake Inhibitor [EPC]']},\n",
       " {'product_ndc': '72162-1600',\n",
       "  'generic_name': 'DULOXETINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Duloxetine Delayed-Release',\n",
       "  'brand_name_suffix': 'Delayed-Release',\n",
       "  'active_ingredients': [{'name': 'DULOXETINE HYDROCHLORIDE',\n",
       "    'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1600-3',\n",
       "    'description': '30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (72162-1600-3)',\n",
       "    'marketing_start_date': '20180521',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['616402'],\n",
       "   'spl_set_id': ['f66f63c8-51db-4183-a452-78205cf3a263'],\n",
       "   'unii': ['9044SC542W']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, DELAYED RELEASE PELLETS',\n",
       "  'spl_id': 'f66f63c8-51db-4183-a452-78205cf3a263',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180521',\n",
       "  'product_id': '72162-1600_f66f63c8-51db-4183-a452-78205cf3a263',\n",
       "  'application_number': 'ANDA203088',\n",
       "  'brand_name_base': 'Duloxetine',\n",
       "  'pharm_class': ['Norepinephrine Uptake Inhibitors [MoA]',\n",
       "   'Serotonin Uptake Inhibitors [MoA]',\n",
       "   'Serotonin and Norepinephrine Reuptake Inhibitor [EPC]']},\n",
       " {'product_ndc': '72162-1624',\n",
       "  'generic_name': 'SPIRONOLACTONE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'SPIRONOLACTONE',\n",
       "  'active_ingredients': [{'name': 'SPIRONOLACTONE', 'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1624-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1624-1)',\n",
       "    'marketing_start_date': '20230602',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1624-3',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72162-1624-3)',\n",
       "    'marketing_start_date': '20230602',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1624-5',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72162-1624-5)',\n",
       "    'marketing_start_date': '20230602',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1624-6',\n",
       "    'description': '60 TABLET in 1 BOTTLE (72162-1624-6)',\n",
       "    'marketing_start_date': '20230602',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1624-9',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72162-1624-9)',\n",
       "    'marketing_start_date': '20230602',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['313096'],\n",
       "   'spl_set_id': ['3791d79c-d960-4790-b689-ea32ddf7226a'],\n",
       "   'nui': ['N0000175557', 'N0000011310'],\n",
       "   'pharm_class_epc': ['Aldosterone Antagonist [EPC]'],\n",
       "   'pharm_class_moa': ['Aldosterone Antagonists [MoA]'],\n",
       "   'unii': ['27O7W4T232']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '86328f22-a0e2-4bec-a8c0-d56a42d30670',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19860723',\n",
       "  'product_id': '72162-1624_86328f22-a0e2-4bec-a8c0-d56a42d30670',\n",
       "  'application_number': 'ANDA089424',\n",
       "  'brand_name_base': 'SPIRONOLACTONE',\n",
       "  'pharm_class': ['Aldosterone Antagonist [EPC]',\n",
       "   'Aldosterone Antagonists [MoA]']},\n",
       " {'product_ndc': '72162-1627',\n",
       "  'generic_name': 'SPIRONOLACTONE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'SPIRONOLACTONE',\n",
       "  'active_ingredients': [{'name': 'SPIRONOLACTONE', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1627-1',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72162-1627-1)',\n",
       "    'marketing_start_date': '20230516',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1627-2',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72162-1627-2)',\n",
       "    'marketing_start_date': '20230516',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1627-3',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72162-1627-3)',\n",
       "    'marketing_start_date': '20230516',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1627-4',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (72162-1627-4)',\n",
       "    'marketing_start_date': '20230516',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1627-5',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (72162-1627-5)',\n",
       "    'marketing_start_date': '20230516',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1627-6',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (72162-1627-6)',\n",
       "    'marketing_start_date': '20230516',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198222'],\n",
       "   'spl_set_id': ['d4cf1136-df3a-4fc2-9a21-9032949eca41'],\n",
       "   'nui': ['N0000175557', 'N0000011310'],\n",
       "   'pharm_class_epc': ['Aldosterone Antagonist [EPC]'],\n",
       "   'pharm_class_moa': ['Aldosterone Antagonists [MoA]'],\n",
       "   'unii': ['27O7W4T232']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '4d692b7f-14f9-4f89-b815-a21a0de97a00',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19860723',\n",
       "  'product_id': '72162-1627_4d692b7f-14f9-4f89-b815-a21a0de97a00',\n",
       "  'application_number': 'ANDA089424',\n",
       "  'brand_name_base': 'SPIRONOLACTONE',\n",
       "  'pharm_class': ['Aldosterone Antagonist [EPC]',\n",
       "   'Aldosterone Antagonists [MoA]']},\n",
       " {'product_ndc': '72162-1675',\n",
       "  'generic_name': 'Labetalol Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Labetalol Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'LABETALOL', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1675-1',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72162-1675-1)',\n",
       "    'marketing_start_date': '20191122',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1675-5',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (72162-1675-5)',\n",
       "    'marketing_start_date': '20191122',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['896758'],\n",
       "   'spl_set_id': ['35e7bce0-d9ff-4f8b-95c5-218da2a2d929'],\n",
       "   'nui': ['N0000000161', 'N0000175556'],\n",
       "   'pharm_class_moa': ['Adrenergic beta-Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['beta-Adrenergic Blocker [EPC]'],\n",
       "   'unii': ['R5H8897N95']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '35e7bce0-d9ff-4f8b-95c5-218da2a2d929',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20191122',\n",
       "  'product_id': '72162-1675_35e7bce0-d9ff-4f8b-95c5-218da2a2d929',\n",
       "  'application_number': 'ANDA075215',\n",
       "  'brand_name_base': 'Labetalol Hydrochloride',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72162-1681',\n",
       "  'generic_name': 'Clonidine Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Clonidine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'CLONIDINE HYDROCHLORIDE',\n",
       "    'strength': '.3 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1681-0',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72162-1681-0)',\n",
       "    'marketing_start_date': '20231003',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1681-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1681-1)',\n",
       "    'marketing_start_date': '20231003',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1681-5',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72162-1681-5)',\n",
       "    'marketing_start_date': '20231003',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['884189'],\n",
       "   'spl_set_id': ['849cafb5-0a98-4434-80bb-b16e7109dd06'],\n",
       "   'unii': ['W76I6XXF06']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'a81f5bc2-a959-40fd-ab09-46dbe5258bad',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200701',\n",
       "  'product_id': '72162-1681_a81f5bc2-a959-40fd-ab09-46dbe5258bad',\n",
       "  'application_number': 'ANDA202297',\n",
       "  'brand_name_base': 'Clonidine Hydrochloride',\n",
       "  'pharm_class': ['Adrenergic alpha2-Agonists [MoA]',\n",
       "   'Central alpha-2 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72162-1690',\n",
       "  'generic_name': 'Meclizine Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'MECLIZINE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'MECLIZINE HYDROCHLORIDE',\n",
       "    'strength': '12.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1690-0',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72162-1690-0)',\n",
       "    'marketing_start_date': '20230912',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['995624'],\n",
       "   'spl_set_id': ['522b55a2-313c-45e8-b1be-07746ada5b0a'],\n",
       "   'unii': ['HDP7W44CIO']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '5d7595a6-9998-4d70-af1b-7f7ca2a67a31',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20100604',\n",
       "  'product_id': '72162-1690_5d7595a6-9998-4d70-af1b-7f7ca2a67a31',\n",
       "  'application_number': 'ANDA040659',\n",
       "  'brand_name_base': 'MECLIZINE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Antiemetic [EPC]', 'Emesis Suppression [PE]']},\n",
       " {'product_ndc': '0536-1303',\n",
       "  'generic_name': 'Simethicone',\n",
       "  'labeler_name': 'RUGBY LABORATORIES',\n",
       "  'brand_name': 'Infants',\n",
       "  'active_ingredients': [{'name': 'DIMETHICONE, UNSPECIFIED',\n",
       "    'strength': '20 mg/.3mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1303-75',\n",
       "    'description': '1 BOTTLE, DROPPER in 1 CARTON (0536-1303-75)  / 30 mL in 1 BOTTLE, DROPPER',\n",
       "    'marketing_start_date': '20200901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['RUGBY LABORATORIES'],\n",
       "   'rxcui': ['198857'],\n",
       "   'spl_set_id': ['c6fa71bc-de48-47f4-80c4-7d92643d2664'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305361303754'],\n",
       "   'unii': ['92RU3N3Y1O']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SUSPENSION/ DROPS',\n",
       "  'spl_id': '8127a100-e644-462a-9fb9-841024a87c9c',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200901',\n",
       "  'product_id': '0536-1303_8127a100-e644-462a-9fb9-841024a87c9c',\n",
       "  'application_number': 'M002',\n",
       "  'brand_name_base': 'Infants',\n",
       "  'pharm_class': ['Skin Barrier Activity [PE]']},\n",
       " {'product_ndc': '72162-1692',\n",
       "  'generic_name': 'Cyclobenzaprine Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Cyclobenzaprine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'CYCLOBENZAPRINE HYDROCHLORIDE',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1692-0',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (72162-1692-0)',\n",
       "    'marketing_start_date': '20240131',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['828320'],\n",
       "   'spl_set_id': ['3f1b9c8a-8f75-4b84-af0c-739815937fd7'],\n",
       "   'unii': ['0VE05JYS2P']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'cef08ee7-2cc7-40cb-9195-d4b974df9dbb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20060404',\n",
       "  'product_id': '72162-1692_cef08ee7-2cc7-40cb-9195-d4b974df9dbb',\n",
       "  'application_number': 'ANDA077563',\n",
       "  'brand_name_base': 'Cyclobenzaprine Hydrochloride',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '72162-1700',\n",
       "  'generic_name': 'losartan potassium and hydrochlorothiazide',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Losartan Potassium and Hydrochlorothiazide',\n",
       "  'active_ingredients': [{'name': 'HYDROCHLOROTHIAZIDE',\n",
       "    'strength': '12.5 mg/1'},\n",
       "   {'name': 'LOSARTAN POTASSIUM', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1700-0',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (72162-1700-0)',\n",
       "    'marketing_start_date': '20240206',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['979464'],\n",
       "   'spl_set_id': ['1d6712a3-bfb3-4081-b8f6-6057eb4baa27'],\n",
       "   'nui': ['N0000175359', 'N0000175419', 'M0471776'],\n",
       "   'pharm_class_pe': ['Increased Diuresis [PE]'],\n",
       "   'pharm_class_epc': ['Thiazide Diuretic [EPC]'],\n",
       "   'pharm_class_cs': ['Thiazides [CS]'],\n",
       "   'unii': ['0J48LPH2TH', '3ST302B24A']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '10601686-e8a2-47d6-9413-bb5862e598f2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20121030',\n",
       "  'product_id': '72162-1700_10601686-e8a2-47d6-9413-bb5862e598f2',\n",
       "  'application_number': 'ANDA201845',\n",
       "  'brand_name_base': 'Losartan Potassium and Hydrochlorothiazide',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]',\n",
       "   'Increased Diuresis [PE]',\n",
       "   'Thiazide Diuretic [EPC]',\n",
       "   'Thiazides [CS]']},\n",
       " {'product_ndc': '72162-1724',\n",
       "  'marketing_end_date': '20261231',\n",
       "  'generic_name': 'acyclovir',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'acyclovir',\n",
       "  'active_ingredients': [{'name': 'ACYCLOVIR', 'strength': '800 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1724-0',\n",
       "    'description': '40 TABLET in 1 BOTTLE (72162-1724-0)',\n",
       "    'marketing_start_date': '20240812',\n",
       "    'marketing_end_date': '20261231',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1724-1',\n",
       "    'description': '21 TABLET in 1 BOTTLE (72162-1724-1)',\n",
       "    'marketing_start_date': '20240812',\n",
       "    'marketing_end_date': '20261231',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1724-2',\n",
       "    'description': '25 TABLET in 1 BOTTLE (72162-1724-2)',\n",
       "    'marketing_start_date': '20240812',\n",
       "    'marketing_end_date': '20261231',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1724-3',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72162-1724-3)',\n",
       "    'marketing_start_date': '20240812',\n",
       "    'marketing_end_date': '20261231',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1724-4',\n",
       "    'description': '35 TABLET in 1 BOTTLE (72162-1724-4)',\n",
       "    'marketing_start_date': '20240812',\n",
       "    'marketing_end_date': '20261231',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1724-5',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72162-1724-5)',\n",
       "    'marketing_start_date': '20240812',\n",
       "    'marketing_end_date': '20261231',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1724-6',\n",
       "    'description': '60 TABLET in 1 BOTTLE (72162-1724-6)',\n",
       "    'marketing_start_date': '20240812',\n",
       "    'marketing_end_date': '20261231',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1724-7',\n",
       "    'description': '50 TABLET in 1 BOTTLE (72162-1724-7)',\n",
       "    'marketing_start_date': '20240812',\n",
       "    'marketing_end_date': '20261231',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1724-8',\n",
       "    'description': '10 TABLET in 1 BOTTLE (72162-1724-8)',\n",
       "    'marketing_start_date': '20240812',\n",
       "    'marketing_end_date': '20261231',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1724-9',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72162-1724-9)',\n",
       "    'marketing_start_date': '20240812',\n",
       "    'marketing_end_date': '20261231',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197313'],\n",
       "   'spl_set_id': ['a7fd298b-3914-4316-8484-2d3ae188221a'],\n",
       "   'nui': ['N0000020060',\n",
       "    'N0000180187',\n",
       "    'N0000180188',\n",
       "    'N0000175468',\n",
       "    'N0000175459'],\n",
       "   'pharm_class_moa': ['DNA Polymerase Inhibitors [MoA]'],\n",
       "   'pharm_class_epc': ['Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "    'Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "    'Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]'],\n",
       "   'unii': ['X4HES1O11F']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'a45392d2-5725-47dc-a6c5-50a98f93031a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20060313',\n",
       "  'product_id': '72162-1724_a45392d2-5725-47dc-a6c5-50a98f93031a',\n",
       "  'application_number': 'ANDA077309',\n",
       "  'brand_name_base': 'acyclovir',\n",
       "  'pharm_class': ['DNA Polymerase Inhibitors [MoA]',\n",
       "   'Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "   'Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "   'Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "   'Nucleoside Analog [EXT]']},\n",
       " {'product_ndc': '72162-1737',\n",
       "  'generic_name': 'Famotidine',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Famotidine',\n",
       "  'active_ingredients': [{'name': 'FAMOTIDINE', 'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1737-0',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72162-1737-0)',\n",
       "    'marketing_start_date': '20240917',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1737-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1737-1)',\n",
       "    'marketing_start_date': '20240917',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['284245'],\n",
       "   'spl_set_id': ['67a6e7f3-04d6-426c-b952-7677a84ace4d'],\n",
       "   'nui': ['N0000000151', 'N0000175784'],\n",
       "   'pharm_class_moa': ['Histamine H2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Histamine-2 Receptor Antagonist [EPC]'],\n",
       "   'unii': ['5QZO15J2Z8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '67a6e7f3-04d6-426c-b952-7677a84ace4d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20010416',\n",
       "  'product_id': '72162-1737_67a6e7f3-04d6-426c-b952-7677a84ace4d',\n",
       "  'application_number': 'ANDA075805',\n",
       "  'brand_name_base': 'Famotidine',\n",
       "  'pharm_class': ['Histamine H2 Receptor Antagonists [MoA]',\n",
       "   'Histamine-2 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72162-1747',\n",
       "  'generic_name': 'Esterified Estrogens and Methyltestosterone',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CIII',\n",
       "  'brand_name': 'Esterified Estrogens and Methyltestosterone',\n",
       "  'active_ingredients': [{'name': 'ESTROGENS, ESTERIFIED',\n",
       "    'strength': '1.25 mg/1'},\n",
       "   {'name': 'METHYLTESTOSTERONE', 'strength': '2.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1747-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1747-1)',\n",
       "    'marketing_start_date': '20230830',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197670'],\n",
       "   'spl_set_id': ['759907a1-2da7-47df-bf7f-e642f60b998f'],\n",
       "   'nui': ['N0000175824', 'N0000000146', 'M0001109'],\n",
       "   'pharm_class_epc': ['Androgen [EPC]'],\n",
       "   'pharm_class_moa': ['Androgen Receptor Agonists [MoA]'],\n",
       "   'pharm_class_cs': ['Androstanes [CS]'],\n",
       "   'unii': ['3ASP8Q3768', 'V9EFU16ZIF']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '467eaca7-2673-41bf-9063-e99432622f68',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20101222',\n",
       "  'product_id': '72162-1747_467eaca7-2673-41bf-9063-e99432622f68',\n",
       "  'brand_name_base': 'Esterified Estrogens and Methyltestosterone',\n",
       "  'pharm_class': ['Androgen Receptor Agonists [MoA]',\n",
       "   'Androgen [EPC]',\n",
       "   'Androstanes [CS]']},\n",
       " {'product_ndc': '0536-1309',\n",
       "  'generic_name': 'Guaifenesin/phenylephrine',\n",
       "  'labeler_name': 'Rugby Laboratories',\n",
       "  'brand_name': 'Rugby Chest Congestion Relief PE',\n",
       "  'brand_name_suffix': 'PE',\n",
       "  'active_ingredients': [{'name': 'GUAIFENESIN', 'strength': '400 mg/1'},\n",
       "   {'name': 'PHENYLEPHRINE HYDROCHLORIDE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1309-07',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (0536-1309-07)  / 30 TABLET in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20200909',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0536-1309-08',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (0536-1309-08)  / 60 TABLET in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20200909',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Rugby Laboratories'],\n",
       "   'rxcui': ['1304111'],\n",
       "   'spl_set_id': ['2fb83580-7fe1-41a5-abf6-0dc25520f260'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305361309084'],\n",
       "   'nui': ['N0000193956', 'N0000008867', 'N0000009560'],\n",
       "   'pharm_class_epc': ['Expectorant [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "    'Increased Respiratory Secretions [PE]'],\n",
       "   'unii': ['495W7451VQ', '04JA59TNSJ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '465a62c5-b8d6-47ee-99b2-aafb23563774',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200909',\n",
       "  'product_id': '0536-1309_465a62c5-b8d6-47ee-99b2-aafb23563774',\n",
       "  'application_number': 'part341',\n",
       "  'brand_name_base': 'Rugby Chest Congestion Relief',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'Decreased Respiratory Secretion Viscosity [PE]',\n",
       "   'Expectorant [EPC]',\n",
       "   'Increased Respiratory Secretions [PE]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72162-1775',\n",
       "  'generic_name': 'Vancomycin Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Vancomycin Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'VANCOMYCIN HYDROCHLORIDE',\n",
       "    'strength': '250 mg/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1775-2',\n",
       "    'description': '150 mL in 1 BOTTLE, PLASTIC (72162-1775-2)',\n",
       "    'marketing_start_date': '20230927',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1775-4',\n",
       "    'description': '300 mL in 1 BOTTLE, PLASTIC (72162-1775-4)',\n",
       "    'marketing_start_date': '20230927',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1775-7',\n",
       "    'description': '80 mL in 1 BOTTLE, PLASTIC (72162-1775-7)',\n",
       "    'marketing_start_date': '20230927',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['2000134'],\n",
       "   'spl_set_id': ['28fe3c01-cf87-41c0-87fd-f93a40524335'],\n",
       "   'unii': ['71WO621TJD']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'POWDER, FOR SOLUTION',\n",
       "  'spl_id': '06df93d3-7d4e-41e0-ae36-d5c667e13c27',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190909',\n",
       "  'product_id': '72162-1775_06df93d3-7d4e-41e0-ae36-d5c667e13c27',\n",
       "  'application_number': 'ANDA061667',\n",
       "  'brand_name_base': 'Vancomycin Hydrochloride',\n",
       "  'pharm_class': ['Glycopeptide Antibacterial [EPC]', 'Glycopeptides [CS]']},\n",
       " {'product_ndc': '72162-1789',\n",
       "  'generic_name': 'morphine sulfate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Morphine sulfate',\n",
       "  'active_ingredients': [{'name': 'MORPHINE SULFATE', 'strength': '15 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1789-1',\n",
       "    'description': '100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72162-1789-1)',\n",
       "    'marketing_start_date': '20120511',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1789-3',\n",
       "    'description': '30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72162-1789-3)',\n",
       "    'marketing_start_date': '20120511',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1789-6',\n",
       "    'description': '60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72162-1789-6)',\n",
       "    'marketing_start_date': '20120511',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1789-9',\n",
       "    'description': '90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72162-1789-9)',\n",
       "    'marketing_start_date': '20120511',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['891881'],\n",
       "   'spl_set_id': ['fb9f929b-8c5a-442b-9695-9d3d45272a5e'],\n",
       "   'unii': ['X3P646A2J0']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED, EXTENDED RELEASE',\n",
       "  'spl_id': 'cb782a20-cb25-4a65-a984-ff428d1898af',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20120511',\n",
       "  'product_id': '72162-1789_cb782a20-cb25-4a65-a984-ff428d1898af',\n",
       "  'application_number': 'ANDA078761',\n",
       "  'brand_name_base': 'Morphine sulfate',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '72162-1802',\n",
       "  'generic_name': 'methimazole',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Methimazole',\n",
       "  'active_ingredients': [{'name': 'METHIMAZOLE', 'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1802-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1802-1)',\n",
       "    'marketing_start_date': '20230330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1802-2',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1802-2)',\n",
       "    'marketing_start_date': '20240618',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1802-5',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72162-1802-5)',\n",
       "    'marketing_start_date': '20230330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1802-9',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72162-1802-9)',\n",
       "    'marketing_start_date': '20240716',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197942'],\n",
       "   'spl_set_id': ['94d2e57b-685f-4cfd-a5a5-129e869c794c'],\n",
       "   'nui': ['N0000175918', 'N0000175917'],\n",
       "   'pharm_class_epc': ['Thyroid Hormone Synthesis Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Thyroid Hormone Synthesis Inhibitors [MoA]'],\n",
       "   'unii': ['554Z48XN5E']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '64edaa8c-1967-4542-b20f-aa3eed18a7e1',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220314',\n",
       "  'product_id': '72162-1802_64edaa8c-1967-4542-b20f-aa3eed18a7e1',\n",
       "  'application_number': 'ANDA040350',\n",
       "  'brand_name_base': 'Methimazole',\n",
       "  'pharm_class': ['Thyroid Hormone Synthesis Inhibitor [EPC]',\n",
       "   'Thyroid Hormone Synthesis Inhibitors [MoA]']},\n",
       " {'product_ndc': '72162-1804',\n",
       "  'marketing_end_date': '20261031',\n",
       "  'generic_name': 'Mesalamine',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Mesalamine',\n",
       "  'active_ingredients': [{'name': 'MESALAMINE', 'strength': '1000 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1804-1',\n",
       "    'description': '5 PACKAGE in 1 CARTON (72162-1804-1)  / 6 SUPPOSITORY in 1 PACKAGE',\n",
       "    'marketing_start_date': '20190605',\n",
       "    'marketing_end_date': '20261031',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['248420'],\n",
       "   'spl_set_id': ['b48df65a-a717-479e-9122-8b0f1406c841'],\n",
       "   'nui': ['N0000175781', 'M0000971'],\n",
       "   'pharm_class_epc': ['Aminosalicylate [EPC]'],\n",
       "   'pharm_class_cs': ['Aminosalicylic Acids [CS]'],\n",
       "   'unii': ['4Q81I59GXC']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SUPPOSITORY',\n",
       "  'spl_id': 'f9f95283-e509-42a4-bcdf-f471c0bac950',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['RECTAL'],\n",
       "  'marketing_start_date': '20190605',\n",
       "  'product_id': '72162-1804_f9f95283-e509-42a4-bcdf-f471c0bac950',\n",
       "  'application_number': 'ANDA207448',\n",
       "  'brand_name_base': 'Mesalamine',\n",
       "  'pharm_class': ['Aminosalicylate [EPC]', 'Aminosalicylic Acids [CS]']},\n",
       " {'product_ndc': '72162-1815',\n",
       "  'generic_name': 'Nitrofurantoin monohydrate/macrocrystals',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Nitrofurantoin (monohydrate/macrocrystals)',\n",
       "  'brand_name_suffix': '(monohydrate/macrocrystals)',\n",
       "  'active_ingredients': [{'name': 'NITROFURANTOIN', 'strength': '25 mg/1'},\n",
       "   {'name': 'NITROFURANTOIN MONOHYDRATE', 'strength': '75 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1815-2',\n",
       "    'description': '20 CAPSULE in 1 BOTTLE (72162-1815-2)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1815-3',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (72162-1815-3)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1815-4',\n",
       "    'description': '14 CAPSULE in 1 BOTTLE (72162-1815-4)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1815-8',\n",
       "    'description': '10 CAPSULE in 1 BOTTLE (72162-1815-8)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1815-9',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (72162-1815-9)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1648755'],\n",
       "   'spl_set_id': ['47b76c41-711d-4ff3-bfe4-314950e4b040'],\n",
       "   'nui': ['N0000175494', 'M0014892'],\n",
       "   'pharm_class_epc': ['Nitrofuran Antibacterial [EPC]'],\n",
       "   'pharm_class_cs': ['Nitrofurans [CS]'],\n",
       "   'unii': ['927AH8112L', 'E1QI2CQQ1I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '47b76c41-711d-4ff3-bfe4-314950e4b040',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170525',\n",
       "  'product_id': '72162-1815_47b76c41-711d-4ff3-bfe4-314950e4b040',\n",
       "  'application_number': 'ANDA207372',\n",
       "  'brand_name_base': 'Nitrofurantoin',\n",
       "  'pharm_class': ['Nitrofuran Antibacterial [EPC]',\n",
       "   'Nitrofuran Antibacterial [EPC]',\n",
       "   'Nitrofurans [CS]',\n",
       "   'Nitrofurans [CS]']},\n",
       " {'product_ndc': '72162-1824',\n",
       "  'generic_name': 'temazepam',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'temazepam',\n",
       "  'active_ingredients': [{'name': 'TEMAZEPAM', 'strength': '15 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1824-1',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (72162-1824-1)',\n",
       "    'marketing_start_date': '20240307',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1824-5',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (72162-1824-5)',\n",
       "    'marketing_start_date': '20240307',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198241'],\n",
       "   'spl_set_id': ['432252c6-648f-4c53-976c-ee271ba435bd'],\n",
       "   'nui': ['N0000175694', 'M0002356'],\n",
       "   'pharm_class_epc': ['Benzodiazepine [EPC]'],\n",
       "   'pharm_class_cs': ['Benzodiazepines [CS]'],\n",
       "   'unii': ['CHB1QD2QSS']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '6c8efa4c-2cd1-47c0-8e82-cfdd16a7455b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19870421',\n",
       "  'product_id': '72162-1824_6c8efa4c-2cd1-47c0-8e82-cfdd16a7455b',\n",
       "  'application_number': 'ANDA071456',\n",
       "  'brand_name_base': 'temazepam',\n",
       "  'pharm_class': ['Benzodiazepine [EPC]', 'Benzodiazepines [CS]']},\n",
       " {'product_ndc': '0536-1314',\n",
       "  'generic_name': 'Guaifenesin',\n",
       "  'labeler_name': 'RUGBY LABORATORIES',\n",
       "  'brand_name': 'Chest Congestion Relief',\n",
       "  'active_ingredients': [{'name': 'GUAIFENESIN', 'strength': '100 mg/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1314-85',\n",
       "    'description': '473 mL in 1 BOTTLE (0536-1314-85)',\n",
       "    'marketing_start_date': '20201001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['RUGBY LABORATORIES'],\n",
       "   'rxcui': ['310604'],\n",
       "   'spl_set_id': ['51b088bc-b44f-44b9-a08e-133509a35a2c'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305361314859'],\n",
       "   'nui': ['N0000193956', 'N0000008867', 'N0000009560'],\n",
       "   'pharm_class_epc': ['Expectorant [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "    'Increased Respiratory Secretions [PE]'],\n",
       "   'unii': ['495W7451VQ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'f78f166a-24ff-429a-b043-daa72a2be9f6',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201001',\n",
       "  'product_id': '0536-1314_f78f166a-24ff-429a-b043-daa72a2be9f6',\n",
       "  'application_number': 'part341',\n",
       "  'brand_name_base': 'Chest Congestion Relief',\n",
       "  'pharm_class': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "   'Expectorant [EPC]',\n",
       "   'Increased Respiratory Secretions [PE]']},\n",
       " {'product_ndc': '72162-1847',\n",
       "  'generic_name': 'Colesevelam hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Colesevelam hydrochloride',\n",
       "  'active_ingredients': [{'name': 'COLESEVELAM HYDROCHLORIDE',\n",
       "    'strength': '3.75 g/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1847-2',\n",
       "    'description': '30 POWDER, FOR SUSPENSION in 1 PACKET (72162-1847-2)',\n",
       "    'marketing_start_date': '20240312',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['866905'],\n",
       "   'spl_set_id': ['dbed6967-b261-44a1-bee4-638810e2efe9'],\n",
       "   'unii': ['P4SG24WI5Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'POWDER, FOR SUSPENSION',\n",
       "  'spl_id': '20b5003a-89c2-4de9-bba3-b9bb064a7678',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190509',\n",
       "  'product_id': '72162-1847_20b5003a-89c2-4de9-bba3-b9bb064a7678',\n",
       "  'application_number': 'ANDA210316',\n",
       "  'brand_name_base': 'Colesevelam hydrochloride',\n",
       "  'pharm_class': ['Bile Acid Sequestrant [EPC]',\n",
       "   'Bile-acid Binding Activity [MoA]']},\n",
       " {'product_ndc': '72162-1848',\n",
       "  'generic_name': 'Solifenacin Succinate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Solifenacin Succinate',\n",
       "  'active_ingredients': [{'name': 'SOLIFENACIN SUCCINATE',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1848-3',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72162-1848-3)',\n",
       "    'marketing_start_date': '20190521',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1848-9',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (72162-1848-9)',\n",
       "    'marketing_start_date': '20190521',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['477367'],\n",
       "   'spl_set_id': ['3788df43-42dd-4778-8289-e32b5844358e'],\n",
       "   'unii': ['KKA5DLD701']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '177476fb-9eed-4307-bb28-b3749f60aecb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190521',\n",
       "  'product_id': '72162-1848_177476fb-9eed-4307-bb28-b3749f60aecb',\n",
       "  'application_number': 'ANDA210224',\n",
       "  'brand_name_base': 'Solifenacin Succinate',\n",
       "  'pharm_class': ['Cholinergic Muscarinic Antagonist [EPC]',\n",
       "   'Cholinergic Muscarinic Antagonists [MoA]']},\n",
       " {'product_ndc': '72162-1858',\n",
       "  'generic_name': 'Metoprolol Succinate ER Tablets',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Metoprolol Succinate',\n",
       "  'active_ingredients': [{'name': 'METOPROLOL SUCCINATE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1858-0',\n",
       "    'description': '1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72162-1858-0)',\n",
       "    'marketing_start_date': '20240305',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1858-1',\n",
       "    'description': '100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72162-1858-1)',\n",
       "    'marketing_start_date': '20240305',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1858-5',\n",
       "    'description': '500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72162-1858-5)',\n",
       "    'marketing_start_date': '20240305',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['866412'],\n",
       "   'spl_set_id': ['e602c70f-9ea3-480f-a7df-15f23c6b3307'],\n",
       "   'unii': ['TH25PD4CCB']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED, EXTENDED RELEASE',\n",
       "  'spl_id': '6260a342-1887-46ad-ae1e-06e7e8bf2195',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201127',\n",
       "  'product_id': '72162-1858_6260a342-1887-46ad-ae1e-06e7e8bf2195',\n",
       "  'application_number': 'ANDA211143',\n",
       "  'brand_name_base': 'Metoprolol Succinate',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72162-1890',\n",
       "  'generic_name': 'Pimecrolimus',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Pimecrolimus',\n",
       "  'active_ingredients': [{'name': 'PIMECROLIMUS', 'strength': '10 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1890-6',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-1890-6)  / 60 g in 1 TUBE',\n",
       "    'marketing_start_date': '20240321',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['562806'],\n",
       "   'spl_set_id': ['0a269aab-a911-4a40-9f62-4ac4c81f407c'],\n",
       "   'nui': ['N0000175457', 'N0000175458'],\n",
       "   'pharm_class_epc': ['Calcineurin Inhibitor Immunosuppressant [EPC]'],\n",
       "   'pharm_class_moa': ['Calcineurin Inhibitors [MoA]'],\n",
       "   'unii': ['7KYV510875']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': 'de43c9b0-3b64-466a-9d59-e5b4096cea52',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20181126',\n",
       "  'product_id': '72162-1890_de43c9b0-3b64-466a-9d59-e5b4096cea52',\n",
       "  'application_number': 'NDA021302',\n",
       "  'brand_name_base': 'Pimecrolimus',\n",
       "  'pharm_class': ['Calcineurin Inhibitor Immunosuppressant [EPC]',\n",
       "   'Calcineurin Inhibitors [MoA]']},\n",
       " {'product_ndc': '72162-1915',\n",
       "  'generic_name': 'Paricalcitol',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Paricalcitol',\n",
       "  'active_ingredients': [{'name': 'PARICALCITOL', 'strength': '1 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1915-3',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE, PLASTIC (72162-1915-3)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['577315'],\n",
       "   'spl_set_id': ['664253fb-d99d-4af6-971b-95c0087406d9'],\n",
       "   'nui': ['M0007651', 'N0000175907', 'N0000175849'],\n",
       "   'pharm_class_cs': ['Ergocalciferols [CS]'],\n",
       "   'pharm_class_epc': ['Vitamin D2 Analog [EPC]', 'Vitamin D Analog [EPC]'],\n",
       "   'unii': ['6702D36OG5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '664253fb-d99d-4af6-971b-95c0087406d9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20160816',\n",
       "  'product_id': '72162-1915_664253fb-d99d-4af6-971b-95c0087406d9',\n",
       "  'application_number': 'ANDA202539',\n",
       "  'brand_name_base': 'Paricalcitol',\n",
       "  'pharm_class': ['Ergocalciferols [CS]',\n",
       "   'Vitamin D Analog [EPC]',\n",
       "   'Vitamin D2 Analog [EPC]']},\n",
       " {'product_ndc': '72162-1928',\n",
       "  'generic_name': 'Carisoprodol',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Carisoprodol',\n",
       "  'active_ingredients': [{'name': 'CARISOPRODOL', 'strength': '350 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1928-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1928-1)',\n",
       "    'marketing_start_date': '20240208',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197446'],\n",
       "   'spl_set_id': ['f8aee817-c652-441e-b99a-8cbc4e6d06ef'],\n",
       "   'nui': ['N0000175730', 'N0000175737'],\n",
       "   'pharm_class_pe': ['Centrally-mediated Muscle Relaxation [PE]'],\n",
       "   'pharm_class_epc': ['Muscle Relaxant [EPC]'],\n",
       "   'unii': ['21925K482H']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '42c39973-fdca-4b96-9d1a-ae72762f80ed',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200120',\n",
       "  'product_id': '72162-1928_42c39973-fdca-4b96-9d1a-ae72762f80ed',\n",
       "  'application_number': 'ANDA040188',\n",
       "  'brand_name_base': 'Carisoprodol',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '72162-1930',\n",
       "  'generic_name': 'methocarbamol',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Methocarbamol',\n",
       "  'active_ingredients': [{'name': 'METHOCARBAMOL', 'strength': '750 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1930-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1930-1)',\n",
       "    'marketing_start_date': '20190815',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-1930-5',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72162-1930-5)',\n",
       "    'marketing_start_date': '20190815',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197944'],\n",
       "   'spl_set_id': ['cc004f5c-d5fc-48c5-9f37-c59b9c37e113'],\n",
       "   'nui': ['N0000175730', 'N0000175737'],\n",
       "   'pharm_class_pe': ['Centrally-mediated Muscle Relaxation [PE]'],\n",
       "   'pharm_class_epc': ['Muscle Relaxant [EPC]'],\n",
       "   'unii': ['125OD7737X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'c357ebcd-4bcf-4021-963b-8a54a11c4736',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190815',\n",
       "  'product_id': '72162-1930_c357ebcd-4bcf-4021-963b-8a54a11c4736',\n",
       "  'application_number': 'ANDA040489',\n",
       "  'brand_name_base': 'Methocarbamol',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '72162-1931',\n",
       "  'generic_name': 'Sotalol Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Sotalol Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'SOTALOL HYDROCHLORIDE',\n",
       "    'strength': '80 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1931-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1931-1)',\n",
       "    'marketing_start_date': '20200724',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1923426'],\n",
       "   'spl_set_id': ['89b33c45-ece8-496f-9c3a-94ebabf73b1b'],\n",
       "   'unii': ['HEC37C70XX']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '89b33c45-ece8-496f-9c3a-94ebabf73b1b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200724',\n",
       "  'product_id': '72162-1931_89b33c45-ece8-496f-9c3a-94ebabf73b1b',\n",
       "  'application_number': 'ANDA075563',\n",
       "  'brand_name_base': 'Sotalol Hydrochloride',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Cardiac Rhythm Alteration [PE]']},\n",
       " {'product_ndc': '0536-1322',\n",
       "  'generic_name': 'Omeprazole',\n",
       "  'labeler_name': 'Rugby Laboratories',\n",
       "  'brand_name': 'Acid Reducer',\n",
       "  'active_ingredients': [{'name': 'OMEPRAZOLE MAGNESIUM',\n",
       "    'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1322-13',\n",
       "    'description': '3 BOTTLE in 1 CARTON (0536-1322-13)  / 14 TABLET, DELAYED RELEASE in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200915',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0536-1322-71',\n",
       "    'description': '2 BOTTLE in 1 CARTON (0536-1322-71)  / 14 TABLET, DELAYED RELEASE in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200915',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0536-1322-88',\n",
       "    'description': '1 BOTTLE in 1 CARTON (0536-1322-88)  / 14 TABLET, DELAYED RELEASE in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200915',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Rugby Laboratories'],\n",
       "   'rxcui': ['402014'],\n",
       "   'spl_set_id': ['33990795-e994-4307-a570-9e8e8b44c473'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['426QFE7XLK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, DELAYED RELEASE',\n",
       "  'spl_id': '06f00797-a33b-48da-8c7a-c7a6a7ba8709',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200915',\n",
       "  'product_id': '0536-1322_06f00797-a33b-48da-8c7a-c7a6a7ba8709',\n",
       "  'application_number': 'ANDA206877',\n",
       "  'brand_name_base': 'Acid Reducer',\n",
       "  'pharm_class': ['Cytochrome P450 2C19 Inhibitors [MoA]',\n",
       "   'Proton Pump Inhibitor [EPC]',\n",
       "   'Proton Pump Inhibitors [MoA]']},\n",
       " {'product_ndc': '72162-1941',\n",
       "  'generic_name': 'Hyoscyamine Sulfate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Hyoscyamine Sulfate',\n",
       "  'active_ingredients': [{'name': 'HYOSCYAMINE SULFATE',\n",
       "    'strength': '.125 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1941-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1941-1)',\n",
       "    'marketing_start_date': '20230831',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1046985'],\n",
       "   'spl_set_id': ['44119cad-489b-4866-b150-8fbc47f516f6'],\n",
       "   'unii': ['F2R8V82B84']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '11fb20e6-62ca-4bbf-82a3-2234f341c322',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181001',\n",
       "  'product_id': '72162-1941_11fb20e6-62ca-4bbf-82a3-2234f341c322',\n",
       "  'brand_name_base': 'Hyoscyamine Sulfate'},\n",
       " {'product_ndc': '72162-1991',\n",
       "  'generic_name': 'Hydrocodone Bitartrate and Acetaminophen',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Hydrocodone Bitartrate and Acetaminophen',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '325 mg/1'},\n",
       "   {'name': 'HYDROCODONE BITARTRATE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-1991-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-1991-1)',\n",
       "    'marketing_start_date': '20180713',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['856999'],\n",
       "   'spl_set_id': ['c534f784-0e21-4891-8f7e-2dc327b267f1'],\n",
       "   'unii': ['362O9ITL9D', 'NO70W886KK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'fffa9909-202f-414d-aba5-bef53f23c8f5',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180713',\n",
       "  'product_id': '72162-1991_fffa9909-202f-414d-aba5-bef53f23c8f5',\n",
       "  'application_number': 'ANDA210211',\n",
       "  'brand_name_base': 'Hydrocodone Bitartrate and Acetaminophen',\n",
       "  'pharm_class': ['Opioid Agonist [EPC]', 'Opioid Agonists [MoA]']},\n",
       " {'product_ndc': '72162-2029',\n",
       "  'generic_name': 'guanfacine',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Guanfacine extended-release',\n",
       "  'active_ingredients': [{'name': 'GUANFACINE HYDROCHLORIDE',\n",
       "    'strength': '3 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2029-1',\n",
       "    'description': '100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2029-1)',\n",
       "    'marketing_start_date': '20181003',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2029-3',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2029-3)',\n",
       "    'marketing_start_date': '20181003',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['862019'],\n",
       "   'spl_set_id': ['5d14cbd4-d390-40eb-8775-d870380ce67c'],\n",
       "   'unii': ['PML56A160O']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '8a6a9371-7ecf-49a0-9c20-6347d656d675',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181003',\n",
       "  'product_id': '72162-2029_8a6a9371-7ecf-49a0-9c20-6347d656d675',\n",
       "  'application_number': 'ANDA205430',\n",
       "  'brand_name_base': 'Guanfacine extended-release',\n",
       "  'pharm_class': ['Adrenergic alpha2-Agonists [MoA]',\n",
       "   'Central alpha-2 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72162-2038',\n",
       "  'generic_name': 'Theophylline',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Theophylline',\n",
       "  'active_ingredients': [{'name': 'THEOPHYLLINE ANHYDROUS',\n",
       "    'strength': '80 mg/15mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2038-2',\n",
       "    'description': '473 mL in 1 BOTTLE (72162-2038-2)',\n",
       "    'marketing_start_date': '20230606',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['313306'],\n",
       "   'spl_set_id': ['955dba5e-c3b7-4a45-8650-e1b4722dbaea'],\n",
       "   'nui': ['N0000175790', 'M0023046'],\n",
       "   'pharm_class_epc': ['Methylxanthine [EPC]'],\n",
       "   'pharm_class_cs': ['Xanthines [CS]'],\n",
       "   'unii': ['0I55128JYK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '601b3954-8a02-425f-abb9-100069663c9a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20120802',\n",
       "  'product_id': '72162-2038_601b3954-8a02-425f-abb9-100069663c9a',\n",
       "  'application_number': 'ANDA091586',\n",
       "  'brand_name_base': 'Theophylline',\n",
       "  'pharm_class': ['Methylxanthine [EPC]', 'Xanthines [CS]']},\n",
       " {'product_ndc': '72162-2057',\n",
       "  'generic_name': 'Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate',\n",
       "  'active_ingredients': [{'name': 'AMPHETAMINE ASPARTATE MONOHYDRATE',\n",
       "    'strength': '3.75 mg/1'},\n",
       "   {'name': 'AMPHETAMINE SULFATE', 'strength': '3.75 mg/1'},\n",
       "   {'name': 'DEXTROAMPHETAMINE SACCHARATE', 'strength': '3.75 mg/1'},\n",
       "   {'name': 'DEXTROAMPHETAMINE SULFATE', 'strength': '3.75 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2057-1',\n",
       "    'description': '100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72162-2057-1)',\n",
       "    'marketing_start_date': '20230614',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2057-3',\n",
       "    'description': '30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72162-2057-3)',\n",
       "    'marketing_start_date': '20230614',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2057-6',\n",
       "    'description': '60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72162-2057-6)',\n",
       "    'marketing_start_date': '20230614',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2057-9',\n",
       "    'description': '90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72162-2057-9)',\n",
       "    'marketing_start_date': '20230614',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['861223'],\n",
       "   'spl_set_id': ['774f1954-d906-4096-bdef-e7426da3b568'],\n",
       "   'unii': ['O1ZPV620O4', '6DPV8NK46S', 'G83415V073', 'JJ768O327N']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, EXTENDED RELEASE',\n",
       "  'spl_id': 'cd6beb57-c465-4411-b961-94016108c689',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20191216',\n",
       "  'product_id': '72162-2057_cd6beb57-c465-4411-b961-94016108c689',\n",
       "  'application_number': 'ANDA212037',\n",
       "  'brand_name_base': 'Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate',\n",
       "  'pharm_class': ['Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Central Nervous System Stimulation [PE]']},\n",
       " {'product_ndc': '72162-2070',\n",
       "  'generic_name': 'TRIAMCINOLONE ACETONIDE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'TRIAMCINOLONE ACETONIDE',\n",
       "  'active_ingredients': [{'name': 'TRIAMCINOLONE ACETONIDE',\n",
       "    'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2070-6',\n",
       "    'description': '60 mL in 1 BOTTLE, WITH APPLICATOR (72162-2070-6)',\n",
       "    'marketing_start_date': '20230815',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1085745'],\n",
       "   'spl_set_id': ['f85e36df-15d8-4b8f-94a5-39742d572804'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['F446C597KA']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '2b7aabe1-51e5-41ae-b5fa-74769de7b4de',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200701',\n",
       "  'product_id': '72162-2070_2b7aabe1-51e5-41ae-b5fa-74769de7b4de',\n",
       "  'application_number': 'ANDA213559',\n",
       "  'brand_name_base': 'TRIAMCINOLONE ACETONIDE',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72162-2072',\n",
       "  'generic_name': 'PROPYLTHIOURACIL',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'PROPYLTHIOURACIL',\n",
       "  'active_ingredients': [{'name': 'PROPYLTHIOURACIL', 'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2072-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-2072-1)',\n",
       "    'marketing_start_date': '20230815',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2072-2',\n",
       "    'description': '180 TABLET in 1 BOTTLE (72162-2072-2)',\n",
       "    'marketing_start_date': '20230815',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198175'],\n",
       "   'spl_set_id': ['ae65e8b0-91b2-4a3f-8e1a-279e47eee951'],\n",
       "   'nui': ['N0000175918', 'N0000175917'],\n",
       "   'pharm_class_epc': ['Thyroid Hormone Synthesis Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Thyroid Hormone Synthesis Inhibitors [MoA]'],\n",
       "   'unii': ['721M9407IY']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'a2a5cff0-be4e-4b04-ad87-7ce9b9f2b0fe',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210318',\n",
       "  'product_id': '72162-2072_a2a5cff0-be4e-4b04-ad87-7ce9b9f2b0fe',\n",
       "  'application_number': 'ANDA080154',\n",
       "  'brand_name_base': 'PROPYLTHIOURACIL',\n",
       "  'pharm_class': ['Thyroid Hormone Synthesis Inhibitor [EPC]',\n",
       "   'Thyroid Hormone Synthesis Inhibitors [MoA]']},\n",
       " {'product_ndc': '72162-2076',\n",
       "  'generic_name': 'Ciclopirox',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Ciclopirox',\n",
       "  'active_ingredients': [{'name': 'CICLOPIROX', 'strength': '80 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2076-1',\n",
       "    'description': '1 BOTTLE, WITH APPLICATOR in 1 CARTON (72162-2076-1)  / 6.6 mL in 1 BOTTLE, WITH APPLICATOR',\n",
       "    'marketing_start_date': '20230816',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['309291'],\n",
       "   'spl_set_id': ['d7e22682-1485-47e5-b6ae-94534bd3d889'],\n",
       "   'nui': ['N0000008577', 'N0000008841', 'N0000008853', 'N0000000150'],\n",
       "   'pharm_class_pe': ['Decreased DNA Replication [PE]',\n",
       "    'Decreased Protein Synthesis [PE]',\n",
       "    'Decreased RNA Replication [PE]'],\n",
       "   'pharm_class_moa': ['Protein Synthesis Inhibitors [MoA]'],\n",
       "   'unii': ['19W019ZDRJ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '541d2200-cc21-4df7-ba10-10c7001cf031',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20070919',\n",
       "  'product_id': '72162-2076_541d2200-cc21-4df7-ba10-10c7001cf031',\n",
       "  'application_number': 'ANDA077623',\n",
       "  'brand_name_base': 'Ciclopirox',\n",
       "  'pharm_class': ['Decreased DNA Replication [PE]',\n",
       "   'Decreased Protein Synthesis [PE]',\n",
       "   'Decreased RNA Replication [PE]',\n",
       "   'Protein Synthesis Inhibitors [MoA]']},\n",
       " {'product_ndc': '72162-2086',\n",
       "  'generic_name': 'METHYLPHENIDATE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'METHYLPHENIDATE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'METHYLPHENIDATE HYDROCHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2086-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-2086-1)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1091150'],\n",
       "   'spl_set_id': ['11f4ec97-ed86-48b5-af3a-446b882294cb'],\n",
       "   'unii': ['4B3SC438HI']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '11f4ec97-ed86-48b5-af3a-446b882294cb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20140407',\n",
       "  'product_id': '72162-2086_11f4ec97-ed86-48b5-af3a-446b882294cb',\n",
       "  'application_number': 'ANDA091159',\n",
       "  'brand_name_base': 'METHYLPHENIDATE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulation [PE]']},\n",
       " {'product_ndc': '72162-2093',\n",
       "  'generic_name': 'Amlodipine and Atorvastatin',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Amlodipine and Atorvastatin',\n",
       "  'active_ingredients': [{'name': 'AMLODIPINE BESYLATE', 'strength': '5 mg/1'},\n",
       "   {'name': 'ATORVASTATIN CALCIUM TRIHYDRATE', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2093-3',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72162-2093-3)',\n",
       "    'marketing_start_date': '20240814',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['597980'],\n",
       "   'spl_set_id': ['50112e22-5a69-47c9-90cd-82bbacae7418'],\n",
       "   'unii': ['864V2Q084H', '48A5M73Z4Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'e233ff20-804e-43f5-9d46-0b1cf39c6af6',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200729',\n",
       "  'product_id': '72162-2093_e233ff20-804e-43f5-9d46-0b1cf39c6af6',\n",
       "  'application_number': 'ANDA205199',\n",
       "  'brand_name_base': 'Amlodipine and Atorvastatin',\n",
       "  'pharm_class': ['Calcium Channel Antagonists [MoA]',\n",
       "   'Calcium Channel Blocker [EPC]',\n",
       "   'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "   'Dihydropyridine Calcium Channel Blocker [EPC]',\n",
       "   'Dihydropyridines [CS]',\n",
       "   'HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '72162-2096',\n",
       "  'generic_name': 'Brimonidine Tartrate and Timolol Maleate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution',\n",
       "  'active_ingredients': [{'name': 'BRIMONIDINE TARTRATE',\n",
       "    'strength': '2 mg/mL'},\n",
       "   {'name': 'TIMOLOL MALEATE', 'strength': '5 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2096-2',\n",
       "    'description': '1 BOTTLE, DROPPER in 1 CARTON (72162-2096-2)  / 10 mL in 1 BOTTLE, DROPPER',\n",
       "    'marketing_start_date': '20221019',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2096-4',\n",
       "    'description': '1 BOTTLE, DROPPER in 1 CARTON (72162-2096-4)  / 15 mL in 1 BOTTLE, DROPPER',\n",
       "    'marketing_start_date': '20221019',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2096-7',\n",
       "    'description': '1 BOTTLE, DROPPER in 1 CARTON (72162-2096-7)  / 5 mL in 1 BOTTLE, DROPPER',\n",
       "    'marketing_start_date': '20221019',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['861635'],\n",
       "   'spl_set_id': ['71e50a17-54dd-4d08-b5ae-b5f46e38b3e1'],\n",
       "   'unii': ['4S9CL2DY2H', 'P8Y54F701R']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '0ad1758c-b483-4436-8628-6472f9e8076f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20221019',\n",
       "  'product_id': '72162-2096_0ad1758c-b483-4436-8628-6472f9e8076f',\n",
       "  'application_number': 'ANDA091442',\n",
       "  'brand_name_base': 'Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution',\n",
       "  'pharm_class': ['Adrenergic alpha-Agonists [MoA]',\n",
       "   'Adrenergic beta-Antagonists [MoA]',\n",
       "   'alpha-Adrenergic Agonist [EPC]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '0536-1349',\n",
       "  'generic_name': 'Muscle Rub Cream',\n",
       "  'labeler_name': 'Rugby Laboratories',\n",
       "  'brand_name': 'Rugby Muscle Rub Cream',\n",
       "  'active_ingredients': [{'name': 'MENTHOL', 'strength': '100 mg/g'},\n",
       "   {'name': 'METHYL SALICYLATE', 'strength': '150 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1349-57',\n",
       "    'description': '1 TUBE in 1 CARTON (0536-1349-57)  / 85 g in 1 TUBE',\n",
       "    'marketing_start_date': '20220228',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Rugby Laboratories'],\n",
       "   'rxcui': ['311498'],\n",
       "   'spl_set_id': ['7c6f49d9-0ecd-494a-abd3-cdda6d6e5d06'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['L7T10EIP3A', 'LAV5U5022Y']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': 'a2222582-cb3a-4698-ad64-83e8ab228dfd',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220228',\n",
       "  'product_id': '0536-1349_a2222582-cb3a-4698-ad64-83e8ab228dfd',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Rugby Muscle Rub Cream'},\n",
       " {'product_ndc': '72162-2119',\n",
       "  'generic_name': 'Gemfibrozil',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'GEMFIBROZIL',\n",
       "  'active_ingredients': [{'name': 'GEMFIBROZIL', 'strength': '600 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2119-6',\n",
       "    'description': '60 TABLET in 1 BOTTLE (72162-2119-6)',\n",
       "    'marketing_start_date': '20230915',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['310459'],\n",
       "   'spl_set_id': ['54c65a5d-2ff9-493a-90d9-2cff48d1a072'],\n",
       "   'nui': ['N0000175596', 'N0000175375', 'M0199111'],\n",
       "   'pharm_class_epc': ['Peroxisome Proliferator Receptor alpha Agonist [EPC]'],\n",
       "   'pharm_class_moa': ['Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]'],\n",
       "   'pharm_class_cs': ['PPAR alpha [CS]'],\n",
       "   'unii': ['Q8X02027X3']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'cfb9ebc5-4268-4d5b-a5db-1078913644bf',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210120',\n",
       "  'product_id': '72162-2119_cfb9ebc5-4268-4d5b-a5db-1078913644bf',\n",
       "  'application_number': 'ANDA214603',\n",
       "  'brand_name_base': 'GEMFIBROZIL',\n",
       "  'pharm_class': ['PPAR alpha [CS]',\n",
       "   'Peroxisome Proliferator Receptor alpha Agonist [EPC]',\n",
       "   'Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]']},\n",
       " {'product_ndc': '72162-2128',\n",
       "  'generic_name': 'Calcitonin Salmon',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Calcitonin Salmon',\n",
       "  'active_ingredients': [{'name': 'CALCITONIN SALMON',\n",
       "    'strength': '200 [iU]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2128-3',\n",
       "    'description': '1 BOTTLE, GLASS in 1 CARTON (72162-2128-3)  / 30 SPRAY, METERED in 1 BOTTLE, GLASS',\n",
       "    'marketing_start_date': '20081209',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['313919'],\n",
       "   'spl_set_id': ['a5da2960-d113-4c6a-bb3f-c6ce65731b1f'],\n",
       "   'nui': ['M0003145', 'N0000175942'],\n",
       "   'pharm_class_cs': ['Calcitonin [CS]'],\n",
       "   'pharm_class_epc': ['Calcitonin [EPC]'],\n",
       "   'unii': ['7SFC6U2VI5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SPRAY, METERED',\n",
       "  'spl_id': '63f277bd-9a57-4074-b48b-e9820a2d43e3',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['NASAL'],\n",
       "  'marketing_start_date': '20081209',\n",
       "  'product_id': '72162-2128_63f277bd-9a57-4074-b48b-e9820a2d43e3',\n",
       "  'application_number': 'ANDA076396',\n",
       "  'brand_name_base': 'Calcitonin Salmon',\n",
       "  'pharm_class': ['Calcitonin [CS]', 'Calcitonin [EPC]']},\n",
       " {'product_ndc': '72162-2141',\n",
       "  'generic_name': 'GABAPENTIN',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Gabapentin',\n",
       "  'active_ingredients': [{'name': 'GABAPENTIN', 'strength': '600 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2141-1',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72162-2141-1)',\n",
       "    'marketing_start_date': '20231012',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2141-5',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (72162-2141-5)',\n",
       "    'marketing_start_date': '20231012',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['310433'],\n",
       "   'spl_set_id': ['0eb27e64-1488-4083-82c7-cebb8c0605de'],\n",
       "   'nui': ['N0000008486'],\n",
       "   'pharm_class_pe': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]'],\n",
       "   'unii': ['6CW7F3G59X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '8b6e731b-e52c-4a2d-8fba-c994d9f015d3',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20140111',\n",
       "  'product_id': '72162-2141_8b6e731b-e52c-4a2d-8fba-c994d9f015d3',\n",
       "  'application_number': 'ANDA203244',\n",
       "  'brand_name_base': 'Gabapentin',\n",
       "  'pharm_class': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]']},\n",
       " {'product_ndc': '72162-2152',\n",
       "  'generic_name': 'fenofibrate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Fenofibrate',\n",
       "  'active_ingredients': [{'name': 'FENOFIBRATE', 'strength': '160 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2152-9',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72162-2152-9)',\n",
       "    'marketing_start_date': '20231207',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['349287'],\n",
       "   'spl_set_id': ['11616da5-54ae-400c-9acc-6efc729f6a17'],\n",
       "   'nui': ['N0000175596', 'N0000175375', 'M0199111'],\n",
       "   'pharm_class_epc': ['Peroxisome Proliferator Receptor alpha Agonist [EPC]'],\n",
       "   'pharm_class_moa': ['Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]'],\n",
       "   'pharm_class_cs': ['PPAR alpha [CS]'],\n",
       "   'unii': ['U202363UOS']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '797ce897-04ec-461a-a733-f3afe7658ebc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20091222',\n",
       "  'product_id': '72162-2152_797ce897-04ec-461a-a733-f3afe7658ebc',\n",
       "  'application_number': 'ANDA076520',\n",
       "  'brand_name_base': 'Fenofibrate',\n",
       "  'pharm_class': ['Peroxisome Proliferator Receptor alpha Agonist [EPC]']},\n",
       " {'product_ndc': '72162-2172',\n",
       "  'generic_name': 'Polyethylene Glycol 3350',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Polyethylene Glycol 3350',\n",
       "  'active_ingredients': [{'name': 'POLYETHYLENE GLYCOL 3350',\n",
       "    'strength': '17 g/17g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2172-2',\n",
       "    'description': '238 g in 1 BOTTLE (72162-2172-2)',\n",
       "    'marketing_start_date': '20240123',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2172-4',\n",
       "    'description': '510 g in 1 BOTTLE (72162-2172-4)',\n",
       "    'marketing_start_date': '20240123',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['876193'],\n",
       "   'spl_set_id': ['5df518fb-ad58-4f17-af34-f66066f1313a'],\n",
       "   'nui': ['N0000010288', 'N0000175811', 'N0000009871'],\n",
       "   'pharm_class_moa': ['Osmotic Activity [MoA]'],\n",
       "   'pharm_class_epc': ['Osmotic Laxative [EPC]'],\n",
       "   'pharm_class_pe': ['Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]'],\n",
       "   'unii': ['G2M7P15E5P']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'POWDER, FOR SOLUTION',\n",
       "  'spl_id': '609af786-f257-4f83-93ed-9dae86798a98',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20091013',\n",
       "  'product_id': '72162-2172_609af786-f257-4f83-93ed-9dae86798a98',\n",
       "  'application_number': 'ANDA090685',\n",
       "  'brand_name_base': 'Polyethylene Glycol 3350',\n",
       "  'pharm_class': ['Osmotic Activity [MoA]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]']},\n",
       " {'product_ndc': '72162-2174',\n",
       "  'generic_name': 'Methotrexate Sodium',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Methotrexate',\n",
       "  'active_ingredients': [{'name': 'METHOTREXATE SODIUM',\n",
       "    'strength': '2.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2174-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-2174-1)',\n",
       "    'marketing_start_date': '20231207',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['105585'],\n",
       "   'spl_set_id': ['c7592288-ac24-46c6-8cec-9abe23d7e81e'],\n",
       "   'unii': ['3IG1E710ZN']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '2a3d5064-e336-459f-b0dc-28e50256b32e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171110',\n",
       "  'product_id': '72162-2174_2a3d5064-e336-459f-b0dc-28e50256b32e',\n",
       "  'application_number': 'ANDA201749',\n",
       "  'brand_name_base': 'Methotrexate',\n",
       "  'pharm_class': ['Folate Analog Metabolic Inhibitor [EPC]',\n",
       "   'Folic Acid Metabolism Inhibitors [MoA]']},\n",
       " {'product_ndc': '72162-2183',\n",
       "  'generic_name': 'Terazosin Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Terazosin',\n",
       "  'active_ingredients': [{'name': 'TERAZOSIN HYDROCHLORIDE',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2183-0',\n",
       "    'description': '1000 CAPSULE in 1 BOTTLE (72162-2183-0)',\n",
       "    'marketing_start_date': '20231207',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['313219'],\n",
       "   'spl_set_id': ['3822068f-f160-4493-a207-4d75dad6af73'],\n",
       "   'unii': ['D32S14F082']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'f9207674-ed52-47b9-b675-ce98abbab9a8',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20041220',\n",
       "  'product_id': '72162-2183_f9207674-ed52-47b9-b675-ce98abbab9a8',\n",
       "  'application_number': 'ANDA075317',\n",
       "  'brand_name_base': 'Terazosin',\n",
       "  'pharm_class': ['Adrenergic alpha-Antagonists [MoA]',\n",
       "   'alpha-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72162-2198',\n",
       "  'generic_name': 'Nadolol',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Nadolol',\n",
       "  'active_ingredients': [{'name': 'NADOLOL', 'strength': '80 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2198-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-2198-1)',\n",
       "    'marketing_start_date': '20190726',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198008'],\n",
       "   'spl_set_id': ['2d126308-c58d-4950-9dcb-eaadb1a2054f'],\n",
       "   'nui': ['N0000000161', 'N0000175556'],\n",
       "   'pharm_class_moa': ['Adrenergic beta-Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['beta-Adrenergic Blocker [EPC]'],\n",
       "   'unii': ['FEN504330V']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '020d534d-6879-45d9-856f-1f82a39d4b1f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190726',\n",
       "  'product_id': '72162-2198_020d534d-6879-45d9-856f-1f82a39d4b1f',\n",
       "  'application_number': 'ANDA210955',\n",
       "  'brand_name_base': 'Nadolol',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72162-2199',\n",
       "  'generic_name': 'Buspirone hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Buspirone hydrochloride',\n",
       "  'active_ingredients': [{'name': 'BUSPIRONE HYDROCHLORIDE',\n",
       "    'strength': '7.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2199-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-2199-1)',\n",
       "    'marketing_start_date': '20231215',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['866111'],\n",
       "   'spl_set_id': ['b07c0a91-892c-47f5-819e-a128e0ef1ed7'],\n",
       "   'unii': ['207LT9J9OC']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '9215bf81-1137-4e26-989d-a52124afbff9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230321',\n",
       "  'product_id': '72162-2199_9215bf81-1137-4e26-989d-a52124afbff9',\n",
       "  'application_number': 'ANDA078888',\n",
       "  'brand_name_base': 'Buspirone hydrochloride'},\n",
       " {'product_ndc': '72162-2209',\n",
       "  'generic_name': 'Tamoxifen Citrate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Tamoxifen Citrate',\n",
       "  'active_ingredients': [{'name': 'TAMOXIFEN CITRATE', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2209-3',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72162-2209-3)',\n",
       "    'marketing_start_date': '20240105',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['313195'],\n",
       "   'spl_set_id': ['9b4a8abc-6e56-40c5-a826-1d1f3c0786e1'],\n",
       "   'unii': ['7FRV7310N6']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '8222e567-8174-40fc-afd8-ab6bde6dc073',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200814',\n",
       "  'product_id': '72162-2209_8222e567-8174-40fc-afd8-ab6bde6dc073',\n",
       "  'application_number': 'ANDA213358',\n",
       "  'brand_name_base': 'Tamoxifen Citrate',\n",
       "  'pharm_class': ['Estrogen Agonist/Antagonist [EPC]',\n",
       "   'Selective Estrogen Receptor Modulators [MoA]']},\n",
       " {'product_ndc': '72162-2219',\n",
       "  'generic_name': 'VARENICLINE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'VARENICLINE',\n",
       "  'active_ingredients': [{'name': 'VARENICLINE TARTRATE',\n",
       "    'strength': '1 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2219-2',\n",
       "    'description': '56 TABLET, FILM COATED in 1 BOTTLE (72162-2219-2)',\n",
       "    'marketing_start_date': '20240105',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2219-3',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72162-2219-3)',\n",
       "    'marketing_start_date': '20240105',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['636676'],\n",
       "   'spl_set_id': ['dc0d2c60-b197-4bbf-a3fd-78e0f5a21440'],\n",
       "   'unii': ['82269ASB48']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'a2386f55-4425-4caf-9b74-af9f5a80c2f9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230130',\n",
       "  'product_id': '72162-2219_a2386f55-4425-4caf-9b74-af9f5a80c2f9',\n",
       "  'application_number': 'ANDA201962',\n",
       "  'brand_name_base': 'VARENICLINE',\n",
       "  'pharm_class': ['Cholinergic Agonists [MoA]',\n",
       "   'Cholinergic Receptor Agonist [EPC]',\n",
       "   'Partial Cholinergic Nicotinic Agonist [EPC]',\n",
       "   'Partial Cholinergic Nicotinic Agonists [MoA]']},\n",
       " {'product_ndc': '0065-1795',\n",
       "  'generic_name': 'balanced salt solution',\n",
       "  'labeler_name': 'Alcon Laboratories, Inc.',\n",
       "  'brand_name': 'BSS',\n",
       "  'active_ingredients': [{'name': 'CALCIUM CHLORIDE', 'strength': '.48 mg/mL'},\n",
       "   {'name': 'MAGNESIUM CHLORIDE', 'strength': '.3 mg/mL'},\n",
       "   {'name': 'POTASSIUM CHLORIDE', 'strength': '.75 mg/mL'},\n",
       "   {'name': 'SODIUM ACETATE', 'strength': '3.9 mg/mL'},\n",
       "   {'name': 'SODIUM CHLORIDE', 'strength': '6.4 mg/mL'},\n",
       "   {'name': 'SODIUM CITRATE', 'strength': '1.7 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0065-1795-04',\n",
       "    'description': '500 mL in 1 BAG (0065-1795-04)',\n",
       "    'marketing_start_date': '19690328',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Alcon Laboratories, Inc.'],\n",
       "   'rxcui': ['806392', '806396'],\n",
       "   'spl_set_id': ['28488c7b-cf6a-4a03-916f-cc66b3afdc57'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['M4I0D6VV5M',\n",
       "    '02F3473H9O',\n",
       "    '660YQ98I10',\n",
       "    '4550K0SC9B',\n",
       "    '451W47IQ8X',\n",
       "    '1Q73Q2JULR']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': 'e84e5d87-f672-4e37-b65b-7f6a93db552a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '19690328',\n",
       "  'product_id': '0065-1795_e84e5d87-f672-4e37-b65b-7f6a93db552a',\n",
       "  'application_number': 'NDA020742',\n",
       "  'brand_name_base': 'BSS',\n",
       "  'pharm_class': ['Blood Coagulation Factor [EPC]',\n",
       "   'Calcium [CS]',\n",
       "   'Calculi Dissolution Agent [EPC]',\n",
       "   'Cations',\n",
       "   'Divalent [CS]',\n",
       "   'Increased Coagulation Factor Activity [PE]',\n",
       "   'Increased Large Intestinal Motility [PE]',\n",
       "   'Increased Large Intestinal Motility [PE]',\n",
       "   'Increased Large Intestinal Motility [PE]',\n",
       "   'Increased Large Intestinal Motility [PE]',\n",
       "   'Increased Large Intestinal Motility [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Magnesium Ion Exchange Activity [MoA]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Phosphate Binder [EPC]',\n",
       "   'Phosphate Chelating Activity [MoA]',\n",
       "   'Potassium Compounds [CS]',\n",
       "   'Potassium Salt [EPC]',\n",
       "   'Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]']},\n",
       " {'product_ndc': '0536-1376',\n",
       "  'generic_name': 'Acetaminophen and Ibuprofen',\n",
       "  'labeler_name': 'RUGBY LABORATORIES',\n",
       "  'brand_name': 'Acetaminophen and Ibuprofen',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '250 mg/1'},\n",
       "   {'name': 'IBUPROFEN', 'strength': '125 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1376-36',\n",
       "    'description': '36 TABLET in 1 BOTTLE (0536-1376-36)',\n",
       "    'marketing_start_date': '20230715',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['RUGBY LABORATORIES'],\n",
       "   'rxcui': ['2387532'],\n",
       "   'spl_set_id': ['ed340993-04e6-b084-e053-2a95a90abf60'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['362O9ITL9D', 'WK2XYI10QM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '27341419-7fa1-89d7-e063-6394a90a70d1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230715',\n",
       "  'product_id': '0536-1376_27341419-7fa1-89d7-e063-6394a90a70d1',\n",
       "  'application_number': 'ANDA216592',\n",
       "  'brand_name_base': 'Acetaminophen and Ibuprofen',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72162-2229',\n",
       "  'generic_name': 'warfarin sodium',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Warfarin Sodium',\n",
       "  'active_ingredients': [{'name': 'WARFARIN SODIUM', 'strength': '1 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2229-0',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72162-2229-0)',\n",
       "    'marketing_start_date': '20240126',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['855288'],\n",
       "   'spl_set_id': ['823e4594-6645-4770-a95b-8fe6938fa546'],\n",
       "   'unii': ['6153CWM0CL']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'd1057caf-f404-4c44-94d6-50bb3cfb8709',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20111111',\n",
       "  'product_id': '72162-2229_d1057caf-f404-4c44-94d6-50bb3cfb8709',\n",
       "  'application_number': 'ANDA090935',\n",
       "  'brand_name_base': 'Warfarin Sodium',\n",
       "  'pharm_class': ['Vitamin K Antagonist [EPC]', 'Vitamin K Inhibitors [MoA]']},\n",
       " {'product_ndc': '72162-2235',\n",
       "  'generic_name': 'Vardenafil Hydrochloride',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Vardenafil Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'VARDENAFIL HYDROCHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2235-3',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72162-2235-3)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['349479'],\n",
       "   'spl_set_id': ['6d2859a7-6def-455f-856b-9db86b1fd355'],\n",
       "   'unii': ['5M8S2CU0TS']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'aaf09699-ccf7-4fe5-92b7-83719fdac362',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181101',\n",
       "  'product_id': '72162-2235_aaf09699-ccf7-4fe5-92b7-83719fdac362',\n",
       "  'application_number': 'ANDA209057',\n",
       "  'brand_name_base': 'Vardenafil Hydrochloride',\n",
       "  'pharm_class': ['Phosphodiesterase 5 Inhibitor [EPC]',\n",
       "   'Phosphodiesterase 5 Inhibitors [MoA]']},\n",
       " {'product_ndc': '72162-2239',\n",
       "  'generic_name': 'dexlansoprazole',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Dexlansoprazole delayed release',\n",
       "  'brand_name_suffix': 'delayed release',\n",
       "  'active_ingredients': [{'name': 'DEXLANSOPRAZOLE', 'strength': '60 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2239-3',\n",
       "    'description': '30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (72162-2239-3)',\n",
       "    'marketing_start_date': '20221201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2239-9',\n",
       "    'description': '90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (72162-2239-9)',\n",
       "    'marketing_start_date': '20221201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['833213'],\n",
       "   'spl_set_id': ['dcfe880a-b96d-4a3c-aa21-3998d0bcfe9e'],\n",
       "   'nui': ['N0000175525', 'N0000000147'],\n",
       "   'pharm_class_epc': ['Proton Pump Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Proton Pump Inhibitors [MoA]'],\n",
       "   'unii': ['UYE4T5I70X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, DELAYED RELEASE',\n",
       "  'spl_id': 'e2456b53-466f-4dbc-bd4a-e21d5e487303',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20221201',\n",
       "  'product_id': '72162-2239_e2456b53-466f-4dbc-bd4a-e21d5e487303',\n",
       "  'application_number': 'ANDA202666',\n",
       "  'brand_name_base': 'Dexlansoprazole',\n",
       "  'pharm_class': ['Proton Pump Inhibitor [EPC]',\n",
       "   'Proton Pump Inhibitors [MoA]']},\n",
       " {'product_ndc': '72162-2262',\n",
       "  'generic_name': 'Prochlorperazine maleate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'PROCHLORPERAZINE MALEATE',\n",
       "  'active_ingredients': [{'name': 'PROCHLORPERAZINE MALEATE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2262-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-2262-1)',\n",
       "    'marketing_start_date': '20240223',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198365'],\n",
       "   'spl_set_id': ['7e3aa80a-3a5f-4937-b5aa-4ce2aa6ece1b'],\n",
       "   'unii': ['I1T8O1JTL6']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '8573c962-70c5-46a7-a07c-c4e796be294f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19980301',\n",
       "  'product_id': '72162-2262_8573c962-70c5-46a7-a07c-c4e796be294f',\n",
       "  'application_number': 'ANDA040268',\n",
       "  'brand_name_base': 'PROCHLORPERAZINE MALEATE',\n",
       "  'pharm_class': ['Phenothiazine [EPC]', 'Phenothiazines [CS]']},\n",
       " {'product_ndc': '72162-2268',\n",
       "  'generic_name': 'Digoxin',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Digoxin',\n",
       "  'active_ingredients': [{'name': 'DIGOXIN', 'strength': '125 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2268-0',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72162-2268-0)',\n",
       "    'marketing_start_date': '20240221',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2268-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-2268-1)',\n",
       "    'marketing_start_date': '20240221',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2268-2',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72162-2268-2)',\n",
       "    'marketing_start_date': '20240221',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2268-4',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-2268-4)',\n",
       "    'marketing_start_date': '20240221',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197604'],\n",
       "   'spl_set_id': ['e23bf2a6-1c24-44c4-8135-e469900f84b2'],\n",
       "   'nui': ['N0000175568', 'M0003451'],\n",
       "   'pharm_class_epc': ['Cardiac Glycoside [EPC]'],\n",
       "   'pharm_class_cs': ['Cardiac Glycosides [CS]'],\n",
       "   'unii': ['73K4184T59']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'a9a30c4c-9372-45a5-97ec-8d6e167e9f09',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220901',\n",
       "  'product_id': '72162-2268_a9a30c4c-9372-45a5-97ec-8d6e167e9f09',\n",
       "  'application_number': 'ANDA076268',\n",
       "  'brand_name_base': 'Digoxin',\n",
       "  'pharm_class': ['Cardiac Glycoside [EPC]', 'Cardiac Glycosides [CS]']},\n",
       " {'product_ndc': '72162-2273',\n",
       "  'generic_name': 'SODIUM FLUORIDE, VITAMIN A ACETATE, SODIUM ASCORBATE, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE CALCIUM, and CYANOCOBALAMIN',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Multi-Vit-Flor',\n",
       "  'active_ingredients': [{'name': '.ALPHA.-TOCOPHEROL, D-',\n",
       "    'strength': '10 mg/1'},\n",
       "   {'name': 'CHOLECALCIFEROL', 'strength': '10 ug/1'},\n",
       "   {'name': 'CYANOCOBALAMIN', 'strength': '4.5 ug/1'},\n",
       "   {'name': 'LEVOMEFOLATE CALCIUM', 'strength': '230 ug/1'},\n",
       "   {'name': 'NIACINAMIDE', 'strength': '10 mg/1'},\n",
       "   {'name': 'PYRIDOXINE HYDROCHLORIDE', 'strength': '1 mg/1'},\n",
       "   {'name': 'RIBOFLAVIN', 'strength': '1.2 mg/1'},\n",
       "   {'name': 'SODIUM ASCORBATE', 'strength': '60 mg/1'},\n",
       "   {'name': 'SODIUM FLUORIDE', 'strength': '.5 mg/1'},\n",
       "   {'name': 'THIAMINE HYDROCHLORIDE', 'strength': '1 mg/1'},\n",
       "   {'name': 'VITAMIN A ACETATE', 'strength': '600 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2273-3',\n",
       "    'description': '30 TABLET, CHEWABLE in 1 BOTTLE (72162-2273-3)',\n",
       "    'marketing_start_date': '20240430',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'spl_set_id': ['85b9ea54-0d3e-4fd7-a9c4-a57632fcdc8a'],\n",
       "   'nui': ['M0022797', 'N0000175952', 'M0022794', 'N0000175951'],\n",
       "   'pharm_class_cs': ['Vitamin D [CS]', 'Vitamin B 12 [CS]'],\n",
       "   'pharm_class_epc': ['Vitamin D [EPC]', 'Vitamin B12 [EPC]'],\n",
       "   'unii': ['N9PR3490H9',\n",
       "    '1C6V77QF41',\n",
       "    'P6YC3EG204',\n",
       "    'A9R10K3F2F',\n",
       "    '25X51I8RD4',\n",
       "    '68Y4CF58BV',\n",
       "    'TLM2976OFR',\n",
       "    'S033EH8359',\n",
       "    '8ZYQ1474W7',\n",
       "    'M572600E5P',\n",
       "    '3LE3D9D6OY']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'TABLET, CHEWABLE',\n",
       "  'spl_id': 'c8ef5525-85af-4319-bc93-73deb724f45b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220202',\n",
       "  'product_id': '72162-2273_c8ef5525-85af-4319-bc93-73deb724f45b',\n",
       "  'brand_name_base': 'Multi-Vit-Flor',\n",
       "  'pharm_class': ['Analogs/Derivatives [Chemical/Ingredient]',\n",
       "   'Ascorbic Acid [CS]',\n",
       "   'Folate Analog [EPC]',\n",
       "   'Folic Acid [CS]',\n",
       "   'Vitamin A [CS]',\n",
       "   'Vitamin A [EPC]',\n",
       "   'Vitamin B 12 [CS]',\n",
       "   'Vitamin B 6 [Chemical/Ingredient]',\n",
       "   'Vitamin B12 [EPC]',\n",
       "   'Vitamin B6 Analog [EPC]',\n",
       "   'Vitamin C [EPC]',\n",
       "   'Vitamin D [CS]',\n",
       "   'Vitamin D [EPC]']},\n",
       " {'product_ndc': '0536-1387',\n",
       "  'generic_name': 'Carboxymethylcellulose sodium',\n",
       "  'labeler_name': 'Rugby Laboratories',\n",
       "  'brand_name': 'Rugby Lubricant Eye Drops',\n",
       "  'active_ingredients': [{'name': 'CARBOXYMETHYLCELLULOSE SODIUM',\n",
       "    'strength': '.5 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1387-92',\n",
       "    'description': '30 VIAL, SINGLE-USE in 1 BOX (0536-1387-92)  / .4 mL in 1 VIAL, SINGLE-USE',\n",
       "    'marketing_start_date': '20230323',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0536-1387-93',\n",
       "    'description': '50 VIAL, SINGLE-USE in 1 BOX (0536-1387-93)  / .4 mL in 1 VIAL, SINGLE-USE',\n",
       "    'marketing_start_date': '20230323',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Rugby Laboratories'],\n",
       "   'rxcui': ['1188426'],\n",
       "   'spl_set_id': ['f9292d5d-e0a3-9287-e053-6294a90a43e9'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305361387938', '0305361387921'],\n",
       "   'unii': ['K679OBS311']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOLUTION/ DROPS',\n",
       "  'spl_id': '0cf9f932-b521-ab8b-e063-6394a90a4620',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20230323',\n",
       "  'product_id': '0536-1387_0cf9f932-b521-ab8b-e063-6394a90a4620',\n",
       "  'application_number': 'M018',\n",
       "  'brand_name_base': 'Rugby Lubricant Eye Drops'},\n",
       " {'product_ndc': '72162-2283',\n",
       "  'generic_name': 'Hydrocortisone',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'hydrocortisone',\n",
       "  'active_ingredients': [{'name': 'HYDROCORTISONE', 'strength': '1 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2283-2',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-2283-2)  / 28 g in 1 TUBE',\n",
       "    'marketing_start_date': '20110506',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2283-4',\n",
       "    'description': '1 JAR in 1 CARTON (72162-2283-4)  / 454 g in 1 JAR',\n",
       "    'marketing_start_date': '20110506',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['106258'],\n",
       "   'spl_set_id': ['484fe5e4-a058-49c0-a382-c8fc3e20c3b2'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['WI4X0X7BPJ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': 'fff8a0a9-bb19-42d0-a1ce-765d57987bc3',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20110506',\n",
       "  'product_id': '72162-2283_fff8a0a9-bb19-42d0-a1ce-765d57987bc3',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'hydrocortisone',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72162-2294',\n",
       "  'generic_name': 'Ivermectin',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Ivermectin',\n",
       "  'active_ingredients': [{'name': 'IVERMECTIN', 'strength': '10 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2294-2',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-2294-2)  / 45 g in 1 TUBE',\n",
       "    'marketing_start_date': '20240430',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1598068'],\n",
       "   'spl_set_id': ['75973e89-a03f-48dd-8fe8-8eafc1938d09'],\n",
       "   'nui': ['N0000175484', 'N0000181811'],\n",
       "   'pharm_class_epc': ['Antiparasitic [EPC]', 'Pediculicide [EPC]'],\n",
       "   'unii': ['8883YP2R6D']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '52941169-0451-420d-ae84-6ade7484946a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240108',\n",
       "  'product_id': '72162-2294_52941169-0451-420d-ae84-6ade7484946a',\n",
       "  'application_number': 'ANDA210225',\n",
       "  'brand_name_base': 'Ivermectin',\n",
       "  'pharm_class': ['Antiparasitic [EPC]', 'Pediculicide [EPC]']},\n",
       " {'product_ndc': '72162-2314',\n",
       "  'generic_name': 'SODIUM BICARBONATE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Sodium Bicarbonate',\n",
       "  'active_ingredients': [{'name': 'SODIUM BICARBONATE',\n",
       "    'strength': '84 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2314-2',\n",
       "    'description': '20 VIAL in 1 CARTON (72162-2314-2)  / 50 mL in 1 VIAL (72162-2314-7)',\n",
       "    'marketing_start_date': '20240522',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2314-4',\n",
       "    'description': '25 VIAL in 1 CARTON (72162-2314-4)  / 50 mL in 1 VIAL (72162-2314-8)',\n",
       "    'marketing_start_date': '20240522',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1868486'],\n",
       "   'spl_set_id': ['ccf8e08c-2efb-4a92-a4c2-042dba2eacfa'],\n",
       "   'unii': ['8MDF5V39QO']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'f11159cc-64d6-401c-8aab-1db92bd22415',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20230616',\n",
       "  'product_id': '72162-2314_f11159cc-64d6-401c-8aab-1db92bd22415',\n",
       "  'application_number': 'ANDA216364',\n",
       "  'brand_name_base': 'Sodium Bicarbonate',\n",
       "  'pharm_class': ['Alkalinizing Activity [MoA]']},\n",
       " {'product_ndc': '72162-2319',\n",
       "  'generic_name': 'fluocinolone acetonide',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Fluocinolone Acetonide',\n",
       "  'active_ingredients': [{'name': 'FLUOCINOLONE ACETONIDE',\n",
       "    'strength': '.11 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2319-2',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72162-2319-2)  / 118.28 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20240520',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1191307'],\n",
       "   'spl_set_id': ['8ca4528d-7afa-451e-97ae-9c1c21c07a6e'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['0CD5FD6S2M']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'OIL',\n",
       "  'spl_id': '8d41874c-cf04-42e2-9069-d9474736dae6',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210402',\n",
       "  'product_id': '72162-2319_8d41874c-cf04-42e2-9069-d9474736dae6',\n",
       "  'application_number': 'ANDA212760',\n",
       "  'brand_name_base': 'Fluocinolone Acetonide',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72162-2325',\n",
       "  'generic_name': 'Atenolol',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Atenolol',\n",
       "  'active_ingredients': [{'name': 'ATENOLOL', 'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2325-0',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72162-2325-0)',\n",
       "    'marketing_start_date': '20240605',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2325-9',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72162-2325-9)',\n",
       "    'marketing_start_date': '20240605',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197381'],\n",
       "   'spl_set_id': ['ecfcebcc-8fcd-48e6-871e-151074df3abc'],\n",
       "   'nui': ['N0000000161', 'N0000175556'],\n",
       "   'pharm_class_moa': ['Adrenergic beta-Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['beta-Adrenergic Blocker [EPC]'],\n",
       "   'unii': ['50VV3VW0TI']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '927127b5-6f5f-48d4-b1f9-fdac0b4669eb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20221219',\n",
       "  'product_id': '72162-2325_927127b5-6f5f-48d4-b1f9-fdac0b4669eb',\n",
       "  'application_number': 'ANDA073026',\n",
       "  'brand_name_base': 'Atenolol',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72162-2328',\n",
       "  'generic_name': 'benazepril hydrochloride and hydrochlorothiazide',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'benazepril hydrochloride and hydrochlorothiazide',\n",
       "  'active_ingredients': [{'name': 'BENAZEPRIL HYDROCHLORIDE',\n",
       "    'strength': '20 mg/1'},\n",
       "   {'name': 'HYDROCHLOROTHIAZIDE', 'strength': '12.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2328-1',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72162-2328-1)',\n",
       "    'marketing_start_date': '20240618',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['898367'],\n",
       "   'spl_set_id': ['f4120568-dd9b-47a5-bd44-4de6ed343bbe'],\n",
       "   'nui': ['N0000175359', 'N0000175419', 'M0471776'],\n",
       "   'pharm_class_pe': ['Increased Diuresis [PE]'],\n",
       "   'pharm_class_epc': ['Thiazide Diuretic [EPC]'],\n",
       "   'pharm_class_cs': ['Thiazides [CS]'],\n",
       "   'unii': ['N1SN99T69T', '0J48LPH2TH']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '8c875109-8488-4162-9a8c-d679347c4c0a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190407',\n",
       "  'product_id': '72162-2328_8c875109-8488-4162-9a8c-d679347c4c0a',\n",
       "  'application_number': 'NDA020033',\n",
       "  'brand_name_base': 'benazepril hydrochloride and hydrochlorothiazide',\n",
       "  'pharm_class': ['Angiotensin Converting Enzyme Inhibitor [EPC]',\n",
       "   'Angiotensin-converting Enzyme Inhibitors [MoA]',\n",
       "   'Decreased Blood Pressure [PE]',\n",
       "   'Increased Diuresis [PE]',\n",
       "   'Thiazide Diuretic [EPC]',\n",
       "   'Thiazides [CS]']},\n",
       " {'product_ndc': '72162-2330',\n",
       "  'generic_name': 'Desoximetasone',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Desoximetasone',\n",
       "  'active_ingredients': [{'name': 'DESOXIMETASONE', 'strength': '2.5 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2330-2',\n",
       "    'description': '1 TUBE in 1 CARTON (72162-2330-2)  / 15 g in 1 TUBE',\n",
       "    'marketing_start_date': '20240618',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['197574'],\n",
       "   'spl_set_id': ['302fc53a-2779-4168-b76c-9ae0cf0b3331'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['4E07GXB7AU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '1529aea8-6af6-4351-aec7-4dcc1790e4ff',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20061024',\n",
       "  'product_id': '72162-2330_1529aea8-6af6-4351-aec7-4dcc1790e4ff',\n",
       "  'application_number': 'ANDA076510',\n",
       "  'brand_name_base': 'Desoximetasone',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72162-2349',\n",
       "  'generic_name': 'Dextroamphetamine Sulfate',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Dextroamphetamine Sulfate',\n",
       "  'active_ingredients': [{'name': 'DEXTROAMPHETAMINE SULFATE',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2349-3',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72162-2349-3)',\n",
       "    'marketing_start_date': '20210414',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['884386'],\n",
       "   'spl_set_id': ['fc164327-dd48-4851-b613-71d957ee6066'],\n",
       "   'unii': ['JJ768O327N']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '590aeb8e-4cb1-449a-b209-14c9adbf8875',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20120716',\n",
       "  'product_id': '72162-2349_590aeb8e-4cb1-449a-b209-14c9adbf8875',\n",
       "  'application_number': 'ANDA090533',\n",
       "  'brand_name_base': 'Dextroamphetamine Sulfate',\n",
       "  'pharm_class': ['Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulation [PE]']},\n",
       " {'product_ndc': '72162-2354',\n",
       "  'generic_name': 'Irbesartan',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Irbesartan',\n",
       "  'active_ingredients': [{'name': 'IRBESARTAN', 'strength': '150 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2354-3',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72162-2354-3)',\n",
       "    'marketing_start_date': '20240628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2354-9',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72162-2354-9)',\n",
       "    'marketing_start_date': '20240628',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['200095'],\n",
       "   'spl_set_id': ['5c125c2a-a709-4cf1-b2d5-6e1d24a77377'],\n",
       "   'nui': ['N0000000070', 'N0000175561'],\n",
       "   'pharm_class_moa': ['Angiotensin 2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Angiotensin 2 Receptor Blocker [EPC]'],\n",
       "   'unii': ['J0E2756Z7N']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '791ade0d-bcd2-4f5d-8908-336ae6372b96',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20120927',\n",
       "  'product_id': '72162-2354_791ade0d-bcd2-4f5d-8908-336ae6372b96',\n",
       "  'application_number': 'ANDA202910',\n",
       "  'brand_name_base': 'Irbesartan',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]']},\n",
       " {'product_ndc': '72162-2361',\n",
       "  'generic_name': 'Zafirlukast',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Zafirlukast',\n",
       "  'active_ingredients': [{'name': 'ZAFIRLUKAST', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2361-6',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (72162-2361-6)',\n",
       "    'marketing_start_date': '20240628',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['199655'],\n",
       "   'spl_set_id': ['d2256673-fe8b-4fba-a73a-a81e24e47cf8'],\n",
       "   'nui': ['N0000175777', 'N0000000083', 'N0000185504'],\n",
       "   'pharm_class_epc': ['Leukotriene Receptor Antagonist [EPC]'],\n",
       "   'pharm_class_moa': ['Leukotriene Receptor Antagonists [MoA]',\n",
       "    'Cytochrome P450 2C9 Inhibitors [MoA]'],\n",
       "   'unii': ['XZ629S5L50']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '50679c31-2161-47a0-a704-13a01760fdbf',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200910',\n",
       "  'product_id': '72162-2361_50679c31-2161-47a0-a704-13a01760fdbf',\n",
       "  'application_number': 'ANDA212475',\n",
       "  'brand_name_base': 'Zafirlukast',\n",
       "  'pharm_class': ['Cytochrome P450 2C9 Inhibitors [MoA]',\n",
       "   'Leukotriene Receptor Antagonist [EPC]',\n",
       "   'Leukotriene Receptor Antagonists [MoA]']},\n",
       " {'product_ndc': '72162-2384',\n",
       "  'generic_name': 'Ketorolac Tromethamine',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Ketorolac Tromethamine',\n",
       "  'active_ingredients': [{'name': 'KETOROLAC TROMETHAMINE',\n",
       "    'strength': '5 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2384-2',\n",
       "    'description': '5 mL in 1 BOTTLE (72162-2384-2)',\n",
       "    'marketing_start_date': '20190603',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2384-4',\n",
       "    'description': '10 mL in 1 BOTTLE (72162-2384-4)',\n",
       "    'marketing_start_date': '20190603',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['860107'],\n",
       "   'spl_set_id': ['8a495869-cbf7-4164-b3b2-6d4215edae6a'],\n",
       "   'unii': ['4EVE5946BQ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': 'eec8e994-405d-452b-9b3e-44652fedf105',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20190603',\n",
       "  'product_id': '72162-2384_eec8e994-405d-452b-9b3e-44652fedf105',\n",
       "  'application_number': 'ANDA203410',\n",
       "  'brand_name_base': 'Ketorolac Tromethamine',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitor [EPC]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72162-2396',\n",
       "  'generic_name': 'Perphenazine',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Perphenazine',\n",
       "  'active_ingredients': [{'name': 'PERPHENAZINE', 'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2396-1',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72162-2396-1)',\n",
       "    'marketing_start_date': '20240930',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198076'],\n",
       "   'spl_set_id': ['e2e52bd9-b9c2-4f04-af03-bdb54b48c16c'],\n",
       "   'nui': ['N0000175746', 'M0016525'],\n",
       "   'pharm_class_epc': ['Phenothiazine [EPC]'],\n",
       "   'pharm_class_cs': ['Phenothiazines [CS]'],\n",
       "   'unii': ['FTA7XXY4EZ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '4eea02d5-6ac3-4f06-9969-5a72d1d1062e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180206',\n",
       "  'product_id': '72162-2396_4eea02d5-6ac3-4f06-9969-5a72d1d1062e',\n",
       "  'application_number': 'ANDA205973',\n",
       "  'brand_name_base': 'Perphenazine',\n",
       "  'pharm_class': ['Phenothiazine [EPC]', 'Phenothiazines [CS]']},\n",
       " {'product_ndc': '72162-2402',\n",
       "  'generic_name': 'DOXYCYCLINE HYCLATE',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'DOXYCYCLINE HYCLATE',\n",
       "  'active_ingredients': [{'name': 'DOXYCYCLINE HYCLATE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2402-2',\n",
       "    'description': '14 TABLET in 1 BOTTLE (72162-2402-2)',\n",
       "    'marketing_start_date': '20241008',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['1650143'],\n",
       "   'spl_set_id': ['fd58dbe5-aab2-4378-b054-d5c60d87074e'],\n",
       "   'unii': ['19XTS3T51U']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'ffaac40e-5fd1-4115-ab63-cb13723c1f7d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20191009',\n",
       "  'product_id': '72162-2402_ffaac40e-5fd1-4115-ab63-cb13723c1f7d',\n",
       "  'application_number': 'ANDA211343',\n",
       "  'brand_name_base': 'DOXYCYCLINE HYCLATE',\n",
       "  'pharm_class': ['Tetracycline-class Drug [EPC]', 'Tetracyclines [CS]']},\n",
       " {'product_ndc': '72162-2411',\n",
       "  'generic_name': 'Sertraline',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Sertraline',\n",
       "  'active_ingredients': [{'name': 'SERTRALINE HYDROCHLORIDE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2411-0',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (72162-2411-0)',\n",
       "    'marketing_start_date': '20241030',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2411-1',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72162-2411-1)',\n",
       "    'marketing_start_date': '20241030',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2411-5',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (72162-2411-5)',\n",
       "    'marketing_start_date': '20241030',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['312938'],\n",
       "   'spl_set_id': ['e0adb991-ec4e-4cd1-b54e-6d8c731a1d59'],\n",
       "   'unii': ['UTI8907Y6X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '5b0fcd43-bf70-46ac-bd7a-a35287d6c9bb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230223',\n",
       "  'product_id': '72162-2411_5b0fcd43-bf70-46ac-bd7a-a35287d6c9bb',\n",
       "  'application_number': 'ANDA076465',\n",
       "  'brand_name_base': 'Sertraline',\n",
       "  'pharm_class': ['Cytochrome P450 2D6 Inhibitors [MoA]',\n",
       "   'Serotonin Reuptake Inhibitor [EPC]',\n",
       "   'Serotonin Uptake Inhibitors [MoA]']},\n",
       " {'product_ndc': '72162-2421',\n",
       "  'generic_name': 'Celecoxib',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Celecoxib',\n",
       "  'active_ingredients': [{'name': 'CELECOXIB', 'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72162-2421-1',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (72162-2421-1)',\n",
       "    'marketing_start_date': '20241111',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72162-2421-5',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (72162-2421-5)',\n",
       "    'marketing_start_date': '20241111',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['205323'],\n",
       "   'spl_set_id': ['1bf407db-8bc6-4aea-8bcc-eaa4c24cb7a6'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['JCX84Q7J1L']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'ee36adc1-dbb8-4415-965e-7ef6d3160cd2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210823',\n",
       "  'product_id': '72162-2421_ee36adc1-dbb8-4415-965e-7ef6d3160cd2',\n",
       "  'application_number': 'ANDA208701',\n",
       "  'brand_name_base': 'Celecoxib',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72164-005',\n",
       "  'generic_name': 'POTASSIUM NITRATE, SODIUM FLUORIDE',\n",
       "  'labeler_name': 'Smiletwice, Inc.',\n",
       "  'brand_name': 'Wintergreen Peppermint',\n",
       "  'active_ingredients': [{'name': 'POTASSIUM NITRATE', 'strength': '50 mg/g'},\n",
       "   {'name': 'SODIUM FLUORIDE', 'strength': '1.5 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72164-005-00',\n",
       "    'description': '96 g in 1 TUBE (72164-005-00)',\n",
       "    'marketing_start_date': '20220301',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Smiletwice, Inc.'],\n",
       "   'rxcui': ['1038929'],\n",
       "   'spl_set_id': ['7b7beec2-e070-4102-a2a4-68c332fc9fb3'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0854679008009'],\n",
       "   'unii': ['RU45X2JN0Z', '8ZYQ1474W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'PASTE, DENTIFRICE',\n",
       "  'spl_id': '0d0b8a06-8584-2cfe-e063-6294a90af7a0',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['DENTAL'],\n",
       "  'marketing_start_date': '20220301',\n",
       "  'product_id': '72164-005_0d0b8a06-8584-2cfe-e063-6294a90af7a0',\n",
       "  'application_number': 'M022',\n",
       "  'brand_name_base': 'Wintergreen Peppermint'},\n",
       " {'product_ndc': '0536-1433',\n",
       "  'generic_name': 'Levonorgestrel',\n",
       "  'labeler_name': 'Rugby Laboratories',\n",
       "  'brand_name': 'Levonorgestrel',\n",
       "  'active_ingredients': [{'name': 'LEVONORGESTREL', 'strength': '1.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0536-1433-63',\n",
       "    'description': '1 BLISTER PACK in 1 CARTON (0536-1433-63)  / 1 TABLET in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20240524',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Rugby Laboratories'],\n",
       "   'rxcui': ['483325'],\n",
       "   'spl_set_id': ['076126e4-9d76-45cd-a86b-5b35c56b620a'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175830', 'M0447349', 'N0000175602', 'N0000175832'],\n",
       "   'pharm_class_pe': ['Inhibit Ovum Fertilization [PE]'],\n",
       "   'pharm_class_cs': ['Progesterone Congeners [CS]'],\n",
       "   'pharm_class_epc': ['Progestin [EPC]',\n",
       "    'Progestin-containing Intrauterine System [EPC]'],\n",
       "   'unii': ['5W7SIA7YZW']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '07d19c73-967d-49d7-8c7b-1d2273a8818b',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240524',\n",
       "  'product_id': '0536-1433_07d19c73-967d-49d7-8c7b-1d2273a8818b',\n",
       "  'application_number': 'ANDA206867',\n",
       "  'brand_name_base': 'Levonorgestrel',\n",
       "  'pharm_class': ['Inhibit Ovum Fertilization [PE]',\n",
       "   'Progesterone Congeners [CS]',\n",
       "   'Progesterone Congeners [CS]',\n",
       "   'Progestin [EPC]',\n",
       "   'Progestin-containing Intrauterine System [EPC]']},\n",
       " {'product_ndc': '72172-001',\n",
       "  'generic_name': 'Alcohol',\n",
       "  'labeler_name': 'Microbe Solutions, LLC',\n",
       "  'brand_name': 'Common Sense',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '62 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72172-001-01',\n",
       "    'description': '50 mL in 1 BOTTLE, PLASTIC (72172-001-01)',\n",
       "    'marketing_start_date': '20180815',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72172-001-02',\n",
       "    'description': '500 mL in 1 BOTTLE, PLASTIC (72172-001-02)',\n",
       "    'marketing_start_date': '20180815',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72172-001-03',\n",
       "    'description': '1000 mL in 1 BOTTLE, PLASTIC (72172-001-03)',\n",
       "    'marketing_start_date': '20180815',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72172-001-04',\n",
       "    'description': '250 mL in 1 BOTTLE, PLASTIC (72172-001-04)',\n",
       "    'marketing_start_date': '20180815',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72172-001-05',\n",
       "    'description': '59 mL in 1 BOTTLE, PLASTIC (72172-001-05)',\n",
       "    'marketing_start_date': '20180815',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Microbe Solutions, LLC'],\n",
       "   'rxcui': ['247835'],\n",
       "   'spl_set_id': ['ad7f89fe-3b10-425e-9362-0bcffbcff3e0'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'eff39617-fb01-331e-e053-2995a90a1c76',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180815',\n",
       "  'product_id': '72172-001_eff39617-fb01-331e-e053-2995a90a1c76',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'Common Sense'},\n",
       " {'product_ndc': '72189-031',\n",
       "  'generic_name': 'DONEPEZIL HYDROCHLORIDE',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'DONEPEZIL HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'DONEPEZIL HYDROCHLORIDE',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-031-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72189-031-30)',\n",
       "    'marketing_start_date': '20191001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['997229'],\n",
       "   'spl_set_id': ['93dddf28-094b-dd8c-e053-2995a90a63e9'],\n",
       "   'unii': ['3O2T2PJ89D']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'ca90724d-86f5-8353-e053-2a95a90af420',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20191001',\n",
       "  'product_id': '72189-031_ca90724d-86f5-8353-e053-2a95a90af420',\n",
       "  'application_number': 'ANDA200292',\n",
       "  'brand_name_base': 'DONEPEZIL HYDROCHLORIDE',\n",
       "  'pharm_class': ['Cholinesterase Inhibitor [EPC]',\n",
       "   'Cholinesterase Inhibitors [MoA]']},\n",
       " {'product_ndc': '72189-098',\n",
       "  'generic_name': 'LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE',\n",
       "  'active_ingredients': [{'name': 'HYDROCHLOROTHIAZIDE',\n",
       "    'strength': '12.5 mg/1'},\n",
       "   {'name': 'LOSARTAN POTASSIUM', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-098-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (72189-098-90)',\n",
       "    'marketing_start_date': '20200612',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['979464', '979468', '979471'],\n",
       "   'spl_set_id': ['8de04bf2-83dd-c494-e053-2a95a90abade'],\n",
       "   'nui': ['N0000175359', 'N0000175419', 'M0471776'],\n",
       "   'pharm_class_pe': ['Increased Diuresis [PE]'],\n",
       "   'pharm_class_epc': ['Thiazide Diuretic [EPC]'],\n",
       "   'pharm_class_cs': ['Thiazides [CS]'],\n",
       "   'unii': ['3ST302B24A', '0J48LPH2TH']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'ff328439-b70e-9387-e053-6294a90a45cb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200612',\n",
       "  'product_id': '72189-098_ff328439-b70e-9387-e053-6294a90a45cb',\n",
       "  'application_number': 'ANDA077157',\n",
       "  'brand_name_base': 'LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]',\n",
       "   'Increased Diuresis [PE]',\n",
       "   'Thiazide Diuretic [EPC]',\n",
       "   'Thiazides [CS]']},\n",
       " {'product_ndc': '72189-102',\n",
       "  'generic_name': 'TORSEMIDE',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'TORSEMIDE',\n",
       "  'active_ingredients': [{'name': 'TORSEMIDE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-102-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72189-102-30)',\n",
       "    'marketing_start_date': '20200511',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['198369'],\n",
       "   'spl_set_id': ['91d45625-5ba6-b50f-e053-2a95a90ac314'],\n",
       "   'nui': ['N0000175366', 'N0000175590'],\n",
       "   'pharm_class_pe': ['Increased Diuresis at Loop of Henle [PE]'],\n",
       "   'pharm_class_epc': ['Loop Diuretic [EPC]'],\n",
       "   'unii': ['W31X2H97FB']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'd31f75dc-1261-3d92-e053-2995a90afb56',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200511',\n",
       "  'product_id': '72189-102_d31f75dc-1261-3d92-e053-2995a90afb56',\n",
       "  'application_number': 'ANDA079234',\n",
       "  'brand_name_base': 'TORSEMIDE',\n",
       "  'pharm_class': ['Increased Diuresis at Loop of Henle [PE]',\n",
       "   'Loop Diuretic [EPC]']},\n",
       " {'product_ndc': '72189-117',\n",
       "  'generic_name': 'DOXAZOSIN',\n",
       "  'labeler_name': 'direct rx',\n",
       "  'brand_name': 'DOXAZOSIN',\n",
       "  'active_ingredients': [{'name': 'DOXAZOSIN MESYLATE', 'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-117-60',\n",
       "    'description': '60 TABLET in 1 BOTTLE (72189-117-60)',\n",
       "    'marketing_start_date': '20201202',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['direct rx'],\n",
       "   'rxcui': ['197626'],\n",
       "   'spl_set_id': ['b57cf33b-e0bd-54e9-e053-2a95a90a5a6a'],\n",
       "   'unii': ['86P6PQK0MU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'b57cf33b-e0be-54e9-e053-2a95a90a5a6a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201202',\n",
       "  'product_id': '72189-117_b57cf33b-e0be-54e9-e053-2a95a90a5a6a',\n",
       "  'application_number': 'ANDA202824',\n",
       "  'brand_name_base': 'DOXAZOSIN',\n",
       "  'pharm_class': ['Adrenergic alpha-Antagonists [MoA]',\n",
       "   'alpha-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '0065-4274',\n",
       "  'generic_name': 'OLOPATADINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Alcon Laboratories, Inc.',\n",
       "  'brand_name': 'PATADAY TWICE A DAY RELIEF',\n",
       "  'active_ingredients': [{'name': 'OLOPATADINE HYDROCHLORIDE',\n",
       "    'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0065-4274-01',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (0065-4274-01)  / 5 mL in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20200225',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Alcon Laboratories, Inc.'],\n",
       "   'rxcui': ['1111339', '2281304'],\n",
       "   'spl_set_id': ['b7a24375-25df-4405-aa7c-34c46af51194'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['2XG66W44KF']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': 'ac033450-8f36-4649-85c3-ddd5b5b7195f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20200225',\n",
       "  'product_id': '0065-4274_ac033450-8f36-4649-85c3-ddd5b5b7195f',\n",
       "  'application_number': 'NDA020688',\n",
       "  'brand_name_base': 'PATADAY TWICE A DAY RELIEF',\n",
       "  'pharm_class': ['Decreased Histamine Release [PE]',\n",
       "   'Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]',\n",
       "   'Histamine-1 Receptor Inhibitor [EPC]',\n",
       "   'Mast Cell Stabilizer [EPC]']},\n",
       " {'product_ndc': '72189-129',\n",
       "  'generic_name': 'losartan potassium and hydrochlorothiazide',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE',\n",
       "  'active_ingredients': [{'name': 'HYDROCHLOROTHIAZIDE',\n",
       "    'strength': '12.5 mg/1'},\n",
       "   {'name': 'LOSARTAN POTASSIUM', 'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-129-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72189-129-30)',\n",
       "    'marketing_start_date': '20201015',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-129-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (72189-129-90)',\n",
       "    'marketing_start_date': '20201015',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['979464', '979468', '979471'],\n",
       "   'spl_set_id': ['8de04bf2-83dd-c494-e053-2a95a90abade'],\n",
       "   'nui': ['N0000175359', 'N0000175419', 'M0471776'],\n",
       "   'pharm_class_pe': ['Increased Diuresis [PE]'],\n",
       "   'pharm_class_epc': ['Thiazide Diuretic [EPC]'],\n",
       "   'pharm_class_cs': ['Thiazides [CS]'],\n",
       "   'unii': ['3ST302B24A', '0J48LPH2TH']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'ff328439-b70e-9387-e053-6294a90a45cb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201015',\n",
       "  'product_id': '72189-129_ff328439-b70e-9387-e053-6294a90a45cb',\n",
       "  'application_number': 'ANDA201845',\n",
       "  'brand_name_base': 'LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]',\n",
       "   'Increased Diuresis [PE]',\n",
       "   'Thiazide Diuretic [EPC]',\n",
       "   'Thiazides [CS]']},\n",
       " {'product_ndc': '72189-132',\n",
       "  'generic_name': 'OXYBUTYNIN CHLORIDE',\n",
       "  'labeler_name': 'DIRECT RX',\n",
       "  'brand_name': 'OXYBUTYNIN CHLORIDE',\n",
       "  'active_ingredients': [{'name': 'OXYBUTYNIN CHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-132-30',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-132-30)',\n",
       "    'marketing_start_date': '20200824',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['DIRECT RX'],\n",
       "   'rxcui': ['863619'],\n",
       "   'spl_set_id': ['ada3be87-2cdd-75f7-e053-2995a90aa95b'],\n",
       "   'unii': ['L9F3D9RENQ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': 'ada3be87-2cde-75f7-e053-2995a90aa95b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200824',\n",
       "  'product_id': '72189-132_ada3be87-2cde-75f7-e053-2995a90aa95b',\n",
       "  'application_number': 'ANDA207138',\n",
       "  'brand_name_base': 'OXYBUTYNIN CHLORIDE',\n",
       "  'pharm_class': ['Cholinergic Muscarinic Antagonist [EPC]',\n",
       "   'Cholinergic Muscarinic Antagonists [MoA]']},\n",
       " {'product_ndc': '72189-152',\n",
       "  'generic_name': 'atenolol',\n",
       "  'labeler_name': 'direct rx',\n",
       "  'brand_name': 'atenolol',\n",
       "  'active_ingredients': [{'name': 'ATENOLOL', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-152-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72189-152-90)',\n",
       "    'marketing_start_date': '20201110',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['direct rx'],\n",
       "   'rxcui': ['197379'],\n",
       "   'spl_set_id': ['b3c757de-1cbf-61f5-e053-2995a90accfc'],\n",
       "   'nui': ['N0000000161', 'N0000175556'],\n",
       "   'pharm_class_moa': ['Adrenergic beta-Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['beta-Adrenergic Blocker [EPC]'],\n",
       "   'unii': ['50VV3VW0TI']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'b3c757de-1cc0-61f5-e053-2995a90accfc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201110',\n",
       "  'product_id': '72189-152_b3c757de-1cc0-61f5-e053-2995a90accfc',\n",
       "  'application_number': 'ANDA077443',\n",
       "  'brand_name_base': 'atenolol',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72189-159',\n",
       "  'generic_name': 'LEVOTHYROXINE SODIUM',\n",
       "  'labeler_name': 'DIRECT RX',\n",
       "  'brand_name': 'LEVOTHYROXINE SODIUM',\n",
       "  'active_ingredients': [{'name': 'LEVOTHYROXINE SODIUM',\n",
       "    'strength': '112 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-159-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72189-159-30)',\n",
       "    'marketing_start_date': '20201201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-159-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72189-159-90)',\n",
       "    'marketing_start_date': '20201201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['DIRECT RX'],\n",
       "   'rxcui': ['892246',\n",
       "    '966220',\n",
       "    '966221',\n",
       "    '966222',\n",
       "    '966224',\n",
       "    '966225',\n",
       "    '966248',\n",
       "    '966253',\n",
       "    '966270'],\n",
       "   'spl_set_id': ['a5f15022-1166-09fe-e053-2a95a90aa218'],\n",
       "   'unii': ['9J765S329G']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '1922dbd9-96de-8652-e063-6294a90a0afe',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201201',\n",
       "  'product_id': '72189-159_1922dbd9-96de-8652-e063-6294a90a0afe',\n",
       "  'application_number': 'NDA021116',\n",
       "  'brand_name_base': 'LEVOTHYROXINE SODIUM',\n",
       "  'pharm_class': ['Thyroxine [CS]', 'l-Thyroxine [EPC]']},\n",
       " {'product_ndc': '72189-161',\n",
       "  'generic_name': 'DOXEPIN HYDROCHLORIDE',\n",
       "  'labeler_name': 'direct rx',\n",
       "  'brand_name': 'DOXEPIN HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'DOXEPIN HYDROCHLORIDE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-161-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (72189-161-30)',\n",
       "    'marketing_start_date': '20201201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['direct rx'],\n",
       "   'rxcui': ['1000070'],\n",
       "   'spl_set_id': ['b56cdaee-6187-c763-e053-2995a90acc3f'],\n",
       "   'unii': ['3U9A0FE9N5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'b56cdaee-6188-c763-e053-2995a90acc3f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201201',\n",
       "  'product_id': '72189-161_b56cdaee-6188-c763-e053-2995a90acc3f',\n",
       "  'application_number': 'ANDA213063',\n",
       "  'brand_name_base': 'DOXEPIN HYDROCHLORIDE',\n",
       "  'pharm_class': ['Tricyclic Antidepressant [EPC]']},\n",
       " {'product_ndc': '72189-162',\n",
       "  'generic_name': 'AMLODIPINE BESYLATE',\n",
       "  'labeler_name': 'DIRECT RX',\n",
       "  'brand_name': 'AMLODIPINE BESYLATE',\n",
       "  'active_ingredients': [{'name': 'AMLODIPINE BESYLATE',\n",
       "    'strength': '2.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-162-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72189-162-90)',\n",
       "    'marketing_start_date': '20210112',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['DIRECT RX'],\n",
       "   'rxcui': ['308136', '898342'],\n",
       "   'spl_set_id': ['b8b9a3cd-c4e7-dfeb-e053-2a95a90aa719'],\n",
       "   'unii': ['864V2Q084H']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'c9397a25-8fec-48d0-e053-2a95a90ab495',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210112',\n",
       "  'product_id': '72189-162_c9397a25-8fec-48d0-e053-2a95a90ab495',\n",
       "  'application_number': 'ANDA078925',\n",
       "  'brand_name_base': 'AMLODIPINE BESYLATE',\n",
       "  'pharm_class': ['Calcium Channel Antagonists [MoA]',\n",
       "   'Dihydropyridine Calcium Channel Blocker [EPC]',\n",
       "   'Dihydropyridines [CS]']},\n",
       " {'product_ndc': '72189-174',\n",
       "  'generic_name': 'LEVOTHYROXINE SODIUM',\n",
       "  'labeler_name': 'DIRECT RX',\n",
       "  'brand_name': 'LEVOTHYROXINE SODIUM',\n",
       "  'active_ingredients': [{'name': 'LEVOTHYROXINE SODIUM',\n",
       "    'strength': '25 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-174-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72189-174-30)',\n",
       "    'marketing_start_date': '20210209',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-174-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72189-174-90)',\n",
       "    'marketing_start_date': '20210209',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['DIRECT RX'],\n",
       "   'rxcui': ['892246',\n",
       "    '966220',\n",
       "    '966221',\n",
       "    '966222',\n",
       "    '966224',\n",
       "    '966225',\n",
       "    '966248',\n",
       "    '966253',\n",
       "    '966270'],\n",
       "   'spl_set_id': ['a5f15022-1166-09fe-e053-2a95a90aa218'],\n",
       "   'unii': ['9J765S329G']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '1922dbd9-96de-8652-e063-6294a90a0afe',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210209',\n",
       "  'product_id': '72189-174_1922dbd9-96de-8652-e063-6294a90a0afe',\n",
       "  'application_number': 'NDA021116',\n",
       "  'brand_name_base': 'LEVOTHYROXINE SODIUM',\n",
       "  'pharm_class': ['Thyroxine [CS]', 'l-Thyroxine [EPC]']},\n",
       " {'product_ndc': '72189-186',\n",
       "  'generic_name': 'CEFDINIR',\n",
       "  'labeler_name': 'DIRECT RX',\n",
       "  'brand_name': 'CEFDINIR',\n",
       "  'active_ingredients': [{'name': 'CEFDINIR', 'strength': '250 mg/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-186-32',\n",
       "    'description': '60 mL in 1 BOTTLE (72189-186-32)',\n",
       "    'marketing_start_date': '20210412',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['DIRECT RX'],\n",
       "   'rxcui': ['309054', '476576'],\n",
       "   'spl_set_id': ['982d0f53-20bc-1cb4-e053-2995a90ad33c'],\n",
       "   'nui': ['N0000175488', 'M0003827'],\n",
       "   'pharm_class_epc': ['Cephalosporin Antibacterial [EPC]'],\n",
       "   'pharm_class_cs': ['Cephalosporins [CS]'],\n",
       "   'unii': ['CI0FAO63WC']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'POWDER, FOR SUSPENSION',\n",
       "  'spl_id': 'cc1f06ae-3fc2-714c-e053-2995a90ac865',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210412',\n",
       "  'product_id': '72189-186_cc1f06ae-3fc2-714c-e053-2995a90ac865',\n",
       "  'application_number': 'ANDA065473',\n",
       "  'brand_name_base': 'CEFDINIR',\n",
       "  'pharm_class': ['Cephalosporin Antibacterial [EPC]', 'Cephalosporins [CS]']},\n",
       " {'product_ndc': '72189-192',\n",
       "  'generic_name': 'BENZONATATE',\n",
       "  'labeler_name': 'DIRECT RX',\n",
       "  'brand_name': 'BENZONATATE',\n",
       "  'active_ingredients': [{'name': 'BENZONATATE', 'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-192-20',\n",
       "    'description': '20 CAPSULE in 1 BOTTLE (72189-192-20)',\n",
       "    'marketing_start_date': '20210603',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-192-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (72189-192-30)',\n",
       "    'marketing_start_date': '20210603',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['DIRECT RX'],\n",
       "   'rxcui': ['197397', '283417'],\n",
       "   'spl_set_id': ['bec39717-eb88-6ca1-e053-2a95a90a9d9d'],\n",
       "   'nui': ['N0000009010', 'N0000175796'],\n",
       "   'pharm_class_pe': ['Decreased Tracheobronchial Stretch Receptor Activity [PE]'],\n",
       "   'pharm_class_epc': ['Non-narcotic Antitussive [EPC]'],\n",
       "   'unii': ['5P4DHS6ENR']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'ff331e8f-7603-e825-e053-6294a90af20a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210603',\n",
       "  'product_id': '72189-192_ff331e8f-7603-e825-e053-6294a90af20a',\n",
       "  'application_number': 'ANDA206948',\n",
       "  'brand_name_base': 'BENZONATATE',\n",
       "  'pharm_class': ['Decreased Tracheobronchial Stretch Receptor Activity [PE]',\n",
       "   'Non-narcotic Antitussive [EPC]']},\n",
       " {'product_ndc': '72189-209',\n",
       "  'generic_name': 'HYDROCORTISONE',\n",
       "  'labeler_name': 'DIRECT RX',\n",
       "  'brand_name': 'HYDROCORTISONE',\n",
       "  'active_ingredients': [{'name': 'HYDROCORTISONE', 'strength': '10 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-209-28',\n",
       "    'description': '28.4 g in 1 TUBE (72189-209-28)',\n",
       "    'marketing_start_date': '20210517',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['DIRECT RX'],\n",
       "   'rxcui': ['106258'],\n",
       "   'spl_set_id': ['c28c3ceb-1807-b43b-e053-2995a90a2aba'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['WI4X0X7BPJ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': 'c583b93e-c941-2e9b-e053-2a95a90a1b08',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210517',\n",
       "  'product_id': '72189-209_c583b93e-c941-2e9b-e053-2a95a90a1b08',\n",
       "  'application_number': 'ANDA087795',\n",
       "  'brand_name_base': 'HYDROCORTISONE',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72189-222',\n",
       "  'generic_name': 'ROPINIROLE',\n",
       "  'labeler_name': 'DIRECT RX',\n",
       "  'brand_name': 'ROPINIROLE',\n",
       "  'active_ingredients': [{'name': 'ROPINIROLE HYDROCHLORIDE',\n",
       "    'strength': '1 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-222-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72189-222-30)',\n",
       "    'marketing_start_date': '20210520',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-222-60',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (72189-222-60)',\n",
       "    'marketing_start_date': '20210520',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['DIRECT RX'],\n",
       "   'rxcui': ['314208'],\n",
       "   'spl_set_id': ['c2c38b4c-b139-45f2-e053-2995a90a262c'],\n",
       "   'unii': ['D7ZD41RZI9']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'd160b5f9-4265-9337-e053-2a95a90ae2c6',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210520',\n",
       "  'product_id': '72189-222_d160b5f9-4265-9337-e053-2a95a90ae2c6',\n",
       "  'application_number': 'ANDA204022',\n",
       "  'brand_name_base': 'ROPINIROLE',\n",
       "  'pharm_class': ['Dopamine Agonists [MoA]',\n",
       "   'Nonergot Dopamine Agonist [EPC]']},\n",
       " {'product_ndc': '72189-240',\n",
       "  'generic_name': 'ALPRAZOLAM',\n",
       "  'labeler_name': 'Direct Rx',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'ALPRAZOLAM',\n",
       "  'active_ingredients': [{'name': 'ALPRAZOLAM', 'strength': '.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-240-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72189-240-30)',\n",
       "    'marketing_start_date': '20210916',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-240-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72189-240-90)',\n",
       "    'marketing_start_date': '20210916',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct Rx'],\n",
       "   'rxcui': ['197321', '197322', '308048'],\n",
       "   'spl_set_id': ['ac886819-5bf1-2294-e053-2995a90ad058'],\n",
       "   'nui': ['N0000175694', 'M0002356'],\n",
       "   'pharm_class_epc': ['Benzodiazepine [EPC]'],\n",
       "   'pharm_class_cs': ['Benzodiazepines [CS]'],\n",
       "   'unii': ['YU55MQ3IZY']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'ff44e969-fc5e-ac2d-e053-6294a90a25bb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210916',\n",
       "  'product_id': '72189-240_ff44e969-fc5e-ac2d-e053-6294a90a25bb',\n",
       "  'application_number': 'ANDA207507',\n",
       "  'brand_name_base': 'ALPRAZOLAM',\n",
       "  'pharm_class': ['Benzodiazepine [EPC]', 'Benzodiazepines [CS]']},\n",
       " {'product_ndc': '72189-267',\n",
       "  'generic_name': 'VALPROIC ACID',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'VALPROIC ACID',\n",
       "  'active_ingredients': [{'name': 'VALPROIC ACID', 'strength': '250 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-267-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (72189-267-30)',\n",
       "    'marketing_start_date': '20210916',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['1099681'],\n",
       "   'spl_set_id': ['8bdbacb1-b38a-3282-e053-2a95a90af022'],\n",
       "   'nui': ['N0000175753', 'N0000008486', 'N0000175751'],\n",
       "   'pharm_class_epc': ['Anti-epileptic Agent [EPC]', 'Mood Stabilizer [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]'],\n",
       "   'unii': ['614OI1Z5WI']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'cc1e3db1-1345-59df-e053-2995a90a8ffc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210916',\n",
       "  'product_id': '72189-267_cc1e3db1-1345-59df-e053-2995a90a8ffc',\n",
       "  'application_number': 'ANDA207611',\n",
       "  'brand_name_base': 'VALPROIC ACID',\n",
       "  'pharm_class': ['Anti-epileptic Agent [EPC]',\n",
       "   'Decreased Central Nervous System Disorganized Electrical Activity [PE]',\n",
       "   'Mood Stabilizer [EPC]']},\n",
       " {'product_ndc': '72189-285',\n",
       "  'generic_name': 'AMOXICILLIN',\n",
       "  'labeler_name': 'DirectRx',\n",
       "  'brand_name': 'AMOXICILLIN',\n",
       "  'active_ingredients': [{'name': 'AMOXICILLIN', 'strength': '400 mg/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-285-32',\n",
       "    'description': '100 mL in 1 BOTTLE (72189-285-32)',\n",
       "    'marketing_start_date': '20211021',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['DirectRx'],\n",
       "   'rxcui': ['308189'],\n",
       "   'spl_set_id': ['cedde8f5-aadd-53de-e053-2995a90aab16'],\n",
       "   'unii': ['804826J2HU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'POWDER, FOR SUSPENSION',\n",
       "  'spl_id': 'd124c443-a2ec-7984-e053-2995a90ad7cd',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20211021',\n",
       "  'product_id': '72189-285_d124c443-a2ec-7984-e053-2995a90ad7cd',\n",
       "  'application_number': 'ANDA065334',\n",
       "  'brand_name_base': 'AMOXICILLIN',\n",
       "  'pharm_class': ['Penicillin-class Antibacterial [EPC]', 'Penicillins [CS]']},\n",
       " {'product_ndc': '72189-293',\n",
       "  'generic_name': 'PIOGLITAZONE',\n",
       "  'labeler_name': 'DirectRX',\n",
       "  'brand_name': 'PIOGLITAZONE',\n",
       "  'active_ingredients': [{'name': 'PIOGLITAZONE HYDROCHLORIDE',\n",
       "    'strength': '45 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-293-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72189-293-90)',\n",
       "    'marketing_start_date': '20211110',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['DirectRX'],\n",
       "   'rxcui': ['312441'],\n",
       "   'spl_set_id': ['d06fe500-4968-ba97-e053-2995a90ab1f6'],\n",
       "   'unii': ['JQT35NPK6C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'd06fe500-4969-ba97-e053-2995a90ab1f6',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20211110',\n",
       "  'product_id': '72189-293_d06fe500-4969-ba97-e053-2995a90ab1f6',\n",
       "  'application_number': 'ANDA200044',\n",
       "  'brand_name_base': 'PIOGLITAZONE',\n",
       "  'pharm_class': ['PPAR alpha [CS]',\n",
       "   'PPAR gamma [CS]',\n",
       "   'Peroxisome Proliferator Receptor alpha Agonist [EPC]',\n",
       "   'Peroxisome Proliferator Receptor gamma Agonist [EPC]',\n",
       "   'Peroxisome Proliferator-activated Receptor Activity [MoA]',\n",
       "   'Thiazolidinedione [EPC]',\n",
       "   'Thiazolidinediones [CS]']},\n",
       " {'product_ndc': '72189-301',\n",
       "  'generic_name': 'PHENTERMINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'DirectRx',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'PHENTERMINE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'PHENTERMINE HYDROCHLORIDE',\n",
       "    'strength': '37.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-301-14',\n",
       "    'description': '14 TABLET in 1 BOTTLE (72189-301-14)',\n",
       "    'marketing_start_date': '20211206',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-301-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72189-301-30)',\n",
       "    'marketing_start_date': '20211206',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['DirectRx'],\n",
       "   'rxcui': ['803353'],\n",
       "   'spl_set_id': ['d27d8379-aa3c-4688-e053-2995a90a44f6'],\n",
       "   'unii': ['0K2I505OTV']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'df498577-46cd-b389-e053-2a95a90a711e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20211206',\n",
       "  'product_id': '72189-301_df498577-46cd-b389-e053-2a95a90a711e',\n",
       "  'application_number': 'ANDA040876',\n",
       "  'brand_name_base': 'PHENTERMINE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Appetite Suppression [PE]',\n",
       "   'Increased Sympathetic Activity [PE]',\n",
       "   'Sympathomimetic Amine Anorectic [EPC]']},\n",
       " {'product_ndc': '72189-310',\n",
       "  'generic_name': 'CARISOPRODOL',\n",
       "  'labeler_name': 'Directrx',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'CARISOPRODOL',\n",
       "  'active_ingredients': [{'name': 'CARISOPRODOL', 'strength': '350 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-310-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72189-310-30)',\n",
       "    'marketing_start_date': '20220117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-310-60',\n",
       "    'description': '60 TABLET in 1 BOTTLE (72189-310-60)',\n",
       "    'marketing_start_date': '20220117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-310-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72189-310-90)',\n",
       "    'marketing_start_date': '20220117',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Directrx'],\n",
       "   'rxcui': ['197446'],\n",
       "   'spl_set_id': ['d5cc9f99-59ae-55db-e053-2995a90affb7'],\n",
       "   'nui': ['N0000175730', 'N0000175737'],\n",
       "   'pharm_class_pe': ['Centrally-mediated Muscle Relaxation [PE]'],\n",
       "   'pharm_class_epc': ['Muscle Relaxant [EPC]'],\n",
       "   'unii': ['21925K482H']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'ffc05799-7862-7c4f-e053-6394a90abd09',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220117',\n",
       "  'product_id': '72189-310_ffc05799-7862-7c4f-e053-6394a90abd09',\n",
       "  'application_number': 'ANDA040188',\n",
       "  'brand_name_base': 'CARISOPRODOL',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '72189-314',\n",
       "  'generic_name': 'AZITHROMYCIN',\n",
       "  'labeler_name': 'DirectRx',\n",
       "  'brand_name': 'AZITHROMYCIN',\n",
       "  'active_ingredients': [{'name': 'AZITHROMYCIN MONOHYDRATE',\n",
       "    'strength': '200 mg/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-314-22',\n",
       "    'description': '22.5 mL in 1 BOTTLE (72189-314-22)',\n",
       "    'marketing_start_date': '20220112',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['DirectRx'],\n",
       "   'rxcui': ['141963'],\n",
       "   'spl_set_id': ['d564d91e-3039-c120-e053-2995a90ae6db'],\n",
       "   'unii': ['JTE4MNN1MD']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'POWDER, FOR SUSPENSION',\n",
       "  'spl_id': 'd564d91e-303a-c120-e053-2995a90ae6db',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220112',\n",
       "  'product_id': '72189-314_d564d91e-303a-c120-e053-2995a90ae6db',\n",
       "  'application_number': 'ANDA207531',\n",
       "  'brand_name_base': 'AZITHROMYCIN',\n",
       "  'pharm_class': ['Macrolide Antimicrobial [EPC]', 'Macrolides [CS]']},\n",
       " {'product_ndc': '72189-323',\n",
       "  'generic_name': 'CIPROFLOXACIN',\n",
       "  'labeler_name': 'Direct Rx',\n",
       "  'brand_name': 'CIPROFLOXACIN',\n",
       "  'active_ingredients': [{'name': 'CIPROFLOXACIN HYDROCHLORIDE',\n",
       "    'strength': '250 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-323-06',\n",
       "    'description': '6 TABLET, COATED in 1 BOTTLE (72189-323-06)',\n",
       "    'marketing_start_date': '20220221',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct Rx'],\n",
       "   'rxcui': ['197511'],\n",
       "   'spl_set_id': ['d88a22f4-2f61-17f2-e053-2995a90acd14'],\n",
       "   'unii': ['4BA73M5E37']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': 'd88a22f4-2f62-17f2-e053-2995a90acd14',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220221',\n",
       "  'product_id': '72189-323_d88a22f4-2f62-17f2-e053-2995a90acd14',\n",
       "  'application_number': 'ANDA208921',\n",
       "  'brand_name_base': 'CIPROFLOXACIN',\n",
       "  'pharm_class': ['Quinolone Antimicrobial [EPC]', 'Quinolones [CS]']},\n",
       " {'product_ndc': '72189-342',\n",
       "  'generic_name': 'FLUCONAZOLE',\n",
       "  'labeler_name': 'Direct Rx',\n",
       "  'brand_name': 'FLUCONAZOLE',\n",
       "  'active_ingredients': [{'name': 'FLUCONAZOLE', 'strength': '150 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-342-01',\n",
       "    'description': '1 TABLET in 1 BOTTLE (72189-342-01)',\n",
       "    'marketing_start_date': '20220331',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct Rx'],\n",
       "   'rxcui': ['197699'],\n",
       "   'spl_set_id': ['db886cfe-ea23-50c9-e053-2995a90a4d10'],\n",
       "   'nui': ['N0000175487',\n",
       "    'M0002083',\n",
       "    'N0000182140',\n",
       "    'N0000182141',\n",
       "    'N0000185504'],\n",
       "   'pharm_class_epc': ['Azole Antifungal [EPC]'],\n",
       "   'pharm_class_cs': ['Azoles [CS]'],\n",
       "   'pharm_class_moa': ['Cytochrome P450 2C19 Inhibitors [MoA]',\n",
       "    'Cytochrome P450 3A4 Inhibitors [MoA]',\n",
       "    'Cytochrome P450 2C9 Inhibitors [MoA]'],\n",
       "   'unii': ['8VZV102JFY']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'db886cfe-ea24-50c9-e053-2995a90a4d10',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220331',\n",
       "  'product_id': '72189-342_db886cfe-ea24-50c9-e053-2995a90a4d10',\n",
       "  'application_number': 'ANDA077253',\n",
       "  'brand_name_base': 'FLUCONAZOLE',\n",
       "  'pharm_class': ['Azole Antifungal [EPC]',\n",
       "   'Azoles [CS]',\n",
       "   'Cytochrome P450 2C19 Inhibitors [MoA]',\n",
       "   'Cytochrome P450 2C9 Inhibitors [MoA]',\n",
       "   'Cytochrome P450 3A4 Inhibitors [MoA]']},\n",
       " {'product_ndc': '72189-343',\n",
       "  'generic_name': 'HYDROCODONE BITARTRATE AND ACETAMINOPHEN',\n",
       "  'labeler_name': 'Direct Rx',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'HYDROCODONE BITARTRATE AND ACETAMINOPHEN',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '325 mg/1'},\n",
       "   {'name': 'HYDROCODONE BITARTRATE', 'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-343-08',\n",
       "    'description': '8 TABLET in 1 BOTTLE (72189-343-08)',\n",
       "    'marketing_start_date': '20220922',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-343-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72189-343-30)',\n",
       "    'marketing_start_date': '20220330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-343-60',\n",
       "    'description': '60 TABLET in 1 BOTTLE (72189-343-60)',\n",
       "    'marketing_start_date': '20220330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-343-72',\n",
       "    'description': '120 TABLET in 1 BOTTLE (72189-343-72)',\n",
       "    'marketing_start_date': '20220330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-343-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72189-343-90)',\n",
       "    'marketing_start_date': '20220330',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct Rx'],\n",
       "   'rxcui': ['857002'],\n",
       "   'spl_set_id': ['db73b8ed-9747-6a49-e053-2a95a90a93a1'],\n",
       "   'unii': ['362O9ITL9D', 'NO70W886KK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'ffc1465a-4d9d-96f3-e053-6294a90af88b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220330',\n",
       "  'product_id': '72189-343_ffc1465a-4d9d-96f3-e053-6294a90af88b',\n",
       "  'application_number': 'ANDA211487',\n",
       "  'brand_name_base': 'HYDROCODONE BITARTRATE AND ACETAMINOPHEN',\n",
       "  'pharm_class': ['Opioid Agonist [EPC]', 'Opioid Agonists [MoA]']},\n",
       " {'product_ndc': '72189-346',\n",
       "  'generic_name': 'LEVOTHYROXINE SODIUM',\n",
       "  'labeler_name': 'Direct Rx',\n",
       "  'brand_name': 'LEVOTHYROXINE SODIUM',\n",
       "  'active_ingredients': [{'name': 'LEVOTHYROXINE SODIUM',\n",
       "    'strength': '200 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-346-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72189-346-90)',\n",
       "    'marketing_start_date': '20220419',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct Rx'],\n",
       "   'rxcui': ['892251'],\n",
       "   'spl_set_id': ['dd032289-acee-49fc-e053-2a95a90a5999'],\n",
       "   'unii': ['9J765S329G']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'dd032289-acef-49fc-e053-2a95a90a5999',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220419',\n",
       "  'product_id': '72189-346_dd032289-acef-49fc-e053-2a95a90a5999',\n",
       "  'application_number': 'ANDA212399',\n",
       "  'brand_name_base': 'LEVOTHYROXINE SODIUM',\n",
       "  'pharm_class': ['Thyroxine [CS]', 'l-Thyroxine [EPC]']},\n",
       " {'product_ndc': '72189-350',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-350-60',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (72189-350-60)',\n",
       "    'marketing_start_date': '20230427',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['198108'],\n",
       "   'spl_set_id': ['fa56b439-893d-003e-e053-6294a90a865b'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'fa56b439-893e-003e-e053-6294a90a865b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230427',\n",
       "  'product_id': '72189-350_fa56b439-893e-003e-e053-6294a90a865b',\n",
       "  'application_number': 'ANDA210347',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72189-364',\n",
       "  'generic_name': 'Ropinirole',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Ropinirole',\n",
       "  'active_ingredients': [{'name': 'ROPINIROLE HYDROCHLORIDE',\n",
       "    'strength': '.25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-364-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72189-364-30)',\n",
       "    'marketing_start_date': '20220621',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['312845'],\n",
       "   'spl_set_id': ['e1fb0b51-4f8a-965d-e053-2a95a90ad936'],\n",
       "   'unii': ['D7ZD41RZI9']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'e1fb0b51-4f8b-965d-e053-2a95a90ad936',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220621',\n",
       "  'product_id': '72189-364_e1fb0b51-4f8b-965d-e053-2a95a90ad936',\n",
       "  'application_number': 'ANDA204022',\n",
       "  'brand_name_base': 'Ropinirole',\n",
       "  'pharm_class': ['Dopamine Agonists [MoA]',\n",
       "   'Nonergot Dopamine Agonist [EPC]']},\n",
       " {'product_ndc': '0002-8214',\n",
       "  'generic_name': 'Insulin glargine',\n",
       "  'labeler_name': 'Eli Lilly and Company',\n",
       "  'brand_name': 'BASAGLAR Tempo Pen',\n",
       "  'brand_name_suffix': 'Tempo Pen',\n",
       "  'active_ingredients': [{'name': 'INSULIN GLARGINE',\n",
       "    'strength': '100 [iU]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0002-8214-05',\n",
       "    'description': '5 SYRINGE in 1 CARTON (0002-8214-05)  / 3 mL in 1 SYRINGE (0002-8214-01)',\n",
       "    'marketing_start_date': '20191115',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Eli Lilly and Company'],\n",
       "   'rxcui': ['847230', '1736863', '2268064', '2268065'],\n",
       "   'spl_set_id': ['0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['M0011417', 'N0000175453'],\n",
       "   'pharm_class_cs': ['Insulin [CS]'],\n",
       "   'pharm_class_epc': ['Insulin Analog [EPC]'],\n",
       "   'unii': ['2ZM8CX04RZ']},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'dbb5654d-96c0-4cce-adba-5ae8c36acf80',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20151216',\n",
       "  'product_id': '0002-8214_dbb5654d-96c0-4cce-adba-5ae8c36acf80',\n",
       "  'application_number': 'BLA205692',\n",
       "  'brand_name_base': 'BASAGLAR',\n",
       "  'pharm_class': ['Insulin Analog [EPC]', 'Insulin [CS]']},\n",
       " {'product_ndc': '72189-389',\n",
       "  'generic_name': 'Cyclobenzaprine HCL ER',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Cyclobenzaprine HCL ER',\n",
       "  'active_ingredients': [{'name': 'CYCLOBENZAPRINE HYDROCHLORIDE',\n",
       "    'strength': '15 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-389-60',\n",
       "    'description': '60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72189-389-60)',\n",
       "    'marketing_start_date': '20221109',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['828358'],\n",
       "   'spl_set_id': ['ed0b9acc-132f-64c0-e053-2995a90a198c'],\n",
       "   'unii': ['0VE05JYS2P']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'CAPSULE, EXTENDED RELEASE',\n",
       "  'spl_id': 'ed0b9acc-1330-64c0-e053-2995a90a198c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20221109',\n",
       "  'product_id': '72189-389_ed0b9acc-1330-64c0-e053-2995a90a198c',\n",
       "  'application_number': 'NDA021777',\n",
       "  'brand_name_base': 'Cyclobenzaprine HCL ER',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '0548-5607',\n",
       "  'generic_name': 'Enoxaparin sodium',\n",
       "  'labeler_name': 'Amphastar Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Enoxaparin Sodium',\n",
       "  'active_ingredients': [{'name': 'ENOXAPARIN SODIUM',\n",
       "    'strength': '150 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0548-5607-00',\n",
       "    'description': '10 SYRINGE in 1 CARTON (0548-5607-00)  / 1 mL in 1 SYRINGE',\n",
       "    'marketing_start_date': '20110919',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Amphastar Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['854228',\n",
       "    '854235',\n",
       "    '854238',\n",
       "    '854241',\n",
       "    '854245',\n",
       "    '854248',\n",
       "    '854252',\n",
       "    '854255'],\n",
       "   'spl_set_id': ['3e6bf2b3-9339-4104-bda3-ad86a1949703'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['8NZ41MIK1O']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': '26be8717-95ce-4c2c-ad2f-3e58d202afde',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20110919',\n",
       "  'product_id': '0548-5607_26be8717-95ce-4c2c-ad2f-3e58d202afde',\n",
       "  'application_number': 'ANDA076684',\n",
       "  'brand_name_base': 'Enoxaparin Sodium',\n",
       "  'pharm_class': ['Heparin',\n",
       "   'Low-Molecular-Weight [CS]',\n",
       "   'Low Molecular Weight Heparin [EPC]']},\n",
       " {'product_ndc': '72189-401',\n",
       "  'generic_name': 'Diazepam',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Diazepam',\n",
       "  'active_ingredients': [{'name': 'DIAZEPAM', 'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-401-02',\n",
       "    'description': '2 TABLET in 1 BOTTLE (72189-401-02)',\n",
       "    'marketing_start_date': '20221205',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-401-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72189-401-30)',\n",
       "    'marketing_start_date': '20221205',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['197591'],\n",
       "   'spl_set_id': ['ef1a2b14-13ee-5d01-e053-2995a90a48c7'],\n",
       "   'nui': ['N0000175694', 'M0002356'],\n",
       "   'pharm_class_epc': ['Benzodiazepine [EPC]'],\n",
       "   'pharm_class_cs': ['Benzodiazepines [CS]'],\n",
       "   'unii': ['Q3JTX2Q7TU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'f63e967a-bb5a-1fe5-e053-2a95a90a829e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20221205',\n",
       "  'product_id': '72189-401_f63e967a-bb5a-1fe5-e053-2a95a90a829e',\n",
       "  'application_number': 'ANDA071135',\n",
       "  'brand_name_base': 'Diazepam',\n",
       "  'pharm_class': ['Benzodiazepine [EPC]', 'Benzodiazepines [CS]']},\n",
       " {'product_ndc': '72189-417',\n",
       "  'generic_name': 'ALLOPURINOL',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'ALLOPURINOL',\n",
       "  'active_ingredients': [{'name': 'ALLOPURINOL', 'strength': '300 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-417-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72189-417-90)',\n",
       "    'marketing_start_date': '20230202',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['197320'],\n",
       "   'spl_set_id': ['f3bd5852-8e43-6b5d-e053-2995a90a194f'],\n",
       "   'nui': ['N0000175698', 'N0000000206'],\n",
       "   'pharm_class_epc': ['Xanthine Oxidase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Xanthine Oxidase Inhibitors [MoA]'],\n",
       "   'unii': ['63CZ7GJN5I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'f3bd5852-8e44-6b5d-e053-2995a90a194f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230202',\n",
       "  'product_id': '72189-417_f3bd5852-8e44-6b5d-e053-2995a90a194f',\n",
       "  'application_number': 'ANDA204467',\n",
       "  'brand_name_base': 'ALLOPURINOL',\n",
       "  'pharm_class': ['Xanthine Oxidase Inhibitor [EPC]',\n",
       "   'Xanthine Oxidase Inhibitors [MoA]']},\n",
       " {'product_ndc': '72189-420',\n",
       "  'generic_name': 'AMITRIPTYLINE HCL',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'AMITRIPTYLINE HCL',\n",
       "  'active_ingredients': [{'name': 'AMITRIPTYLINE HYDROCHLORIDE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-420-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72189-420-30)',\n",
       "    'marketing_start_date': '20230207',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-420-60',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (72189-420-60)',\n",
       "    'marketing_start_date': '20230207',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-420-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (72189-420-90)',\n",
       "    'marketing_start_date': '20230207',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['856834'],\n",
       "   'spl_set_id': ['f420498a-bfcc-4549-e053-2995a90a7b09'],\n",
       "   'unii': ['26LUD4JO9K']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'ffc1f165-6d53-ba77-e053-6394a90a77a3',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230207',\n",
       "  'product_id': '72189-420_ffc1f165-6d53-ba77-e053-6394a90a77a3',\n",
       "  'application_number': 'ANDA214548',\n",
       "  'brand_name_base': 'AMITRIPTYLINE HCL',\n",
       "  'pharm_class': ['Tricyclic Antidepressant [EPC]']},\n",
       " {'product_ndc': '72189-430',\n",
       "  'generic_name': 'Prednisone',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Prednisone',\n",
       "  'active_ingredients': [{'name': 'PREDNISONE', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-430-05',\n",
       "    'description': '5 TABLET in 1 BOTTLE (72189-430-05)',\n",
       "    'marketing_start_date': '20230303',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-430-10',\n",
       "    'description': '10 TABLET in 1 BOTTLE (72189-430-10)',\n",
       "    'marketing_start_date': '20230303',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-430-15',\n",
       "    'description': '15 TABLET in 1 BOTTLE (72189-430-15)',\n",
       "    'marketing_start_date': '20230303',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-430-20',\n",
       "    'description': '20 TABLET in 1 BOTTLE (72189-430-20)',\n",
       "    'marketing_start_date': '20230303',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-430-21',\n",
       "    'description': '21 TABLET in 1 BOTTLE (72189-430-21)',\n",
       "    'marketing_start_date': '20230303',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['312615'],\n",
       "   'spl_set_id': ['f6051257-2144-4487-e053-2995a90a973b'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['VB0R961HZT']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '17e0f64e-7458-54f4-e063-6394a90ac637',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230303',\n",
       "  'product_id': '72189-430_17e0f64e-7458-54f4-e063-6394a90ac637',\n",
       "  'application_number': 'ANDA208412',\n",
       "  'brand_name_base': 'Prednisone',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72189-434',\n",
       "  'generic_name': 'Zolmitriptan',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Zolmitriptan',\n",
       "  'active_ingredients': [{'name': 'ZOLMITRIPTAN', 'strength': '2.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-434-06',\n",
       "    'description': '6 TABLET in 1 BOTTLE (72189-434-06)',\n",
       "    'marketing_start_date': '20230313',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['200193'],\n",
       "   'spl_set_id': ['f6ca7d28-8322-f151-e053-6394a90a39b7'],\n",
       "   'nui': ['N0000175763', 'N0000175764', 'N0000175765'],\n",
       "   'pharm_class_moa': ['Serotonin 1b Receptor Agonists [MoA]',\n",
       "    'Serotonin 1d Receptor Agonists [MoA]'],\n",
       "   'pharm_class_epc': ['Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]'],\n",
       "   'unii': ['2FS66TH3YW']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'f7f50ee3-b945-fd20-e053-6294a90a2be9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230313',\n",
       "  'product_id': '72189-434_f7f50ee3-b945-fd20-e053-6294a90a2be9',\n",
       "  'application_number': 'ANDA204041',\n",
       "  'brand_name_base': 'Zolmitriptan',\n",
       "  'pharm_class': ['Serotonin 1b Receptor Agonists [MoA]',\n",
       "   'Serotonin 1d Receptor Agonists [MoA]',\n",
       "   'Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]']},\n",
       " {'product_ndc': '72189-440',\n",
       "  'generic_name': 'Amitriptyline HCL',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Amitriptyline HCL',\n",
       "  'active_ingredients': [{'name': 'AMITRIPTYLINE HYDROCHLORIDE',\n",
       "    'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-440-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72189-440-30)',\n",
       "    'marketing_start_date': '20230313',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-440-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (72189-440-90)',\n",
       "    'marketing_start_date': '20230313',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['856845'],\n",
       "   'spl_set_id': ['f6cafc62-6aa9-ca32-e053-6394a90a2086'],\n",
       "   'unii': ['26LUD4JO9K']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '020666b0-c52a-bbd8-e063-6294a90aed7e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230313',\n",
       "  'product_id': '72189-440_020666b0-c52a-bbd8-e063-6294a90aed7e',\n",
       "  'application_number': 'ANDA214548',\n",
       "  'brand_name_base': 'Amitriptyline HCL',\n",
       "  'pharm_class': ['Tricyclic Antidepressant [EPC]']},\n",
       " {'product_ndc': '72189-453',\n",
       "  'generic_name': 'Glimepiride',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Glimepiride',\n",
       "  'active_ingredients': [{'name': 'GLIMEPIRIDE', 'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-453-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72189-453-90)',\n",
       "    'marketing_start_date': '20230324',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['199247'],\n",
       "   'spl_set_id': ['f7a9cca6-e460-c9d2-e053-6294a90af51b'],\n",
       "   'nui': ['N0000175608', 'M0020795'],\n",
       "   'pharm_class_epc': ['Sulfonylurea [EPC]'],\n",
       "   'pharm_class_cs': ['Sulfonylurea Compounds [CS]'],\n",
       "   'unii': ['6KY687524K']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'f8328cd4-1784-b819-e053-6294a90a96f2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230324',\n",
       "  'product_id': '72189-453_f8328cd4-1784-b819-e053-6294a90a96f2',\n",
       "  'application_number': 'ANDA202112',\n",
       "  'brand_name_base': 'Glimepiride',\n",
       "  'pharm_class': ['Sulfonylurea Compounds [CS]', 'Sulfonylurea [EPC]']},\n",
       " {'product_ndc': '72189-462',\n",
       "  'generic_name': 'Potassium Chloride ER',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Potassium Chloride ER',\n",
       "  'active_ingredients': [{'name': 'POTASSIUM CHLORIDE',\n",
       "    'strength': '1500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-462-30',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-462-30)',\n",
       "    'marketing_start_date': '20230417',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['1801294'],\n",
       "   'spl_set_id': ['f988aa11-60ef-411e-e053-6294a90a522a'],\n",
       "   'unii': ['660YQ98I10']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': 'f988aa11-60f0-411e-e053-6294a90a522a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230417',\n",
       "  'product_id': '72189-462_f988aa11-60f0-411e-e053-6294a90a522a',\n",
       "  'application_number': 'ANDA203562',\n",
       "  'brand_name_base': 'Potassium Chloride ER',\n",
       "  'pharm_class': ['Increased Large Intestinal Motility [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Potassium Compounds [CS]',\n",
       "   'Potassium Salt [EPC]']},\n",
       " {'product_ndc': '72189-468',\n",
       "  'generic_name': 'Dexamethasone',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Dexamethasone',\n",
       "  'active_ingredients': [{'name': 'DEXAMETHASONE', 'strength': '1.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-468-15',\n",
       "    'description': '15 TABLET in 1 BOTTLE (72189-468-15)',\n",
       "    'marketing_start_date': '20230504',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-468-21',\n",
       "    'description': '21 TABLET in 1 BOTTLE (72189-468-21)',\n",
       "    'marketing_start_date': '20230504',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['197580'],\n",
       "   'spl_set_id': ['fade983c-81fb-df94-e053-6394a90a7560'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['7S5I7G3JQL']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'fade983c-81fc-df94-e053-6394a90a7560',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230504',\n",
       "  'product_id': '72189-468_fade983c-81fc-df94-e053-6394a90a7560',\n",
       "  'application_number': 'ANDA215604',\n",
       "  'brand_name_base': 'Dexamethasone',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72189-482',\n",
       "  'generic_name': 'Quetiapine Fumarate ER',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Quetiapine Fumarate ER',\n",
       "  'active_ingredients': [{'name': 'QUETIAPINE FUMARATE',\n",
       "    'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-482-30',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-482-30)',\n",
       "    'marketing_start_date': '20230601',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['721791'],\n",
       "   'spl_set_id': ['fd12e3cb-8b9b-4ea0-e053-6294a90a4e7a'],\n",
       "   'unii': ['2S3PL1B6UJ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': 'fd12e3cb-8b9c-4ea0-e053-6294a90a4e7a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230601',\n",
       "  'product_id': '72189-482_fd12e3cb-8b9c-4ea0-e053-6294a90a4e7a',\n",
       "  'application_number': 'ANDA090681',\n",
       "  'brand_name_base': 'Quetiapine Fumarate ER',\n",
       "  'pharm_class': ['Atypical Antipsychotic [EPC]']},\n",
       " {'product_ndc': '72189-492',\n",
       "  'generic_name': 'Paroxetine',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Paroxetine',\n",
       "  'active_ingredients': [{'name': 'PAROXETINE HYDROCHLORIDE HEMIHYDRATE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-492-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72189-492-30)',\n",
       "    'marketing_start_date': '20230621',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['1738483'],\n",
       "   'spl_set_id': ['fea936a5-fdeb-e4fb-e053-6294a90a8995'],\n",
       "   'unii': ['X2ELS050D8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'fea936a5-fdec-e4fb-e053-6294a90a8995',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230621',\n",
       "  'product_id': '72189-492_fea936a5-fdec-e4fb-e053-6294a90a8995',\n",
       "  'application_number': 'ANDA077584',\n",
       "  'brand_name_base': 'Paroxetine',\n",
       "  'pharm_class': ['Serotonin Reuptake Inhibitor [EPC]',\n",
       "   'Serotonin Uptake Inhibitors [MoA]']},\n",
       " {'product_ndc': '72189-496',\n",
       "  'generic_name': 'Spironolactone',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Spironolactone',\n",
       "  'active_ingredients': [{'name': 'SPIRONOLACTONE', 'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-496-30',\n",
       "    'description': '30 TABLET, COATED in 1 BOTTLE (72189-496-30)',\n",
       "    'marketing_start_date': '20230706',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-496-90',\n",
       "    'description': '90 TABLET, COATED in 1 BOTTLE (72189-496-90)',\n",
       "    'marketing_start_date': '20230706',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['198223'],\n",
       "   'spl_set_id': ['ffd1ed7a-b6a4-4240-e053-6394a90a7db1'],\n",
       "   'nui': ['N0000175557', 'N0000011310'],\n",
       "   'pharm_class_epc': ['Aldosterone Antagonist [EPC]'],\n",
       "   'pharm_class_moa': ['Aldosterone Antagonists [MoA]'],\n",
       "   'unii': ['27O7W4T232']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '00ee4acc-fde1-5504-e063-6294a90aabd0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230706',\n",
       "  'product_id': '72189-496_00ee4acc-fde1-5504-e063-6294a90aabd0',\n",
       "  'application_number': 'ANDA040750',\n",
       "  'brand_name_base': 'Spironolactone',\n",
       "  'pharm_class': ['Aldosterone Antagonist [EPC]',\n",
       "   'Aldosterone Antagonists [MoA]']},\n",
       " {'product_ndc': '72189-499',\n",
       "  'generic_name': 'Lidocaine',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Lidocaine',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '50 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-499-50',\n",
       "    'description': '50 g in 1 JAR (72189-499-50)',\n",
       "    'marketing_start_date': '20230714',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['1543069'],\n",
       "   'spl_set_id': ['00725e5b-694c-b9e1-e063-6294a90a4182'],\n",
       "   'nui': ['N0000175682', 'M0000897', 'N0000175426', 'N0000175976'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]', 'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'unii': ['98PI200987']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': '00725e5b-694d-b9e1-e063-6294a90a4182',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230714',\n",
       "  'product_id': '72189-499_00725e5b-694d-b9e1-e063-6294a90a4182',\n",
       "  'application_number': 'ANDA206498',\n",
       "  'brand_name_base': 'Lidocaine',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '72189-526',\n",
       "  'generic_name': 'Tizanidine',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Tizanidine',\n",
       "  'active_ingredients': [{'name': 'TIZANIDINE HYDROCHLORIDE',\n",
       "    'strength': '6 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-526-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (72189-526-30)',\n",
       "    'marketing_start_date': '20231206',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['485484'],\n",
       "   'spl_set_id': ['0bdc188d-b895-acbc-e063-6294a90acd68'],\n",
       "   'unii': ['B53E3NMY5C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '0c3c67cf-a8a3-fdad-e063-6394a90a43cb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231206',\n",
       "  'product_id': '72189-526_0c3c67cf-a8a3-fdad-e063-6394a90a43cb',\n",
       "  'application_number': 'ANDA210267',\n",
       "  'brand_name_base': 'Tizanidine',\n",
       "  'pharm_class': ['Adrenergic alpha2-Agonists [MoA]',\n",
       "   'Central alpha-2 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72189-527',\n",
       "  'generic_name': 'Diclofenac Sodium',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Diclofenac Sodium',\n",
       "  'active_ingredients': [{'name': 'DICLOFENAC SODIUM',\n",
       "    'strength': '16.05 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-527-05',\n",
       "    'description': '150 mL in 1 BOTTLE (72189-527-05)',\n",
       "    'marketing_start_date': '20231211',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['857700'],\n",
       "   'spl_set_id': ['0c41977f-8dad-1d26-e063-6294a90a9b22'],\n",
       "   'unii': ['QTG126297Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '0c41977f-8dae-1d26-e063-6294a90a9b22',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20231211',\n",
       "  'product_id': '72189-527_0c41977f-8dae-1d26-e063-6294a90a9b22',\n",
       "  'application_number': 'ANDA206116',\n",
       "  'brand_name_base': 'Diclofenac Sodium',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Decreased Prostaglandin Production [PE]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72189-532',\n",
       "  'generic_name': 'Neo/Poly-B/Dex Ophth Oint',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Neo/Poly-B/Dex Ophth Oint',\n",
       "  'active_ingredients': [{'name': 'DEXAMETHASONE', 'strength': '1 mg/g'},\n",
       "   {'name': 'NEOMYCIN SULFATE', 'strength': '3.5 mg/g'},\n",
       "   {'name': 'POLYMYXIN B SULFATE', 'strength': \"10000 [USP'U]/g\"}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-532-35',\n",
       "    'description': '3.5 g in 1 BOTTLE (72189-532-35)',\n",
       "    'marketing_start_date': '20240112',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['309679'],\n",
       "   'spl_set_id': ['0ec1dfdf-b63f-fb0c-e063-6294a90a843d'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['7S5I7G3JQL', '057Y626693', '19371312D4']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': '0ec1dfdf-b640-fb0c-e063-6294a90a843d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20240112',\n",
       "  'product_id': '72189-532_0ec1dfdf-b640-fb0c-e063-6294a90a843d',\n",
       "  'application_number': 'ANDA064063',\n",
       "  'brand_name_base': 'Neo/Poly-B/Dex Ophth Oint',\n",
       "  'pharm_class': ['Aminoglycoside Antibacterial [EPC]',\n",
       "   'Aminoglycosides [CS]',\n",
       "   'Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]',\n",
       "   'Polymyxin-class Antibacterial [EPC]',\n",
       "   'Polymyxins [CS]']},\n",
       " {'product_ndc': '72189-539',\n",
       "  'generic_name': 'Bupropion HCL ER (XL)',\n",
       "  'labeler_name': 'Direct_RX',\n",
       "  'brand_name': 'Bupropion HCL ER (XL)',\n",
       "  'active_ingredients': [{'name': 'BUPROPION HYDROCHLORIDE',\n",
       "    'strength': '300 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-539-30',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-539-30)',\n",
       "    'marketing_start_date': '20240301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-539-90',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-539-90)',\n",
       "    'marketing_start_date': '20240301',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_RX'],\n",
       "   'rxcui': ['993557'],\n",
       "   'spl_set_id': ['129ce80c-0333-873e-e063-6394a90a33e0'],\n",
       "   'unii': ['ZG7E5POY8O']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '19b02d9d-9104-0442-e063-6394a90a3154',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240301',\n",
       "  'product_id': '72189-539_19b02d9d-9104-0442-e063-6394a90a3154',\n",
       "  'application_number': 'ANDA210015',\n",
       "  'brand_name_base': 'Bupropion HCL ER (XL)',\n",
       "  'pharm_class': ['Aminoketone [EPC]',\n",
       "   'Dopamine Uptake Inhibitors [MoA]',\n",
       "   'Increased Dopamine Activity [PE]',\n",
       "   'Increased Norepinephrine Activity [PE]',\n",
       "   'Norepinephrine Uptake Inhibitors [MoA]']},\n",
       " {'product_ndc': '72189-545',\n",
       "  'generic_name': 'Cyclobenzaprine Hydrochloride',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Cyclobenzaprine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'CYCLOBENZAPRINE HYDROCHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-545-15',\n",
       "    'description': '15 TABLET, FILM COATED in 1 BOTTLE (72189-545-15)',\n",
       "    'marketing_start_date': '20240409',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-545-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72189-545-30)',\n",
       "    'marketing_start_date': '20240409',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-545-60',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (72189-545-60)',\n",
       "    'marketing_start_date': '20240409',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-545-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (72189-545-90)',\n",
       "    'marketing_start_date': '20240409',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['828348'],\n",
       "   'spl_set_id': ['15aad4af-5c05-be36-e063-6294a90a9bb3'],\n",
       "   'unii': ['0VE05JYS2P']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '17f10bfd-b6a6-e6b6-e063-6294a90a5a58',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240409',\n",
       "  'product_id': '72189-545_17f10bfd-b6a6-e6b6-e063-6294a90a5a58',\n",
       "  'application_number': 'ANDA208170',\n",
       "  'brand_name_base': 'Cyclobenzaprine Hydrochloride',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '72189-549',\n",
       "  'generic_name': 'Olmesartan Medoxomil',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Olmesartan Medoxomil',\n",
       "  'active_ingredients': [{'name': 'OLMESARTAN MEDOXOMIL',\n",
       "    'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-549-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72189-549-30)',\n",
       "    'marketing_start_date': '20240419',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-549-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (72189-549-90)',\n",
       "    'marketing_start_date': '20240419',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['349405'],\n",
       "   'spl_set_id': ['16754802-d5a4-0350-e063-6394a90aa967'],\n",
       "   'unii': ['6M97XTV3HD']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '23080f85-3974-7803-e063-6394a90aa11d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240419',\n",
       "  'product_id': '72189-549_23080f85-3974-7803-e063-6394a90aa11d',\n",
       "  'application_number': 'ANDA204798',\n",
       "  'brand_name_base': 'Olmesartan Medoxomil',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]']},\n",
       " {'product_ndc': '72189-565',\n",
       "  'generic_name': 'Baclofen',\n",
       "  'labeler_name': 'Direct_rx',\n",
       "  'brand_name': 'Baclofen',\n",
       "  'active_ingredients': [{'name': 'BACLOFEN', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-565-60',\n",
       "    'description': '60 TABLET in 1 BOTTLE (72189-565-60)',\n",
       "    'marketing_start_date': '20240628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-565-82',\n",
       "    'description': '180 TABLET in 1 BOTTLE (72189-565-82)',\n",
       "    'marketing_start_date': '20240628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-565-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72189-565-90)',\n",
       "    'marketing_start_date': '20240628',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_rx'],\n",
       "   'rxcui': ['197392'],\n",
       "   'spl_set_id': ['1bf59c3b-f8eb-972e-e063-6394a90aeccc'],\n",
       "   'nui': ['N0000000196', 'N0000000116', 'N0000175759'],\n",
       "   'pharm_class_moa': ['GABA A Agonists [MoA]', 'GABA B Agonists [MoA]'],\n",
       "   'pharm_class_epc': ['gamma-Aminobutyric Acid-ergic Agonist [EPC]'],\n",
       "   'unii': ['H789N3FKE8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '1bf59c3b-f8ec-972e-e063-6394a90aeccc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240628',\n",
       "  'product_id': '72189-565_1bf59c3b-f8ec-972e-e063-6394a90aeccc',\n",
       "  'application_number': 'ANDA214374',\n",
       "  'brand_name_base': 'Baclofen',\n",
       "  'pharm_class': ['GABA A Agonists [MoA]',\n",
       "   'GABA B Agonists [MoA]',\n",
       "   'gamma-Aminobutyric Acid-ergic Agonist [EPC]']},\n",
       " {'product_ndc': '72189-572',\n",
       "  'generic_name': 'Dexamethasone',\n",
       "  'labeler_name': 'Direct_rx',\n",
       "  'brand_name': 'Dexamethasone',\n",
       "  'active_ingredients': [{'name': 'DEXAMETHASONE', 'strength': '1.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-572-15',\n",
       "    'description': '15 TABLET in 1 BOTTLE (72189-572-15)',\n",
       "    'marketing_start_date': '20240904',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72189-572-21',\n",
       "    'description': '21 TABLET in 1 BOTTLE (72189-572-21)',\n",
       "    'marketing_start_date': '20240904',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_rx'],\n",
       "   'rxcui': ['197580'],\n",
       "   'spl_set_id': ['214dea63-d77a-922a-e063-6294a90a967e'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['7S5I7G3JQL']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '214dea63-d77b-922a-e063-6294a90a967e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240904',\n",
       "  'product_id': '72189-572_214dea63-d77b-922a-e063-6294a90a967e',\n",
       "  'application_number': 'ANDA216282',\n",
       "  'brand_name_base': 'Dexamethasone',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72189-579',\n",
       "  'generic_name': 'Buprenorphine Sublingual',\n",
       "  'labeler_name': 'Direct_rx',\n",
       "  'dea_schedule': 'CIII',\n",
       "  'brand_name': 'Buprenorphine Sublingual',\n",
       "  'active_ingredients': [{'name': 'BUPRENORPHINE HYDROCHLORIDE',\n",
       "    'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-579-60',\n",
       "    'description': '60 TABLET in 1 BOTTLE (72189-579-60)',\n",
       "    'marketing_start_date': '20240913',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_rx'],\n",
       "   'rxcui': ['351264'],\n",
       "   'spl_set_id': ['2204e135-6a0c-68a2-e063-6394a90ac019'],\n",
       "   'unii': ['56W8MW3EN1']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '2204e135-6a0d-68a2-e063-6394a90ac019',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBLINGUAL'],\n",
       "  'marketing_start_date': '20240913',\n",
       "  'product_id': '72189-579_2204e135-6a0d-68a2-e063-6394a90ac019',\n",
       "  'application_number': 'ANDA201760',\n",
       "  'brand_name_base': 'Buprenorphine Sublingual',\n",
       "  'pharm_class': ['Partial Opioid Agonist [EPC]',\n",
       "   'Partial Opioid Agonists [MoA]']},\n",
       " {'product_ndc': '72189-584',\n",
       "  'generic_name': 'Cefazolin Sodium',\n",
       "  'labeler_name': 'Direct_rx',\n",
       "  'brand_name': 'Cefazolin Sodium',\n",
       "  'active_ingredients': [{'name': 'CEFAZOLIN SODIUM', 'strength': '1 g/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-584-01',\n",
       "    'description': '1 INJECTION, POWDER, FOR SOLUTION in 1 CARTON (72189-584-01)',\n",
       "    'marketing_start_date': '20240924',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_rx'],\n",
       "   'rxcui': ['1665050'],\n",
       "   'spl_set_id': ['22dfc2e4-07a7-8d13-e063-6394a90a3e9f'],\n",
       "   'unii': ['P380M0454Z']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, FOR SOLUTION',\n",
       "  'spl_id': '22dfc2e4-07a8-8d13-e063-6394a90a3e9f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS'],\n",
       "  'marketing_start_date': '20240924',\n",
       "  'product_id': '72189-584_22dfc2e4-07a8-8d13-e063-6394a90a3e9f',\n",
       "  'application_number': 'ANDA203661',\n",
       "  'brand_name_base': 'Cefazolin Sodium',\n",
       "  'pharm_class': ['Cephalosporin Antibacterial [EPC]', 'Cephalosporins [CS]']},\n",
       " {'product_ndc': '72189-590',\n",
       "  'generic_name': 'Doxepin HCL',\n",
       "  'labeler_name': 'Direct_rx',\n",
       "  'brand_name': 'Doxepin HCL',\n",
       "  'active_ingredients': [{'name': 'DOXEPIN HYDROCHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-590-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (72189-590-30)',\n",
       "    'marketing_start_date': '20241016',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_rx'],\n",
       "   'rxcui': ['1000048'],\n",
       "   'spl_set_id': ['249c8a57-fbec-47d5-e063-6394a90a6696'],\n",
       "   'unii': ['3U9A0FE9N5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '249c8a57-fbed-47d5-e063-6394a90a6696',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20241016',\n",
       "  'product_id': '72189-590_249c8a57-fbed-47d5-e063-6394a90a6696',\n",
       "  'application_number': 'ANDA215710',\n",
       "  'brand_name_base': 'Doxepin HCL',\n",
       "  'pharm_class': ['Tricyclic Antidepressant [EPC]']},\n",
       " {'product_ndc': '0555-0159',\n",
       "  'generic_name': 'Chlordiazepoxide Hydrochloride',\n",
       "  'labeler_name': 'Teva Pharmaceuticals USA, Inc.',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Chlordiazepoxide Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'CHLORDIAZEPOXIDE HYDROCHLORIDE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0555-0159-02',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (0555-0159-02)',\n",
       "    'marketing_start_date': '19760701',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0555-0159-04',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (0555-0159-04)',\n",
       "    'marketing_start_date': '19760701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Teva Pharmaceuticals USA, Inc.'],\n",
       "   'rxcui': ['905369', '905495', '905516'],\n",
       "   'spl_set_id': ['e3ff8641-ae8a-4016-acb1-cb1b7890f5ed'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['MFM6K1XWDK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'a55dccdc-fa34-4d50-8993-1de5dcebd232',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19760701',\n",
       "  'product_id': '0555-0159_a55dccdc-fa34-4d50-8993-1de5dcebd232',\n",
       "  'application_number': 'ANDA084769',\n",
       "  'brand_name_base': 'Chlordiazepoxide Hydrochloride',\n",
       "  'pharm_class': ['Benzodiazepine [EPC]', 'Benzodiazepines [CS]']},\n",
       " {'product_ndc': '72197-011',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'American Consumer Products Corp',\n",
       "  'brand_name': 'PHARMACYS PRESCRIPTION 8OZ HAND SANITIZER',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '62 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72197-011-08',\n",
       "    'description': '237 mL in 1 BOTTLE, PUMP (72197-011-08)',\n",
       "    'marketing_start_date': '20190501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['American Consumer Products Corp'],\n",
       "   'rxcui': ['581660'],\n",
       "   'spl_set_id': ['7a048607-f4c3-6724-e053-2a91aa0ab6f2'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0757437972126'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '7a048607-f4c4-6724-e053-2a91aa0ab6f2',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190501',\n",
       "  'product_id': '72197-011_7a048607-f4c4-6724-e053-2a91aa0ab6f2',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'PHARMACYS PRESCRIPTION 8OZ HAND SANITIZER'},\n",
       " {'product_ndc': '72197-033',\n",
       "  'generic_name': 'Benzalkonium Chloride',\n",
       "  'labeler_name': 'American Consumer Products Corp',\n",
       "  'brand_name': 'Sanitaxe Antibacterial',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '.13 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72197-033-27',\n",
       "    'description': '800 mL in 1 BOX (72197-033-27)',\n",
       "    'marketing_start_date': '20200715',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['American Consumer Products Corp'],\n",
       "   'spl_set_id': ['a9ca8aaa-ea76-7eb5-e053-2995a90adef9'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'adbcc0e6-5c1a-4281-e053-2a95a90a94dc',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200715',\n",
       "  'product_id': '72197-033_adbcc0e6-5c1a-4281-e053-2a95a90a94dc',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'Sanitaxe Antibacterial'},\n",
       " {'product_ndc': '72197-044',\n",
       "  'generic_name': 'Petrolatum',\n",
       "  'labeler_name': 'American Consumer Products Corp',\n",
       "  'brand_name': 'Pharmacys Prescription Petroleum Jelly',\n",
       "  'active_ingredients': [{'name': 'PETROLATUM', 'strength': '99.9 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72197-044-06',\n",
       "    'description': '170 g in 1 JAR (72197-044-06)',\n",
       "    'marketing_start_date': '20210615',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['American Consumer Products Corp'],\n",
       "   'rxcui': ['204754'],\n",
       "   'spl_set_id': ['c4d29ecb-bb00-cb0b-e053-2995a90a37ef'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0757437703027'],\n",
       "   'unii': ['4T6H12BN9U']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'c4d29ee7-6893-27e0-e053-2a95a90a3166',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210615',\n",
       "  'product_id': '72197-044_c4d29ee7-6893-27e0-e053-2a95a90a3166',\n",
       "  'application_number': 'part347',\n",
       "  'brand_name_base': 'Pharmacys Prescription Petroleum Jelly'},\n",
       " {'product_ndc': '72203-001',\n",
       "  'generic_name': 'Avobenzone, Homosalate, Octisalate, and Octocrylene',\n",
       "  'labeler_name': 'Bluemercury',\n",
       "  'brand_name': 'Hydraboost Moisturizer SPF 30',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '30 mg/mL'},\n",
       "   {'name': 'HOMOSALATE', 'strength': '80 mg/mL'},\n",
       "   {'name': 'OCTISALATE', 'strength': '50 mg/mL'},\n",
       "   {'name': 'OCTOCRYLENE', 'strength': '60 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72203-001-01',\n",
       "    'description': '1 BOTTLE, PUMP in 1 CARTON (72203-001-01)  / 50 mL in 1 BOTTLE, PUMP',\n",
       "    'marketing_start_date': '20180520',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Bluemercury'],\n",
       "   'spl_set_id': ['eca867e6-4deb-4be2-ae3f-6850fb6223b3'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['G63QQF2NOX', 'V06SV4M95S', '4X49Y0596W', '5A68WGF6WM']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '4f3374cd-fda8-4045-97a0-3d45acb892cc',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180520',\n",
       "  'product_id': '72203-001_4f3374cd-fda8-4045-97a0-3d45acb892cc',\n",
       "  'application_number': 'part352',\n",
       "  'brand_name_base': 'Hydraboost Moisturizer SPF 30'},\n",
       " {'product_ndc': '72203-017',\n",
       "  'generic_name': 'Zinc Oxide',\n",
       "  'labeler_name': 'Bluemercury, Inc.',\n",
       "  'brand_name': 'Perfect Sunscreen Tinted Mineral SPF50',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '.12 g/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72203-017-01',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72203-017-01)  / 50 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20220415',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Bluemercury, Inc.'],\n",
       "   'spl_set_id': ['4c978154-679f-472a-95ab-56878c5c70cd'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '41b075a5-cb84-4909-82d0-d4e68e250482',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220415',\n",
       "  'product_id': '72203-017_41b075a5-cb84-4909-82d0-d4e68e250482',\n",
       "  'application_number': 'part352',\n",
       "  'brand_name_base': 'Perfect Sunscreen Tinted Mineral SPF50'},\n",
       " {'product_ndc': '72205-002',\n",
       "  'generic_name': 'Rosuvastatin Calcium',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'Rosuvastatin Calcium',\n",
       "  'active_ingredients': [{'name': 'ROSUVASTATIN CALCIUM',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['859419', '859424', '859747', '859751'],\n",
       "   'spl_set_id': ['d58f1f63-4bb6-413c-9730-ded3e8078618'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205004900',\n",
       "    '0372205005051',\n",
       "    '0372205027909',\n",
       "    '0372205003903',\n",
       "    '0372205003996',\n",
       "    '0372205005907',\n",
       "    '0372205005303',\n",
       "    '0372205027053',\n",
       "    '0372205004054',\n",
       "    '0372205005990',\n",
       "    '0372205027992',\n",
       "    '0372205004993',\n",
       "    '0372205003057'],\n",
       "   'unii': ['83MVU38M7Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '6fc8cae8-aa7d-4957-9604-d725d97a754d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171122',\n",
       "  'product_id': '72205-002_6fc8cae8-aa7d-4957-9604-d725d97a754d',\n",
       "  'application_number': 'ANDA208898',\n",
       "  'brand_name_base': 'Rosuvastatin Calcium',\n",
       "  'pharm_class': ['HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '72205-003',\n",
       "  'generic_name': 'Rosuvastatin Calcium',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'Rosuvastatin Calcium',\n",
       "  'active_ingredients': [{'name': 'ROSUVASTATIN CALCIUM',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-003-05',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (72205-003-05)',\n",
       "    'marketing_start_date': '20190225',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-003-06',\n",
       "    'description': '100 BLISTER PACK in 1 CARTON (72205-003-06)  / 10 TABLET, FILM COATED in 1 BLISTER PACK (72205-003-11)',\n",
       "    'marketing_start_date': '20171122',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-003-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (72205-003-90)',\n",
       "    'marketing_start_date': '20171122',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-003-99',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (72205-003-99)',\n",
       "    'marketing_start_date': '20171122',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['859419', '859424', '859747', '859751'],\n",
       "   'spl_set_id': ['d58f1f63-4bb6-413c-9730-ded3e8078618'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205004900',\n",
       "    '0372205005051',\n",
       "    '0372205027909',\n",
       "    '0372205003903',\n",
       "    '0372205003996',\n",
       "    '0372205005907',\n",
       "    '0372205005303',\n",
       "    '0372205027053',\n",
       "    '0372205004054',\n",
       "    '0372205005990',\n",
       "    '0372205027992',\n",
       "    '0372205004993',\n",
       "    '0372205003057'],\n",
       "   'unii': ['83MVU38M7Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '6fc8cae8-aa7d-4957-9604-d725d97a754d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171122',\n",
       "  'product_id': '72205-003_6fc8cae8-aa7d-4957-9604-d725d97a754d',\n",
       "  'application_number': 'ANDA208898',\n",
       "  'brand_name_base': 'Rosuvastatin Calcium',\n",
       "  'pharm_class': ['HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '72205-004',\n",
       "  'generic_name': 'Rosuvastatin Calcium',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'Rosuvastatin Calcium',\n",
       "  'active_ingredients': [{'name': 'ROSUVASTATIN CALCIUM',\n",
       "    'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-004-05',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (72205-004-05)',\n",
       "    'marketing_start_date': '20190225',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-004-06',\n",
       "    'description': '100 BLISTER PACK in 1 CARTON (72205-004-06)  / 10 TABLET, FILM COATED in 1 BLISTER PACK (72205-004-11)',\n",
       "    'marketing_start_date': '20171122',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-004-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (72205-004-90)',\n",
       "    'marketing_start_date': '20171122',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-004-99',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (72205-004-99)',\n",
       "    'marketing_start_date': '20171122',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['859419', '859424', '859747', '859751'],\n",
       "   'spl_set_id': ['d58f1f63-4bb6-413c-9730-ded3e8078618'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205004900',\n",
       "    '0372205005051',\n",
       "    '0372205027909',\n",
       "    '0372205003903',\n",
       "    '0372205003996',\n",
       "    '0372205005907',\n",
       "    '0372205005303',\n",
       "    '0372205027053',\n",
       "    '0372205004054',\n",
       "    '0372205005990',\n",
       "    '0372205027992',\n",
       "    '0372205004993',\n",
       "    '0372205003057'],\n",
       "   'unii': ['83MVU38M7Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '6fc8cae8-aa7d-4957-9604-d725d97a754d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20171122',\n",
       "  'product_id': '72205-004_6fc8cae8-aa7d-4957-9604-d725d97a754d',\n",
       "  'application_number': 'ANDA208898',\n",
       "  'brand_name_base': 'Rosuvastatin Calcium',\n",
       "  'pharm_class': ['HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '72205-007',\n",
       "  'generic_name': 'Capecitabine',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'Capecitabine',\n",
       "  'active_ingredients': [{'name': 'CAPECITABINE', 'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-007-92',\n",
       "    'description': '120 TABLET, FILM COATED in 1 BOTTLE (72205-007-92)',\n",
       "    'marketing_start_date': '20180721',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['200327', '200328'],\n",
       "   'spl_set_id': ['29885ada-b743-419c-8f15-edd4247c76ca'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205007925', '0372205006607'],\n",
       "   'nui': ['N0000000233', 'N0000175595'],\n",
       "   'pharm_class_moa': ['Nucleic Acid Synthesis Inhibitors [MoA]'],\n",
       "   'pharm_class_epc': ['Nucleoside Metabolic Inhibitor [EPC]'],\n",
       "   'unii': ['6804DJ8Z9U']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '136d5048-1342-4a83-b6ce-db9f8933741c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180721',\n",
       "  'product_id': '72205-007_136d5048-1342-4a83-b6ce-db9f8933741c',\n",
       "  'application_number': 'ANDA209365',\n",
       "  'brand_name_base': 'Capecitabine',\n",
       "  'pharm_class': ['Nucleic Acid Synthesis Inhibitors [MoA]',\n",
       "   'Nucleoside Metabolic Inhibitor [EPC]']},\n",
       " {'product_ndc': '72205-016',\n",
       "  'generic_name': 'Pregabalin',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'dea_schedule': 'CV',\n",
       "  'brand_name': 'Pregabalin',\n",
       "  'active_ingredients': [{'name': 'PREGABALIN', 'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-016-06',\n",
       "    'description': '100 BLISTER PACK in 1 CARTON (72205-016-06)  / 10 CAPSULE in 1 BLISTER PACK (72205-016-11)',\n",
       "    'marketing_start_date': '20190719',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-016-90',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (72205-016-90)',\n",
       "    'marketing_start_date': '20190719',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-016-99',\n",
       "    'description': '1000 CAPSULE in 1 BOTTLE (72205-016-99)',\n",
       "    'marketing_start_date': '20190719',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['483438',\n",
       "    '483440',\n",
       "    '483442',\n",
       "    '483444',\n",
       "    '483446',\n",
       "    '483448',\n",
       "    '483450',\n",
       "    '577127'],\n",
       "   'spl_set_id': ['193666f7-3c55-43b1-947a-2ffec40c687f'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205016903',\n",
       "    '0372205014909',\n",
       "    '0372205018907',\n",
       "    '0372205017900',\n",
       "    '0372205015906',\n",
       "    '0372205013902',\n",
       "    '0372205012905',\n",
       "    '0372205011908'],\n",
       "   'unii': ['55JG375S6M']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '9052621a-b793-4c86-937b-b87dcf7133fe',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190719',\n",
       "  'product_id': '72205-016_9052621a-b793-4c86-937b-b87dcf7133fe',\n",
       "  'application_number': 'ANDA209357',\n",
       "  'brand_name_base': 'Pregabalin'},\n",
       " {'product_ndc': '72205-024',\n",
       "  'generic_name': 'Atorvastatin calcium',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'Atorvastatin calcium',\n",
       "  'active_ingredients': [{'name': 'ATORVASTATIN CALCIUM TRIHYDRATE',\n",
       "    'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-024-05',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (72205-024-05)',\n",
       "    'marketing_start_date': '20190208',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-024-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72205-024-30)',\n",
       "    'marketing_start_date': '20190208',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-024-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (72205-024-90)',\n",
       "    'marketing_start_date': '20190208',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-024-99',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (72205-024-99)',\n",
       "    'marketing_start_date': '20210719',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['259255', '617310', '617311', '617312'],\n",
       "   'spl_set_id': ['bc448f40-421c-490f-8c39-fa8135507973'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205025905', '0372205025059', '0372205024052'],\n",
       "   'unii': ['48A5M73Z4Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '11823aa6-547f-4c0b-983a-65b837f94e89',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190208',\n",
       "  'product_id': '72205-024_11823aa6-547f-4c0b-983a-65b837f94e89',\n",
       "  'application_number': 'ANDA211933',\n",
       "  'brand_name_base': 'Atorvastatin calcium',\n",
       "  'pharm_class': ['HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '72205-037',\n",
       "  'generic_name': 'levetiracetam',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'levetiracetam',\n",
       "  'active_ingredients': [{'name': 'LEVETIRACETAM', 'strength': '100 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-037-72',\n",
       "    'description': '473 mL in 1 BOTTLE, PLASTIC (72205-037-72)',\n",
       "    'marketing_start_date': '20220718',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['403884'],\n",
       "   'spl_set_id': ['1ec4c05d-7fba-4c02-a3bf-4343a8a421d5'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000008486'],\n",
       "   'pharm_class_pe': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]'],\n",
       "   'unii': ['44YRR34555']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': 'e0ff0141-0572-43f6-b9be-ea5f868abfba',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220716',\n",
       "  'product_id': '72205-037_e0ff0141-0572-43f6-b9be-ea5f868abfba',\n",
       "  'application_number': 'ANDA214757',\n",
       "  'brand_name_base': 'levetiracetam',\n",
       "  'pharm_class': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]']},\n",
       " {'product_ndc': '72205-040',\n",
       "  'generic_name': 'Dofetilide',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'Dofetilide',\n",
       "  'active_ingredients': [{'name': 'DOFETILIDE', 'strength': '.25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-040-37',\n",
       "    'description': '4 BLISTER PACK in 1 CARTON (72205-040-37)  / 10 CAPSULE in 1 BLISTER PACK (72205-040-11)',\n",
       "    'marketing_start_date': '20200612',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-040-60',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (72205-040-60)',\n",
       "    'marketing_start_date': '20200612',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['310003', '310004', '310005'],\n",
       "   'spl_set_id': ['b8323987-90fe-4e6c-a71c-76e3c501713c'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205039605', '0372205040601', '0372205041608'],\n",
       "   'nui': ['N0000175426'],\n",
       "   'pharm_class_epc': ['Antiarrhythmic [EPC]'],\n",
       "   'unii': ['R4Z9X1N2ND']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'feb8626e-9d88-4a06-919f-f8169a69814b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200612',\n",
       "  'product_id': '72205-040_feb8626e-9d88-4a06-919f-f8169a69814b',\n",
       "  'application_number': 'ANDA213220',\n",
       "  'brand_name_base': 'Dofetilide',\n",
       "  'pharm_class': ['Antiarrhythmic [EPC]']},\n",
       " {'product_ndc': '72205-046',\n",
       "  'generic_name': 'Thiotepa',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'Thiotepa',\n",
       "  'active_ingredients': [{'name': 'THIOTEPA', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-046-01',\n",
       "    'description': '1 VIAL, GLASS in 1 BOX (72205-046-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS',\n",
       "    'marketing_start_date': '20200201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['1660004', '1660009'],\n",
       "   'spl_set_id': ['b702dcc9-dd0e-4386-b1e2-f20562fd2ad9'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000236', 'N0000175558'],\n",
       "   'pharm_class_moa': ['Alkylating Activity [MoA]'],\n",
       "   'pharm_class_epc': ['Alkylating Drug [EPC]'],\n",
       "   'unii': ['905Z5W3GKH']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION',\n",
       "  'spl_id': 'b702dcc9-dd0e-4386-b1e2-f20562fd2ad9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRACAVITARY', 'INTRAVENOUS', 'INTRAVESICAL'],\n",
       "  'marketing_start_date': '20200201',\n",
       "  'product_id': '72205-046_b702dcc9-dd0e-4386-b1e2-f20562fd2ad9',\n",
       "  'application_number': 'ANDA213049',\n",
       "  'brand_name_base': 'Thiotepa',\n",
       "  'pharm_class': ['Alkylating Activity [MoA]', 'Alkylating Drug [EPC]']},\n",
       " {'product_ndc': '72205-064',\n",
       "  'generic_name': 'HALOPERIDOL',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'HALOPERIDOL',\n",
       "  'active_ingredients': [{'name': 'HALOPERIDOL', 'strength': '.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-064-91',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72205-064-91)',\n",
       "    'marketing_start_date': '20221122',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-064-99',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72205-064-99)',\n",
       "    'marketing_start_date': '20221122',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['197754', '310670', '310671', '310672', '314034', '314035'],\n",
       "   'spl_set_id': ['3a474e06-fb00-40cb-aa3a-6edad43c2c0a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205064997',\n",
       "    '0372205064911',\n",
       "    '0372205067998',\n",
       "    '0372205067912',\n",
       "    '0372205069916',\n",
       "    '0372205066991',\n",
       "    '0372205068919',\n",
       "    '0372205066915',\n",
       "    '0372205065918',\n",
       "    '0372205065994'],\n",
       "   'nui': ['N0000180182'],\n",
       "   'pharm_class_epc': ['Typical Antipsychotic [EPC]'],\n",
       "   'unii': ['J6292F8L3D']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '3a474e06-fb00-40cb-aa3a-6edad43c2c0a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20221118',\n",
       "  'product_id': '72205-064_3a474e06-fb00-40cb-aa3a-6edad43c2c0a',\n",
       "  'application_number': 'ANDA216004',\n",
       "  'brand_name_base': 'HALOPERIDOL',\n",
       "  'pharm_class': ['Typical Antipsychotic [EPC]']},\n",
       " {'product_ndc': '72205-072',\n",
       "  'generic_name': 'Droxidopa',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'Droxidopa',\n",
       "  'active_ingredients': [{'name': 'DROXIDOPA', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-072-05',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (72205-072-05)',\n",
       "    'marketing_start_date': '20210219',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-072-90',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (72205-072-90)',\n",
       "    'marketing_start_date': '20210219',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['1490026', '1490034', '1490038'],\n",
       "   'spl_set_id': ['381ffe44-d5d8-4380-a3cd-6d6a5e9ef55d'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205073050',\n",
       "    '0372205072909',\n",
       "    '0372205072053',\n",
       "    '0372205073906',\n",
       "    '0372205074903',\n",
       "    '0372205074057'],\n",
       "   'nui': ['M0003647', 'N0000178478'],\n",
       "   'pharm_class_cs': ['Catecholamines [CS]'],\n",
       "   'pharm_class_pe': ['Increased Blood Pressure [PE]'],\n",
       "   'unii': ['J7A92W69L7']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '381ffe44-d5d8-4380-a3cd-6d6a5e9ef55d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210219',\n",
       "  'product_id': '72205-072_381ffe44-d5d8-4380-a3cd-6d6a5e9ef55d',\n",
       "  'application_number': 'ANDA211741',\n",
       "  'brand_name_base': 'Droxidopa',\n",
       "  'pharm_class': ['Catecholamines [CS]', 'Increased Blood Pressure [PE]']},\n",
       " {'product_ndc': '72205-088',\n",
       "  'generic_name': 'Doxepin Hydrochloride',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'Doxepin Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'DOXEPIN HYDROCHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-088-91',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE, PLASTIC (72205-088-91)',\n",
       "    'marketing_start_date': '20220627',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-088-99',\n",
       "    'description': '1000 CAPSULE in 1 BOTTLE, PLASTIC (72205-088-99)',\n",
       "    'marketing_start_date': '20220627',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['1000048', '1000058', '1000070', '1000076', '1000097'],\n",
       "   'spl_set_id': ['2b1f0144-65d8-451f-8054-6be1675f102c'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205092990',\n",
       "    '0372205088917',\n",
       "    '0372205090996',\n",
       "    '0372205089990',\n",
       "    '0372205088993',\n",
       "    '0372205089914',\n",
       "    '0372205092914',\n",
       "    '0372205091917',\n",
       "    '0372205091993',\n",
       "    '0372205090910'],\n",
       "   'unii': ['3U9A0FE9N5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '2b1f0144-65d8-451f-8054-6be1675f102c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220627',\n",
       "  'product_id': '72205-088_2b1f0144-65d8-451f-8054-6be1675f102c',\n",
       "  'application_number': 'ANDA215113',\n",
       "  'brand_name_base': 'Doxepin Hydrochloride',\n",
       "  'pharm_class': ['Tricyclic Antidepressant [EPC]']},\n",
       " {'product_ndc': '72205-093',\n",
       "  'generic_name': 'vigabatrin',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'Vigabatrin',\n",
       "  'active_ingredients': [{'name': 'VIGABATRIN', 'strength': '50 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-093-50',\n",
       "    'description': '50 PACKET in 1 CARTON (72205-093-50)  / 10 mL in 1 PACKET (72205-093-61)',\n",
       "    'marketing_start_date': '20220908',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['250820'],\n",
       "   'spl_set_id': ['082d818a-4f4e-4675-98c6-91db0294e63c'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205093508'],\n",
       "   'nui': ['N0000175753'],\n",
       "   'pharm_class_epc': ['Anti-epileptic Agent [EPC]'],\n",
       "   'unii': ['GR120KRT6K']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'FOR SOLUTION',\n",
       "  'spl_id': '082d818a-4f4e-4675-98c6-91db0294e63c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220907',\n",
       "  'product_id': '72205-093_082d818a-4f4e-4675-98c6-91db0294e63c',\n",
       "  'application_number': 'ANDA215363',\n",
       "  'brand_name_base': 'Vigabatrin',\n",
       "  'pharm_class': ['Anti-epileptic Agent [EPC]']},\n",
       " {'product_ndc': '72205-132',\n",
       "  'generic_name': 'Lisdexamfetamine dimesylate',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Lisdexamfetamine dimesylate',\n",
       "  'active_ingredients': [{'name': 'LISDEXAMFETAMINE DIMESYLATE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-132-91',\n",
       "    'description': '100 TABLET, CHEWABLE in 1 BOTTLE (72205-132-91)',\n",
       "    'marketing_start_date': '20240217',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['1871456', '1871460', '1871462', '1871464', '1871466', '1871468'],\n",
       "   'spl_set_id': ['a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205133914',\n",
       "    '0372205137912',\n",
       "    '0372205135918',\n",
       "    '0372205134911',\n",
       "    '0372205136915',\n",
       "    '0372205132917'],\n",
       "   'unii': ['SJT761GEGS']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, CHEWABLE',\n",
       "  'spl_id': 'a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240202',\n",
       "  'product_id': '72205-132_a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811',\n",
       "  'application_number': 'ANDA218306',\n",
       "  'brand_name_base': 'Lisdexamfetamine dimesylate',\n",
       "  'pharm_class': ['Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulation [PE]']},\n",
       " {'product_ndc': '72205-165',\n",
       "  'generic_name': 'Olmesartan medoxomil',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'Olmesartan medoxomil',\n",
       "  'active_ingredients': [{'name': 'OLMESARTAN MEDOXOMIL',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-165-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72205-165-30)',\n",
       "    'marketing_start_date': '20231218',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-165-66',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (72205-165-66)',\n",
       "    'marketing_start_date': '20240216',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-165-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (72205-165-90)',\n",
       "    'marketing_start_date': '20240216',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['349373', '349401', '349405'],\n",
       "   'spl_set_id': ['4238a064-1bfd-4ce3-b9d9-12c96eee8af0'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205166660',\n",
       "    '0372205165908',\n",
       "    '0372205166905',\n",
       "    '0372205167902',\n",
       "    '0372205165663',\n",
       "    '0372205166301',\n",
       "    '0372205167308',\n",
       "    '0372205165304',\n",
       "    '0372205167667'],\n",
       "   'unii': ['6M97XTV3HD']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'c81a0bea-32c1-4a0a-ac3c-5afe99cecdf2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230118',\n",
       "  'product_id': '72205-165_c81a0bea-32c1-4a0a-ac3c-5afe99cecdf2',\n",
       "  'application_number': 'ANDA217399',\n",
       "  'brand_name_base': 'Olmesartan medoxomil',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]']},\n",
       " {'product_ndc': '72205-184',\n",
       "  'generic_name': 'Darunavir',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'Darunavir',\n",
       "  'active_ingredients': [{'name': 'DARUNAVIR', 'strength': '600 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-184-60',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-184-60)',\n",
       "    'marketing_start_date': '20231129',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['670026', '1359269'],\n",
       "   'spl_set_id': ['ea6e0136-75b2-4793-9500-04e6658a0a73'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205184602', '0372205185302'],\n",
       "   'nui': ['N0000000246', 'N0000175889', 'N0000190114', 'N0000182137'],\n",
       "   'pharm_class_moa': ['HIV Protease Inhibitors [MoA]',\n",
       "    'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "    'Cytochrome P450 2D6 Inhibitors [MoA]'],\n",
       "   'pharm_class_epc': ['Protease Inhibitor [EPC]'],\n",
       "   'unii': ['YO603Y8113']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'ea6e0136-75b2-4793-9500-04e6658a0a73',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231128',\n",
       "  'product_id': '72205-184_ea6e0136-75b2-4793-9500-04e6658a0a73',\n",
       "  'application_number': 'ANDA215389',\n",
       "  'brand_name_base': 'Darunavir',\n",
       "  'pharm_class': ['Cytochrome P450 2D6 Inhibitors [MoA]',\n",
       "   'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "   'HIV Protease Inhibitors [MoA]',\n",
       "   'Protease Inhibitor [EPC]']},\n",
       " {'product_ndc': '72205-199',\n",
       "  'generic_name': 'CLOPIDOGREL BISULFATE',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'CLOPIDOGREL',\n",
       "  'active_ingredients': [{'name': 'CLOPIDOGREL BISULFATE',\n",
       "    'strength': '75 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-199-05',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (72205-199-05)',\n",
       "    'marketing_start_date': '20241122',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-199-06',\n",
       "    'description': '10 BLISTER PACK in 1 CARTON (72205-199-06)  / 10 TABLET, FILM COATED in 1 BLISTER PACK (72205-199-11)',\n",
       "    'marketing_start_date': '20241122',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-199-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72205-199-30)',\n",
       "    'marketing_start_date': '20241122',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72205-199-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (72205-199-90)',\n",
       "    'marketing_start_date': '20241122',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['309362'],\n",
       "   'spl_set_id': ['1447a095-c663-4f05-91d4-f09bfc0c3d42'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205199057', '0372205199309', '0372205199903'],\n",
       "   'unii': ['08I79HTP27']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '1447a095-c663-4f05-91d4-f09bfc0c3d42',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240920',\n",
       "  'product_id': '72205-199_1447a095-c663-4f05-91d4-f09bfc0c3d42',\n",
       "  'application_number': 'ANDA215388',\n",
       "  'brand_name_base': 'CLOPIDOGREL',\n",
       "  'pharm_class': ['Cytochrome P450 2C8 Inhibitors [MoA]',\n",
       "   'Decreased Platelet Aggregation [PE]',\n",
       "   'P2Y12 Platelet Inhibitor [EPC]',\n",
       "   'P2Y12 Receptor Antagonists [MoA]']},\n",
       " {'product_ndc': '72205-260',\n",
       "  'generic_name': 'vilazodone hydrochloride',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'vilazodone hydrochloride',\n",
       "  'active_ingredients': [{'name': 'VILAZODONE HYDROCHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-260-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72205-260-30)',\n",
       "    'marketing_start_date': '20230714',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['1086772', '1086778', '1086784'],\n",
       "   'spl_set_id': ['c3e167cd-7f56-45eb-80df-a60fa1392e57'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205262300', '0372205261303', '0372205260306'],\n",
       "   'unii': ['U8HTX2GK8J']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'c3e167cd-7f56-45eb-80df-a60fa1392e57',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230707',\n",
       "  'product_id': '72205-260_c3e167cd-7f56-45eb-80df-a60fa1392e57',\n",
       "  'application_number': 'ANDA208228',\n",
       "  'brand_name_base': 'vilazodone hydrochloride'},\n",
       " {'product_ndc': '72205-261',\n",
       "  'generic_name': 'vilazodone hydrochloride',\n",
       "  'labeler_name': 'Novadoz Pharmaceuticals LLC',\n",
       "  'brand_name': 'vilazodone hydrochloride',\n",
       "  'active_ingredients': [{'name': 'VILAZODONE HYDROCHLORIDE',\n",
       "    'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72205-261-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72205-261-30)',\n",
       "    'marketing_start_date': '20230714',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novadoz Pharmaceuticals LLC'],\n",
       "   'rxcui': ['1086772', '1086778', '1086784'],\n",
       "   'spl_set_id': ['c3e167cd-7f56-45eb-80df-a60fa1392e57'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372205262300', '0372205261303', '0372205260306'],\n",
       "   'unii': ['U8HTX2GK8J']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'c3e167cd-7f56-45eb-80df-a60fa1392e57',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230707',\n",
       "  'product_id': '72205-261_c3e167cd-7f56-45eb-80df-a60fa1392e57',\n",
       "  'application_number': 'ANDA208228',\n",
       "  'brand_name_base': 'vilazodone hydrochloride'},\n",
       " {'product_ndc': '72238-003',\n",
       "  'generic_name': 'sodium chloride and eucalyptus globulus leaf',\n",
       "  'labeler_name': 'Alliance Pharma Inc.',\n",
       "  'brand_name': 'Vamousse Lice Treatment Complete Kit',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72238-003-01',\n",
       "    'description': '1 KIT in 1 BOX (72238-003-01)  *  1 mL in 1 BOTTLE, WITH APPLICATOR *  118 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20190823',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Alliance Pharma Inc.'],\n",
       "   'spl_set_id': ['90cffb2a-7be4-4f63-e053-2995a90a83f3'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0358962190407']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': '24383a9a-b80f-e0bd-e063-6294a90a78ae',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190823',\n",
       "  'product_id': '72238-003_24383a9a-b80f-e0bd-e063-6294a90a78ae',\n",
       "  'brand_name_base': 'Vamousse Lice Treatment Complete Kit'},\n",
       " {'product_ndc': '72241-003',\n",
       "  'generic_name': 'Nateglinide',\n",
       "  'labeler_name': 'Modavar Pharmaceuticals LLC',\n",
       "  'brand_name': 'Nateglinide',\n",
       "  'active_ingredients': [{'name': 'NATEGLINIDE', 'strength': '120 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72241-003-04',\n",
       "    'description': '90 TABLET, COATED in 1 BOTTLE (72241-003-04)',\n",
       "    'marketing_start_date': '20210819',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72241-003-05',\n",
       "    'description': '100 TABLET, COATED in 1 BOTTLE (72241-003-05)',\n",
       "    'marketing_start_date': '20210819',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Modavar Pharmaceuticals LLC'],\n",
       "   'rxcui': ['311919', '314142'],\n",
       "   'spl_set_id': ['af81465b-5f49-4eeb-8122-ef7fe5d90ddc'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175428', 'N0000175448'],\n",
       "   'pharm_class_epc': ['Glinide [EPC]'],\n",
       "   'pharm_class_moa': ['Potassium Channel Antagonists [MoA]'],\n",
       "   'unii': ['41X3PWK4O2']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': 'af81465b-5f49-4eeb-8122-ef7fe5d90ddc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210819',\n",
       "  'product_id': '72241-003_af81465b-5f49-4eeb-8122-ef7fe5d90ddc',\n",
       "  'application_number': 'ANDA206432',\n",
       "  'brand_name_base': 'Nateglinide',\n",
       "  'pharm_class': ['Glinide [EPC]', 'Potassium Channel Antagonists [MoA]']},\n",
       " {'product_ndc': '72241-014',\n",
       "  'generic_name': 'Rivastigmine Tartrate',\n",
       "  'labeler_name': 'Modavar Pharmaceuticals LLC',\n",
       "  'brand_name': 'Rivastigmine Tartrate',\n",
       "  'active_ingredients': [{'name': 'RIVASTIGMINE TARTRATE',\n",
       "    'strength': '6 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72241-014-03',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (72241-014-03)',\n",
       "    'marketing_start_date': '20211005',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72241-014-10',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (72241-014-10)',\n",
       "    'marketing_start_date': '20211005',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Modavar Pharmaceuticals LLC'],\n",
       "   'rxcui': ['312835', '312836', '314214', '314215'],\n",
       "   'spl_set_id': ['209f3b02-0acf-46e9-b355-91c918a20eb3'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372241014031', '0372241012037', '0372241011030'],\n",
       "   'unii': ['9IY2357JPE']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '27f32649-68c4-4f16-abaf-35cba6ac6b75',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20211005',\n",
       "  'product_id': '72241-014_27f32649-68c4-4f16-abaf-35cba6ac6b75',\n",
       "  'application_number': 'ANDA203844',\n",
       "  'brand_name_base': 'Rivastigmine Tartrate',\n",
       "  'pharm_class': ['Cholinesterase Inhibitor [EPC]',\n",
       "   'Cholinesterase Inhibitors [MoA]']},\n",
       " {'product_ndc': '72241-052',\n",
       "  'generic_name': 'Olanzapine',\n",
       "  'labeler_name': 'Modavar Pharmaceuticals LLC',\n",
       "  'brand_name': 'Olanzapine',\n",
       "  'active_ingredients': [{'name': 'OLANZAPINE', 'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72241-052-05',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72241-052-05)',\n",
       "    'marketing_start_date': '20240117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72241-052-10',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72241-052-10)',\n",
       "    'marketing_start_date': '20240117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72241-052-11',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72241-052-11)',\n",
       "    'marketing_start_date': '20240117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72241-052-22',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72241-052-22)',\n",
       "    'marketing_start_date': '20240117',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Modavar Pharmaceuticals LLC'],\n",
       "   'rxcui': ['200034', '283639', '312077', '312078', '312079', '314154'],\n",
       "   'spl_set_id': ['f0943b4e-6bdc-48c1-8ecd-39cf732e16f5'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372241055225',\n",
       "    '0372241056222',\n",
       "    '0372241056116',\n",
       "    '0372241054112',\n",
       "    '0372241052118',\n",
       "    '0372241051111',\n",
       "    '0372241053115'],\n",
       "   'nui': ['N0000175430'],\n",
       "   'pharm_class_epc': ['Atypical Antipsychotic [EPC]'],\n",
       "   'unii': ['N7U69T4SZR']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'c8dcda0f-abda-4c4b-afb1-49f1f071a2c1',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230227',\n",
       "  'product_id': '72241-052_c8dcda0f-abda-4c4b-afb1-49f1f071a2c1',\n",
       "  'application_number': 'ANDA210022',\n",
       "  'brand_name_base': 'Olanzapine',\n",
       "  'pharm_class': ['Atypical Antipsychotic [EPC]']},\n",
       " {'product_ndc': '72241-054',\n",
       "  'generic_name': 'Olanzapine',\n",
       "  'labeler_name': 'Modavar Pharmaceuticals LLC',\n",
       "  'brand_name': 'Olanzapine',\n",
       "  'active_ingredients': [{'name': 'OLANZAPINE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72241-054-05',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72241-054-05)',\n",
       "    'marketing_start_date': '20240117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72241-054-10',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72241-054-10)',\n",
       "    'marketing_start_date': '20240117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72241-054-11',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72241-054-11)',\n",
       "    'marketing_start_date': '20240117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72241-054-22',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72241-054-22)',\n",
       "    'marketing_start_date': '20240117',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Modavar Pharmaceuticals LLC'],\n",
       "   'rxcui': ['200034', '283639', '312077', '312078', '312079', '314154'],\n",
       "   'spl_set_id': ['f0943b4e-6bdc-48c1-8ecd-39cf732e16f5'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372241055225',\n",
       "    '0372241056222',\n",
       "    '0372241056116',\n",
       "    '0372241054112',\n",
       "    '0372241052118',\n",
       "    '0372241051111',\n",
       "    '0372241053115'],\n",
       "   'nui': ['N0000175430'],\n",
       "   'pharm_class_epc': ['Atypical Antipsychotic [EPC]'],\n",
       "   'unii': ['N7U69T4SZR']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'c8dcda0f-abda-4c4b-afb1-49f1f071a2c1',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230227',\n",
       "  'product_id': '72241-054_c8dcda0f-abda-4c4b-afb1-49f1f071a2c1',\n",
       "  'application_number': 'ANDA210022',\n",
       "  'brand_name_base': 'Olanzapine',\n",
       "  'pharm_class': ['Atypical Antipsychotic [EPC]']},\n",
       " {'product_ndc': '72245-193',\n",
       "  'generic_name': 'oxycodone and acetaminophen',\n",
       "  'labeler_name': 'Forte Bio-Pharma LLC',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Nalocet',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '300 mg/1'},\n",
       "   {'name': 'OXYCODONE HYDROCHLORIDE', 'strength': '2.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72245-193-03',\n",
       "    'description': '30 TABLET in 1 BOTTLE, PLASTIC (72245-193-03)',\n",
       "    'marketing_start_date': '20180523',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72245-193-10',\n",
       "    'description': '100 TABLET in 1 BOTTLE, PLASTIC (72245-193-10)',\n",
       "    'marketing_start_date': '20180523',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Forte Bio-Pharma LLC'],\n",
       "   'rxcui': ['1037259', '2045500'],\n",
       "   'spl_set_id': ['f5f7dfca-a5c7-4445-8a5e-9ec62f33f5be'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['362O9ITL9D', 'C1ENJ2TE6C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '1f08bded-8a63-5cb4-e063-6294a90a0a7a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180523',\n",
       "  'product_id': '72245-193_1f08bded-8a63-5cb4-e063-6294a90a0a7a',\n",
       "  'application_number': 'ANDA040608',\n",
       "  'brand_name_base': 'Nalocet',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '0555-0971',\n",
       "  'generic_name': 'Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate',\n",
       "  'labeler_name': 'Teva Pharmaceuticals USA, Inc.',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate',\n",
       "  'active_ingredients': [{'name': 'AMPHETAMINE ASPARTATE MONOHYDRATE',\n",
       "    'strength': '1.25 mg/1'},\n",
       "   {'name': 'AMPHETAMINE SULFATE', 'strength': '1.25 mg/1'},\n",
       "   {'name': 'DEXTROAMPHETAMINE SACCHARATE', 'strength': '1.25 mg/1'},\n",
       "   {'name': 'DEXTROAMPHETAMINE SULFATE', 'strength': '1.25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0555-0971-02',\n",
       "    'description': '100 TABLET in 1 BOTTLE (0555-0971-02)',\n",
       "    'marketing_start_date': '20020211',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Teva Pharmaceuticals USA, Inc.'],\n",
       "   'rxcui': ['541363',\n",
       "    '541878',\n",
       "    '541892',\n",
       "    '577957',\n",
       "    '577961',\n",
       "    '687043',\n",
       "    '1009145'],\n",
       "   'spl_set_id': ['cffbbb15-d776-41ae-a8a6-687f2c07bfa4'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['G83415V073', 'O1ZPV620O4', 'JJ768O327N', '6DPV8NK46S']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '88468f3d-7d03-4cee-aabf-3abc8c9b5e38',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20020211',\n",
       "  'product_id': '0555-0971_88468f3d-7d03-4cee-aabf-3abc8c9b5e38',\n",
       "  'application_number': 'ANDA040422',\n",
       "  'brand_name_base': 'Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate',\n",
       "  'pharm_class': ['Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Central Nervous System Stimulation [PE]']},\n",
       " {'product_ndc': '72266-103',\n",
       "  'generic_name': 'Labetalol Hydrochloride',\n",
       "  'labeler_name': 'Fosun Pharma USA Inc.',\n",
       "  'brand_name': 'Labetalol Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'LABETALOL HYDROCHLORIDE',\n",
       "    'strength': '5 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72266-103-01',\n",
       "    'description': '1 VIAL, MULTI-DOSE in 1 CARTON (72266-103-01)  / 40 mL in 1 VIAL, MULTI-DOSE',\n",
       "    'marketing_start_date': '20190402',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Fosun Pharma USA Inc.'],\n",
       "   'rxcui': ['896771'],\n",
       "   'spl_set_id': ['4a5ffab2-a3b8-411e-992d-7f38d508643a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372266103017', '0372266102010'],\n",
       "   'unii': ['1GEV3BAW9J']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': '189abc58-65af-e772-e063-6394a90a5ed3',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20190402',\n",
       "  'product_id': '72266-103_189abc58-65af-e772-e063-6394a90a5ed3',\n",
       "  'application_number': 'ANDA090699',\n",
       "  'brand_name_base': 'Labetalol Hydrochloride',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72266-108',\n",
       "  'generic_name': 'CLOFARABINE',\n",
       "  'labeler_name': 'Fosun Pharma USA Inc.',\n",
       "  'brand_name': 'CLOFARABINE',\n",
       "  'active_ingredients': [{'name': 'CLOFARABINE', 'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72266-108-01',\n",
       "    'description': '1 VIAL, SINGLE-DOSE in 1 CARTON (72266-108-01)  / 20 mL in 1 VIAL, SINGLE-DOSE',\n",
       "    'marketing_start_date': '20190819',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Fosun Pharma USA Inc.'],\n",
       "   'rxcui': ['486419'],\n",
       "   'spl_set_id': ['e956b1e0-2829-4872-8c09-99462d60e922'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000233', 'N0000175595'],\n",
       "   'pharm_class_moa': ['Nucleic Acid Synthesis Inhibitors [MoA]'],\n",
       "   'pharm_class_epc': ['Nucleoside Metabolic Inhibitor [EPC]'],\n",
       "   'unii': ['762RDY0Y2H']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'f4c48f34-ebdd-cb2b-e053-2995a90ad691',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20190819',\n",
       "  'product_id': '72266-108_f4c48f34-ebdd-cb2b-e053-2995a90ad691',\n",
       "  'application_number': 'ANDA207831',\n",
       "  'brand_name_base': 'CLOFARABINE',\n",
       "  'pharm_class': ['Nucleic Acid Synthesis Inhibitors [MoA]',\n",
       "   'Nucleoside Metabolic Inhibitor [EPC]']},\n",
       " {'product_ndc': '72266-124',\n",
       "  'generic_name': 'Ondansetron',\n",
       "  'labeler_name': 'Fosun Pharma USA Inc.',\n",
       "  'brand_name': 'Ondansetron',\n",
       "  'active_ingredients': [{'name': 'ONDANSETRON HYDROCHLORIDE',\n",
       "    'strength': '2 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72266-124-01',\n",
       "    'description': '1 VIAL in 1 CARTON (72266-124-01)  / 20 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20190402',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Fosun Pharma USA Inc.'],\n",
       "   'rxcui': ['283504', '1740467'],\n",
       "   'spl_set_id': ['e3f22b7e-b6ad-4799-93c7-d30540cada85'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372266124012'],\n",
       "   'unii': ['NMH84OZK2B']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': '1807c451-e39c-6291-e063-6294a90a4359',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS'],\n",
       "  'marketing_start_date': '20190402',\n",
       "  'product_id': '72266-124_1807c451-e39c-6291-e063-6294a90a4359',\n",
       "  'application_number': 'ANDA090648',\n",
       "  'brand_name_base': 'Ondansetron',\n",
       "  'pharm_class': ['Serotonin 3 Receptor Antagonists [MoA]',\n",
       "   'Serotonin-3 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72266-142',\n",
       "  'generic_name': 'Bromfenac',\n",
       "  'labeler_name': 'Fosun Pharma USA Inc.',\n",
       "  'brand_name': 'BROMFENAC',\n",
       "  'active_ingredients': [{'name': 'BROMFENAC SODIUM', 'strength': '.9 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72266-142-01',\n",
       "    'description': '1 BOTTLE, DROPPER in 1 CARTON (72266-142-01)  / 1.7 mL in 1 BOTTLE, DROPPER',\n",
       "    'marketing_start_date': '20200706',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Fosun Pharma USA Inc.'],\n",
       "   'rxcui': ['578018'],\n",
       "   'spl_set_id': ['a8f1d85a-5585-4632-bdfa-a54a535b5c17'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372266142016'],\n",
       "   'unii': ['8ECV571Y37']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION/ DROPS',\n",
       "  'spl_id': '177b4223-206b-759e-e063-6294a90aa947',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20200706',\n",
       "  'product_id': '72266-142_177b4223-206b-759e-e063-6294a90aa947',\n",
       "  'application_number': 'ANDA211029',\n",
       "  'brand_name_base': 'BROMFENAC',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72266-161',\n",
       "  'generic_name': 'Oxaliplatin',\n",
       "  'labeler_name': 'FOSUN PHARMA USA INC.',\n",
       "  'brand_name': 'Oxaliplatin',\n",
       "  'active_ingredients': [{'name': 'OXALIPLATIN', 'strength': '5 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72266-161-01',\n",
       "    'description': '1 VIAL, SINGLE-USE in 1 CARTON (72266-161-01)  / 10 mL in 1 VIAL, SINGLE-USE',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['FOSUN PHARMA USA INC.'],\n",
       "   'rxcui': ['1736776', '1736781'],\n",
       "   'spl_set_id': ['fad0f147-6595-4412-87a7-2afca0192a96'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372266161017', '0372266162014'],\n",
       "   'nui': ['N0000175413', 'N0000175073'],\n",
       "   'pharm_class_epc': ['Platinum-based Drug [EPC]'],\n",
       "   'unii': ['04ZR38536J']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '1c7fc397-2fb4-cc3a-e063-6394a90a67e8',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20200330',\n",
       "  'product_id': '72266-161_1c7fc397-2fb4-cc3a-e063-6394a90a67e8',\n",
       "  'application_number': 'ANDA207325',\n",
       "  'brand_name_base': 'Oxaliplatin',\n",
       "  'pharm_class': ['Platinum-based Drug [EPC]',\n",
       "   'Platinum-containing Compounds [EXT]']},\n",
       " {'product_ndc': '72266-197',\n",
       "  'generic_name': 'Dorzolamide Hydrochloride',\n",
       "  'labeler_name': 'FOSUN PHARMA USA INC',\n",
       "  'brand_name': 'Dorzolamide Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'DORZOLAMIDE HYDROCHLORIDE',\n",
       "    'strength': '20 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72266-197-01',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72266-197-01)  / 10 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20230123',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['FOSUN PHARMA USA INC'],\n",
       "   'rxcui': ['310015'],\n",
       "   'spl_set_id': ['ef173b63-499f-301b-e053-2995a90a4771'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['QZO5366EW7']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '17513b9f-3768-8428-e063-6394a90a6762',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20230123',\n",
       "  'product_id': '72266-197_17513b9f-3768-8428-e063-6394a90a6762',\n",
       "  'application_number': 'ANDA215660',\n",
       "  'brand_name_base': 'Dorzolamide Hydrochloride',\n",
       "  'pharm_class': ['Carbonic Anhydrase Inhibitor [EPC]',\n",
       "   'Carbonic Anhydrase Inhibitors [MoA]']},\n",
       " {'product_ndc': '0555-0997',\n",
       "  'marketing_end_date': '20250731',\n",
       "  'generic_name': 'Fludrocortisone Acetate',\n",
       "  'labeler_name': 'Teva Pharmaceuticals USA, Inc.',\n",
       "  'brand_name': 'Fludrocortisone Acetate',\n",
       "  'active_ingredients': [{'name': 'FLUDROCORTISONE ACETATE',\n",
       "    'strength': '.1 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0555-0997-02',\n",
       "    'description': '100 TABLET in 1 BOTTLE (0555-0997-02)',\n",
       "    'marketing_start_date': '20030214',\n",
       "    'marketing_end_date': '20250731',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Teva Pharmaceuticals USA, Inc.'],\n",
       "   'rxcui': ['313979'],\n",
       "   'spl_set_id': ['f5cffa20-9a22-43c5-9e89-3225852c2dfa'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305550997023'],\n",
       "   'unii': ['V47IF0PVH4']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'ff82c388-18e1-44f6-af03-f52337219dc7',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20030214',\n",
       "  'product_id': '0555-0997_ff82c388-18e1-44f6-af03-f52337219dc7',\n",
       "  'application_number': 'ANDA040425',\n",
       "  'brand_name_base': 'Fludrocortisone Acetate'},\n",
       " {'product_ndc': '72288-005',\n",
       "  'generic_name': 'Lidocaine HCl',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'Sunburn Relief Gel',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE HYDROCHLORIDE',\n",
       "    'strength': '5 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-005-34',\n",
       "    'description': '226 g in 1 BOTTLE, PUMP (72288-005-34)',\n",
       "    'marketing_start_date': '20180831',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['1011849'],\n",
       "   'spl_set_id': ['adb638ec-4a7c-42f2-b249-0ac53a8dd4b2'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['V13007Z41A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '1eb4c4a3-7524-830d-e063-6294a90aa5b6',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180831',\n",
       "  'product_id': '72288-005_1eb4c4a3-7524-830d-e063-6294a90aa5b6',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Sunburn Relief Gel',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '72288-069',\n",
       "  'generic_name': 'White Petrolatum',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'Petroleum',\n",
       "  'active_ingredients': [{'name': 'PETROLATUM', 'strength': '1 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-069-54',\n",
       "    'description': '106 g in 1 JAR (72288-069-54)',\n",
       "    'marketing_start_date': '20180425',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-069-96',\n",
       "    'description': '213 g in 1 JAR (72288-069-96)',\n",
       "    'marketing_start_date': '20180425',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['204754'],\n",
       "   'spl_set_id': ['616ef87d-1518-46aa-8e12-9a1b678d4980'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['4T6H12BN9U']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'JELLY',\n",
       "  'spl_id': '23582e99-a555-dd78-e063-6394a90af4da',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180425',\n",
       "  'product_id': '72288-069_23582e99-a555-dd78-e063-6394a90af4da',\n",
       "  'application_number': 'M016',\n",
       "  'brand_name_base': 'Petroleum'},\n",
       " {'product_ndc': '72288-120',\n",
       "  'generic_name': 'BENZOYL PEROXIDE',\n",
       "  'labeler_name': 'AMAZON.COM SERVICES LLC',\n",
       "  'brand_name': 'amazon basics step 1 cleanser Acne treatment',\n",
       "  'brand_name_suffix': 'Acne treatment',\n",
       "  'active_ingredients': [{'name': 'BENZOYL PEROXIDE', 'strength': '25 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-120-01',\n",
       "    'description': '120 mL in 1 BOTTLE (72288-120-01)',\n",
       "    'marketing_start_date': '20240802',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['AMAZON.COM SERVICES LLC'],\n",
       "   'rxcui': ['845836'],\n",
       "   'spl_set_id': ['23a060f0-d379-4370-9a79-ca6e854419b4'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['W9WZN9A0GM']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '1e5915fa-297f-43ae-81ee-ec5c21afa0be',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240802',\n",
       "  'product_id': '72288-120_1e5915fa-297f-43ae-81ee-ec5c21afa0be',\n",
       "  'application_number': 'M006',\n",
       "  'brand_name_base': 'amazon basics step 1 cleanser'},\n",
       " {'product_ndc': '72288-170',\n",
       "  'generic_name': 'Nicotine Polacrilex',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'basic care nicotine',\n",
       "  'active_ingredients': [{'name': 'NICOTINE', 'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-170-02',\n",
       "    'description': '310 BLISTER PACK in 1 CARTON (72288-170-02)  / 1 GUM, CHEWING in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20211014',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-170-29',\n",
       "    'description': '220 BLISTER PACK in 1 CARTON (72288-170-29)  / 1 GUM, CHEWING in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20211021',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-170-60',\n",
       "    'description': '20 BLISTER PACK in 1 CARTON (72288-170-60)  / 1 GUM, CHEWING in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20210107',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['311975'],\n",
       "   'spl_set_id': ['63ac801f-02ed-43a1-a2a8-2ad35d8fd7a9'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175706', 'M0014836'],\n",
       "   'pharm_class_epc': ['Cholinergic Nicotinic Agonist [EPC]'],\n",
       "   'pharm_class_cs': ['Nicotine [CS]'],\n",
       "   'unii': ['6M3C89ZY6R']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'GUM, CHEWING',\n",
       "  'spl_id': '8544e051-d6d8-4817-8b22-4ed86ac8bc3c',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210107',\n",
       "  'product_id': '72288-170_8544e051-d6d8-4817-8b22-4ed86ac8bc3c',\n",
       "  'application_number': 'ANDA076789',\n",
       "  'brand_name_base': 'basic care nicotine',\n",
       "  'pharm_class': ['Cholinergic Nicotinic Agonist [EPC]', 'Nicotine [CS]']},\n",
       " {'product_ndc': '72288-194',\n",
       "  'generic_name': 'Famotidine',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'basic care acid reducer',\n",
       "  'active_ingredients': [{'name': 'FAMOTIDINE', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-194-00',\n",
       "    'description': '2 BOTTLE in 1 CARTON (72288-194-00)  / 200 TABLET, FILM COATED in 1 BOTTLE',\n",
       "    'marketing_start_date': '20220411',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-194-02',\n",
       "    'description': '25 BLISTER PACK in 1 CARTON (72288-194-02)  / 1 TABLET, FILM COATED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20210709',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-194-71',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72288-194-71)  / 50 TABLET, FILM COATED in 1 BOTTLE',\n",
       "    'marketing_start_date': '20210731',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-194-82',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72288-194-82)  / 200 TABLET, FILM COATED in 1 BOTTLE',\n",
       "    'marketing_start_date': '20201006',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['310273'],\n",
       "   'spl_set_id': ['0983cef7-b8b6-4ed9-a01e-c699fa6d2d06'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000151', 'N0000175784'],\n",
       "   'pharm_class_moa': ['Histamine H2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Histamine-2 Receptor Antagonist [EPC]'],\n",
       "   'unii': ['5QZO15J2Z8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'c3f1857c-2561-43fd-8fb6-abb3f5c94aee',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201006',\n",
       "  'product_id': '72288-194_c3f1857c-2561-43fd-8fb6-abb3f5c94aee',\n",
       "  'application_number': 'ANDA077351',\n",
       "  'brand_name_base': 'basic care acid reducer',\n",
       "  'pharm_class': ['Histamine H2 Receptor Antagonists [MoA]',\n",
       "   'Histamine-2 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72288-213',\n",
       "  'generic_name': 'Sodium Fluoride',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'Anticavity Fluoride Rinse',\n",
       "  'active_ingredients': [{'name': 'SODIUM FLUORIDE', 'strength': '.2 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-213-44',\n",
       "    'description': '532 mL in 1 BOTTLE, PLASTIC (72288-213-44)',\n",
       "    'marketing_start_date': '20180424',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['240698'],\n",
       "   'spl_set_id': ['f275755f-7879-4ca1-ae03-fa709e88cdad'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['8ZYQ1474W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'MOUTHWASH',\n",
       "  'spl_id': '12728e0b-1894-f751-e063-6294a90ae5e1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180424',\n",
       "  'product_id': '72288-213_12728e0b-1894-f751-e063-6294a90ae5e1',\n",
       "  'application_number': 'M021',\n",
       "  'brand_name_base': 'Anticavity Fluoride Rinse'},\n",
       " {'product_ndc': '72288-223',\n",
       "  'generic_name': 'nicotine polacrilex',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'basic care nicotine',\n",
       "  'active_ingredients': [{'name': 'NICOTINE', 'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-223-07',\n",
       "    'description': '3 CONTAINER in 1 CARTON (72288-223-07)  / 27 LOZENGE in 1 CONTAINER',\n",
       "    'marketing_start_date': '20220513',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-223-60',\n",
       "    'description': '1 CONTAINER in 1 CARTON (72288-223-60)  / 20 LOZENGE in 1 CONTAINER',\n",
       "    'marketing_start_date': '20210506',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['359817'],\n",
       "   'spl_set_id': ['8b6d7617-ce92-4bad-9f38-81a7f2e9cfa3'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175706', 'M0014836'],\n",
       "   'pharm_class_epc': ['Cholinergic Nicotinic Agonist [EPC]'],\n",
       "   'pharm_class_cs': ['Nicotine [CS]'],\n",
       "   'unii': ['6M3C89ZY6R']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'LOZENGE',\n",
       "  'spl_id': 'ebf2ad10-e6ab-4542-b7c6-84af9d2832eb',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210506',\n",
       "  'product_id': '72288-223_ebf2ad10-e6ab-4542-b7c6-84af9d2832eb',\n",
       "  'application_number': 'ANDA203690',\n",
       "  'brand_name_base': 'basic care nicotine',\n",
       "  'pharm_class': ['Cholinergic Nicotinic Agonist [EPC]', 'Nicotine [CS]']},\n",
       " {'product_ndc': '72288-224',\n",
       "  'generic_name': 'Loperamide HCl',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'basic care loperamide hydrochloride',\n",
       "  'active_ingredients': [{'name': 'LOPERAMIDE HYDROCHLORIDE',\n",
       "    'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-224-62',\n",
       "    'description': '24 BLISTER PACK in 1 CARTON (72288-224-62)  / 1 TABLET, FILM COATED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20210216',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['978010'],\n",
       "   'spl_set_id': ['732edad8-9a3f-4ce0-a323-c8bffa4acb5f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['77TI35393C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '732edad8-9a3f-4ce0-a323-c8bffa4acb5f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210216',\n",
       "  'product_id': '72288-224_732edad8-9a3f-4ce0-a323-c8bffa4acb5f',\n",
       "  'application_number': 'ANDA075232',\n",
       "  'brand_name_base': 'basic care loperamide hydrochloride',\n",
       "  'pharm_class': ['Opioid Agonist [EPC]', 'Opioid Agonists [MoA]']},\n",
       " {'product_ndc': '72288-298',\n",
       "  'generic_name': 'Guaifenesin',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'basic care mucus er',\n",
       "  'active_ingredients': [{'name': 'GUAIFENESIN', 'strength': '600 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-298-02',\n",
       "    'description': '5 BLISTER PACK in 1 CARTON (72288-298-02)  / 20 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20211021',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-298-33',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72288-298-33)  / 60 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE',\n",
       "    'marketing_start_date': '20210114',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-298-60',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72288-298-60)  / 20 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE',\n",
       "    'marketing_start_date': '20210820',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['636522'],\n",
       "   'spl_set_id': ['14213a15-5842-456f-a5ab-654268c58f78'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000193956', 'N0000008867', 'N0000009560'],\n",
       "   'pharm_class_epc': ['Expectorant [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "    'Increased Respiratory Secretions [PE]'],\n",
       "   'unii': ['495W7451VQ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, MULTILAYER, EXTENDED RELEASE',\n",
       "  'spl_id': 'ca339682-ad63-4580-a252-1f464d64d2cf',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210114',\n",
       "  'product_id': '72288-298_ca339682-ad63-4580-a252-1f464d64d2cf',\n",
       "  'application_number': 'ANDA078912',\n",
       "  'brand_name_base': 'basic care mucus er',\n",
       "  'pharm_class': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "   'Expectorant [EPC]',\n",
       "   'Increased Respiratory Secretions [PE]']},\n",
       " {'product_ndc': '72288-303',\n",
       "  'generic_name': 'Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'Basic Care Severe Cold and Flu',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '500 mg/1'},\n",
       "   {'name': 'DEXTROMETHORPHAN HYDROBROMIDE', 'strength': '20 mg/1'},\n",
       "   {'name': 'PHENYLEPHRINE HYDROCHLORIDE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-303-91',\n",
       "    'description': '6 POWDER, FOR SOLUTION in 1 CARTON (72288-303-91)',\n",
       "    'marketing_start_date': '20210811',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['1189316'],\n",
       "   'spl_set_id': ['968c605e-fea3-4c79-b650-6021aa17db7a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['362O9ITL9D', '9D2RTI9KYH', '04JA59TNSJ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'POWDER, FOR SOLUTION',\n",
       "  'spl_id': '2b64c1cb-da06-460b-9f0f-fe49b1f69b46',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210811',\n",
       "  'product_id': '72288-303_2b64c1cb-da06-460b-9f0f-fe49b1f69b46',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'Basic Care Severe Cold and Flu',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'Sigma-1 Agonist [EPC]',\n",
       "   'Sigma-1 Receptor Agonists [MoA]',\n",
       "   'Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]',\n",
       "   'Uncompetitive NMDA Receptor Antagonists [MoA]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72288-321',\n",
       "  'generic_name': 'famotidine, calcium carbonate and magnesium hydroxide',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'Basic Care Dual Action Complete',\n",
       "  'active_ingredients': [{'name': 'CALCIUM CARBONATE', 'strength': '800 mg/1'},\n",
       "   {'name': 'FAMOTIDINE', 'strength': '10 mg/1'},\n",
       "   {'name': 'MAGNESIUM HYDROXIDE', 'strength': '165 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-321-71',\n",
       "    'description': '50 TABLET, CHEWABLE in 1 BOTTLE (72288-321-71)',\n",
       "    'marketing_start_date': '20200613',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['283641'],\n",
       "   'spl_set_id': ['27235c87-2fe9-458f-8eb0-b9880199cd5a'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000151', 'N0000175784'],\n",
       "   'pharm_class_moa': ['Histamine H2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Histamine-2 Receptor Antagonist [EPC]'],\n",
       "   'unii': ['H0G9379FGK', '5QZO15J2Z8', 'NBZ3QY004S']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, CHEWABLE',\n",
       "  'spl_id': '8193363b-ea3e-415d-8940-5d58be9fe3cf',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200613',\n",
       "  'product_id': '72288-321_8193363b-ea3e-415d-8940-5d58be9fe3cf',\n",
       "  'application_number': 'ANDA077355',\n",
       "  'brand_name_base': 'Basic Care Dual Action Complete',\n",
       "  'pharm_class': ['Calculi Dissolution Agent [EPC]',\n",
       "   'Histamine H2 Receptor Antagonists [MoA]',\n",
       "   'Histamine-2 Receptor Antagonist [EPC]',\n",
       "   'Increased Large Intestinal Motility [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Magnesium Ion Exchange Activity [MoA]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]']},\n",
       " {'product_ndc': '72288-386',\n",
       "  'generic_name': 'Salicylic Acid',\n",
       "  'labeler_name': 'AMAZON.COM SERVICES LLC',\n",
       "  'brand_name': 'amazon basics advanced blemish spot treatment Acne medication',\n",
       "  'brand_name_suffix': 'Acne medication',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '20 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-386-01',\n",
       "    'description': '1 TUBE in 1 CARTON (72288-386-01)  / 22 mL in 1 TUBE',\n",
       "    'marketing_start_date': '20230828',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['AMAZON.COM SERVICES LLC'],\n",
       "   'rxcui': ['103568'],\n",
       "   'spl_set_id': ['67c1ef50-ecae-46a5-924e-1cff19481050'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['O414PZ4LPZ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': 'ac2f22b2-bb62-4de2-ba29-9c100722e278',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230828',\n",
       "  'product_id': '72288-386_ac2f22b2-bb62-4de2-ba29-9c100722e278',\n",
       "  'application_number': 'M006',\n",
       "  'brand_name_base': 'amazon basics advanced blemish spot treatment'},\n",
       " {'product_ndc': '72288-436',\n",
       "  'generic_name': 'Calamine, Pramoxine HCl',\n",
       "  'labeler_name': 'Amazon.Com Services LLC',\n",
       "  'brand_name': 'Calamine',\n",
       "  'active_ingredients': [{'name': 'FERRIC OXIDE RED', 'strength': '80 mg/mL'},\n",
       "   {'name': 'PRAMOXINE HYDROCHLORIDE', 'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-436-30',\n",
       "    'description': '177 mL in 1 BOTTLE, PLASTIC (72288-436-30)',\n",
       "    'marketing_start_date': '20180521',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.Com Services LLC'],\n",
       "   'rxcui': ['1234532'],\n",
       "   'spl_set_id': ['aceb0b10-8c90-4a06-8c47-cd1a2b4676a3'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['1K09F3G675', '88AYB867L5']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '2166ffe2-74d8-dbfc-e063-6294a90a840e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180521',\n",
       "  'product_id': '72288-436_2166ffe2-74d8-dbfc-e063-6294a90a840e',\n",
       "  'application_number': 'M016',\n",
       "  'brand_name_base': 'Calamine'},\n",
       " {'product_ndc': '72288-439',\n",
       "  'generic_name': 'Sodium fluoride',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'Anticavity',\n",
       "  'active_ingredients': [{'name': 'SODIUM FLUORIDE', 'strength': '.2 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-439-43',\n",
       "    'description': '473 mL in 1 BOTTLE, PLASTIC (72288-439-43)',\n",
       "    'marketing_start_date': '20180501',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-439-45',\n",
       "    'description': '946 mL in 1 BOTTLE, PLASTIC (72288-439-45)',\n",
       "    'marketing_start_date': '20180501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['313029'],\n",
       "   'spl_set_id': ['4a0220f8-748f-4a4a-9a8b-948756468f82'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['8ZYQ1474W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'MOUTHWASH',\n",
       "  'spl_id': '1273501c-2268-28a9-e063-6394a90add9e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180501',\n",
       "  'product_id': '72288-439_1273501c-2268-28a9-e063-6394a90add9e',\n",
       "  'application_number': 'M021',\n",
       "  'brand_name_base': 'Anticavity'},\n",
       " {'product_ndc': '72288-484',\n",
       "  'marketing_end_date': '20260228',\n",
       "  'generic_name': 'Acetaminophen',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'basic care acetaminophen',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-484-78',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72288-484-78)  / 100 TABLET in 1 BOTTLE',\n",
       "    'marketing_start_date': '20210803',\n",
       "    'marketing_end_date': '20260228',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-484-82',\n",
       "    'description': '200 TABLET in 1 BOTTLE (72288-484-82)',\n",
       "    'marketing_start_date': '20201005',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-484-83',\n",
       "    'description': '225 TABLET in 1 BOTTLE (72288-484-83)',\n",
       "    'marketing_start_date': '20201008',\n",
       "    'marketing_end_date': '20250731',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-484-93',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72288-484-93)',\n",
       "    'marketing_start_date': '20200415',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['198440'],\n",
       "   'spl_set_id': ['e3058c3c-6a73-4dc0-820f-c0c036ef1d19'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0370030114078'],\n",
       "   'unii': ['362O9ITL9D']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '2e4ed997-b20c-4c05-9146-0ccb94405bc1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200415',\n",
       "  'product_id': '72288-484_2e4ed997-b20c-4c05-9146-0ccb94405bc1',\n",
       "  'application_number': 'M013',\n",
       "  'brand_name_base': 'basic care acetaminophen'},\n",
       " {'product_ndc': '72288-575',\n",
       "  'generic_name': 'Benzalkonium chloride',\n",
       "  'labeler_name': 'Amozon.com Services LLC',\n",
       "  'brand_name': 'Hand Wash',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '.999 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-575-45',\n",
       "    'description': '946 mL in 1 BOTTLE, PLASTIC (72288-575-45)',\n",
       "    'marketing_start_date': '20180425',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amozon.com Services LLC'],\n",
       "   'spl_set_id': ['0884c8e6-3f7c-44eb-b3cf-6b5731bf3da1'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '1273642e-9c3f-7699-e063-6294a90ac5bb',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180425',\n",
       "  'product_id': '72288-575_1273642e-9c3f-7699-e063-6294a90ac5bb',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Hand Wash'},\n",
       " {'product_ndc': '72288-577',\n",
       "  'generic_name': 'Nicotine Polacrilex',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'basic care nicotine',\n",
       "  'active_ingredients': [{'name': 'NICOTINE', 'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-577-06',\n",
       "    'description': '160 BLISTER PACK in 1 CARTON (72288-577-06)  / 1 GUM, CHEWING in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20230712',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-577-60',\n",
       "    'description': '20 BLISTER PACK in 1 CARTON (72288-577-60)  / 1 GUM, CHEWING in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20230719',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['311975'],\n",
       "   'spl_set_id': ['44cce141-dd0e-47ba-b7fe-7cd6f7935ba5'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175706', 'M0014836'],\n",
       "   'pharm_class_epc': ['Cholinergic Nicotinic Agonist [EPC]'],\n",
       "   'pharm_class_cs': ['Nicotine [CS]'],\n",
       "   'unii': ['6M3C89ZY6R']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'GUM, CHEWING',\n",
       "  'spl_id': '1324b035-2f65-4da1-b576-9a1c672a04cf',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230712',\n",
       "  'product_id': '72288-577_1324b035-2f65-4da1-b576-9a1c672a04cf',\n",
       "  'application_number': 'ANDA206393',\n",
       "  'brand_name_base': 'basic care nicotine',\n",
       "  'pharm_class': ['Cholinergic Nicotinic Agonist [EPC]', 'Nicotine [CS]']},\n",
       " {'product_ndc': '0555-9034',\n",
       "  'generic_name': 'Norethindrone and Ethinyl Estradiol',\n",
       "  'labeler_name': 'Teva Pharmaceuticals USA, Inc.',\n",
       "  'brand_name': 'Balziva',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0555-9034-58',\n",
       "    'description': '6 POUCH in 1 CARTON (0555-9034-58)  / 1 BLISTER PACK in 1 POUCH (0555-9034-79)  / 1 KIT in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20061016',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Teva Pharmaceuticals USA, Inc.'],\n",
       "   'rxcui': ['238015', '748797', '749736', '1095362'],\n",
       "   'spl_set_id': ['36a282d2-7285-442b-9574-dfce2d9456f1'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': 'e954d96a-4a26-42db-a129-1f8d4b646507',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'marketing_start_date': '20061016',\n",
       "  'product_id': '0555-9034_e954d96a-4a26-42db-a129-1f8d4b646507',\n",
       "  'application_number': 'ANDA076238',\n",
       "  'brand_name_base': 'Balziva'},\n",
       " {'product_ndc': '72288-623',\n",
       "  'generic_name': 'NICOTINE POLACRILEX',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'AMAZON BASIC CARE NICOTINE POLACRILEX',\n",
       "  'active_ingredients': [{'name': 'NICOTINE', 'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-623-14',\n",
       "    'description': '6 CONTAINER in 1 CARTON (72288-623-14)  / 24 LOZENGE in 1 CONTAINER',\n",
       "    'marketing_start_date': '20240515',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-623-21',\n",
       "    'description': '9 CONTAINER in 1 CARTON (72288-623-21)  / 24 LOZENGE in 1 CONTAINER',\n",
       "    'marketing_start_date': '20240515',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['359817'],\n",
       "   'spl_set_id': ['113e0be9-7edc-4766-e063-6294a90af752'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175706', 'M0014836'],\n",
       "   'pharm_class_epc': ['Cholinergic Nicotinic Agonist [EPC]'],\n",
       "   'pharm_class_cs': ['Nicotine [CS]'],\n",
       "   'unii': ['6M3C89ZY6R']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'LOZENGE',\n",
       "  'spl_id': 'edf1e90f-1314-4906-b04b-4c0f15dce0c2',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240515',\n",
       "  'product_id': '72288-623_edf1e90f-1314-4906-b04b-4c0f15dce0c2',\n",
       "  'application_number': 'ANDA213266',\n",
       "  'brand_name_base': 'AMAZON BASIC CARE NICOTINE POLACRILEX',\n",
       "  'pharm_class': ['Cholinergic Nicotinic Agonist [EPC]', 'Nicotine [CS]']},\n",
       " {'product_ndc': '72288-664',\n",
       "  'generic_name': 'Eucalyptol, menthol, methyl salicylate, thymol',\n",
       "  'labeler_name': 'Amazon.Com Services LLC',\n",
       "  'brand_name': 'Antispetic',\n",
       "  'active_ingredients': [{'name': 'EUCALYPTOL', 'strength': '.92 mg/mL'},\n",
       "   {'name': 'MENTHOL', 'strength': '.42 mg/mL'},\n",
       "   {'name': 'METHYL SALICYLATE', 'strength': '.6 mg/mL'},\n",
       "   {'name': 'THYMOL', 'strength': '.64 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-664-12',\n",
       "    'description': '1500 mL in 1 BOTTLE, PLASTIC (72288-664-12)',\n",
       "    'marketing_start_date': '20180501',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-664-19',\n",
       "    'description': '94 mL in 1 BOTTLE, PLASTIC (72288-664-19)',\n",
       "    'marketing_start_date': '20180501',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-664-69',\n",
       "    'description': '250 mL in 1 BOTTLE, PLASTIC (72288-664-69)',\n",
       "    'marketing_start_date': '20180501',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-664-77',\n",
       "    'description': '500 mL in 1 BOTTLE, PLASTIC (72288-664-77)',\n",
       "    'marketing_start_date': '20180501',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-664-86',\n",
       "    'description': '1000 mL in 1 BOTTLE, PLASTIC (72288-664-86)',\n",
       "    'marketing_start_date': '20180501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.Com Services LLC'],\n",
       "   'rxcui': ['1043619'],\n",
       "   'spl_set_id': ['7e628443-81b5-4728-b4c3-c02abecbdaa8'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['RV6J6604TK', 'L7T10EIP3A', 'LAV5U5022Y', '3J50XA376E']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'MOUTHWASH',\n",
       "  'spl_id': '12737029-ad21-420a-e063-6394a90ae92c',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180501',\n",
       "  'product_id': '72288-664_12737029-ad21-420a-e063-6394a90ae92c',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Antispetic'},\n",
       " {'product_ndc': '72288-668',\n",
       "  'marketing_end_date': '20250630',\n",
       "  'generic_name': 'Dextromethorphan HBr, Doxylamine succinate',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'basic care night time cough',\n",
       "  'active_ingredients': [{'name': 'DEXTROMETHORPHAN HYDROBROMIDE',\n",
       "    'strength': '30 mg/30mL'},\n",
       "   {'name': 'DOXYLAMINE SUCCINATE', 'strength': '12.5 mg/30mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-668-40',\n",
       "    'description': '355 mL in 1 BOTTLE (72288-668-40)',\n",
       "    'marketing_start_date': '20211217',\n",
       "    'marketing_end_date': '20250630',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['1234386'],\n",
       "   'spl_set_id': ['31fc1943-583b-444b-91f5-0c7cc7dd171b'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['9D2RTI9KYH', 'V9BI9B5YI2']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': 'cd8f4509-d0bd-44b2-95a1-aeebfe916a7b',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20211217',\n",
       "  'product_id': '72288-668_cd8f4509-d0bd-44b2-95a1-aeebfe916a7b',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'basic care night time cough',\n",
       "  'pharm_class': ['Antihistamine [EPC]',\n",
       "   'Histamine Receptor Antagonists [MoA]',\n",
       "   'Sigma-1 Agonist [EPC]',\n",
       "   'Sigma-1 Receptor Agonists [MoA]',\n",
       "   'Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]',\n",
       "   'Uncompetitive NMDA Receptor Antagonists [MoA]']},\n",
       " {'product_ndc': '72288-722',\n",
       "  'generic_name': 'Fexofenadine Hydrochloride',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'Basic Care Allergy',\n",
       "  'active_ingredients': [{'name': 'FEXOFENADINE HYDROCHLORIDE',\n",
       "    'strength': '180 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-722-01',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72288-722-01)  / 70 TABLET, FILM COATED in 1 BOTTLE',\n",
       "    'marketing_start_date': '20240425',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['997420'],\n",
       "   'spl_set_id': ['27202f58-a488-42cc-b63f-be892c5b4de2'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['2S068B75ZU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'c6e01971-d70a-4d6a-be69-9e1f03d99a54',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240425',\n",
       "  'product_id': '72288-722_c6e01971-d70a-4d6a-be69-9e1f03d99a54',\n",
       "  'application_number': 'ANDA212971',\n",
       "  'brand_name_base': 'Basic Care Allergy',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72288-766',\n",
       "  'generic_name': 'Acetaminophen',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'basic care infants pain and fever',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '160 mg/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-766-16',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72288-766-16)  / 59 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20201210',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['307668'],\n",
       "   'spl_set_id': ['40329d8c-eb3d-4143-b4ae-9bafd0a1cb3c'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['362O9ITL9D']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SUSPENSION',\n",
       "  'spl_id': 'ef977c88-c6d2-41fd-a19c-b7a05601cf43',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201210',\n",
       "  'product_id': '72288-766_ef977c88-c6d2-41fd-a19c-b7a05601cf43',\n",
       "  'application_number': 'M013',\n",
       "  'brand_name_base': 'basic care infants pain and fever'},\n",
       " {'product_ndc': '72288-800',\n",
       "  'generic_name': 'cocoa butter, phenylephrine HCl',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'basic care hemorrhoidal',\n",
       "  'active_ingredients': [{'name': 'COCOA BUTTER', 'strength': '2211 mg/1'},\n",
       "   {'name': 'PHENYLEPHRINE HYDROCHLORIDE', 'strength': '6.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-800-62',\n",
       "    'description': '24 BLISTER PACK in 1 CARTON (72288-800-62)  / 1 SUPPOSITORY in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20220501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['1438497'],\n",
       "   'spl_set_id': ['617d9213-31f0-4c71-be0c-7961b96e5143'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['512OYT1CRR', '04JA59TNSJ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SUPPOSITORY',\n",
       "  'spl_id': '8475f48d-38f7-48ef-8357-96e7b42c64e7',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['RECTAL'],\n",
       "  'marketing_start_date': '20220501',\n",
       "  'product_id': '72288-800_8475f48d-38f7-48ef-8357-96e7b42c64e7',\n",
       "  'application_number': 'M015',\n",
       "  'brand_name_base': 'basic care hemorrhoidal',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72288-957',\n",
       "  'generic_name': 'Nicotine Polacrilex',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'basic care nicotine',\n",
       "  'active_ingredients': [{'name': 'NICOTINE', 'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-957-01',\n",
       "    'description': '1 CONTAINER in 1 CARTON (72288-957-01)  / 27 LOZENGE in 1 CONTAINER',\n",
       "    'marketing_start_date': '20210806',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-957-04',\n",
       "    'description': '5 CONTAINER in 1 CARTON (72288-957-04)  / 27 LOZENGE in 1 CONTAINER',\n",
       "    'marketing_start_date': '20210826',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72288-957-07',\n",
       "    'description': '8 CONTAINER in 1 CARTON (72288-957-07)  / 27 LOZENGE in 1 CONTAINER',\n",
       "    'marketing_start_date': '20211111',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['359818'],\n",
       "   'spl_set_id': ['d7e1e75c-a491-486f-9ca2-4f994658845e'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0012345678905'],\n",
       "   'nui': ['N0000175706', 'M0014836'],\n",
       "   'pharm_class_epc': ['Cholinergic Nicotinic Agonist [EPC]'],\n",
       "   'pharm_class_cs': ['Nicotine [CS]'],\n",
       "   'unii': ['6M3C89ZY6R']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'LOZENGE',\n",
       "  'spl_id': '2ce82de4-768b-4b16-9869-e831fbe9846d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210806',\n",
       "  'product_id': '72288-957_2ce82de4-768b-4b16-9869-e831fbe9846d',\n",
       "  'application_number': 'ANDA203690',\n",
       "  'brand_name_base': 'basic care nicotine',\n",
       "  'pharm_class': ['Cholinergic Nicotinic Agonist [EPC]', 'Nicotine [CS]']},\n",
       " {'product_ndc': '72288-967',\n",
       "  'generic_name': 'Lidocaine',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'Amazon Basics Pain Relief Patch with 4% Lidocaine',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '4 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-967-15',\n",
       "    'description': '15 PATCH in 1 CARTON (72288-967-15)  / 1 g in 1 PATCH',\n",
       "    'marketing_start_date': '20230101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['1737778'],\n",
       "   'spl_set_id': ['e3b4f9b1-ac6b-cb2a-e053-2a95a90a9e1e'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175682', 'M0000897', 'N0000175426', 'N0000175976'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]', 'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'unii': ['98PI200987']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'PATCH',\n",
       "  'spl_id': '190ff98c-11ce-dae6-e063-6394a90a69e8',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230101',\n",
       "  'product_id': '72288-967_190ff98c-11ce-dae6-e063-6394a90a69e8',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Amazon Basics Pain Relief Patch with 4% Lidocaine',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '72288-987',\n",
       "  'generic_name': 'Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl',\n",
       "  'labeler_name': 'Amazon.com Services LLC',\n",
       "  'brand_name': 'basic care childrens cold and cough',\n",
       "  'active_ingredients': [{'name': 'BROMPHENIRAMINE MALEATE',\n",
       "    'strength': '2 mg/10mL'},\n",
       "   {'name': 'DEXTROMETHORPHAN HYDROBROMIDE', 'strength': '10 mg/10mL'},\n",
       "   {'name': 'PHENYLEPHRINE HYDROCHLORIDE', 'strength': '5 mg/10mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72288-987-34',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72288-987-34)  / 237 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20210121',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amazon.com Services LLC'],\n",
       "   'rxcui': ['1090463'],\n",
       "   'spl_set_id': ['8cea1101-e91e-41ab-9fb5-da6ab61ea34f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['IXA7C9ZN03', '9D2RTI9KYH', '04JA59TNSJ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '1725c8c8-98b0-4c23-85da-d4a133d7b938',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210121',\n",
       "  'product_id': '72288-987_1725c8c8-98b0-4c23-85da-d4a133d7b938',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'basic care childrens cold and cough',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'Sigma-1 Agonist [EPC]',\n",
       "   'Sigma-1 Receptor Agonists [MoA]',\n",
       "   'Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]',\n",
       "   'Uncompetitive NMDA Receptor Antagonists [MoA]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72296-090',\n",
       "  'marketing_end_date': '20250601',\n",
       "  'generic_name': 'Sulfur Lotion',\n",
       "  'labeler_name': 'Tula Life LLC',\n",
       "  'brand_name': 'Acne All-Star 3-in-1 Acne Cleanser, Mask and Spot Treatment',\n",
       "  'active_ingredients': [{'name': 'SULFUR', 'strength': '.03 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72296-090-01',\n",
       "    'description': '1 TUBE in 1 CARTON (72296-090-01)  / 113 g in 1 TUBE',\n",
       "    'marketing_start_date': '20220725',\n",
       "    'marketing_end_date': '20250601',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Tula Life LLC'],\n",
       "   'rxcui': ['1046894'],\n",
       "   'spl_set_id': ['3a129fc9-9008-4d8e-acee-4d08c0fbb103'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['70FD1KFU70']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '28a77c9b-e25c-57db-e063-6394a90a05b9',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220725',\n",
       "  'product_id': '72296-090_28a77c9b-e25c-57db-e063-6394a90a05b9',\n",
       "  'application_number': 'M006',\n",
       "  'brand_name_base': 'Acne All-Star 3-in-1 Acne Cleanser, Mask and Spot Treatment'},\n",
       " {'product_ndc': '72296-103',\n",
       "  'marketing_end_date': '20250601',\n",
       "  'generic_name': 'Avobenzone, Octisalate Serum',\n",
       "  'labeler_name': 'Tula Life LLC',\n",
       "  'brand_name': 'TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30 Very Light Warm',\n",
       "  'brand_name_suffix': 'Very Light Warm',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '30 mg/mL'},\n",
       "   {'name': 'OCTISALATE', 'strength': '50 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72296-103-01',\n",
       "    'description': '1 TUBE in 1 CARTON (72296-103-01)  / 30 mL in 1 TUBE',\n",
       "    'marketing_start_date': '20241209',\n",
       "    'marketing_end_date': '20250601',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Tula Life LLC'],\n",
       "   'spl_set_id': ['32e29d36-edac-4aee-b503-ac55b6681d5c'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['4X49Y0596W', 'G63QQF2NOX']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '28e3970a-451a-beca-e063-6294a90aed5d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20241209',\n",
       "  'product_id': '72296-103_28e3970a-451a-beca-e063-6294a90aed5d',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30'},\n",
       " {'product_ndc': '72296-119',\n",
       "  'marketing_end_date': '20250601',\n",
       "  'generic_name': 'Avobenzone, Octisalate Serum',\n",
       "  'labeler_name': 'Tula Life LLC',\n",
       "  'brand_name': 'TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30 Tan Warm',\n",
       "  'brand_name_suffix': 'Tan Warm',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '30 mg/mL'},\n",
       "   {'name': 'OCTISALATE', 'strength': '50 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72296-119-01',\n",
       "    'description': '1 TUBE in 1 CARTON (72296-119-01)  / 30 mL in 1 TUBE',\n",
       "    'marketing_start_date': '20241209',\n",
       "    'marketing_end_date': '20250601',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Tula Life LLC'],\n",
       "   'spl_set_id': ['32e29d36-edac-4aee-b503-ac55b6681d5c'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['4X49Y0596W', 'G63QQF2NOX']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '28e3970a-451a-beca-e063-6294a90aed5d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20241209',\n",
       "  'product_id': '72296-119_28e3970a-451a-beca-e063-6294a90aed5d',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30'},\n",
       " {'product_ndc': '72296-128',\n",
       "  'marketing_end_date': '20250601',\n",
       "  'generic_name': 'Avobenzone, Octisalate Serum',\n",
       "  'labeler_name': 'Tula Life LLC',\n",
       "  'brand_name': 'TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30 Deep Neutral-Cool',\n",
       "  'brand_name_suffix': 'Deep Neutral-Cool',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '30 mg/mL'},\n",
       "   {'name': 'OCTISALATE', 'strength': '50 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72296-128-01',\n",
       "    'description': '1 TUBE in 1 CARTON (72296-128-01)  / 30 mL in 1 TUBE',\n",
       "    'marketing_start_date': '20241209',\n",
       "    'marketing_end_date': '20250601',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Tula Life LLC'],\n",
       "   'spl_set_id': ['32e29d36-edac-4aee-b503-ac55b6681d5c'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['4X49Y0596W', 'G63QQF2NOX']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '28e3970a-451a-beca-e063-6294a90aed5d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20241209',\n",
       "  'product_id': '72296-128_28e3970a-451a-beca-e063-6294a90aed5d',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30'},\n",
       " {'product_ndc': '72296-906',\n",
       "  'marketing_end_date': '20250601',\n",
       "  'generic_name': 'Acne and Blemish Fighting Kit',\n",
       "  'labeler_name': 'TULA Life LLC',\n",
       "  'brand_name': 'TULA Skincare Clear Skin Starters Travel-size Acne and Blemish Fighting Kit',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72296-906-01',\n",
       "    'description': '1 KIT in 1 CARTON (72296-906-01)  *  15 g in 1 TUBE *  15 g in 1 BOTTLE, PLASTIC *  14 g in 1 TUBE *  50 g in 1 BOTTLE, PUMP',\n",
       "    'marketing_start_date': '20230214',\n",
       "    'marketing_end_date': '20250601',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['TULA Life LLC'],\n",
       "   'spl_set_id': ['f481cd10-fe53-1cb6-e053-2a95a90a0516'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': '28a6b2a8-b420-4000-e063-6394a90ae752',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230214',\n",
       "  'product_id': '72296-906_28a6b2a8-b420-4000-e063-6394a90ae752',\n",
       "  'application_number': 'M006',\n",
       "  'brand_name_base': 'TULA Skincare Clear Skin Starters Travel-size Acne and Blemish Fighting Kit'},\n",
       " {'product_ndc': '72299-021',\n",
       "  'generic_name': 'SODIUM FLUORIDE',\n",
       "  'labeler_name': 'The Humble Company North America Inc',\n",
       "  'brand_name': 'Humble Brush Bamboo with FRESH MINT FLOURIDE',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72299-021-01',\n",
       "    'description': '1 KIT in 1 KIT (72299-021-01)  *  7 g in 1 TUBE (72299-022-01)',\n",
       "    'marketing_start_date': '20210901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['The Humble Company North America Inc'],\n",
       "   'rxcui': ['891775'],\n",
       "   'spl_set_id': ['ac1f73f2-f96d-465e-b081-dcb7188d6467'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': '090d4133-3435-57a8-e063-6294a90a6f30',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'marketing_start_date': '20210901',\n",
       "  'product_id': '72299-021_090d4133-3435-57a8-e063-6294a90a6f30',\n",
       "  'application_number': 'M021',\n",
       "  'brand_name_base': 'Humble Brush Bamboo with FRESH MINT FLOURIDE'},\n",
       " {'product_ndc': '72305-200',\n",
       "  'generic_name': 'levothyroxine sodium',\n",
       "  'labeler_name': 'Provell Pharmaceuticals, LLC',\n",
       "  'brand_name': 'EUTHYROX',\n",
       "  'active_ingredients': [{'name': 'LEVOTHYROXINE SODIUM',\n",
       "    'strength': '200 ug/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72305-200-30',\n",
       "    'description': '2 BLISTER PACK in 1 CARTON (72305-200-30)  / 15 TABLET in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20181017',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72305-200-90',\n",
       "    'description': '6 BLISTER PACK in 1 CARTON (72305-200-90)  / 15 TABLET in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20230101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Provell Pharmaceuticals, LLC'],\n",
       "   'rxcui': ['892246',\n",
       "    '892251',\n",
       "    '966153',\n",
       "    '966160',\n",
       "    '966166',\n",
       "    '966173',\n",
       "    '966177',\n",
       "    '966182',\n",
       "    '966187',\n",
       "    '966196',\n",
       "    '966202',\n",
       "    '966207',\n",
       "    '966220',\n",
       "    '966221',\n",
       "    '966222',\n",
       "    '966224',\n",
       "    '966225',\n",
       "    '966248',\n",
       "    '966249',\n",
       "    '966253',\n",
       "    '966270',\n",
       "    '2104866'],\n",
       "   'spl_set_id': ['bc3c6830-ba68-4ba3-9896-a12d0ad0b275'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['9J765S329G']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '45657074-8874-49f4-a8ef-3ca7e210c16e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181017',\n",
       "  'product_id': '72305-200_45657074-8874-49f4-a8ef-3ca7e210c16e',\n",
       "  'application_number': 'NDA021292',\n",
       "  'brand_name_base': 'EUTHYROX',\n",
       "  'pharm_class': ['Thyroxine [CS]', 'l-Thyroxine [EPC]']},\n",
       " {'product_ndc': '72330-052',\n",
       "  'generic_name': 'Ensulizole, Titanium Dioxide',\n",
       "  'labeler_name': 'fmg Co.Ltd',\n",
       "  'brand_name': 'THEFACESHOP Cushion CC SPF 50 Apricot Beige Oil-Free',\n",
       "  'brand_name_suffix': 'Oil-Free',\n",
       "  'active_ingredients': [{'name': 'ENSULIZOLE', 'strength': '.405 g/15g'},\n",
       "   {'name': 'TITANIUM DIOXIDE', 'strength': '.819 g/15g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72330-052-01',\n",
       "    'description': '2 CONTAINER in 1 BOX (72330-052-01)  / 15 g in 1 CONTAINER',\n",
       "    'marketing_start_date': '20210204',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['fmg Co.Ltd'],\n",
       "   'spl_set_id': ['d30ac897-3a30-7bba-e053-2995a90ac342'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['9YQ9DI1W42', '15FIX9V2JP']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'POWDER',\n",
       "  'spl_id': 'd30aeaa6-3420-401c-e053-2a95a90a8fe9',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210204',\n",
       "  'product_id': '72330-052_d30aeaa6-3420-401c-e053-2a95a90a8fe9',\n",
       "  'application_number': 'part352',\n",
       "  'brand_name_base': 'THEFACESHOP Cushion CC SPF 50 Apricot Beige'},\n",
       " {'product_ndc': '72330-251',\n",
       "  'generic_name': 'Zinc Oxide',\n",
       "  'labeler_name': 'fmg Co.Ltd',\n",
       "  'brand_name': 'PHYSIOGEL Daily Moisture Therapy Barrier Mineral Sunscreen Broad Spectrum SPF 50',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '15.52 g/50mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72330-251-50',\n",
       "    'description': '1 TUBE in 1 BOX (72330-251-50)  / 50 mL in 1 TUBE',\n",
       "    'marketing_start_date': '20240318',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['fmg Co.Ltd'],\n",
       "   'spl_set_id': ['1410c6d9-eff0-f90b-e063-6394a90a9403'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0803954309102'],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '1410c6e4-8052-33dc-e063-6294a90a0df1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240318',\n",
       "  'product_id': '72330-251_1410c6e4-8052-33dc-e063-6294a90a0df1',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'PHYSIOGEL Daily Moisture Therapy Barrier Mineral Sunscreen Broad Spectrum SPF 50'},\n",
       " {'product_ndc': '72330-601',\n",
       "  'generic_name': 'Titanium Dioxide',\n",
       "  'labeler_name': 'fmg Co.Ltd',\n",
       "  'brand_name': 'OHUI Ultimate Cover CC Cushion Compact 02 Natural Beige',\n",
       "  'active_ingredients': [{'name': 'ENSULIZOLE', 'strength': '.405 g/15g'},\n",
       "   {'name': 'TITANIUM DIOXIDE', 'strength': '.819 g/15g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72330-601-03',\n",
       "    'description': '3 CONTAINER in 1 CARTON (72330-601-03)  / 15 g in 1 CONTAINER',\n",
       "    'marketing_start_date': '20160125',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['fmg Co.Ltd'],\n",
       "   'spl_set_id': ['d3078dd2-ae9e-d81a-e053-2a95a90a47bf'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['8801051796278'],\n",
       "   'unii': ['9YQ9DI1W42', '15FIX9V2JP']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'POWDER',\n",
       "  'spl_id': 'd307b366-b9b7-1d68-e053-2995a90af94e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20160125',\n",
       "  'product_id': '72330-601_d307b366-b9b7-1d68-e053-2995a90af94e',\n",
       "  'application_number': 'part352',\n",
       "  'brand_name_base': 'OHUI Ultimate Cover CC Cushion Compact 02 Natural Beige'},\n",
       " {'product_ndc': '72336-910',\n",
       "  'generic_name': 'Valsartan',\n",
       "  'labeler_name': 'Lifsa Drugs LLC',\n",
       "  'brand_name': 'Valsartan',\n",
       "  'active_ingredients': [{'name': 'VALSARTAN', 'strength': '4 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72336-910-79',\n",
       "    'description': '120 mL in 1 BOTTLE, PLASTIC (72336-910-79)',\n",
       "    'marketing_start_date': '20220404',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72336-910-89',\n",
       "    'description': '473 mL in 1 BOTTLE, PLASTIC (72336-910-89)',\n",
       "    'marketing_start_date': '20220404',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Lifsa Drugs LLC'],\n",
       "   'rxcui': ['1996254'],\n",
       "   'spl_set_id': ['130e1659-9c2d-49ca-9db8-d28aa23fd133'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000070', 'N0000175561'],\n",
       "   'pharm_class_moa': ['Angiotensin 2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Angiotensin 2 Receptor Blocker [EPC]'],\n",
       "   'unii': ['80M03YXJ7I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': 'dd4cbd3f-572e-400b-8fe7-98d537557b80',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220404',\n",
       "  'product_id': '72336-910_dd4cbd3f-572e-400b-8fe7-98d537557b80',\n",
       "  'application_number': 'ANDA214102',\n",
       "  'brand_name_base': 'Valsartan',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]']},\n",
       " {'product_ndc': '72342-130',\n",
       "  'generic_name': 'MENTHOL, UNSPECIFIED FORM',\n",
       "  'labeler_name': 'J.R. Watkins, LLC.',\n",
       "  'brand_name': 'Pain Relief Extra Strength, Cooling',\n",
       "  'brand_name_suffix': 'Extra Strength, Cooling',\n",
       "  'active_ingredients': [{'name': 'MENTHOL, UNSPECIFIED FORM',\n",
       "    'strength': '6 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72342-130-18',\n",
       "    'description': '118 mL in 1 BOTTLE, SPRAY (72342-130-18)',\n",
       "    'marketing_start_date': '20201215',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['J.R. Watkins, LLC.'],\n",
       "   'rxcui': ['259550'],\n",
       "   'spl_set_id': ['92805cde-44d8-4962-9b65-e31e2d7ad4ee'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'AEROSOL, SPRAY',\n",
       "  'spl_id': '141d807c-ae73-d9f8-e063-6294a90ac691',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20201215',\n",
       "  'product_id': '72342-130_141d807c-ae73-d9f8-e063-6294a90ac691',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Pain Relief'},\n",
       " {'product_ndc': '72342-220',\n",
       "  'generic_name': 'CAMPHOR (NATURAL) and MENTHOL, UNSPECIFIED FORM',\n",
       "  'labeler_name': 'J.R. Watkins, LLC.',\n",
       "  'brand_name': 'Menthol Camphor Cough Suppressant Topical Analgesic Rub',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (NATURAL)',\n",
       "    'strength': '5.3 g/100g'},\n",
       "   {'name': 'MENTHOL, UNSPECIFIED FORM', 'strength': '2.8 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72342-220-04',\n",
       "    'description': '1 JAR in 1 BOX (72342-220-04)  / 116 g in 1 JAR',\n",
       "    'marketing_start_date': '20230801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['J.R. Watkins, LLC.'],\n",
       "   'rxcui': ['1112692'],\n",
       "   'spl_set_id': ['fd0ea70a-ef12-48b1-8d9d-cc5f6417f854'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['N20HL7Q941', 'L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': '10e11e75-6321-b9b4-e063-6394a90a0e63',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230801',\n",
       "  'product_id': '72342-220_10e11e75-6321-b9b4-e063-6394a90a0e63',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Menthol Camphor Cough Suppressant Topical Analgesic Rub'},\n",
       " {'product_ndc': '72346-110',\n",
       "  'generic_name': 'Hydrogen Peroxide Solution, Colloidal Silicon Dioxide',\n",
       "  'labeler_name': 'MEDIF CO.,LTD',\n",
       "  'brand_name': 'Medi W Tooth',\n",
       "  'active_ingredients': [{'name': 'HYDROGEN PEROXIDE',\n",
       "    'strength': '2.35 g/110g'},\n",
       "   {'name': 'SILICON DIOXIDE', 'strength': '7.7 g/110g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72346-110-02',\n",
       "    'description': '1 TUBE in 1 CARTON (72346-110-02)  / 110 g in 1 TUBE (72346-110-01)',\n",
       "    'marketing_start_date': '20200801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['MEDIF CO.,LTD'],\n",
       "   'spl_set_id': ['e36ad94c-ed88-4142-af39-e6f948204abc'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['8809296112006'],\n",
       "   'unii': ['BBX060AN9V', 'ETJ7Z6XBU4']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'PASTE, DENTIFRICE',\n",
       "  'spl_id': '8866028c-e5a6-4dca-a095-81321d7997cd',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200801',\n",
       "  'product_id': '72346-110_8866028c-e5a6-4dca-a095-81321d7997cd',\n",
       "  'brand_name_base': 'Medi W Tooth'},\n",
       " {'product_ndc': '72363-006',\n",
       "  'marketing_end_date': '20250314',\n",
       "  'generic_name': 'Argentum Metallicum',\n",
       "  'labeler_name': 'AG Essence',\n",
       "  'brand_name': 'Germproof',\n",
       "  'active_ingredients': [{'name': 'SILVER', 'strength': '1 g/28.5g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72363-006-03',\n",
       "    'description': '1 BOTTLE, SPRAY in 1 BOX (72363-006-03)  / 28.5 g in 1 BOTTLE, SPRAY (72363-006-02)',\n",
       "    'marketing_start_date': '20220314',\n",
       "    'marketing_end_date': '20250314',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['AG Essence'],\n",
       "   'spl_set_id': ['d9e2cfe3-a65d-2637-e053-2a95a90afc56'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3M4G523W1G']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'd9e2cfe3-a65e-2637-e053-2a95a90afc56',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220314',\n",
       "  'product_id': '72363-006_d9e2cfe3-a65e-2637-e053-2a95a90afc56',\n",
       "  'brand_name_base': 'Germproof'},\n",
       " {'product_ndc': '72363-017',\n",
       "  'generic_name': 'Argentum Metallicum',\n",
       "  'labeler_name': 'AG Essence',\n",
       "  'brand_name': 'PetSilver Wound 4',\n",
       "  'active_ingredients': [{'name': 'SILVER', 'strength': '.0035 g/118g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72363-017-01',\n",
       "    'description': '118 g in 1 BOTTLE (72363-017-01)',\n",
       "    'marketing_start_date': '20240101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['AG Essence'],\n",
       "   'spl_set_id': ['0c7940fa-0e54-90f3-e063-6394a90a344f'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0718122643462'],\n",
       "   'unii': ['3M4G523W1G']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '0c7940fa-0e55-90f3-e063-6394a90a344f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240101',\n",
       "  'product_id': '72363-017_0c7940fa-0e55-90f3-e063-6394a90a344f',\n",
       "  'brand_name_base': 'PetSilver Wound 4'},\n",
       " {'product_ndc': '72384-753',\n",
       "  'generic_name': 'avanafil',\n",
       "  'labeler_name': 'Metuchen Pharmaceuticals, LLC',\n",
       "  'brand_name': 'Stendra',\n",
       "  'active_ingredients': [{'name': 'AVANAFIL', 'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72384-753-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72384-753-30)',\n",
       "    'marketing_start_date': '20131227',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72384-753-99',\n",
       "    'description': '6 BLISTER PACK in 1 CARTON (72384-753-99)  / 1 TABLET in 1 BLISTER PACK (72384-753-01)',\n",
       "    'marketing_start_date': '20200810',\n",
       "    'sample': True}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Metuchen Pharmaceuticals, LLC'],\n",
       "   'rxcui': ['1291306', '1291312', '1291365', '1291367', '1291369', '1291371'],\n",
       "   'spl_set_id': ['fa7d93e3-b69b-4e02-8146-89760cd8e9d6'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175599', 'N0000020026'],\n",
       "   'pharm_class_epc': ['Phosphodiesterase 5 Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Phosphodiesterase 5 Inhibitors [MoA]'],\n",
       "   'unii': ['DR5S136IVO']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'f44369fe-9831-437f-aa49-d1e833973371',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20131227',\n",
       "  'product_id': '72384-753_f44369fe-9831-437f-aa49-d1e833973371',\n",
       "  'application_number': 'NDA202276',\n",
       "  'brand_name_base': 'Stendra',\n",
       "  'pharm_class': ['Phosphodiesterase 5 Inhibitor [EPC]',\n",
       "   'Phosphodiesterase 5 Inhibitors [MoA]']},\n",
       " {'product_ndc': '72400-203',\n",
       "  'generic_name': 'Colloidal Oatmeal 1%',\n",
       "  'labeler_name': 'Era Organics, Inc.',\n",
       "  'brand_name': 'Relief',\n",
       "  'active_ingredients': [{'name': 'OATMEAL', 'strength': '1.3 g/1.3g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72400-203-04',\n",
       "    'description': '113 g in 1 JAR (72400-203-04)',\n",
       "    'marketing_start_date': '20240101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72400-203-08',\n",
       "    'description': '227 g in 1 JAR (72400-203-08)',\n",
       "    'marketing_start_date': '20240101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Era Organics, Inc.'],\n",
       "   'spl_set_id': ['0ad58a99-e41a-a830-e063-6294a90af9cb'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0850004022986'],\n",
       "   'nui': ['N0000185371',\n",
       "    'N0000185375',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'M0000728',\n",
       "    'M0006342',\n",
       "    'M0016962',\n",
       "    'N0000185016'],\n",
       "   'pharm_class_epc': ['Non-Standardized Food Allergenic Extract [EPC]',\n",
       "    'Non-Standardized Plant Allergenic Extract [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]',\n",
       "    'Dietary Proteins [CS]',\n",
       "    'Plant Proteins [CS]'],\n",
       "   'unii': ['8PI54V663Y']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '12ecaf2c-31cd-c87c-e063-6394a90a5f10',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240101',\n",
       "  'product_id': '72400-203_12ecaf2c-31cd-c87c-e063-6394a90a5f10',\n",
       "  'application_number': 'M006',\n",
       "  'brand_name_base': 'Relief',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Grain Proteins [EXT]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]']},\n",
       " {'product_ndc': '72400-300',\n",
       "  'generic_name': 'Colloidal Oatmeal 1%',\n",
       "  'labeler_name': 'Era Organics, Inc.',\n",
       "  'brand_name': 'Superbalm',\n",
       "  'active_ingredients': [{'name': 'OATMEAL', 'strength': '.57 g/.57g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72400-300-02',\n",
       "    'description': '57 g in 1 JAR (72400-300-02)',\n",
       "    'marketing_start_date': '20240919',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72400-300-04',\n",
       "    'description': '113 g in 1 JAR (72400-300-04)',\n",
       "    'marketing_start_date': '20240919',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Era Organics, Inc.'],\n",
       "   'spl_set_id': ['f5298e5e-583d-d74c-e053-2995a90affb5'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0712411779160'],\n",
       "   'nui': ['N0000185371',\n",
       "    'N0000185375',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'M0000728',\n",
       "    'M0006342',\n",
       "    'M0016962',\n",
       "    'N0000185016'],\n",
       "   'pharm_class_epc': ['Non-Standardized Food Allergenic Extract [EPC]',\n",
       "    'Non-Standardized Plant Allergenic Extract [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]',\n",
       "    'Dietary Proteins [CS]',\n",
       "    'Plant Proteins [CS]'],\n",
       "   'unii': ['8PI54V663Y']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SALVE',\n",
       "  'spl_id': '227d89cf-99b0-4cc1-e063-6394a90a3c42',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240919',\n",
       "  'product_id': '72400-300_227d89cf-99b0-4cc1-e063-6394a90a3c42',\n",
       "  'application_number': 'M006',\n",
       "  'brand_name_base': 'Superbalm',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Grain Proteins [EXT]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]']},\n",
       " {'product_ndc': '72427-4314',\n",
       "  'generic_name': 'Pectin',\n",
       "  'labeler_name': 'BFY LLC',\n",
       "  'brand_name': 'Sootheez Watermelon Mint',\n",
       "  'active_ingredients': [{'name': 'PECTIN', 'strength': '11.5 mg/3.5g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72427-4314-1',\n",
       "    'description': '14 CANISTER in 1 CONTAINER (72427-4314-1)  / 49 g in 1 CANISTER',\n",
       "    'marketing_start_date': '20240604',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['BFY LLC'],\n",
       "   'rxcui': ['2204565', '2667489'],\n",
       "   'spl_set_id': ['f561685a-5260-59c6-e053-2a95a90ae206'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0860444001601'],\n",
       "   'unii': ['H0G9379FGK', '89NA02M4RX']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOZENGE',\n",
       "  'spl_id': '230b9601-001f-09ac-e063-6394a90ae27b',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240604',\n",
       "  'product_id': '72427-4314_230b9601-001f-09ac-e063-6394a90ae27b',\n",
       "  'application_number': 'M022',\n",
       "  'brand_name_base': 'Sootheez Watermelon Mint'},\n",
       " {'product_ndc': '72427-4615',\n",
       "  'generic_name': 'Pectin',\n",
       "  'labeler_name': 'BFY LLC',\n",
       "  'brand_name': 'Lolleez Birthday Cake - Conventional',\n",
       "  'active_ingredients': [{'name': 'PECTIN', 'strength': '11.5 mg/7g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72427-4615-1',\n",
       "    'description': '105 g in 1 POUCH (72427-4615-1)',\n",
       "    'marketing_start_date': '20240926',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['BFY LLC'],\n",
       "   'rxcui': ['2204565', '2667489'],\n",
       "   'spl_set_id': ['f561685a-5260-59c6-e053-2a95a90ae206'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0860444001601'],\n",
       "   'unii': ['H0G9379FGK', '89NA02M4RX']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOZENGE',\n",
       "  'spl_id': '230b9601-001f-09ac-e063-6394a90ae27b',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240926',\n",
       "  'product_id': '72427-4615_230b9601-001f-09ac-e063-6394a90ae27b',\n",
       "  'application_number': 'M022',\n",
       "  'brand_name_base': 'Lolleez Birthday Cake - Conventional'},\n",
       " {'product_ndc': '72459-012',\n",
       "  'generic_name': 'POVIDONE-IODINE',\n",
       "  'labeler_name': 'Yiwu Ori-Power Medtech Co.,Ltd.',\n",
       "  'brand_name': 'OP First Aid Series Povidone Iodine Prep Pad',\n",
       "  'active_ingredients': [{'name': 'POVIDONE-IODINE', 'strength': '100 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72459-012-01',\n",
       "    'description': '1 PATCH in 1 POUCH (72459-012-01)  / .55 mL in 1 PATCH',\n",
       "    'marketing_start_date': '20201103',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Yiwu Ori-Power Medtech Co.,Ltd.'],\n",
       "   'rxcui': ['797730'],\n",
       "   'spl_set_id': ['b43ae55f-dc21-09b2-e053-2995a90adf4c'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175486', 'M0011640'],\n",
       "   'pharm_class_epc': ['Antiseptic [EPC]'],\n",
       "   'pharm_class_cs': ['Iodine [CS]'],\n",
       "   'unii': ['85H0HZU99M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CLOTH',\n",
       "  'spl_id': '0c86d49a-27b6-7f18-e063-6394a90ad534',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20201103',\n",
       "  'product_id': '72459-012_0c86d49a-27b6-7f18-e063-6394a90ad534',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'OP First Aid Series Povidone Iodine Prep Pad'},\n",
       " {'product_ndc': '0573-0179',\n",
       "  'generic_name': 'ibuprofen',\n",
       "  'labeler_name': 'GlaxoSmithKline Consumer Healthcare Holdings (US) LLC',\n",
       "  'brand_name': 'JUNIOR STRENGTH ADVIL',\n",
       "  'active_ingredients': [{'name': 'IBUPROFEN', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0573-0179-20',\n",
       "    'description': '1 BOTTLE in 1 CARTON (0573-0179-20)  / 24 TABLET, CHEWABLE in 1 BOTTLE',\n",
       "    'marketing_start_date': '20110601',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['GlaxoSmithKline Consumer Healthcare Holdings (US) LLC'],\n",
       "   'rxcui': ['310963', '731536'],\n",
       "   'spl_set_id': ['07d4c400-b182-92f7-7574-9e0e94c39cce'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['WK2XYI10QM']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET, CHEWABLE',\n",
       "  'spl_id': '4898214f-e425-4ca8-b8e1-c865cd131ed2',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20110601',\n",
       "  'product_id': '0573-0179_4898214f-e425-4ca8-b8e1-c865cd131ed2',\n",
       "  'application_number': 'NDA020944',\n",
       "  'brand_name_base': 'JUNIOR STRENGTH ADVIL',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '0573-0180',\n",
       "  'generic_name': 'ibuprofen and pseudoephedrine hydrochloride',\n",
       "  'labeler_name': 'Haleon US Holdings LLC',\n",
       "  'brand_name': 'ADVIL COLD AND SINUS',\n",
       "  'active_ingredients': [{'name': 'IBUPROFEN', 'strength': '200 mg/1'},\n",
       "   {'name': 'PSEUDOEPHEDRINE HYDROCHLORIDE', 'strength': '30 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0573-0180-10',\n",
       "    'description': '2 BLISTER PACK in 1 CARTON (0573-0180-10)  / 10 TABLET, COATED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '19890919',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0573-0180-21',\n",
       "    'description': '4 BLISTER PACK in 1 CARTON (0573-0180-21)  / 10 TABLET, COATED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '19890919',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Haleon US Holdings LLC'],\n",
       "   'rxcui': ['1299021'],\n",
       "   'spl_set_id': ['fac22a47-f0de-4505-fd8a-768430cda0c1'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['WK2XYI10QM', '6V9V2RYJ8N']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '1b68a8f1-8bf4-8445-e063-6394a90a75eb',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19890919',\n",
       "  'product_id': '0573-0180_1b68a8f1-8bf4-8445-e063-6394a90a75eb',\n",
       "  'application_number': 'NDA019771',\n",
       "  'brand_name_base': 'ADVIL COLD AND SINUS',\n",
       "  'pharm_class': ['Adrenergic alpha-Agonists [MoA]',\n",
       "   'Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]',\n",
       "   'alpha-Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72476-018',\n",
       "  'generic_name': 'ASPIRIN',\n",
       "  'labeler_name': 'RETAIL BUSINESS SERVICES , LLC.',\n",
       "  'brand_name': 'Aspirin Regular Strength',\n",
       "  'brand_name_suffix': 'Regular Strength',\n",
       "  'active_ingredients': [{'name': 'ASPIRIN', 'strength': '325 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-018-11',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (72476-018-11)  / 100 TABLET, COATED in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20240301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72476-018-19',\n",
       "    'description': '300 TABLET, COATED in 1 BOTTLE, PLASTIC (72476-018-19)',\n",
       "    'marketing_start_date': '20240301',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['RETAIL BUSINESS SERVICES , LLC.'],\n",
       "   'rxcui': ['212033'],\n",
       "   'spl_set_id': ['093182a6-3ed8-5a3f-e063-6294a90a354a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0341520313608'],\n",
       "   'nui': ['N0000000160',\n",
       "    'N0000008836',\n",
       "    'M0001335',\n",
       "    'N0000175722',\n",
       "    'N0000175578',\n",
       "    'N0000008832'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_pe': ['Decreased Prostaglandin Production [PE]',\n",
       "    'Decreased Platelet Aggregation [PE]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]',\n",
       "    'Platelet Aggregation Inhibitor [EPC]'],\n",
       "   'unii': ['R16CO5Y76E']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '1adb0b7f-24d7-282e-e063-6394a90ae2c4',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240301',\n",
       "  'product_id': '72476-018_1adb0b7f-24d7-282e-e063-6394a90ae2c4',\n",
       "  'application_number': 'M013',\n",
       "  'brand_name_base': 'Aspirin',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Decreased Platelet Aggregation [PE]',\n",
       "   'Decreased Prostaglandin Production [PE]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]',\n",
       "   'Platelet Aggregation Inhibitor [EPC]']},\n",
       " {'product_ndc': '72476-034',\n",
       "  'marketing_end_date': '20250630',\n",
       "  'generic_name': 'Diphenhydramine HCl',\n",
       "  'labeler_name': 'Care One (Retail Business Services, LLC.)',\n",
       "  'brand_name': 'Nighttime Sleep Aid',\n",
       "  'active_ingredients': [{'name': 'DIPHENHYDRAMINE HYDROCHLORIDE',\n",
       "    'strength': '50 mg/30mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-034-06',\n",
       "    'description': '177 mL in 1 BOTTLE, PLASTIC (72476-034-06)',\n",
       "    'marketing_start_date': '20190630',\n",
       "    'marketing_end_date': '20250630',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72476-034-12',\n",
       "    'description': '355 mL in 1 BOTTLE, PLASTIC (72476-034-12)',\n",
       "    'marketing_start_date': '20190630',\n",
       "    'marketing_end_date': '20250630',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Care One (Retail Business Services, LLC.)'],\n",
       "   'rxcui': ['1248354'],\n",
       "   'spl_set_id': ['c5cfe533-9942-48df-8da3-1846a35da4d5'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0341520000591'],\n",
       "   'unii': ['TC2D6JAD40']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '18a7dde5-7c8b-4f92-9f3d-98ce3693e488',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190630',\n",
       "  'product_id': '72476-034_18a7dde5-7c8b-4f92-9f3d-98ce3693e488',\n",
       "  'application_number': 'part341',\n",
       "  'brand_name_base': 'Nighttime Sleep Aid',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72476-063',\n",
       "  'generic_name': 'FERRIC OXIDE RED',\n",
       "  'labeler_name': 'Retail Business Services, LLC',\n",
       "  'brand_name': 'Calamine',\n",
       "  'active_ingredients': [{'name': 'FERRIC OXIDE RED', 'strength': '8 g/mL'},\n",
       "   {'name': 'ZINC OXIDE', 'strength': '8 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-063-30',\n",
       "    'description': '177 mL in 1 BOTTLE, PLASTIC (72476-063-30)',\n",
       "    'marketing_start_date': '20130206',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Retail Business Services, LLC'],\n",
       "   'rxcui': ['617954'],\n",
       "   'spl_set_id': ['7291e175-a9b6-4c47-93ce-227ce11e4599'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['1K09F3G675', 'SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '21660256-bd07-39c9-e063-6394a90a7bce',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20130206',\n",
       "  'product_id': '72476-063_21660256-bd07-39c9-e063-6394a90a7bce',\n",
       "  'application_number': 'M016',\n",
       "  'brand_name_base': 'Calamine'},\n",
       " {'product_ndc': '72476-123',\n",
       "  'generic_name': 'ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'RETAIL BUSINESS SERVICES , LLC.',\n",
       "  'brand_name': 'SINUS AND HEADACHE',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '325 mg/1'},\n",
       "   {'name': 'PHENYLEPHRINE HYDROCHLORIDE', 'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-123-05',\n",
       "    'description': '2 BLISTER PACK in 1 CARTON (72476-123-05)  / 12 TABLET, COATED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20200801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['RETAIL BUSINESS SERVICES , LLC.'],\n",
       "   'rxcui': ['1046378'],\n",
       "   'spl_set_id': ['9f95b2e8-dea4-ef59-e053-2a95a90a0bcb'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['362O9ITL9D', '04JA59TNSJ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '24898f7f-5baf-5e70-e063-6394a90a91cc',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200801',\n",
       "  'product_id': '72476-123_24898f7f-5baf-5e70-e063-6394a90a91cc',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'SINUS AND HEADACHE',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72476-131',\n",
       "  'generic_name': 'Acetaminophen and Ibuprofen (NSAID)',\n",
       "  'labeler_name': 'RETAIL BUSINESS SERVICES,LLC',\n",
       "  'brand_name': 'Acetaminophen and Ibuprofen (NSAID)',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '250 mg/1'},\n",
       "   {'name': 'IBUPROFEN', 'strength': '125 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-131-72',\n",
       "    'description': '72 TABLET in 1 BOTTLE (72476-131-72)',\n",
       "    'marketing_start_date': '20230720',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72476-131-81',\n",
       "    'description': '18 TABLET in 1 BOTTLE (72476-131-81)',\n",
       "    'marketing_start_date': '20230720',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['RETAIL BUSINESS SERVICES,LLC'],\n",
       "   'spl_set_id': ['e7b7009a-89a4-720d-e053-2a95a90abff7'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['362O9ITL9D', 'WK2XYI10QM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '29666764-c2f2-84e4-e063-6294a90a084d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230720',\n",
       "  'product_id': '72476-131_29666764-c2f2-84e4-e063-6294a90a084d',\n",
       "  'application_number': 'ANDA216592',\n",
       "  'brand_name_base': 'Acetaminophen and Ibuprofen (NSAID)',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72476-171',\n",
       "  'generic_name': 'Acetaminophen and Diphenhydramine Hydrochloride',\n",
       "  'labeler_name': 'RETAIL BUSINESS SERVICES , LLC.',\n",
       "  'brand_name': 'ACETAMINOPHEN PM',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '500 mg/1'},\n",
       "   {'name': 'DIPHENHYDRAMINE HYDROCHLORIDE', 'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-171-01',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (72476-171-01)  / 20 TABLET, COATED in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20240301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72476-171-03',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (72476-171-03)  / 80 TABLET, COATED in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20240301',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['RETAIL BUSINESS SERVICES , LLC.'],\n",
       "   'rxcui': ['1092189'],\n",
       "   'spl_set_id': ['093199be-e92a-6f60-e063-6294a90a8533'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0341520319624'],\n",
       "   'unii': ['362O9ITL9D', 'TC2D6JAD40']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '1adb0e1c-a806-ed20-e063-6294a90a46ee',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240301',\n",
       "  'product_id': '72476-171_1adb0e1c-a806-ed20-e063-6294a90a46ee',\n",
       "  'application_number': 'M013',\n",
       "  'brand_name_base': 'ACETAMINOPHEN PM',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72476-482',\n",
       "  'generic_name': 'Sodium fluoride',\n",
       "  'labeler_name': 'Retail Business Services, LLC',\n",
       "  'brand_name': 'Alcohol-Free Anticavity',\n",
       "  'active_ingredients': [{'name': 'SODIUM FLUORIDE', 'strength': '.1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-482-86',\n",
       "    'description': '1000 mL in 1 BOTTLE, PLASTIC (72476-482-86)',\n",
       "    'marketing_start_date': '20130203',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Retail Business Services, LLC'],\n",
       "   'rxcui': ['313029'],\n",
       "   'spl_set_id': ['542e067a-c134-44c9-b962-f2a2b667b76f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['8ZYQ1474W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '22677223-15d5-0ded-e063-6394a90afaa2',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20130201',\n",
       "  'product_id': '72476-482_22677223-15d5-0ded-e063-6394a90afaa2',\n",
       "  'application_number': 'M021',\n",
       "  'brand_name_base': 'Alcohol-Free Anticavity'},\n",
       " {'product_ndc': '72476-503',\n",
       "  'generic_name': 'aluminum hydroxide, magnesium hydroxide, simethicone',\n",
       "  'labeler_name': 'Retail Business Services, LLC.',\n",
       "  'brand_name': 'Antacid Antigas',\n",
       "  'active_ingredients': [{'name': 'ALUMINUM HYDROXIDE',\n",
       "    'strength': '400 mg/10mL'},\n",
       "   {'name': 'DIMETHICONE', 'strength': '40 mg/10mL'},\n",
       "   {'name': 'MAGNESIUM HYDROXIDE', 'strength': '400 mg/10mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-503-05',\n",
       "    'description': '355 mL in 1 BOTTLE (72476-503-05)',\n",
       "    'marketing_start_date': '20210526',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Retail Business Services, LLC.'],\n",
       "   'rxcui': ['307746'],\n",
       "   'spl_set_id': ['c8173d42-f900-4527-aa56-472d1177a9bc'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000010282'],\n",
       "   'pharm_class_pe': ['Skin Barrier Activity [PE]'],\n",
       "   'unii': ['5QB0T2IUN0', '92RU3N3Y1O', 'NBZ3QY004S']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'c8173d42-f900-4527-aa56-472d1177a9bc',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210526',\n",
       "  'product_id': '72476-503_c8173d42-f900-4527-aa56-472d1177a9bc',\n",
       "  'application_number': 'part331',\n",
       "  'brand_name_base': 'Antacid Antigas',\n",
       "  'pharm_class': ['Calculi Dissolution Agent [EPC]',\n",
       "   'Increased Large Intestinal Motility [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Magnesium Ion Exchange Activity [MoA]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Skin Barrier Activity [PE]',\n",
       "   'Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]']},\n",
       " {'product_ndc': '72476-516',\n",
       "  'generic_name': 'aluminum hydroxide, magnesium hydroxide, simethicone',\n",
       "  'labeler_name': 'Retail Business Services, LLC.',\n",
       "  'brand_name': 'Antacid',\n",
       "  'active_ingredients': [{'name': 'ALUMINUM HYDROXIDE',\n",
       "    'strength': '800 mg/10mL'},\n",
       "   {'name': 'DIMETHICONE', 'strength': '80 mg/10mL'},\n",
       "   {'name': 'MAGNESIUM HYDROXIDE', 'strength': '800 mg/10mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-516-05',\n",
       "    'description': '355 mL in 1 BOTTLE (72476-516-05)',\n",
       "    'marketing_start_date': '20210527',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Retail Business Services, LLC.'],\n",
       "   'spl_set_id': ['ce2edc57-e550-4aa9-bbfe-37933913c9eb'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0341520006036'],\n",
       "   'nui': ['N0000010282'],\n",
       "   'pharm_class_pe': ['Skin Barrier Activity [PE]'],\n",
       "   'unii': ['5QB0T2IUN0', '92RU3N3Y1O', 'NBZ3QY004S']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'da456848-d97d-4b41-9e55-f4ae189d3a36',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210527',\n",
       "  'product_id': '72476-516_da456848-d97d-4b41-9e55-f4ae189d3a36',\n",
       "  'application_number': 'M001',\n",
       "  'brand_name_base': 'Antacid',\n",
       "  'pharm_class': ['Calculi Dissolution Agent [EPC]',\n",
       "   'Increased Large Intestinal Motility [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Magnesium Ion Exchange Activity [MoA]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Skin Barrier Activity [PE]',\n",
       "   'Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]']},\n",
       " {'product_ndc': '72476-602',\n",
       "  'generic_name': 'Magnesium Sulfate',\n",
       "  'labeler_name': 'Retail Business Services, LLC',\n",
       "  'brand_name': 'Epsom Salt',\n",
       "  'active_ingredients': [{'name': 'MAGNESIUM SULFATE HEPTAHYDRATE',\n",
       "    'strength': '1 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-602-04',\n",
       "    'description': '1814 g in 1 POUCH (72476-602-04)',\n",
       "    'marketing_start_date': '20150506',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72476-602-43',\n",
       "    'description': '454 g in 1 POUCH (72476-602-43)',\n",
       "    'marketing_start_date': '20150506',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Retail Business Services, LLC'],\n",
       "   'rxcui': ['1053346'],\n",
       "   'spl_set_id': ['1a8b540c-b66e-4dca-b7af-23705ae247b6'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SK47B8698T']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GRANULE, FOR SOLUTION',\n",
       "  'spl_id': '21776bbb-ebe9-8dc2-e063-6394a90ab411',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL', 'TOPICAL'],\n",
       "  'marketing_start_date': '20150506',\n",
       "  'product_id': '72476-602_21776bbb-ebe9-8dc2-e063-6394a90ab411',\n",
       "  'application_number': 'M007',\n",
       "  'brand_name_base': 'Epsom Salt',\n",
       "  'pharm_class': ['Calculi Dissolution Agent [EPC]',\n",
       "   'Increased Large Intestinal Motility [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Magnesium Ion Exchange Activity [MoA]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]']},\n",
       " {'product_ndc': '72476-804',\n",
       "  'generic_name': 'Isopropyl Alcohol',\n",
       "  'labeler_name': 'Retail Business Services, LLC',\n",
       "  'brand_name': 'Isopropyl Alcohol',\n",
       "  'active_ingredients': [{'name': 'ISOPROPYL ALCOHOL',\n",
       "    'strength': '91 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-804-43',\n",
       "    'description': '473 mL in 1 BOTTLE, PLASTIC (72476-804-43)',\n",
       "    'marketing_start_date': '20150308',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72476-804-45',\n",
       "    'description': '946 mL in 1 BOTTLE, PLASTIC (72476-804-45)',\n",
       "    'marketing_start_date': '20150308',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Retail Business Services, LLC'],\n",
       "   'rxcui': ['582901'],\n",
       "   'spl_set_id': ['d95a9736-345b-4b7e-9b24-23edb3cbf7e8'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['ND2M416302']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '2177c2a1-7283-5971-e063-6394a90a9282',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20150308',\n",
       "  'product_id': '72476-804_2177c2a1-7283-5971-e063-6394a90a9282',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'Isopropyl Alcohol'},\n",
       " {'product_ndc': '72476-851',\n",
       "  'generic_name': 'OLOPATADINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Retail Business Services, LLC.',\n",
       "  'brand_name': 'OLOPATADINE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'OLOPATADINE HYDROCHLORIDE',\n",
       "    'strength': '2 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-851-21',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (72476-851-21)  / 2.5 mL in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20210402',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Retail Business Services, LLC.'],\n",
       "   'rxcui': ['1111343'],\n",
       "   'spl_set_id': ['bca27f6a-d1b1-1d6a-e053-2995a90a37b5'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0341520005923'],\n",
       "   'unii': ['2XG66W44KF']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': 'bca27f6a-d1b1-1d6a-e053-2995a90a37b5',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20210402',\n",
       "  'product_id': '72476-851_bca27f6a-d1b1-1d6a-e053-2995a90a37b5',\n",
       "  'application_number': 'ANDA209995',\n",
       "  'brand_name_base': 'OLOPATADINE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Decreased Histamine Release [PE]',\n",
       "   'Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Inhibitor [EPC]']},\n",
       " {'product_ndc': '72476-855',\n",
       "  'generic_name': 'docusate sodium and sennosides',\n",
       "  'labeler_name': 'Care One (Retail Business Services, LLC.)',\n",
       "  'brand_name': 'Stool Softener Plus Stimulant Laxative',\n",
       "  'brand_name_suffix': 'Plus Stimulant Laxative',\n",
       "  'active_ingredients': [{'name': 'DOCUSATE SODIUM', 'strength': '50 mg/1'},\n",
       "   {'name': 'SENNOSIDES', 'strength': '8.6 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-855-10',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 BOX (72476-855-10)  / 100 TABLET in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20200630',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Care One (Retail Business Services, LLC.)'],\n",
       "   'rxcui': ['998740'],\n",
       "   'spl_set_id': ['7f4f7fcb-5202-4184-80ef-b4b6c6460c2f'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0341520314063'],\n",
       "   'unii': ['F05Q2T2JA0', '3FYP5M0IJX']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '534f880e-9723-427d-8841-6817c4f3a8ef',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200630',\n",
       "  'product_id': '72476-855_534f880e-9723-427d-8841-6817c4f3a8ef',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Stool Softener'},\n",
       " {'product_ndc': '72476-898',\n",
       "  'generic_name': 'Acetaminophen, Dextromethorphan HBr, Phenylephrine HCL',\n",
       "  'labeler_name': 'Care One (Retail Business Services, LLC.)',\n",
       "  'brand_name': 'Daytime Cold and Flu',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '325 mg/1'},\n",
       "   {'name': 'DEXTROMETHORPHAN HYDROBROMIDE', 'strength': '10 mg/1'},\n",
       "   {'name': 'PHENYLEPHRINE HYDROCHLORIDE', 'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-898-24',\n",
       "    'description': '24 BLISTER PACK in 1 CARTON (72476-898-24)  / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20191129',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Care One (Retail Business Services, LLC.)'],\n",
       "   'rxcui': ['1086997'],\n",
       "   'spl_set_id': ['6ca7372b-50c4-4b15-b133-fefa35525ade'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0341520000409'],\n",
       "   'unii': ['362O9ITL9D', '9D2RTI9KYH', '04JA59TNSJ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CAPSULE, LIQUID FILLED',\n",
       "  'spl_id': '75190564-82fe-4d4c-bb92-706448e476e9',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20191129',\n",
       "  'product_id': '72476-898_75190564-82fe-4d4c-bb92-706448e476e9',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'Daytime Cold and Flu',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'Sigma-1 Agonist [EPC]',\n",
       "   'Sigma-1 Receptor Agonists [MoA]',\n",
       "   'Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]',\n",
       "   'Uncompetitive NMDA Receptor Antagonists [MoA]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72476-922',\n",
       "  'generic_name': 'Docosanol',\n",
       "  'labeler_name': 'Care One (Retail Business Services, LLC.)',\n",
       "  'brand_name': 'Docosanol',\n",
       "  'active_ingredients': [{'name': 'DOCOSANOL', 'strength': '100 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-922-07',\n",
       "    'description': '1 TUBE in 1 PACKAGE (72476-922-07)  / 2 g in 1 TUBE',\n",
       "    'marketing_start_date': '20200630',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Care One (Retail Business Services, LLC.)'],\n",
       "   'rxcui': ['797534'],\n",
       "   'spl_set_id': ['c3f386e2-68da-4d64-809a-e170d473731d'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0341520005084'],\n",
       "   'unii': ['9G1OE216XY']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': 'ca6bd819-d850-4d5d-b213-c27f8f858749',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200630',\n",
       "  'product_id': '72476-922_ca6bd819-d850-4d5d-b213-c27f8f858749',\n",
       "  'application_number': 'ANDA208754',\n",
       "  'brand_name_base': 'Docosanol'},\n",
       " {'product_ndc': '72476-935',\n",
       "  'generic_name': 'Avobenzone, Homosalate, Octisalate',\n",
       "  'labeler_name': 'Retail Business Services, LLC',\n",
       "  'brand_name': 'Sheer Touch Sunscreen SPF 70',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '30 mg/mL'},\n",
       "   {'name': 'HOMOSALATE', 'strength': '150 mg/mL'},\n",
       "   {'name': 'OCTISALATE', 'strength': '50 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-935-21',\n",
       "    'description': '88 mL in 1 TUBE (72476-935-21)',\n",
       "    'marketing_start_date': '20231107',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Retail Business Services, LLC'],\n",
       "   'spl_set_id': ['d8a55217-ae50-4c7f-a440-f4de079d08ae'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['G63QQF2NOX', 'V06SV4M95S', '4X49Y0596W']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '217aa862-4685-b952-e063-6394a90af7ab',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20231107',\n",
       "  'product_id': '72476-935_217aa862-4685-b952-e063-6394a90af7ab',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Sheer Touch Sunscreen SPF 70'},\n",
       " {'product_ndc': '72476-951',\n",
       "  'generic_name': 'Sunscreen',\n",
       "  'labeler_name': 'RETAIL BUSINESS SERVICES , LLC',\n",
       "  'brand_name': 'Sunscreen',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '30 mg/mL'},\n",
       "   {'name': 'HOMOSALATE', 'strength': '120 mg/mL'},\n",
       "   {'name': 'OCTISALATE', 'strength': '50 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72476-951-30',\n",
       "    'description': '177 mL in 1 TUBE (72476-951-30)',\n",
       "    'marketing_start_date': '20230929',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['RETAIL BUSINESS SERVICES , LLC'],\n",
       "   'spl_set_id': ['96221c10-ebfe-4385-b6b5-d504258df36c'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['G63QQF2NOX', 'V06SV4M95S', '4X49Y0596W']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '21b0dddd-a3d4-2988-e063-6394a90a2491',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230929',\n",
       "  'product_id': '72476-951_21b0dddd-a3d4-2988-e063-6394a90a2491',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Sunscreen'},\n",
       " {'product_ndc': '0573-0558',\n",
       "  'generic_name': 'witch hazel',\n",
       "  'labeler_name': 'Haleon US Holdings LLC',\n",
       "  'brand_name': 'PREPARATION H TOTABLES IRRITATION RELIEF WIPES',\n",
       "  'active_ingredients': [{'name': 'WITCH HAZEL', 'strength': '5 g/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0573-0558-07',\n",
       "    'description': '10 PACKET in 1 CARTON (0573-0558-07)  / 1 CLOTH in 1 PACKET',\n",
       "    'marketing_start_date': '20101121',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Haleon US Holdings LLC'],\n",
       "   'rxcui': ['844379'],\n",
       "   'spl_set_id': ['1953ec64-20ce-488b-8f14-44e15cc9e720'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['101I4J0U34']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CLOTH',\n",
       "  'spl_id': '128b4b14-27ae-e6ea-e063-6394a90a8f3a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20101121',\n",
       "  'product_id': '0573-0558_128b4b14-27ae-e6ea-e063-6394a90a8f3a',\n",
       "  'application_number': 'M015',\n",
       "  'brand_name_base': 'PREPARATION H TOTABLES IRRITATION RELIEF WIPES'},\n",
       " {'product_ndc': '72485-101',\n",
       "  'generic_name': 'Diphenhydramine Hydrochloride',\n",
       "  'labeler_name': 'Armas Pharmaceuticals Inc.',\n",
       "  'brand_name': 'Diphenhydramine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'DIPHENHYDRAMINE HYDROCHLORIDE',\n",
       "    'strength': '50 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72485-101-05',\n",
       "    'description': '5 VIAL, SINGLE-DOSE in 1 CARTON (72485-101-05)  / 1 mL in 1 VIAL, SINGLE-DOSE (72485-101-01)',\n",
       "    'marketing_start_date': '20230505',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72485-101-25',\n",
       "    'description': '25 VIAL, SINGLE-DOSE in 1 CARTON (72485-101-25)  / 1 mL in 1 VIAL, SINGLE-DOSE (72485-101-01)',\n",
       "    'marketing_start_date': '20190501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Armas Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['1723740'],\n",
       "   'spl_set_id': ['c1cd6138-ca31-4bb5-ae47-2d80d4d54f9d'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372485101016'],\n",
       "   'unii': ['TC2D6JAD40']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'd949ac61-1864-4cf8-9b51-738b29952cc2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS'],\n",
       "  'marketing_start_date': '20190501',\n",
       "  'product_id': '72485-101_d949ac61-1864-4cf8-9b51-738b29952cc2',\n",
       "  'application_number': 'ANDA205723',\n",
       "  'brand_name_base': 'Diphenhydramine Hydrochloride',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72485-210',\n",
       "  'generic_name': 'Busulfan',\n",
       "  'labeler_name': 'Armas Pharmaceuticals Inc.',\n",
       "  'brand_name': 'Busulfan',\n",
       "  'active_ingredients': [{'name': 'BUSULFAN', 'strength': '6 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72485-210-08',\n",
       "    'description': '8 VIAL, SINGLE-DOSE in 1 CARTON (72485-210-08)  / 10 mL in 1 VIAL, SINGLE-DOSE (72485-210-01)',\n",
       "    'marketing_start_date': '20190601',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Armas Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['253113'],\n",
       "   'spl_set_id': ['4049d57f-342e-4233-8292-fed6b8f128ec'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372485210015'],\n",
       "   'nui': ['N0000000236', 'N0000175558'],\n",
       "   'pharm_class_moa': ['Alkylating Activity [MoA]'],\n",
       "   'pharm_class_epc': ['Alkylating Drug [EPC]'],\n",
       "   'unii': ['G1LN9045DK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'ae29e15b-df07-403f-8d07-f99e3ce501e7',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20190601',\n",
       "  'product_id': '72485-210_ae29e15b-df07-403f-8d07-f99e3ce501e7',\n",
       "  'application_number': 'ANDA210931',\n",
       "  'brand_name_base': 'Busulfan',\n",
       "  'pharm_class': ['Alkylating Activity [MoA]', 'Alkylating Drug [EPC]']},\n",
       " {'product_ndc': '72485-216',\n",
       "  'generic_name': 'Docetaxel',\n",
       "  'labeler_name': 'Armas Pharmaceuticals Inc.',\n",
       "  'brand_name': 'Docetaxel',\n",
       "  'active_ingredients': [{'name': 'DOCETAXEL', 'strength': '160 mg/8mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72485-216-08',\n",
       "    'description': '1 VIAL, SINGLE-USE in 1 CARTON (72485-216-08)  / 8 mL in 1 VIAL, SINGLE-USE',\n",
       "    'marketing_start_date': '20200115',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Armas Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['1861411'],\n",
       "   'spl_set_id': ['0dd863ec-f9dc-456c-9df5-4e9210d6cbb0'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['15H5577CQD']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': '10308491-d534-4e9f-9fcc-8d8a3eda213d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20200115',\n",
       "  'product_id': '72485-216_10308491-d534-4e9f-9fcc-8d8a3eda213d',\n",
       "  'application_number': 'ANDA210327',\n",
       "  'brand_name_base': 'Docetaxel',\n",
       "  'pharm_class': ['Microtubule Inhibition [PE]',\n",
       "   'Microtubule Inhibitor [EPC]']},\n",
       " {'product_ndc': '72485-406',\n",
       "  'generic_name': 'NAFCILLIN SODIUM',\n",
       "  'labeler_name': 'Armas Pharmaceuticals Inc.',\n",
       "  'brand_name': 'NAFCILLIN SODIUM',\n",
       "  'active_ingredients': [{'name': 'NAFCILLIN SODIUM', 'strength': '2 g/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72485-406-10',\n",
       "    'description': '10 VIAL in 1 CARTON (72485-406-10)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL',\n",
       "    'marketing_start_date': '20231101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Armas Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['1721458', '1721460'],\n",
       "   'spl_set_id': ['090fda61-b9c8-640e-e063-6294a90a7363'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['49G3001BCK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, FOR SOLUTION',\n",
       "  'spl_id': '090fe986-0ab2-c9a6-e063-6394a90ab171',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS'],\n",
       "  'marketing_start_date': '20231101',\n",
       "  'product_id': '72485-406_090fe986-0ab2-c9a6-e063-6394a90ab171',\n",
       "  'application_number': 'ANDA200002',\n",
       "  'brand_name_base': 'NAFCILLIN SODIUM',\n",
       "  'pharm_class': ['Penicillin-class Antibacterial [EPC]', 'Penicillins [CS]']},\n",
       " {'product_ndc': '72485-412',\n",
       "  'generic_name': 'Meropenem',\n",
       "  'labeler_name': 'ARMAS PHARMACEUTICALS INC',\n",
       "  'brand_name': 'Meropenem',\n",
       "  'active_ingredients': [{'name': 'MEROPENEM', 'strength': '1 g/20mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72485-412-01',\n",
       "    'description': '1 VIAL in 1 CARTON (72485-412-01)  / 20 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20230810',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72485-412-10',\n",
       "    'description': '10 VIAL in 1 CARTON (72485-412-10)  / 20 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20230810',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72485-412-25',\n",
       "    'description': '25 VIAL in 1 CARTON (72485-412-25)  / 20 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20230810',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['ARMAS PHARMACEUTICALS INC'],\n",
       "   'rxcui': ['1722934', '1722939'],\n",
       "   'spl_set_id': ['e1122310-c3ed-42f1-b189-301c221ff1f0'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['FV9J3JU8B1']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': '0251fe30-65ad-120d-e063-6394a90a64c5',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20230531',\n",
       "  'product_id': '72485-412_0251fe30-65ad-120d-e063-6394a90a64c5',\n",
       "  'application_number': 'ANDA216154',\n",
       "  'brand_name_base': 'Meropenem',\n",
       "  'pharm_class': ['Carbapenems [CS]', 'Penem Antibacterial [EPC]']},\n",
       " {'product_ndc': '72485-501',\n",
       "  'generic_name': 'Milrinone Lactate',\n",
       "  'labeler_name': 'Armas Pharmaceuticals Inc.',\n",
       "  'brand_name': 'Milrinone Lactate',\n",
       "  'active_ingredients': [{'name': 'MILRINONE LACTATE', 'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72485-501-10',\n",
       "    'description': '10 VIAL in 1 CARTON (72485-501-10)  / 10 mL in 1 VIAL (72485-501-01)',\n",
       "    'marketing_start_date': '20230405',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Armas Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['1791854', '1791859', '1791861'],\n",
       "   'spl_set_id': ['fde1e354-4f15-4ade-9ae3-db2ba67e0431'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372485503018', '0372485501014', '0372485502011', '0372485502103'],\n",
       "   'unii': ['9K8XR81MO8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'fde1e354-4f15-4ade-9ae3-db2ba67e0431',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20230405',\n",
       "  'product_id': '72485-501_fde1e354-4f15-4ade-9ae3-db2ba67e0431',\n",
       "  'application_number': 'ANDA214380',\n",
       "  'brand_name_base': 'Milrinone Lactate',\n",
       "  'pharm_class': ['Phosphodiesterase 3 Inhibitor [EPC]',\n",
       "   'Phosphodiesterase 3 Inhibitors [MoA]']},\n",
       " {'product_ndc': '72485-502',\n",
       "  'generic_name': 'Milrinone Lactate',\n",
       "  'labeler_name': 'Armas Pharmaceuticals Inc.',\n",
       "  'brand_name': 'Milrinone Lactate',\n",
       "  'active_ingredients': [{'name': 'MILRINONE LACTATE', 'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72485-502-10',\n",
       "    'description': '10 VIAL in 1 CARTON (72485-502-10)  / 20 mL in 1 VIAL (72485-502-01)',\n",
       "    'marketing_start_date': '20230405',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Armas Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['1791854', '1791859', '1791861'],\n",
       "   'spl_set_id': ['fde1e354-4f15-4ade-9ae3-db2ba67e0431'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372485503018', '0372485501014', '0372485502011', '0372485502103'],\n",
       "   'unii': ['9K8XR81MO8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'fde1e354-4f15-4ade-9ae3-db2ba67e0431',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20230405',\n",
       "  'product_id': '72485-502_fde1e354-4f15-4ade-9ae3-db2ba67e0431',\n",
       "  'application_number': 'ANDA214380',\n",
       "  'brand_name_base': 'Milrinone Lactate',\n",
       "  'pharm_class': ['Phosphodiesterase 3 Inhibitor [EPC]',\n",
       "   'Phosphodiesterase 3 Inhibitors [MoA]']},\n",
       " {'product_ndc': '0573-0725',\n",
       "  'generic_name': 'avobenzone, octinoxate, and white petrolatum',\n",
       "  'labeler_name': 'Haleon US Holdings LLC',\n",
       "  'brand_name': 'Chapstick Moisturizer Original',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '30 mg/g'},\n",
       "   {'name': 'OCTINOXATE', 'strength': '75 mg/g'},\n",
       "   {'name': 'PETROLATUM', 'strength': '423 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0573-0725-12',\n",
       "    'description': '1 CYLINDER in 1 BLISTER PACK (0573-0725-12)  / 4 g in 1 CYLINDER',\n",
       "    'marketing_start_date': '20180628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0573-0725-14',\n",
       "    'description': '2 CYLINDER in 1 BLISTER PACK (0573-0725-14)  / 4 g in 1 CYLINDER',\n",
       "    'marketing_start_date': '20230901',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0573-0725-30',\n",
       "    'description': '3 CYLINDER in 1 BLISTER PACK (0573-0725-30)  / 4 g in 1 CYLINDER',\n",
       "    'marketing_start_date': '20180628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0573-0725-40',\n",
       "    'description': '3 CYLINDER in 1 BLISTER PACK (0573-0725-40)  / 4 g in 1 CYLINDER',\n",
       "    'marketing_start_date': '20180628',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0573-0725-51',\n",
       "    'description': '4 g in 1 CYLINDER (0573-0725-51)',\n",
       "    'marketing_start_date': '20180628',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Haleon US Holdings LLC'],\n",
       "   'spl_set_id': ['9cd13fbb-887f-46a8-9f0b-4450ad3e07b7'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['G63QQF2NOX', '4Y5P7MUD51', '4T6H12BN9U']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'STICK',\n",
       "  'spl_id': '779fb329-9bd6-44ed-ae2d-305caa1e765b',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20180628',\n",
       "  'product_id': '0573-0725_779fb329-9bd6-44ed-ae2d-305caa1e765b',\n",
       "  'application_number': 'M016',\n",
       "  'brand_name_base': 'Chapstick Moisturizer Original'},\n",
       " {'product_ndc': '72485-506',\n",
       "  'generic_name': 'PHENYLEPHRINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Armas Pharmaceuticals Inc.',\n",
       "  'brand_name': 'PHENYLEPHRINE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'PHENYLEPHRINE HYDROCHLORIDE',\n",
       "    'strength': '100 mg/10mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72485-506-01',\n",
       "    'description': '1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72485-506-01)  / 10 mL in 1 VIAL, PHARMACY BULK PACKAGE',\n",
       "    'marketing_start_date': '20230328',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Armas Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['1232651', '1666372'],\n",
       "   'spl_set_id': ['16c02d53-fd3f-4fd7-abbe-f1358ea0891f'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372485506019', '0372485504251'],\n",
       "   'unii': ['04JA59TNSJ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': '16c02d53-fd3f-4fd7-abbe-f1358ea0891f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20230328',\n",
       "  'product_id': '72485-506_16c02d53-fd3f-4fd7-abbe-f1358ea0891f',\n",
       "  'application_number': 'ANDA213318',\n",
       "  'brand_name_base': 'PHENYLEPHRINE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72485-617',\n",
       "  'generic_name': 'Ketotifen Fumarate',\n",
       "  'labeler_name': 'Armas Pharmaceuticals Inc.',\n",
       "  'brand_name': 'Ketotifen Fumarate Ophthalmic Solution',\n",
       "  'active_ingredients': [{'name': 'KETOTIFEN FUMARATE',\n",
       "    'strength': '.25 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72485-617-10',\n",
       "    'description': '1 BOTTLE, DROPPER in 1 CARTON (72485-617-10)  / 5 mL in 1 BOTTLE, DROPPER',\n",
       "    'marketing_start_date': '20231009',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Armas Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['311237'],\n",
       "   'spl_set_id': ['b1ea15a5-5354-4086-a22d-cc1b3e0e1eb3'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372485617104'],\n",
       "   'unii': ['HBD503WORO']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION/ DROPS',\n",
       "  'spl_id': 'cd02d900-5bfc-494b-a588-8f6098fe058e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20231009',\n",
       "  'product_id': '72485-617_cd02d900-5bfc-494b-a588-8f6098fe058e',\n",
       "  'application_number': 'ANDA077958',\n",
       "  'brand_name_base': 'Ketotifen Fumarate Ophthalmic Solution',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Inhibitor [EPC]']},\n",
       " {'product_ndc': '72485-670',\n",
       "  'generic_name': 'Erythromycin',\n",
       "  'labeler_name': 'ARMAS PHARMACEUTICALS INC.',\n",
       "  'brand_name': 'Erythromycin',\n",
       "  'active_ingredients': [{'name': 'ERYTHROMYCIN', 'strength': '5 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72485-670-31',\n",
       "    'description': '50 TUBE in 1 CARTON (72485-670-31)  / 1 g in 1 TUBE',\n",
       "    'marketing_start_date': '20231018',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72485-670-35',\n",
       "    'description': '1 TUBE in 1 CARTON (72485-670-35)  / 3.5 g in 1 TUBE',\n",
       "    'marketing_start_date': '20231018',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['ARMAS PHARMACEUTICALS INC.'],\n",
       "   'rxcui': ['310149'],\n",
       "   'spl_set_id': ['07fdeac5-f690-d74b-e063-6394a90a5c5b'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000009982', 'N0000175877', 'N0000175935', 'M0028311'],\n",
       "   'pharm_class_pe': ['Decreased Sebaceous Gland Activity [PE]'],\n",
       "   'pharm_class_epc': ['Macrolide [EPC]', 'Macrolide Antimicrobial [EPC]'],\n",
       "   'pharm_class_cs': ['Macrolides [CS]'],\n",
       "   'unii': ['63937KV33D']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': '086299e1-e483-5e65-e063-6394a90a29fb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20231018',\n",
       "  'product_id': '72485-670_086299e1-e483-5e65-e063-6394a90a29fb',\n",
       "  'application_number': 'ANDA064030',\n",
       "  'brand_name_base': 'Erythromycin',\n",
       "  'pharm_class': ['Decreased Sebaceous Gland Activity [PE]',\n",
       "   'Macrolide Antimicrobial [EPC]',\n",
       "   'Macrolide [EPC]',\n",
       "   'Macrolides [CS]']},\n",
       " {'product_ndc': '72490-035',\n",
       "  'generic_name': 'Capsaicin',\n",
       "  'labeler_name': 'Nufabrx LLC',\n",
       "  'brand_name': 'Nufabrx Back Wrap',\n",
       "  'active_ingredients': [{'name': 'CAPSAICIN', 'strength': '.14 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72490-035-10',\n",
       "    'description': '1 g in 1 BOX (72490-035-10)',\n",
       "    'marketing_start_date': '20220729',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Nufabrx LLC'],\n",
       "   'spl_set_id': ['e4f85ac8-57cb-46eb-e053-2995a90a9b1c'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['S07O44R1ZM']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CLOTH',\n",
       "  'spl_id': '27eca7a9-b462-b195-e063-6394a90a7c0d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220729',\n",
       "  'product_id': '72490-035_27eca7a9-b462-b195-e063-6394a90a7c0d',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Nufabrx Back Wrap'},\n",
       " {'product_ndc': '72493-103',\n",
       "  'generic_name': 'mitomycin',\n",
       "  'labeler_name': 'UroGen Pharma, Inc.',\n",
       "  'brand_name': 'JELMYTO',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72493-103-03',\n",
       "    'description': '1 KIT in 1 CARTON (72493-103-03)  *  1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72493-101-40)  *  20 mL in 1 VIAL, SINGLE-DOSE (72493-102-20)',\n",
       "    'marketing_start_date': '20200501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['UroGen Pharma, Inc.'],\n",
       "   'rxcui': ['2375818', '2375823'],\n",
       "   'spl_set_id': ['3d3d5053-5427-4a68-a40b-edb60699521e'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': '372ce4fc-0c31-46e1-b61c-2c447637d68a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'marketing_start_date': '20200501',\n",
       "  'product_id': '72493-103_372ce4fc-0c31-46e1-b61c-2c447637d68a',\n",
       "  'application_number': 'NDA211728',\n",
       "  'brand_name_base': 'JELMYTO'},\n",
       " {'product_ndc': '0573-0805',\n",
       "  'generic_name': 'white petrolatum',\n",
       "  'labeler_name': 'Haleon US Holdings LLC',\n",
       "  'brand_name': 'Chapstick Holiday Classics Kit',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0573-0805-01',\n",
       "    'description': '1 KIT in 1 PACKAGE (0573-0805-01)  *  1 CYLINDER in 1 BLISTER PACK (0573-0715-12)  / 4 g in 1 CYLINDER *  1 CYLINDER in 1 BLISTER PACK (0573-0705-12)  / 4 g in 1 CYLINDER *  1 CYLINDER in 1 BLISTER PACK (0573-0711-12)  / 4 g in 1 CYLINDER *  1 CYLINDER in 1 BLISTER PACK (0573-0701-12)  / 4 g in 1 CYLINDER',\n",
       "    'marketing_start_date': '20230801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Haleon US Holdings LLC'],\n",
       "   'spl_set_id': ['6df216dc-c03d-463a-8029-5e54c1dc3d27'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': '15d9c0b3-b4fd-242a-e063-6294a90a3946',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'marketing_start_date': '20230801',\n",
       "  'product_id': '0573-0805_15d9c0b3-b4fd-242a-e063-6294a90a3946',\n",
       "  'application_number': 'M016',\n",
       "  'brand_name_base': 'Chapstick Holiday Classics Kit'},\n",
       " {'product_ndc': '72496-1115',\n",
       "  'generic_name': 'Hand Sanitizer',\n",
       "  'labeler_name': 'Naturich Labs',\n",
       "  'brand_name': 'Germaphobe Crisp Pine Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '65 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72496-1115-1',\n",
       "    'description': '60 mL in 1 BOTTLE (72496-1115-1)',\n",
       "    'marketing_start_date': '20210101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Naturich Labs'],\n",
       "   'rxcui': ['902515'],\n",
       "   'spl_set_id': ['b86c2269-c157-5f7a-e053-2995a90a5350'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': 'f929f942-2fa4-ea42-e053-6294a90a3658',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210101',\n",
       "  'product_id': '72496-1115_f929f942-2fa4-ea42-e053-6294a90a3658',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'Germaphobe Crisp Pine Hand Sanitizer'},\n",
       " {'product_ndc': '72496-1119',\n",
       "  'generic_name': 'Hand Sanitizer spray',\n",
       "  'labeler_name': 'Naturich Labs',\n",
       "  'brand_name': 'GC Hand Sanitizer Lavender',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '65 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72496-1119-1',\n",
       "    'description': '60 mL in 1 BOTTLE (72496-1119-1)',\n",
       "    'marketing_start_date': '20210101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Naturich Labs'],\n",
       "   'spl_set_id': ['b8b74713-2c1c-3d18-e053-2a95a90a43b7'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': 'fc4d4e13-1bf5-03c6-e053-6294a90a3399',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210101',\n",
       "  'product_id': '72496-1119_fc4d4e13-1bf5-03c6-e053-6294a90a3399',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'GC Hand Sanitizer Lavender'},\n",
       " {'product_ndc': '72496-1125',\n",
       "  'generic_name': 'hand sanitizer',\n",
       "  'labeler_name': 'Naturich Labs',\n",
       "  'brand_name': 'GIR The Guardian Gel Sanitize',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '65 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72496-1125-1',\n",
       "    'description': '236 mL in 1 BOTTLE (72496-1125-1)',\n",
       "    'marketing_start_date': '20210101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Naturich Labs'],\n",
       "   'rxcui': ['902574'],\n",
       "   'spl_set_id': ['b8ba3303-9ba9-092a-e053-2995a90aa234'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'f92a12e0-1e84-0a74-e053-6294a90a8cc2',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210101',\n",
       "  'product_id': '72496-1125_f92a12e0-1e84-0a74-e053-6294a90a8cc2',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'GIR The Guardian Gel Sanitize'},\n",
       " {'product_ndc': '72511-482',\n",
       "  'generic_name': 'adalimumab-atto',\n",
       "  'labeler_name': 'Amgen USA Inc.',\n",
       "  'brand_name': 'AMJEVITA',\n",
       "  'active_ingredients': [{'name': 'ADALIMUMAB', 'strength': '40 mg/.4mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72511-482-01',\n",
       "    'description': '1 SYRINGE in 1 CARTON (72511-482-01)  / .4 mL in 1 SYRINGE',\n",
       "    'marketing_start_date': '20230814',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72511-482-02',\n",
       "    'description': '2 SYRINGE in 1 CARTON (72511-482-02)  / .4 mL in 1 SYRINGE',\n",
       "    'marketing_start_date': '20230814',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Amgen USA Inc.'],\n",
       "   'rxcui': ['2627719',\n",
       "    '2627722',\n",
       "    '2663901',\n",
       "    '2663904',\n",
       "    '2663906',\n",
       "    '2663907',\n",
       "    '2663908',\n",
       "    '2663910',\n",
       "    '2663914',\n",
       "    '2663915'],\n",
       "   'spl_set_id': ['b7178e36-6787-45ab-8fee-be59bc6a4aa4'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372511400014',\n",
       "    '0071100008975',\n",
       "    '0372511482027',\n",
       "    '0372511481020',\n",
       "    '0000000000000'],\n",
       "   'nui': ['N0000175610', 'N0000175451', 'M0001357'],\n",
       "   'pharm_class_epc': ['Tumor Necrosis Factor Blocker [EPC]'],\n",
       "   'pharm_class_moa': ['Tumor Necrosis Factor Receptor Blocking Activity [MoA]'],\n",
       "   'pharm_class_cs': ['Antibodies, Monoclonal [CS]'],\n",
       "   'unii': ['FYS6T7F842']},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'ef428e54-7987-490a-8122-d3eb62515b97',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20230814',\n",
       "  'product_id': '72511-482_ef428e54-7987-490a-8122-d3eb62515b97',\n",
       "  'application_number': 'BLA761024',\n",
       "  'brand_name_base': 'AMJEVITA',\n",
       "  'pharm_class': ['Antibodies',\n",
       "   'Monoclonal [CS]',\n",
       "   'Tumor Necrosis Factor Blocker [EPC]',\n",
       "   'Tumor Necrosis Factor Receptor Blocking Activity [MoA]']},\n",
       " {'product_ndc': '72516-024',\n",
       "  'generic_name': 'Papaverine Hydrochloride',\n",
       "  'labeler_name': 'Oryza Pharmaceuticals Inc.',\n",
       "  'brand_name': 'Papaverine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PAPAVERINE HYDROCHLORIDE',\n",
       "    'strength': '30 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72516-024-10',\n",
       "    'description': '10 VIAL in 1 CARTON (72516-024-10)  / 2 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20210201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72516-024-25',\n",
       "    'description': '25 VIAL in 1 CARTON (72516-024-25)  / 2 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20210201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Oryza Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['1789947'],\n",
       "   'spl_set_id': ['5ba6e650-a5b5-4381-a62a-b7a6df73e8e6'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['23473EC6BQ']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'e6894d2b-727f-4cef-a0ba-ab408584fee9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20210201',\n",
       "  'product_id': '72516-024_e6894d2b-727f-4cef-a0ba-ab408584fee9',\n",
       "  'brand_name_base': 'Papaverine Hydrochloride'},\n",
       " {'product_ndc': '0573-1378',\n",
       "  'generic_name': 'Phenylephrine hydrochloride',\n",
       "  'labeler_name': 'Haleon US Holdings LLC',\n",
       "  'brand_name': 'PREPARATION H',\n",
       "  'active_ingredients': [{'name': 'PHENYLEPHRINE HYDROCHLORIDE',\n",
       "    'strength': '6.25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0573-1378-00',\n",
       "    'description': '48 BLISTER PACK in 1 CARTON (0573-1378-00)  / 1 SUPPOSITORY in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20221216',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0573-1378-01',\n",
       "    'description': '12 BLISTER PACK in 1 CARTON (0573-1378-01)  / 1 SUPPOSITORY in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20221216',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0573-1378-06',\n",
       "    'description': '24 BLISTER PACK in 1 CARTON (0573-1378-06)  / 1 SUPPOSITORY in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20221216',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Haleon US Holdings LLC'],\n",
       "   'rxcui': ['312398'],\n",
       "   'spl_set_id': ['96d2e0e7-2de0-4660-9ffd-9edb2ad224d8'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['04JA59TNSJ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SUPPOSITORY',\n",
       "  'spl_id': '12ae175a-90ee-3aee-e063-6394a90a45f8',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['RECTAL'],\n",
       "  'marketing_start_date': '20221216',\n",
       "  'product_id': '0573-1378_12ae175a-90ee-3aee-e063-6394a90a45f8',\n",
       "  'application_number': 'M015',\n",
       "  'brand_name_base': 'PREPARATION H',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72521-001',\n",
       "  'generic_name': 'SALICYLIC ACID',\n",
       "  'labeler_name': 'Clearly Pte Ltd',\n",
       "  'brand_name': 'STOP SPOT',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '2 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72521-001-01',\n",
       "    'description': '1 TUBE in 1 CARTON (72521-001-01)  / 15 mL in 1 TUBE',\n",
       "    'marketing_start_date': '20210701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Clearly Pte Ltd'],\n",
       "   'rxcui': ['346298'],\n",
       "   'spl_set_id': ['a0ede9a8-ff34-4c00-a6ca-f227d0df17a7'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['O414PZ4LPZ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'f2258c7d-4acd-2570-e053-2995a90a76f2',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210701',\n",
       "  'product_id': '72521-001_f2258c7d-4acd-2570-e053-2995a90a76f2',\n",
       "  'application_number': 'part333D',\n",
       "  'brand_name_base': 'STOP SPOT'},\n",
       " {'product_ndc': '72542-147',\n",
       "  'generic_name': 'arimoclomol citrate',\n",
       "  'labeler_name': 'Acer Therapeutics Inc.',\n",
       "  'brand_name': 'MIPLYFFA',\n",
       "  'active_ingredients': [{'name': 'ARIMOCLOMOL CITRATE',\n",
       "    'strength': '47 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72542-147-01',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72542-147-01)  / 90 CAPSULE in 1 BOTTLE',\n",
       "    'marketing_start_date': '20240920',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Acer Therapeutics Inc.'],\n",
       "   'rxcui': ['2694288',\n",
       "    '2694294',\n",
       "    '2694296',\n",
       "    '2694298',\n",
       "    '2694300',\n",
       "    '2694302',\n",
       "    '2694304',\n",
       "    '2694306'],\n",
       "   'spl_set_id': ['5feffc0e-453d-47fa-91dd-38d4952309bc'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372542162011', '0372542193015', '0372542147018', '0372542124019'],\n",
       "   'unii': ['Q85FFY6179']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '237eff06-015b-5bc7-e063-6394a90a9fed',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240920',\n",
       "  'product_id': '72542-147_237eff06-015b-5bc7-e063-6394a90a9fed',\n",
       "  'application_number': 'NDA214927',\n",
       "  'brand_name_base': 'MIPLYFFA'},\n",
       " {'product_ndc': '72559-027',\n",
       "  'generic_name': 'Fexofenadine Hydrochloride 180 mg',\n",
       "  'labeler_name': 'Little Pharma, Inc.',\n",
       "  'brand_name': 'Curist Allergy Relief',\n",
       "  'active_ingredients': [{'name': 'FEXOFENADINE HYDROCHLORIDE',\n",
       "    'strength': '180 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72559-027-22',\n",
       "    'description': '200 TABLET in 1 BOTTLE (72559-027-22)',\n",
       "    'marketing_start_date': '20230330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72559-027-23',\n",
       "    'description': '300 TABLET in 1 BOTTLE (72559-027-23)',\n",
       "    'marketing_start_date': '20240131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72559-027-46',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72559-027-46)',\n",
       "    'marketing_start_date': '20240222',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Little Pharma, Inc.'],\n",
       "   'rxcui': ['997420'],\n",
       "   'spl_set_id': ['f8228938-b5e3-0fa8-e053-6294a90a1d7c'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372559027228'],\n",
       "   'unii': ['2S068B75ZU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '26fb001f-b630-acf5-e063-6294a90aedde',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230330',\n",
       "  'product_id': '72559-027_26fb001f-b630-acf5-e063-6294a90aedde',\n",
       "  'application_number': 'ANDA204507',\n",
       "  'brand_name_base': 'Curist Allergy Relief',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72562-167',\n",
       "  'generic_name': 'Camphor 3.5%, Menthol 3.5%',\n",
       "  'labeler_name': 'Tommie Copper, Inc.',\n",
       "  'brand_name': 'Pain Relief Liquid Roller',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (SYNTHETIC)',\n",
       "    'strength': '3.5 g/100g'},\n",
       "   {'name': 'MENTHOL', 'strength': '3.5 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72562-167-25',\n",
       "    'description': '70 g in 1 BOTTLE, PLASTIC (72562-167-25)',\n",
       "    'marketing_start_date': '20210819',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Tommie Copper, Inc.'],\n",
       "   'spl_set_id': ['c9f0447e-de43-16a5-e053-2995a90a05c1'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0843041125925'],\n",
       "   'unii': ['5TJD82A1ET', 'L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '29591578-c164-5ed4-e063-6394a90a7df3',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210819',\n",
       "  'product_id': '72562-167_29591578-c164-5ed4-e063-6394a90a7df3',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Pain Relief Liquid Roller'},\n",
       " {'product_ndc': '72572-076',\n",
       "  'generic_name': 'Clindamycin in 5 Percent Dextrose',\n",
       "  'labeler_name': 'Civica, Inc.',\n",
       "  'brand_name': 'Clindamycin in 5 Percent Dextrose',\n",
       "  'active_ingredients': [{'name': 'CLINDAMYCIN', 'strength': '18 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72572-076-24',\n",
       "    'description': '24 BAG in 1 CARTON (72572-076-24)  / 50 mL in 1 BAG (72572-076-01)',\n",
       "    'marketing_start_date': '20220113',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Civica, Inc.'],\n",
       "   'rxcui': ['309335', '309336'],\n",
       "   'spl_set_id': ['80217bd6-2bc4-401c-9345-22532b36a24f'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000009982', 'N0000175443', 'M0515779', 'N0000175731'],\n",
       "   'pharm_class_pe': ['Decreased Sebaceous Gland Activity [PE]',\n",
       "    'Neuromuscular Blockade [PE]'],\n",
       "   'pharm_class_epc': ['Lincosamide Antibacterial [EPC]'],\n",
       "   'pharm_class_cs': ['Lincosamides [CS]'],\n",
       "   'unii': ['3U02EL437C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'e40b6e7f-1d37-4d0a-ace3-e5accc461e02',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20220113',\n",
       "  'product_id': '72572-076_e40b6e7f-1d37-4d0a-ace3-e5accc461e02',\n",
       "  'application_number': 'ANDA201692',\n",
       "  'brand_name_base': 'Clindamycin in 5 Percent Dextrose',\n",
       "  'pharm_class': ['Decreased Sebaceous Gland Activity [PE]',\n",
       "   'Lincosamide Antibacterial [EPC]',\n",
       "   'Lincosamides [CS]',\n",
       "   'Neuromuscular Blockade [PE]']},\n",
       " {'product_ndc': '72572-170',\n",
       "  'generic_name': 'Fentanyl Citrate',\n",
       "  'labeler_name': 'Civica, Inc.',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Fentanyl Citrate',\n",
       "  'active_ingredients': [{'name': 'FENTANYL CITRATE', 'strength': '50 ug/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72572-170-25',\n",
       "    'description': '25 VIAL in 1 CARTON (72572-170-25)  / 2 mL in 1 VIAL (72572-170-01)',\n",
       "    'marketing_start_date': '20191210',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Civica, Inc.'],\n",
       "   'rxcui': ['1735003', '1735007', '1735013'],\n",
       "   'spl_set_id': ['aacf276b-e133-4199-ad3f-67b894744c04'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['MUN5LYG46H']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'fc2d5b1b-c1bd-4c91-b067-3df70ae0f82c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS'],\n",
       "  'marketing_start_date': '20191210',\n",
       "  'product_id': '72572-170_fc2d5b1b-c1bd-4c91-b067-3df70ae0f82c',\n",
       "  'application_number': 'NDA019101',\n",
       "  'brand_name_base': 'Fentanyl Citrate',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '72572-225',\n",
       "  'generic_name': 'Glycopyrrolate',\n",
       "  'labeler_name': 'Civica, Inc.',\n",
       "  'brand_name': 'Glycopyrrolate',\n",
       "  'active_ingredients': [{'name': 'GLYCOPYRROLATE', 'strength': '.2 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72572-225-25',\n",
       "    'description': '25 VIAL, SINGLE-DOSE in 1 CARTON (72572-225-25)  / 1 mL in 1 VIAL, SINGLE-DOSE (72572-225-01)',\n",
       "    'marketing_start_date': '20191210',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Civica, Inc.'],\n",
       "   'rxcui': ['1731582'],\n",
       "   'spl_set_id': ['9f7f1ebf-58e8-4ae7-8157-1595df8ad6f4'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['V92SO9WP2I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': '4605bea0-172d-4eac-b510-0395189a99ff',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS'],\n",
       "  'marketing_start_date': '20191210',\n",
       "  'product_id': '72572-225_4605bea0-172d-4eac-b510-0395189a99ff',\n",
       "  'application_number': 'ANDA090963',\n",
       "  'brand_name_base': 'Glycopyrrolate',\n",
       "  'pharm_class': ['Anticholinergic [EPC]', 'Cholinergic Antagonists [MoA]']},\n",
       " {'product_ndc': '72572-350',\n",
       "  'generic_name': 'Labetalol Hydrochloride',\n",
       "  'labeler_name': 'Civica, Inc.',\n",
       "  'brand_name': 'Labetalol Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'LABETALOL HYDROCHLORIDE',\n",
       "    'strength': '5 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72572-350-01',\n",
       "    'description': '1 VIAL in 1 BOX, UNIT-DOSE (72572-350-01)  / 20 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20191121',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Civica, Inc.'],\n",
       "   'rxcui': ['896771'],\n",
       "   'spl_set_id': ['d7c53b1c-b6a5-482a-a7c8-7425d9cd9ef8'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372572350013'],\n",
       "   'unii': ['1GEV3BAW9J']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': '076e0f01-e1cb-4948-9d90-865ff7d4a47c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20191121',\n",
       "  'product_id': '72572-350_076e0f01-e1cb-4948-9d90-865ff7d4a47c',\n",
       "  'application_number': 'ANDA075303',\n",
       "  'brand_name_base': 'Labetalol Hydrochloride',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72572-420',\n",
       "  'generic_name': 'Metoroprolol Tartrate',\n",
       "  'labeler_name': 'Civica, Inc.',\n",
       "  'brand_name': 'Metoprolol Tartrate',\n",
       "  'active_ingredients': [{'name': 'METOPROLOL TARTRATE',\n",
       "    'strength': '5 mg/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72572-420-10',\n",
       "    'description': '10 VIAL in 1 CARTON (72572-420-10)  / 5 mL in 1 VIAL (72572-420-01)',\n",
       "    'marketing_start_date': '20191210',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Civica, Inc.'],\n",
       "   'rxcui': ['866508'],\n",
       "   'spl_set_id': ['8dae76a2-32e7-40a2-bb70-9c6380b9b330'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372572420105'],\n",
       "   'unii': ['W5S57Y3A5L']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '74676c66-099b-421c-b0dc-b2886a2e4496',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20191210',\n",
       "  'product_id': '72572-420_74676c66-099b-421c-b0dc-b2886a2e4496',\n",
       "  'application_number': 'ANDA077761',\n",
       "  'brand_name_base': 'Metoprolol Tartrate',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72572-570',\n",
       "  'generic_name': 'Phenylephrine Hydrochloride',\n",
       "  'labeler_name': 'Civica, Inc.',\n",
       "  'brand_name': 'Phenylephrine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PHENYLEPHRINE HYDROCHLORIDE',\n",
       "    'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72572-570-10',\n",
       "    'description': '10 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72572-570-10)  / 10 mL in 1 VIAL, PHARMACY BULK PACKAGE (72572-570-01)',\n",
       "    'marketing_start_date': '20201202',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Civica, Inc.'],\n",
       "   'rxcui': ['1232651', '1666372'],\n",
       "   'spl_set_id': ['7a23ed28-3912-4398-b660-bf9ec3ee3926'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['04JA59TNSJ']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'e8388f3b-845a-427e-a45c-fa46b49a5040',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20201202',\n",
       "  'product_id': '72572-570_e8388f3b-845a-427e-a45c-fa46b49a5040',\n",
       "  'application_number': 'NDA203826',\n",
       "  'brand_name_base': 'Phenylephrine Hydrochloride',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72572-573',\n",
       "  'generic_name': 'piperacillin sodium and tazobactam sodium',\n",
       "  'labeler_name': 'Civica, Inc.',\n",
       "  'brand_name': 'Piperacillin and Tazobactam',\n",
       "  'active_ingredients': [{'name': 'PIPERACILLIN SODIUM',\n",
       "    'strength': '3 g/15mL'},\n",
       "   {'name': 'TAZOBACTAM SODIUM', 'strength': '.375 g/15mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72572-573-10',\n",
       "    'description': '10 VIAL, SINGLE-DOSE in 1 CARTON (72572-573-10)  / 15 mL in 1 VIAL, SINGLE-DOSE (72572-573-01)',\n",
       "    'marketing_start_date': '20201201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Civica, Inc.'],\n",
       "   'rxcui': ['1659137', '1659149'],\n",
       "   'spl_set_id': ['19e89f8b-316b-4dd2-9724-bfe0faeba408'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['M98T69Q7HP', 'UXA545ABTT']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, FOR SOLUTION',\n",
       "  'spl_id': '682d4f3f-bbc2-4365-bdf6-0fa8323392d5',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20201201',\n",
       "  'product_id': '72572-573_682d4f3f-bbc2-4365-bdf6-0fa8323392d5',\n",
       "  'application_number': 'ANDA065523',\n",
       "  'brand_name_base': 'Piperacillin and Tazobactam',\n",
       "  'pharm_class': ['Penicillin-class Antibacterial [EPC]',\n",
       "   'Penicillins [CS]',\n",
       "   'beta Lactamase Inhibitor [EPC]',\n",
       "   'beta Lactamase Inhibitors [MoA]']},\n",
       " {'product_ndc': '72577-101',\n",
       "  'generic_name': 'ZINC OXIDE',\n",
       "  'labeler_name': 'Volition Beauty',\n",
       "  'brand_name': 'Getaway Glow SPF 30 Radiant Sunscreen Broad Spectrum SPF 30 Sunscreen',\n",
       "  'brand_name_suffix': 'Broad Spectrum SPF 30 Sunscreen',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '10 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72577-101-12',\n",
       "    'description': '1 TUBE in 1 BOX (72577-101-12)  / 120 mL in 1 TUBE (72577-101-11)',\n",
       "    'marketing_start_date': '20241105',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Volition Beauty'],\n",
       "   'spl_set_id': ['2631de4b-66e3-0547-e063-6394a90a822c'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '2631de3d-7a03-0b26-e063-6394a90afbb1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20241105',\n",
       "  'product_id': '72577-101_2631de3d-7a03-0b26-e063-6394a90afbb1',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Getaway Glow SPF 30 Radiant Sunscreen'},\n",
       " {'product_ndc': '0573-2840',\n",
       "  'generic_name': 'phenylephrine hcl, witch hazel',\n",
       "  'labeler_name': 'Haleon US Holdings LLC',\n",
       "  'brand_name': 'Preparation H Cooling Gel',\n",
       "  'active_ingredients': [{'name': 'PHENYLEPHRINE HYDROCHLORIDE',\n",
       "    'strength': '2.5 mg/g'},\n",
       "   {'name': 'WITCH HAZEL', 'strength': '500 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0573-2840-10',\n",
       "    'description': '1 TUBE in 1 CARTON (0573-2840-10)  / 26 g in 1 TUBE',\n",
       "    'marketing_start_date': '20040101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0573-2840-20',\n",
       "    'description': '1 TUBE in 1 CARTON (0573-2840-20)  / 51 g in 1 TUBE',\n",
       "    'marketing_start_date': '20040101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Haleon US Holdings LLC'],\n",
       "   'rxcui': ['249465'],\n",
       "   'spl_set_id': ['cebee3f7-8591-e4f7-e66a-e43b4ba3aaf4'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['04JA59TNSJ', '101I4J0U34']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '15581b30-e802-550a-e063-6394a90a3aae',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20040101',\n",
       "  'product_id': '0573-2840_15581b30-e802-550a-e063-6394a90a3aae',\n",
       "  'application_number': 'M015',\n",
       "  'brand_name_base': 'Preparation H Cooling Gel',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72578-055',\n",
       "  'generic_name': 'Doxycycline hyclate',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'Doxycycline hyclate',\n",
       "  'active_ingredients': [{'name': 'DOXYCYCLINE HYCLATE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-055-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (72578-055-01)',\n",
       "    'marketing_start_date': '20220110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-055-05',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (72578-055-05)',\n",
       "    'marketing_start_date': '20220110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-055-10',\n",
       "    'description': '1000 CAPSULE in 1 BOTTLE (72578-055-10)',\n",
       "    'marketing_start_date': '20220110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-055-18',\n",
       "    'description': '50 CAPSULE in 1 BOTTLE (72578-055-18)',\n",
       "    'marketing_start_date': '20220110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-055-77',\n",
       "    'description': '10 BLISTER PACK in 1 CARTON (72578-055-77)  / 10 CAPSULE in 1 BLISTER PACK (72578-055-30)',\n",
       "    'marketing_start_date': '20220110',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['1649405', '1649988'],\n",
       "   'spl_set_id': ['51d245a3-ef51-474a-bc91-377d5f42dde3'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['19XTS3T51U']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '067c94b6-7574-46ad-ac24-d33b9a1d0a57',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220110',\n",
       "  'product_id': '72578-055_067c94b6-7574-46ad-ac24-d33b9a1d0a57',\n",
       "  'application_number': 'ANDA207774',\n",
       "  'brand_name_base': 'Doxycycline hyclate',\n",
       "  'pharm_class': ['Tetracycline-class Drug [EPC]', 'Tetracyclines [CS]']},\n",
       " {'product_ndc': '72578-057',\n",
       "  'generic_name': 'Felbamate',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'Felbamate',\n",
       "  'active_ingredients': [{'name': 'FELBAMATE', 'strength': '600 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-057-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72578-057-01)',\n",
       "    'marketing_start_date': '20200303',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-057-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72578-057-05)',\n",
       "    'marketing_start_date': '20200303',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-057-06',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72578-057-06)',\n",
       "    'marketing_start_date': '20200303',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-057-16',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72578-057-16)',\n",
       "    'marketing_start_date': '20200303',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-057-28',\n",
       "    'description': '180 TABLET in 1 BOTTLE (72578-057-28)',\n",
       "    'marketing_start_date': '20200303',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-057-77',\n",
       "    'description': '10 BLISTER PACK in 1 CARTON (72578-057-77)  / 10 TABLET in 1 BLISTER PACK (72578-057-30)',\n",
       "    'marketing_start_date': '20200303',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['198358', '198359'],\n",
       "   'spl_set_id': ['96f4357c-720c-4651-b638-7b1181531dc5'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175753', 'N0000008486'],\n",
       "   'pharm_class_epc': ['Anti-epileptic Agent [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]'],\n",
       "   'unii': ['X72RBB02N8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'd66a589d-eb0f-47e6-9d90-da34938b5641',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200303',\n",
       "  'product_id': '72578-057_d66a589d-eb0f-47e6-9d90-da34938b5641',\n",
       "  'application_number': 'ANDA208970',\n",
       "  'brand_name_base': 'Felbamate',\n",
       "  'pharm_class': ['Anti-epileptic Agent [EPC]',\n",
       "   'Decreased Central Nervous System Disorganized Electrical Activity [PE]']},\n",
       " {'product_ndc': '72578-085',\n",
       "  'generic_name': 'Clobetasol Propionate',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'Clobetasol Propionate',\n",
       "  'active_ingredients': [{'name': 'CLOBETASOL PROPIONATE',\n",
       "    'strength': '.05 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-085-01',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72578-085-01)  / 59 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200430',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-085-02',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72578-085-02)  / 118 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200430',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['861505'],\n",
       "   'spl_set_id': ['2fc7de5f-094f-400c-b87e-750b16046f46'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372578085018'],\n",
       "   'unii': ['779619577M']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '7885e4e8-e37e-4eaf-b632-f09f28f825cf',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200430',\n",
       "  'product_id': '72578-085_7885e4e8-e37e-4eaf-b632-f09f28f825cf',\n",
       "  'application_number': 'ANDA205249',\n",
       "  'brand_name_base': 'Clobetasol Propionate',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72578-089',\n",
       "  'generic_name': 'Nystatin',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'Nystatin',\n",
       "  'active_ingredients': [{'name': 'NYSTATIN', 'strength': '100000 U/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-089-01',\n",
       "    'description': '15 g in 1 TUBE (72578-089-01)',\n",
       "    'marketing_start_date': '20200624',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-089-04',\n",
       "    'description': '30 g in 1 TUBE (72578-089-04)',\n",
       "    'marketing_start_date': '20200624',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['884308'],\n",
       "   'spl_set_id': ['e135a7d2-adba-48a2-b3e1-07b778cce9b0'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372578089016'],\n",
       "   'nui': ['N0000175498', 'M0017172'],\n",
       "   'pharm_class_epc': ['Polyene Antifungal [EPC]'],\n",
       "   'pharm_class_cs': ['Polyenes [CS]'],\n",
       "   'unii': ['BDF1O1C72E']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': '3d917a6c-4e9a-4c45-9e79-caf91f8b11b0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200624',\n",
       "  'product_id': '72578-089_3d917a6c-4e9a-4c45-9e79-caf91f8b11b0',\n",
       "  'application_number': 'ANDA207767',\n",
       "  'brand_name_base': 'Nystatin',\n",
       "  'pharm_class': ['Polyene Antifungal [EPC]', 'Polyenes [CS]']},\n",
       " {'product_ndc': '72578-092',\n",
       "  'generic_name': 'Diclofenac sodium',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'Diclofenac sodium',\n",
       "  'active_ingredients': [{'name': 'DICLOFENAC SODIUM',\n",
       "    'strength': '16.05 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-092-01',\n",
       "    'description': '1 BOTTLE, DROPPER in 1 CARTON (72578-092-01)  / 150 mL in 1 BOTTLE, DROPPER',\n",
       "    'marketing_start_date': '20200720',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['857700'],\n",
       "   'spl_set_id': ['6b8e965f-79ca-4f48-8c02-ea44c8f1d5cf'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['QTG126297Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '34b62d19-06c3-4c93-9982-2003fd7aa792',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200720',\n",
       "  'product_id': '72578-092_34b62d19-06c3-4c93-9982-2003fd7aa792',\n",
       "  'application_number': 'ANDA206411',\n",
       "  'brand_name_base': 'Diclofenac sodium',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Decreased Prostaglandin Production [PE]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72578-096',\n",
       "  'generic_name': 'tizanidine',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'tizanidine',\n",
       "  'active_ingredients': [{'name': 'TIZANIDINE HYDROCHLORIDE',\n",
       "    'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-096-06',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72578-096-06)',\n",
       "    'marketing_start_date': '20210304',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-096-10',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72578-096-10)',\n",
       "    'marketing_start_date': '20210304',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-096-21',\n",
       "    'description': '150 TABLET in 1 BOTTLE (72578-096-21)',\n",
       "    'marketing_start_date': '20210304',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-096-77',\n",
       "    'description': '10 BLISTER PACK in 1 CARTON (72578-096-77)  / 10 TABLET in 1 BLISTER PACK (72578-096-30)',\n",
       "    'marketing_start_date': '20210304',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '3a4d865a-737a-46e9-ad43-6bf61ae66055',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210304',\n",
       "  'product_id': '72578-096_3a4d865a-737a-46e9-ad43-6bf61ae66055',\n",
       "  'application_number': 'ANDA208187',\n",
       "  'brand_name_base': 'tizanidine',\n",
       "  'pharm_class': ['Adrenergic alpha2-Agonists [MoA]',\n",
       "   'Central alpha-2 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72578-098',\n",
       "  'generic_name': 'levofloxacin',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'levofloxacin',\n",
       "  'active_ingredients': [{'name': 'LEVOFLOXACIN', 'strength': '250 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-098-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72578-098-01)',\n",
       "    'marketing_start_date': '20220110',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '72578-098-05',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (72578-098-05)',\n",
       "    'marketing_start_date': '20220110',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '72578-098-18',\n",
       "    'description': '50 TABLET, FILM COATED in 1 BOTTLE (72578-098-18)',\n",
       "    'marketing_start_date': '20220110',\n",
       "    'sample': True}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['199884', '199885', '311296'],\n",
       "   'spl_set_id': ['0948bff7-efc6-4f0e-a9dd-adca5bdc7fc2'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000193223', 'M0372253'],\n",
       "   'pharm_class_epc': ['Fluoroquinolone Antibacterial [EPC]'],\n",
       "   'pharm_class_cs': ['Fluoroquinolones [CS]'],\n",
       "   'unii': ['6GNT3Y5LMF']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '6295ff00-86a9-454c-987b-a1fe1c4386e8',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220110',\n",
       "  'product_id': '72578-098_6295ff00-86a9-454c-987b-a1fe1c4386e8',\n",
       "  'application_number': 'ANDA077652',\n",
       "  'brand_name_base': 'levofloxacin'},\n",
       " {'product_ndc': '72578-101',\n",
       "  'generic_name': 'Acyclovir',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'Acyclovir',\n",
       "  'active_ingredients': [{'name': 'ACYCLOVIR', 'strength': '50 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-101-04',\n",
       "    'description': '1 TUBE in 1 CARTON (72578-101-04)  / 2 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230303',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-101-05',\n",
       "    'description': '1 TUBE in 1 CARTON (72578-101-05)  / 5 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230303',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['141859'],\n",
       "   'spl_set_id': ['a2966b6d-c6c0-4afd-8eda-045df497cb9d'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000020060',\n",
       "    'N0000180187',\n",
       "    'N0000180188',\n",
       "    'N0000175468',\n",
       "    'N0000175459'],\n",
       "   'pharm_class_moa': ['DNA Polymerase Inhibitors [MoA]'],\n",
       "   'pharm_class_epc': ['Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "    'Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "    'Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]'],\n",
       "   'unii': ['X4HES1O11F']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '611d8237-2516-413c-81c3-99252bb5f597',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230303',\n",
       "  'product_id': '72578-101_611d8237-2516-413c-81c3-99252bb5f597',\n",
       "  'application_number': 'ANDA206770',\n",
       "  'brand_name_base': 'Acyclovir',\n",
       "  'pharm_class': ['DNA Polymerase Inhibitors [MoA]',\n",
       "   'Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "   'Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "   'Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "   'Nucleoside Analog [EXT]']},\n",
       " {'product_ndc': '72578-120',\n",
       "  'generic_name': 'ivermectin',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'ivermectin',\n",
       "  'active_ingredients': [{'name': 'IVERMECTIN', 'strength': '10 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-120-02',\n",
       "    'description': '1 TUBE in 1 CARTON (72578-120-02)  / 60 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230610',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-120-06',\n",
       "    'description': '1 TUBE in 1 CARTON (72578-120-06)  / 30 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230610',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-120-08',\n",
       "    'description': '1 TUBE in 1 CARTON (72578-120-08)  / 45 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230610',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['1598068'],\n",
       "   'spl_set_id': ['6b4a7400-d34c-4947-90e6-340f7087a702'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372578120085'],\n",
       "   'nui': ['N0000175484', 'N0000181811'],\n",
       "   'pharm_class_epc': ['Antiparasitic [EPC]', 'Pediculicide [EPC]'],\n",
       "   'unii': ['8883YP2R6D']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '23a90438-439e-4a43-86a1-ea2343657d85',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230610',\n",
       "  'product_id': '72578-120_23a90438-439e-4a43-86a1-ea2343657d85',\n",
       "  'application_number': 'ANDA215210',\n",
       "  'brand_name_base': 'ivermectin',\n",
       "  'pharm_class': ['Antiparasitic [EPC]', 'Pediculicide [EPC]']},\n",
       " {'product_ndc': '72578-126',\n",
       "  'generic_name': 'Ziprasidone',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'Ziprasidone',\n",
       "  'active_ingredients': [{'name': 'ZIPRASIDONE HYDROCHLORIDE',\n",
       "    'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-126-05',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (72578-126-05)',\n",
       "    'marketing_start_date': '20200915',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-126-14',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (72578-126-14)',\n",
       "    'marketing_start_date': '20200915',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-126-80',\n",
       "    'description': '8 BLISTER PACK in 1 CARTON (72578-126-80)  / 10 CAPSULE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20200915',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['313776', '313777', '313778', '314286'],\n",
       "   'spl_set_id': ['8f78b278-a0b3-47ce-bbad-5dad7012896a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['216X081ORU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'e02b7585-27db-4f92-a018-4ed89374da48',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200915',\n",
       "  'product_id': '72578-126_e02b7585-27db-4f92-a018-4ed89374da48',\n",
       "  'application_number': 'ANDA208988',\n",
       "  'brand_name_base': 'Ziprasidone',\n",
       "  'pharm_class': ['Atypical Antipsychotic [EPC]']},\n",
       " {'product_ndc': '72578-127',\n",
       "  'generic_name': 'Ziprasidone',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'Ziprasidone',\n",
       "  'active_ingredients': [{'name': 'ZIPRASIDONE HYDROCHLORIDE',\n",
       "    'strength': '60 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-127-05',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (72578-127-05)',\n",
       "    'marketing_start_date': '20200915',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-127-14',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (72578-127-14)',\n",
       "    'marketing_start_date': '20200915',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-127-80',\n",
       "    'description': '8 BLISTER PACK in 1 CARTON (72578-127-80)  / 10 CAPSULE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20200915',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['313776', '313777', '313778', '314286'],\n",
       "   'spl_set_id': ['8f78b278-a0b3-47ce-bbad-5dad7012896a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['216X081ORU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'e02b7585-27db-4f92-a018-4ed89374da48',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200915',\n",
       "  'product_id': '72578-127_e02b7585-27db-4f92-a018-4ed89374da48',\n",
       "  'application_number': 'ANDA208988',\n",
       "  'brand_name_base': 'Ziprasidone',\n",
       "  'pharm_class': ['Atypical Antipsychotic [EPC]']},\n",
       " {'product_ndc': '72578-128',\n",
       "  'generic_name': 'Ziprasidone',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'Ziprasidone',\n",
       "  'active_ingredients': [{'name': 'ZIPRASIDONE HYDROCHLORIDE',\n",
       "    'strength': '80 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-128-05',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (72578-128-05)',\n",
       "    'marketing_start_date': '20200915',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-128-14',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (72578-128-14)',\n",
       "    'marketing_start_date': '20200915',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-128-80',\n",
       "    'description': '8 BLISTER PACK in 1 CARTON (72578-128-80)  / 10 CAPSULE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20200915',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['313776', '313777', '313778', '314286'],\n",
       "   'spl_set_id': ['8f78b278-a0b3-47ce-bbad-5dad7012896a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['216X081ORU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'e02b7585-27db-4f92-a018-4ed89374da48',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200915',\n",
       "  'product_id': '72578-128_e02b7585-27db-4f92-a018-4ed89374da48',\n",
       "  'application_number': 'ANDA208988',\n",
       "  'brand_name_base': 'Ziprasidone',\n",
       "  'pharm_class': ['Atypical Antipsychotic [EPC]']},\n",
       " {'product_ndc': '72578-143',\n",
       "  'generic_name': 'DOXEPIN HYDROCHLORIDE',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'DOXEPIN HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'DOXEPIN HYDROCHLORIDE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-143-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (72578-143-01)',\n",
       "    'marketing_start_date': '20240301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-143-10',\n",
       "    'description': '1000 CAPSULE in 1 BOTTLE (72578-143-10)',\n",
       "    'marketing_start_date': '20240301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-143-77',\n",
       "    'description': '10 BLISTER PACK in 1 CARTON (72578-143-77)  / 10 CAPSULE in 1 BLISTER PACK (72578-143-30)',\n",
       "    'marketing_start_date': '20240301',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['1000048', '1000058', '1000070', '1000076', '1000097'],\n",
       "   'spl_set_id': ['047c25d1-baaf-4184-ba0a-cc260757cc74'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372578139018', '0372578140014', '0372578141011'],\n",
       "   'unii': ['3U9A0FE9N5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '434f7b30-30fa-4b4e-b0a0-42a455713057',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240301',\n",
       "  'product_id': '72578-143_434f7b30-30fa-4b4e-b0a0-42a455713057',\n",
       "  'application_number': 'ANDA210700',\n",
       "  'brand_name_base': 'DOXEPIN HYDROCHLORIDE',\n",
       "  'pharm_class': ['Tricyclic Antidepressant [EPC]']},\n",
       " {'product_ndc': '72578-149',\n",
       "  'generic_name': 'acetaZOLAMIDE',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'acetaZOLAMIDE',\n",
       "  'active_ingredients': [{'name': 'ACETAZOLAMIDE', 'strength': '125 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-149-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72578-149-01)',\n",
       "    'marketing_start_date': '20230715',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['197303', '197304'],\n",
       "   'spl_set_id': ['5473c171-dc2d-4a82-bbf1-0f5fad10f673'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372578150013', '0372578149017'],\n",
       "   'nui': ['N0000175517', 'N0000000235', 'M0020790'],\n",
       "   'pharm_class_epc': ['Carbonic Anhydrase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Carbonic Anhydrase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Sulfonamides [CS]'],\n",
       "   'unii': ['O3FX965V0I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '3a31af68-01f4-4a81-994f-ee24250c6703',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230715',\n",
       "  'product_id': '72578-149_3a31af68-01f4-4a81-994f-ee24250c6703',\n",
       "  'application_number': 'ANDA211069',\n",
       "  'brand_name_base': 'acetaZOLAMIDE',\n",
       "  'pharm_class': ['Carbonic Anhydrase Inhibitor [EPC]',\n",
       "   'Carbonic Anhydrase Inhibitors [MoA]',\n",
       "   'Sulfonamides [CS]']},\n",
       " {'product_ndc': '72578-171',\n",
       "  'generic_name': 'Dexamethasone',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'Dexamethasone',\n",
       "  'active_ingredients': [{'name': 'DEXAMETHASONE', 'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-171-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72578-171-01)',\n",
       "    'marketing_start_date': '20240415',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['197577', '197580', '197582', '197583', '343033'],\n",
       "   'spl_set_id': ['93bb34a7-c8ca-4dab-b2a0-cbe011e1090c'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['7S5I7G3JQL']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '0b2ad1c2-aa4a-4741-ae0b-645a3943dd77',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240415',\n",
       "  'product_id': '72578-171_0b2ad1c2-aa4a-4741-ae0b-645a3943dd77',\n",
       "  'application_number': 'ANDA216282',\n",
       "  'brand_name_base': 'Dexamethasone',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72578-182',\n",
       "  'generic_name': 'doxepin',\n",
       "  'labeler_name': 'Viona Pharmaceuticals Inc',\n",
       "  'brand_name': 'doxepin',\n",
       "  'active_ingredients': [{'name': 'DOXEPIN HYDROCHLORIDE',\n",
       "    'strength': '6 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72578-182-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72578-182-01)',\n",
       "    'marketing_start_date': '20240630',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-182-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72578-182-05)',\n",
       "    'marketing_start_date': '20240630',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-182-06',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72578-182-06)',\n",
       "    'marketing_start_date': '20240630',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-182-10',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72578-182-10)',\n",
       "    'marketing_start_date': '20240630',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-182-16',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72578-182-16)',\n",
       "    'marketing_start_date': '20240630',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72578-182-77',\n",
       "    'description': '10 BLISTER PACK in 1 CARTON (72578-182-77)  / 10 TABLET in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20240630',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Viona Pharmaceuticals Inc'],\n",
       "   'rxcui': ['966787', '966793'],\n",
       "   'spl_set_id': ['3377541d-db46-4fd9-9a4b-faa5f6108e67'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372578181062', '0372578182069'],\n",
       "   'unii': ['3U9A0FE9N5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '4e781c2d-e54c-46cb-a10f-9b37097e090a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240630',\n",
       "  'product_id': '72578-182_4e781c2d-e54c-46cb-a10f-9b37097e090a',\n",
       "  'application_number': 'ANDA202761',\n",
       "  'brand_name_base': 'doxepin',\n",
       "  'pharm_class': ['Tricyclic Antidepressant [EPC]']},\n",
       " {'product_ndc': '0574-0107',\n",
       "  'generic_name': 'clotrimazole',\n",
       "  'labeler_name': 'Padagis US LLC',\n",
       "  'brand_name': 'Clotrimazole',\n",
       "  'active_ingredients': [{'name': 'CLOTRIMAZOLE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0574-0107-14',\n",
       "    'description': '140 LOZENGE in 1 BOTTLE, PLASTIC (0574-0107-14)',\n",
       "    'marketing_start_date': '20051201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0574-0107-70',\n",
       "    'description': '70 LOZENGE in 1 BOTTLE, PLASTIC (0574-0107-70)',\n",
       "    'marketing_start_date': '20051201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0574-0107-77',\n",
       "    'description': '70 PACKET in 1 BOX (0574-0107-77)  / 1 LOZENGE in 1 PACKET',\n",
       "    'marketing_start_date': '20051201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Padagis US LLC'],\n",
       "   'rxcui': ['309371'],\n",
       "   'spl_set_id': ['3f57ef51-8202-4d0b-95a8-d2df468b8d9a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305740107706'],\n",
       "   'nui': ['N0000175487', 'M0002083'],\n",
       "   'pharm_class_epc': ['Azole Antifungal [EPC]'],\n",
       "   'pharm_class_cs': ['Azoles [CS]'],\n",
       "   'unii': ['G07GZ97H65']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'LOZENGE',\n",
       "  'spl_id': 'c3d8e3ce-0429-4979-a91d-58dd19bbe996',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20051201',\n",
       "  'product_id': '0574-0107_c3d8e3ce-0429-4979-a91d-58dd19bbe996',\n",
       "  'application_number': 'ANDA076763',\n",
       "  'brand_name_base': 'Clotrimazole',\n",
       "  'pharm_class': ['Azole Antifungal [EPC]', 'Azoles [CS]']},\n",
       " {'product_ndc': '72603-128',\n",
       "  'generic_name': 'Pantoprazole Sodium',\n",
       "  'labeler_name': 'Northstar Rx LLC',\n",
       "  'brand_name': 'Pantoprazole Sodium',\n",
       "  'active_ingredients': [{'name': 'PANTOPRAZOLE SODIUM',\n",
       "    'strength': '40 mg/10mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-128-10',\n",
       "    'description': '10 VIAL, SINGLE-DOSE in 1 CARTON (72603-128-10)  / 10 mL in 1 VIAL, SINGLE-DOSE (72603-128-01)',\n",
       "    'marketing_start_date': '20220829',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Northstar Rx LLC'],\n",
       "   'rxcui': ['283669'],\n",
       "   'spl_set_id': ['7e0c5dac-6832-4692-b012-ca59d5e88987'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372603128109'],\n",
       "   'unii': ['6871619Q5X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, FOR SOLUTION',\n",
       "  'spl_id': 'e6f21248-e12b-4d74-a573-52b189338de2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20220829',\n",
       "  'product_id': '72603-128_e6f21248-e12b-4d74-a573-52b189338de2',\n",
       "  'application_number': 'ANDA215860',\n",
       "  'brand_name_base': 'Pantoprazole Sodium',\n",
       "  'pharm_class': ['Proton Pump Inhibitor [EPC]',\n",
       "   'Proton Pump Inhibitors [MoA]']},\n",
       " {'product_ndc': '0574-0115',\n",
       "  'generic_name': 'FLAVOXATE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Padagis US LLC',\n",
       "  'brand_name': 'FLAVOXATE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'FLAVOXATE HYDROCHLORIDE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0574-0115-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0574-0115-01)',\n",
       "    'marketing_start_date': '20041222',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Padagis US LLC'],\n",
       "   'rxcui': ['1095229'],\n",
       "   'spl_set_id': ['a9c44c4b-5b3c-45bf-9bc9-ce858e3d06c5'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305740115015'],\n",
       "   'unii': ['9C05J6089W']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '40f486b9-82af-4308-bca6-f911d1094dc8',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20041222',\n",
       "  'product_id': '0574-0115_40f486b9-82af-4308-bca6-f911d1094dc8',\n",
       "  'application_number': 'ANDA076831',\n",
       "  'brand_name_base': 'FLAVOXATE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Cholinergic Muscarinic Antagonist [EPC]',\n",
       "   'Cholinergic Muscarinic Antagonists [MoA]']},\n",
       " {'product_ndc': '72603-134',\n",
       "  'generic_name': 'SPIRONOLACTONE',\n",
       "  'labeler_name': 'NorthStar Rx LLC',\n",
       "  'brand_name': 'SPIRONOLACTONE',\n",
       "  'active_ingredients': [{'name': 'SPIRONOLACTONE', 'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-134-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72603-134-01)',\n",
       "    'marketing_start_date': '20191213',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72603-134-02',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72603-134-02)',\n",
       "    'marketing_start_date': '20191213',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72603-134-03',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72603-134-03)',\n",
       "    'marketing_start_date': '20191213',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar Rx LLC'],\n",
       "   'rxcui': ['198222', '198223', '313096'],\n",
       "   'spl_set_id': ['ae0dcb4e-63df-459c-8e60-0caa817b8135'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175557', 'N0000011310'],\n",
       "   'pharm_class_epc': ['Aldosterone Antagonist [EPC]'],\n",
       "   'pharm_class_moa': ['Aldosterone Antagonists [MoA]'],\n",
       "   'unii': ['27O7W4T232']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'ffaeea5c-aa86-4a43-bacf-89a9c6293282',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20191213',\n",
       "  'product_id': '72603-134_ffaeea5c-aa86-4a43-bacf-89a9c6293282',\n",
       "  'application_number': 'ANDA202187',\n",
       "  'brand_name_base': 'SPIRONOLACTONE',\n",
       "  'pharm_class': ['Aldosterone Antagonist [EPC]',\n",
       "   'Aldosterone Antagonists [MoA]']},\n",
       " {'product_ndc': '72603-140',\n",
       "  'marketing_end_date': '20250331',\n",
       "  'generic_name': 'Lacosamide',\n",
       "  'labeler_name': 'Northstar Rx LLC.',\n",
       "  'dea_schedule': 'CV',\n",
       "  'brand_name': 'LACOSAMIDE',\n",
       "  'active_ingredients': [{'name': 'LACOSAMIDE', 'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-140-02',\n",
       "    'description': '10 VIAL in 1 CARTON (72603-140-02)  / 20 mL in 1 VIAL (72603-140-01)',\n",
       "    'marketing_start_date': '20230313',\n",
       "    'marketing_end_date': '20250331',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Northstar Rx LLC.'],\n",
       "   'spl_set_id': ['5ec0d31a-7974-4d62-9203-eee9abeb86a6'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372603140026', '0372603140019'],\n",
       "   'nui': ['N0000008486'],\n",
       "   'pharm_class_pe': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]'],\n",
       "   'unii': ['563KS2PQY5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': '7a00caec-5af8-4fbb-8f11-f8e1bed2762f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20230313',\n",
       "  'product_id': '72603-140_7a00caec-5af8-4fbb-8f11-f8e1bed2762f',\n",
       "  'application_number': 'ANDA209465',\n",
       "  'brand_name_base': 'LACOSAMIDE',\n",
       "  'pharm_class': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]']},\n",
       " {'product_ndc': '72603-153',\n",
       "  'generic_name': 'ketorolac tromethamine',\n",
       "  'labeler_name': 'NorthStar Rx LLC',\n",
       "  'brand_name': 'KETOROLAC TROMETHAMINE',\n",
       "  'active_ingredients': [{'name': 'KETOROLAC TROMETHAMINE',\n",
       "    'strength': '15 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-153-25',\n",
       "    'description': '25 VIAL, SINGLE-DOSE in 1 CARTON (72603-153-25)  / 1 mL in 1 VIAL, SINGLE-DOSE (72603-153-01)',\n",
       "    'marketing_start_date': '20230708',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar Rx LLC'],\n",
       "   'rxcui': ['860092', '1665459', '1665461'],\n",
       "   'spl_set_id': ['bdfb7f14-ad9c-4901-844b-aacfbb4429c3'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372603153019', '0372603161014'],\n",
       "   'unii': ['4EVE5946BQ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'dc321c26-5466-4443-bae2-76aad2de4087',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS'],\n",
       "  'marketing_start_date': '20230708',\n",
       "  'product_id': '72603-153_dc321c26-5466-4443-bae2-76aad2de4087',\n",
       "  'application_number': 'ANDA217789',\n",
       "  'brand_name_base': 'KETOROLAC TROMETHAMINE',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitor [EPC]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72603-160',\n",
       "  'generic_name': 'Tobramycin',\n",
       "  'labeler_name': 'Northstar Rx LLC',\n",
       "  'brand_name': 'Tobramycin',\n",
       "  'active_ingredients': [{'name': 'TOBRAMYCIN SULFATE',\n",
       "    'strength': '1.2 g/30mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-160-06',\n",
       "    'description': '6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06)  / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE',\n",
       "    'marketing_start_date': '20240401',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Northstar Rx LLC'],\n",
       "   'rxcui': ['597823'],\n",
       "   'spl_set_id': ['55d09ffd-4f32-8aeb-3904-8a17db635e3a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372603160062', '0372603160017'],\n",
       "   'unii': ['HJT0RXD7JK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION',\n",
       "  'spl_id': 'e9ac0d06-849a-1348-2b6a-4ed2201c6628',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20240401',\n",
       "  'product_id': '72603-160_e9ac0d06-849a-1348-2b6a-4ed2201c6628',\n",
       "  'application_number': 'ANDA211189',\n",
       "  'brand_name_base': 'Tobramycin',\n",
       "  'pharm_class': ['Aminoglycoside Antibacterial [EPC]',\n",
       "   'Aminoglycosides [CS]']},\n",
       " {'product_ndc': '0574-0129',\n",
       "  'marketing_end_date': '20250630',\n",
       "  'generic_name': 'Clindamycin Palmitate Hydrochloride',\n",
       "  'labeler_name': 'Padagis US LLC',\n",
       "  'brand_name': 'Clindamycin Palmitate Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'CLINDAMYCIN PALMITATE HYDROCHLORIDE',\n",
       "    'strength': '75 mg/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0574-0129-01',\n",
       "    'description': '1 BOTTLE, GLASS in 1 CARTON (0574-0129-01)  / 100 mL in 1 BOTTLE, GLASS',\n",
       "    'marketing_start_date': '20100121',\n",
       "    'marketing_end_date': '20250630',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Padagis US LLC'],\n",
       "   'rxcui': ['562266'],\n",
       "   'spl_set_id': ['98f47953-c344-421c-a171-3a822be34728'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['VN9A8JM7M7']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'GRANULE, FOR SOLUTION',\n",
       "  'spl_id': '2361ba91-a492-498a-aeff-ddfac2a534cd',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20100121',\n",
       "  'product_id': '0574-0129_2361ba91-a492-498a-aeff-ddfac2a534cd',\n",
       "  'application_number': 'ANDA090902',\n",
       "  'brand_name_base': 'Clindamycin Palmitate Hydrochloride',\n",
       "  'pharm_class': ['Decreased Sebaceous Gland Activity [PE]',\n",
       "   'Lincosamide Antibacterial [EPC]',\n",
       "   'Lincosamides [CS]',\n",
       "   'Neuromuscular Blockade [PE]']},\n",
       " {'product_ndc': '72603-165',\n",
       "  'generic_name': 'Enoxaparin Sodium',\n",
       "  'labeler_name': 'NorthStar RxLLC',\n",
       "  'brand_name': 'Enoxaparin Sodium',\n",
       "  'active_ingredients': [{'name': 'ENOXAPARIN SODIUM',\n",
       "    'strength': '30 mg/.3mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-165-10',\n",
       "    'description': '10 SYRINGE in 1 CARTON (72603-165-10)  / .3 mL in 1 SYRINGE (72603-165-01)',\n",
       "    'marketing_start_date': '20230714',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar RxLLC'],\n",
       "   'rxcui': ['854228',\n",
       "    '854235',\n",
       "    '854238',\n",
       "    '854241',\n",
       "    '854245',\n",
       "    '854248',\n",
       "    '854252'],\n",
       "   'spl_set_id': ['014c6710-f2c4-fd1e-e063-6394a90ae525'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372603225105',\n",
       "    '0372603185102',\n",
       "    '0372603195019',\n",
       "    '0372603165104',\n",
       "    '0372603215014',\n",
       "    '0372603205107',\n",
       "    '0372603215106',\n",
       "    '0372603195101',\n",
       "    '0372603165012',\n",
       "    '0372603225013',\n",
       "    '0372603185010',\n",
       "    '0372603175103',\n",
       "    '0372603175011',\n",
       "    '0372603205015'],\n",
       "   'unii': ['8NZ41MIK1O']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '1b5d6d46-a8fc-ed74-e063-6294a90af6c1',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20230315',\n",
       "  'product_id': '72603-165_1b5d6d46-a8fc-ed74-e063-6294a90af6c1',\n",
       "  'application_number': 'ANDA205660',\n",
       "  'brand_name_base': 'Enoxaparin Sodium',\n",
       "  'pharm_class': ['Heparin',\n",
       "   'Low-Molecular-Weight [CS]',\n",
       "   'Low Molecular Weight Heparin [EPC]']},\n",
       " {'product_ndc': '72603-169',\n",
       "  'generic_name': 'Prochlorperazine Maleate',\n",
       "  'labeler_name': 'Northstar Rx LLC',\n",
       "  'brand_name': 'Prochlorperazine Maleate',\n",
       "  'active_ingredients': [{'name': 'PROCHLORPERAZINE MALEATE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-169-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72603-169-01)',\n",
       "    'marketing_start_date': '20230907',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Northstar Rx LLC'],\n",
       "   'rxcui': ['198365', '312635'],\n",
       "   'spl_set_id': ['04bf8a16-218a-c648-e063-6294a90a1afb'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['I1T8O1JTL6']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '04bf8a28-8d50-d2a5-e063-6394a90a259d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230907',\n",
       "  'product_id': '72603-169_04bf8a28-8d50-d2a5-e063-6394a90a259d',\n",
       "  'application_number': 'ANDA216202',\n",
       "  'brand_name_base': 'Prochlorperazine Maleate',\n",
       "  'pharm_class': ['Phenothiazine [EPC]', 'Phenothiazines [CS]']},\n",
       " {'product_ndc': '72603-176',\n",
       "  'generic_name': 'Nitrofurantoin',\n",
       "  'labeler_name': 'NorthStar Rx LLC',\n",
       "  'brand_name': 'Nitrofurantoin',\n",
       "  'active_ingredients': [{'name': 'NITROFURANTOIN', 'strength': '25 mg/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-176-01',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72603-176-01)  / 230 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20230417',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar Rx LLC'],\n",
       "   'rxcui': ['311989'],\n",
       "   'spl_set_id': ['04af8b73-7e15-7da8-e063-6294a90af284'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175494', 'M0014892'],\n",
       "   'pharm_class_epc': ['Nitrofuran Antibacterial [EPC]'],\n",
       "   'pharm_class_cs': ['Nitrofurans [CS]'],\n",
       "   'unii': ['927AH8112L']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SUSPENSION',\n",
       "  'spl_id': '14c9efac-c0b1-7afe-e063-6294a90a39e4',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230417',\n",
       "  'product_id': '72603-176_14c9efac-c0b1-7afe-e063-6294a90a39e4',\n",
       "  'application_number': 'ANDA216385',\n",
       "  'brand_name_base': 'Nitrofurantoin',\n",
       "  'pharm_class': ['Nitrofuran Antibacterial [EPC]', 'Nitrofurans [CS]']},\n",
       " {'product_ndc': '72603-177',\n",
       "  'generic_name': 'Pantoprazole',\n",
       "  'labeler_name': 'NorthStar RxLLC',\n",
       "  'brand_name': 'Pantoprazole',\n",
       "  'active_ingredients': [{'name': 'PANTOPRAZOLE SODIUM',\n",
       "    'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-177-01',\n",
       "    'description': '90 TABLET, DELAYED RELEASE in 1 BOTTLE (72603-177-01)',\n",
       "    'marketing_start_date': '20231215',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar RxLLC'],\n",
       "   'rxcui': ['251872', '314200'],\n",
       "   'spl_set_id': ['82f0103a-2b97-d210-6d7d-c627d60ad694'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['6871619Q5X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, DELAYED RELEASE',\n",
       "  'spl_id': '57338853-6995-de1e-62ca-be5505c8d656',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231215',\n",
       "  'product_id': '72603-177_57338853-6995-de1e-62ca-be5505c8d656',\n",
       "  'application_number': 'ANDA077619',\n",
       "  'brand_name_base': 'Pantoprazole',\n",
       "  'pharm_class': ['Proton Pump Inhibitor [EPC]',\n",
       "   'Proton Pump Inhibitors [MoA]']},\n",
       " {'product_ndc': '72603-179',\n",
       "  'generic_name': 'Heparin Sodium',\n",
       "  'labeler_name': 'NorthStar RxLLC',\n",
       "  'brand_name': 'Heparin Sodium',\n",
       "  'active_ingredients': [{'name': 'HEPARIN SODIUM',\n",
       "    'strength': \"1000 [USP'U]/mL\"}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-179-25',\n",
       "    'description': '25 VIAL, MULTI-DOSE in 1 CARTON (72603-179-25)  / 10 mL in 1 VIAL, MULTI-DOSE (72603-179-01)',\n",
       "    'marketing_start_date': '20240401',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar RxLLC'],\n",
       "   'rxcui': ['1361226', '1361615', '1658637', '1658659', '1659263'],\n",
       "   'spl_set_id': ['c4fa6d34-e76b-4c3c-b74d-21ce41432a04'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372603412253'],\n",
       "   'unii': ['ZZ45AB24CA']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'e0944c7d-ec7c-48ef-8737-96ad1c08ecbd',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS', 'SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20240401',\n",
       "  'product_id': '72603-179_e0944c7d-ec7c-48ef-8737-96ad1c08ecbd',\n",
       "  'application_number': 'ANDA211007',\n",
       "  'brand_name_base': 'Heparin Sodium',\n",
       "  'pharm_class': ['Anti-coagulant [EPC]',\n",
       "   'Heparin [CS]',\n",
       "   'Unfractionated Heparin [EPC]']},\n",
       " {'product_ndc': '72603-183',\n",
       "  'generic_name': 'nitrofurantoin macrocrystals',\n",
       "  'labeler_name': 'NorthStar RxLLC',\n",
       "  'brand_name': 'nitrofurantoin macrocrystals',\n",
       "  'active_ingredients': [{'name': 'NITROFURANTOIN', 'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-183-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (72603-183-01)',\n",
       "    'marketing_start_date': '20231201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar RxLLC'],\n",
       "   'rxcui': ['311994', '311995', '1648759'],\n",
       "   'spl_set_id': ['1e3c284a-539d-4923-a5f6-547390baf811'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372603183016', '0372603182019', '0372603184013'],\n",
       "   'nui': ['N0000175494', 'M0014892'],\n",
       "   'pharm_class_epc': ['Nitrofuran Antibacterial [EPC]'],\n",
       "   'pharm_class_cs': ['Nitrofurans [CS]'],\n",
       "   'unii': ['927AH8112L']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '3dfb2c77-98f5-4810-a491-b0b0198bd9c1',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231201',\n",
       "  'product_id': '72603-183_3dfb2c77-98f5-4810-a491-b0b0198bd9c1',\n",
       "  'application_number': 'ANDA217272',\n",
       "  'brand_name_base': 'nitrofurantoin macrocrystals',\n",
       "  'pharm_class': ['Nitrofuran Antibacterial [EPC]', 'Nitrofurans [CS]']},\n",
       " {'product_ndc': '72603-188',\n",
       "  'generic_name': 'Dexamethasone',\n",
       "  'labeler_name': 'NorthStar Rx LLC',\n",
       "  'brand_name': 'Dexamethasone',\n",
       "  'active_ingredients': [{'name': 'DEXAMETHASONE', 'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-188-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72603-188-01)',\n",
       "    'marketing_start_date': '20230807',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar Rx LLC'],\n",
       "   'rxcui': ['197577', '197580', '197581', '197582', '197583', '343033'],\n",
       "   'spl_set_id': ['05c77a4c-c508-babd-e063-6294a90a450a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372603188011', '0372603187014', '0372603190014', '0372603189018'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['7S5I7G3JQL']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '132845af-9ab6-2327-e063-6294a90a6673',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230807',\n",
       "  'product_id': '72603-188_132845af-9ab6-2327-e063-6294a90a6673',\n",
       "  'application_number': 'ANDA217696',\n",
       "  'brand_name_base': 'Dexamethasone',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72603-193',\n",
       "  'generic_name': 'Sapropterin dihydrochloride',\n",
       "  'labeler_name': 'NorthStar RxLLC',\n",
       "  'brand_name': 'Sapropterin dihydrochloride',\n",
       "  'active_ingredients': [{'name': 'SAPROPTERIN DIHYDROCHLORIDE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-193-30',\n",
       "    'description': '30 PACKET in 1 CARTON (72603-193-30)  / 1 POWDER, FOR SOLUTION in 1 PACKET (72603-193-01)',\n",
       "    'marketing_start_date': '20231201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar RxLLC'],\n",
       "   'rxcui': ['1111018', '1653217'],\n",
       "   'spl_set_id': ['b3999f74-920d-4444-afa7-f4211e4eb431'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['RG277LF5B3']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'POWDER, FOR SOLUTION',\n",
       "  'spl_id': '1ccf4222-e182-b467-e063-6394a90a76ec',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231201',\n",
       "  'product_id': '72603-193_1ccf4222-e182-b467-e063-6394a90a76ec',\n",
       "  'application_number': 'ANDA215420',\n",
       "  'brand_name_base': 'Sapropterin dihydrochloride',\n",
       "  'pharm_class': ['Breast Cancer Resistance Protein Inhibitors [MoA]',\n",
       "   'P-Glycoprotein Inhibitors [MoA]',\n",
       "   'Phenylalanine Hydroxylase Activator [EPC]',\n",
       "   'Phenylalanine Hydroxylase Activators [MoA]']},\n",
       " {'product_ndc': '72603-205',\n",
       "  'generic_name': 'Enoxaparin Sodium',\n",
       "  'labeler_name': 'NorthStar RxLLC',\n",
       "  'brand_name': 'Enoxaparin Sodium',\n",
       "  'active_ingredients': [{'name': 'ENOXAPARIN SODIUM',\n",
       "    'strength': '100 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-205-10',\n",
       "    'description': '10 SYRINGE in 1 CARTON (72603-205-10)  / 1 mL in 1 SYRINGE (72603-205-01)',\n",
       "    'marketing_start_date': '20230714',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar RxLLC'],\n",
       "   'rxcui': ['854228',\n",
       "    '854235',\n",
       "    '854238',\n",
       "    '854241',\n",
       "    '854245',\n",
       "    '854248',\n",
       "    '854252'],\n",
       "   'spl_set_id': ['014c6710-f2c4-fd1e-e063-6394a90ae525'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372603225105',\n",
       "    '0372603185102',\n",
       "    '0372603195019',\n",
       "    '0372603165104',\n",
       "    '0372603215014',\n",
       "    '0372603205107',\n",
       "    '0372603215106',\n",
       "    '0372603195101',\n",
       "    '0372603165012',\n",
       "    '0372603225013',\n",
       "    '0372603185010',\n",
       "    '0372603175103',\n",
       "    '0372603175011',\n",
       "    '0372603205015'],\n",
       "   'unii': ['8NZ41MIK1O']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '1b5d6d46-a8fc-ed74-e063-6294a90af6c1',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20230315',\n",
       "  'product_id': '72603-205_1b5d6d46-a8fc-ed74-e063-6294a90af6c1',\n",
       "  'application_number': 'ANDA205660',\n",
       "  'brand_name_base': 'Enoxaparin Sodium',\n",
       "  'pharm_class': ['Heparin',\n",
       "   'Low-Molecular-Weight [CS]',\n",
       "   'Low Molecular Weight Heparin [EPC]']},\n",
       " {'product_ndc': '72603-208',\n",
       "  'generic_name': 'arformoterol tartrate',\n",
       "  'labeler_name': 'NorthStar RxLLC',\n",
       "  'brand_name': 'arformoterol tartrate',\n",
       "  'active_ingredients': [{'name': 'ARFORMOTEROL TARTRATE',\n",
       "    'strength': '15 ug/2mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-208-30',\n",
       "    'description': '30 POUCH in 1 CARTON (72603-208-30)  / 1 VIAL in 1 POUCH (72603-208-01)  / 2 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20240601',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72603-208-60',\n",
       "    'description': '60 POUCH in 1 CARTON (72603-208-60)  / 4 VIAL in 1 POUCH (72603-208-04)  / 2 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20240601',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar RxLLC'],\n",
       "   'rxcui': ['668956'],\n",
       "   'spl_set_id': ['6a498c49-042f-481f-bc5c-a2fc00dc5668'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['5P8VJ2I235']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '8f4d31ae-a0b8-426a-92c8-7583ee585abd',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['RESPIRATORY (INHALATION)'],\n",
       "  'marketing_start_date': '20240601',\n",
       "  'product_id': '72603-208_8f4d31ae-a0b8-426a-92c8-7583ee585abd',\n",
       "  'application_number': 'ANDA216128',\n",
       "  'brand_name_base': 'arformoterol tartrate',\n",
       "  'pharm_class': ['Adrenergic beta2-Agonists [MoA]',\n",
       "   'beta2-Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '0574-0227',\n",
       "  'generic_name': 'benazepril hydrochloride and hydrochlorothiazide',\n",
       "  'labeler_name': 'Padagis US LLC',\n",
       "  'brand_name': 'benazepril hydrochloride and hydrochlorothiazide',\n",
       "  'active_ingredients': [{'name': 'BENAZEPRIL HYDROCHLORIDE',\n",
       "    'strength': '10 mg/1'},\n",
       "   {'name': 'HYDROCHLOROTHIAZIDE', 'strength': '12.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0574-0227-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (0574-0227-01)',\n",
       "    'marketing_start_date': '20190407',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Padagis US LLC'],\n",
       "   'rxcui': ['898362', '898367', '898372'],\n",
       "   'spl_set_id': ['3e2d3974-38b0-49d0-8020-f74107584724'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305740227015', '0305740228012', '0305740229019'],\n",
       "   'nui': ['N0000175359', 'N0000175419', 'M0471776'],\n",
       "   'pharm_class_pe': ['Increased Diuresis [PE]'],\n",
       "   'pharm_class_epc': ['Thiazide Diuretic [EPC]'],\n",
       "   'pharm_class_cs': ['Thiazides [CS]'],\n",
       "   'unii': ['N1SN99T69T', '0J48LPH2TH']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '1d6c07ee-7f41-4184-8dc5-aca58cb2eb78',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190407',\n",
       "  'product_id': '0574-0227_1d6c07ee-7f41-4184-8dc5-aca58cb2eb78',\n",
       "  'application_number': 'NDA020033',\n",
       "  'brand_name_base': 'benazepril hydrochloride and hydrochlorothiazide',\n",
       "  'pharm_class': ['Angiotensin Converting Enzyme Inhibitor [EPC]',\n",
       "   'Angiotensin-converting Enzyme Inhibitors [MoA]',\n",
       "   'Decreased Blood Pressure [PE]',\n",
       "   'Increased Diuresis [PE]',\n",
       "   'Thiazide Diuretic [EPC]',\n",
       "   'Thiazides [CS]']},\n",
       " {'product_ndc': '72603-257',\n",
       "  'generic_name': 'everolimus',\n",
       "  'labeler_name': 'NorthStar RxLLC',\n",
       "  'brand_name': 'EVEROLIMUS',\n",
       "  'active_ingredients': [{'name': 'EVEROLIMUS', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-257-01',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72603-257-01)',\n",
       "    'marketing_start_date': '20241001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar RxLLC'],\n",
       "   'rxcui': ['845507', '845515', '998189', '1119400'],\n",
       "   'spl_set_id': ['5cfca904-b75c-5a39-8cb9-b99bb421bceb'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372603254013'],\n",
       "   'nui': ['N0000175605',\n",
       "    'N0000175076',\n",
       "    'N0000182141',\n",
       "    'N0000182137',\n",
       "    'N0000175625',\n",
       "    'N0000175624',\n",
       "    'N0000175550'],\n",
       "   'pharm_class_epc': ['Kinase Inhibitor [EPC]',\n",
       "    'mTOR Inhibitor Immunosuppressant [EPC]'],\n",
       "   'pharm_class_moa': ['Protein Kinase Inhibitors [MoA]',\n",
       "    'Cytochrome P450 3A4 Inhibitors [MoA]',\n",
       "    'Cytochrome P450 2D6 Inhibitors [MoA]',\n",
       "    'mTOR Inhibitors [MoA]'],\n",
       "   'pharm_class_pe': ['Decreased Immunologic Activity [PE]'],\n",
       "   'unii': ['9HW64Q8G6G']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '37cc941b-bf1e-1218-4af9-b2e5860871da',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20241001',\n",
       "  'product_id': '72603-257_37cc941b-bf1e-1218-4af9-b2e5860871da',\n",
       "  'application_number': 'ANDA214182',\n",
       "  'brand_name_base': 'EVEROLIMUS',\n",
       "  'pharm_class': ['Cytochrome P450 2D6 Inhibitors [MoA]',\n",
       "   'Cytochrome P450 3A4 Inhibitors [MoA]',\n",
       "   'Decreased Immunologic Activity [PE]',\n",
       "   'Kinase Inhibitor [EPC]',\n",
       "   'Protein Kinase Inhibitors [MoA]',\n",
       "   'mTOR Inhibitor Immunosuppressant [EPC]',\n",
       "   'mTOR Inhibitors [MoA]']},\n",
       " {'product_ndc': '72603-271',\n",
       "  'generic_name': 'OXCARBAZEPINE',\n",
       "  'labeler_name': 'NorthStar RxLLC',\n",
       "  'brand_name': 'OXCARBAZEPINE',\n",
       "  'active_ingredients': [{'name': 'OXCARBAZEPINE', 'strength': '300 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-271-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72603-271-01)',\n",
       "    'marketing_start_date': '20240901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar RxLLC'],\n",
       "   'rxcui': ['312137', '312138'],\n",
       "   'spl_set_id': ['20d826cd-fa4a-4570-9e10-9d7d10fb725b'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372603271010', '0372603272017'],\n",
       "   'nui': ['N0000175753', 'N0000008486'],\n",
       "   'pharm_class_epc': ['Anti-epileptic Agent [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]'],\n",
       "   'unii': ['VZI5B1W380']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '21e97c53-4c59-4525-e063-6394a90a2efd',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240901',\n",
       "  'product_id': '72603-271_21e97c53-4c59-4525-e063-6394a90a2efd',\n",
       "  'application_number': 'ANDA215939',\n",
       "  'brand_name_base': 'OXCARBAZEPINE',\n",
       "  'pharm_class': ['Anti-epileptic Agent [EPC]',\n",
       "   'Decreased Central Nervous System Disorganized Electrical Activity [PE]']},\n",
       " {'product_ndc': '0067-0122',\n",
       "  'generic_name': 'acetaminophen, dextromethorphan hbr, diphenhydramine hcl',\n",
       "  'labeler_name': 'Haleon US Holdings LLC',\n",
       "  'brand_name': 'Theraflu Severe Cold Relief Combo Pack',\n",
       "  'brand_name_suffix': 'Severe Cold Relief Combo Pack',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0067-0122-01',\n",
       "    'description': '1 KIT in 1 PACKAGE, COMBINATION (0067-0122-01)  *  6 PACKET in 1 CARTON (0067-0100-06)  / 1 POWDER, FOR SOLUTION in 1 PACKET *  6 PACKET in 1 CARTON (0067-0101-06)  / 1 POWDER, FOR SOLUTION in 1 PACKET',\n",
       "    'marketing_start_date': '20240415',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Haleon US Holdings LLC'],\n",
       "   'rxcui': ['2670598', '2670677', '2679420', '2679425', '2679426'],\n",
       "   'spl_set_id': ['f147d82e-4429-4c7b-bd2b-e21a09f21c92'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': 'f147d82e-4429-4c7b-bd2b-e21a09f21c92',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'marketing_start_date': '20240415',\n",
       "  'product_id': '0067-0122_f147d82e-4429-4c7b-bd2b-e21a09f21c92',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'Theraflu'},\n",
       " {'product_ndc': '72603-350',\n",
       "  'generic_name': 'Lidocaine Hydrochloride',\n",
       "  'labeler_name': 'NorthStar RxLLC',\n",
       "  'brand_name': 'Lidocaine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE HYDROCHLORIDE',\n",
       "    'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-350-10',\n",
       "    'description': '10 VIAL in 1 CARTON (72603-350-10)  / 2 mL in 1 VIAL (72603-350-01)',\n",
       "    'marketing_start_date': '20240501',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72603-350-25',\n",
       "    'description': '25 VIAL in 1 CARTON (72603-350-25)  / 2 mL in 1 VIAL (72603-350-01)',\n",
       "    'marketing_start_date': '20240501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar RxLLC'],\n",
       "   'rxcui': ['1737568', '1737757', '1737761'],\n",
       "   'spl_set_id': ['f065e6d2-b47e-433d-a1fb-f0449cd725f1'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372603505016', '0372603350012'],\n",
       "   'unii': ['V13007Z41A']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '103c8a6c-c0cf-4cff-92d3-920aaeb39802',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL'],\n",
       "  'marketing_start_date': '20240501',\n",
       "  'product_id': '72603-350_103c8a6c-c0cf-4cff-92d3-920aaeb39802',\n",
       "  'application_number': 'ANDA217692',\n",
       "  'brand_name_base': 'Lidocaine Hydrochloride',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '0574-0297',\n",
       "  'generic_name': 'hydromorphone hydrochloride',\n",
       "  'labeler_name': 'Padagis US LLC',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'hydromorphone hydrochloride',\n",
       "  'active_ingredients': [{'name': 'HYDROMORPHONE HYDROCHLORIDE',\n",
       "    'strength': '32 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0574-0297-01',\n",
       "    'description': '100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0297-01)',\n",
       "    'marketing_start_date': '20170929',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Padagis US LLC'],\n",
       "   'rxcui': ['902729', '902736', '902741', '1306898'],\n",
       "   'spl_set_id': ['780a2616-0392-4715-bc50-71799bea1957'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['L960UP2KRW']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '92b33262-9514-4ec5-b0d9-01454813313c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20150522',\n",
       "  'product_id': '0574-0297_92b33262-9514-4ec5-b0d9-01454813313c',\n",
       "  'application_number': 'ANDA204278',\n",
       "  'brand_name_base': 'hydromorphone hydrochloride',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '0574-0520',\n",
       "  'generic_name': 'activated charcoal',\n",
       "  'labeler_name': 'Padagis US LLC',\n",
       "  'brand_name': 'ACTIDOSE',\n",
       "  'active_ingredients': [{'name': 'ACTIVATED CHARCOAL',\n",
       "    'strength': '208 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0574-0520-04',\n",
       "    'description': '120 mL in 1 BOTTLE (0574-0520-04)',\n",
       "    'marketing_start_date': '20201205',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0574-0520-08',\n",
       "    'description': '240 mL in 1 BOTTLE (0574-0520-08)',\n",
       "    'marketing_start_date': '20210210',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0574-0520-74',\n",
       "    'description': '120 mL in 1 TUBE (0574-0520-74)',\n",
       "    'marketing_start_date': '20210219',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0574-0520-76',\n",
       "    'description': '240 mL in 1 TUBE (0574-0520-76)',\n",
       "    'marketing_start_date': '20201205',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Padagis US LLC'],\n",
       "   'rxcui': ['309150', '1251411'],\n",
       "   'spl_set_id': ['76e4fe6a-afd4-4f68-b12d-0b094f750615'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['2P3VWU3H10']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SUSPENSION',\n",
       "  'spl_id': 'b2cc844e-4d19-4dd5-8ec8-23ff000c7e4e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201205',\n",
       "  'product_id': '0574-0520_b2cc844e-4d19-4dd5-8ec8-23ff000c7e4e',\n",
       "  'application_number': 'M023',\n",
       "  'brand_name_base': 'ACTIDOSE'},\n",
       " {'product_ndc': '0574-0521',\n",
       "  'generic_name': 'activated charcoal',\n",
       "  'labeler_name': 'Padagis US LLC',\n",
       "  'brand_name': 'ACTIDOSE AQUA',\n",
       "  'active_ingredients': [{'name': 'ACTIVATED CHARCOAL',\n",
       "    'strength': '208 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0574-0521-04',\n",
       "    'description': '120 mL in 1 BOTTLE (0574-0521-04)',\n",
       "    'marketing_start_date': '20201111',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0574-0521-08',\n",
       "    'description': '240 mL in 1 BOTTLE (0574-0521-08)',\n",
       "    'marketing_start_date': '20201111',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0574-0521-25',\n",
       "    'description': '72 mL in 1 TUBE (0574-0521-25)',\n",
       "    'marketing_start_date': '20230131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0574-0521-74',\n",
       "    'description': '120 mL in 1 TUBE (0574-0521-74)',\n",
       "    'marketing_start_date': '20201110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0574-0521-76',\n",
       "    'description': '240 mL in 1 TUBE (0574-0521-76)',\n",
       "    'marketing_start_date': '20201213',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Padagis US LLC'],\n",
       "   'rxcui': ['309150', '1251411'],\n",
       "   'spl_set_id': ['c85dc235-3f42-4361-9bd2-1aaff798ad75'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['2P3VWU3H10']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SUSPENSION',\n",
       "  'spl_id': 'fb90ddf4-da3c-44a9-861c-44853f4b7aae',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201110',\n",
       "  'product_id': '0574-0521_fb90ddf4-da3c-44a9-861c-44853f4b7aae',\n",
       "  'application_number': 'M023',\n",
       "  'brand_name_base': 'ACTIDOSE AQUA'},\n",
       " {'product_ndc': '72603-650',\n",
       "  'generic_name': 'Cyanocobalamin',\n",
       "  'labeler_name': 'NorthStar RxLLC',\n",
       "  'brand_name': 'Cyanocobalamin',\n",
       "  'active_ingredients': [{'name': 'CYANOCOBALAMIN', 'strength': '1000 ug/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72603-650-25',\n",
       "    'description': '25 VIAL in 1 CARTON (72603-650-25)  / 1 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20240901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NorthStar RxLLC'],\n",
       "   'rxcui': ['309594'],\n",
       "   'spl_set_id': ['ce0183b3-4410-466a-b57d-cd360d461b7c'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['M0022794', 'N0000175951'],\n",
       "   'pharm_class_cs': ['Vitamin B 12 [CS]'],\n",
       "   'pharm_class_epc': ['Vitamin B12 [EPC]'],\n",
       "   'unii': ['P6YC3EG204']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '5336e173-ea91-4afb-bda0-6bf7cce2b5a4',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20240901',\n",
       "  'product_id': '72603-650_5336e173-ea91-4afb-bda0-6bf7cce2b5a4',\n",
       "  'application_number': 'ANDA217839',\n",
       "  'brand_name_base': 'Cyanocobalamin',\n",
       "  'pharm_class': ['Vitamin B 12 [CS]', 'Vitamin B12 [EPC]']},\n",
       " {'product_ndc': '72606-012',\n",
       "  'generic_name': 'bevacizumab-adcd',\n",
       "  'labeler_name': 'CELLTRION USA, Inc.',\n",
       "  'brand_name': 'Vegzelma',\n",
       "  'active_ingredients': [{'name': 'BEVACIZUMAB', 'strength': '400 mg/16mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72606-012-01',\n",
       "    'description': '1 VIAL, SINGLE-USE in 1 CARTON (72606-012-01)  / 16 mL in 1 VIAL, SINGLE-USE',\n",
       "    'marketing_start_date': '20230403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72606-012-10',\n",
       "    'description': '10 VIAL, SINGLE-USE in 1 CARTON (72606-012-10)  / 16 mL in 1 VIAL, SINGLE-USE',\n",
       "    'marketing_start_date': '20230403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['CELLTRION USA, Inc.'],\n",
       "   'rxcui': ['2627650', '2627656', '2627658', '2627659'],\n",
       "   'spl_set_id': ['4cdcccda-7b9a-49d0-ac50-f4605a3c0ebe'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000193543', 'N0000178291', 'N0000193542'],\n",
       "   'pharm_class_epc': ['Vascular Endothelial Growth Factor Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]',\n",
       "    'Vascular Endothelial Growth Factor Inhibitors [MoA]'],\n",
       "   'unii': ['2S9ZZM9Q9V']},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'd58b28c8-9a47-4869-92c5-a55895ec1605',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20230403',\n",
       "  'product_id': '72606-012_d58b28c8-9a47-4869-92c5-a55895ec1605',\n",
       "  'application_number': 'BLA761268',\n",
       "  'brand_name_base': 'Vegzelma',\n",
       "  'pharm_class': ['Vascular Endothelial Growth Factor Inhibitor [EPC]',\n",
       "   'Vascular Endothelial Growth Factor Inhibitors [MoA]',\n",
       "   'Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]']},\n",
       " {'product_ndc': '72606-558',\n",
       "  'generic_name': 'azacitidine',\n",
       "  'labeler_name': 'CELLTRION USA, INC.',\n",
       "  'brand_name': 'AZACITIDINE',\n",
       "  'active_ingredients': [{'name': 'AZACITIDINE', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72606-558-01',\n",
       "    'description': '1 VIAL in 1 CARTON (72606-558-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL',\n",
       "    'marketing_start_date': '20200106',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['CELLTRION USA, INC.'],\n",
       "   'rxcui': ['485246'],\n",
       "   'spl_set_id': ['b4bcca95-d0b0-42dd-9dbb-637ab98effcc'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372606558019'],\n",
       "   'nui': ['N0000000233', 'N0000175595'],\n",
       "   'pharm_class_moa': ['Nucleic Acid Synthesis Inhibitors [MoA]'],\n",
       "   'pharm_class_epc': ['Nucleoside Metabolic Inhibitor [EPC]'],\n",
       "   'unii': ['M801H13NRU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION',\n",
       "  'spl_id': '1542236d-9049-4a6b-8956-c53d38f8520c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS', 'SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20200106',\n",
       "  'product_id': '72606-558_1542236d-9049-4a6b-8956-c53d38f8520c',\n",
       "  'application_number': 'ANDA207518',\n",
       "  'brand_name_base': 'AZACITIDINE',\n",
       "  'pharm_class': ['Nucleic Acid Synthesis Inhibitors [MoA]',\n",
       "   'Nucleoside Metabolic Inhibitor [EPC]']},\n",
       " {'product_ndc': '72606-559',\n",
       "  'generic_name': 'Busulfan',\n",
       "  'labeler_name': 'CELLTRION USA, INC.',\n",
       "  'brand_name': 'Busulfan',\n",
       "  'active_ingredients': [{'name': 'BUSULFAN', 'strength': '6 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72606-559-02',\n",
       "    'description': '8 CARTON in 1 CARTON (72606-559-02)  / 1 VIAL, SINGLE-DOSE in 1 CARTON (72606-559-01)  / 10 mL in 1 VIAL, SINGLE-DOSE',\n",
       "    'marketing_start_date': '20191201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['CELLTRION USA, INC.'],\n",
       "   'rxcui': ['253113'],\n",
       "   'spl_set_id': ['3ab9b45c-b63a-4152-a242-4f218c520b3b'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000236', 'N0000175558'],\n",
       "   'pharm_class_moa': ['Alkylating Activity [MoA]'],\n",
       "   'pharm_class_epc': ['Alkylating Drug [EPC]'],\n",
       "   'unii': ['G1LN9045DK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': '63ede55c-8326-4a52-a873-f46ce8427ae6',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20191201',\n",
       "  'product_id': '72606-559_63ede55c-8326-4a52-a873-f46ce8427ae6',\n",
       "  'application_number': 'ANDA210931',\n",
       "  'brand_name_base': 'Busulfan',\n",
       "  'pharm_class': ['Alkylating Activity [MoA]', 'Alkylating Drug [EPC]']},\n",
       " {'product_ndc': '72606-566',\n",
       "  'generic_name': 'Abiraterone acetate',\n",
       "  'labeler_name': 'CELLTRION USA, INC.',\n",
       "  'brand_name': 'Abiraterone acetate',\n",
       "  'active_ingredients': [{'name': 'ABIRATERONE ACETATE',\n",
       "    'strength': '250 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72606-566-01',\n",
       "    'description': '120 TABLET in 1 BOTTLE (72606-566-01)',\n",
       "    'marketing_start_date': '20200107',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['CELLTRION USA, INC.'],\n",
       "   'rxcui': ['1100075', '1918042'],\n",
       "   'spl_set_id': ['915b825a-2649-4079-9169-5e33a39c779d'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372606573012'],\n",
       "   'unii': ['EM5OCB9YJ6']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '2765ab03-f2d2-4e68-a704-c1c45505b50a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200107',\n",
       "  'product_id': '72606-566_2765ab03-f2d2-4e68-a704-c1c45505b50a',\n",
       "  'application_number': 'ANDA212462',\n",
       "  'brand_name_base': 'Abiraterone acetate',\n",
       "  'pharm_class': ['Cytochrome P450 17A1 Inhibitor [EPC]',\n",
       "   'Cytochrome P450 17A1 Inhibitors [MoA]',\n",
       "   'Cytochrome P450 2C8 Inhibitors [MoA]',\n",
       "   'Cytochrome P450 2D6 Inhibitors [MoA]']},\n",
       " {'product_ndc': '0574-0621',\n",
       "  'generic_name': 'Podofilox',\n",
       "  'labeler_name': 'Padagis US LLC',\n",
       "  'brand_name': 'Podofilox',\n",
       "  'active_ingredients': [{'name': 'PODOFILOX', 'strength': '5 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0574-0621-05',\n",
       "    'description': '3.5 g in 1 TUBE, WITH APPLICATOR (0574-0621-05)',\n",
       "    'marketing_start_date': '20231213',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Padagis US LLC'],\n",
       "   'rxcui': ['312466'],\n",
       "   'spl_set_id': ['d2e70c5e-d4a9-4295-9eff-517ffb974e61'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000008732'],\n",
       "   'pharm_class_pe': ['Decreased Mitosis [PE]'],\n",
       "   'unii': ['L36H50F353']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'd2e70c5e-d4a9-4295-9eff-517ffb974e61',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20231213',\n",
       "  'product_id': '0574-0621_d2e70c5e-d4a9-4295-9eff-517ffb974e61',\n",
       "  'application_number': 'ANDA211871',\n",
       "  'brand_name_base': 'Podofilox',\n",
       "  'pharm_class': ['Decreased Mitosis [PE]']},\n",
       " {'product_ndc': '72609-045',\n",
       "  'generic_name': 'MENTHOL',\n",
       "  'labeler_name': 'Smith Amish, LLC',\n",
       "  'brand_name': 'Joint Ease',\n",
       "  'active_ingredients': [{'name': 'MENTHOL', 'strength': '1.25 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72609-045-04',\n",
       "    'description': '1 JAR in 1 BOX (72609-045-04)  / 114 g in 1 JAR',\n",
       "    'marketing_start_date': '20240828',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Smith Amish, LLC'],\n",
       "   'rxcui': ['416982'],\n",
       "   'spl_set_id': ['20c4a0f8-bdc6-d89a-e063-6294a90aa8d8'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0895393000450'],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '26d52087-827b-4252-e063-6394a90a828d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240828',\n",
       "  'product_id': '72609-045_26d52087-827b-4252-e063-6394a90a828d',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Joint Ease'},\n",
       " {'product_ndc': '72609-704',\n",
       "  'generic_name': 'COLLOIDAL OATMEAL',\n",
       "  'labeler_name': 'Smith Amish, LLC',\n",
       "  'brand_name': 'ECZEMA',\n",
       "  'active_ingredients': [{'name': 'OATMEAL', 'strength': '1.25 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72609-704-02',\n",
       "    'description': '1 TUBE in 1 BOX (72609-704-02)  / 59 g in 1 TUBE',\n",
       "    'marketing_start_date': '20240828',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Smith Amish, LLC'],\n",
       "   'spl_set_id': ['20c4bc16-ba20-47ec-e063-6394a90a8b4e'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185371',\n",
       "    'N0000185375',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'M0000728',\n",
       "    'M0006342',\n",
       "    'M0016962',\n",
       "    'N0000185016'],\n",
       "   'pharm_class_epc': ['Non-Standardized Food Allergenic Extract [EPC]',\n",
       "    'Non-Standardized Plant Allergenic Extract [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]',\n",
       "    'Dietary Proteins [CS]',\n",
       "    'Plant Proteins [CS]'],\n",
       "   'unii': ['8PI54V663Y']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '26d53255-d3e1-218b-e063-6394a90abe39',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240828',\n",
       "  'product_id': '72609-704_26d53255-d3e1-218b-e063-6394a90abe39',\n",
       "  'application_number': 'M016',\n",
       "  'brand_name_base': 'ECZEMA',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Grain Proteins [EXT]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]']},\n",
       " {'product_ndc': '72611-716',\n",
       "  'generic_name': 'Dexrazoxane for Injection',\n",
       "  'labeler_name': 'Almaject, Inc.',\n",
       "  'brand_name': 'Dexrazoxane',\n",
       "  'active_ingredients': [{'name': 'DEXRAZOXANE HYDROCHLORIDE',\n",
       "    'strength': '500 mg/50mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72611-716-01',\n",
       "    'description': '1 VIAL, SINGLE-DOSE in 1 CARTON (72611-716-01)  / 50 mL in 1 VIAL, SINGLE-DOSE',\n",
       "    'marketing_start_date': '20200901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Almaject, Inc.'],\n",
       "   'rxcui': ['1736590'],\n",
       "   'spl_set_id': ['e9550d22-6069-a6de-9968-6a18c9e0448f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['5346058Q7S']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION',\n",
       "  'spl_id': '1ebef6b9-09ec-6c27-51a9-42fcbe71b4e2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20200901',\n",
       "  'product_id': '72611-716_1ebef6b9-09ec-6c27-51a9-42fcbe71b4e2',\n",
       "  'application_number': 'ANDA207321',\n",
       "  'brand_name_base': 'Dexrazoxane',\n",
       "  'pharm_class': ['Cytoprotective Agent [EPC]']},\n",
       " {'product_ndc': '72611-757',\n",
       "  'marketing_end_date': '20250301',\n",
       "  'generic_name': 'rocuronium bromide',\n",
       "  'labeler_name': 'Almaject, Inc.',\n",
       "  'brand_name': 'Rocuronium Bromide',\n",
       "  'active_ingredients': [{'name': 'ROCURONIUM BROMIDE',\n",
       "    'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72611-757-10',\n",
       "    'description': '10 VIAL, MULTI-DOSE in 1 CARTON (72611-757-10)  / 10 mL in 1 VIAL, MULTI-DOSE (72611-757-01)',\n",
       "    'marketing_start_date': '20200327',\n",
       "    'marketing_end_date': '20250301',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Almaject, Inc.'],\n",
       "   'rxcui': ['1234995'],\n",
       "   'spl_set_id': ['a348f4bf-bf54-9a24-0e91-0fa44f8eb468'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['I65MW4OFHZ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'd03156e5-49f7-37b7-ab36-5a443d1c32f4',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20200327',\n",
       "  'product_id': '72611-757_d03156e5-49f7-37b7-ab36-5a443d1c32f4',\n",
       "  'application_number': 'ANDA205656',\n",
       "  'brand_name_base': 'Rocuronium Bromide',\n",
       "  'pharm_class': ['Neuromuscular Nondepolarizing Blockade [PE]',\n",
       "   'Nondepolarizing Neuromuscular Blocker [EPC]']},\n",
       " {'product_ndc': '72614-265',\n",
       "  'generic_name': 'LIDOCAINE HYDROCHLORIDE, MENTHOL',\n",
       "  'labeler_name': 'Hempagenix, LLC',\n",
       "  'brand_name': 'CANNA NUMB Roll On',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE HYDROCHLORIDE',\n",
       "    'strength': '40 mg/mL'},\n",
       "   {'name': 'MENTHOL', 'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72614-265-02',\n",
       "    'description': '73 mL in 1 CONTAINER (72614-265-02)',\n",
       "    'marketing_start_date': '20181001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Hempagenix, LLC'],\n",
       "   'spl_set_id': ['c1eb0348-3b0e-4f1c-a46b-1ff4aa165fb4'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['V13007Z41A', 'L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '0974736c-8d20-767b-e063-6294a90a5abe',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20181001',\n",
       "  'product_id': '72614-265_0974736c-8d20-767b-e063-6294a90a5abe',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'CANNA NUMB Roll On',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '0574-0792',\n",
       "  'marketing_end_date': '20260131',\n",
       "  'generic_name': 'pilocarpine hydrchloride',\n",
       "  'labeler_name': 'Padagis US LLC',\n",
       "  'brand_name': 'pilocarpine hydrchloride',\n",
       "  'active_ingredients': [{'name': 'PILOCARPINE HYDROCHLORIDE',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0574-0792-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0574-0792-01)',\n",
       "    'marketing_start_date': '20200824',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Padagis US LLC'],\n",
       "   'rxcui': ['1000913'],\n",
       "   'spl_set_id': ['8c546251-60ab-499c-a61c-1f678ed548eb'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['0WW6D218XJ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'ebab7d4d-d764-4477-b4e1-5b084dd56072',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200824',\n",
       "  'product_id': '0574-0792_ebab7d4d-d764-4477-b4e1-5b084dd56072',\n",
       "  'application_number': 'ANDA076746',\n",
       "  'brand_name_base': 'pilocarpine hydrchloride',\n",
       "  'pharm_class': ['Cholinergic Agonists [MoA]',\n",
       "   'Cholinergic Muscarinic Agonists [MoA]',\n",
       "   'Cholinergic Receptor Agonist [EPC]']},\n",
       " {'product_ndc': '72628-111',\n",
       "  'generic_name': 'Menthol',\n",
       "  'labeler_name': 'BOSTON NUTRACEUTICAL PRODUCTION, S.L',\n",
       "  'brand_name': 'Natural Herbal Cough Drops',\n",
       "  'active_ingredients': [{'name': 'MENTHOL', 'strength': '4.8 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72628-111-01',\n",
       "    'description': '50 PASTILLE in 1 BAG (72628-111-01)',\n",
       "    'marketing_start_date': '20210512',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['BOSTON NUTRACEUTICAL PRODUCTION, S.L'],\n",
       "   'rxcui': ['637119'],\n",
       "   'spl_set_id': ['c2340f56-9a8e-4eea-e053-2995a90a78fc'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'PASTILLE',\n",
       "  'spl_id': '23e649d7-c8ff-4d2b-e063-6394a90a638e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210512',\n",
       "  'product_id': '72628-111_23e649d7-c8ff-4d2b-e063-6394a90a638e',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'Natural Herbal Cough Drops'},\n",
       " {'product_ndc': '72647-330',\n",
       "  'generic_name': 'pyrimethamine',\n",
       "  'labeler_name': 'OAKRUM PHARMA, LLC',\n",
       "  'brand_name': 'Pyrimethamine',\n",
       "  'active_ingredients': [{'name': 'PYRIMETHAMINE', 'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72647-330-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE, PLASTIC (72647-330-01)',\n",
       "    'marketing_start_date': '20200313',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72647-330-03',\n",
       "    'description': '30 TABLET in 1 BOTTLE, PLASTIC (72647-330-03)',\n",
       "    'marketing_start_date': '20200313',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['OAKRUM PHARMA, LLC'],\n",
       "   'rxcui': ['198182'],\n",
       "   'spl_set_id': ['8ed8141b-e6c0-4a6b-8a08-2858c8c8bd4a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372647330018', '0372647330032'],\n",
       "   'nui': ['N0000175934', 'N0000000191'],\n",
       "   'pharm_class_epc': ['Dihydrofolate Reductase Inhibitor Antimalarial [EPC]'],\n",
       "   'pharm_class_moa': ['Dihydrofolate Reductase Inhibitors [MoA]'],\n",
       "   'unii': ['Z3614QOX8W']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'd61ffa19-149f-4402-884a-4d16becb80ba',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200313',\n",
       "  'product_id': '72647-330_d61ffa19-149f-4402-884a-4d16becb80ba',\n",
       "  'application_number': 'NDA008578',\n",
       "  'brand_name_base': 'Pyrimethamine',\n",
       "  'pharm_class': ['Dihydrofolate Reductase Inhibitor Antimalarial [EPC]',\n",
       "   'Dihydrofolate Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '72654-002',\n",
       "  'generic_name': 'LIDOCAINE, PHENYLEPHRINE',\n",
       "  'labeler_name': 'Ebanel Laboratories, Inc',\n",
       "  'brand_name': 'Hemorrhoid Master',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '40 mg/g'},\n",
       "   {'name': 'PHENYLEPHRINE', 'strength': '2.5 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72654-002-01',\n",
       "    'description': '45 g in 1 TUBE (72654-002-01)',\n",
       "    'marketing_start_date': '20191101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Ebanel Laboratories, Inc'],\n",
       "   'rxcui': ['2673304'],\n",
       "   'spl_set_id': ['41292d65-dabe-4bc3-872f-34a3912aa342'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175682',\n",
       "    'M0000897',\n",
       "    'N0000175426',\n",
       "    'N0000175976',\n",
       "    'N0000186105',\n",
       "    'N0000009917'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]',\n",
       "    'Antiarrhythmic [EPC]',\n",
       "    'alpha-1 Adrenergic Agonist [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'pharm_class_moa': ['Adrenergic alpha1-Agonists [MoA]'],\n",
       "   'unii': ['98PI200987', '1WS297W6MV']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': '0d77230e-fbf0-c95e-e063-6394a90ab484',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20191101',\n",
       "  'product_id': '72654-002_0d77230e-fbf0-c95e-e063-6394a90ab484',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Hemorrhoid Master',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72657-113',\n",
       "  'generic_name': 'Famotidine',\n",
       "  'labeler_name': 'GLENMARK THERAPEUTICS INC., USA',\n",
       "  'brand_name': 'Famotidine',\n",
       "  'active_ingredients': [{'name': 'FAMOTIDINE', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72657-113-20',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72657-113-20)  / 200 TABLET, FILM COATED in 1 BOTTLE',\n",
       "    'marketing_start_date': '20220601',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72657-113-88',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72657-113-88)  / 85 TABLET, FILM COATED in 1 BOTTLE',\n",
       "    'marketing_start_date': '20220601',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['GLENMARK THERAPEUTICS INC., USA'],\n",
       "   'rxcui': ['199047', '310273'],\n",
       "   'spl_set_id': ['95f51f27-d367-4cfd-a15f-7856c9e361fb'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372657112901', '0372657113885'],\n",
       "   'nui': ['N0000000151', 'N0000175784'],\n",
       "   'pharm_class_moa': ['Histamine H2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Histamine-2 Receptor Antagonist [EPC]'],\n",
       "   'unii': ['5QZO15J2Z8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'ee1f9ca9-3c23-4662-8194-68ec5ea7a6bd',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220601',\n",
       "  'product_id': '72657-113_ee1f9ca9-3c23-4662-8194-68ec5ea7a6bd',\n",
       "  'application_number': 'ANDA215822',\n",
       "  'brand_name_base': 'Famotidine',\n",
       "  'pharm_class': ['Histamine H2 Receptor Antagonists [MoA]',\n",
       "   'Histamine-2 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72657-168',\n",
       "  'generic_name': 'Olopatadine Hydrochloride ophthalmic',\n",
       "  'labeler_name': 'GLENMARK THERAPEUTICS INC., USA',\n",
       "  'brand_name': 'OLOPATADINE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'OLOPATADINE HYDROCHLORIDE',\n",
       "    'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72657-168-50',\n",
       "    'description': '1 BOTTLE, PLASTIC in 1 CARTON (72657-168-50)  / 5 mL in 1 BOTTLE, PLASTIC',\n",
       "    'marketing_start_date': '20240726',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['GLENMARK THERAPEUTICS INC., USA'],\n",
       "   'rxcui': ['1111339'],\n",
       "   'spl_set_id': ['a80c3fd2-47b7-4ed0-b862-9c5099684607'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372657168502'],\n",
       "   'unii': ['2XG66W44KF']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '0de466c5-7659-431b-b0a7-2d64ded8d341',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20240726',\n",
       "  'product_id': '72657-168_0de466c5-7659-431b-b0a7-2d64ded8d341',\n",
       "  'application_number': 'ANDA200810',\n",
       "  'brand_name_base': 'OLOPATADINE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Decreased Histamine Release [PE]',\n",
       "   'Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]',\n",
       "   'Histamine-1 Receptor Inhibitor [EPC]',\n",
       "   'Mast Cell Stabilizer [EPC]']},\n",
       " {'product_ndc': '0574-0850',\n",
       "  'marketing_end_date': '20250131',\n",
       "  'generic_name': 'Dihydroergotamine Mesylate',\n",
       "  'labeler_name': 'Padagis US LLC',\n",
       "  'brand_name': 'Dihydroergotamine Mesylate',\n",
       "  'active_ingredients': [{'name': 'DIHYDROERGOTAMINE MESYLATE',\n",
       "    'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0574-0850-05',\n",
       "    'description': '5 AMPULE in 1 CARTON (0574-0850-05)  / 1 mL in 1 AMPULE',\n",
       "    'marketing_start_date': '20030429',\n",
       "    'marketing_end_date': '20250131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0574-0850-10',\n",
       "    'description': '10 AMPULE in 1 CARTON (0574-0850-10)  / 1 mL in 1 AMPULE',\n",
       "    'marketing_start_date': '20030429',\n",
       "    'marketing_end_date': '20250131',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Padagis US LLC'],\n",
       "   'rxcui': ['861672'],\n",
       "   'spl_set_id': ['111f628a-7e1e-4d47-8ac1-f898cbfc9b74'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['81AXN7R2QT']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '2736e2a6-160d-4282-bed0-cf21b7b542a0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20030429',\n",
       "  'product_id': '0574-0850_2736e2a6-160d-4282-bed0-cf21b7b542a0',\n",
       "  'application_number': 'ANDA040475',\n",
       "  'brand_name_base': 'Dihydroergotamine Mesylate',\n",
       "  'pharm_class': ['Ergotamine Derivative [EPC]', 'Ergotamines [CS]']},\n",
       " {'product_ndc': '72663-561',\n",
       "  'generic_name': 'bacitracin zinc, neomycin sulfate, polymyxin b sulfate',\n",
       "  'labeler_name': 'Welly Health PBC',\n",
       "  'brand_name': 'Welly Bravery Balm',\n",
       "  'active_ingredients': [{'name': 'BACITRACIN ZINC', 'strength': '400 [iU]/g'},\n",
       "   {'name': 'NEOMYCIN SULFATE', 'strength': '3.5 mg/g'},\n",
       "   {'name': 'POLYMYXIN B SULFATE', 'strength': '5000 [iU]/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72663-561-12',\n",
       "    'description': '12 POUCH in 1 BOX (72663-561-12)  / .5 g in 1 POUCH (72663-561-34)',\n",
       "    'marketing_start_date': '20190906',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Welly Health PBC'],\n",
       "   'rxcui': ['204602'],\n",
       "   'spl_set_id': ['619f858b-23fd-4bca-9077-5ecc04a1e350'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372663000001'],\n",
       "   'unii': ['89Y4M234ES', '057Y626693', '19371312D4']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': 'd477bcd9-0c60-a423-e053-2a95a90ac022',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190906',\n",
       "  'product_id': '72663-561_d477bcd9-0c60-a423-e053-2a95a90ac022',\n",
       "  'application_number': 'part333B',\n",
       "  'brand_name_base': 'Welly Bravery Balm',\n",
       "  'pharm_class': ['Aminoglycoside Antibacterial [EPC]',\n",
       "   'Aminoglycosides [CS]',\n",
       "   'Decreased Cell Wall Synthesis & Repair [PE]',\n",
       "   'Polymyxin-class Antibacterial [EPC]',\n",
       "   'Polymyxins [CS]']},\n",
       " {'product_ndc': '72664-229',\n",
       "  'generic_name': 'Dofetilide',\n",
       "  'labeler_name': 'VGYAAN Pharmaceuticals LLC',\n",
       "  'brand_name': 'Dofetilide',\n",
       "  'active_ingredients': [{'name': 'DOFETILIDE', 'strength': '.125 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72664-229-60',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (72664-229-60)',\n",
       "    'marketing_start_date': '20210731',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['VGYAAN Pharmaceuticals LLC'],\n",
       "   'rxcui': ['310003', '310004', '310005'],\n",
       "   'spl_set_id': ['9bea7ddd-681c-4be5-8cf4-2e2df462745a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372664229609', '0372664230605', '0372664231602'],\n",
       "   'nui': ['N0000175426'],\n",
       "   'pharm_class_epc': ['Antiarrhythmic [EPC]'],\n",
       "   'unii': ['R4Z9X1N2ND']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '06f10c20-8274-cef9-e063-6294a90aed71',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210731',\n",
       "  'product_id': '72664-229_06f10c20-8274-cef9-e063-6294a90aed71',\n",
       "  'application_number': 'ANDA215323',\n",
       "  'brand_name_base': 'Dofetilide',\n",
       "  'pharm_class': ['Antiarrhythmic [EPC]']},\n",
       " {'product_ndc': '72664-231',\n",
       "  'generic_name': 'Dofetilide',\n",
       "  'labeler_name': 'VGYAAN Pharmaceuticals LLC',\n",
       "  'brand_name': 'Dofetilide',\n",
       "  'active_ingredients': [{'name': 'DOFETILIDE', 'strength': '.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72664-231-60',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (72664-231-60)',\n",
       "    'marketing_start_date': '20210731',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['VGYAAN Pharmaceuticals LLC'],\n",
       "   'rxcui': ['310003', '310004', '310005'],\n",
       "   'spl_set_id': ['9bea7ddd-681c-4be5-8cf4-2e2df462745a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372664229609', '0372664230605', '0372664231602'],\n",
       "   'nui': ['N0000175426'],\n",
       "   'pharm_class_epc': ['Antiarrhythmic [EPC]'],\n",
       "   'unii': ['R4Z9X1N2ND']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '06f10c20-8274-cef9-e063-6294a90aed71',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210731',\n",
       "  'product_id': '72664-231_06f10c20-8274-cef9-e063-6294a90aed71',\n",
       "  'application_number': 'ANDA215323',\n",
       "  'brand_name_base': 'Dofetilide',\n",
       "  'pharm_class': ['Antiarrhythmic [EPC]']},\n",
       " {'product_ndc': '72667-062',\n",
       "  'generic_name': 'Zinc Oxide, Titanium Dioxide',\n",
       "  'labeler_name': 'Inspec Solutions LLC.',\n",
       "  'brand_name': 'Hawaiian Blend Sensitive Zinc SPF 50',\n",
       "  'active_ingredients': [{'name': 'TITANIUM DIOXIDE', 'strength': '4 g/100g'},\n",
       "   {'name': 'ZINC OXIDE', 'strength': '19.5 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72667-062-01',\n",
       "    'description': '142 g in 1 CAN (72667-062-01)',\n",
       "    'marketing_start_date': '20230103',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Inspec Solutions LLC.'],\n",
       "   'spl_set_id': ['f161c0df-479a-63ed-e053-2995a90a59e8'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['15FIX9V2JP', 'SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'AEROSOL',\n",
       "  'spl_id': 'f161c099-7e1b-56b7-e053-2995a90ae1d0',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230103',\n",
       "  'product_id': '72667-062_f161c099-7e1b-56b7-e053-2995a90ae1d0',\n",
       "  'application_number': 'part352',\n",
       "  'brand_name_base': 'Hawaiian Blend Sensitive Zinc SPF 50'},\n",
       " {'product_ndc': '72667-072',\n",
       "  'generic_name': 'Lidocaine',\n",
       "  'labeler_name': 'Inspec Solutions',\n",
       "  'brand_name': 'MyDerm Medical 5 Lidocaine Numbing Roll-On',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '5 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72667-072-01',\n",
       "    'description': '89 g in 1 BOTTLE, PLASTIC (72667-072-01)',\n",
       "    'marketing_start_date': '20240306',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Inspec Solutions'],\n",
       "   'spl_set_id': ['12ff170d-ce16-083a-e063-6394a90a4120'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0685757118743'],\n",
       "   'nui': ['N0000175682', 'M0000897', 'N0000175426', 'N0000175976'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]', 'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'unii': ['98PI200987']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'STICK',\n",
       "  'spl_id': '1ba1a028-c249-22c5-e063-6394a90ac2ae',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240306',\n",
       "  'product_id': '72667-072_1ba1a028-c249-22c5-e063-6394a90ac2ae',\n",
       "  'application_number': 'M015',\n",
       "  'brand_name_base': 'MyDerm Medical 5 Lidocaine Numbing Roll-On',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '0002-8222',\n",
       "  'generic_name': 'Insulin lispro',\n",
       "  'labeler_name': 'Eli Lilly and Company',\n",
       "  'brand_name': 'Insulin Lispro KwikPen',\n",
       "  'brand_name_suffix': 'KwikPen',\n",
       "  'active_ingredients': [{'name': 'INSULIN LISPRO',\n",
       "    'strength': '100 [iU]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0002-8222-59',\n",
       "    'description': '5 SYRINGE in 1 CARTON (0002-8222-59)  / 3 mL in 1 SYRINGE (0002-8222-01)',\n",
       "    'marketing_start_date': '20200212',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Eli Lilly and Company'],\n",
       "   'spl_set_id': ['97d5e596-aae1-42c9-ae89-c3780959c467'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000004931', 'N0000175453'],\n",
       "   'pharm_class_cs': ['Insulin [Chemical/Ingredient]'],\n",
       "   'pharm_class_epc': ['Insulin Analog [EPC]'],\n",
       "   'unii': ['GFX7QIS1II']},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'eda411c4-c836-4f58-85de-ad1aa165e92a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS', 'SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20200212',\n",
       "  'product_id': '0002-8222_eda411c4-c836-4f58-85de-ad1aa165e92a',\n",
       "  'application_number': 'BLA020563',\n",
       "  'brand_name_base': 'Insulin Lispro',\n",
       "  'pharm_class': ['Insulin Analog [EPC]', 'Insulin [Chemical/Ingredient]']},\n",
       " {'product_ndc': '0067-0129',\n",
       "  'generic_name': 'Simethicone',\n",
       "  'labeler_name': 'Haleon US Holdings LLC',\n",
       "  'brand_name': 'Gas-X Extra Strength',\n",
       "  'brand_name_suffix': 'Extra Strength',\n",
       "  'active_ingredients': [{'name': 'DIMETHICONE', 'strength': '125 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0067-0129-18',\n",
       "    'description': '2 BLISTER PACK in 1 CARTON (0067-0129-18)  / 9 TABLET, CHEWABLE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20121201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0067-0129-27',\n",
       "    'description': '3 BLISTER PACK in 1 CARTON (0067-0129-27)  / 9 TABLET, CHEWABLE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20121201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0067-0129-48',\n",
       "    'description': '4 BLISTER PACK in 1 CARTON (0067-0129-48)  / 12 TABLET, CHEWABLE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20121201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Haleon US Holdings LLC'],\n",
       "   'rxcui': ['210295', '314221'],\n",
       "   'spl_set_id': ['f553374b-c20e-4c92-a8c0-cef0aeda8d1c'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000010282'],\n",
       "   'pharm_class_pe': ['Skin Barrier Activity [PE]'],\n",
       "   'unii': ['92RU3N3Y1O']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, CHEWABLE',\n",
       "  'spl_id': '155a5f50-4f74-5939-e063-6394a90abc52',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20120101',\n",
       "  'product_id': '0067-0129_155a5f50-4f74-5939-e063-6394a90abc52',\n",
       "  'application_number': 'M002',\n",
       "  'brand_name_base': 'Gas-X',\n",
       "  'pharm_class': ['Skin Barrier Activity [PE]']},\n",
       " {'product_ndc': '72698-711',\n",
       "  'generic_name': 'Pyrithione Zinc',\n",
       "  'labeler_name': 'AOS GROUP INC, THE',\n",
       "  'brand_name': 'Art of Sport Anti Dandruff Victory',\n",
       "  'active_ingredients': [{'name': 'PYRITHIONE ZINC', 'strength': '100 g/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72698-711-11',\n",
       "    'description': '400 mL in 1 BOTTLE, PLASTIC (72698-711-11)',\n",
       "    'marketing_start_date': '20191212',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['AOS GROUP INC, THE'],\n",
       "   'spl_set_id': ['994f13dd-da52-13cf-e053-2995a90a6a9f'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0855502008760'],\n",
       "   'unii': ['R953O2RHZ5']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'SHAMPOO',\n",
       "  'spl_id': 'f3811a9b-ebc1-4bb8-e053-2a95a90a8f38',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20191212',\n",
       "  'product_id': '72698-711_f3811a9b-ebc1-4bb8-e053-2a95a90a8f38',\n",
       "  'application_number': 'part358H',\n",
       "  'brand_name_base': 'Art of Sport Anti Dandruff Victory'},\n",
       " {'product_ndc': '72701-105',\n",
       "  'generic_name': 'Glycerin',\n",
       "  'labeler_name': 'Bliss GVS Pharma Limited',\n",
       "  'brand_name': 'Bliss GVS Children',\n",
       "  'brand_name_suffix': 'Children',\n",
       "  'active_ingredients': [{'name': 'GLYCERIN', 'strength': '1.2 g/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72701-105-12',\n",
       "    'description': '2 BLISTER PACK in 1 CARTON (72701-105-12)  / 6 SUPPOSITORY in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20200120',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72701-105-25',\n",
       "    'description': '5 BLISTER PACK in 1 CARTON (72701-105-25)  / 5 SUPPOSITORY in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20200120',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bliss GVS Pharma Limited'],\n",
       "   'rxcui': ['421299'],\n",
       "   'spl_set_id': ['03237ed2-265f-4acd-b504-d82b9263287c'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185370',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'N0000185001',\n",
       "    'M0000728',\n",
       "    'M0009417'],\n",
       "   'pharm_class_epc': ['Non-Standardized Chemical Allergen [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]',\n",
       "    'Increased IgG Production [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]', 'Glycerol [CS]'],\n",
       "   'unii': ['PDC6A3C0OX']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SUPPOSITORY',\n",
       "  'spl_id': '24aa2d9b-97e2-780c-e063-6394a90aa591',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['RECTAL'],\n",
       "  'marketing_start_date': '20200120',\n",
       "  'product_id': '72701-105_24aa2d9b-97e2-780c-e063-6394a90aa591',\n",
       "  'application_number': 'M007',\n",
       "  'brand_name_base': 'Bliss GVS',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Glycerol [CS]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Increased IgG Production [PE]',\n",
       "   'Non-Standardized Chemical Allergen [EPC]']},\n",
       " {'product_ndc': '72705-251',\n",
       "  'generic_name': 'Witch Hazel',\n",
       "  'labeler_name': 'Fridababy, LLC',\n",
       "  'brand_name': 'frida mom Labor and Delivery Plus Postpartum Recovery',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72705-251-02',\n",
       "    'description': '1 KIT in 1 CARTON (72705-251-02)  *  24 CLOTH in 1 POUCH (72705-100-01)  *  141.75 g in 1 BOTTLE, PUMP (72705-150-01)',\n",
       "    'marketing_start_date': '20190501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Fridababy, LLC'],\n",
       "   'rxcui': ['844379', '2166922'],\n",
       "   'spl_set_id': ['4b5fc312-4c8c-4396-a70c-b1ed129038c7'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': '6eb56d87-2690-469c-8901-89030fed550f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'marketing_start_date': '20190501',\n",
       "  'product_id': '72705-251_6eb56d87-2690-469c-8901-89030fed550f',\n",
       "  'application_number': 'part346',\n",
       "  'brand_name_base': 'frida mom Labor and Delivery Plus Postpartum Recovery'},\n",
       " {'product_ndc': '72722-104',\n",
       "  'generic_name': 'zolpidem tartrate',\n",
       "  'labeler_name': 'The ACME Laboratories Ltd.',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'ZOLPIDEM TARTRATE',\n",
       "  'active_ingredients': [{'name': 'ZOLPIDEM TARTRATE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72722-104-01',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72722-104-01)',\n",
       "    'marketing_start_date': '20241130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72722-104-05',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72722-104-05)',\n",
       "    'marketing_start_date': '20241130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72722-104-07',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (72722-104-07)',\n",
       "    'marketing_start_date': '20241130',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['The ACME Laboratories Ltd.'],\n",
       "   'rxcui': ['854873', '854876'],\n",
       "   'spl_set_id': ['5679ed64-8424-4e63-a3c9-91d80fff2ca6'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372722103070', '0372722104077'],\n",
       "   'unii': ['WY6W63843K']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'e49e41d7-0f51-464f-8e31-2fb446e5f1e8',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200924',\n",
       "  'product_id': '72722-104_e49e41d7-0f51-464f-8e31-2fb446e5f1e8',\n",
       "  'application_number': 'ANDA077214',\n",
       "  'brand_name_base': 'ZOLPIDEM TARTRATE',\n",
       "  'pharm_class': ['Central Nervous System Depression [PE]',\n",
       "   'GABA A Receptor Positive Modulators [MoA]',\n",
       "   'gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]']},\n",
       " {'product_ndc': '72727-0001',\n",
       "  'generic_name': 'ISOPROPYL ALCOHOL',\n",
       "  'labeler_name': 'Global Biomedical Technologies, LLC',\n",
       "  'brand_name': 'Alcohol Prep Pad-Large',\n",
       "  'active_ingredients': [{'name': 'ISOPROPYL ALCOHOL',\n",
       "    'strength': '.7 mL/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72727-0001-2',\n",
       "    'description': '20 POUCH in 1 BOX (72727-0001-2)  / .4 mL in 1 POUCH',\n",
       "    'marketing_start_date': '20190320',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Global Biomedical Technologies, LLC'],\n",
       "   'rxcui': ['797544'],\n",
       "   'spl_set_id': ['93d00515-e93f-48a3-b66b-7d933e734e54'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['ND2M416302']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'SWAB',\n",
       "  'spl_id': '9ca2ecd8-3b80-439e-949f-dd20d42a2886',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190320',\n",
       "  'product_id': '72727-0001_9ca2ecd8-3b80-439e-949f-dd20d42a2886',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'Alcohol Prep Pad-Large'},\n",
       " {'product_ndc': '72766-019',\n",
       "  'generic_name': 'Antiseptic Wipe',\n",
       "  'labeler_name': 'Yangzhou Suxiang Medical Instrument Co., Ltd.',\n",
       "  'brand_name': 'Everlit Survival Antiseptic Wipe',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '1.22 g/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72766-019-01',\n",
       "    'description': '1 CLOTH in 1 BAG (72766-019-01)',\n",
       "    'marketing_start_date': '20230929',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Yangzhou Suxiang Medical Instrument Co., Ltd.'],\n",
       "   'rxcui': ['1038558'],\n",
       "   'spl_set_id': ['056f6d12-d371-4c0e-e063-6394a90a8666'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'CLOTH',\n",
       "  'spl_id': '0570529f-e11c-a54c-e063-6394a90a0b36',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230929',\n",
       "  'product_id': '72766-019_0570529f-e11c-a54c-e063-6394a90a0b36',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'Everlit Survival Antiseptic Wipe'},\n",
       " {'product_ndc': '72789-018',\n",
       "  'generic_name': 'Sulfamethoxazole and Trimethoprim',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Sulfamethoxazole and Trimethoprim',\n",
       "  'active_ingredients': [{'name': 'SULFAMETHOXAZOLE', 'strength': '800 mg/1'},\n",
       "   {'name': 'TRIMETHOPRIM', 'strength': '160 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-018-02',\n",
       "    'description': '2 TABLET in 1 BOTTLE, PLASTIC (72789-018-02)',\n",
       "    'marketing_start_date': '20200410',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-018-04',\n",
       "    'description': '4 TABLET in 1 BOTTLE, PLASTIC (72789-018-04)',\n",
       "    'marketing_start_date': '20200226',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-018-06',\n",
       "    'description': '6 TABLET in 1 BOTTLE, PLASTIC (72789-018-06)',\n",
       "    'marketing_start_date': '20191017',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-018-10',\n",
       "    'description': '10 TABLET in 1 BOTTLE, PLASTIC (72789-018-10)',\n",
       "    'marketing_start_date': '20191029',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-018-14',\n",
       "    'description': '14 TABLET in 1 BOTTLE, PLASTIC (72789-018-14)',\n",
       "    'marketing_start_date': '20191101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-018-20',\n",
       "    'description': '20 TABLET in 1 BOTTLE, PLASTIC (72789-018-20)',\n",
       "    'marketing_start_date': '20191017',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-018-28',\n",
       "    'description': '28 TABLET in 1 BOTTLE, PLASTIC (72789-018-28)',\n",
       "    'marketing_start_date': '20200213',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-018-40',\n",
       "    'description': '40 TABLET in 1 BOTTLE, PLASTIC (72789-018-40)',\n",
       "    'marketing_start_date': '20191122',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-018-60',\n",
       "    'description': '60 TABLET in 1 BOTTLE, PLASTIC (72789-018-60)',\n",
       "    'marketing_start_date': '20191017',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['198335'],\n",
       "   'spl_set_id': ['3ef62512-0dc3-4821-9b60-6b375841c4c0'],\n",
       "   'upc': ['0372789018065'],\n",
       "   'nui': ['N0000175504',\n",
       "    'M0020790',\n",
       "    'N0000185504',\n",
       "    'N0000175489',\n",
       "    'N0000000191',\n",
       "    'N0000187062',\n",
       "    'N0000187061'],\n",
       "   'pharm_class_epc': ['Sulfonamide Antimicrobial [EPC]',\n",
       "    'Dihydrofolate Reductase Inhibitor Antibacterial [EPC]'],\n",
       "   'pharm_class_cs': ['Sulfonamides [CS]'],\n",
       "   'pharm_class_moa': ['Cytochrome P450 2C9 Inhibitors [MoA]',\n",
       "    'Dihydrofolate Reductase Inhibitors [MoA]',\n",
       "    'Cytochrome P450 2C8 Inhibitors [MoA]',\n",
       "    'Organic Cation Transporter 2 Inhibitors [MoA]'],\n",
       "   'unii': ['JE42381TNV', 'AN164J8Y0X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '20ae7cb4-d11a-0901-e063-6394a90aa7fc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20100216',\n",
       "  'product_id': '72789-018_20ae7cb4-d11a-0901-e063-6394a90aa7fc',\n",
       "  'application_number': 'ANDA090624',\n",
       "  'brand_name_base': 'Sulfamethoxazole and Trimethoprim',\n",
       "  'pharm_class': ['Cytochrome P450 2C8 Inhibitors [MoA]',\n",
       "   'Cytochrome P450 2C9 Inhibitors [MoA]',\n",
       "   'Dihydrofolate Reductase Inhibitor Antibacterial [EPC]',\n",
       "   'Dihydrofolate Reductase Inhibitors [MoA]',\n",
       "   'Organic Cation Transporter 2 Inhibitors [MoA]',\n",
       "   'Sulfonamide Antimicrobial [EPC]',\n",
       "   'Sulfonamides [CS]']},\n",
       " {'product_ndc': '72789-025',\n",
       "  'generic_name': 'BENZONATATE',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'BENZONATATE',\n",
       "  'active_ingredients': [{'name': 'BENZONATATE', 'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-025-21',\n",
       "    'description': '21 CAPSULE in 1 BOTTLE, PLASTIC (72789-025-21)',\n",
       "    'marketing_start_date': '20191104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-025-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE, PLASTIC (72789-025-30)',\n",
       "    'marketing_start_date': '20191104',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['283417'],\n",
       "   'spl_set_id': ['5c4fdf0d-b4d1-481c-8b4d-9ccf5b65421f'],\n",
       "   'nui': ['N0000009010', 'N0000175796'],\n",
       "   'pharm_class_pe': ['Decreased Tracheobronchial Stretch Receptor Activity [PE]'],\n",
       "   'pharm_class_epc': ['Non-narcotic Antitussive [EPC]'],\n",
       "   'unii': ['5P4DHS6ENR']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '23f8d4a5-acb2-f02d-e063-6294a90a9d35',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180501',\n",
       "  'product_id': '72789-025_23f8d4a5-acb2-f02d-e063-6294a90a9d35',\n",
       "  'application_number': 'ANDA040682',\n",
       "  'brand_name_base': 'BENZONATATE',\n",
       "  'pharm_class': ['Decreased Tracheobronchial Stretch Receptor Activity [PE]',\n",
       "   'Non-narcotic Antitussive [EPC]']},\n",
       " {'product_ndc': '72789-034',\n",
       "  'generic_name': 'Ondansetron Hydrochloride',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Ondansetron Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'ONDANSETRON HYDROCHLORIDE',\n",
       "    'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-034-12',\n",
       "    'description': '12 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-034-12)',\n",
       "    'marketing_start_date': '20191202',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['198052'],\n",
       "   'spl_set_id': ['426ba54f-199a-41d1-8c27-f827bea56854'],\n",
       "   'upc': ['0372789034126'],\n",
       "   'unii': ['NMH84OZK2B']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '0fb4a94b-f10d-f273-e063-6394a90a375e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20070731',\n",
       "  'product_id': '72789-034_0fb4a94b-f10d-f273-e063-6394a90a375e',\n",
       "  'application_number': 'ANDA078539',\n",
       "  'brand_name_base': 'Ondansetron Hydrochloride',\n",
       "  'pharm_class': ['Serotonin 3 Receptor Antagonists [MoA]',\n",
       "   'Serotonin-3 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72789-066',\n",
       "  'generic_name': 'Azithromycin Dihydrate',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Azithromycin Dihydrate',\n",
       "  'active_ingredients': [{'name': 'AZITHROMYCIN DIHYDRATE',\n",
       "    'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-066-02',\n",
       "    'description': '2 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-066-02)',\n",
       "    'marketing_start_date': '20200323',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-066-03',\n",
       "    'description': '3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-066-03)',\n",
       "    'marketing_start_date': '20200420',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-066-07',\n",
       "    'description': '7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-066-07)',\n",
       "    'marketing_start_date': '20190701',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-066-79',\n",
       "    'description': '1 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-066-79)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['248656'],\n",
       "   'spl_set_id': ['d07bb450-f0ac-4faa-8289-9d4e45bb0a88'],\n",
       "   'upc': ['0372789066028'],\n",
       "   'unii': ['5FD1131I7S']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '23fb87c3-e8fb-6680-e063-6294a90a3784',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190701',\n",
       "  'product_id': '72789-066_23fb87c3-e8fb-6680-e063-6294a90a3784',\n",
       "  'application_number': 'ANDA208249',\n",
       "  'brand_name_base': 'Azithromycin Dihydrate',\n",
       "  'pharm_class': ['Macrolide Antimicrobial [EPC]', 'Macrolides [CS]']},\n",
       " {'product_ndc': '72789-079',\n",
       "  'generic_name': 'Trazodone Hydrochloride',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Trazodone Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'TRAZODONE HYDROCHLORIDE',\n",
       "    'strength': '150 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-079-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE, PLASTIC (72789-079-30)',\n",
       "    'marketing_start_date': '20200406',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['856364'],\n",
       "   'spl_set_id': ['9b022ae9-dd52-43ae-804b-ddf8e7cfd530'],\n",
       "   'upc': ['0372789079301'],\n",
       "   'unii': ['6E8ZO8LRNM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '23fbb99c-2eda-9828-e063-6294a90a7f63',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200311',\n",
       "  'product_id': '72789-079_23fbb99c-2eda-9828-e063-6294a90a7f63',\n",
       "  'application_number': 'ANDA071525',\n",
       "  'brand_name_base': 'Trazodone Hydrochloride',\n",
       "  'pharm_class': ['Serotonin Reuptake Inhibitor [EPC]']},\n",
       " {'product_ndc': '72789-093',\n",
       "  'generic_name': 'Lisinopril',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Lisinopril',\n",
       "  'active_ingredients': [{'name': 'LISINOPRIL', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-093-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE, PLASTIC (72789-093-30)',\n",
       "    'marketing_start_date': '20200623',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-093-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE, PLASTIC (72789-093-90)',\n",
       "    'marketing_start_date': '20200619',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['314077'],\n",
       "   'spl_set_id': ['9470b102-3c81-469a-a4c5-6816d9d39b07'],\n",
       "   'unii': ['E7199S1YWR']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '1d7637b1-72b5-82be-e063-6394a90a6314',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170512',\n",
       "  'product_id': '72789-093_1d7637b1-72b5-82be-e063-6394a90a6314',\n",
       "  'application_number': 'ANDA077321',\n",
       "  'brand_name_base': 'Lisinopril',\n",
       "  'pharm_class': ['Angiotensin Converting Enzyme Inhibitor [EPC]',\n",
       "   'Angiotensin-converting Enzyme Inhibitors [MoA]']},\n",
       " {'product_ndc': '72789-153',\n",
       "  'generic_name': 'Atorvastatin calcium',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Atorvastatin calcium',\n",
       "  'active_ingredients': [{'name': 'ATORVASTATIN CALCIUM TRIHYDRATE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-153-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-153-30)',\n",
       "    'marketing_start_date': '20200201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['617312'],\n",
       "   'spl_set_id': ['4509aa67-06d4-41d1-80b6-c9bd8ad0bf07'],\n",
       "   'upc': ['0372789153308'],\n",
       "   'unii': ['48A5M73Z4Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '1d7656b4-b2a5-e4f7-e063-6394a90ab933',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190208',\n",
       "  'product_id': '72789-153_1d7656b4-b2a5-e4f7-e063-6394a90ab933',\n",
       "  'application_number': 'ANDA211933',\n",
       "  'brand_name_base': 'Atorvastatin calcium',\n",
       "  'pharm_class': ['HMG-CoA Reductase Inhibitor [EPC]',\n",
       "   'Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]']},\n",
       " {'product_ndc': '72789-205',\n",
       "  'generic_name': 'Ursodiol',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Ursodiol',\n",
       "  'active_ingredients': [{'name': 'URSODIOL', 'strength': '300 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-205-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE, PLASTIC (72789-205-01)',\n",
       "    'marketing_start_date': '20211011',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['858747'],\n",
       "   'spl_set_id': ['1276283e-21b0-4932-864f-547c62bd49e5'],\n",
       "   'upc': ['0372789205014'],\n",
       "   'nui': ['N0000175802', 'M0002475'],\n",
       "   'pharm_class_epc': ['Bile Acid [EPC]'],\n",
       "   'pharm_class_cs': ['Bile Acids and Salts [CS]'],\n",
       "   'unii': ['724L30Y2QR']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '1184ed0c-3943-8d1a-e063-6294a90a72c5',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200205',\n",
       "  'product_id': '72789-205_1184ed0c-3943-8d1a-e063-6294a90a72c5',\n",
       "  'application_number': 'ANDA212452',\n",
       "  'brand_name_base': 'Ursodiol',\n",
       "  'pharm_class': ['Bile Acid [EPC]', 'Bile Acids and Salts [CS]']},\n",
       " {'product_ndc': '0574-7093',\n",
       "  'generic_name': 'HYDROCORTISONE ACETATE',\n",
       "  'labeler_name': 'Padagis US LLC',\n",
       "  'brand_name': 'Hydrocortisone Acetate',\n",
       "  'active_ingredients': [{'name': 'HYDROCORTISONE ACETATE',\n",
       "    'strength': '30 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0574-7093-12',\n",
       "    'description': '12 PACKET in 1 BOX (0574-7093-12)  / 1 SUPPOSITORY in 1 PACKET',\n",
       "    'marketing_start_date': '19900701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Padagis US LLC'],\n",
       "   'spl_set_id': ['2fdb9940-6da8-49b0-a236-9817943f7a4b'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3X7931PO74']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'SUPPOSITORY',\n",
       "  'spl_id': '5ae35aec-6ba9-48b8-8b5f-c1b5accb9e1c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['RECTAL'],\n",
       "  'marketing_start_date': '19900701',\n",
       "  'product_id': '0574-7093_5ae35aec-6ba9-48b8-8b5f-c1b5accb9e1c',\n",
       "  'brand_name_base': 'Hydrocortisone Acetate',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '72789-212',\n",
       "  'generic_name': 'Ibuprofen',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Ibuprofen',\n",
       "  'active_ingredients': [{'name': 'IBUPROFEN', 'strength': '600 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-212-06',\n",
       "    'description': '6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-212-06)',\n",
       "    'marketing_start_date': '20220802',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-212-10',\n",
       "    'description': '10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-212-10)',\n",
       "    'marketing_start_date': '20220802',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-212-15',\n",
       "    'description': '15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-212-15)',\n",
       "    'marketing_start_date': '20211027',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-212-20',\n",
       "    'description': '20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-212-20)',\n",
       "    'marketing_start_date': '20211119',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-212-21',\n",
       "    'description': '21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-212-21)',\n",
       "    'marketing_start_date': '20200821',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-212-24',\n",
       "    'description': '24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-212-24)',\n",
       "    'marketing_start_date': '20211026',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-212-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-212-30)',\n",
       "    'marketing_start_date': '20211019',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-212-40',\n",
       "    'description': '40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-212-40)',\n",
       "    'marketing_start_date': '20220103',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-212-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-212-90)',\n",
       "    'marketing_start_date': '20211025',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['197806'],\n",
       "   'spl_set_id': ['09621787-9a5c-4abf-9ccd-d6f8d581738f'],\n",
       "   'upc': ['0372789212159'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['WK2XYI10QM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '240f3088-c30b-1698-e063-6394a90a43d2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200821',\n",
       "  'product_id': '72789-212_240f3088-c30b-1698-e063-6394a90a43d2',\n",
       "  'application_number': 'ANDA078329',\n",
       "  'brand_name_base': 'Ibuprofen',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72789-219',\n",
       "  'generic_name': 'Nifedipine',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Nifedipine',\n",
       "  'active_ingredients': [{'name': 'NIFEDIPINE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-219-08',\n",
       "    'description': '8 CAPSULE in 1 BOTTLE, PLASTIC (72789-219-08)',\n",
       "    'marketing_start_date': '20211215',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['198032'],\n",
       "   'spl_set_id': ['51cdb22b-035f-47d7-8048-38006e2589f2'],\n",
       "   'upc': ['0372789219080'],\n",
       "   'nui': ['N0000000069', 'N0000175421', 'M0006414'],\n",
       "   'pharm_class_moa': ['Calcium Channel Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Dihydropyridine Calcium Channel Blocker [EPC]'],\n",
       "   'pharm_class_cs': ['Dihydropyridines [CS]'],\n",
       "   'unii': ['I9ZF7L6G2L']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '11855dad-b858-cd60-e063-6294a90a88f8',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20101207',\n",
       "  'product_id': '72789-219_11855dad-b858-cd60-e063-6294a90a88f8',\n",
       "  'application_number': 'ANDA202644',\n",
       "  'brand_name_base': 'Nifedipine',\n",
       "  'pharm_class': ['Calcium Channel Antagonists [MoA]',\n",
       "   'Dihydropyridine Calcium Channel Blocker [EPC]',\n",
       "   'Dihydropyridines [CS]']},\n",
       " {'product_ndc': '72789-220',\n",
       "  'generic_name': 'Doxepin Hydrochloride',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Doxepin Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'DOXEPIN HYDROCHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-220-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE, PLASTIC (72789-220-30)',\n",
       "    'marketing_start_date': '20211222',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-220-90',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE, PLASTIC (72789-220-90)',\n",
       "    'marketing_start_date': '20240906',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['1000048'],\n",
       "   'spl_set_id': ['2bf7d838-6274-4d8a-91cb-b27e1e81d273'],\n",
       "   'upc': ['0372789220307'],\n",
       "   'unii': ['3U9A0FE9N5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '2175b1dc-50fe-b463-e063-6294a90af172',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190327',\n",
       "  'product_id': '72789-220_2175b1dc-50fe-b463-e063-6294a90af172',\n",
       "  'application_number': 'ANDA211603',\n",
       "  'brand_name_base': 'Doxepin Hydrochloride',\n",
       "  'pharm_class': ['Tricyclic Antidepressant [EPC]']},\n",
       " {'product_ndc': '72789-223',\n",
       "  'generic_name': 'Penicillin V Potassium',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Penicillin V Potassium',\n",
       "  'active_ingredients': [{'name': 'PENICILLIN V POTASSIUM',\n",
       "    'strength': '250 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-223-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-223-01)',\n",
       "    'marketing_start_date': '20220211',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['834061', '834102'],\n",
       "   'spl_set_id': ['7aef4c8b-aee7-453d-bb6f-fce8e4588e3b'],\n",
       "   'upc': ['0372789222011', '0372789223018'],\n",
       "   'unii': ['146T0TU1JB']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '273776ce-aa82-2c24-e063-6394a90ab3c9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20131011',\n",
       "  'product_id': '72789-223_273776ce-aa82-2c24-e063-6394a90ab3c9',\n",
       "  'application_number': 'ANDA090549',\n",
       "  'brand_name_base': 'Penicillin V Potassium',\n",
       "  'pharm_class': ['Penicillin-class Antibacterial [EPC]', 'Penicillins [CS]']},\n",
       " {'product_ndc': '0574-7112',\n",
       "  'generic_name': 'MORPHINE SULFATE',\n",
       "  'labeler_name': 'Padagis US LLC',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Morphine Sulfate',\n",
       "  'active_ingredients': [{'name': 'MORPHINE SULFATE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0574-7112-12',\n",
       "    'description': '12 PACKET in 1 BOX (0574-7112-12)  / 1 SUPPOSITORY in 1 PACKET',\n",
       "    'marketing_start_date': '19900901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Padagis US LLC'],\n",
       "   'rxcui': ['892516', '892603', '892678', '894807'],\n",
       "   'spl_set_id': ['649d731b-962a-45df-b043-7e0781e8a530'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['X3P646A2J0']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'SUPPOSITORY',\n",
       "  'spl_id': 'fa18ac09-a625-47aa-8cde-7051dc4d0c49',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['RECTAL'],\n",
       "  'marketing_start_date': '19900901',\n",
       "  'product_id': '0574-7112_fa18ac09-a625-47aa-8cde-7051dc4d0c49',\n",
       "  'brand_name_base': 'Morphine Sulfate',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '72789-231',\n",
       "  'generic_name': 'Benzonatate',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Benzonatate',\n",
       "  'active_ingredients': [{'name': 'BENZONATATE', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-231-15',\n",
       "    'description': '15 CAPSULE in 1 BOTTLE, PLASTIC (72789-231-15)',\n",
       "    'marketing_start_date': '20220208',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['197397'],\n",
       "   'spl_set_id': ['55b64aee-d4c4-4aad-9016-0dd879e979e6'],\n",
       "   'nui': ['N0000009010', 'N0000175796'],\n",
       "   'pharm_class_pe': ['Decreased Tracheobronchial Stretch Receptor Activity [PE]'],\n",
       "   'pharm_class_epc': ['Non-narcotic Antitussive [EPC]'],\n",
       "   'unii': ['5P4DHS6ENR']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '240f5575-e27c-3ecc-e063-6394a90ad169',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181221',\n",
       "  'product_id': '72789-231_240f5575-e27c-3ecc-e063-6394a90ad169',\n",
       "  'application_number': 'ANDA206948',\n",
       "  'brand_name_base': 'Benzonatate',\n",
       "  'pharm_class': ['Decreased Tracheobronchial Stretch Receptor Activity [PE]',\n",
       "   'Non-narcotic Antitussive [EPC]']},\n",
       " {'product_ndc': '72789-254',\n",
       "  'generic_name': 'Amoxicillin',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Amoxicillin',\n",
       "  'active_ingredients': [{'name': 'AMOXICILLIN', 'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-254-21',\n",
       "    'description': '21 CAPSULE in 1 BOTTLE, PLASTIC (72789-254-21)',\n",
       "    'marketing_start_date': '20230823',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-254-60',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE, PLASTIC (72789-254-60)',\n",
       "    'marketing_start_date': '20240122',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['308191'],\n",
       "   'spl_set_id': ['039d2677-b04f-436c-e063-6294a90ac519'],\n",
       "   'upc': ['0372789254302'],\n",
       "   'unii': ['804826J2HU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '0f8c71c7-0dd1-3f97-e063-6394a90aede8',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20070301',\n",
       "  'product_id': '72789-254_0f8c71c7-0dd1-3f97-e063-6394a90aede8',\n",
       "  'application_number': 'ANDA065291',\n",
       "  'brand_name_base': 'Amoxicillin',\n",
       "  'pharm_class': ['Penicillin-class Antibacterial [EPC]', 'Penicillins [CS]']},\n",
       " {'product_ndc': '72789-256',\n",
       "  'generic_name': 'Clorazepate Dipotassium',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Clorazepate Dipotassium',\n",
       "  'active_ingredients': [{'name': 'CLORAZEPATE DIPOTASSIUM',\n",
       "    'strength': '15 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-256-06',\n",
       "    'description': '6 TABLET in 1 BOTTLE, PLASTIC (72789-256-06)',\n",
       "    'marketing_start_date': '20220701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['197464'],\n",
       "   'spl_set_id': ['7b59a3ab-3dff-4458-a63a-ef0d9e0d996d'],\n",
       "   'unii': ['63FN7G03XY']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '1185e936-0db5-9591-e063-6394a90aaf83',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20000427',\n",
       "  'product_id': '72789-256_1185e936-0db5-9591-e063-6394a90aaf83',\n",
       "  'application_number': 'ANDA075731',\n",
       "  'brand_name_base': 'Clorazepate Dipotassium',\n",
       "  'pharm_class': ['Benzodiazepine [EPC]', 'Benzodiazepines [CS]']},\n",
       " {'product_ndc': '72789-257',\n",
       "  'generic_name': 'Omeprazole',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Omeprazole',\n",
       "  'active_ingredients': [{'name': 'OMEPRAZOLE', 'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-257-90',\n",
       "    'description': '90 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC (72789-257-90)',\n",
       "    'marketing_start_date': '20220705',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['200329'],\n",
       "   'spl_set_id': ['0344268f-d8e6-48d5-b1e1-f750ed1d8a52'],\n",
       "   'upc': ['0372789257907'],\n",
       "   'nui': ['N0000175525', 'N0000000147', 'N0000182140'],\n",
       "   'pharm_class_epc': ['Proton Pump Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Proton Pump Inhibitors [MoA]',\n",
       "    'Cytochrome P450 2C19 Inhibitors [MoA]'],\n",
       "   'unii': ['KG60484QX9']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, DELAYED RELEASE',\n",
       "  'spl_id': '1d783b8d-a8f8-be38-e063-6294a90ac956',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20140301',\n",
       "  'product_id': '72789-257_1d783b8d-a8f8-be38-e063-6294a90ac956',\n",
       "  'application_number': 'ANDA078490',\n",
       "  'brand_name_base': 'Omeprazole',\n",
       "  'pharm_class': ['Cytochrome P450 2C19 Inhibitors [MoA]',\n",
       "   'Proton Pump Inhibitor [EPC]',\n",
       "   'Proton Pump Inhibitors [MoA]']},\n",
       " {'product_ndc': '72789-276',\n",
       "  'generic_name': 'Doxycycline Hyclate',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Doxycycline Hyclate',\n",
       "  'active_ingredients': [{'name': 'DOXYCYCLINE HYCLATE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-276-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-276-01)',\n",
       "    'marketing_start_date': '20240119',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-276-07',\n",
       "    'description': '7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-276-07)',\n",
       "    'marketing_start_date': '20240119',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-276-10',\n",
       "    'description': '10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-276-10)',\n",
       "    'marketing_start_date': '20230713',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-276-14',\n",
       "    'description': '14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-276-14)',\n",
       "    'marketing_start_date': '20221118',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-276-20',\n",
       "    'description': '20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-276-20)',\n",
       "    'marketing_start_date': '20221117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-276-71',\n",
       "    'description': '210 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-276-71)',\n",
       "    'marketing_start_date': '20230117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-276-74',\n",
       "    'description': '400 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-276-74)',\n",
       "    'marketing_start_date': '20230117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-276-82',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-276-82)',\n",
       "    'marketing_start_date': '20221007',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-276-85',\n",
       "    'description': '330 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-276-85)',\n",
       "    'marketing_start_date': '20240220',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-276-87',\n",
       "    'description': '300 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-276-87)',\n",
       "    'marketing_start_date': '20230303',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-276-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-276-90)',\n",
       "    'marketing_start_date': '20230117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-276-93',\n",
       "    'description': '180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-276-93)',\n",
       "    'marketing_start_date': '20230117',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['1650143'],\n",
       "   'spl_set_id': ['1401d590-0967-4c6b-b52b-a83e9f6df097'],\n",
       "   'upc': ['0372789276205'],\n",
       "   'unii': ['19XTS3T51U']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '2737a383-c4a5-6510-e063-6394a90a0e4c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19860710',\n",
       "  'product_id': '72789-276_2737a383-c4a5-6510-e063-6394a90a0e4c',\n",
       "  'application_number': 'ANDA062677',\n",
       "  'brand_name_base': 'Doxycycline Hyclate',\n",
       "  'pharm_class': ['Tetracycline-class Drug [EPC]', 'Tetracyclines [CS]']},\n",
       " {'product_ndc': '72789-287',\n",
       "  'generic_name': 'phentermine hydrochloride',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Phentermine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PHENTERMINE HYDROCHLORIDE',\n",
       "    'strength': '30 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-287-14',\n",
       "    'description': '14 CAPSULE in 1 BOTTLE, PLASTIC (72789-287-14)',\n",
       "    'marketing_start_date': '20221115',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-287-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE, PLASTIC (72789-287-30)',\n",
       "    'marketing_start_date': '20221115',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['900038'],\n",
       "   'spl_set_id': ['e4508aa9-1e7a-4af7-829e-5fa353c92f5e'],\n",
       "   'upc': ['0372789287300'],\n",
       "   'unii': ['0K2I505OTV']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '24102ec9-7007-6985-e063-6394a90aff94',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170124',\n",
       "  'product_id': '72789-287_24102ec9-7007-6985-e063-6394a90aff94',\n",
       "  'application_number': 'ANDA205019',\n",
       "  'brand_name_base': 'Phentermine Hydrochloride',\n",
       "  'pharm_class': ['Appetite Suppression [PE]',\n",
       "   'Increased Sympathetic Activity [PE]',\n",
       "   'Sympathomimetic Amine Anorectic [EPC]']},\n",
       " {'product_ndc': '72789-290',\n",
       "  'generic_name': 'Spironolactone',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Spironolactone',\n",
       "  'active_ingredients': [{'name': 'SPIRONOLACTONE', 'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-290-30',\n",
       "    'description': '30 TABLET, COATED in 1 BOTTLE, PLASTIC (72789-290-30)',\n",
       "    'marketing_start_date': '20221208',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-290-60',\n",
       "    'description': '60 TABLET, COATED in 1 BOTTLE, PLASTIC (72789-290-60)',\n",
       "    'marketing_start_date': '20221208',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-290-90',\n",
       "    'description': '90 TABLET, COATED in 1 BOTTLE, PLASTIC (72789-290-90)',\n",
       "    'marketing_start_date': '20221208',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-290-95',\n",
       "    'description': '1000 TABLET, COATED in 1 BOTTLE, PLASTIC (72789-290-95)',\n",
       "    'marketing_start_date': '20221212',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['313096'],\n",
       "   'spl_set_id': ['73564b3d-8ede-4008-b75c-1277153b5bb6'],\n",
       "   'upc': ['0372789290904'],\n",
       "   'nui': ['N0000175557', 'N0000011310'],\n",
       "   'pharm_class_epc': ['Aldosterone Antagonist [EPC]'],\n",
       "   'pharm_class_moa': ['Aldosterone Antagonists [MoA]'],\n",
       "   'unii': ['27O7W4T232']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '2737a153-5526-8303-e063-6394a90a5f5f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210104',\n",
       "  'product_id': '72789-290_2737a153-5526-8303-e063-6394a90a5f5f',\n",
       "  'application_number': 'ANDA040750',\n",
       "  'brand_name_base': 'Spironolactone',\n",
       "  'pharm_class': ['Aldosterone Antagonist [EPC]',\n",
       "   'Aldosterone Antagonists [MoA]']},\n",
       " {'product_ndc': '72789-291',\n",
       "  'generic_name': 'Spironolactone',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Spironolactone',\n",
       "  'active_ingredients': [{'name': 'SPIRONOLACTONE', 'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-291-30',\n",
       "    'description': '30 TABLET, COATED in 1 BOTTLE, PLASTIC (72789-291-30)',\n",
       "    'marketing_start_date': '20221212',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-291-60',\n",
       "    'description': '60 TABLET, COATED in 1 BOTTLE, PLASTIC (72789-291-60)',\n",
       "    'marketing_start_date': '20221212',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-291-82',\n",
       "    'description': '500 TABLET, COATED in 1 BOTTLE, PLASTIC (72789-291-82)',\n",
       "    'marketing_start_date': '20221212',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-291-90',\n",
       "    'description': '90 TABLET, COATED in 1 BOTTLE, PLASTIC (72789-291-90)',\n",
       "    'marketing_start_date': '20221212',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['198223'],\n",
       "   'spl_set_id': ['8a66d90e-5450-4716-8c01-e7dc1967d00d'],\n",
       "   'upc': ['0372789291901'],\n",
       "   'nui': ['N0000175557', 'N0000011310'],\n",
       "   'pharm_class_epc': ['Aldosterone Antagonist [EPC]'],\n",
       "   'pharm_class_moa': ['Aldosterone Antagonists [MoA]'],\n",
       "   'unii': ['27O7W4T232']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '2865fef2-ead9-435d-e063-6394a90ac0bd',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210104',\n",
       "  'product_id': '72789-291_2865fef2-ead9-435d-e063-6394a90ac0bd',\n",
       "  'application_number': 'ANDA040750',\n",
       "  'brand_name_base': 'Spironolactone',\n",
       "  'pharm_class': ['Aldosterone Antagonist [EPC]',\n",
       "   'Aldosterone Antagonists [MoA]']},\n",
       " {'product_ndc': '0591-0343',\n",
       "  'generic_name': 'Verapamil Hydrochloride',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Verapamil Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'VERAPAMIL HYDROCHLORIDE',\n",
       "    'strength': '80 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-0343-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0343-01)',\n",
       "    'marketing_start_date': '19861001',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0591-0343-05',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0343-05)',\n",
       "    'marketing_start_date': '19861001',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0591-0343-10',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0343-10)',\n",
       "    'marketing_start_date': '19861001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['897666', '897683', '897722'],\n",
       "   'spl_set_id': ['a0343397-897b-46d6-943f-a87e07e1de10'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['V3888OEY5R']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'e3d79e3a-c6e7-42ae-9edb-0f2bf6ddb236',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19861001',\n",
       "  'product_id': '0591-0343_e3d79e3a-c6e7-42ae-9edb-0f2bf6ddb236',\n",
       "  'application_number': 'ANDA070995',\n",
       "  'brand_name_base': 'Verapamil Hydrochloride',\n",
       "  'pharm_class': ['Calcium Channel Antagonists [MoA]',\n",
       "   'Calcium Channel Blocker [EPC]',\n",
       "   'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "   'Cytochrome P450 3A4 Inhibitors [MoA]',\n",
       "   'P-Glycoprotein Inhibitors [MoA]']},\n",
       " {'product_ndc': '72789-315',\n",
       "  'generic_name': 'clonazepam',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Clonazepam',\n",
       "  'active_ingredients': [{'name': 'CLONAZEPAM', 'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-315-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE, PLASTIC (72789-315-30)',\n",
       "    'marketing_start_date': '20230320',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['197529'],\n",
       "   'spl_set_id': ['9a74ea97-1c00-4d96-a06f-81c183943dc6'],\n",
       "   'upc': ['0372789315300'],\n",
       "   'nui': ['N0000175694', 'M0002356'],\n",
       "   'pharm_class_epc': ['Benzodiazepine [EPC]'],\n",
       "   'pharm_class_cs': ['Benzodiazepines [CS]'],\n",
       "   'unii': ['5PE9FDE8GB']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '2410d5b4-8be3-1c78-e063-6394a90a1f1d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180215',\n",
       "  'product_id': '72789-315_2410d5b4-8be3-1c78-e063-6394a90a1f1d',\n",
       "  'application_number': 'ANDA077856',\n",
       "  'brand_name_base': 'Clonazepam',\n",
       "  'pharm_class': ['Benzodiazepine [EPC]', 'Benzodiazepines [CS]']},\n",
       " {'product_ndc': '72789-318',\n",
       "  'generic_name': 'Enalapril Maleate',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Enalapril Maleate',\n",
       "  'active_ingredients': [{'name': 'ENALAPRIL MALEATE', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-318-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE, PLASTIC (72789-318-90)',\n",
       "    'marketing_start_date': '20230404',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['858810'],\n",
       "   'spl_set_id': ['cbaaa849-0f9d-4294-b122-090ff17fdcc7'],\n",
       "   'upc': ['0372789318905'],\n",
       "   'unii': ['9O25354EPJ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '2411278a-37a2-9901-e063-6394a90a344c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220424',\n",
       "  'product_id': '72789-318_2411278a-37a2-9901-e063-6394a90a344c',\n",
       "  'application_number': 'ANDA213273',\n",
       "  'brand_name_base': 'Enalapril Maleate',\n",
       "  'pharm_class': ['Angiotensin Converting Enzyme Inhibitor [EPC]',\n",
       "   'Angiotensin-converting Enzyme Inhibitors [MoA]',\n",
       "   'Decreased Blood Pressure [PE]']},\n",
       " {'product_ndc': '0591-0347',\n",
       "  'generic_name': 'Hydrochlorothiazide',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Hydrochlorothiazide',\n",
       "  'active_ingredients': [{'name': 'HYDROCHLOROTHIAZIDE',\n",
       "    'strength': '12.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-0347-01',\n",
       "    'description': '100 CAPSULE, GELATIN COATED in 1 BOTTLE (0591-0347-01)',\n",
       "    'marketing_start_date': '19961227',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0591-0347-05',\n",
       "    'description': '500 CAPSULE, GELATIN COATED in 1 BOTTLE (0591-0347-05)',\n",
       "    'marketing_start_date': '19961227',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['199903'],\n",
       "   'spl_set_id': ['a3eb7294-f913-434b-896c-da028bfebc73'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175359', 'N0000175419', 'M0471776'],\n",
       "   'pharm_class_pe': ['Increased Diuresis [PE]'],\n",
       "   'pharm_class_epc': ['Thiazide Diuretic [EPC]'],\n",
       "   'pharm_class_cs': ['Thiazides [CS]'],\n",
       "   'unii': ['0J48LPH2TH']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'CAPSULE, GELATIN COATED',\n",
       "  'spl_id': 'aba4d4aa-b0fd-4871-badb-79d5c9472b3b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19961227',\n",
       "  'product_id': '0591-0347_aba4d4aa-b0fd-4871-badb-79d5c9472b3b',\n",
       "  'application_number': 'NDA020504',\n",
       "  'brand_name_base': 'Hydrochlorothiazide',\n",
       "  'pharm_class': ['Increased Diuresis [PE]',\n",
       "   'Thiazide Diuretic [EPC]',\n",
       "   'Thiazides [CS]']},\n",
       " {'product_ndc': '72789-327',\n",
       "  'generic_name': 'Tizanidine',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Tizanidine',\n",
       "  'active_ingredients': [{'name': 'TIZANIDINE HYDROCHLORIDE',\n",
       "    'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-327-20',\n",
       "    'description': '20 TABLET in 1 BOTTLE, PLASTIC (72789-327-20)',\n",
       "    'marketing_start_date': '20230612',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['313413'],\n",
       "   'spl_set_id': ['fdf4f09d-4537-a438-e053-6394a90a573d'],\n",
       "   'upc': ['0372789327204'],\n",
       "   'unii': ['B53E3NMY5C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '24114009-67a7-4609-e063-6294a90a99e2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20031211',\n",
       "  'product_id': '72789-327_24114009-67a7-4609-e063-6294a90a99e2',\n",
       "  'application_number': 'ANDA076416',\n",
       "  'brand_name_base': 'Tizanidine',\n",
       "  'pharm_class': ['Adrenergic alpha2-Agonists [MoA]',\n",
       "   'Central alpha-2 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72789-331',\n",
       "  'generic_name': 'Famotidine',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Famotidine',\n",
       "  'active_ingredients': [{'name': 'FAMOTIDINE', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-331-02',\n",
       "    'description': '2 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-331-02)',\n",
       "    'marketing_start_date': '20240730',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-331-20',\n",
       "    'description': '20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-331-20)',\n",
       "    'marketing_start_date': '20230710',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-331-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-331-30)',\n",
       "    'marketing_start_date': '20230801',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-331-60',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-331-60)',\n",
       "    'marketing_start_date': '20230728',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-331-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-331-90)',\n",
       "    'marketing_start_date': '20230717',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-331-93',\n",
       "    'description': '180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-331-93)',\n",
       "    'marketing_start_date': '20230807',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['310273'],\n",
       "   'spl_set_id': ['002875d2-8c30-2d2e-e063-6294a90ae01e'],\n",
       "   'upc': ['0372789331201'],\n",
       "   'nui': ['N0000000151', 'N0000175784'],\n",
       "   'pharm_class_moa': ['Histamine H2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Histamine-2 Receptor Antagonist [EPC]'],\n",
       "   'unii': ['5QZO15J2Z8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '1e77e8b1-43b9-7b2b-e063-6294a90ad7e9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20211104',\n",
       "  'product_id': '72789-331_1e77e8b1-43b9-7b2b-e063-6294a90ad7e9',\n",
       "  'application_number': 'ANDA215767',\n",
       "  'brand_name_base': 'Famotidine',\n",
       "  'pharm_class': ['Histamine H2 Receptor Antagonists [MoA]',\n",
       "   'Histamine-2 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '72789-335',\n",
       "  'generic_name': 'Doxepin Hydrochloride',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Doxepin Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'DOXEPIN HYDROCHLORIDE',\n",
       "    'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-335-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE, PLASTIC (72789-335-01)',\n",
       "    'marketing_start_date': '20230728',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-335-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE, PLASTIC (72789-335-30)',\n",
       "    'marketing_start_date': '20230728',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['1000048', '1000058', '1000070', '1000076', '1000097'],\n",
       "   'spl_set_id': ['8f7e9677-cc84-414b-8eb8-33993d285bb3'],\n",
       "   'upc': ['0372789336305',\n",
       "    '0372789333014',\n",
       "    '0372789335308',\n",
       "    '0372789337302',\n",
       "    '0372789334301'],\n",
       "   'unii': ['3U9A0FE9N5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '0f3d79f3-5272-29de-e063-6394a90a27e9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210501',\n",
       "  'product_id': '72789-335_0f3d79f3-5272-29de-e063-6394a90a27e9',\n",
       "  'application_number': 'ANDA213474',\n",
       "  'brand_name_base': 'Doxepin Hydrochloride',\n",
       "  'pharm_class': ['Tricyclic Antidepressant [EPC]']},\n",
       " {'product_ndc': '72789-337',\n",
       "  'generic_name': 'Doxepin Hydrochloride',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Doxepin Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'DOXEPIN HYDROCHLORIDE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-337-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE, PLASTIC (72789-337-01)',\n",
       "    'marketing_start_date': '20230728',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-337-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE, PLASTIC (72789-337-30)',\n",
       "    'marketing_start_date': '20230728',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['1000048', '1000058', '1000070', '1000076', '1000097'],\n",
       "   'spl_set_id': ['8f7e9677-cc84-414b-8eb8-33993d285bb3'],\n",
       "   'upc': ['0372789336305',\n",
       "    '0372789333014',\n",
       "    '0372789335308',\n",
       "    '0372789337302',\n",
       "    '0372789334301'],\n",
       "   'unii': ['3U9A0FE9N5']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '0f3d79f3-5272-29de-e063-6394a90a27e9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210501',\n",
       "  'product_id': '72789-337_0f3d79f3-5272-29de-e063-6394a90a27e9',\n",
       "  'application_number': 'ANDA213474',\n",
       "  'brand_name_base': 'Doxepin Hydrochloride',\n",
       "  'pharm_class': ['Tricyclic Antidepressant [EPC]']},\n",
       " {'product_ndc': '72789-359',\n",
       "  'generic_name': 'Chlorthalidone',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Chlorthalidone',\n",
       "  'active_ingredients': [{'name': 'CHLORTHALIDONE', 'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-359-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE, PLASTIC (72789-359-30)',\n",
       "    'marketing_start_date': '20231027',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-359-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE, PLASTIC (72789-359-90)',\n",
       "    'marketing_start_date': '20231027',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['197499', '197500'],\n",
       "   'spl_set_id': ['08b7ee65-53a5-ffbb-e063-6294a90ad4ee'],\n",
       "   'upc': ['0372789359304'],\n",
       "   'nui': ['N0000175359', 'N0000175420'],\n",
       "   'pharm_class_pe': ['Increased Diuresis [PE]'],\n",
       "   'pharm_class_epc': ['Thiazide-like Diuretic [EPC]'],\n",
       "   'unii': ['Q0MQD1073Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '28d8b919-fb50-0730-e063-6294a90a1c40',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231027',\n",
       "  'product_id': '72789-359_28d8b919-fb50-0730-e063-6294a90a1c40',\n",
       "  'application_number': 'ANDA089286',\n",
       "  'brand_name_base': 'Chlorthalidone',\n",
       "  'pharm_class': ['Increased Diuresis [PE]', 'Thiazide-like Diuretic [EPC]']},\n",
       " {'product_ndc': '72789-363',\n",
       "  'generic_name': 'Ibuprofen',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Ibuprofen',\n",
       "  'active_ingredients': [{'name': 'IBUPROFEN', 'strength': '600 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-363-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-363-01)',\n",
       "    'marketing_start_date': '20231127',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-363-10',\n",
       "    'description': '10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-363-10)',\n",
       "    'marketing_start_date': '20231110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-363-15',\n",
       "    'description': '15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-363-15)',\n",
       "    'marketing_start_date': '20231128',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-363-20',\n",
       "    'description': '20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-363-20)',\n",
       "    'marketing_start_date': '20231114',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-363-21',\n",
       "    'description': '21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-363-21)',\n",
       "    'marketing_start_date': '20231227',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-363-24',\n",
       "    'description': '24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-363-24)',\n",
       "    'marketing_start_date': '20231107',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-363-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-363-30)',\n",
       "    'marketing_start_date': '20231113',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-363-40',\n",
       "    'description': '40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-363-40)',\n",
       "    'marketing_start_date': '20231128',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-363-60',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-363-60)',\n",
       "    'marketing_start_date': '20231117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-363-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-363-90)',\n",
       "    'marketing_start_date': '20240221',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['197806'],\n",
       "   'spl_set_id': ['d3a7ebef-f7ab-4b34-b62e-278a8deabf78'],\n",
       "   'upc': ['0372789363240'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['WK2XYI10QM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '11e664d9-b40a-6047-e063-6294a90a657b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20151221',\n",
       "  'product_id': '72789-363_11e664d9-b40a-6047-e063-6294a90a657b',\n",
       "  'application_number': 'ANDA091625',\n",
       "  'brand_name_base': 'Ibuprofen',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '0591-0372',\n",
       "  'generic_name': 'Loxapine',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Loxapine',\n",
       "  'active_ingredients': [{'name': 'LOXAPINE SUCCINATE',\n",
       "    'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-0372-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE, PLASTIC (0591-0372-01)',\n",
       "    'marketing_start_date': '19880615',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['311385', '311386', '314075', '314078'],\n",
       "   'spl_set_id': ['a6107bb1-3e23-4c5d-bbf4-5e29deff6728'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305910370015', '0305910371012'],\n",
       "   'unii': ['X59SG0MRYU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '67a96a99-d792-4f7a-bc85-e1bcbc8355a0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19880615',\n",
       "  'product_id': '0591-0372_67a96a99-d792-4f7a-bc85-e1bcbc8355a0',\n",
       "  'application_number': 'ANDA072062',\n",
       "  'brand_name_base': 'Loxapine'},\n",
       " {'product_ndc': '72789-373',\n",
       "  'generic_name': 'sulindac',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'SULINDAC',\n",
       "  'active_ingredients': [{'name': 'SULINDAC', 'strength': '150 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-373-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE, PLASTIC (72789-373-01)',\n",
       "    'marketing_start_date': '20240119',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72789-373-82',\n",
       "    'description': '500 TABLET in 1 BOTTLE, PLASTIC (72789-373-82)',\n",
       "    'marketing_start_date': '20240125',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['198238'],\n",
       "   'spl_set_id': ['eb7acb87-6565-4524-a91a-02064ea8bd1a'],\n",
       "   'upc': ['0372789373010'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['184SNS8VUH']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '2865dbce-02f7-ebe7-e063-6294a90ab3cb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20090904',\n",
       "  'product_id': '72789-373_2865dbce-02f7-ebe7-e063-6294a90ab3cb',\n",
       "  'application_number': 'ANDA072050',\n",
       "  'brand_name_base': 'SULINDAC',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72789-430',\n",
       "  'generic_name': 'Tadalafil',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'tadalafil',\n",
       "  'active_ingredients': [{'name': 'TADALAFIL', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-430-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-430-90)',\n",
       "    'marketing_start_date': '20240916',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['484814'],\n",
       "   'spl_set_id': ['6c680b37-d515-4fc2-83e6-411f1017e18c'],\n",
       "   'upc': ['0372789430904'],\n",
       "   'nui': ['N0000175599', 'N0000020026'],\n",
       "   'pharm_class_epc': ['Phosphodiesterase 5 Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Phosphodiesterase 5 Inhibitors [MoA]'],\n",
       "   'unii': ['742SXX0ICT']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '2243124c-8b92-3cc8-e063-6294a90ae854',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230401',\n",
       "  'product_id': '72789-430_2243124c-8b92-3cc8-e063-6294a90ae854',\n",
       "  'application_number': 'ANDA215556',\n",
       "  'brand_name_base': 'tadalafil',\n",
       "  'pharm_class': ['Phosphodiesterase 5 Inhibitor [EPC]',\n",
       "   'Phosphodiesterase 5 Inhibitors [MoA]']},\n",
       " {'product_ndc': '72789-432',\n",
       "  'generic_name': 'Amlodipine Besylate and Benazepril Hydrochloride',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Amlodipine Besylate and Benazepril Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'AMLODIPINE BESYLATE', 'strength': '5 mg/1'},\n",
       "   {'name': 'BENAZEPRIL HYDROCHLORIDE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-432-90',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE, PLASTIC (72789-432-90)',\n",
       "    'marketing_start_date': '20240926',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['898353'],\n",
       "   'spl_set_id': ['ff807933-7433-4f8c-9d09-02a57e51d0fc'],\n",
       "   'upc': ['0372789432908'],\n",
       "   'unii': ['864V2Q084H', 'N1SN99T69T']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '230a65c5-2856-7524-e063-6394a90ac2ca',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20100205',\n",
       "  'product_id': '72789-432_230a65c5-2856-7524-e063-6394a90ac2ca',\n",
       "  'application_number': 'ANDA078466',\n",
       "  'brand_name_base': 'Amlodipine Besylate and Benazepril Hydrochloride',\n",
       "  'pharm_class': ['Angiotensin Converting Enzyme Inhibitor [EPC]',\n",
       "   'Angiotensin-converting Enzyme Inhibitors [MoA]',\n",
       "   'Calcium Channel Antagonists [MoA]',\n",
       "   'Calcium Channel Blocker [EPC]',\n",
       "   'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "   'Decreased Blood Pressure [PE]',\n",
       "   'Dihydropyridine Calcium Channel Blocker [EPC]',\n",
       "   'Dihydropyridines [CS]']},\n",
       " {'product_ndc': '72789-441',\n",
       "  'generic_name': 'Theophylline',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Theophylline',\n",
       "  'active_ingredients': [{'name': 'THEOPHYLLINE ANHYDROUS',\n",
       "    'strength': '300 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-441-01',\n",
       "    'description': '100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-441-01)',\n",
       "    'marketing_start_date': '20241016',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['317769'],\n",
       "   'spl_set_id': ['c6ca5cc9-4e5e-40cf-a36e-227aa4cb55c6'],\n",
       "   'upc': ['0372789441016'],\n",
       "   'nui': ['N0000175790', 'M0023046'],\n",
       "   'pharm_class_epc': ['Methylxanthine [EPC]'],\n",
       "   'pharm_class_cs': ['Xanthines [CS]'],\n",
       "   'unii': ['0I55128JYK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '24991b3f-9d1c-4e22-e063-6394a90a9428',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240927',\n",
       "  'product_id': '72789-441_24991b3f-9d1c-4e22-e063-6394a90a9428',\n",
       "  'application_number': 'ANDA215312',\n",
       "  'brand_name_base': 'Theophylline',\n",
       "  'pharm_class': ['Methylxanthine [EPC]', 'Xanthines [CS]']},\n",
       " {'product_ndc': '72789-444',\n",
       "  'generic_name': 'Phentermine Hydrochloride',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Phentermine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PHENTERMINE HYDROCHLORIDE',\n",
       "    'strength': '37.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-444-28',\n",
       "    'description': '28 TABLET in 1 BOTTLE, PLASTIC (72789-444-28)',\n",
       "    'marketing_start_date': '20241015',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['803353'],\n",
       "   'spl_set_id': ['b621a368-3017-4ba3-ba9f-8557fa0210a6'],\n",
       "   'upc': ['0372789444284'],\n",
       "   'unii': ['0K2I505OTV']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '248b304c-beac-150c-e063-6294a90a1468',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240215',\n",
       "  'product_id': '72789-444_248b304c-beac-150c-e063-6294a90a1468',\n",
       "  'application_number': 'ANDA200272',\n",
       "  'brand_name_base': 'Phentermine Hydrochloride',\n",
       "  'pharm_class': ['Appetite Suppression [PE]',\n",
       "   'Increased Sympathetic Activity [PE]',\n",
       "   'Sympathomimetic Amine Anorectic [EPC]']},\n",
       " {'product_ndc': '72793-201',\n",
       "  'generic_name': 'Menthol',\n",
       "  'labeler_name': 'Mountainside Medical Equipment, Inc.',\n",
       "  'brand_name': 'Mountain Ice Sports Recovery',\n",
       "  'active_ingredients': [{'name': 'MENTHOL, UNSPECIFIED FORM',\n",
       "    'strength': '6 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72793-201-01',\n",
       "    'description': '6 mL in 1 PACKET (72793-201-01)',\n",
       "    'marketing_start_date': '20221101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72793-201-03',\n",
       "    'description': '946 mL in 1 BOTTLE, PUMP (72793-201-03)',\n",
       "    'marketing_start_date': '20221101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72793-201-04',\n",
       "    'description': '99 mL in 1 BOTTLE, WITH APPLICATOR (72793-201-04)',\n",
       "    'marketing_start_date': '20221101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72793-201-05',\n",
       "    'description': '118 mL in 1 TUBE (72793-201-05)',\n",
       "    'marketing_start_date': '20221101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Mountainside Medical Equipment, Inc.'],\n",
       "   'rxcui': ['415976'],\n",
       "   'spl_set_id': ['98638529-3c17-436e-901f-c8aea52bdab6'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'bd0c20f7-a163-43b2-bf69-93496063f8e0',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20221101',\n",
       "  'product_id': '72793-201_bd0c20f7-a163-43b2-bf69-93496063f8e0',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Mountain Ice Sports Recovery'},\n",
       " {'product_ndc': '72793-400',\n",
       "  'generic_name': 'Colloidal Oatmeal',\n",
       "  'labeler_name': 'Mountainside Medical Equipment, Inc.',\n",
       "  'brand_name': 'Mountain Ice Eczema',\n",
       "  'active_ingredients': [{'name': 'OATMEAL', 'strength': '10 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72793-400-01',\n",
       "    'description': '118 g in 1 TUBE (72793-400-01)',\n",
       "    'marketing_start_date': '20210218',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72793-400-02',\n",
       "    'description': '4 g in 1 PACKET (72793-400-02)',\n",
       "    'marketing_start_date': '20210218',\n",
       "    'sample': True}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Mountainside Medical Equipment, Inc.'],\n",
       "   'rxcui': ['240651'],\n",
       "   'spl_set_id': ['1a91f33e-dd85-4d5a-b61c-e460a507e292'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185371',\n",
       "    'N0000185375',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'M0000728',\n",
       "    'M0006342',\n",
       "    'M0016962',\n",
       "    'N0000185016'],\n",
       "   'pharm_class_epc': ['Non-Standardized Food Allergenic Extract [EPC]',\n",
       "    'Non-Standardized Plant Allergenic Extract [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]',\n",
       "    'Dietary Proteins [CS]',\n",
       "    'Plant Proteins [CS]'],\n",
       "   'unii': ['8PI54V663Y']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '53a8fe84-88a9-4b57-bc3f-73dce0f94721',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210218',\n",
       "  'product_id': '72793-400_53a8fe84-88a9-4b57-bc3f-73dce0f94721',\n",
       "  'application_number': 'M016',\n",
       "  'brand_name_base': 'Mountain Ice Eczema',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Grain Proteins [EXT]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]']},\n",
       " {'product_ndc': '72797-009',\n",
       "  'generic_name': 'Benzethonium Chloride',\n",
       "  'labeler_name': 'Yangzhou H&R Plastic Daily Chemical Co., Ltd.',\n",
       "  'brand_name': 'MERIDIAN WARPPED ANTIBACTERIAL DEODORANT 3',\n",
       "  'active_ingredients': [{'name': 'BENZETHONIUM CHLORIDE',\n",
       "    'strength': '.1 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72797-009-01',\n",
       "    'description': '144 PACKAGE in 1 BOX (72797-009-01)  / 75 g in 1 PACKAGE',\n",
       "    'marketing_start_date': '20241205',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Yangzhou H&R Plastic Daily Chemical Co., Ltd.'],\n",
       "   'spl_set_id': ['3ed3332e-f888-4b9c-aab7-99f8719b835e'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['PH41D05744']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOAP',\n",
       "  'spl_id': '2881e0a3-db68-67e2-e063-6394a90a2b76',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20241205',\n",
       "  'product_id': '72797-009_2881e0a3-db68-67e2-e063-6394a90a2b76',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'MERIDIAN WARPPED ANTIBACTERIAL DEODORANT 3'},\n",
       " {'product_ndc': '72812-150',\n",
       "  'generic_name': 'Zinc Oxide',\n",
       "  'labeler_name': 'Earth Mama Angel Baby LLC',\n",
       "  'brand_name': 'Earth Mama Lady Face Mineral Sunscreen - Medium/Dark Tint Broad Spectrum SPF 40',\n",
       "  'brand_name_suffix': 'SPF 40',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '22 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72812-150-01',\n",
       "    'description': '1 TUBE in 1 CARTON (72812-150-01)  / 21 g in 1 TUBE',\n",
       "    'marketing_start_date': '20200608',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Earth Mama Angel Baby LLC'],\n",
       "   'spl_set_id': ['908c41fd-0496-4237-813b-1135e10ae0c5'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'STICK',\n",
       "  'spl_id': 'e2b92c61-6e3e-4540-9b06-158ada335605',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200605',\n",
       "  'product_id': '72812-150_e2b92c61-6e3e-4540-9b06-158ada335605',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Earth Mama Lady Face Mineral Sunscreen - Medium/Dark Tint Broad Spectrum',\n",
       "  'pharm_class': ['Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]']},\n",
       " {'product_ndc': '72812-152',\n",
       "  'generic_name': 'Zinc Oxide',\n",
       "  'labeler_name': 'Earth Mama Angel Baby, LLC',\n",
       "  'brand_name': 'Tinted Mineral Sunscreen Broad Spectrum SPF 25',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '200 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72812-152-01',\n",
       "    'description': '84 g in 1 TUBE (72812-152-01)',\n",
       "    'marketing_start_date': '20200801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Earth Mama Angel Baby, LLC'],\n",
       "   'spl_set_id': ['2aa44439-663a-400b-b432-e2dc5ac2a3d1'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '454a2e16-e349-4c7d-9aba-e43c9bfcf428',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200801',\n",
       "  'product_id': '72812-152_454a2e16-e349-4c7d-9aba-e43c9bfcf428',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Tinted Mineral Sunscreen Broad Spectrum SPF 25'},\n",
       " {'product_ndc': '72817-001',\n",
       "  'generic_name': 'Oxygen',\n",
       "  'labeler_name': 'All About Pediatrics, LLC dba Pediatric Home Service',\n",
       "  'brand_name': 'Oxygen',\n",
       "  'active_ingredients': [{'name': 'OXYGEN', 'strength': '99 L/100L'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72817-001-01',\n",
       "    'description': '41 L in 1 DEWAR (72817-001-01)',\n",
       "    'marketing_start_date': '20000201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72817-001-02',\n",
       "    'description': '100 L in 1 DEWAR (72817-001-02)',\n",
       "    'marketing_start_date': '20000201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['All About Pediatrics, LLC dba Pediatric Home Service'],\n",
       "   'rxcui': ['312172'],\n",
       "   'spl_set_id': ['8349a34e-ac6d-79c3-e053-2a91aa0a857a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['S88TT14065']},\n",
       "  'marketing_category': 'UNAPPROVED MEDICAL GAS',\n",
       "  'dosage_form': 'GAS',\n",
       "  'spl_id': '2474a8e2-60ad-cb5d-e063-6394a90af6d0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['RESPIRATORY (INHALATION)'],\n",
       "  'marketing_start_date': '20000201',\n",
       "  'product_id': '72817-001_2474a8e2-60ad-cb5d-e063-6394a90af6d0',\n",
       "  'brand_name_base': 'Oxygen'},\n",
       " {'product_ndc': '72819-183',\n",
       "  'generic_name': 'valsartan',\n",
       "  'labeler_name': 'Archis Pharma LLC',\n",
       "  'brand_name': 'Valsartan',\n",
       "  'active_ingredients': [{'name': 'VALSARTAN', 'strength': '160 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72819-183-09',\n",
       "    'description': '90 TABLET, COATED in 1 BOTTLE, PLASTIC (72819-183-09)',\n",
       "    'marketing_start_date': '20220901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Archis Pharma LLC'],\n",
       "   'rxcui': ['349199', '349200', '349201', '349483'],\n",
       "   'spl_set_id': ['00b235b2-a909-4628-b37c-bb02bc5bf7c6'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372819183091'],\n",
       "   'nui': ['N0000000070', 'N0000175561'],\n",
       "   'pharm_class_moa': ['Angiotensin 2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Angiotensin 2 Receptor Blocker [EPC]'],\n",
       "   'unii': ['80M03YXJ7I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '0037a1a4-d769-2567-e063-6394a90a721c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220901',\n",
       "  'product_id': '72819-183_0037a1a4-d769-2567-e063-6394a90a721c',\n",
       "  'application_number': 'ANDA205347',\n",
       "  'brand_name_base': 'Valsartan',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]']},\n",
       " {'product_ndc': '72819-234',\n",
       "  'generic_name': 'CUPRIC CHLORIDE',\n",
       "  'labeler_name': 'Archis Pharma LLC',\n",
       "  'brand_name': 'CUPRIC CHLORIDE',\n",
       "  'active_ingredients': [{'name': 'CUPRIC CHLORIDE', 'strength': '.4 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72819-234-99',\n",
       "    'description': '25 VIAL, SINGLE-DOSE in 1 PACKAGE (72819-234-99)  / 10 mL in 1 VIAL, SINGLE-DOSE (72819-234-96)',\n",
       "    'marketing_start_date': '20241001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Archis Pharma LLC'],\n",
       "   'rxcui': ['204536'],\n",
       "   'spl_set_id': ['45586a5f-4864-4b01-9211-002c77585249'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372819234991'],\n",
       "   'unii': ['S2QG84156O']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '249680fd-f7e7-6e1a-e063-6394a90a87e7',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20241001',\n",
       "  'product_id': '72819-234_249680fd-f7e7-6e1a-e063-6394a90a87e7',\n",
       "  'application_number': 'ANDA217626',\n",
       "  'brand_name_base': 'CUPRIC CHLORIDE'},\n",
       " {'product_ndc': '72839-108',\n",
       "  'generic_name': 'Lidocaine HCl 4%',\n",
       "  'labeler_name': 'Derma Care Research Labs, LLC',\n",
       "  'brand_name': 'Warrior Pain Relief Roll-On Maximum Strength',\n",
       "  'brand_name_suffix': 'Maximum Strength',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE HYDROCHLORIDE',\n",
       "    'strength': '4 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72839-108-02',\n",
       "    'description': '71 g in 1 JAR (72839-108-02)',\n",
       "    'marketing_start_date': '20200814',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Derma Care Research Labs, LLC'],\n",
       "   'rxcui': ['1010077'],\n",
       "   'spl_set_id': ['dd80e560-6467-2166-e053-2995a90a88a8'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0814660011548'],\n",
       "   'unii': ['V13007Z41A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'dd80e560-6468-2166-e053-2995a90a88a8',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200814',\n",
       "  'product_id': '72839-108_dd80e560-6468-2166-e053-2995a90a88a8',\n",
       "  'application_number': 'part348',\n",
       "  'brand_name_base': 'Warrior Pain Relief Roll-On',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '72839-201',\n",
       "  'generic_name': 'Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%',\n",
       "  'labeler_name': 'Derma Care Research Labs, LLC',\n",
       "  'brand_name': 'Habana SPF 50 Sunscreen',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '3 g/100g'},\n",
       "   {'name': 'HOMOSALATE', 'strength': '15 g/100g'},\n",
       "   {'name': 'OCTISALATE', 'strength': '5 g/100g'},\n",
       "   {'name': 'OCTOCRYLENE', 'strength': '10 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72839-201-06',\n",
       "    'description': '170 g in 1 CAN (72839-201-06)',\n",
       "    'marketing_start_date': '20220131',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Derma Care Research Labs, LLC'],\n",
       "   'spl_set_id': ['db6193ee-c63c-a9aa-e053-2995a90a0ee7'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0850009221308', '0850009221292'],\n",
       "   'unii': ['G63QQF2NOX', 'V06SV4M95S', '4X49Y0596W', '5A68WGF6WM']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': 'db6193ee-c63b-a9aa-e053-2995a90a0ee7',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220131',\n",
       "  'product_id': '72839-201_db6193ee-c63b-a9aa-e053-2995a90a0ee7',\n",
       "  'application_number': 'part352',\n",
       "  'brand_name_base': 'Habana SPF 50 Sunscreen'},\n",
       " {'product_ndc': '72839-213',\n",
       "  'generic_name': 'Trolamin Salicylate 10%',\n",
       "  'labeler_name': 'Derma Care Research Labs, LLC',\n",
       "  'brand_name': 'Warrior Arthritis Relief',\n",
       "  'active_ingredients': [{'name': 'TROLAMINE SALICYLATE',\n",
       "    'strength': '10 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72839-213-03',\n",
       "    'description': '1 TUBE in 1 CARTON (72839-213-03)  / 85 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230421',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Derma Care Research Labs, LLC'],\n",
       "   'rxcui': ['313518'],\n",
       "   'spl_set_id': ['013f48b9-913f-b283-e063-6394a90abd73'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0814660011760'],\n",
       "   'unii': ['H8O4040BHD']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '013f48b9-913e-b283-e063-6394a90abd73',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230421',\n",
       "  'product_id': '72839-213_013f48b9-913e-b283-e063-6394a90abd73',\n",
       "  'application_number': 'part348',\n",
       "  'brand_name_base': 'Warrior Arthritis Relief'},\n",
       " {'product_ndc': '72839-217',\n",
       "  'generic_name': 'Glycerin 14.4%, Lidocaine 5%, Petrolatum 15%, Phenylephrine HCl 0.25%',\n",
       "  'labeler_name': 'Derma Care Research Labs, LLC',\n",
       "  'brand_name': 'DCH Hemorrhoidal',\n",
       "  'active_ingredients': [{'name': 'GLYCERIN', 'strength': '14.4 g/100g'},\n",
       "   {'name': 'LIDOCAINE', 'strength': '5 g/100g'},\n",
       "   {'name': 'PETROLATUM', 'strength': '15 g/100g'},\n",
       "   {'name': 'PHENYLEPHRINE HYDROCHLORIDE', 'strength': '.25 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72839-217-01',\n",
       "    'description': '1 TUBE in 1 CARTON (72839-217-01)  / 28 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230512',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Derma Care Research Labs, LLC'],\n",
       "   'rxcui': ['2642220'],\n",
       "   'spl_set_id': ['0050701f-4393-3f01-e063-6394a90a4e0e'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0850009221995'],\n",
       "   'nui': ['N0000185370',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'N0000185001',\n",
       "    'M0000728',\n",
       "    'M0009417',\n",
       "    'N0000175682',\n",
       "    'M0000897',\n",
       "    'N0000175426',\n",
       "    'N0000175976'],\n",
       "   'pharm_class_epc': ['Non-Standardized Chemical Allergen [EPC]',\n",
       "    'Amide Local Anesthetic [EPC]',\n",
       "    'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]',\n",
       "    'Increased IgG Production [PE]',\n",
       "    'Local Anesthesia [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]', 'Glycerol [CS]', 'Amides [CS]'],\n",
       "   'unii': ['PDC6A3C0OX', '98PI200987', '4T6H12BN9U', '04JA59TNSJ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '0050701f-4394-3f01-e063-6394a90a4e0e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230512',\n",
       "  'product_id': '72839-217_0050701f-4394-3f01-e063-6394a90a4e0e',\n",
       "  'application_number': 'M015',\n",
       "  'brand_name_base': 'DCH Hemorrhoidal',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'Allergens [CS]',\n",
       "   'Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Glycerol [CS]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Increased IgG Production [PE]',\n",
       "   'Local Anesthesia [PE]',\n",
       "   'Non-Standardized Chemical Allergen [EPC]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72839-218',\n",
       "  'generic_name': 'Lidocaine 5%',\n",
       "  'labeler_name': 'Derma Care Research Labs',\n",
       "  'brand_name': 'Moshe Numbing Hemorrhoidal',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '5 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72839-218-01',\n",
       "    'description': '42.5 g in 1 JAR (72839-218-01)',\n",
       "    'marketing_start_date': '20230523',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Derma Care Research Labs'],\n",
       "   'rxcui': ['1366789'],\n",
       "   'spl_set_id': ['fbd5b488-1921-e9b7-e053-6294a90aba70'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175682', 'M0000897', 'N0000175426', 'N0000175976'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]', 'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'unii': ['98PI200987']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': 'fbd5b488-1922-e9b7-e053-6294a90aba70',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230123',\n",
       "  'product_id': '72839-218_fbd5b488-1922-e9b7-e053-6294a90aba70',\n",
       "  'application_number': 'M015',\n",
       "  'brand_name_base': 'Moshe Numbing Hemorrhoidal',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '72839-226',\n",
       "  'generic_name': 'Lidocaine 4%',\n",
       "  'labeler_name': 'Derma Care Research Labs, LLC',\n",
       "  'brand_name': 'DCH Pain Relief',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '4 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72839-226-04',\n",
       "    'description': '113 g in 1 CAN (72839-226-04)',\n",
       "    'marketing_start_date': '20210610',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Derma Care Research Labs, LLC'],\n",
       "   'rxcui': ['1869797'],\n",
       "   'spl_set_id': ['00efda74-d434-04be-e063-6294a90a6d98'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0850009221643'],\n",
       "   'nui': ['N0000175682', 'M0000897', 'N0000175426', 'N0000175976'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]', 'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'unii': ['98PI200987']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '00efda74-d433-04be-e063-6294a90a6d98',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210610',\n",
       "  'product_id': '72839-226_00efda74-d433-04be-e063-6294a90a6d98',\n",
       "  'application_number': 'part348',\n",
       "  'brand_name_base': 'DCH Pain Relief',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '72839-955',\n",
       "  'generic_name': 'Lidocaine HCl',\n",
       "  'labeler_name': 'Derma Care Research Labs, LLC',\n",
       "  'brand_name': 'DCH Burn Relief',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE HYDROCHLORIDE',\n",
       "    'strength': '.5 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72839-955-08',\n",
       "    'description': '227 g in 1 BOTTLE, PLASTIC (72839-955-08)',\n",
       "    'marketing_start_date': '20210311',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Derma Care Research Labs, LLC'],\n",
       "   'rxcui': ['1011849'],\n",
       "   'spl_set_id': ['ff227154-cf3b-9796-e053-6294a90a5535'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0850009221599'],\n",
       "   'unii': ['V13007Z41A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'ff227154-cf3a-9796-e053-6294a90a5535',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210311',\n",
       "  'product_id': '72839-955_ff227154-cf3a-9796-e053-6294a90a5535',\n",
       "  'application_number': 'part348',\n",
       "  'brand_name_base': 'DCH Burn Relief',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '72839-987',\n",
       "  'generic_name': 'Camphor 6%, Menthol 16%',\n",
       "  'labeler_name': 'Derma Care Research Labs, LLC',\n",
       "  'brand_name': 'Outback Pain Relief',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (SYNTHETIC)',\n",
       "    'strength': '6 g/100g'},\n",
       "   {'name': 'MENTHOL', 'strength': '16 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72839-987-02',\n",
       "    'description': '57 g in 1 TUBE (72839-987-02)',\n",
       "    'marketing_start_date': '20210513',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Derma Care Research Labs, LLC'],\n",
       "   'rxcui': ['2542732'],\n",
       "   'spl_set_id': ['c238c930-2012-2d48-e053-2a95a90a8a4a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['5TJD82A1ET', 'L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': 'f1dba692-7a60-99bb-e053-2a95a90a1ef1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210513',\n",
       "  'product_id': '72839-987_f1dba692-7a60-99bb-e053-2a95a90a1ef1',\n",
       "  'application_number': 'part348',\n",
       "  'brand_name_base': 'Outback Pain Relief'},\n",
       " {'product_ndc': '72843-440',\n",
       "  'generic_name': 'DESMOPRESSIN ACETATE',\n",
       "  'labeler_name': 'UBI Pharma Inc.',\n",
       "  'brand_name': 'DESMOPRESSIN ACETATE',\n",
       "  'active_ingredients': [{'name': 'DESMOPRESSIN ACETATE',\n",
       "    'strength': '40 ug/10mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72843-440-01',\n",
       "    'description': '1 VIAL in 1 CARTON (72843-440-01)  / 10 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20200917',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['UBI Pharma Inc.'],\n",
       "   'rxcui': ['849501', '1723232'],\n",
       "   'spl_set_id': ['b01c22dc-eecd-11b2-e053-2a95a90a529a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0072843440015'],\n",
       "   'unii': ['XB13HYU18U']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': '23152a05-523f-1364-e063-6394a90a2e8b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS', 'SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20200917',\n",
       "  'product_id': '72843-440_23152a05-523f-1364-e063-6394a90a2e8b',\n",
       "  'application_number': 'ANDA210223',\n",
       "  'brand_name_base': 'DESMOPRESSIN ACETATE',\n",
       "  'pharm_class': ['Factor VIII Activator [EPC]',\n",
       "   'Increased Coagulation Factor VIII Activity [PE]',\n",
       "   'Increased Coagulation Factor VIII Concentration [PE]',\n",
       "   'Vasopressin Analog [EPC]',\n",
       "   'Vasopressins [CS]']},\n",
       " {'product_ndc': '72852-585',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'Alan Environmental Product Inc.',\n",
       "  'brand_name': 'Insta Clean Foam Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '.62 mL/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72852-585-10',\n",
       "    'description': '1000 mL in 1 CARTRIDGE (72852-585-10)',\n",
       "    'marketing_start_date': '20190204',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72852-585-14',\n",
       "    'description': '3785 mL in 1 BOTTLE, PLASTIC (72852-585-14)',\n",
       "    'marketing_start_date': '20190204',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72852-585-17',\n",
       "    'description': '532 mL in 1 BOTTLE, PLASTIC (72852-585-17)',\n",
       "    'marketing_start_date': '20190204',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72852-585-18',\n",
       "    'description': '50 mL in 1 BOTTLE, PLASTIC (72852-585-18)',\n",
       "    'marketing_start_date': '20190204',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72852-585-24',\n",
       "    'description': '118 mL in 1 BOTTLE, PLASTIC (72852-585-24)',\n",
       "    'marketing_start_date': '20190204',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72852-585-28',\n",
       "    'description': '149 mL in 1 BOTTLE, PLASTIC (72852-585-28)',\n",
       "    'marketing_start_date': '20190204',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Alan Environmental Product Inc.'],\n",
       "   'rxcui': ['616763'],\n",
       "   'spl_set_id': ['a9f55d9a-ae48-4f7d-a230-20c84d5ef564'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'd72e8fda-71cd-44a8-8f98-270c6c83cf2a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190204',\n",
       "  'product_id': '72852-585_d72e8fda-71cd-44a8-8f98-270c6c83cf2a',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'Insta Clean Foam Hand Sanitizer'},\n",
       " {'product_ndc': '72854-139',\n",
       "  'generic_name': 'Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI, Triprolidine HCI',\n",
       "  'labeler_name': 'RB Health (US) LLC',\n",
       "  'brand_name': 'MUCINEX FAST MAX Liquid Cold and Flu Kickstart and MUCINEX Nightshift Kickstart',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72854-139-26',\n",
       "    'description': '1 KIT in 1 CARTON (72854-139-26)  *  180 mL in 1 BOTTLE (72854-138-66)  *  180 mL in 1 BOTTLE (72854-140-66)',\n",
       "    'marketing_start_date': '20230501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['RB Health (US) LLC'],\n",
       "   'rxcui': ['1116572', '2173662', '2637727'],\n",
       "   'spl_set_id': ['fdb70793-5dd1-0455-e053-6394a90ac621'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': 'fdb70793-5dd2-0455-e053-6394a90ac621',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'marketing_start_date': '20230501',\n",
       "  'product_id': '72854-139_fdb70793-5dd2-0455-e053-6394a90ac621',\n",
       "  'application_number': 'part341',\n",
       "  'brand_name_base': 'MUCINEX FAST MAX Liquid Cold and Flu Kickstart and MUCINEX Nightshift Kickstart'},\n",
       " {'product_ndc': '72854-153',\n",
       "  'generic_name': 'Dextromethorphan Hydrobromide, Guaifenesin',\n",
       "  'labeler_name': 'RB Health (US) LLC',\n",
       "  'brand_name': 'Mucinex Fast-Max Severe Congestion and Cough Maximum Strength',\n",
       "  'brand_name_suffix': 'Maximum Strength',\n",
       "  'active_ingredients': [{'name': 'DEXTROMETHORPHAN HYDROBROMIDE',\n",
       "    'strength': '10 mg/1'},\n",
       "   {'name': 'GUAIFENESIN', 'strength': '200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72854-153-16',\n",
       "    'description': '2 BLISTER PACK in 1 CARTON (72854-153-16)  / 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20240601',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['RB Health (US) LLC'],\n",
       "   'rxcui': ['1111663'],\n",
       "   'spl_set_id': ['14be3ab0-d6ae-e342-e063-6294a90ab851'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0363824998398'],\n",
       "   'nui': ['N0000193956', 'N0000008867', 'N0000009560'],\n",
       "   'pharm_class_epc': ['Expectorant [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "    'Increased Respiratory Secretions [PE]'],\n",
       "   'unii': ['9D2RTI9KYH', '495W7451VQ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CAPSULE, LIQUID FILLED',\n",
       "  'spl_id': '14be3ab0-d6af-e342-e063-6294a90ab851',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240601',\n",
       "  'product_id': '72854-153_14be3ab0-d6af-e342-e063-6294a90ab851',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'Mucinex Fast-Max Severe Congestion and Cough',\n",
       "  'pharm_class': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "   'Expectorant [EPC]',\n",
       "   'Increased Respiratory Secretions [PE]',\n",
       "   'Sigma-1 Agonist [EPC]',\n",
       "   'Sigma-1 Receptor Agonists [MoA]',\n",
       "   'Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]',\n",
       "   'Uncompetitive NMDA Receptor Antagonists [MoA]']},\n",
       " {'product_ndc': '72854-233',\n",
       "  'generic_name': 'acetaminophen, dextromethorphan hydrobromide, and triprolidine hydrochloride',\n",
       "  'labeler_name': 'RB Health (US) LLC',\n",
       "  'brand_name': 'Mucinex Nightshift Cold and Flu Maximum Strength',\n",
       "  'brand_name_suffix': 'Maximum Strength',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '325 mg/1'},\n",
       "   {'name': 'DEXTROMETHORPHAN HYDROBROMIDE', 'strength': '10 mg/1'},\n",
       "   {'name': 'TRIPROLIDINE HYDROCHLORIDE', 'strength': '1.25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72854-233-20',\n",
       "    'description': '2 BLISTER PACK in 1 CARTON (72854-233-20)  / 10 TABLET, COATED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20210701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['RB Health (US) LLC'],\n",
       "   'rxcui': ['2549034'],\n",
       "   'spl_set_id': ['d9467ca2-df75-4fa1-92b3-d2101eb54a77'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['362O9ITL9D', '9D2RTI9KYH', 'YAN7R5L890']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': 'fda420fa-f5fd-312e-e053-6394a90a2b81',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210701',\n",
       "  'product_id': '72854-233_fda420fa-f5fd-312e-e053-6394a90a2b81',\n",
       "  'application_number': 'part341',\n",
       "  'brand_name_base': 'Mucinex Nightshift Cold and Flu',\n",
       "  'pharm_class': ['Sigma-1 Agonist [EPC]',\n",
       "   'Sigma-1 Receptor Agonists [MoA]',\n",
       "   'Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]',\n",
       "   'Uncompetitive NMDA Receptor Antagonists [MoA]']},\n",
       " {'product_ndc': '72854-234',\n",
       "  'generic_name': 'Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride',\n",
       "  'labeler_name': 'RB Health (US) LLC',\n",
       "  'brand_name': 'Mucinex Nightshift Severe Cold and Flu Maximum Strength',\n",
       "  'brand_name_suffix': 'Maximum Strength',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '325 mg/1'},\n",
       "   {'name': 'DEXTROMETHORPHAN HYDROBROMIDE', 'strength': '10 mg/1'},\n",
       "   {'name': 'PHENYLEPHRINE HYDROCHLORIDE', 'strength': '5 mg/1'},\n",
       "   {'name': 'TRIPROLIDINE HYDROCHLORIDE', 'strength': '1.25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72854-234-02',\n",
       "    'description': '2 TABLET, COATED in 1 PACKET (72854-234-02)',\n",
       "    'marketing_start_date': '20210701',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '72854-234-20',\n",
       "    'description': '2 BLISTER PACK in 1 CARTON (72854-234-20)  / 10 TABLET, COATED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20210701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['RB Health (US) LLC'],\n",
       "   'rxcui': ['2549037'],\n",
       "   'spl_set_id': ['12420092-3ef6-464b-9106-2d56cd6ef200'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['362O9ITL9D', '9D2RTI9KYH', '04JA59TNSJ', 'YAN7R5L890']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '07621dc9-9ae8-1c1e-e063-6294a90a88f3',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210701',\n",
       "  'product_id': '72854-234_07621dc9-9ae8-1c1e-e063-6294a90a88f3',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'Mucinex Nightshift Severe Cold and Flu',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'Sigma-1 Agonist [EPC]',\n",
       "   'Sigma-1 Receptor Agonists [MoA]',\n",
       "   'Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]',\n",
       "   'Uncompetitive NMDA Receptor Antagonists [MoA]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '72865-113',\n",
       "  'generic_name': 'Oxycodone and Acetaminophen',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals, Inc.',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'OXYCODONE AND ACETAMINOPHEN',\n",
       "  'active_ingredients': [{'name': 'ACETAMINOPHEN', 'strength': '325 mg/1'},\n",
       "   {'name': 'OXYCODONE HYDROCHLORIDE', 'strength': '2.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-113-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72865-113-01)',\n",
       "    'marketing_start_date': '20190315',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-113-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72865-113-05)',\n",
       "    'marketing_start_date': '20190315',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['1049214', '1049221', '1049225', '1049635'],\n",
       "   'spl_set_id': ['7f3c6dd7-6bc8-450e-aded-997f9cf63a8f'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865113059',\n",
       "    '0372865116050',\n",
       "    '0372865113011',\n",
       "    '0372865115053',\n",
       "    '0372865115015',\n",
       "    '0372865114056',\n",
       "    '0372865116012',\n",
       "    '0372865114018'],\n",
       "   'unii': ['362O9ITL9D', 'C1ENJ2TE6C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '9194f464-1cd1-44ac-8758-ae96b6643d5e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170411',\n",
       "  'product_id': '72865-113_9194f464-1cd1-44ac-8758-ae96b6643d5e',\n",
       "  'application_number': 'ANDA207419',\n",
       "  'brand_name_base': 'OXYCODONE AND ACETAMINOPHEN',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '72865-120',\n",
       "  'generic_name': 'Methadone Hydrochloride',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals, Inc',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'Methadone Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'METHADONE HYDROCHLORIDE',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-120-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72865-120-01)',\n",
       "    'marketing_start_date': '20190103',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals, Inc'],\n",
       "   'rxcui': ['864706', '864718'],\n",
       "   'spl_set_id': ['1a536622-dda3-41af-ab08-28e7c1bc9300'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865121016', '0372865120019'],\n",
       "   'unii': ['229809935B']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '639b24e8-927d-46ef-82f8-914a10528f21',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190103',\n",
       "  'product_id': '72865-120_639b24e8-927d-46ef-82f8-914a10528f21',\n",
       "  'application_number': 'ANDA211228',\n",
       "  'brand_name_base': 'Methadone Hydrochloride',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '72865-122',\n",
       "  'generic_name': 'METHYLPHENIDATE HYDROCHLORIDE',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals Inc',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'METHYLPHENIDATE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'METHYLPHENIDATE HYDROCHLORIDE',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-122-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72865-122-01)',\n",
       "    'marketing_start_date': '20200226',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-122-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72865-122-05)',\n",
       "    'marketing_start_date': '20200226',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals Inc'],\n",
       "   'rxcui': ['1091150', '1091392', '1091497'],\n",
       "   'spl_set_id': ['94dc74d4-b4ef-45bc-b502-54ec692e9bd5'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865124017', '0372865123010', '0372865122013'],\n",
       "   'unii': ['4B3SC438HI']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '0a38c200-2e90-42b8-97e8-e5b64a7078e0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200226',\n",
       "  'product_id': '72865-122_0a38c200-2e90-42b8-97e8-e5b64a7078e0',\n",
       "  'application_number': 'ANDA207416',\n",
       "  'brand_name_base': 'METHYLPHENIDATE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulation [PE]']},\n",
       " {'product_ndc': '72865-139',\n",
       "  'generic_name': 'Omega-3-acid ethyl esters',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Omega-3-acid ethyl esters',\n",
       "  'active_ingredients': [{'name': 'OMEGA-3-ACID ETHYL ESTERS',\n",
       "    'strength': '1 g/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-139-05',\n",
       "    'description': '500 CAPSULE, LIQUID FILLED in 1 BOTTLE (72865-139-05)',\n",
       "    'marketing_start_date': '20200217',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-139-12',\n",
       "    'description': '120 CAPSULE, LIQUID FILLED in 1 BOTTLE (72865-139-12)',\n",
       "    'marketing_start_date': '20200217',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['577208'],\n",
       "   'spl_set_id': ['18947318-31b4-42fb-83be-8f1bfe732e95'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865139127'],\n",
       "   'unii': ['D87YGH4Z0Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, LIQUID FILLED',\n",
       "  'spl_id': '74f8b700-c6a0-406f-ade2-14615adefab5',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200217',\n",
       "  'product_id': '72865-139_74f8b700-c6a0-406f-ade2-14615adefab5',\n",
       "  'application_number': 'ANDA207420',\n",
       "  'brand_name_base': 'Omega-3-acid ethyl esters',\n",
       "  'pharm_class': ['Fatty Acids', 'Omega-3 [CS]', 'Omega-3 Fatty Acid [EPC]']},\n",
       " {'product_ndc': '72865-148',\n",
       "  'generic_name': 'Indomethacin',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals Inc.',\n",
       "  'brand_name': 'Indomethacin',\n",
       "  'active_ingredients': [{'name': 'INDOMETHACIN', 'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-148-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (72865-148-01)',\n",
       "    'marketing_start_date': '20210727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-148-05',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (72865-148-05)',\n",
       "    'marketing_start_date': '20210727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-148-10',\n",
       "    'description': '1000 CAPSULE in 1 BOTTLE (72865-148-10)',\n",
       "    'marketing_start_date': '20210727',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-148-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (72865-148-30)',\n",
       "    'marketing_start_date': '20210727',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['197817', '197818'],\n",
       "   'spl_set_id': ['bc8a572d-e0e1-4d37-b3c4-b85415d50393'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865148013', '0372865149010'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['XXE1CET956']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'f26f7451-69b2-99d7-e053-2a95a90af7a1',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210727',\n",
       "  'product_id': '72865-148_f26f7451-69b2-99d7-e053-2a95a90af7a1',\n",
       "  'application_number': 'ANDA091240',\n",
       "  'brand_name_base': 'Indomethacin',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72865-153',\n",
       "  'generic_name': 'Aripiprazole',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Aripiprazole',\n",
       "  'active_ingredients': [{'name': 'ARIPIPRAZOLE', 'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-153-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72865-153-05)',\n",
       "    'marketing_start_date': '20201120',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-153-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72865-153-30)',\n",
       "    'marketing_start_date': '20201120',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['349490', '349545', '349547', '349553', '402131', '602964'],\n",
       "   'spl_set_id': ['b284b294-40a0-4ccd-b7b7-b61267cd4e76'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865155059', '0372865153055', '0372865154052'],\n",
       "   'nui': ['N0000175430'],\n",
       "   'pharm_class_epc': ['Atypical Antipsychotic [EPC]'],\n",
       "   'unii': ['82VFR53I78']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'f26f3784-b822-9efd-e053-2a95a90ab6ee',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201120',\n",
       "  'product_id': '72865-153_f26f3784-b822-9efd-e053-2a95a90ab6ee',\n",
       "  'application_number': 'ANDA205064',\n",
       "  'brand_name_base': 'Aripiprazole',\n",
       "  'pharm_class': ['Atypical Antipsychotic [EPC]']},\n",
       " {'product_ndc': '0591-2131',\n",
       "  'generic_name': 'azelaic acid',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'azelaic acid',\n",
       "  'active_ingredients': [{'name': 'AZELAIC ACID', 'strength': '.15 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-2131-55',\n",
       "    'description': '1 TUBE in 1 CARTON (0591-2131-55)  / 50 g in 1 TUBE',\n",
       "    'marketing_start_date': '20181119',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['1041518'],\n",
       "   'spl_set_id': ['66298d50-d4e2-4852-bbab-581389c488cb'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000008841', 'N0000009982'],\n",
       "   'pharm_class_pe': ['Decreased Protein Synthesis [PE]',\n",
       "    'Decreased Sebaceous Gland Activity [PE]'],\n",
       "   'unii': ['F2VW3D43YT']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '38d8c966-bb27-4b39-b436-4e7ffbd2d134',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20181119',\n",
       "  'product_id': '0591-2131_38d8c966-bb27-4b39-b436-4e7ffbd2d134',\n",
       "  'application_number': 'ANDA208011',\n",
       "  'brand_name_base': 'azelaic acid',\n",
       "  'pharm_class': ['Decreased Protein Synthesis [PE]',\n",
       "   'Decreased Sebaceous Gland Activity [PE]']},\n",
       " {'product_ndc': '72865-156',\n",
       "  'generic_name': 'Aripiprazole',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Aripiprazole',\n",
       "  'active_ingredients': [{'name': 'ARIPIPRAZOLE', 'strength': '15 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-156-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72865-156-05)',\n",
       "    'marketing_start_date': '20201120',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-156-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72865-156-30)',\n",
       "    'marketing_start_date': '20201120',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['349490', '349545', '349547', '349553', '402131', '602964'],\n",
       "   'spl_set_id': ['b284b294-40a0-4ccd-b7b7-b61267cd4e76'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865155059', '0372865153055', '0372865154052'],\n",
       "   'nui': ['N0000175430'],\n",
       "   'pharm_class_epc': ['Atypical Antipsychotic [EPC]'],\n",
       "   'unii': ['82VFR53I78']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'f26f3784-b822-9efd-e053-2a95a90ab6ee',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201120',\n",
       "  'product_id': '72865-156_f26f3784-b822-9efd-e053-2a95a90ab6ee',\n",
       "  'application_number': 'ANDA205064',\n",
       "  'brand_name_base': 'Aripiprazole',\n",
       "  'pharm_class': ['Atypical Antipsychotic [EPC]']},\n",
       " {'product_ndc': '72865-168',\n",
       "  'generic_name': 'hydromorphone hydrochloride',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals, Inc.',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'hydromorphone hydrochloride',\n",
       "  'active_ingredients': [{'name': 'HYDROMORPHONE HYDROCHLORIDE',\n",
       "    'strength': '8 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-168-01',\n",
       "    'description': '100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-168-01)',\n",
       "    'marketing_start_date': '20200924',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['902729', '902736', '902741', '1306898'],\n",
       "   'spl_set_id': ['90bda45c-9dbe-4ed5-91d0-df8446ad7026'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865168011', '0372865171011', '0372865170014', '0372865169018'],\n",
       "   'unii': ['L960UP2KRW']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '55fb6272-5677-43cf-b92d-5a6a6f484b6e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200924',\n",
       "  'product_id': '72865-168_55fb6272-5677-43cf-b92d-5a6a6f484b6e',\n",
       "  'application_number': 'ANDA212133',\n",
       "  'brand_name_base': 'hydromorphone hydrochloride',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '72865-185',\n",
       "  'generic_name': 'Aripiprazole',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Aripiprazole',\n",
       "  'active_ingredients': [{'name': 'ARIPIPRAZOLE', 'strength': '30 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-185-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72865-185-05)',\n",
       "    'marketing_start_date': '20210105',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-185-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72865-185-30)',\n",
       "    'marketing_start_date': '20210105',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['349490', '349545', '349547', '349553', '402131', '602964'],\n",
       "   'spl_set_id': ['0a6fa113-6bb2-4f88-af07-ce0914c98ff2'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865182055', '0372865181058', '0372865180051'],\n",
       "   'nui': ['N0000175430'],\n",
       "   'pharm_class_epc': ['Atypical Antipsychotic [EPC]'],\n",
       "   'unii': ['82VFR53I78']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'a45172c6-a7a6-46f3-bfc4-a7b12eac07c5',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210105',\n",
       "  'product_id': '72865-185_a45172c6-a7a6-46f3-bfc4-a7b12eac07c5',\n",
       "  'application_number': 'ANDA205064',\n",
       "  'brand_name_base': 'Aripiprazole',\n",
       "  'pharm_class': ['Atypical Antipsychotic [EPC]']},\n",
       " {'product_ndc': '72865-200',\n",
       "  'generic_name': 'venlafaxine',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'VENLAFAXINE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'VENLAFAXINE HYDROCHLORIDE',\n",
       "    'strength': '225 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-200-30',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-200-30)',\n",
       "    'marketing_start_date': '20210226',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-200-90',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-200-90)',\n",
       "    'marketing_start_date': '20210226',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['808744', '808748', '808751', '808753'],\n",
       "   'spl_set_id': ['68f40801-d35e-464e-ac94-21016b617ea2'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865198902',\n",
       "    '0372865199909',\n",
       "    '0372865197301',\n",
       "    '0372865198308',\n",
       "    '0372865200308',\n",
       "    '0372865200902',\n",
       "    '0372865199305',\n",
       "    '0372865197905'],\n",
       "   'unii': ['7D7RX5A8MO']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '2cdc9267-9619-474a-abe4-a0b85ac3fb2d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210226',\n",
       "  'product_id': '72865-200_2cdc9267-9619-474a-abe4-a0b85ac3fb2d',\n",
       "  'application_number': 'ANDA214419',\n",
       "  'brand_name_base': 'VENLAFAXINE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Norepinephrine Uptake Inhibitors [MoA]',\n",
       "   'Serotonin Uptake Inhibitors [MoA]',\n",
       "   'Serotonin and Norepinephrine Reuptake Inhibitor [EPC]']},\n",
       " {'product_ndc': '72865-211',\n",
       "  'generic_name': 'Lisinopril',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals Inc.',\n",
       "  'brand_name': 'Lisinopril',\n",
       "  'active_ingredients': [{'name': 'LISINOPRIL', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-211-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72865-211-01)',\n",
       "    'marketing_start_date': '20210817',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-211-10',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72865-211-10)',\n",
       "    'marketing_start_date': '20210817',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-211-18',\n",
       "    'description': '180 TABLET in 1 BOTTLE (72865-211-18)',\n",
       "    'marketing_start_date': '20210817',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-211-45',\n",
       "    'description': '45 TABLET in 1 BOTTLE (72865-211-45)',\n",
       "    'marketing_start_date': '20210817',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-211-50',\n",
       "    'description': '5000 TABLET in 1 BOTTLE (72865-211-50)',\n",
       "    'marketing_start_date': '20210817',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-211-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72865-211-90)',\n",
       "    'marketing_start_date': '20210817',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['197884', '205326', '311353', '311354', '314076', '314077'],\n",
       "   'spl_set_id': ['c008ecb6-970d-4ac9-9402-e21e8d9d76b2'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865210505', '0372865212059', '0372865211502', '0372865213100'],\n",
       "   'unii': ['E7199S1YWR']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'c008ecb6-970d-4ac9-9402-e21e8d9d76b2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210817',\n",
       "  'product_id': '72865-211_c008ecb6-970d-4ac9-9402-e21e8d9d76b2',\n",
       "  'application_number': 'ANDA075903',\n",
       "  'brand_name_base': 'Lisinopril',\n",
       "  'pharm_class': ['Angiotensin Converting Enzyme Inhibitor [EPC]',\n",
       "   'Angiotensin-converting Enzyme Inhibitors [MoA]']},\n",
       " {'product_ndc': '72865-232',\n",
       "  'generic_name': 'Maraviroc',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals Inc.',\n",
       "  'brand_name': 'Maraviroc',\n",
       "  'active_ingredients': [{'name': 'MARAVIROC', 'strength': '300 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-232-60',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (72865-232-60)',\n",
       "    'marketing_start_date': '20230601',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['728223', '728225'],\n",
       "   'spl_set_id': ['d3a728e2-1866-462e-bfcc-5f3c9dd88794'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175572', 'N0000175445'],\n",
       "   'pharm_class_epc': ['CCR5 Co-receptor Antagonist [EPC]'],\n",
       "   'pharm_class_moa': ['Chemokine Co-receptor 5 Antagonists [MoA]'],\n",
       "   'unii': ['MD6P741W8A']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '00498e1e-2c96-4932-e063-6294a90abfc4',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230601',\n",
       "  'product_id': '72865-232_00498e1e-2c96-4932-e063-6294a90abfc4',\n",
       "  'application_number': 'ANDA203347',\n",
       "  'brand_name_base': 'Maraviroc',\n",
       "  'pharm_class': ['CCR5 Co-receptor Antagonist [EPC]',\n",
       "   'Chemokine Co-receptor 5 Antagonists [MoA]']},\n",
       " {'product_ndc': '0591-2258',\n",
       "  'generic_name': 'scopolamine',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'scopolamine',\n",
       "  'active_ingredients': [{'name': 'SCOPOLAMINE', 'strength': '1 mg/3d'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-2258-04',\n",
       "    'description': '4 POUCH in 1 CARTON (0591-2258-04)  / 1 PATCH in 1 POUCH / 3 d in 1 PATCH',\n",
       "    'marketing_start_date': '20220512',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0591-2258-23',\n",
       "    'description': '24 POUCH in 1 CARTON (0591-2258-23)  / 1 PATCH in 1 POUCH / 3 d in 1 PATCH',\n",
       "    'marketing_start_date': '20220512',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0591-2258-79',\n",
       "    'description': '10 POUCH in 1 CARTON (0591-2258-79)  / 1 PATCH in 1 POUCH / 3 d in 1 PATCH',\n",
       "    'marketing_start_date': '20220512',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['226552'],\n",
       "   'spl_set_id': ['800b6421-48eb-47f5-b255-c12f75e59068'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175574', 'N0000175370'],\n",
       "   'pharm_class_epc': ['Anticholinergic [EPC]'],\n",
       "   'pharm_class_moa': ['Cholinergic Antagonists [MoA]'],\n",
       "   'unii': ['DL48G20X8X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SYSTEM',\n",
       "  'spl_id': '81341278-b576-4af8-8c76-7e14ca420df2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TRANSDERMAL'],\n",
       "  'marketing_start_date': '20220512',\n",
       "  'product_id': '0591-2258_81341278-b576-4af8-8c76-7e14ca420df2',\n",
       "  'application_number': 'ANDA208769',\n",
       "  'brand_name_base': 'scopolamine',\n",
       "  'pharm_class': ['Anticholinergic [EPC]', 'Cholinergic Antagonists [MoA]']},\n",
       " {'product_ndc': '72865-241',\n",
       "  'generic_name': 'levothyroxine sodium',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'LEVOTHYROXINE SODIUM',\n",
       "  'active_ingredients': [{'name': 'LEVOTHYROXINE SODIUM',\n",
       "    'strength': '.112 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-241-10',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72865-241-10)',\n",
       "    'marketing_start_date': '20230118',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-241-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72865-241-90)',\n",
       "    'marketing_start_date': '20230118',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['892246',\n",
       "    '892251',\n",
       "    '892255',\n",
       "    '966220',\n",
       "    '966221',\n",
       "    '966222',\n",
       "    '966224',\n",
       "    '966225',\n",
       "    '966248',\n",
       "    '966249',\n",
       "    '966253',\n",
       "    '966270'],\n",
       "   'spl_set_id': ['51a27110-e787-409b-98ba-c6471d0ad5cf'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865240106',\n",
       "    '0372865242100',\n",
       "    '0372865243107',\n",
       "    '0372865241103',\n",
       "    '0372865246108',\n",
       "    '0372865245101',\n",
       "    '0372865244104',\n",
       "    '0372865237106',\n",
       "    '0372865237908',\n",
       "    '0372865247105',\n",
       "    '0372865236109',\n",
       "    '0372865239100',\n",
       "    '0372865238905',\n",
       "    '0372865238103'],\n",
       "   'unii': ['9J765S329G']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '16376b6d-2936-4208-ab94-3e0969dce769',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230118',\n",
       "  'product_id': '72865-241_16376b6d-2936-4208-ab94-3e0969dce769',\n",
       "  'application_number': 'ANDA215259',\n",
       "  'brand_name_base': 'LEVOTHYROXINE SODIUM',\n",
       "  'pharm_class': ['Thyroxine [CS]', 'l-Thyroxine [EPC]']},\n",
       " {'product_ndc': '72865-246',\n",
       "  'generic_name': 'levothyroxine sodium',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'LEVOTHYROXINE SODIUM',\n",
       "  'active_ingredients': [{'name': 'LEVOTHYROXINE SODIUM',\n",
       "    'strength': '.2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-246-10',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72865-246-10)',\n",
       "    'marketing_start_date': '20230118',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-246-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72865-246-90)',\n",
       "    'marketing_start_date': '20230118',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['892246',\n",
       "    '892251',\n",
       "    '892255',\n",
       "    '966220',\n",
       "    '966221',\n",
       "    '966222',\n",
       "    '966224',\n",
       "    '966225',\n",
       "    '966248',\n",
       "    '966249',\n",
       "    '966253',\n",
       "    '966270'],\n",
       "   'spl_set_id': ['51a27110-e787-409b-98ba-c6471d0ad5cf'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865240106',\n",
       "    '0372865242100',\n",
       "    '0372865243107',\n",
       "    '0372865241103',\n",
       "    '0372865246108',\n",
       "    '0372865245101',\n",
       "    '0372865244104',\n",
       "    '0372865237106',\n",
       "    '0372865237908',\n",
       "    '0372865247105',\n",
       "    '0372865236109',\n",
       "    '0372865239100',\n",
       "    '0372865238905',\n",
       "    '0372865238103'],\n",
       "   'unii': ['9J765S329G']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '16376b6d-2936-4208-ab94-3e0969dce769',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230118',\n",
       "  'product_id': '72865-246_16376b6d-2936-4208-ab94-3e0969dce769',\n",
       "  'application_number': 'ANDA215259',\n",
       "  'brand_name_base': 'LEVOTHYROXINE SODIUM',\n",
       "  'pharm_class': ['Thyroxine [CS]', 'l-Thyroxine [EPC]']},\n",
       " {'product_ndc': '72865-255',\n",
       "  'generic_name': 'Gabapentin',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'GABAPENTIN',\n",
       "  'active_ingredients': [{'name': 'GABAPENTIN', 'strength': '600 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-255-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72865-255-05)',\n",
       "    'marketing_start_date': '20211001',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-255-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72865-255-90)',\n",
       "    'marketing_start_date': '20211001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['310433', '310434'],\n",
       "   'spl_set_id': ['707ed63a-67ca-4a62-9cbe-cdeb5c4ab506'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372865256909', '0372865255056', '0372865255902', '0372865256053'],\n",
       "   'nui': ['N0000008486'],\n",
       "   'pharm_class_pe': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]'],\n",
       "   'unii': ['6CW7F3G59X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '800c60ab-e34e-496f-b813-d805c88d8e64',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20211001',\n",
       "  'product_id': '72865-255_800c60ab-e34e-496f-b813-d805c88d8e64',\n",
       "  'application_number': 'ANDA214957',\n",
       "  'brand_name_base': 'GABAPENTIN',\n",
       "  'pharm_class': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]']},\n",
       " {'product_ndc': '72865-261',\n",
       "  'generic_name': 'Torsemide',\n",
       "  'labeler_name': 'XLCare Pharmaceuticals Inc.',\n",
       "  'brand_name': 'Torsemide',\n",
       "  'active_ingredients': [{'name': 'TORSEMIDE', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72865-261-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72865-261-01)',\n",
       "    'marketing_start_date': '20240910',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72865-261-90',\n",
       "    'description': '90 TABLET in 1 BOTTLE (72865-261-90)',\n",
       "    'marketing_start_date': '20240910',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['XLCare Pharmaceuticals Inc.'],\n",
       "   'rxcui': ['198369', '198370', '198371', '198372'],\n",
       "   'spl_set_id': ['234ff9d7-a02e-417f-a1f9-94038783cc77'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175366', 'N0000175590'],\n",
       "   'pharm_class_pe': ['Increased Diuresis at Loop of Henle [PE]'],\n",
       "   'pharm_class_epc': ['Loop Diuretic [EPC]'],\n",
       "   'unii': ['W31X2H97FB']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '21c3ca92-aba8-297c-e063-6394a90a7255',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240910',\n",
       "  'product_id': '72865-261_21c3ca92-aba8-297c-e063-6394a90a7255',\n",
       "  'application_number': 'ANDA079234',\n",
       "  'brand_name_base': 'Torsemide',\n",
       "  'pharm_class': ['Increased Diuresis at Loop of Henle [PE]',\n",
       "   'Loop Diuretic [EPC]']},\n",
       " {'product_ndc': '0591-2287',\n",
       "  'generic_name': 'Propafenone Hydrochloride',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Propafenone Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'PROPAFENONE HYDROCHLORIDE',\n",
       "    'strength': '425 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-2287-60',\n",
       "    'description': '60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-2287-60)',\n",
       "    'marketing_start_date': '20151015',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['861156', '861164', '861171'],\n",
       "   'spl_set_id': ['4a8c7594-3576-4e87-9513-8849ef92d509'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['33XCH0HOCD']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE, EXTENDED RELEASE',\n",
       "  'spl_id': 'c182c2d8-9287-465e-b7f0-4a0fe30d96c9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20151015',\n",
       "  'product_id': '0591-2287_c182c2d8-9287-465e-b7f0-4a0fe30d96c9',\n",
       "  'application_number': 'ANDA202688',\n",
       "  'brand_name_base': 'Propafenone Hydrochloride',\n",
       "  'pharm_class': ['Antiarrhythmic [EPC]']},\n",
       " {'product_ndc': '0591-2312',\n",
       "  'generic_name': 'Alvimopan',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Alvimopan',\n",
       "  'active_ingredients': [{'name': 'ALVIMOPAN', 'strength': '12 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-2312-15',\n",
       "    'description': '30 BLISTER PACK in 1 CARTON (0591-2312-15)  / 1 CAPSULE in 1 BLISTER PACK (0591-2312-45)',\n",
       "    'marketing_start_date': '20201201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['799835'],\n",
       "   'spl_set_id': ['2a0645b4-daf8-421f-b987-a4e478843c5d'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['677C126AET']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'ef9ffdef-f019-4329-b6a4-658fa872d3b8',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20201201',\n",
       "  'product_id': '0591-2312_ef9ffdef-f019-4329-b6a4-658fa872d3b8',\n",
       "  'application_number': 'ANDA208295',\n",
       "  'brand_name_base': 'Alvimopan',\n",
       "  'pharm_class': ['Opioid Antagonist [EPC]', 'Opioid Antagonists [MoA]']},\n",
       " {'product_ndc': '72866-001',\n",
       "  'marketing_end_date': '20250630',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'Merci Handy Corporation',\n",
       "  'brand_name': 'Hand Sanitizer, Flower Power',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '670 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72866-001-30',\n",
       "    'description': '30 mL in 1 BOTTLE (72866-001-30)',\n",
       "    'marketing_start_date': '20190301',\n",
       "    'marketing_end_date': '20250630',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Merci Handy Corporation'],\n",
       "   'rxcui': ['1039708'],\n",
       "   'spl_set_id': ['24caf482-4e87-499e-8115-a5f4632f7135'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'ee9fbfd4-aad6-5189-e053-2a95a90a4ff2',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190301',\n",
       "  'product_id': '72866-001_ee9fbfd4-aad6-5189-e053-2a95a90a4ff2',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'Hand Sanitizer, Flower Power'},\n",
       " {'product_ndc': '72866-004',\n",
       "  'marketing_end_date': '20250630',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'Merci Handy Corporation',\n",
       "  'brand_name': 'Hand Sanitizer, Cross the lime',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '670 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72866-004-30',\n",
       "    'description': '30 mL in 1 BOTTLE (72866-004-30)',\n",
       "    'marketing_start_date': '20190301',\n",
       "    'marketing_end_date': '20250630',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Merci Handy Corporation'],\n",
       "   'rxcui': ['1039708'],\n",
       "   'spl_set_id': ['d0dd8fad-2afa-4c31-96f9-5dd001c71af4'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'b4cb62d4-a1d0-30d1-e053-2995a90ad0ad',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190301',\n",
       "  'product_id': '72866-004_b4cb62d4-a1d0-30d1-e053-2995a90ad0ad',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'Hand Sanitizer, Cross the lime'},\n",
       " {'product_ndc': '72866-015',\n",
       "  'marketing_end_date': '20250630',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'Merci Handy Corp',\n",
       "  'brand_name': 'Merci Handy Hand Sanitizer Orange and Peppermint Energizing',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '.7 mL/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72866-015-50',\n",
       "    'description': '50 mL in 1 BOTTLE (72866-015-50)',\n",
       "    'marketing_start_date': '20200101',\n",
       "    'marketing_end_date': '20250630',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Merci Handy Corp'],\n",
       "   'rxcui': ['1041849'],\n",
       "   'spl_set_id': ['b8292b69-f447-22fa-e053-2a95a90a52e8'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': 'ee9e1f7f-d462-1538-e053-2a95a90a7efc',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200101',\n",
       "  'product_id': '72866-015_ee9e1f7f-d462-1538-e053-2a95a90a7efc',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'Merci Handy Hand Sanitizer Orange and Peppermint Energizing'},\n",
       " {'product_ndc': '0591-2405',\n",
       "  'generic_name': 'Ambrisentan',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Ambrisentan',\n",
       "  'active_ingredients': [{'name': 'AMBRISENTAN', 'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-2405-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (0591-2405-30)',\n",
       "    'marketing_start_date': '20190430',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['722116', '722122'],\n",
       "   'spl_set_id': ['32549c43-f8ff-422c-b42d-ca0877e661cf'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175581', 'N0000175364'],\n",
       "   'pharm_class_epc': ['Endothelin Receptor Antagonist [EPC]'],\n",
       "   'pharm_class_moa': ['Endothelin Receptor Antagonists [MoA]'],\n",
       "   'unii': ['HW6NV07QEC']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '2642df14-b8bc-4f7f-8290-495ae31a279d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190430',\n",
       "  'product_id': '0591-2405_2642df14-b8bc-4f7f-8290-495ae31a279d',\n",
       "  'application_number': 'ANDA208252',\n",
       "  'brand_name_base': 'Ambrisentan',\n",
       "  'pharm_class': ['Endothelin Receptor Antagonist [EPC]',\n",
       "   'Endothelin Receptor Antagonists [MoA]']},\n",
       " {'product_ndc': '72887-160',\n",
       "  'generic_name': 'GLYCOPYRROLATE',\n",
       "  'labeler_name': 'FH2 Pharma LLC',\n",
       "  'brand_name': 'GLYCOPYRROLATE',\n",
       "  'active_ingredients': [{'name': 'GLYCOPYRROLATE', 'strength': '1.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72887-160-03',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72887-160-03)',\n",
       "    'marketing_start_date': '20211129',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['FH2 Pharma LLC'],\n",
       "   'rxcui': ['1247658'],\n",
       "   'spl_set_id': ['18ca98ed-522d-470f-bb22-908bbd7d489a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['V92SO9WP2I']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '5bc26249-4e9b-4870-a696-99779c90dc27',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20211129',\n",
       "  'product_id': '72887-160_5bc26249-4e9b-4870-a696-99779c90dc27',\n",
       "  'application_number': 'ANDA091522',\n",
       "  'brand_name_base': 'GLYCOPYRROLATE',\n",
       "  'pharm_class': ['Anticholinergic [EPC]',\n",
       "   'Cholinergic Antagonists [MoA]',\n",
       "   'Cholinergic Muscarinic Antagonist [EPC]',\n",
       "   'Cholinergic Muscarinic Antagonists [MoA]']},\n",
       " {'product_ndc': '72887-873',\n",
       "  'generic_name': 'methocarbamol',\n",
       "  'labeler_name': 'FH2 PHARMA LLC',\n",
       "  'brand_name': 'methocarbamol',\n",
       "  'active_ingredients': [{'name': 'METHOCARBAMOL', 'strength': '1000 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72887-873-03',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72887-873-03)',\n",
       "    'marketing_start_date': '20240830',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['FH2 PHARMA LLC'],\n",
       "   'rxcui': ['2611794'],\n",
       "   'spl_set_id': ['1dd56e3d-7ca7-1443-e063-6294a90a13c5'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175730', 'N0000175737'],\n",
       "   'pharm_class_pe': ['Centrally-mediated Muscle Relaxation [PE]'],\n",
       "   'pharm_class_epc': ['Muscle Relaxant [EPC]'],\n",
       "   'unii': ['125OD7737X']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '1c804f03-51f8-18fc-e063-6394a90af793',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240830',\n",
       "  'product_id': '72887-873_1c804f03-51f8-18fc-e063-6394a90af793',\n",
       "  'application_number': 'ANDA212707',\n",
       "  'brand_name_base': 'methocarbamol',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '72888-004',\n",
       "  'generic_name': 'Metoprolol Tartrate',\n",
       "  'labeler_name': 'Advagen Pharma Limited',\n",
       "  'brand_name': 'Metoprolol Tartrate',\n",
       "  'active_ingredients': [{'name': 'METOPROLOL TARTRATE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-004-00',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (72888-004-00)',\n",
       "    'marketing_start_date': '20181201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-004-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72888-004-01)',\n",
       "    'marketing_start_date': '20181201',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '72888-004-05',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (72888-004-05)',\n",
       "    'marketing_start_date': '20211126',\n",
       "    'sample': True}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Limited'],\n",
       "   'rxcui': ['866511', '866514', '866924', '1606347', '1606349'],\n",
       "   'spl_set_id': ['a401fe31-d51a-49d9-a062-c9d22088db56'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888004013',\n",
       "    '0372888101019',\n",
       "    '0372888004006',\n",
       "    '0372888006000',\n",
       "    '0372888004051',\n",
       "    '0372888005010',\n",
       "    '0372888006017',\n",
       "    '0372888101057',\n",
       "    '0372888023052',\n",
       "    '0372888023014',\n",
       "    '0372888005058',\n",
       "    '0372888005003'],\n",
       "   'unii': ['W5S57Y3A5L']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'e655d13a-7b74-63d5-e053-2a95a90abe8f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20181201',\n",
       "  'product_id': '72888-004_e655d13a-7b74-63d5-e053-2a95a90abe8f',\n",
       "  'application_number': 'ANDA200981',\n",
       "  'brand_name_base': 'Metoprolol Tartrate',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72888-012',\n",
       "  'generic_name': 'cyclobenzaprine hydrochloride',\n",
       "  'labeler_name': 'Advagen Pharma Limited',\n",
       "  'brand_name': 'CYCLOBENZAPRINE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'CYCLOBENZAPRINE HYDROCHLORIDE',\n",
       "    'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-012-00',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (72888-012-00)',\n",
       "    'marketing_start_date': '20211101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-012-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72888-012-01)',\n",
       "    'marketing_start_date': '20170531',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-012-05',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (72888-012-05)',\n",
       "    'marketing_start_date': '20170531',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Limited'],\n",
       "   'rxcui': ['828299', '828320', '828348'],\n",
       "   'spl_set_id': ['b2169957-9083-412c-a175-3071860c2b43'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888012001',\n",
       "    '0372888014005',\n",
       "    '0372888014012',\n",
       "    '0372888014050',\n",
       "    '0372888012018',\n",
       "    '0372888012056',\n",
       "    '0372888013015'],\n",
       "   'unii': ['0VE05JYS2P']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'd1ff27a2-a8c1-424a-e053-2995a90a3bac',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170531',\n",
       "  'product_id': '72888-012_d1ff27a2-a8c1-424a-e053-2995a90a3bac',\n",
       "  'application_number': 'ANDA208170',\n",
       "  'brand_name_base': 'CYCLOBENZAPRINE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Centrally-mediated Muscle Relaxation [PE]',\n",
       "   'Muscle Relaxant [EPC]']},\n",
       " {'product_ndc': '72888-017',\n",
       "  'generic_name': 'sildenafil',\n",
       "  'labeler_name': 'Advagen Pharma Ltd',\n",
       "  'brand_name': 'SILDENAFIL',\n",
       "  'active_ingredients': [{'name': 'SILDENAFIL CITRATE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-017-00',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (72888-017-00)',\n",
       "    'marketing_start_date': '20211108',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-017-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72888-017-01)',\n",
       "    'marketing_start_date': '20210617',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-017-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72888-017-30)',\n",
       "    'marketing_start_date': '20210617',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Ltd'],\n",
       "   'rxcui': ['312950', '314228', '314229'],\n",
       "   'spl_set_id': ['e671d887-2317-4c1c-9b68-e24cda3d3aef'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888017303',\n",
       "    '0372888015309',\n",
       "    '0372888017006',\n",
       "    '0372888016009',\n",
       "    '0372888015057',\n",
       "    '0372888017013',\n",
       "    '0372888016016',\n",
       "    '0372888016306'],\n",
       "   'unii': ['BW9B0ZE037']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'd0530f0d-ce7d-09f9-e053-2a95a90a3b7c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210617',\n",
       "  'product_id': '72888-017_d0530f0d-ce7d-09f9-e053-2a95a90a3b7c',\n",
       "  'application_number': 'ANDA204882',\n",
       "  'brand_name_base': 'SILDENAFIL',\n",
       "  'pharm_class': ['Phosphodiesterase 5 Inhibitor [EPC]',\n",
       "   'Phosphodiesterase 5 Inhibitors [MoA]']},\n",
       " {'product_ndc': '72888-034',\n",
       "  'generic_name': 'CARVEDILOL',\n",
       "  'labeler_name': 'Advagen Pharma Ltd',\n",
       "  'brand_name': 'CARVEDILOL',\n",
       "  'active_ingredients': [{'name': 'CARVEDILOL', 'strength': '3.125 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-034-00',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (72888-034-00)',\n",
       "    'marketing_start_date': '20210729',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-034-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72888-034-01)',\n",
       "    'marketing_start_date': '20210729',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-034-05',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (72888-034-05)',\n",
       "    'marketing_start_date': '20210729',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-034-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72888-034-30)',\n",
       "    'marketing_start_date': '20210729',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Ltd'],\n",
       "   'rxcui': ['200031', '200032', '200033', '686924'],\n",
       "   'spl_set_id': ['7a7d3ca1-05b0-4c7e-aefa-492cc441585d'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888036007',\n",
       "    '0372888036014',\n",
       "    '0372888036304',\n",
       "    '0372888037301',\n",
       "    '0372888037011',\n",
       "    '0372888036052',\n",
       "    '0372888037059',\n",
       "    '0372888034003',\n",
       "    '0372888034010',\n",
       "    '0372888037004',\n",
       "    '0372888034058',\n",
       "    '0372888035017',\n",
       "    '0372888035055',\n",
       "    '0372888035000',\n",
       "    '0372888034300',\n",
       "    '0372888035307'],\n",
       "   'nui': ['N0000000099',\n",
       "    'N0000009923',\n",
       "    'N0000009924',\n",
       "    'N0000175553',\n",
       "    'N0000175556'],\n",
       "   'pharm_class_moa': ['Adrenergic alpha-Antagonists [MoA]',\n",
       "    'Adrenergic beta1-Antagonists [MoA]',\n",
       "    'Adrenergic beta2-Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['alpha-Adrenergic Blocker [EPC]',\n",
       "    'beta-Adrenergic Blocker [EPC]'],\n",
       "   'unii': ['0K47UL67F2']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'c9c39fa9-e682-1aac-e053-2995a90aa2f9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210729',\n",
       "  'product_id': '72888-034_c9c39fa9-e682-1aac-e053-2995a90aa2f9',\n",
       "  'application_number': 'ANDA078165',\n",
       "  'brand_name_base': 'CARVEDILOL',\n",
       "  'pharm_class': ['Adrenergic alpha-Antagonists [MoA]',\n",
       "   'Adrenergic beta1-Antagonists [MoA]',\n",
       "   'Adrenergic beta2-Antagonists [MoA]',\n",
       "   'alpha-Adrenergic Blocker [EPC]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72888-036',\n",
       "  'generic_name': 'CARVEDILOL',\n",
       "  'labeler_name': 'Advagen Pharma Ltd',\n",
       "  'brand_name': 'CARVEDILOL',\n",
       "  'active_ingredients': [{'name': 'CARVEDILOL', 'strength': '12.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-036-00',\n",
       "    'description': '1000 TABLET, FILM COATED in 1 BOTTLE (72888-036-00)',\n",
       "    'marketing_start_date': '20210729',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-036-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (72888-036-01)',\n",
       "    'marketing_start_date': '20210729',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-036-05',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE (72888-036-05)',\n",
       "    'marketing_start_date': '20210729',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-036-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (72888-036-30)',\n",
       "    'marketing_start_date': '20210729',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Ltd'],\n",
       "   'rxcui': ['200031', '200032', '200033', '686924'],\n",
       "   'spl_set_id': ['7a7d3ca1-05b0-4c7e-aefa-492cc441585d'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888036007',\n",
       "    '0372888036014',\n",
       "    '0372888036304',\n",
       "    '0372888037301',\n",
       "    '0372888037011',\n",
       "    '0372888036052',\n",
       "    '0372888037059',\n",
       "    '0372888034003',\n",
       "    '0372888034010',\n",
       "    '0372888037004',\n",
       "    '0372888034058',\n",
       "    '0372888035017',\n",
       "    '0372888035055',\n",
       "    '0372888035000',\n",
       "    '0372888034300',\n",
       "    '0372888035307'],\n",
       "   'nui': ['N0000000099',\n",
       "    'N0000009923',\n",
       "    'N0000009924',\n",
       "    'N0000175553',\n",
       "    'N0000175556'],\n",
       "   'pharm_class_moa': ['Adrenergic alpha-Antagonists [MoA]',\n",
       "    'Adrenergic beta1-Antagonists [MoA]',\n",
       "    'Adrenergic beta2-Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['alpha-Adrenergic Blocker [EPC]',\n",
       "    'beta-Adrenergic Blocker [EPC]'],\n",
       "   'unii': ['0K47UL67F2']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'c9c39fa9-e682-1aac-e053-2995a90aa2f9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210729',\n",
       "  'product_id': '72888-036_c9c39fa9-e682-1aac-e053-2995a90aa2f9',\n",
       "  'application_number': 'ANDA078165',\n",
       "  'brand_name_base': 'CARVEDILOL',\n",
       "  'pharm_class': ['Adrenergic alpha-Antagonists [MoA]',\n",
       "   'Adrenergic beta1-Antagonists [MoA]',\n",
       "   'Adrenergic beta2-Antagonists [MoA]',\n",
       "   'alpha-Adrenergic Blocker [EPC]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72888-049',\n",
       "  'generic_name': 'Pregabalin',\n",
       "  'labeler_name': 'Advagen Pharma Ltd.',\n",
       "  'dea_schedule': 'CV',\n",
       "  'brand_name': 'Pregabalin',\n",
       "  'active_ingredients': [{'name': 'PREGABALIN', 'strength': '82.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-049-30',\n",
       "    'description': '30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72888-049-30)',\n",
       "    'marketing_start_date': '20220322',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Ltd.'],\n",
       "   'rxcui': ['1988974', '1988977', '1988980'],\n",
       "   'spl_set_id': ['2ffee7e7-bfa0-4933-9baf-7df55080816e'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888051307', '0372888049304', '0372888050300'],\n",
       "   'unii': ['55JG375S6M']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED, EXTENDED RELEASE',\n",
       "  'spl_id': 'fac73c6c-11e2-54dc-e053-6394a90a9b28',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220322',\n",
       "  'product_id': '72888-049_fac73c6c-11e2-54dc-e053-6394a90a9b28',\n",
       "  'application_number': 'ANDA215249',\n",
       "  'brand_name_base': 'Pregabalin'},\n",
       " {'product_ndc': '72888-080',\n",
       "  'generic_name': 'Tramadol Hydrochloride',\n",
       "  'labeler_name': 'Advagen Pharma Limited',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Tramadol Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'TRAMADOL HYDROCHLORIDE',\n",
       "    'strength': '50 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-080-00',\n",
       "    'description': '1000 TABLET, COATED in 1 BOTTLE (72888-080-00)',\n",
       "    'marketing_start_date': '20230724',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-080-01',\n",
       "    'description': '100 TABLET, COATED in 1 BOTTLE (72888-080-01)',\n",
       "    'marketing_start_date': '20230724',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-080-05',\n",
       "    'description': '500 TABLET, COATED in 1 BOTTLE (72888-080-05)',\n",
       "    'marketing_start_date': '20230724',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Limited'],\n",
       "   'rxcui': ['835603', '2179635', '2670390', '2692878'],\n",
       "   'spl_set_id': ['93b12089-3a0f-4b57-abb1-2429cf31995d'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888163000',\n",
       "    '0372888008059',\n",
       "    '0372888080055',\n",
       "    '0372888163307',\n",
       "    '0372888008011',\n",
       "    '0372888008004',\n",
       "    '0372888162300',\n",
       "    '0372888163055',\n",
       "    '0372888080017',\n",
       "    '0372888162003',\n",
       "    '0372888162010',\n",
       "    '0372888080000',\n",
       "    '0372888163017',\n",
       "    '0372888162058'],\n",
       "   'unii': ['9N7R477WCK']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '21706a21-fd04-07a0-e063-6294a90adbbc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230724',\n",
       "  'product_id': '72888-080_21706a21-fd04-07a0-e063-6294a90adbbc',\n",
       "  'application_number': 'ANDA208708',\n",
       "  'brand_name_base': 'Tramadol Hydrochloride',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '72888-099',\n",
       "  'generic_name': 'POTASSIUM CHLORIDE',\n",
       "  'labeler_name': 'Advagen Pharma Ltd.',\n",
       "  'brand_name': 'POTASSIUM CHLORIDE',\n",
       "  'active_ingredients': [{'name': 'POTASSIUM CHLORIDE',\n",
       "    'strength': '1500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-099-00',\n",
       "    'description': '1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-099-00)',\n",
       "    'marketing_start_date': '20230630',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-099-01',\n",
       "    'description': '100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-099-01)',\n",
       "    'marketing_start_date': '20230630',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Ltd.'],\n",
       "   'rxcui': ['403888', '1801294', '1801298'],\n",
       "   'spl_set_id': ['f4497c26-da16-45b0-975d-81f2c2132704'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888098012',\n",
       "    '0372888098005',\n",
       "    '0372888097015',\n",
       "    '0372888099002',\n",
       "    '0372888097008',\n",
       "    '0372888099019'],\n",
       "   'unii': ['660YQ98I10']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': 'ffa769eb-0d3f-06c8-e053-6394a90a1fdc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230616',\n",
       "  'product_id': '72888-099_ffa769eb-0d3f-06c8-e053-6394a90a1fdc',\n",
       "  'application_number': 'ANDA216321',\n",
       "  'brand_name_base': 'POTASSIUM CHLORIDE',\n",
       "  'pharm_class': ['Increased Large Intestinal Motility [PE]',\n",
       "   'Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]',\n",
       "   'Osmotic Activity [MoA]',\n",
       "   'Osmotic Laxative [EPC]',\n",
       "   'Potassium Compounds [CS]',\n",
       "   'Potassium Salt [EPC]']},\n",
       " {'product_ndc': '72888-117',\n",
       "  'generic_name': 'Glipizide',\n",
       "  'labeler_name': 'Advagen Pharma Limited',\n",
       "  'brand_name': 'Glipizide',\n",
       "  'active_ingredients': [{'name': 'GLIPIZIDE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-117-00',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72888-117-00)',\n",
       "    'marketing_start_date': '20231003',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-117-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72888-117-01)',\n",
       "    'marketing_start_date': '20231003',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-117-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72888-117-05)',\n",
       "    'marketing_start_date': '20231003',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-117-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72888-117-30)',\n",
       "    'marketing_start_date': '20231003',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Limited'],\n",
       "   'rxcui': ['310488', '310490', '379804'],\n",
       "   'spl_set_id': ['e954afb8-52eb-416a-8f1b-14b0fcb3bac2'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888117003',\n",
       "    '0372888116303',\n",
       "    '0372888117010',\n",
       "    '0372888117300',\n",
       "    '0372888115306',\n",
       "    '0372888116051',\n",
       "    '0372888116013',\n",
       "    '0372888115009',\n",
       "    '0372888115016',\n",
       "    '0372888116006',\n",
       "    '0372888117058',\n",
       "    '0372888115054'],\n",
       "   'nui': ['N0000175608', 'M0020795'],\n",
       "   'pharm_class_epc': ['Sulfonylurea [EPC]'],\n",
       "   'pharm_class_cs': ['Sulfonylurea Compounds [CS]'],\n",
       "   'unii': ['X7WDT95N5C']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '076b60e7-5901-02a0-e063-6294a90a2587',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231003',\n",
       "  'product_id': '72888-117_076b60e7-5901-02a0-e063-6294a90a2587',\n",
       "  'application_number': 'ANDA214874',\n",
       "  'brand_name_base': 'Glipizide',\n",
       "  'pharm_class': ['Sulfonylurea Compounds [CS]', 'Sulfonylurea [EPC]']},\n",
       " {'product_ndc': '72888-139',\n",
       "  'generic_name': 'nitroglycerin',\n",
       "  'labeler_name': 'Advagen Pharma Ltd',\n",
       "  'brand_name': 'Nitroglycerin',\n",
       "  'active_ingredients': [{'name': 'NITROGLYCERIN', 'strength': '.4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-139-01',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72888-139-01)  / 100 TABLET in 1 BOTTLE',\n",
       "    'marketing_start_date': '20230520',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-139-33',\n",
       "    'description': '4 BOTTLE in 1 CARTON (72888-139-33)  / 25 TABLET in 1 BOTTLE',\n",
       "    'marketing_start_date': '20230520',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Ltd'],\n",
       "   'rxcui': ['198038', '198039', '198040'],\n",
       "   'spl_set_id': ['5a36dac2-7d35-4cbf-be3d-705b7135754d'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888140018',\n",
       "    '0372888138015',\n",
       "    '0372888139333',\n",
       "    '0372888139012',\n",
       "    '0372888139326'],\n",
       "   'nui': ['N0000175415', 'M0014874', 'N0000009909'],\n",
       "   'pharm_class_epc': ['Nitrate Vasodilator [EPC]'],\n",
       "   'pharm_class_cs': ['Nitrates [CS]'],\n",
       "   'pharm_class_pe': ['Vasodilation [PE]'],\n",
       "   'unii': ['G59M7S0WS3']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '06562ef8-c11b-7975-e063-6394a90a722a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBLINGUAL'],\n",
       "  'marketing_start_date': '20210503',\n",
       "  'product_id': '72888-139_06562ef8-c11b-7975-e063-6394a90a722a',\n",
       "  'application_number': 'ANDA209779',\n",
       "  'brand_name_base': 'Nitroglycerin',\n",
       "  'pharm_class': ['Nitrate Vasodilator [EPC]',\n",
       "   'Nitrates [CS]',\n",
       "   'Vasodilation [PE]']},\n",
       " {'product_ndc': '72888-140',\n",
       "  'generic_name': 'nitroglycerin',\n",
       "  'labeler_name': 'Advagen Pharma Ltd',\n",
       "  'brand_name': 'Nitroglycerin',\n",
       "  'active_ingredients': [{'name': 'NITROGLYCERIN', 'strength': '.6 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-140-01',\n",
       "    'description': '1 BOTTLE in 1 CARTON (72888-140-01)  / 100 TABLET in 1 BOTTLE',\n",
       "    'marketing_start_date': '20230520',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Ltd'],\n",
       "   'rxcui': ['198038', '198039', '198040'],\n",
       "   'spl_set_id': ['5a36dac2-7d35-4cbf-be3d-705b7135754d'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888140018',\n",
       "    '0372888138015',\n",
       "    '0372888139333',\n",
       "    '0372888139012',\n",
       "    '0372888139326'],\n",
       "   'nui': ['N0000175415', 'M0014874', 'N0000009909'],\n",
       "   'pharm_class_epc': ['Nitrate Vasodilator [EPC]'],\n",
       "   'pharm_class_cs': ['Nitrates [CS]'],\n",
       "   'pharm_class_pe': ['Vasodilation [PE]'],\n",
       "   'unii': ['G59M7S0WS3']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '06562ef8-c11b-7975-e063-6394a90a722a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBLINGUAL'],\n",
       "  'marketing_start_date': '20210503',\n",
       "  'product_id': '72888-140_06562ef8-c11b-7975-e063-6394a90a722a',\n",
       "  'application_number': 'ANDA209779',\n",
       "  'brand_name_base': 'Nitroglycerin',\n",
       "  'pharm_class': ['Nitrate Vasodilator [EPC]',\n",
       "   'Nitrates [CS]',\n",
       "   'Vasodilation [PE]']},\n",
       " {'product_ndc': '0591-2501',\n",
       "  'generic_name': 'Isotretinoin',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Isotretinoin',\n",
       "  'active_ingredients': [{'name': 'ISOTRETINOIN', 'strength': '35 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-2501-15',\n",
       "    'description': '3 BLISTER PACK in 1 CARTON (0591-2501-15)  / 10 CAPSULE in 1 BLISTER PACK (0591-2501-45)',\n",
       "    'marketing_start_date': '20210429',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['197843', '197844', '197845', '403930', '1547561', '1547565'],\n",
       "   'spl_set_id': ['1cf11710-f966-4529-8e08-02175f588bca'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175607', 'M0018962'],\n",
       "   'pharm_class_epc': ['Retinoid [EPC]'],\n",
       "   'pharm_class_cs': ['Retinoids [CS]'],\n",
       "   'unii': ['EH28UP18IF']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'f0923b95-8ad4-4992-9753-27f265fb2fb9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210429',\n",
       "  'product_id': '0591-2501_f0923b95-8ad4-4992-9753-27f265fb2fb9',\n",
       "  'application_number': 'ANDA205063',\n",
       "  'brand_name_base': 'Isotretinoin',\n",
       "  'pharm_class': ['Retinoid [EPC]', 'Retinoids [CS]']},\n",
       " {'product_ndc': '72888-152',\n",
       "  'generic_name': 'Clonazepam',\n",
       "  'labeler_name': 'Advagen Pharma Ltd',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Clonazepam',\n",
       "  'active_ingredients': [{'name': 'CLONAZEPAM', 'strength': '.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-152-00',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72888-152-00)',\n",
       "    'marketing_start_date': '20220414',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-152-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72888-152-01)',\n",
       "    'marketing_start_date': '20220414',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-152-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72888-152-05)',\n",
       "    'marketing_start_date': '20221010',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-152-30',\n",
       "    'description': '30 TABLET in 1 BOTTLE (72888-152-30)',\n",
       "    'marketing_start_date': '20220414',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Ltd'],\n",
       "   'rxcui': ['197527', '197528', '197529'],\n",
       "   'spl_set_id': ['30d674f9-f1b3-4c2d-a8e9-3bc8e476f1ec'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888152004',\n",
       "    '0372888152011',\n",
       "    '0372888153001',\n",
       "    '0372888153056',\n",
       "    '0372888152059',\n",
       "    '0372888154008',\n",
       "    '0372888153018',\n",
       "    '0372888152301',\n",
       "    '0372888153308',\n",
       "    '0372888154053',\n",
       "    '0372888154305',\n",
       "    '0372888154015'],\n",
       "   'nui': ['N0000175694', 'M0002356'],\n",
       "   'pharm_class_epc': ['Benzodiazepine [EPC]'],\n",
       "   'pharm_class_cs': ['Benzodiazepines [CS]'],\n",
       "   'unii': ['5PE9FDE8GB']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'f2261f75-a525-5bdc-e053-2a95a90aed79',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220414',\n",
       "  'product_id': '72888-152_f2261f75-a525-5bdc-e053-2a95a90aed79',\n",
       "  'application_number': 'ANDA075468',\n",
       "  'brand_name_base': 'Clonazepam',\n",
       "  'pharm_class': ['Benzodiazepine [EPC]', 'Benzodiazepines [CS]']},\n",
       " {'product_ndc': '72888-172',\n",
       "  'generic_name': 'Lithium',\n",
       "  'labeler_name': 'Advagen Pharma Ltd',\n",
       "  'brand_name': 'Lithium',\n",
       "  'active_ingredients': [{'name': 'LITHIUM CITRATE', 'strength': '8 meq/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-172-46',\n",
       "    'description': '500 mL in 1 BOTTLE (72888-172-46)',\n",
       "    'marketing_start_date': '20221109',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Ltd'],\n",
       "   'rxcui': ['756059'],\n",
       "   'spl_set_id': ['ff9baf45-830f-4a8a-8986-5caeaa1b38cf'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888172460'],\n",
       "   'unii': ['5Z6E9K79YV']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '03bf22bc-626c-eaf3-e063-6394a90a1e3a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20221109',\n",
       "  'product_id': '72888-172_03bf22bc-626c-eaf3-e063-6394a90a1e3a',\n",
       "  'application_number': 'ANDA218036',\n",
       "  'brand_name_base': 'Lithium',\n",
       "  'pharm_class': ['Mood Stabilizer [EPC]']},\n",
       " {'product_ndc': '72888-175',\n",
       "  'generic_name': 'DESVENLAFAXINE',\n",
       "  'labeler_name': 'Advagen Pharma Ltd',\n",
       "  'brand_name': 'DESVENLAFAXINE',\n",
       "  'active_ingredients': [{'name': 'DESVENLAFAXINE SUCCINATE',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-175-00',\n",
       "    'description': '1000 TABLET, EXTENDED RELEASE in 1 PACKAGE (72888-175-00)',\n",
       "    'marketing_start_date': '20230314',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-175-05',\n",
       "    'description': '500 TABLET, EXTENDED RELEASE in 1 PACKAGE (72888-175-05)',\n",
       "    'marketing_start_date': '20230314',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-175-30',\n",
       "    'description': '30 TABLET, EXTENDED RELEASE in 1 PACKAGE (72888-175-30)',\n",
       "    'marketing_start_date': '20230314',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-175-90',\n",
       "    'description': '90 TABLET, EXTENDED RELEASE in 1 PACKAGE (72888-175-90)',\n",
       "    'marketing_start_date': '20230314',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Ltd'],\n",
       "   'rxcui': ['1607617', '1874553', '1874559'],\n",
       "   'spl_set_id': ['ff837eb1-24c3-4c63-9b4b-c6b5935a9b47'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888175003',\n",
       "    '0372888175058',\n",
       "    '0372888144054',\n",
       "    '0372888144900',\n",
       "    '0372888144009',\n",
       "    '0372888143903',\n",
       "    '0372888143309',\n",
       "    '0372888143002',\n",
       "    '0372888175904',\n",
       "    '0372888143057',\n",
       "    '0372888144306'],\n",
       "   'unii': ['ZB22ENF0XR']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '0cddab65-5933-5be8-e063-6394a90a20b2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220131',\n",
       "  'product_id': '72888-175_0cddab65-5933-5be8-e063-6394a90a20b2',\n",
       "  'application_number': 'ANDA204028',\n",
       "  'brand_name_base': 'DESVENLAFAXINE',\n",
       "  'pharm_class': ['Cytochrome P450 2D6 Inhibitors [MoA]',\n",
       "   'Norepinephrine Uptake Inhibitors [MoA]',\n",
       "   'Serotonin Uptake Inhibitors [MoA]',\n",
       "   'Serotonin and Norepinephrine Reuptake Inhibitor [EPC]']},\n",
       " {'product_ndc': '72888-211',\n",
       "  'generic_name': 'METOPROLOL TARTRATE',\n",
       "  'labeler_name': 'Advagen Pharma Ltd',\n",
       "  'brand_name': 'METOPROLOL TARTRATE',\n",
       "  'active_ingredients': [{'name': 'METOPROLOL TARTRATE',\n",
       "    'strength': '75 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-211-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72888-211-01)',\n",
       "    'marketing_start_date': '20240117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-211-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72888-211-05)',\n",
       "    'marketing_start_date': '20240117',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Ltd'],\n",
       "   'rxcui': ['866511', '866514', '866924', '1606347', '1606349'],\n",
       "   'spl_set_id': ['3ecff825-34ea-4535-b935-627bf2c13d93'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888212005',\n",
       "    '0372888209050',\n",
       "    '0372888208008',\n",
       "    '0372888209012',\n",
       "    '0372888211053',\n",
       "    '0372888212012',\n",
       "    '0372888212050',\n",
       "    '0372888211015',\n",
       "    '0372888210056',\n",
       "    '0372888208015',\n",
       "    '0372888210001',\n",
       "    '0372888210018',\n",
       "    '0372888208053'],\n",
       "   'unii': ['W5S57Y3A5L']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '21706a21-fd4b-07a0-e063-6294a90adbbc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240117',\n",
       "  'product_id': '72888-211_21706a21-fd4b-07a0-e063-6294a90adbbc',\n",
       "  'application_number': 'ANDA200981',\n",
       "  'brand_name_base': 'METOPROLOL TARTRATE',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72888-212',\n",
       "  'generic_name': 'METOPROLOL TARTRATE',\n",
       "  'labeler_name': 'Advagen Pharma Ltd',\n",
       "  'brand_name': 'METOPROLOL TARTRATE',\n",
       "  'active_ingredients': [{'name': 'METOPROLOL TARTRATE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72888-212-00',\n",
       "    'description': '1000 TABLET in 1 BOTTLE (72888-212-00)',\n",
       "    'marketing_start_date': '20240117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-212-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (72888-212-01)',\n",
       "    'marketing_start_date': '20240117',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72888-212-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (72888-212-05)',\n",
       "    'marketing_start_date': '20240117',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Advagen Pharma Ltd'],\n",
       "   'rxcui': ['866511', '866514', '866924', '1606347', '1606349'],\n",
       "   'spl_set_id': ['3ecff825-34ea-4535-b935-627bf2c13d93'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372888212005',\n",
       "    '0372888209050',\n",
       "    '0372888208008',\n",
       "    '0372888209012',\n",
       "    '0372888211053',\n",
       "    '0372888212012',\n",
       "    '0372888212050',\n",
       "    '0372888211015',\n",
       "    '0372888210056',\n",
       "    '0372888208015',\n",
       "    '0372888210001',\n",
       "    '0372888210018',\n",
       "    '0372888208053'],\n",
       "   'unii': ['W5S57Y3A5L']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '21706a21-fd4b-07a0-e063-6294a90adbbc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240117',\n",
       "  'product_id': '72888-212_21706a21-fd4b-07a0-e063-6294a90adbbc',\n",
       "  'application_number': 'ANDA200981',\n",
       "  'brand_name_base': 'METOPROLOL TARTRATE',\n",
       "  'pharm_class': ['Adrenergic beta-Antagonists [MoA]',\n",
       "   'beta-Adrenergic Blocker [EPC]']},\n",
       " {'product_ndc': '72893-001',\n",
       "  'generic_name': 'Melphalan',\n",
       "  'labeler_name': 'Acrotech Biopharma Inc',\n",
       "  'brand_name': 'EVOMELA',\n",
       "  'active_ingredients': [{'name': 'MELPHALAN HYDROCHLORIDE',\n",
       "    'strength': '50 mg/10mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72893-001-01',\n",
       "    'description': '1 VIAL in 1 CARTON (72893-001-01)  / 20 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20160331',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Acrotech Biopharma Inc'],\n",
       "   'rxcui': ['311487', '1745090'],\n",
       "   'spl_set_id': ['69f55869-dc11-408e-8fc7-47634269a52c'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['1VXP4V453T']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION',\n",
       "  'spl_id': '4dd3db2d-aa56-4952-bcad-70fa22e8e93c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20160331',\n",
       "  'product_id': '72893-001_4dd3db2d-aa56-4952-bcad-70fa22e8e93c',\n",
       "  'application_number': 'NDA207155',\n",
       "  'brand_name_base': 'EVOMELA',\n",
       "  'pharm_class': ['Alkylating Activity [MoA]', 'Alkylating Drug [EPC]']},\n",
       " {'product_ndc': '72893-004',\n",
       "  'generic_name': 'levoleucovorin',\n",
       "  'labeler_name': 'Acrotech Biopharma Inc',\n",
       "  'brand_name': 'KHAPZORY',\n",
       "  'active_ingredients': [{'name': 'LEVOLEUCOVORIN DISODIUM',\n",
       "    'strength': '175 mg/3.5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72893-004-01',\n",
       "    'description': '1 VIAL in 1 CARTON (72893-004-01)  / 3.5 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20190102',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Acrotech Biopharma Inc'],\n",
       "   'spl_set_id': ['344f65ac-9f04-49d7-b7c3-4ba19bd7b429'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['5TXQ76K65T']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION',\n",
       "  'spl_id': '077441ae-c84f-470e-81e1-024bafe6033f',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20190102',\n",
       "  'product_id': '72893-004_077441ae-c84f-470e-81e1-024bafe6033f',\n",
       "  'application_number': 'NDA211226',\n",
       "  'brand_name_base': 'KHAPZORY',\n",
       "  'pharm_class': ['Folate Analog [EPC]', 'Folic Acid [CS]']},\n",
       " {'product_ndc': '72894-003',\n",
       "  'marketing_end_date': '20260404',\n",
       "  'generic_name': 'ZINC OXIDE',\n",
       "  'labeler_name': 'NUORI ApS',\n",
       "  'brand_name': 'NUORI MINERAL DEFENCE SUNSCREEN SPF 30',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '230 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72894-003-01',\n",
       "    'description': '1 TUBE in 1 CARTON (72894-003-01)  / 50 mL in 1 TUBE',\n",
       "    'marketing_start_date': '20190601',\n",
       "    'marketing_end_date': '20260404',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['NUORI ApS'],\n",
       "   'spl_set_id': ['8695330d-2426-f590-e053-2a91aa0a86ba'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '288d3eda-c024-e4b7-e063-6394a90abe29',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190601',\n",
       "  'product_id': '72894-003_288d3eda-c024-e4b7-e063-6394a90abe29',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'NUORI MINERAL DEFENCE SUNSCREEN SPF 30'},\n",
       " {'product_ndc': '72903-853',\n",
       "  'generic_name': 'MIRVETUXIMAB SORAVTANSINE',\n",
       "  'labeler_name': 'ImmunoGen, Inc.',\n",
       "  'brand_name': 'ELAHERE',\n",
       "  'active_ingredients': [{'name': 'MIRVETUXIMAB SORAVTANSINE',\n",
       "    'strength': '5 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72903-853-01',\n",
       "    'description': '1 VIAL, SINGLE-USE in 1 CARTON (72903-853-01)  / 20 mL in 1 VIAL, SINGLE-USE',\n",
       "    'marketing_start_date': '20221114',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['ImmunoGen, Inc.'],\n",
       "   'rxcui': ['2621553', '2621559'],\n",
       "   'spl_set_id': ['00c424b5-6ccd-48ab-9e88-1986451120e2'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['98DE7VN88D']},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '4d9a8f9b-d6d5-45ce-867e-6a5686fe36fc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20221114',\n",
       "  'product_id': '72903-853_4d9a8f9b-d6d5-45ce-867e-6a5686fe36fc',\n",
       "  'application_number': 'BLA761310',\n",
       "  'brand_name_base': 'ELAHERE'},\n",
       " {'product_ndc': '72922-011',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'ShangRao chunyu Technology CO.,LTD.',\n",
       "  'brand_name': 'Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '62 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72922-011-01',\n",
       "    'description': '29 mL in 1 BOTTLE (72922-011-01)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72922-011-06',\n",
       "    'description': '250 mL in 1 BOTTLE (72922-011-06)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72922-011-11',\n",
       "    'description': '10 mL in 1 BOTTLE (72922-011-11)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72922-011-12',\n",
       "    'description': '15 mL in 1 BOTTLE (72922-011-12)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72922-011-13',\n",
       "    'description': '30 mL in 1 BOTTLE (72922-011-13)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72922-011-15',\n",
       "    'description': '52 mL in 1 BOTTLE (72922-011-15)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72922-011-16',\n",
       "    'description': '100 mL in 1 BOTTLE (72922-011-16)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72922-011-17',\n",
       "    'description': '150 mL in 1 BOTTLE (72922-011-17)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72922-011-18',\n",
       "    'description': '237 mL in 1 BOTTLE (72922-011-18)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72922-011-19',\n",
       "    'description': '500 mL in 1 BOTTLE (72922-011-19)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72922-011-20',\n",
       "    'description': '60 mL in 1 BOTTLE (72922-011-20)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72922-011-21',\n",
       "    'description': '3800 mL in 1 BOTTLE (72922-011-21)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72922-011-25',\n",
       "    'description': '20 mL in 1 BOTTLE (72922-011-25)',\n",
       "    'marketing_start_date': '20240319',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['ShangRao chunyu Technology CO.,LTD.'],\n",
       "   'spl_set_id': ['13fc883e-dd94-b9c8-e063-6294a90a5f1e'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6923545500771', '6923545500733'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '13fc78df-f9b3-c1f9-e063-6294a90a4598',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['CUTANEOUS'],\n",
       "  'marketing_start_date': '20200330',\n",
       "  'product_id': '72922-011_13fc78df-f9b3-c1f9-e063-6294a90a4598',\n",
       "  'application_number': 'M005',\n",
       "  'brand_name_base': 'Hand Sanitizer'},\n",
       " {'product_ndc': '72927-944',\n",
       "  'generic_name': 'Camphor',\n",
       "  'labeler_name': 'Strides Consumer LLC',\n",
       "  'brand_name': 'Jointflex',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (SYNTHETIC)',\n",
       "    'strength': '3.2 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72927-944-01',\n",
       "    'description': '1 TUBE in 1 CARTON (72927-944-01)  / 85 g in 1 TUBE',\n",
       "    'marketing_start_date': '20200309',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72927-944-02',\n",
       "    'description': '1 TUBE in 1 CARTON (72927-944-02)  / 28 g in 1 TUBE',\n",
       "    'marketing_start_date': '20210901',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72927-944-03',\n",
       "    'description': '1 TUBE in 1 CARTON (72927-944-03)  / 28 g in 1 TUBE',\n",
       "    'marketing_start_date': '20210326',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Strides Consumer LLC'],\n",
       "   'rxcui': ['2181415', '2282659'],\n",
       "   'spl_set_id': ['766b73f2-67bd-4d5c-805c-1057b3981ebf'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372917000245'],\n",
       "   'unii': ['5TJD82A1ET']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '484d0f89-5f66-4b58-bc49-75c87ef52a3a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200309',\n",
       "  'product_id': '72927-944_484d0f89-5f66-4b58-bc49-75c87ef52a3a',\n",
       "  'application_number': 'part348',\n",
       "  'brand_name_base': 'Jointflex'},\n",
       " {'product_ndc': '72927-976',\n",
       "  'generic_name': 'Camphor',\n",
       "  'labeler_name': 'Strides Consumer LLC',\n",
       "  'brand_name': 'Jointflex',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (SYNTHETIC)',\n",
       "    'strength': '3.2 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72927-976-02',\n",
       "    'description': '1 TUBE, WITH APPLICATOR in 1 CARTON (72927-976-02)  / 99 g in 1 TUBE, WITH APPLICATOR',\n",
       "    'marketing_start_date': '20210601',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Strides Consumer LLC'],\n",
       "   'rxcui': ['2181415', '2282659'],\n",
       "   'spl_set_id': ['cb5ca02b-0bc1-4b0b-b4b1-abef3222aa56'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['5TJD82A1ET']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '5aba2ed8-89ca-4c60-8fb8-a3fcc469dc2e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210601',\n",
       "  'product_id': '72927-976_5aba2ed8-89ca-4c60-8fb8-a3fcc469dc2e',\n",
       "  'application_number': 'part348',\n",
       "  'brand_name_base': 'Jointflex'},\n",
       " {'product_ndc': '0591-2579',\n",
       "  'generic_name': 'Valganciclovir hydrochloride',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Valganciclovir hydrochloride for Oral',\n",
       "  'active_ingredients': [{'name': 'VALGANCICLOVIR HYDROCHLORIDE',\n",
       "    'strength': '50 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-2579-20',\n",
       "    'description': '100 mL in 1 BOTTLE, GLASS (0591-2579-20)',\n",
       "    'marketing_start_date': '20160826',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['863559'],\n",
       "   'spl_set_id': ['92281301-5fb5-4eea-8766-4863e241c234'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['4P3T9QF9NZ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'POWDER, FOR SOLUTION',\n",
       "  'spl_id': '9f669f81-9b46-440d-bb4f-0696098da2cc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20160826',\n",
       "  'product_id': '0591-2579_9f669f81-9b46-440d-bb4f-0696098da2cc',\n",
       "  'application_number': 'ANDA205220',\n",
       "  'brand_name_base': 'Valganciclovir hydrochloride for Oral',\n",
       "  'pharm_class': ['Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]',\n",
       "   'DNA Polymerase Inhibitors [MoA]',\n",
       "   'Nucleoside Analog Antiviral [EPC]',\n",
       "   'Nucleoside Analog [EXT]']},\n",
       " {'product_ndc': '72932-012',\n",
       "  'generic_name': 'Aluminum Chlorohydrate',\n",
       "  'labeler_name': 'Wuhan Zonsen Medical Products Co., Ltd.',\n",
       "  'brand_name': 'ZONSEN Roll-On Antiperspirant',\n",
       "  'active_ingredients': [{'name': 'ALUMINUM CHLOROHYDRATE',\n",
       "    'strength': '45 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72932-012-01',\n",
       "    'description': '44 mL in 1 BOTTLE (72932-012-01)',\n",
       "    'marketing_start_date': '20240821',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Wuhan Zonsen Medical Products Co., Ltd.'],\n",
       "   'spl_set_id': ['2032bd55-a9f8-651e-e063-6394a90ab110'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6976128161722'],\n",
       "   'unii': ['HPN8MZW13M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '20a12eb9-4d4a-b359-e063-6394a90a2ec7',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240821',\n",
       "  'product_id': '72932-012_20a12eb9-4d4a-b359-e063-6394a90a2ec7',\n",
       "  'application_number': 'M019',\n",
       "  'brand_name_base': 'ZONSEN Roll-On Antiperspirant'},\n",
       " {'product_ndc': '72937-011',\n",
       "  'generic_name': 'MENTHOL',\n",
       "  'labeler_name': 'SUNSET NOVELTIES, INC',\n",
       "  'brand_name': 'SUNSET PAIN RELIEF - COOLING RELIEF',\n",
       "  'active_ingredients': [{'name': 'MENTHOL', 'strength': '10 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72937-011-01',\n",
       "    'description': '30 mL in 1 CYLINDER (72937-011-01)',\n",
       "    'marketing_start_date': '20220908',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['SUNSET NOVELTIES, INC'],\n",
       "   'spl_set_id': ['e79d0000-bdcc-b51a-e053-2a95a90a9e71'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0200991804681'],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'STICK',\n",
       "  'spl_id': '275a75ce-05e9-5d25-e063-6394a90adf1c',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220908',\n",
       "  'product_id': '72937-011_275a75ce-05e9-5d25-e063-6394a90adf1c',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'SUNSET PAIN RELIEF - COOLING RELIEF'},\n",
       " {'product_ndc': '72937-101',\n",
       "  'generic_name': 'MENTHOL',\n",
       "  'labeler_name': 'SUNSET NOVELTIES, INC',\n",
       "  'brand_name': 'GREEN FARM COOLING PAIN RELIEF',\n",
       "  'active_ingredients': [{'name': 'MENTHOL', 'strength': '10 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72937-101-01',\n",
       "    'description': '30 mL in 1 CYLINDER (72937-101-01)',\n",
       "    'marketing_start_date': '20221219',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['SUNSET NOVELTIES, INC'],\n",
       "   'spl_set_id': ['f03500fd-8e37-413a-e053-2a95a90a73b5'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'STICK',\n",
       "  'spl_id': '275a9811-6f08-4355-e063-6294a90ad6ed',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20221219',\n",
       "  'product_id': '72937-101_275a9811-6f08-4355-e063-6294a90ad6ed',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'GREEN FARM COOLING PAIN RELIEF'},\n",
       " {'product_ndc': '0591-2679',\n",
       "  'generic_name': 'Lidocaine',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Lidocaine',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '50 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-2679-30',\n",
       "    'description': '30 POUCH in 1 CARTON (0591-2679-30)  / 1 g in 1 POUCH (0591-2679-11)',\n",
       "    'marketing_start_date': '20140701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['1745091'],\n",
       "   'spl_set_id': ['c18799cd-9e11-4196-9ab1-0a2a84585e56'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175682', 'M0000897', 'N0000175426', 'N0000175976'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]', 'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'unii': ['98PI200987']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'PATCH',\n",
       "  'spl_id': '7c543a73-d389-4382-9376-07deb206bbc7',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20140701',\n",
       "  'product_id': '0591-2679_7c543a73-d389-4382-9376-07deb206bbc7',\n",
       "  'application_number': 'ANDA200675',\n",
       "  'brand_name_base': 'Lidocaine',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '72937-300',\n",
       "  'generic_name': 'MENTHOL, CAMPHOR',\n",
       "  'labeler_name': 'SUNSET NOVELTIES, INC',\n",
       "  'brand_name': 'MENTHOL, CAMPHOR',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (NATURAL)', 'strength': '3 g/100g'},\n",
       "   {'name': 'MENTHOL, UNSPECIFIED FORM', 'strength': '10 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72937-300-42',\n",
       "    'description': '113 g in 1 TUBE (72937-300-42)',\n",
       "    'marketing_start_date': '20240207',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['SUNSET NOVELTIES, INC'],\n",
       "   'spl_set_id': ['10d08518-a5d5-6576-e063-6294a90ae382'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0755439032817'],\n",
       "   'unii': ['N20HL7Q941', 'L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '10d08518-a5d6-6576-e063-6294a90ae382',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200204',\n",
       "  'product_id': '72937-300_10d08518-a5d6-6576-e063-6294a90ae382',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'MENTHOL, CAMPHOR'},\n",
       " {'product_ndc': '72937-310',\n",
       "  'generic_name': 'MENTHOL, CAMPHOR',\n",
       "  'labeler_name': 'SUNSET NOVELTIES, INC',\n",
       "  'brand_name': 'MENTHOL, CAMPHOR',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (NATURAL)', 'strength': '3 g/100g'},\n",
       "   {'name': 'MENTHOL', 'strength': '10 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72937-310-08',\n",
       "    'description': '226 g in 1 TUBE (72937-310-08)',\n",
       "    'marketing_start_date': '20210304',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['SUNSET NOVELTIES, INC'],\n",
       "   'spl_set_id': ['bcb8a65b-3b2f-b82f-e053-2a95a90a51af'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0202103055370'],\n",
       "   'unii': ['N20HL7Q941', 'L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '1a12ed0d-e597-4b5d-e063-6394a90aefde',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210304',\n",
       "  'product_id': '72937-310_1a12ed0d-e597-4b5d-e063-6394a90aefde',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'MENTHOL, CAMPHOR'},\n",
       " {'product_ndc': '72944-0002',\n",
       "  'generic_name': 'ALLANTOIN',\n",
       "  'labeler_name': 'MEDICELL BIO CO., Ltd.',\n",
       "  'brand_name': 'Kenaf wet wipe kids',\n",
       "  'active_ingredients': [{'name': 'ALLANTOIN', 'strength': '.05 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72944-0002-1',\n",
       "    'description': '190 g in 1 POUCH (72944-0002-1)',\n",
       "    'marketing_start_date': '20170409',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['MEDICELL BIO CO., Ltd.'],\n",
       "   'spl_set_id': ['86106dd8-b20b-15ee-e053-2991aa0aa7b2'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['344S277G0Z']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'f44ab989-c61c-1831-e053-2995a90adc8e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20170409',\n",
       "  'product_id': '72944-0002_f44ab989-c61c-1831-e053-2995a90adc8e',\n",
       "  'brand_name_base': 'Kenaf wet wipe kids'},\n",
       " {'product_ndc': '72944-0004',\n",
       "  'generic_name': 'ALLANTOIN',\n",
       "  'labeler_name': 'MEDICELL BIO CO., Ltd.',\n",
       "  'brand_name': 'Kenaf wet wipe kids',\n",
       "  'active_ingredients': [{'name': 'ALLANTOIN', 'strength': '.05 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72944-0004-1',\n",
       "    'description': '190 g in 1 POUCH (72944-0004-1)',\n",
       "    'marketing_start_date': '20170409',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['MEDICELL BIO CO., Ltd.'],\n",
       "   'spl_set_id': ['f441f544-012e-3d36-e053-2995a90ab758'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['344S277G0Z']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'f441ea6c-bc9c-0c4f-e053-2995a90af39d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20170409',\n",
       "  'product_id': '72944-0004_f441ea6c-bc9c-0c4f-e053-2995a90af39d',\n",
       "  'brand_name_base': 'Kenaf wet wipe kids'},\n",
       " {'product_ndc': '72962-101',\n",
       "  'generic_name': 'ZINC OXIDE',\n",
       "  'labeler_name': 'ETHICAL ZINC PTY LTD',\n",
       "  'brand_name': 'ETHICAL ZINC NATURAL CLEAR ZINC SUNSCREEN SPF-50',\n",
       "  'brand_name_suffix': 'SPF-50',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '22 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72962-101-11',\n",
       "    'description': '100 mL in 1 TUBE (72962-101-11)',\n",
       "    'marketing_start_date': '20190311',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['ETHICAL ZINC PTY LTD'],\n",
       "   'spl_set_id': ['4a8046e3-ddf5-4d57-9dd7-62013fed4ea9'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['9354028000025'],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '0635330b-8894-e407-e063-6394a90aa4de',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20170829',\n",
       "  'product_id': '72962-101_0635330b-8894-e407-e063-6394a90aa4de',\n",
       "  'application_number': 'part352',\n",
       "  'brand_name_base': 'ETHICAL ZINC NATURAL CLEAR ZINC SUNSCREEN',\n",
       "  'pharm_class': ['Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]']},\n",
       " {'product_ndc': '72962-104',\n",
       "  'generic_name': 'ZINC OXIDE',\n",
       "  'labeler_name': 'ETHICAL ZINC PTY LTD',\n",
       "  'brand_name': 'ETHICAL ZINC DAILY WEAR TINTED FACIAL SUNSCREEN LIGHT TINT SPF-50',\n",
       "  'brand_name_suffix': 'LIGHT TINT SPF-50',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '22.7 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72962-104-11',\n",
       "    'description': '100 g in 1 TUBE (72962-104-11)',\n",
       "    'marketing_start_date': '20230728',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['ETHICAL ZINC PTY LTD'],\n",
       "   'spl_set_id': ['017c076d-67d2-f236-e063-6294a90aabf5'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '06325690-ea73-8425-e063-6394a90a28ae',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230728',\n",
       "  'product_id': '72962-104_06325690-ea73-8425-e063-6394a90a28ae',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'ETHICAL ZINC DAILY WEAR TINTED FACIAL SUNSCREEN',\n",
       "  'pharm_class': ['Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]']},\n",
       " {'product_ndc': '72972-001',\n",
       "  'generic_name': 'glycerin',\n",
       "  'labeler_name': 'Scope Health Inc',\n",
       "  'brand_name': 'Optase',\n",
       "  'active_ingredients': [{'name': 'GLYCERIN', 'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72972-001-01',\n",
       "    'description': '1 BOTTLE, SPRAY in 1 BOX (72972-001-01)  / 17 mL in 1 BOTTLE, SPRAY',\n",
       "    'marketing_start_date': '20190422',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '297dae85-6c78-afc6-e063-6294a90af23c',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20190422',\n",
       "  'product_id': '72972-001_297dae85-6c78-afc6-e063-6294a90af23c',\n",
       "  'application_number': 'M018',\n",
       "  'brand_name_base': 'Optase',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Glycerol [CS]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Increased IgG Production [PE]',\n",
       "   'Non-Standardized Chemical Allergen [EPC]']},\n",
       " {'product_ndc': '72972-007',\n",
       "  'generic_name': 'glycerin',\n",
       "  'labeler_name': 'Scope Health Inc',\n",
       "  'brand_name': 'Optase',\n",
       "  'active_ingredients': [{'name': 'GLYCERIN', 'strength': '2 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72972-007-05',\n",
       "    'description': '1 DOSE PACK in 1 BOX (72972-007-05)  / 5 BOTTLE, UNIT-DOSE in 1 DOSE PACK / .5 mL in 1 BOTTLE, UNIT-DOSE',\n",
       "    'marketing_start_date': '20240207',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '72972-007-30',\n",
       "    'description': '1 DOSE PACK in 1 BOX (72972-007-30)  / 30 BOTTLE, UNIT-DOSE in 1 DOSE PACK / .5 mL in 1 BOTTLE, UNIT-DOSE',\n",
       "    'marketing_start_date': '20240207',\n",
       "    'sample': True}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOLUTION/ DROPS',\n",
       "  'spl_id': '297dc649-8807-1c4d-e063-6294a90a11f8',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['OPHTHALMIC'],\n",
       "  'marketing_start_date': '20240207',\n",
       "  'product_id': '72972-007_297dc649-8807-1c4d-e063-6294a90a11f8',\n",
       "  'application_number': 'M018',\n",
       "  'brand_name_base': 'Optase',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Glycerol [CS]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Increased IgG Production [PE]',\n",
       "   'Non-Standardized Chemical Allergen [EPC]']},\n",
       " {'product_ndc': '72974-415',\n",
       "  'generic_name': 'relugolix, estradiol hemihydrate, and norethindrone acetate',\n",
       "  'labeler_name': 'Sumitomo Pharma America, Inc',\n",
       "  'brand_name': 'Myfembree',\n",
       "  'active_ingredients': [{'name': 'ESTRADIOL HEMIHYDRATE',\n",
       "    'strength': '1 mg/1'},\n",
       "   {'name': 'NORETHINDRONE ACETATE', 'strength': '.5 mg/1'},\n",
       "   {'name': 'RELUGOLIX', 'strength': '40 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72974-415-01',\n",
       "    'description': '28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-415-01)',\n",
       "    'marketing_start_date': '20210526',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72974-415-99',\n",
       "    'description': '7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-415-99)',\n",
       "    'marketing_start_date': '20210707',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Sumitomo Pharma America, Inc'],\n",
       "   'rxcui': ['2556799', '2556800'],\n",
       "   'spl_set_id': ['fc3feb73-cc84-43a8-aa32-b262460495e8'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372974415013'],\n",
       "   'nui': ['N0000175839',\n",
       "    'N0000175084',\n",
       "    'N0000008638',\n",
       "    'N0000190118',\n",
       "    'N0000187064',\n",
       "    'N0000190113',\n",
       "    'N0000185503'],\n",
       "   'pharm_class_epc': ['Gonadotropin Releasing Hormone Receptor Antagonist [EPC]'],\n",
       "   'pharm_class_moa': ['Gonadotropin Releasing Hormone Receptor Antagonists [MoA]',\n",
       "    'Cytochrome P450 3A Inducers [MoA]',\n",
       "    'Cytochrome P450 2B6 Inducers [MoA]',\n",
       "    'Breast Cancer Resistance Protein Inhibitors [MoA]',\n",
       "    'P-Glycoprotein Inhibitors [MoA]'],\n",
       "   'pharm_class_pe': ['Decreased GnRH Secretion [PE]'],\n",
       "   'unii': ['CXY7B3Q98Z', '9S44LIC7OJ', 'P76B05O5V6']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'dac3122d-d4ed-4317-9871-1d6ae51bd6f9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210526',\n",
       "  'product_id': '72974-415_dac3122d-d4ed-4317-9871-1d6ae51bd6f9',\n",
       "  'application_number': 'NDA214846',\n",
       "  'brand_name_base': 'Myfembree',\n",
       "  'pharm_class': ['Breast Cancer Resistance Protein Inhibitors [MoA]',\n",
       "   'Cytochrome P450 2B6 Inducers [MoA]',\n",
       "   'Cytochrome P450 3A Inducers [MoA]',\n",
       "   'Decreased GnRH Secretion [PE]',\n",
       "   'Estradiol Congeners [CS]',\n",
       "   'Estrogen Receptor Agonists [MoA]',\n",
       "   'Estrogen [EPC]',\n",
       "   'Gonadotropin Releasing Hormone Receptor Antagonist [EPC]',\n",
       "   'Gonadotropin Releasing Hormone Receptor Antagonists [MoA]',\n",
       "   'P-Glycoprotein Inhibitors [MoA]',\n",
       "   'Progesterone Congeners [CS]',\n",
       "   'Progestin [EPC]']},\n",
       " {'product_ndc': '72976-004',\n",
       "  'generic_name': 'Lidocaine HCI',\n",
       "  'labeler_name': 'Ever Ready First Aid',\n",
       "  'brand_name': 'FIRST SHIELD',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE HYDROCHLORIDE',\n",
       "    'strength': '20 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72976-004-01',\n",
       "    'description': '60 mL in 1 BOTTLE, SPRAY (72976-004-01)',\n",
       "    'marketing_start_date': '20220530',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Ever Ready First Aid'],\n",
       "   'rxcui': ['1010769'],\n",
       "   'spl_set_id': ['e022bf8f-3dd8-de22-e053-2995a90a219b'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['V13007Z41A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '0f0050be-f3b2-c555-e063-6394a90a2ea9',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220530',\n",
       "  'product_id': '72976-004_0f0050be-f3b2-c555-e063-6394a90a2ea9',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'FIRST SHIELD',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '72976-017',\n",
       "  'generic_name': 'Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate',\n",
       "  'labeler_name': 'EVER READY FIRST AID',\n",
       "  'brand_name': 'ER Triple Antibiotic',\n",
       "  'active_ingredients': [{'name': 'BACITRACIN ZINC',\n",
       "    'strength': \"400 [USP'U]/g\"},\n",
       "   {'name': 'NEOMYCIN SULFATE', 'strength': '.0035 g/g'},\n",
       "   {'name': 'POLYMYXIN B SULFATE', 'strength': \"5000 [USP'U]/g\"}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72976-017-01',\n",
       "    'description': '28.3 g in 1 TUBE (72976-017-01)',\n",
       "    'marketing_start_date': '20240111',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['EVER READY FIRST AID'],\n",
       "   'rxcui': ['204602'],\n",
       "   'spl_set_id': ['20f97e1c-584f-4844-afd8-8641ffe2f466'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0843484120723'],\n",
       "   'unii': ['89Y4M234ES', '057Y626693', '19371312D4']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': '0eb46f57-a383-c64a-e063-6294a90a5800',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240111',\n",
       "  'product_id': '72976-017_0eb46f57-a383-c64a-e063-6294a90a5800',\n",
       "  'application_number': 'M004',\n",
       "  'brand_name_base': 'ER Triple Antibiotic',\n",
       "  'pharm_class': ['Aminoglycoside Antibacterial [EPC]',\n",
       "   'Aminoglycosides [CS]',\n",
       "   'Decreased Cell Wall Synthesis & Repair [PE]',\n",
       "   'Polymyxin-class Antibacterial [EPC]',\n",
       "   'Polymyxins [CS]']},\n",
       " {'product_ndc': '72987-001',\n",
       "  'generic_name': 'Oxygen',\n",
       "  'labeler_name': 'Accurate Healthcare, Inc.',\n",
       "  'brand_name': 'Oxygen',\n",
       "  'active_ingredients': [{'name': 'OXYGEN', 'strength': '99 L/100L'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72987-001-01',\n",
       "    'description': '164 L in 1 CYLINDER (72987-001-01)',\n",
       "    'marketing_start_date': '20100830',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72987-001-02',\n",
       "    'description': '425 L in 1 CYLINDER (72987-001-02)',\n",
       "    'marketing_start_date': '20100830',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72987-001-03',\n",
       "    'description': '680 L in 1 CYLINDER (72987-001-03)',\n",
       "    'marketing_start_date': '20100830',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '72987-001-04',\n",
       "    'description': '41 L in 1 DEWAR (72987-001-04)',\n",
       "    'marketing_start_date': '20100830',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Accurate Healthcare, Inc.'],\n",
       "   'rxcui': ['312172'],\n",
       "   'spl_set_id': ['847918dc-8e81-1010-e053-2991aa0ab675'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['S88TT14065']},\n",
       "  'marketing_category': 'UNAPPROVED MEDICAL GAS',\n",
       "  'dosage_form': 'GAS',\n",
       "  'spl_id': '28517fc5-d2d0-77fd-e063-6394a90a7e29',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['RESPIRATORY (INHALATION)'],\n",
       "  'marketing_start_date': '20100830',\n",
       "  'product_id': '72987-001_28517fc5-d2d0-77fd-e063-6394a90a7e29',\n",
       "  'brand_name_base': 'Oxygen'},\n",
       " {'product_ndc': '72988-0024',\n",
       "  'generic_name': 'alcohol',\n",
       "  'labeler_name': 'Lydia Co., Ltd.',\n",
       "  'brand_name': 'Hand and Care Clear Gel',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '62 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72988-0024-1',\n",
       "    'description': '500 mL in 1 BOTTLE (72988-0024-1)',\n",
       "    'marketing_start_date': '20200502',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Lydia Co., Ltd.'],\n",
       "   'rxcui': ['581660'],\n",
       "   'spl_set_id': ['a4a921c9-b0fd-0c12-e053-2a95a90af013'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'a4a921e5-d8e3-6743-e053-2995a90afb31',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200502',\n",
       "  'product_id': '72988-0024_a4a921e5-d8e3-6743-e053-2995a90afb31',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'Hand and Care Clear Gel'},\n",
       " {'product_ndc': '72988-0030',\n",
       "  'generic_name': 'Xylometazoline Hydrochloride',\n",
       "  'labeler_name': 'Lydia Co., Ltd.',\n",
       "  'brand_name': 'Metarivin Soln. 0.1%',\n",
       "  'active_ingredients': [{'name': 'XYLOMETAZOLINE HYDROCHLORIDE',\n",
       "    'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72988-0030-1',\n",
       "    'description': '15 mL in 1 BOTTLE (72988-0030-1)',\n",
       "    'marketing_start_date': '20220930',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Lydia Co., Ltd.'],\n",
       "   'rxcui': ['1363493'],\n",
       "   'spl_set_id': ['e9da6f39-8620-faca-e053-2995a90a8a57'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['X5S84033NZ']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'e9eb354f-e61d-6a3a-e053-2995a90ae200',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['NASAL'],\n",
       "  'marketing_start_date': '20220930',\n",
       "  'product_id': '72988-0030_e9eb354f-e61d-6a3a-e053-2995a90ae200',\n",
       "  'brand_name_base': 'Metarivin Soln. 0.1%'},\n",
       " {'product_ndc': '72988-0037',\n",
       "  'generic_name': 'pine resin',\n",
       "  'labeler_name': 'Lydia Co., Ltd.',\n",
       "  'brand_name': 'EASYDERM BAND',\n",
       "  'active_ingredients': [{'name': 'PINUS HALEPENSIS RESIN',\n",
       "    'strength': '.57 mg/100mg'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72988-0037-1',\n",
       "    'description': '999 mg in 1 PACKAGE (72988-0037-1)',\n",
       "    'marketing_start_date': '20230123',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Lydia Co., Ltd.'],\n",
       "   'spl_set_id': ['f468decc-bc8d-f56c-e053-2a95a90ab43f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['QN24CZ7D5J']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'PATCH',\n",
       "  'spl_id': 'f468dee0-c460-9f28-e053-2a95a90a9834',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230123',\n",
       "  'product_id': '72988-0037_f468dee0-c460-9f28-e053-2a95a90a9834',\n",
       "  'brand_name_base': 'EASYDERM BAND'},\n",
       " {'product_ndc': '72989-372',\n",
       "  'generic_name': 'Progesterone',\n",
       "  'labeler_name': 'Acertis Pharmaceuticals, LLC',\n",
       "  'brand_name': 'Prometrium',\n",
       "  'active_ingredients': [{'name': 'PROGESTERONE', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72989-372-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (72989-372-30)',\n",
       "    'marketing_start_date': '20221101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Acertis Pharmaceuticals, LLC'],\n",
       "   'rxcui': ['260243', '261319', '262080', '312641'],\n",
       "   'spl_set_id': ['1cf237ff-c4f8-4faa-a7aa-77599c856889'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372989372301', '0372989373308'],\n",
       "   'nui': ['M0017672', 'N0000175601'],\n",
       "   'pharm_class_cs': ['Progesterone [CS]'],\n",
       "   'pharm_class_epc': ['Progesterone [EPC]'],\n",
       "   'unii': ['4G7DS2Q64Y']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '26b34721-22be-415a-9246-adcca52ba307',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20221101',\n",
       "  'product_id': '72989-372_26b34721-22be-415a-9246-adcca52ba307',\n",
       "  'application_number': 'NDA019781',\n",
       "  'brand_name_base': 'Prometrium',\n",
       "  'pharm_class': ['Progesterone [CS]', 'Progesterone [EPC]']},\n",
       " {'product_ndc': '72989-409',\n",
       "  'generic_name': 'PHENDIMETRAZINE TARTRATE',\n",
       "  'labeler_name': 'Acertis Pharmaceuticals, LLC',\n",
       "  'dea_schedule': 'CIII',\n",
       "  'brand_name': 'PHENDIMETRAZINE TARTRATE',\n",
       "  'active_ingredients': [{'name': 'PHENDIMETRAZINE TARTRATE',\n",
       "    'strength': '105 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72989-409-30',\n",
       "    'description': '30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72989-409-30)',\n",
       "    'marketing_start_date': '20221101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Acertis Pharmaceuticals, LLC'],\n",
       "   'rxcui': ['979543'],\n",
       "   'spl_set_id': ['162140d3-b833-4633-9759-95821a46a690'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0372989409304'],\n",
       "   'unii': ['6985IP0T80']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'CAPSULE, EXTENDED RELEASE',\n",
       "  'spl_id': '2066873e-a83d-42ad-827b-a8087288555e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20221101',\n",
       "  'product_id': '72989-409_2066873e-a83d-42ad-827b-a8087288555e',\n",
       "  'application_number': 'NDA018074',\n",
       "  'brand_name_base': 'PHENDIMETRAZINE TARTRATE',\n",
       "  'pharm_class': ['Appetite Suppression [PE]',\n",
       "   'Increased Sympathetic Activity [PE]',\n",
       "   'Sympathomimetic Amine Anorectic [EPC]']},\n",
       " {'product_ndc': '72990-103',\n",
       "  'generic_name': 'taurolidine and heparin',\n",
       "  'labeler_name': 'CorMedix Inc.',\n",
       "  'brand_name': 'DEFENCATH',\n",
       "  'active_ingredients': [{'name': 'HEPARIN', 'strength': \"3000 [USP'U]/3mL\"},\n",
       "   {'name': 'TAUROLIDINE', 'strength': '40.5 mg/3mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72990-103-10',\n",
       "    'description': '10 VIAL, SINGLE-DOSE in 1 CARTON (72990-103-10)  / 3 mL in 1 VIAL, SINGLE-DOSE (72990-103-03)',\n",
       "    'marketing_start_date': '20240409',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['CorMedix Inc.'],\n",
       "   'rxcui': ['2670461', '2670468', '2670471', '2670472'],\n",
       "   'spl_set_id': ['13b3a61e-5a4b-4afb-8fa1-d76ebdb344d6'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175980', 'M0010187', 'N0000175474'],\n",
       "   'pharm_class_epc': ['Anti-coagulant [EPC]', 'Unfractionated Heparin [EPC]'],\n",
       "   'pharm_class_cs': ['Heparin [CS]'],\n",
       "   'unii': ['T2410KM04A', '8OBZ1M4V3V']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '46fcf2e1-2611-4089-a8fc-261cee0d4883',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRALUMINAL'],\n",
       "  'marketing_start_date': '20240409',\n",
       "  'product_id': '72990-103_46fcf2e1-2611-4089-a8fc-261cee0d4883',\n",
       "  'application_number': 'NDA214520',\n",
       "  'brand_name_base': 'DEFENCATH',\n",
       "  'pharm_class': ['Anti-coagulant [EPC]',\n",
       "   'Heparin [CS]',\n",
       "   'Unfractionated Heparin [EPC]']},\n",
       " {'product_ndc': '73043-007',\n",
       "  'generic_name': 'amoxicillin and clavulanate potassium',\n",
       "  'labeler_name': 'Devatis, Inc.',\n",
       "  'brand_name': 'Amoxicillin and Clavulanate Potassium',\n",
       "  'active_ingredients': [{'name': 'AMOXICILLIN', 'strength': '500 mg/1'},\n",
       "   {'name': 'CLAVULANATE POTASSIUM', 'strength': '125 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73043-007-20',\n",
       "    'description': '20 TABLET, FILM COATED in 1 BOTTLE (73043-007-20)',\n",
       "    'marketing_start_date': '20241101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Devatis, Inc.'],\n",
       "   'rxcui': ['562508', '617296'],\n",
       "   'spl_set_id': ['d25c8190-3690-4ce6-a525-21850754224d'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['Q42OMW3AT8', '804826J2HU']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'a51715ae-3a5c-4502-a9d9-a7469d5adc69',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20241101',\n",
       "  'product_id': '73043-007_a51715ae-3a5c-4502-a9d9-a7469d5adc69',\n",
       "  'application_number': 'ANDA209992',\n",
       "  'brand_name_base': 'Amoxicillin and Clavulanate Potassium',\n",
       "  'pharm_class': ['Penicillin-class Antibacterial [EPC]',\n",
       "   'Penicillins [CS]',\n",
       "   'beta Lactamase Inhibitor [EPC]',\n",
       "   'beta Lactamase Inhibitors [MoA]']},\n",
       " {'product_ndc': '73043-048',\n",
       "  'generic_name': 'Chlorpromazine hydrochloride',\n",
       "  'labeler_name': 'Devatis, Inc.',\n",
       "  'brand_name': 'Chlorpromazine hydrochloride',\n",
       "  'active_ingredients': [{'name': 'CHLORPROMAZINE HYDROCHLORIDE',\n",
       "    'strength': '25 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73043-048-25',\n",
       "    'description': '25 AMPULE in 1 CARTON (73043-048-25)  / 1 mL in 1 AMPULE (73043-048-01)',\n",
       "    'marketing_start_date': '20241101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Devatis, Inc.'],\n",
       "   'rxcui': ['1730076', '1730078'],\n",
       "   'spl_set_id': ['b73b9044-7132-41b7-83d4-2d135ea831f1'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0373043048255', '0373043049252'],\n",
       "   'unii': ['9WP59609J6']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': '1ab3c4de-0205-4d31-9475-ed6d782cfe86',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR'],\n",
       "  'marketing_start_date': '20241101',\n",
       "  'product_id': '73043-048_1ab3c4de-0205-4d31-9475-ed6d782cfe86',\n",
       "  'application_number': 'ANDA218229',\n",
       "  'brand_name_base': 'Chlorpromazine hydrochloride',\n",
       "  'pharm_class': ['Phenothiazine [EPC]', 'Phenothiazines [CS]']},\n",
       " {'product_ndc': '0591-2884',\n",
       "  'generic_name': 'verapamil hydrochloride',\n",
       "  'labeler_name': 'Teva Pharmaceuticals Inc',\n",
       "  'brand_name': 'Verapamil Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'VERAPAMIL HYDROCHLORIDE',\n",
       "    'strength': '240 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-2884-01',\n",
       "    'description': '100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (0591-2884-01)',\n",
       "    'marketing_start_date': '19900529',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Teva Pharmaceuticals Inc'],\n",
       "   'rxcui': ['897624'],\n",
       "   'spl_set_id': ['0742cf97-601b-4c13-a6c3-1a6a616ed292'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['V3888OEY5R']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'CAPSULE, DELAYED RELEASE PELLETS',\n",
       "  'spl_id': '0afac0f7-3b38-4330-9e34-622223d84df7',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19900529',\n",
       "  'product_id': '0591-2884_0afac0f7-3b38-4330-9e34-622223d84df7',\n",
       "  'application_number': 'NDA019614',\n",
       "  'brand_name_base': 'Verapamil Hydrochloride',\n",
       "  'pharm_class': ['Calcium Channel Antagonists [MoA]',\n",
       "   'Calcium Channel Blocker [EPC]',\n",
       "   'Cytochrome P450 3A Inhibitors [MoA]',\n",
       "   'Cytochrome P450 3A4 Inhibitors [MoA]',\n",
       "   'P-Glycoprotein Inhibitors [MoA]']},\n",
       " {'product_ndc': '73054-103',\n",
       "  'generic_name': 'ZINC OXIDE',\n",
       "  'labeler_name': 'SOLARA SUNCARE, INC.',\n",
       "  'brand_name': 'SOLARA SUNCARE - GLOW GETTER SPF-30 NATURALLY SCENTED',\n",
       "  'brand_name_suffix': 'SPF-30 NATURALLY SCENTED',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '20 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73054-103-11',\n",
       "    'description': '1 TUBE in 1 BOX (73054-103-11)  / 90 mL in 1 TUBE (73054-103-01)',\n",
       "    'marketing_start_date': '20190706',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['SOLARA SUNCARE, INC.'],\n",
       "   'spl_set_id': ['ca99b8c4-6778-43dc-bdd5-ca4a470860a0'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '1fbe85eb-6ae2-3e1e-e063-6394a90afbea',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190706',\n",
       "  'product_id': '73054-103_1fbe85eb-6ae2-3e1e-e063-6394a90afbea',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'SOLARA SUNCARE - GLOW GETTER',\n",
       "  'pharm_class': ['Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]']},\n",
       " {'product_ndc': '0591-2888',\n",
       "  'generic_name': 'Hydroxocobalamin',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Hydroxocobalamin',\n",
       "  'active_ingredients': [{'name': 'HYDROXOCOBALAMIN ACETATE',\n",
       "    'strength': '1000 ug/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-2888-30',\n",
       "    'description': '1 VIAL, MULTI-DOSE in 1 CARTON (0591-2888-30)  / 30 mL in 1 VIAL, MULTI-DOSE',\n",
       "    'marketing_start_date': '20101112',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['317106'],\n",
       "   'spl_set_id': ['a3087a39-f218-4f16-a1e7-17c39bb2eb69'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['S535M27N3Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'c47477bf-6413-4699-ab77-c5441a9d1557',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAMUSCULAR'],\n",
       "  'marketing_start_date': '20101112',\n",
       "  'product_id': '0591-2888_c47477bf-6413-4699-ab77-c5441a9d1557',\n",
       "  'application_number': 'ANDA085998',\n",
       "  'brand_name_base': 'Hydroxocobalamin',\n",
       "  'pharm_class': ['Antidote [EPC]']},\n",
       " {'product_ndc': '73057-386',\n",
       "  'generic_name': 'Meclizine HCl 12.5mg',\n",
       "  'labeler_name': 'Ulai Health LLC',\n",
       "  'brand_name': 'MECLIZINE',\n",
       "  'active_ingredients': [{'name': 'MECLIZINE HYDROCHLORIDE',\n",
       "    'strength': '12.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73057-386-08',\n",
       "    'description': '100 TABLET in 1 BOTTLE, PLASTIC (73057-386-08)',\n",
       "    'marketing_start_date': '20190708',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73057-386-11',\n",
       "    'description': '1000 TABLET in 1 BOTTLE, PLASTIC (73057-386-11)',\n",
       "    'marketing_start_date': '20190708',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Ulai Health LLC'],\n",
       "   'rxcui': ['995624'],\n",
       "   'spl_set_id': ['d304e205-85fa-494a-9a68-ae6855b139b1'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0373057386114'],\n",
       "   'unii': ['HDP7W44CIO']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'd6e7750a-1bab-ba9b-e053-2a95a90acc4b',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190708',\n",
       "  'product_id': '73057-386_d6e7750a-1bab-ba9b-e053-2a95a90acc4b',\n",
       "  'application_number': 'part336',\n",
       "  'brand_name_base': 'MECLIZINE',\n",
       "  'pharm_class': ['Antiemetic [EPC]', 'Emesis Suppression [PE]']},\n",
       " {'product_ndc': '73057-389',\n",
       "  'generic_name': 'GUAIFENESIN 400mg and PHENYLEPHRINE HCL 10MG',\n",
       "  'labeler_name': 'Ulai Health LLC',\n",
       "  'brand_name': 'Pharbinex-PE',\n",
       "  'active_ingredients': [{'name': 'GUAIFENESIN', 'strength': '400 mg/1'},\n",
       "   {'name': 'PHENYLEPHRINE HYDROCHLORIDE', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73057-389-04',\n",
       "    'description': '30 TABLET, COATED in 1 BOTTLE, PLASTIC (73057-389-04)',\n",
       "    'marketing_start_date': '20190718',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Ulai Health LLC'],\n",
       "   'rxcui': ['1304111'],\n",
       "   'spl_set_id': ['e459bb83-b1d6-42fc-aa46-99ad117e6144'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0373057389047'],\n",
       "   'nui': ['N0000193956', 'N0000008867', 'N0000009560'],\n",
       "   'pharm_class_epc': ['Expectorant [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "    'Increased Respiratory Secretions [PE]'],\n",
       "   'unii': ['495W7451VQ', '04JA59TNSJ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': 'd6e72936-4449-f5a0-e053-2995a90a07fa',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190718',\n",
       "  'product_id': '73057-389_d6e72936-4449-f5a0-e053-2995a90a07fa',\n",
       "  'application_number': 'part341',\n",
       "  'brand_name_base': 'Pharbinex-PE',\n",
       "  'pharm_class': ['Adrenergic alpha1-Agonists [MoA]',\n",
       "   'Decreased Respiratory Secretion Viscosity [PE]',\n",
       "   'Expectorant [EPC]',\n",
       "   'Increased Respiratory Secretions [PE]',\n",
       "   'alpha-1 Adrenergic Agonist [EPC]']},\n",
       " {'product_ndc': '73060-001',\n",
       "  'generic_name': 'Oxygen',\n",
       "  'labeler_name': 'Florida Oxygen & Transfilling Inc.',\n",
       "  'brand_name': 'Oxygen',\n",
       "  'active_ingredients': [{'name': 'OXYGEN', 'strength': '99 L/100L'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73060-001-01',\n",
       "    'description': '113 L in 1 CYLINDER (73060-001-01)',\n",
       "    'marketing_start_date': '20120125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73060-001-02',\n",
       "    'description': '165 L in 1 CYLINDER (73060-001-02)',\n",
       "    'marketing_start_date': '20120125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73060-001-03',\n",
       "    'description': '164 L in 1 CYLINDER (73060-001-03)',\n",
       "    'marketing_start_date': '20120125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73060-001-04',\n",
       "    'description': '198 L in 1 CYLINDER (73060-001-04)',\n",
       "    'marketing_start_date': '20120125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73060-001-06',\n",
       "    'description': '425 L in 1 CYLINDER (73060-001-06)',\n",
       "    'marketing_start_date': '20120125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73060-001-07',\n",
       "    'description': '640 L in 1 CYLINDER (73060-001-07)',\n",
       "    'marketing_start_date': '20120125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73060-001-08',\n",
       "    'description': '680 L in 1 CYLINDER (73060-001-08)',\n",
       "    'marketing_start_date': '20120125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73060-001-09',\n",
       "    'description': '1738 L in 1 CYLINDER (73060-001-09)',\n",
       "    'marketing_start_date': '20120125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73060-001-10',\n",
       "    'description': '3455 L in 1 CYLINDER (73060-001-10)',\n",
       "    'marketing_start_date': '20120125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73060-001-11',\n",
       "    'description': '7080 L in 1 CYLINDER (73060-001-11)',\n",
       "    'marketing_start_date': '20120125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73060-001-12',\n",
       "    'description': '180 L in 1 DEWAR (73060-001-12)',\n",
       "    'marketing_start_date': '20120125',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73060-001-13',\n",
       "    'description': '255 L in 1 CYLINDER (73060-001-13)',\n",
       "    'marketing_start_date': '20120125',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Florida Oxygen & Transfilling Inc.'],\n",
       "   'spl_set_id': ['86d3206e-a8c5-3f0c-e053-2991aa0a149f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['S88TT14065']},\n",
       "  'marketing_category': 'UNAPPROVED MEDICAL GAS',\n",
       "  'dosage_form': 'GAS',\n",
       "  'spl_id': '28dde0a6-86f8-45a7-e063-6394a90a5151',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['RESPIRATORY (INHALATION)'],\n",
       "  'marketing_start_date': '20120125',\n",
       "  'product_id': '73060-001_28dde0a6-86f8-45a7-e063-6394a90a5151',\n",
       "  'brand_name_base': 'Oxygen'},\n",
       " {'product_ndc': '73062-032',\n",
       "  'generic_name': 'BENZALKONIUM CHLORIDE',\n",
       "  'labeler_name': 'Avro Enterprises, LLC',\n",
       "  'brand_name': 'Inofoam Antibacterial Foaming Hand Wash',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '1.3 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73062-032-01',\n",
       "    'description': '1 BOTTLE in 1 CARTON (73062-032-01)  / 3800 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20231120',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Avro Enterprises, LLC'],\n",
       "   'rxcui': ['1046593'],\n",
       "   'spl_set_id': ['4fc1e57f-b909-4dde-8c1a-2793af6eafb0'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '0a59627b-cad3-b9b2-e063-6394a90a2f7f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20231120',\n",
       "  'product_id': '73062-032_0a59627b-cad3-b9b2-e063-6394a90a2f7f',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Inofoam Antibacterial Foaming Hand Wash'},\n",
       " {'product_ndc': '73065-0008',\n",
       "  'generic_name': 'precipitated calcium carbonate, aluminum chlorohydroxy allantoinate, aminocaproic acid, dibasic calcium phosphate hydrate',\n",
       "  'labeler_name': 'WOORI LIFE & HEALTH',\n",
       "  'brand_name': 'Hea YanToothpaste',\n",
       "  'active_ingredients': [{'name': 'ALCLOXA', 'strength': '.09 g/100g'},\n",
       "   {'name': 'AMINOCAPROIC ACID', 'strength': '.09 g/100g'},\n",
       "   {'name': 'CALCIUM CARBONATE', 'strength': '37 g/100g'},\n",
       "   {'name': 'DIBASIC CALCIUM PHOSPHATE DIHYDRATE', 'strength': '.09 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73065-0008-1',\n",
       "    'description': '130 g in 1 TUBE (73065-0008-1)',\n",
       "    'marketing_start_date': '20230424',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['WOORI LIFE & HEALTH'],\n",
       "   'spl_set_id': ['fa0ab7bf-4069-4c67-e053-6394a90ae7d7'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175634', 'N0000175632'],\n",
       "   'pharm_class_epc': ['Antifibrinolytic Agent [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Fibrinolysis [PE]'],\n",
       "   'unii': ['18B8O9DQA2', 'U6F3787206', 'H0G9379FGK', 'O7TSZ97GEP']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'PASTE, DENTIFRICE',\n",
       "  'spl_id': 'fa0ab7bf-406a-4c67-e053-6394a90ae7d7',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['DENTAL'],\n",
       "  'marketing_start_date': '20230424',\n",
       "  'product_id': '73065-0008_fa0ab7bf-406a-4c67-e053-6394a90ae7d7',\n",
       "  'brand_name_base': 'Hea YanToothpaste',\n",
       "  'pharm_class': ['Antifibrinolytic Agent [EPC]',\n",
       "   'Blood Coagulation Factor [EPC]',\n",
       "   'Calcium [CS]',\n",
       "   'Cations',\n",
       "   'Divalent [CS]',\n",
       "   'Decreased Fibrinolysis [PE]',\n",
       "   'Increased Coagulation Factor Activity [PE]']},\n",
       " {'product_ndc': '73070-403',\n",
       "  'generic_name': 'insulin degludec',\n",
       "  'labeler_name': 'Novo Nordisk Pharma, Inc.',\n",
       "  'brand_name': 'Insulin Degludec',\n",
       "  'active_ingredients': [{'name': 'INSULIN DEGLUDEC', 'strength': '100 U/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73070-403-15',\n",
       "    'description': '5 SYRINGE, PLASTIC in 1 CARTON (73070-403-15)  / 3 mL in 1 SYRINGE, PLASTIC',\n",
       "    'marketing_start_date': '20220701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Novo Nordisk Pharma, Inc.'],\n",
       "   'rxcui': ['1670011', '1670021', '2107520'],\n",
       "   'spl_set_id': ['c1be283d-4b1d-4996-b2a7-4488dbff3037'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['M0011417', 'N0000175453'],\n",
       "   'pharm_class_cs': ['Insulin [CS]'],\n",
       "   'pharm_class_epc': ['Insulin Analog [EPC]'],\n",
       "   'unii': ['54Q18076QB']},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'c1be283d-4b1d-4996-b2a7-4488dbff3037',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20220701',\n",
       "  'product_id': '73070-403_c1be283d-4b1d-4996-b2a7-4488dbff3037',\n",
       "  'application_number': 'BLA203314',\n",
       "  'brand_name_base': 'Insulin Degludec',\n",
       "  'pharm_class': ['Insulin Analog [EPC]', 'Insulin [CS]']},\n",
       " {'product_ndc': '73076-121',\n",
       "  'generic_name': 'Psoriasis Relief Cream',\n",
       "  'labeler_name': 'Shenzhen Ishan Technology Co., Ltd',\n",
       "  'brand_name': 'iShanCare Psoriasis Relief Cream',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '2 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73076-121-01',\n",
       "    'description': '50 g in 1 PACKAGE (73076-121-01)',\n",
       "    'marketing_start_date': '20221201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73076-121-02',\n",
       "    'description': '100 g in 1 BOTTLE (73076-121-02)',\n",
       "    'marketing_start_date': '20231017',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Shenzhen Ishan Technology Co., Ltd'],\n",
       "   'spl_set_id': ['e88d9c9d-e2d5-7e27-e053-2a95a90aff42'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6973496920975'],\n",
       "   'unii': ['O414PZ4LPZ']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '07e697e3-042d-0cfc-e063-6394a90add8d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20221201',\n",
       "  'product_id': '73076-121_07e697e3-042d-0cfc-e063-6394a90add8d',\n",
       "  'brand_name_base': 'iShanCare Psoriasis Relief Cream'},\n",
       " {'product_ndc': '73076-137',\n",
       "  'generic_name': 'Rosacea Cream',\n",
       "  'labeler_name': 'Shenzhen Ishan Technology Co., Ltd',\n",
       "  'brand_name': 'LMNOOP Rosacea Cream',\n",
       "  'active_ingredients': [{'name': 'OATMEAL', 'strength': '1 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73076-137-02',\n",
       "    'description': '100 g in 1 BOTTLE (73076-137-02)',\n",
       "    'marketing_start_date': '20231221',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Shenzhen Ishan Technology Co., Ltd'],\n",
       "   'spl_set_id': ['0d04ce55-be69-d018-e063-6294a90a988f'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6973496921507'],\n",
       "   'nui': ['N0000185371',\n",
       "    'N0000185375',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'M0000728',\n",
       "    'M0006342',\n",
       "    'M0016962',\n",
       "    'N0000185016'],\n",
       "   'pharm_class_epc': ['Non-Standardized Food Allergenic Extract [EPC]',\n",
       "    'Non-Standardized Plant Allergenic Extract [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]',\n",
       "    'Dietary Proteins [CS]',\n",
       "    'Plant Proteins [CS]'],\n",
       "   'unii': ['8PI54V663Y']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '24d13c7e-8821-822a-e063-6394a90a4ef1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20231221',\n",
       "  'product_id': '73076-137_24d13c7e-8821-822a-e063-6394a90a4ef1',\n",
       "  'brand_name_base': 'LMNOOP Rosacea Cream',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Grain Proteins [EXT]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]']},\n",
       " {'product_ndc': '73076-201',\n",
       "  'generic_name': 'LMNOOP Athletes Foot Cream',\n",
       "  'labeler_name': 'Shenzhen Ishan Technology Co., Ltd',\n",
       "  'brand_name': 'LMNOOP Athletes Foot Cream',\n",
       "  'active_ingredients': [{'name': 'OATMEAL', 'strength': '1 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73076-201-01',\n",
       "    'description': '50 g in 1 TUBE (73076-201-01)',\n",
       "    'marketing_start_date': '20221201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Shenzhen Ishan Technology Co., Ltd'],\n",
       "   'spl_set_id': ['1a0d9b67-fc7a-d275-e063-6294a90ae1f2'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6973496921569'],\n",
       "   'nui': ['N0000185371',\n",
       "    'N0000185375',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'M0000728',\n",
       "    'M0006342',\n",
       "    'M0016962',\n",
       "    'N0000185016'],\n",
       "   'pharm_class_epc': ['Non-Standardized Food Allergenic Extract [EPC]',\n",
       "    'Non-Standardized Plant Allergenic Extract [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]',\n",
       "    'Dietary Proteins [CS]',\n",
       "    'Plant Proteins [CS]'],\n",
       "   'unii': ['8PI54V663Y']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '24d17969-9a3d-1a6e-e063-6394a90aa622',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20221201',\n",
       "  'product_id': '73076-201_24d17969-9a3d-1a6e-e063-6394a90aa622',\n",
       "  'brand_name_base': 'LMNOOP Athletes Foot Cream',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Grain Proteins [EXT]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]']},\n",
       " {'product_ndc': '73086-212',\n",
       "  'generic_name': 'ibuprofen',\n",
       "  'labeler_name': 'SKYA HEALTH, LLC',\n",
       "  'brand_name': 'ibuprofen',\n",
       "  'active_ingredients': [{'name': 'IBUPROFEN', 'strength': '800 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73086-212-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (73086-212-01)',\n",
       "    'marketing_start_date': '20240320',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['SKYA HEALTH, LLC'],\n",
       "   'rxcui': ['197805', '197806', '197807'],\n",
       "   'spl_set_id': ['1c28af16-7246-4e4c-a1be-939655c37242'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['WK2XYI10QM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '591f2c0c-8dd5-4f3b-9936-cd6485343639',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240320',\n",
       "  'product_id': '73086-212_591f2c0c-8dd5-4f3b-9936-cd6485343639',\n",
       "  'application_number': 'ANDA090796',\n",
       "  'brand_name_base': 'ibuprofen',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '73102-115',\n",
       "  'generic_name': 'MENTHOL',\n",
       "  'labeler_name': 'MMG Consumer Brands, LLC',\n",
       "  'brand_name': 'Minted Leaf Cold Therapy Pain Relief',\n",
       "  'active_ingredients': [{'name': 'MENTHOL', 'strength': '40 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73102-115-03',\n",
       "    'description': '88 mL in 1 TUBE (73102-115-03)',\n",
       "    'marketing_start_date': '20190501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['MMG Consumer Brands, LLC'],\n",
       "   'rxcui': ['415974'],\n",
       "   'spl_set_id': ['61b219fa-5e64-4116-a856-918ab27ff528'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0860001017090'],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '0975230a-86da-cc07-e063-6294a90a3873',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190501',\n",
       "  'product_id': '73102-115_0975230a-86da-cc07-e063-6294a90a3873',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Minted Leaf Cold Therapy Pain Relief'},\n",
       " {'product_ndc': '73102-118',\n",
       "  'generic_name': 'HISTAMINE DIHYDROCHLORIDE',\n",
       "  'labeler_name': 'MMG Consumer Brands, LLC',\n",
       "  'brand_name': 'Minted Leaf Odorless Pain Relief',\n",
       "  'active_ingredients': [{'name': 'HISTAMINE DIHYDROCHLORIDE',\n",
       "    'strength': '.3 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73102-118-03',\n",
       "    'description': '1 JAR in 1 BOX (73102-118-03)  / 88 mL in 1 JAR',\n",
       "    'marketing_start_date': '20190501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['MMG Consumer Brands, LLC'],\n",
       "   'rxcui': ['2167855'],\n",
       "   'spl_set_id': ['e9525a9c-d504-498b-9ac0-5354bd6d1241'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0860001017083'],\n",
       "   'unii': ['3POA0Q644U']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '09751fc7-6649-c196-e063-6294a90a4a57',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190501',\n",
       "  'product_id': '73102-118_09751fc7-6649-c196-e063-6294a90a4a57',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Minted Leaf Odorless Pain Relief'},\n",
       " {'product_ndc': '73132-001',\n",
       "  'generic_name': 'Camphor, Menthol, Methyl Salicylate',\n",
       "  'labeler_name': 'Green Compass, Inc.',\n",
       "  'brand_name': 'Green Compass Reduce Topical Pain',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (NATURAL)',\n",
       "    'strength': '3 g/100mL'},\n",
       "   {'name': 'MENTHOL, UNSPECIFIED FORM', 'strength': '10 g/100mL'},\n",
       "   {'name': 'METHYL SALICYLATE', 'strength': '10 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73132-001-50',\n",
       "    'description': '1 BOTTLE in 1 CARTON (73132-001-50)  / 50 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20190724',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Green Compass, Inc.'],\n",
       "   'spl_set_id': ['8cb80362-5d24-1ee3-e053-2a95a90afcdf'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['N20HL7Q941', 'L7T10EIP3A', 'LAV5U5022Y']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': 'f1f03ab2-ee8c-5b3c-e053-2a95a90aaa55',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190724',\n",
       "  'product_id': '73132-001_f1f03ab2-ee8c-5b3c-e053-2a95a90aaa55',\n",
       "  'application_number': 'part348',\n",
       "  'brand_name_base': 'Green Compass Reduce Topical Pain'},\n",
       " {'product_ndc': '73141-025',\n",
       "  'generic_name': 'Maraviroc',\n",
       "  'labeler_name': 'A2A Integrated Pharmaceuticals',\n",
       "  'brand_name': 'Maraviroc',\n",
       "  'active_ingredients': [{'name': 'MARAVIROC', 'strength': '300 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73141-025-02',\n",
       "    'description': '60 TABLET, FILM COATED in 1 BOTTLE (73141-025-02)',\n",
       "    'marketing_start_date': '20240516',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['A2A Integrated Pharmaceuticals'],\n",
       "   'rxcui': ['728223', '728225'],\n",
       "   'spl_set_id': ['2a16417d-a3b8-483b-9dfe-d5263cc16538'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175572', 'N0000175445'],\n",
       "   'pharm_class_epc': ['CCR5 Co-receptor Antagonist [EPC]'],\n",
       "   'pharm_class_moa': ['Chemokine Co-receptor 5 Antagonists [MoA]'],\n",
       "   'unii': ['MD6P741W8A']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '1920fc65-200a-4053-e063-6394a90a29bb',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240516',\n",
       "  'product_id': '73141-025_1920fc65-200a-4053-e063-6394a90a29bb',\n",
       "  'application_number': 'ANDA217114',\n",
       "  'brand_name_base': 'Maraviroc',\n",
       "  'pharm_class': ['CCR5 Co-receptor Antagonist [EPC]',\n",
       "   'Chemokine Co-receptor 5 Antagonists [MoA]']},\n",
       " {'product_ndc': '73162-0001',\n",
       "  'marketing_end_date': '20250226',\n",
       "  'generic_name': 'Fucus Vesiculosus, Kali Carbonicum, Agave Americana, Capsicum Annuum, Phytolacca Decandra, Aurum Metallicum, Calcarea Carbonica, Ferrum Metallicum, Graphites',\n",
       "  'labeler_name': 'Health Masters LLC',\n",
       "  'brand_name': 'Fat Loss Activation Complex',\n",
       "  'active_ingredients': [{'name': 'AGAVE AMERICANA LEAF',\n",
       "    'strength': '4 [hp_X]/mL'},\n",
       "   {'name': 'CAPSICUM', 'strength': '4 [hp_X]/mL'},\n",
       "   {'name': 'FUCUS VESICULOSUS', 'strength': '2 [hp_X]/mL'},\n",
       "   {'name': 'GOLD', 'strength': '8 [hp_X]/mL'},\n",
       "   {'name': 'GRAPHITE', 'strength': '8 [hp_X]/mL'},\n",
       "   {'name': 'IRON', 'strength': '8 [hp_X]/mL'},\n",
       "   {'name': 'OYSTER SHELL CALCIUM CARBONATE, CRUDE',\n",
       "    'strength': '8 [hp_X]/mL'},\n",
       "   {'name': 'PHYTOLACCA AMERICANA ROOT', 'strength': '4 [hp_X]/mL'},\n",
       "   {'name': 'POTASSIUM CARBONATE', 'strength': '2 [hp_X]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73162-0001-1',\n",
       "    'description': '30 mL in 1 BOTTLE, DROPPER (73162-0001-1)',\n",
       "    'marketing_start_date': '20200226',\n",
       "    'marketing_end_date': '20250226',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Health Masters LLC'],\n",
       "   'spl_set_id': ['200590e8-0ef6-4159-803d-b699cf72253f'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185375',\n",
       "    'N0000185371',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'M0000728',\n",
       "    'M0006342',\n",
       "    'M0016962',\n",
       "    'M0022575',\n",
       "    'N0000185508'],\n",
       "   'pharm_class_epc': ['Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "    'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "    'Standardized Chemical Allergen [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]',\n",
       "    'Dietary Proteins [CS]',\n",
       "    'Plant Proteins [CS]',\n",
       "    'Vegetable Proteins [CS]'],\n",
       "   'unii': ['8511ZMP5QK',\n",
       "    '00UK7646FG',\n",
       "    '535G2ABX9M',\n",
       "    '79Y1949PYO',\n",
       "    '4QQN74LH4O',\n",
       "    'E1UOL152H7',\n",
       "    '2E32821G6I',\n",
       "    '11E6VI8VEG',\n",
       "    'BQN1B9B9HA']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '09ad71e3-a245-4ebe-921e-5cccf2692b3e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200226',\n",
       "  'product_id': '73162-0001_09ad71e3-a245-4ebe-921e-5cccf2692b3e',\n",
       "  'brand_name_base': 'Fat Loss Activation Complex',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]',\n",
       "   'Standardized Chemical Allergen [EPC]',\n",
       "   'Vegetable Proteins [CS]']},\n",
       " {'product_ndc': '73162-0002',\n",
       "  'generic_name': 'Carduus Marianus, Cynara Scolymus, Solidago Virgaurea, Taraxacum Officinale, Benzoicum Acidum, Berberis Vulgaris, Bryonia (Alba), Cantharis, Carduus Benedictus, Ceanothus Americanus, Chelidonium Majus, Chionanthus Virginica, Cinchona Officinalis, Dioscorea Villosa, Dolichos Pruriens, Iris Versicolor, Juniperus Communis, Nux Vomica, Ptelea Trifoliata, Uricum Acidum',\n",
       "  'labeler_name': 'Health Masters LLC',\n",
       "  'brand_name': 'Detox Complex',\n",
       "  'active_ingredients': [{'name': 'BENZOIC ACID', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'BERBERIS VULGARIS ROOT BARK', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'BRYONIA ALBA ROOT', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'CEANOTHUS AMERICANUS LEAF', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'CENTAUREA BENEDICTA', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'CHELIDONIUM MAJUS WHOLE', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'CHIONANTHUS VIRGINICUS BARK', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'CINCHONA OFFICINALIS BARK', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'CYNARA SCOLYMUS LEAF', 'strength': '3 [hp_X]/mL'},\n",
       "   {'name': 'DIOSCOREA VILLOSA TUBER', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'IRIS VERSICOLOR ROOT', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'JUNIPER BERRY', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'LYTTA VESICATORIA', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'MILK THISTLE', 'strength': '3 [hp_X]/mL'},\n",
       "   {'name': 'MUCUNA PRURIENS FRUIT TRICHOME', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'PTELEA TRIFOLIATA BARK', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'SOLIDAGO VIRGAUREA FLOWERING TOP', 'strength': '3 [hp_X]/mL'},\n",
       "   {'name': 'STRYCHNOS NUX-VOMICA SEED', 'strength': '15 [hp_X]/mL'},\n",
       "   {'name': 'TARAXACUM OFFICINALE', 'strength': '3 [hp_X]/mL'},\n",
       "   {'name': 'URIC ACID', 'strength': '15 [hp_X]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73162-0002-1',\n",
       "    'description': '30 mL in 1 BOTTLE, DROPPER (73162-0002-1)',\n",
       "    'marketing_start_date': '20200227',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Health Masters LLC'],\n",
       "   'spl_set_id': ['ef0a4a08-8522-45b0-bb21-7c6845f68a18'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175806',\n",
       "    'N0000175807',\n",
       "    'N0000185371',\n",
       "    'N0000185375',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'M0000728',\n",
       "    'M0006342',\n",
       "    'M0016962',\n",
       "    'M0008672',\n",
       "    'N0000185001',\n",
       "    'M0516536'],\n",
       "   'pharm_class_moa': ['Ammonium Ion Binding Activity [MoA]'],\n",
       "   'pharm_class_epc': ['Nitrogen Binding Agent [EPC]',\n",
       "    'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "    'Non-Standardized Plant Allergenic Extract [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]',\n",
       "    'Increased IgG Production [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]',\n",
       "    'Dietary Proteins [CS]',\n",
       "    'Plant Proteins [CS]',\n",
       "    'Food Additives [CS]',\n",
       "    'Seed Storage Proteins [CS]'],\n",
       "   'unii': ['8SKN0B0MIM',\n",
       "    '1TH8Q20J0U',\n",
       "    'T7J046YI2B',\n",
       "    '25B1Y14T8N',\n",
       "    '6L5ZL09795',\n",
       "    '7E889U5RNN',\n",
       "    'S003A158SB',\n",
       "    'B71UA545DE',\n",
       "    'IWY3IWX2G8',\n",
       "    'X43D4L3DQC',\n",
       "    'O84B5194RL',\n",
       "    '3Q034RO3BT',\n",
       "    'U946SH95EE',\n",
       "    '3E271BSI0C',\n",
       "    '5KQR6FTT0D',\n",
       "    '5405K23S50',\n",
       "    '269XH13919',\n",
       "    '39981FM375',\n",
       "    '268B43MJ25']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '38a5694f-3f76-40af-ad10-dc547dc51b5c',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200227',\n",
       "  'product_id': '73162-0002_38a5694f-3f76-40af-ad10-dc547dc51b5c',\n",
       "  'brand_name_base': 'Detox Complex',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Allergens [CS]',\n",
       "   'Ammonium Ion Binding Activity [MoA]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Food Additives [CS]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Increased IgG Production [PE]',\n",
       "   'Nitrogen Binding Agent [EPC]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]',\n",
       "   'Plant Proteins [CS]',\n",
       "   'Seed Storage Proteins [CS]']},\n",
       " {'product_ndc': '73168-004',\n",
       "  'generic_name': 'MENTHOL',\n",
       "  'labeler_name': 'Rejuvica LLC',\n",
       "  'brand_name': 'URIFLEX Fast Acting Analgesic Pain Relief',\n",
       "  'active_ingredients': [{'name': 'MENTHOL', 'strength': '45 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73168-004-00',\n",
       "    'description': '118 mL in 1 JAR (73168-004-00)',\n",
       "    'marketing_start_date': '20190520',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Rejuvica LLC'],\n",
       "   'rxcui': ['2171392'],\n",
       "   'spl_set_id': ['fb78f705-b838-461d-b42c-8c98d3ca5d09'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '09751fc7-6657-c196-e063-6294a90a4a57',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190520',\n",
       "  'product_id': '73168-004_09751fc7-6657-c196-e063-6294a90a4a57',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'URIFLEX Fast Acting Analgesic Pain Relief'},\n",
       " {'product_ndc': '73252-136',\n",
       "  'generic_name': 'ishancare wound care ointment',\n",
       "  'labeler_name': 'Hunan Xiong Shi Pharmaceutical Co., Ltd',\n",
       "  'brand_name': 'ishancare wound care',\n",
       "  'active_ingredients': [{'name': 'CALENDULA OFFICINALIS FLOWER',\n",
       "    'strength': '1 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73252-136-01',\n",
       "    'description': '15 g in 1 BOTTLE (73252-136-01)',\n",
       "    'marketing_start_date': '20221001',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73252-136-02',\n",
       "    'description': '50 g in 1 BOTTLE (73252-136-02)',\n",
       "    'marketing_start_date': '20221001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Hunan Xiong Shi Pharmaceutical Co., Ltd'],\n",
       "   'spl_set_id': ['e8a256fd-50c7-d488-e053-2995a90a3ba1'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['P0M7O4Y7YD']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': '19bab8a0-69e5-49c6-e063-6394a90a9380',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20221001',\n",
       "  'product_id': '73252-136_19bab8a0-69e5-49c6-e063-6394a90a9380',\n",
       "  'brand_name_base': 'ishancare wound care'},\n",
       " {'product_ndc': '73252-161',\n",
       "  'generic_name': 'ishancare diabetic wound and sores cream',\n",
       "  'labeler_name': 'Hunan Xiong Shi Pharmaceutical Co., Ltd',\n",
       "  'brand_name': 'iShancare Diabetic Wounds and Sores Cream',\n",
       "  'active_ingredients': [{'name': 'CALENDULA OFFICINALIS FLOWER',\n",
       "    'strength': '2 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73252-161-01',\n",
       "    'description': '50 g in 1 BOTTLE (73252-161-01)',\n",
       "    'marketing_start_date': '20221001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Hunan Xiong Shi Pharmaceutical Co., Ltd'],\n",
       "   'spl_set_id': ['19bb986c-7797-9542-e063-6394a90a9754'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6973496921378'],\n",
       "   'unii': ['P0M7O4Y7YD']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': '24d0fce2-95dc-f7d4-e063-6394a90a0d97',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20221001',\n",
       "  'product_id': '73252-161_24d0fce2-95dc-f7d4-e063-6394a90a0d97',\n",
       "  'brand_name_base': 'iShancare Diabetic Wounds and Sores Cream'},\n",
       " {'product_ndc': '73266-001',\n",
       "  'generic_name': 'Oxygen',\n",
       "  'labeler_name': 'One Home Medical Equipment, LLC',\n",
       "  'brand_name': 'Oxygen',\n",
       "  'active_ingredients': [{'name': 'OXYGEN', 'strength': '99 L/100L'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73266-001-01',\n",
       "    'description': '164 L in 1 CYLINDER (73266-001-01)',\n",
       "    'marketing_start_date': '20091104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73266-001-02',\n",
       "    'description': '255 L in 1 CYLINDER (73266-001-02)',\n",
       "    'marketing_start_date': '20091104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73266-001-03',\n",
       "    'description': '425 L in 1 CYLINDER (73266-001-03)',\n",
       "    'marketing_start_date': '20091104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73266-001-04',\n",
       "    'description': '680 L in 1 CYLINDER (73266-001-04)',\n",
       "    'marketing_start_date': '20091104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73266-001-05',\n",
       "    'description': '21 L in 1 DEWAR (73266-001-05)',\n",
       "    'marketing_start_date': '20091104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73266-001-06',\n",
       "    'description': '31 L in 1 DEWAR (73266-001-06)',\n",
       "    'marketing_start_date': '20091104',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73266-001-07',\n",
       "    'description': '41 L in 1 DEWAR (73266-001-07)',\n",
       "    'marketing_start_date': '20091104',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['One Home Medical Equipment, LLC'],\n",
       "   'rxcui': ['312172'],\n",
       "   'spl_set_id': ['8f8d1a1f-a5ca-a935-e053-2995a90a2d76'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['S88TT14065']},\n",
       "  'marketing_category': 'UNAPPROVED MEDICAL GAS',\n",
       "  'dosage_form': 'GAS',\n",
       "  'spl_id': '265a0efb-1bf4-7633-e063-6394a90aa0a6',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['RESPIRATORY (INHALATION)'],\n",
       "  'marketing_start_date': '20090926',\n",
       "  'product_id': '73266-001_265a0efb-1bf4-7633-e063-6394a90aa0a6',\n",
       "  'brand_name_base': 'Oxygen'},\n",
       " {'product_ndc': '73282-0012',\n",
       "  'marketing_end_date': '20251231',\n",
       "  'generic_name': 'Diphenhydramine Hydrochloride',\n",
       "  'labeler_name': 'CalmCo LLC',\n",
       "  'brand_name': 'Childrens Allergy Relief',\n",
       "  'active_ingredients': [{'name': 'DIPHENHYDRAMINE HYDROCHLORIDE',\n",
       "    'strength': '12.5 mg/5mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73282-0012-1',\n",
       "    'description': '20 VIAL in 1 CARTON (73282-0012-1)  / 5 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20210806',\n",
       "    'marketing_end_date': '20251231',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['CalmCo LLC'],\n",
       "   'rxcui': ['1049906'],\n",
       "   'spl_set_id': ['c8ea4c6d-19c7-894f-e053-2a95a90a30af'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['TC2D6JAD40']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '1934f523-5307-d72e-e063-6394a90a839e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210806',\n",
       "  'product_id': '73282-0012_1934f523-5307-d72e-e063-6394a90a839e',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'Childrens Allergy Relief',\n",
       "  'pharm_class': ['Histamine H1 Receptor Antagonists [MoA]',\n",
       "   'Histamine-1 Receptor Antagonist [EPC]']},\n",
       " {'product_ndc': '73287-024',\n",
       "  'generic_name': 'Lidocaine',\n",
       "  'labeler_name': 'TELEBRANDS CORP',\n",
       "  'brand_name': 'Hempvana Ultra Strength Pain Relief',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '4 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73287-024-01',\n",
       "    'description': '1 APPLICATOR in 1 CARTON (73287-024-01)  / 71 g in 1 APPLICATOR',\n",
       "    'marketing_start_date': '20220228',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['TELEBRANDS CORP'],\n",
       "   'spl_set_id': ['d91ba9b1-083f-32e9-e053-2a95a90a9bd1'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175682', 'M0000897', 'N0000175426', 'N0000175976'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]', 'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'unii': ['98PI200987']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '275ba3e5-cc21-796e-e063-6394a90a3de4',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220228',\n",
       "  'product_id': '73287-024_275ba3e5-cc21-796e-e063-6394a90a3de4',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Hempvana Ultra Strength Pain Relief',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '73287-026',\n",
       "  'generic_name': 'Lidocaine',\n",
       "  'labeler_name': 'Telebrands Corp',\n",
       "  'brand_name': 'Hempvana Maximum Strength Pain Relief Topical Anesthetic',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '5 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73287-026-01',\n",
       "    'description': '1 JAR in 1 CARTON (73287-026-01)  / 85 g in 1 JAR',\n",
       "    'marketing_start_date': '20230217',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Telebrands Corp'],\n",
       "   'rxcui': ['1534792'],\n",
       "   'spl_set_id': ['f525075a-d7ee-dad0-e053-2a95a90a6f3f'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0097298054587'],\n",
       "   'nui': ['N0000175682', 'M0000897', 'N0000175426', 'N0000175976'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]', 'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'unii': ['98PI200987']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '275a7376-2682-47dd-e063-6394a90ab48e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230217',\n",
       "  'product_id': '73287-026_275a7376-2682-47dd-e063-6394a90ab48e',\n",
       "  'application_number': 'M015',\n",
       "  'brand_name_base': 'Hempvana Maximum Strength Pain Relief Topical Anesthetic',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '73288-001',\n",
       "  'generic_name': 'ISOPROPYL ALCOHOL',\n",
       "  'labeler_name': 'NINGBO TIANBO FIRST AID PRODUCT CO., LTD.',\n",
       "  'brand_name': 'Alcohol Prep Pads',\n",
       "  'active_ingredients': [{'name': 'ISOPROPYL ALCOHOL',\n",
       "    'strength': '70 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73288-001-01',\n",
       "    'description': '2 PATCH in 1 PACKET (73288-001-01)  / 4 mL in 1 PATCH',\n",
       "    'marketing_start_date': '20190818',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NINGBO TIANBO FIRST AID PRODUCT CO., LTD.'],\n",
       "   'rxcui': ['797544'],\n",
       "   'spl_set_id': ['3cce065a-0254-43ad-a96f-aae6979997be'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['ND2M416302']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '2807bacd-9f40-8b71-e063-6394a90a3d2c',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190818',\n",
       "  'product_id': '73288-001_2807bacd-9f40-8b71-e063-6394a90a3d2c',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'Alcohol Prep Pads'},\n",
       " {'product_ndc': '73289-0063',\n",
       "  'generic_name': 'lacosamide',\n",
       "  'labeler_name': 'Aucta Pharmaceuticals, Inc.',\n",
       "  'dea_schedule': 'CV',\n",
       "  'brand_name': 'MOTPOLY XR',\n",
       "  'active_ingredients': [{'name': 'LACOSAMIDE', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73289-0063-1',\n",
       "    'description': '1 BLISTER PACK in 1 CARTON (73289-0063-1)  / 14 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20230505',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '73289-0063-2',\n",
       "    'description': '60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73289-0063-2)',\n",
       "    'marketing_start_date': '20230505',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Aucta Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['2637018', '2637025', '2637027', '2637030', '2637032', '2637035'],\n",
       "   'spl_set_id': ['fb8235b4-4cd3-6f22-e053-6294a90a545c'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000008486'],\n",
       "   'pharm_class_pe': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]'],\n",
       "   'unii': ['563KS2PQY5']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'CAPSULE, EXTENDED RELEASE',\n",
       "  'spl_id': '24b16278-8ead-a1da-e063-6394a90aeb93',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230505',\n",
       "  'product_id': '73289-0063_24b16278-8ead-a1da-e063-6394a90aeb93',\n",
       "  'application_number': 'NDA216185',\n",
       "  'brand_name_base': 'MOTPOLY XR',\n",
       "  'pharm_class': ['Decreased Central Nervous System Disorganized Electrical Activity [PE]']},\n",
       " {'product_ndc': '73292-011',\n",
       "  'generic_name': 'viltolarsen',\n",
       "  'labeler_name': 'NS Pharma, Inc.',\n",
       "  'brand_name': 'Viltepso',\n",
       "  'active_ingredients': [{'name': 'VILTOLARSEN', 'strength': '250 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73292-011-01',\n",
       "    'description': '1 VIAL, GLASS in 1 CARTON (73292-011-01)  / 1 INJECTION, SOLUTION in 1 VIAL, GLASS',\n",
       "    'marketing_start_date': '20200813',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['NS Pharma, Inc.'],\n",
       "   'rxcui': ['2389844', '2389849'],\n",
       "   'spl_set_id': ['1ffff9a8-6d6a-4dcb-8493-1b6cc3a5d123'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SXA7YP6EKX']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '660fd183-2dc3-4e7c-9695-6105573165c9',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20200813',\n",
       "  'product_id': '73292-011_660fd183-2dc3-4e7c-9695-6105573165c9',\n",
       "  'application_number': 'NDA212154',\n",
       "  'brand_name_base': 'Viltepso'},\n",
       " {'product_ndc': '73293-0001',\n",
       "  'generic_name': 'Lidocaine Hydrochloride',\n",
       "  'labeler_name': 'Huons Co., Ltd.',\n",
       "  'brand_name': 'Lidocaine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE HYDROCHLORIDE',\n",
       "    'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73293-0001-2',\n",
       "    'description': '10 VIAL in 1 BOX (73293-0001-2)  / 5 mL in 1 VIAL (73293-0001-1)',\n",
       "    'marketing_start_date': '20200507',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Huons Co., Ltd.'],\n",
       "   'rxcui': ['1737566', '1737761'],\n",
       "   'spl_set_id': ['8ec2d256-fc4f-44f6-bee2-eef2bf3bf580'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0373293000317', '0373293000119', '0373293000126', '0373293000324'],\n",
       "   'unii': ['V13007Z41A']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '14a172be-a2db-c9da-e063-6294a90ad411',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20200507',\n",
       "  'product_id': '73293-0001_14a172be-a2db-c9da-e063-6294a90ad411',\n",
       "  'application_number': 'ANDA212821',\n",
       "  'brand_name_base': 'Lidocaine Hydrochloride',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '73306-1121',\n",
       "  'generic_name': 'antiperspirant above invisible feminino aerosol',\n",
       "  'labeler_name': 'BASTON INDUSTRIA DE AEROSSIS LTDA',\n",
       "  'brand_name': 'ANTIPERSPIRANT ABOVE INVISIBLE FEMININO',\n",
       "  'active_ingredients': [{'name': 'ALUMINUM SESQUICHLOROHYDRATE',\n",
       "    'strength': '16 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73306-1121-1',\n",
       "    'description': '90 g in 1 CAN (73306-1121-1)',\n",
       "    'marketing_start_date': '20191218',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['BASTON INDUSTRIA DE AEROSSIS LTDA'],\n",
       "   'spl_set_id': ['99f94a26-b71f-1474-e053-2995a90a81fb'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['UCN889409V']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'AEROSOL, SPRAY',\n",
       "  'spl_id': '240d4d98-a473-f499-e063-6294a90adc46',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20191218',\n",
       "  'product_id': '73306-1121_240d4d98-a473-f499-e063-6294a90adc46',\n",
       "  'application_number': 'M019',\n",
       "  'brand_name_base': 'ANTIPERSPIRANT ABOVE INVISIBLE FEMININO'},\n",
       " {'product_ndc': '73306-1133',\n",
       "  'generic_name': 'ABOVE ELEMENTS ANTIBAC SHINYSILVER',\n",
       "  'labeler_name': 'BASTON INDUSTRIA DE AEROSSOIS LTDA',\n",
       "  'brand_name': 'ABOVE ELEMENTS ANTIBAC SHINYSILVER',\n",
       "  'active_ingredients': [{'name': 'ALUMINUM CHLOROHYDRATE',\n",
       "    'strength': '12 mg/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73306-1133-1',\n",
       "    'description': '50 g in 1 BOTTLE, PLASTIC (73306-1133-1)',\n",
       "    'marketing_start_date': '20221114',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['BASTON INDUSTRIA DE AEROSSOIS LTDA'],\n",
       "   'spl_set_id': ['ed794904-5cea-5b54-e053-2a95a90af26a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['HPN8MZW13M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '1cd52845-d7c1-59ec-e063-6394a90a4987',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20221114',\n",
       "  'product_id': '73306-1133_1cd52845-d7c1-59ec-e063-6394a90a4987',\n",
       "  'application_number': 'M019',\n",
       "  'brand_name_base': 'ABOVE ELEMENTS ANTIBAC SHINYSILVER'},\n",
       " {'product_ndc': '73306-1143',\n",
       "  'generic_name': 'ANTIPERSPIRANT ABOVE DERMACLINICAL WOMEN',\n",
       "  'labeler_name': 'BASTON INDUSTRIA DE AEROSSOIS LTDA',\n",
       "  'brand_name': 'ANTIPERSPIRANT ABOVE DERMACLINICAL WOMEN',\n",
       "  'active_ingredients': [{'name': 'ALUMINUM SESQUICHLOROHYDRATE',\n",
       "    'strength': '16 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73306-1143-1',\n",
       "    'description': '90 g in 1 BOTTLE, SPRAY (73306-1143-1)',\n",
       "    'marketing_start_date': '20230216',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['BASTON INDUSTRIA DE AEROSSOIS LTDA'],\n",
       "   'spl_set_id': ['f4c3df0a-d16e-0f1f-e053-2995a90a87d8'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['7899674033284'],\n",
       "   'unii': ['UCN889409V']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'AEROSOL, SPRAY',\n",
       "  'spl_id': 'f4c3df0a-d16f-0f1f-e053-2995a90a87d8',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230216',\n",
       "  'product_id': '73306-1143_f4c3df0a-d16f-0f1f-e053-2995a90a87d8',\n",
       "  'application_number': 'M019',\n",
       "  'brand_name_base': 'ANTIPERSPIRANT ABOVE DERMACLINICAL WOMEN'},\n",
       " {'product_ndc': '73306-1159',\n",
       "  'generic_name': 'ABOVE EXTREME MEN BLACK 72 HOURS',\n",
       "  'labeler_name': 'BASTON INDUSTRIA DE AEROSSOIS LTDA',\n",
       "  'brand_name': 'ABOVE EXTREME MEN BLACK 72 HOURS',\n",
       "  'active_ingredients': [{'name': 'ALUMINUM SESQUICHLOROHYDRATE',\n",
       "    'strength': '19 mg/90g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73306-1159-1',\n",
       "    'description': '90 g in 1 BOTTLE, SPRAY (73306-1159-1)',\n",
       "    'marketing_start_date': '20230619',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['BASTON INDUSTRIA DE AEROSSOIS LTDA'],\n",
       "   'spl_set_id': ['fe8026d7-fdff-2e44-e053-6394a90a5a52'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['7899674039552'],\n",
       "   'unii': ['UCN889409V']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'AEROSOL, SPRAY',\n",
       "  'spl_id': '240d3b1b-763a-64e7-e063-6294a90aadee',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230619',\n",
       "  'product_id': '73306-1159_240d3b1b-763a-64e7-e063-6294a90aadee',\n",
       "  'application_number': 'M019',\n",
       "  'brand_name_base': 'ABOVE EXTREME MEN BLACK 72 HOURS'},\n",
       " {'product_ndc': '73306-1175',\n",
       "  'generic_name': 'ABOVE EXTREME MEN BLACK ANTIPERSPIRANT MAXX 72H',\n",
       "  'labeler_name': 'BASTON INDUSTRIA DE AEROSSOIS LTDA',\n",
       "  'brand_name': 'ABOVE EXTREME MEN BLACK ANTIPERSPIRANT MAXX 72H',\n",
       "  'active_ingredients': [{'name': 'ALUMINUM SESQUICHLOROHYDRATE',\n",
       "    'strength': '19.2 mg/150g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73306-1175-1',\n",
       "    'description': '150 g in 1 BOTTLE, SPRAY (73306-1175-1)',\n",
       "    'marketing_start_date': '20240518',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['BASTON INDUSTRIA DE AEROSSOIS LTDA'],\n",
       "   'spl_set_id': ['18bc4f03-7d0c-5294-e063-6394a90aa522'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['7899674040695'],\n",
       "   'unii': ['UCN889409V']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'AEROSOL, SPRAY',\n",
       "  'spl_id': '18bc4f03-7d0d-5294-e063-6394a90aa522',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240518',\n",
       "  'product_id': '73306-1175_18bc4f03-7d0d-5294-e063-6394a90aa522',\n",
       "  'application_number': 'M019',\n",
       "  'brand_name_base': 'ABOVE EXTREME MEN BLACK ANTIPERSPIRANT MAXX 72H'},\n",
       " {'product_ndc': '73318-7005',\n",
       "  'generic_name': 'Body Wash',\n",
       "  'labeler_name': 'Skin PS Brands',\n",
       "  'brand_name': 'BP Body Wash',\n",
       "  'active_ingredients': [{'name': 'BENZOYL PEROXIDE', 'strength': '50 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73318-7005-1',\n",
       "    'description': '1 TUBE in 1 CARTON (73318-7005-1)  / 178 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Skin PS Brands'],\n",
       "   'rxcui': ['308696'],\n",
       "   'spl_set_id': ['0754b6b1-3a62-a95a-e063-6394a90a9229'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['W9WZN9A0GM']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '0754f853-293b-d2fc-e063-6394a90af3bb',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230701',\n",
       "  'product_id': '73318-7005_0754f853-293b-d2fc-e063-6394a90af3bb',\n",
       "  'application_number': 'M006',\n",
       "  'brand_name_base': 'BP Body Wash'},\n",
       " {'product_ndc': '73352-550',\n",
       "  'generic_name': 'Undecylenic acid',\n",
       "  'labeler_name': 'Trifluent Pharma LLC',\n",
       "  'brand_name': 'Tripenicol S',\n",
       "  'active_ingredients': [{'name': 'UNDECYLENIC ACID', 'strength': '.25 g/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73352-550-01',\n",
       "    'description': '37.5 mL in 1 BOTTLE, WITH APPLICATOR (73352-550-01)',\n",
       "    'marketing_start_date': '20231211',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Trifluent Pharma LLC'],\n",
       "   'rxcui': ['998329', '2677081'],\n",
       "   'spl_set_id': ['b57500e1-ea6f-4043-99d6-326a7eb57f2f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['K3D86KJ24N']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '56123977-fd3c-49e3-8072-1e6df529fdfe',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20231211',\n",
       "  'product_id': '73352-550_56123977-fd3c-49e3-8072-1e6df529fdfe',\n",
       "  'application_number': 'M005',\n",
       "  'brand_name_base': 'Tripenicol S'},\n",
       " {'product_ndc': '73354-1280',\n",
       "  'generic_name': 'LIDOCAINE',\n",
       "  'labeler_name': 'Galaxy Bio, Inc.',\n",
       "  'brand_name': 'Lido King Lidocaine 4% Pain Relieving Gel-Patch',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '4 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73354-1280-2',\n",
       "    'description': '5 PATCH in 1 CARTON (73354-1280-2)  / 1 g in 1 PATCH',\n",
       "    'marketing_start_date': '20241111',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Galaxy Bio, Inc.'],\n",
       "   'rxcui': ['1737778'],\n",
       "   'spl_set_id': ['2243734a-4ea2-a5e5-e063-6294a90aba15'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175682', 'M0000897', 'N0000175426', 'N0000175976'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]', 'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'unii': ['98PI200987']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'PATCH',\n",
       "  'spl_id': '2243730e-7cf4-925c-e063-6394a90a4f15',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20241111',\n",
       "  'product_id': '73354-1280_2243730e-7cf4-925c-e063-6394a90a4f15',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Lido King Lidocaine 4% Pain Relieving Gel-Patch',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '0591-3670',\n",
       "  'generic_name': 'Nabumetone',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Nabumetone',\n",
       "  'active_ingredients': [{'name': 'NABUMETONE', 'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-3670-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3670-01)',\n",
       "    'marketing_start_date': '20110613',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0591-3670-05',\n",
       "    'description': '500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3670-05)',\n",
       "    'marketing_start_date': '20110613',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['311892', '311893'],\n",
       "   'spl_set_id': ['53656d70-6572-4669-6465-6c6973555341'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['LW0TIW155Z']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '45b912a8-b643-4107-82a2-6d543d0190bd',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20110613',\n",
       "  'product_id': '0591-3670_45b912a8-b643-4107-82a2-6d543d0190bd',\n",
       "  'application_number': 'ANDA091083',\n",
       "  'brand_name_base': 'Nabumetone',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '73362-010',\n",
       "  'generic_name': 'Lonapegsomatropin-tcgd',\n",
       "  'labeler_name': 'Ascendis Pharma Endocrinology, Inc.',\n",
       "  'brand_name': 'Skytrofa',\n",
       "  'active_ingredients': [{'name': 'LONAPEGSOMATROPIN', 'strength': '11 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73362-010-01',\n",
       "    'description': '4 BLISTER PACK in 1 CARTON (73362-010-01)  / 1 CARTRIDGE in 1 BLISTER PACK (73362-010-02)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTRIDGE',\n",
       "    'marketing_start_date': '20210825',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Ascendis Pharma Endocrinology, Inc.'],\n",
       "   'rxcui': ['2569603',\n",
       "    '2569605',\n",
       "    '2569607',\n",
       "    '2569609',\n",
       "    '2569611',\n",
       "    '2569613',\n",
       "    '2569615',\n",
       "    '2569617',\n",
       "    '2569619',\n",
       "    '2569621',\n",
       "    '2569623',\n",
       "    '2569625',\n",
       "    '2569627',\n",
       "    '2569629',\n",
       "    '2569631',\n",
       "    '2569633',\n",
       "    '2569635',\n",
       "    '2569637'],\n",
       "   'spl_set_id': ['9229f871-bc61-4ddc-8122-d126d40e36ac'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175606', 'M0028842'],\n",
       "   'pharm_class_epc': ['Recombinant Human Growth Hormone [EPC]'],\n",
       "   'pharm_class_cs': ['Human Growth Hormone [CS]'],\n",
       "   'unii': ['OP35X9610Y']},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION',\n",
       "  'spl_id': 'da6dc8ae-337b-415b-a181-069b8a6d54be',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20210825',\n",
       "  'product_id': '73362-010_da6dc8ae-337b-415b-a181-069b8a6d54be',\n",
       "  'application_number': 'BLA761177',\n",
       "  'brand_name_base': 'Skytrofa',\n",
       "  'pharm_class': ['Human Growth Hormone [CS]',\n",
       "   'Recombinant Human Growth Hormone [EPC]']},\n",
       " {'product_ndc': '73369-0010',\n",
       "  'generic_name': 'Hand Santizer',\n",
       "  'labeler_name': 'Kabana Skin Care',\n",
       "  'brand_name': 'Astral Organica Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '64.7 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73369-0010-1',\n",
       "    'description': '43.4 g in 1 BOTTLE, PUMP (73369-0010-1)',\n",
       "    'marketing_start_date': '20200802',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Kabana Skin Care'],\n",
       "   'spl_set_id': ['abea4b76-cafe-799e-e053-2995a90adc3b'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '252a8288-c8a0-ef6f-e063-6294a90a52d8',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200802',\n",
       "  'product_id': '73369-0010_252a8288-c8a0-ef6f-e063-6294a90a52d8',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Astral Organica Hand Sanitizer'},\n",
       " {'product_ndc': '73369-1202',\n",
       "  'generic_name': 'Sunscreen',\n",
       "  'labeler_name': 'Kabana Skin Care',\n",
       "  'brand_name': 'Waxhead Skin Nourishing Tinted Plus Sunscreen SPF 31',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '25 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73369-1202-1',\n",
       "    'description': '115 g in 1 TUBE (73369-1202-1)',\n",
       "    'marketing_start_date': '20160415',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Kabana Skin Care'],\n",
       "   'spl_set_id': ['b82f2bee-e6b4-470c-e053-2a95a90afd22'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '252a08ae-362e-3c76-e063-6394a90a80b6',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20160415',\n",
       "  'product_id': '73369-1202_252a08ae-362e-3c76-e063-6394a90a80b6',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Waxhead Skin Nourishing Tinted Plus Sunscreen SPF 31'},\n",
       " {'product_ndc': '73369-1206',\n",
       "  'generic_name': 'ZINC OXIDE',\n",
       "  'labeler_name': 'Kabana Skin Care',\n",
       "  'brand_name': 'Waxhead Tinted Zinc Oxide Sunscreen SPF 30',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '25 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73369-1206-1',\n",
       "    'description': '110 g in 1 TUBE (73369-1206-1)',\n",
       "    'marketing_start_date': '20160415',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Kabana Skin Care'],\n",
       "   'spl_set_id': ['b8d5274c-a46d-7fe6-e053-2a95a90a06e3'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0747906342307'],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '252a6bd5-805f-391a-e063-6394a90a751e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20160415',\n",
       "  'product_id': '73369-1206_252a6bd5-805f-391a-e063-6394a90a751e',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Waxhead Tinted Zinc Oxide Sunscreen SPF 30'},\n",
       " {'product_ndc': '73382-185',\n",
       "  'generic_name': 'LIDOCAINE HYDROCHLORIDE',\n",
       "  'labeler_name': 'Natures Design Products LLC',\n",
       "  'brand_name': 'NATURES CRAFT LIDOCAINE Male Genital Desensitizer',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE HYDROCHLORIDE',\n",
       "    'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73382-185-01',\n",
       "    'description': '1 BOTTLE, SPRAY in 1 BOX (73382-185-01)  / 30 mL in 1 BOTTLE, SPRAY',\n",
       "    'marketing_start_date': '20210405',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Natures Design Products LLC'],\n",
       "   'spl_set_id': ['61bf1776-5c6c-4307-8348-41fa60164017'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['V13007Z41A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '09dc94a7-aacd-f8c4-e063-6294a90adeee',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210405',\n",
       "  'product_id': '73382-185_09dc94a7-aacd-f8c4-e063-6294a90adeee',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'NATURES CRAFT LIDOCAINE Male Genital Desensitizer',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '73408-035',\n",
       "  'generic_name': 'benzalkonium chloride',\n",
       "  'labeler_name': 'Thompson',\n",
       "  'brand_name': 'Thompson Antiseptic',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '1.3 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73408-035-50',\n",
       "    'description': '50 PACKET in 1 BOX (73408-035-50)  / 1 mL in 1 PACKET',\n",
       "    'marketing_start_date': '20240823',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Thompson'],\n",
       "   'rxcui': ['1038558', '1043307'],\n",
       "   'spl_set_id': ['f537c81d-1fdc-3e0f-e053-2a95a90a6c2b'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0073408130716'],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SWAB',\n",
       "  'spl_id': '205c9ce7-ed0f-d1e6-e063-6294a90a5a73',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240823',\n",
       "  'product_id': '73408-035_205c9ce7-ed0f-d1e6-e063-6294a90a5a73',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'Thompson Antiseptic'},\n",
       " {'product_ndc': '73408-512',\n",
       "  'marketing_end_date': '20280430',\n",
       "  'generic_name': 'Ethyl alcohol',\n",
       "  'labeler_name': 'Thompson',\n",
       "  'brand_name': 'Thompson Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '62 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73408-512-73',\n",
       "    'description': '25 PACKET in 1 BOX (73408-512-73)  / .9 mL in 1 PACKET',\n",
       "    'marketing_start_date': '20220801',\n",
       "    'marketing_end_date': '20280430',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Thompson'],\n",
       "   'rxcui': ['581660'],\n",
       "   'spl_set_id': ['deada606-8a82-9eeb-e053-2a95a90a9e6d'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0073408511737'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '0f168fab-9ef4-4a8b-e063-6294a90adc65',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220801',\n",
       "  'product_id': '73408-512_0f168fab-9ef4-4a8b-e063-6294a90adc65',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'Thompson Hand Sanitizer'},\n",
       " {'product_ndc': '73408-815',\n",
       "  'generic_name': 'Menthol',\n",
       "  'labeler_name': 'Thompson Safety LLC',\n",
       "  'brand_name': 'Thompson Cherry Cough Drops',\n",
       "  'active_ingredients': [{'name': 'MENTHOL', 'strength': '7.6 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73408-815-50',\n",
       "    'description': '50 LOZENGE in 1 BOX (73408-815-50)',\n",
       "    'marketing_start_date': '20210811',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Thompson Safety LLC'],\n",
       "   'rxcui': ['359751'],\n",
       "   'spl_set_id': ['c948f5b0-8491-6f9f-e053-2995a90a55fa'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOZENGE',\n",
       "  'spl_id': '26d0d747-35d5-9ef5-e063-6394a90a0b5f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210811',\n",
       "  'product_id': '73408-815_26d0d747-35d5-9ef5-e063-6394a90a0b5f',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'Thompson Cherry Cough Drops'},\n",
       " {'product_ndc': '73408-930',\n",
       "  'marketing_end_date': '20250901',\n",
       "  'generic_name': 'bacitracin zinc, neomycin sulfate, polymyxin b sulfate',\n",
       "  'labeler_name': 'Crane Safety LLC',\n",
       "  'brand_name': 'Crane Safety Triple Antibiotic',\n",
       "  'active_ingredients': [{'name': 'BACITRACIN ZINC',\n",
       "    'strength': \"400 [USP'U]/g\"},\n",
       "   {'name': 'NEOMYCIN SULFATE', 'strength': '3.5 mg/g'},\n",
       "   {'name': 'POLYMYXIN B SULFATE', 'strength': \"5000 [USP'U]/g\"}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73408-930-73',\n",
       "    'description': '25 PACKET in 1 BOX (73408-930-73)  / .5 g in 1 PACKET',\n",
       "    'marketing_start_date': '20210601',\n",
       "    'marketing_end_date': '20250901',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Crane Safety LLC'],\n",
       "   'rxcui': ['204602'],\n",
       "   'spl_set_id': ['96dbc282-4b3f-aaf3-e053-2995a90a5694'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['19371312D4', '057Y626693', '89Y4M234ES']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'OINTMENT',\n",
       "  'spl_id': '0f28cf0c-6d42-a8fb-e063-6394a90a8636',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210601',\n",
       "  'product_id': '73408-930_0f28cf0c-6d42-a8fb-e063-6394a90a8636',\n",
       "  'application_number': 'M004',\n",
       "  'brand_name_base': 'Crane Safety Triple Antibiotic',\n",
       "  'pharm_class': ['Aminoglycoside Antibacterial [EPC]',\n",
       "   'Aminoglycosides [CS]',\n",
       "   'Decreased Cell Wall Synthesis & Repair [PE]',\n",
       "   'Polymyxin-class Antibacterial [EPC]',\n",
       "   'Polymyxins [CS]']},\n",
       " {'product_ndc': '73421-0526',\n",
       "  'generic_name': 'Arsenicum alb, Avena, Berberis vulg, Lycopodium, Nat mur, Nux vom, Phytolacca, Rhamnus frang, Solidago, Trifolium prat',\n",
       "  'labeler_name': 'White Manufacturing Inc. DBA Micro-West',\n",
       "  'brand_name': 'MET TOX',\n",
       "  'active_ingredients': [{'name': 'ARSENIC TRIOXIDE',\n",
       "    'strength': '12 [hp_X]/29.6mL'},\n",
       "   {'name': 'AVENA SATIVA FLOWERING TOP', 'strength': '3 [hp_X]/29.6mL'},\n",
       "   {'name': 'BERBERIS VULGARIS ROOT BARK', 'strength': '3 [hp_X]/29.6mL'},\n",
       "   {'name': 'FRANGULA ALNUS BARK', 'strength': '3 [hp_X]/29.6mL'},\n",
       "   {'name': 'LYCOPODIUM CLAVATUM SPORE', 'strength': '12 [hp_X]/29.6mL'},\n",
       "   {'name': 'PHYTOLACCA AMERICANA ROOT', 'strength': '3 [hp_X]/29.6mL'},\n",
       "   {'name': 'SODIUM CHLORIDE', 'strength': '12 [hp_X]/29.6mL'},\n",
       "   {'name': 'SOLIDAGO VIRGAUREA FLOWERING TOP', 'strength': '3 [hp_X]/29.6mL'},\n",
       "   {'name': 'STRYCHNOS NUX-VOMICA SEED', 'strength': '12 [hp_X]/29.6mL'},\n",
       "   {'name': 'TRIFOLIUM PRATENSE FLOWER', 'strength': '3 [hp_X]/29.6mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73421-0526-1',\n",
       "    'description': '29.6 mL in 1 BOTTLE, DROPPER (73421-0526-1)',\n",
       "    'marketing_start_date': '20210601',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['White Manufacturing Inc. DBA Micro-West'],\n",
       "   'spl_set_id': ['2653d62b-5dd7-482c-b31c-ce5fa1373900'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185375',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'N0000185001',\n",
       "    'M0000728',\n",
       "    'M0016962',\n",
       "    'M0516536'],\n",
       "   'pharm_class_epc': ['Non-Standardized Plant Allergenic Extract [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]',\n",
       "    'Increased IgG Production [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]',\n",
       "    'Plant Proteins [CS]',\n",
       "    'Seed Storage Proteins [CS]'],\n",
       "   'unii': ['S7V92P67HO',\n",
       "    'MA9CQJ3F7F',\n",
       "    '1TH8Q20J0U',\n",
       "    'S2D77IH61R',\n",
       "    'C88X29Y479',\n",
       "    '11E6VI8VEG',\n",
       "    '451W47IQ8X',\n",
       "    '5405K23S50',\n",
       "    '269XH13919',\n",
       "    '4JS0838828']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'eedfd248-253f-2c60-e053-2a95a90a44f1',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210601',\n",
       "  'product_id': '73421-0526_eedfd248-253f-2c60-e053-2a95a90a44f1',\n",
       "  'brand_name_base': 'MET TOX',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Increased IgG Production [PE]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]',\n",
       "   'Seed Storage Proteins [CS]']},\n",
       " {'product_ndc': '73436-2859',\n",
       "  'generic_name': 'levonorgestrel',\n",
       "  'labeler_name': 'Cadence Health Inc',\n",
       "  'brand_name': 'Morning After Pill',\n",
       "  'active_ingredients': [{'name': 'LEVONORGESTREL', 'strength': '1.5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73436-2859-1',\n",
       "    'description': '1 BLISTER PACK in 1 CARTON (73436-2859-1)  / 1 TABLET in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20231001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Cadence Health Inc'],\n",
       "   'rxcui': ['483325', '1657617'],\n",
       "   'spl_set_id': ['fc5d29bb-4a4b-e61e-e053-6394a90a8a62'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175830', 'M0447349', 'N0000175602', 'N0000175832'],\n",
       "   'pharm_class_pe': ['Inhibit Ovum Fertilization [PE]'],\n",
       "   'pharm_class_cs': ['Progesterone Congeners [CS]'],\n",
       "   'pharm_class_epc': ['Progestin [EPC]',\n",
       "    'Progestin-containing Intrauterine System [EPC]'],\n",
       "   'unii': ['5W7SIA7YZW']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '056c2ecb-4a90-669d-e063-6294a90a90ba',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20231001',\n",
       "  'product_id': '73436-2859_056c2ecb-4a90-669d-e063-6294a90a90ba',\n",
       "  'application_number': 'ANDA202380',\n",
       "  'brand_name_base': 'Morning After Pill',\n",
       "  'pharm_class': ['Inhibit Ovum Fertilization [PE]',\n",
       "   'Progesterone Congeners [CS]',\n",
       "   'Progesterone Congeners [CS]',\n",
       "   'Progestin [EPC]',\n",
       "   'Progestin-containing Intrauterine System [EPC]']},\n",
       " {'product_ndc': '73442-0010',\n",
       "  'generic_name': 'L-Menthol, L-Camphor, Methyl Salicylate',\n",
       "  'labeler_name': 'I World Pharmaceutical Co., Ltd.',\n",
       "  'brand_name': 'ANTIPHLAMINE',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR, (-)-', 'strength': '59 mg/g'},\n",
       "   {'name': 'LEVOMENTHOL', 'strength': '8 mg/g'},\n",
       "   {'name': 'METHYL SALICYLATE', 'strength': '46 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73442-0010-2',\n",
       "    'description': '7 PATCH in 1 POUCH (73442-0010-2)  / 1.433 g in 1 PATCH (73442-0010-1)',\n",
       "    'marketing_start_date': '20200909',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['I World Pharmaceutical Co., Ltd.'],\n",
       "   'rxcui': ['2473372'],\n",
       "   'spl_set_id': ['aed8ba5e-d2d5-672e-e053-2a95a90a93a3'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['213N3S8275', 'BZ1R15MTK7', 'LAV5U5022Y']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'PATCH',\n",
       "  'spl_id': 'aed8b1c6-1208-1499-e053-2a95a90a5dde',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200909',\n",
       "  'product_id': '73442-0010_aed8b1c6-1208-1499-e053-2a95a90a5dde',\n",
       "  'application_number': 'part348',\n",
       "  'brand_name_base': 'ANTIPHLAMINE'},\n",
       " {'product_ndc': '73466-0004',\n",
       "  'generic_name': 'glycerin',\n",
       "  'labeler_name': 'MISOCOS',\n",
       "  'brand_name': 'aewajin Derma Hydrocell',\n",
       "  'active_ingredients': [{'name': 'GLYCERIN', 'strength': '5 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73466-0004-1',\n",
       "    'description': '120 mL in 1 BOTTLE (73466-0004-1)',\n",
       "    'marketing_start_date': '20191116',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['MISOCOS'],\n",
       "   'spl_set_id': ['980fcaea-27ba-da49-e053-2995a90ad506'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000185370',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'N0000185001',\n",
       "    'M0000728',\n",
       "    'M0009417'],\n",
       "   'pharm_class_epc': ['Non-Standardized Chemical Allergen [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]',\n",
       "    'Increased IgG Production [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]', 'Glycerol [CS]'],\n",
       "   'unii': ['PDC6A3C0OX']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '1c79222b-edeb-d38b-e063-6394a90a6e34',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20191116',\n",
       "  'product_id': '73466-0004_1c79222b-edeb-d38b-e063-6394a90a6e34',\n",
       "  'brand_name_base': 'aewajin Derma Hydrocell',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Glycerol [CS]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Increased IgG Production [PE]',\n",
       "   'Non-Standardized Chemical Allergen [EPC]']},\n",
       " {'product_ndc': '73469-0463',\n",
       "  'generic_name': 'Salicylic Acid',\n",
       "  'labeler_name': 'Scholls Wellness Company LLC',\n",
       "  'brand_name': 'Scholls Wellness Company LLC DS EXTRA THICK CALLUS REMOVER',\n",
       "  'brand_name_suffix': 'DS EXTRA THICK CALLUS REMOVER',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '.4 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73469-0463-1',\n",
       "    'description': '4 POUCH in 1 CARTON (73469-0463-1)  / 1 g in 1 POUCH',\n",
       "    'marketing_start_date': '20210101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Scholls Wellness Company LLC'],\n",
       "   'rxcui': ['240559'],\n",
       "   'spl_set_id': ['b7144150-6c81-66c2-e053-2995a90ad6e9'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['O414PZ4LPZ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'DISC',\n",
       "  'spl_id': '239c905b-c7b8-aab4-e063-6394a90abecd',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210101',\n",
       "  'product_id': '73469-0463_239c905b-c7b8-aab4-e063-6394a90abecd',\n",
       "  'application_number': 'M030',\n",
       "  'brand_name_base': 'Scholls Wellness Company LLC'},\n",
       " {'product_ndc': '73469-0644',\n",
       "  'generic_name': 'Salicylic Acid',\n",
       "  'labeler_name': 'Scholls Wellness Company LLC',\n",
       "  'brand_name': 'Scholls Wellness Company LLC Duragel Callus Remover',\n",
       "  'brand_name_suffix': 'Duragel Callus Remover',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '.4 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73469-0644-1',\n",
       "    'description': '4 POUCH in 1 CARTON (73469-0644-1)  / 1 g in 1 POUCH',\n",
       "    'marketing_start_date': '20210101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Scholls Wellness Company LLC'],\n",
       "   'rxcui': ['240559'],\n",
       "   'spl_set_id': ['b7256b0a-3c7e-139f-e053-2a95a90ad344'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['O414PZ4LPZ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'DISC',\n",
       "  'spl_id': '239cb0e6-5bb9-48e9-e063-6394a90a03ff',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210101',\n",
       "  'product_id': '73469-0644_239cb0e6-5bb9-48e9-e063-6394a90a03ff',\n",
       "  'application_number': 'M030',\n",
       "  'brand_name_base': 'Scholls Wellness Company LLC'},\n",
       " {'product_ndc': '73469-2053',\n",
       "  'generic_name': 'Diclofenac',\n",
       "  'labeler_name': \"Scholl's Wellness Company\",\n",
       "  'brand_name': 'Diclofenac sodium',\n",
       "  'active_ingredients': [{'name': 'DICLOFENAC SODIUM', 'strength': '10 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73469-2053-1',\n",
       "    'description': '1 TUBE in 1 CARTON (73469-2053-1)  / 100 g in 1 TUBE',\n",
       "    'marketing_start_date': '20201030',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73469-2053-8',\n",
       "    'description': '1 TUBE in 1 CARTON (73469-2053-8)  / 50 g in 1 TUBE',\n",
       "    'marketing_start_date': '20201030',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': [\"Scholl's Wellness Company\"],\n",
       "   'rxcui': ['855633'],\n",
       "   'spl_set_id': ['8dcbce69-945b-4913-a279-ee10871f6580'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['QTG126297Q']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '98c05bf7-56d6-4a08-b3d6-1ca1bef9a151',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20201030',\n",
       "  'product_id': '73469-2053_98c05bf7-56d6-4a08-b3d6-1ca1bef9a151',\n",
       "  'application_number': 'ANDA208077',\n",
       "  'brand_name_base': 'Diclofenac sodium',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Decreased Prostaglandin Production [PE]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '73469-6321',\n",
       "  'generic_name': 'Salicylic acid',\n",
       "  'labeler_name': 'Scholls Wellness Company LLC',\n",
       "  'brand_name': 'One Step Wart Removers',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '.4 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73469-6321-4',\n",
       "    'description': '14 POUCH in 1 CARTON (73469-6321-4)  / 1 g in 1 POUCH',\n",
       "    'marketing_start_date': '20230531',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Scholls Wellness Company LLC'],\n",
       "   'rxcui': ['240559'],\n",
       "   'spl_set_id': ['fc9e2a45-f044-b008-e053-6394a90a056a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['O414PZ4LPZ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'DISC',\n",
       "  'spl_id': '23a8ff82-8b2e-a0db-e063-6394a90ae6bc',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230523',\n",
       "  'product_id': '73469-6321_23a8ff82-8b2e-a0db-e063-6394a90ae6bc',\n",
       "  'application_number': 'M028',\n",
       "  'brand_name_base': 'One Step Wart Removers'},\n",
       " {'product_ndc': '73469-6331',\n",
       "  'generic_name': 'Salicylic acid',\n",
       "  'labeler_name': 'Scholls Wellness Company LLC',\n",
       "  'brand_name': 'Plantar Wart Removers',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '.4 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73469-6331-2',\n",
       "    'description': '12 POUCH in 1 CARTON (73469-6331-2)  / 1 g in 1 POUCH',\n",
       "    'marketing_start_date': '20230531',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Scholls Wellness Company LLC'],\n",
       "   'rxcui': ['240559'],\n",
       "   'spl_set_id': ['fc9dc984-37c8-5bab-e053-6294a90a3c15'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['O414PZ4LPZ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'DISC',\n",
       "  'spl_id': '239abbb5-c3a4-bcfa-e063-6394a90a66b6',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230523',\n",
       "  'product_id': '73469-6331_239abbb5-c3a4-bcfa-e063-6394a90a66b6',\n",
       "  'application_number': 'M028',\n",
       "  'brand_name_base': 'Plantar Wart Removers'},\n",
       " {'product_ndc': '73473-302',\n",
       "  'generic_name': 'clindamycin phosphate',\n",
       "  'labeler_name': 'Solaris Pharma Corporation',\n",
       "  'brand_name': 'Clindamycin Phosphate',\n",
       "  'active_ingredients': [{'name': 'CLINDAMYCIN PHOSPHATE',\n",
       "    'strength': '1 g/10mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73473-302-75',\n",
       "    'description': '1 BOTTLE in 1 CARTON (73473-302-75)  / 75 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20240915',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Solaris Pharma Corporation'],\n",
       "   'spl_set_id': ['fde07866-b012-47ad-932e-b76f141f86ee'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0373473302750'],\n",
       "   'unii': ['EH6D7113I8']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '3a42199c-8c43-4fe7-83fc-4dd5af82279d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240915',\n",
       "  'product_id': '73473-302_3a42199c-8c43-4fe7-83fc-4dd5af82279d',\n",
       "  'application_number': 'ANDA212842',\n",
       "  'brand_name_base': 'Clindamycin Phosphate',\n",
       "  'pharm_class': ['Decreased Sebaceous Gland Activity [PE]',\n",
       "   'Lincosamide Antibacterial [EPC]',\n",
       "   'Lincosamides [CS]',\n",
       "   'Neuromuscular Blockade [PE]']},\n",
       " {'product_ndc': '73475-3102',\n",
       "  'generic_name': 'efgartigimod alfa and hyaluronidase (human recombinant)',\n",
       "  'labeler_name': 'argenx US',\n",
       "  'brand_name': 'VYVGART Hytrulo',\n",
       "  'active_ingredients': [{'name': 'EFGARTIGIMOD ALFA',\n",
       "    'strength': '180 mg/mL'},\n",
       "   {'name': 'HYALURONIDASE (HUMAN RECOMBINANT)', 'strength': '2000 U/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73475-3102-3',\n",
       "    'description': '1 VIAL, SINGLE-DOSE in 1 CARTON (73475-3102-3)  / 5.6 mL in 1 VIAL, SINGLE-DOSE',\n",
       "    'marketing_start_date': '20230620',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['argenx US'],\n",
       "   'rxcui': ['2639951', '2639957'],\n",
       "   'spl_set_id': ['7104d9e5-9910-47f5-9a93-741ac50f43b6'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000194004', 'N0000194005', 'N0000175531', 'M0009499'],\n",
       "   'pharm_class_epc': ['Neonatal Fc Receptor Blocker [EPC]',\n",
       "    'Endoglycosidase [EPC]'],\n",
       "   'pharm_class_moa': ['Neonatal Fc Receptor Blockers [MoA]'],\n",
       "   'pharm_class_cs': ['Glycoside Hydrolases [CS]'],\n",
       "   'unii': ['961YV2O515', '743QUY4VD8']},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': '4ff4519c-ae5e-482a-90c1-0d3912cc6fc5',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20230620',\n",
       "  'product_id': '73475-3102_4ff4519c-ae5e-482a-90c1-0d3912cc6fc5',\n",
       "  'application_number': 'BLA761304',\n",
       "  'brand_name_base': 'VYVGART Hytrulo',\n",
       "  'pharm_class': ['Endoglycosidase [EPC]',\n",
       "   'Glycoside Hydrolases [CS]',\n",
       "   'Neonatal Fc Receptor Blocker [EPC]',\n",
       "   'Neonatal Fc Receptor Blockers [MoA]']},\n",
       " {'product_ndc': '73479-011',\n",
       "  'generic_name': 'BACILLUS CEREUS',\n",
       "  'labeler_name': 'sanPharmacy Inc.',\n",
       "  'brand_name': 'CereusSAN',\n",
       "  'active_ingredients': [{'name': 'BACILLUS CEREUS',\n",
       "    'strength': '6 [hp_X]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73479-011-01',\n",
       "    'description': '1 CAN in 1 CARTON (73479-011-01)  / 10 CAPSULE in 1 CAN',\n",
       "    'marketing_start_date': '20240423',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['sanPharmacy Inc.'],\n",
       "   'spl_set_id': ['16c13a41-8aa3-3e05-e063-6394a90a687a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['7YC151N82L']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '16c13a41-8aa4-3e05-e063-6394a90a687a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240423',\n",
       "  'product_id': '73479-011_16c13a41-8aa4-3e05-e063-6394a90a687a',\n",
       "  'brand_name_base': 'CereusSAN'},\n",
       " {'product_ndc': '73479-012',\n",
       "  'generic_name': 'BACILLUS CEREUS',\n",
       "  'labeler_name': 'sanPharmacy Inc.',\n",
       "  'brand_name': 'CereusSAN',\n",
       "  'active_ingredients': [{'name': 'BACILLUS CEREUS',\n",
       "    'strength': '6 [hp_X]/10mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73479-012-04',\n",
       "    'description': '1 BOTTLE, DROPPER in 1 CARTON (73479-012-04)  / 10 mL in 1 BOTTLE, DROPPER',\n",
       "    'marketing_start_date': '20240424',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['sanPharmacy Inc.'],\n",
       "   'spl_set_id': ['16d55979-6f08-6000-e063-6294a90a347f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['7YC151N82L']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'SOLUTION/ DROPS',\n",
       "  'spl_id': '16d55979-6f09-6000-e063-6294a90a347f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240424',\n",
       "  'product_id': '73479-012_16d55979-6f09-6000-e063-6294a90a347f',\n",
       "  'brand_name_base': 'CereusSAN'},\n",
       " {'product_ndc': '73479-038',\n",
       "  'generic_name': 'PENICILLIUM GLABRUM',\n",
       "  'labeler_name': 'sanPharmacy Inc.',\n",
       "  'brand_name': 'QuentaSAN',\n",
       "  'active_ingredients': [{'name': 'PENICILLIUM GLABRUM',\n",
       "    'strength': '3 [hp_X]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73479-038-05',\n",
       "    'description': '1 BLISTER PACK in 1 CARTON (73479-038-05)  / 10 SUPPOSITORY in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20231012',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['sanPharmacy Inc.'],\n",
       "   'spl_set_id': ['9942624f-26f7-3733-e053-2995a90a5130'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['2IN23YUE0I']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'SUPPOSITORY',\n",
       "  'spl_id': '0cef86b0-d094-07bb-e063-6394a90a079d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['RECTAL'],\n",
       "  'marketing_start_date': '20231012',\n",
       "  'product_id': '73479-038_0cef86b0-d094-07bb-e063-6394a90a079d',\n",
       "  'brand_name_base': 'QuentaSAN'},\n",
       " {'product_ndc': '73496-009',\n",
       "  'generic_name': 'Avobenzone, Homosalate, Octisalate, Octocrylene',\n",
       "  'labeler_name': 'RoC Skincare',\n",
       "  'brand_name': 'RoC Retinol Correxion Wrinkle Correct Daily Moisturizer SPF 30',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '3 mg/100mL'},\n",
       "   {'name': 'HOMOSALATE', 'strength': '6.6 mg/100mL'},\n",
       "   {'name': 'OCTISALATE', 'strength': '5 mg/100mL'},\n",
       "   {'name': 'OCTOCRYLENE', 'strength': '2 mg/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73496-009-00',\n",
       "    'description': '30 mL in 1 TUBE (73496-009-00)',\n",
       "    'marketing_start_date': '20241001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['RoC Skincare'],\n",
       "   'spl_set_id': ['2888a198-116b-8441-e063-6394a90a0f95'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['G63QQF2NOX', 'V06SV4M95S', '4X49Y0596W', '5A68WGF6WM']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '2888a198-116c-8441-e063-6394a90a0f95',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20241001',\n",
       "  'product_id': '73496-009_2888a198-116c-8441-e063-6394a90a0f95',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'RoC Retinol Correxion Wrinkle Correct Daily Moisturizer SPF 30'},\n",
       " {'product_ndc': '73498-021',\n",
       "  'generic_name': 'Menthol',\n",
       "  'labeler_name': 'WB VENTURES LLC',\n",
       "  'brand_name': 'Natures Willow Balm',\n",
       "  'active_ingredients': [{'name': 'MENTHOL', 'strength': '30 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73498-021-01',\n",
       "    'description': '99 g in 1 TUBE (73498-021-01)',\n",
       "    'marketing_start_date': '20210128',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['WB VENTURES LLC'],\n",
       "   'rxcui': ['1442261'],\n",
       "   'spl_set_id': ['b9f50c43-b0d5-39a8-e053-2995a90a04f1'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0860002874814'],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '0cdefed6-6444-c34c-e063-6394a90a4099',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210128',\n",
       "  'product_id': '73498-021_0cdefed6-6444-c34c-e063-6394a90a4099',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Natures Willow Balm'},\n",
       " {'product_ndc': '73503-013',\n",
       "  'generic_name': 'sulfur',\n",
       "  'labeler_name': 'PSODEX USA INC',\n",
       "  'brand_name': 'Acne Therapy Bar',\n",
       "  'brand_name_suffix': 'Bar',\n",
       "  'active_ingredients': [{'name': 'SULFUR', 'strength': '3 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73503-013-00',\n",
       "    'description': '1000 g in 1 BOX (73503-013-00)',\n",
       "    'marketing_start_date': '20240101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['PSODEX USA INC'],\n",
       "   'rxcui': ['248410'],\n",
       "   'spl_set_id': ['03253625-7be2-7559-e063-6294a90a540a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['70FD1KFU70']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOAP',\n",
       "  'spl_id': '0d0e8dea-e6de-3e60-e063-6294a90aa7d4',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240101',\n",
       "  'product_id': '73503-013_0d0e8dea-e6de-3e60-e063-6294a90aa7d4',\n",
       "  'application_number': 'M006',\n",
       "  'brand_name_base': 'Acne Therapy'},\n",
       " {'product_ndc': '73528-100',\n",
       "  'generic_name': 'Zinc Pyrithione',\n",
       "  'labeler_name': 'Zero Flakes Given, LLC.',\n",
       "  'brand_name': 'Balancing',\n",
       "  'active_ingredients': [{'name': 'PYRITHIONE ZINC', 'strength': '1 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73528-100-01',\n",
       "    'description': '280 mL in 1 BOTTLE, DISPENSING (73528-100-01)',\n",
       "    'marketing_start_date': '20200201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73528-100-02',\n",
       "    'description': '85 mL in 1 BOTTLE, DISPENSING (73528-100-02)',\n",
       "    'marketing_start_date': '20200201',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73528-100-03',\n",
       "    'description': '9 mL in 1 PACKET (73528-100-03)',\n",
       "    'marketing_start_date': '20200201',\n",
       "    'sample': True}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Zero Flakes Given, LLC.'],\n",
       "   'rxcui': ['209884'],\n",
       "   'spl_set_id': ['984780fd-4969-150b-e053-2995a90aed77'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['R953O2RHZ5']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SHAMPOO',\n",
       "  'spl_id': '289cddc1-a936-5cae-e063-6294a90a499a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200201',\n",
       "  'product_id': '73528-100_289cddc1-a936-5cae-e063-6294a90a499a',\n",
       "  'application_number': 'M032',\n",
       "  'brand_name_base': 'Balancing'},\n",
       " {'product_ndc': '73544-001',\n",
       "  'generic_name': 'Oxygen',\n",
       "  'labeler_name': 'MasVida Health Care Solutions, LLC',\n",
       "  'brand_name': 'Oxygen',\n",
       "  'active_ingredients': [{'name': 'OXYGEN', 'strength': '99 L/100L'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73544-001-01',\n",
       "    'description': '680 L in 1 CYLINDER (73544-001-01)',\n",
       "    'marketing_start_date': '20191227',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['MasVida Health Care Solutions, LLC'],\n",
       "   'rxcui': ['312172'],\n",
       "   'spl_set_id': ['9aecc996-dd27-64f3-e053-2995a90ab739'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['S88TT14065']},\n",
       "  'marketing_category': 'UNAPPROVED MEDICAL GAS',\n",
       "  'dosage_form': 'GAS',\n",
       "  'spl_id': '0bb190fe-7187-d4d8-e063-6294a90a8938',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['RESPIRATORY (INHALATION)'],\n",
       "  'marketing_start_date': '20091223',\n",
       "  'product_id': '73544-001_0bb190fe-7187-d4d8-e063-6294a90a8938',\n",
       "  'brand_name_base': 'Oxygen'},\n",
       " {'product_ndc': '73557-133',\n",
       "  'generic_name': 'Menthol',\n",
       "  'labeler_name': 'Shanghai Chuangshi Medical Technology (Group) Co., Ltd.',\n",
       "  'brand_name': 'OVERNIGHT RELIEF Gel-Patch',\n",
       "  'active_ingredients': [{'name': 'MENTHOL', 'strength': '.05 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73557-133-05',\n",
       "    'description': '5 PATCH in 1 BOX (73557-133-05)  / 8 g in 1 PATCH (73557-133-01)',\n",
       "    'marketing_start_date': '20221230',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Shanghai Chuangshi Medical Technology (Group) Co., Ltd.'],\n",
       "   'rxcui': ['420222'],\n",
       "   'spl_set_id': ['f1041b25-eb09-e43d-e053-2995a90a073a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6924239703584', '6924239703591'],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'PATCH',\n",
       "  'spl_id': '17393b75-2c48-522e-e063-6294a90a9182',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20221230',\n",
       "  'product_id': '73557-133_17393b75-2c48-522e-e063-6294a90a9182',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'OVERNIGHT RELIEF Gel-Patch'},\n",
       " {'product_ndc': '73557-158',\n",
       "  'generic_name': 'Lidocaine',\n",
       "  'labeler_name': 'Shanghai Chuangshi Medical Technology (Group) Co., Ltd.',\n",
       "  'brand_name': 'Pain Relieving Gel-Patch',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '.04 g/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73557-158-06',\n",
       "    'description': '6 PATCH in 1 BOX (73557-158-06)  / 12 g in 1 PATCH (73557-158-01)',\n",
       "    'marketing_start_date': '20230601',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Shanghai Chuangshi Medical Technology (Group) Co., Ltd.'],\n",
       "   'rxcui': ['1737778'],\n",
       "   'spl_set_id': ['fd0d4646-4b5e-3fe8-e053-6394a90ad6c4'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6924239705397', '6924239705380'],\n",
       "   'nui': ['N0000175682', 'M0000897', 'N0000175426', 'N0000175976'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]', 'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'unii': ['98PI200987']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'PATCH',\n",
       "  'spl_id': '173941bb-31c4-704f-e063-6294a90a8c8a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230601',\n",
       "  'product_id': '73557-158_173941bb-31c4-704f-e063-6294a90a8c8a',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Pain Relieving Gel-Patch',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '0591-4101',\n",
       "  'generic_name': 'Perphenazine',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Perphenazine',\n",
       "  'active_ingredients': [{'name': 'PERPHENAZINE', 'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-4101-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (0591-4101-01)',\n",
       "    'marketing_start_date': '20170530',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['198075', '198076', '198077', '198078'],\n",
       "   'spl_set_id': ['bb1a3d20-1f93-48a1-9e27-4712a8561757'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175746', 'M0016525'],\n",
       "   'pharm_class_epc': ['Phenothiazine [EPC]'],\n",
       "   'pharm_class_cs': ['Phenothiazines [CS]'],\n",
       "   'unii': ['FTA7XXY4EZ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'fb82b5e6-3550-433f-97c9-9d9dfa99b798',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170530',\n",
       "  'product_id': '0591-4101_fb82b5e6-3550-433f-97c9-9d9dfa99b798',\n",
       "  'application_number': 'ANDA207582',\n",
       "  'brand_name_base': 'Perphenazine',\n",
       "  'pharm_class': ['Phenothiazine [EPC]', 'Phenothiazines [CS]']},\n",
       " {'product_ndc': '0591-4102',\n",
       "  'generic_name': 'Perphenazine',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Perphenazine',\n",
       "  'active_ingredients': [{'name': 'PERPHENAZINE', 'strength': '4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-4102-01',\n",
       "    'description': '100 TABLET, FILM COATED in 1 BOTTLE (0591-4102-01)',\n",
       "    'marketing_start_date': '20170530',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['198075', '198076', '198077', '198078'],\n",
       "   'spl_set_id': ['bb1a3d20-1f93-48a1-9e27-4712a8561757'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175746', 'M0016525'],\n",
       "   'pharm_class_epc': ['Phenothiazine [EPC]'],\n",
       "   'pharm_class_cs': ['Phenothiazines [CS]'],\n",
       "   'unii': ['FTA7XXY4EZ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': 'fb82b5e6-3550-433f-97c9-9d9dfa99b798',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170530',\n",
       "  'product_id': '0591-4102_fb82b5e6-3550-433f-97c9-9d9dfa99b798',\n",
       "  'application_number': 'ANDA207582',\n",
       "  'brand_name_base': 'Perphenazine',\n",
       "  'pharm_class': ['Phenothiazine [EPC]', 'Phenothiazines [CS]']},\n",
       " {'product_ndc': '73567-001',\n",
       "  'generic_name': 'CAMPHOR (SYNTHETIC), CAPSICUM, MENTHOL',\n",
       "  'labeler_name': 'Zhengzhou Daohe Medical Technology Co.,Ltd',\n",
       "  'brand_name': 'EXTERNAL ANALGESIC',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (SYNTHETIC)',\n",
       "    'strength': '96 mg/mL'},\n",
       "   {'name': 'CAPSICUM', 'strength': '.5 mg/mL'},\n",
       "   {'name': 'MENTHOL', 'strength': '78 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73567-001-00',\n",
       "    'description': '1 PATCH in 1 POUCH (73567-001-00)  / 8 mL in 1 PATCH',\n",
       "    'marketing_start_date': '20200401',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Zhengzhou Daohe Medical Technology Co.,Ltd'],\n",
       "   'rxcui': ['1807136'],\n",
       "   'spl_set_id': ['36cb2580-db8f-4926-b498-ae4a074cd576'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6950562935682'],\n",
       "   'nui': ['N0000185375',\n",
       "    'N0000185371',\n",
       "    'N0000175629',\n",
       "    'N0000184306',\n",
       "    'M0000728',\n",
       "    'M0006342',\n",
       "    'M0016962',\n",
       "    'M0022575'],\n",
       "   'pharm_class_epc': ['Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "    'Non-Standardized Food Allergenic Extract [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Histamine Release [PE]',\n",
       "    'Cell-mediated Immunity [PE]'],\n",
       "   'pharm_class_cs': ['Allergens [CS]',\n",
       "    'Dietary Proteins [CS]',\n",
       "    'Plant Proteins [CS]',\n",
       "    'Vegetable Proteins [CS]'],\n",
       "   'unii': ['5TJD82A1ET', '00UK7646FG', 'L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'PATCH',\n",
       "  'spl_id': '0d773c0d-7a28-d567-e063-6394a90a9c54',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200401',\n",
       "  'product_id': '73567-001_0d773c0d-7a28-d567-e063-6394a90a9c54',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'EXTERNAL ANALGESIC',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]',\n",
       "   'Vegetable Proteins [CS]']},\n",
       " {'product_ndc': '73572-007',\n",
       "  'generic_name': 'ZINC OXIDE',\n",
       "  'labeler_name': 'Proven Skincare',\n",
       "  'brand_name': 'Personalized Day Moisturizer with SPF 50',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '120 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73572-007-01',\n",
       "    'description': '30 mL in 1 BOTTLE (73572-007-01)',\n",
       "    'marketing_start_date': '20220301',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Proven Skincare'],\n",
       "   'spl_set_id': ['bb921e91-9faf-4210-9091-ab511af9012a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '09cc9eb2-c5b1-d6fa-e063-6394a90a4ea2',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220301',\n",
       "  'product_id': '73572-007_09cc9eb2-c5b1-d6fa-e063-6394a90a4ea2',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Personalized Day Moisturizer with SPF 50',\n",
       "  'pharm_class': ['Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]']},\n",
       " {'product_ndc': '73581-102',\n",
       "  'generic_name': 'LOPERAMIDE HYDROCHLORIDE',\n",
       "  'labeler_name': 'YYBA CORP',\n",
       "  'brand_name': 'WELMATE Anti Diarrheal Loperamide HCl Softgels',\n",
       "  'active_ingredients': [{'name': 'LOPERAMIDE HYDROCHLORIDE',\n",
       "    'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73581-102-24',\n",
       "    'description': '2 BLISTER PACK in 1 CARTON (73581-102-24)  / 12 CAPSULE in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20200822',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['YYBA CORP'],\n",
       "   'rxcui': ['978006'],\n",
       "   'spl_set_id': ['ae2e15e9-1707-296d-e053-2995a90a1b95'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0373581102242'],\n",
       "   'unii': ['77TI35393C']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'ec6b87f1-e600-21c2-e053-2a95a90ab76d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20200822',\n",
       "  'product_id': '73581-102_ec6b87f1-e600-21c2-e053-2a95a90ab76d',\n",
       "  'application_number': 'NDA021855',\n",
       "  'brand_name_base': 'WELMATE Anti Diarrheal Loperamide HCl Softgels',\n",
       "  'pharm_class': ['Opioid Agonist [EPC]', 'Opioid Agonists [MoA]']},\n",
       " {'product_ndc': '0591-4171',\n",
       "  'generic_name': 'Penicillamine',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Penicillamine',\n",
       "  'active_ingredients': [{'name': 'PENICILLAMINE', 'strength': '250 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-4171-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (0591-4171-01)',\n",
       "    'marketing_start_date': '20190625',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['198070'],\n",
       "   'spl_set_id': ['594d7a82-af1d-41c4-98ee-0ea6895fc237'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175713'],\n",
       "   'pharm_class_epc': ['Antirheumatic Agent [EPC]'],\n",
       "   'unii': ['GNN1DV99GX']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '14d441dd-77c9-4811-ae05-d93f37def6cd',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190625',\n",
       "  'product_id': '0591-4171_14d441dd-77c9-4811-ae05-d93f37def6cd',\n",
       "  'application_number': 'ANDA210976',\n",
       "  'brand_name_base': 'Penicillamine',\n",
       "  'pharm_class': ['Antirheumatic Agent [EPC]']},\n",
       " {'product_ndc': '73581-402',\n",
       "  'generic_name': 'GUAIFENESIN',\n",
       "  'labeler_name': 'YYBA CORP',\n",
       "  'brand_name': 'MUCUS RELIEF GUAIFENESIN EXTENDED-RELEASE 1200 mg',\n",
       "  'brand_name_suffix': 'GUAIFENESIN EXTENDED-RELEASE 1200 mg',\n",
       "  'active_ingredients': [{'name': 'GUAIFENESIN', 'strength': '1200 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73581-402-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (73581-402-01)',\n",
       "    'marketing_start_date': '20220302',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['YYBA CORP'],\n",
       "   'rxcui': ['310621'],\n",
       "   'spl_set_id': ['d9d2539b-bd31-66bd-e053-2a95a90aa583'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0373581000173'],\n",
       "   'nui': ['N0000193956', 'N0000008867', 'N0000009560'],\n",
       "   'pharm_class_epc': ['Expectorant [EPC]'],\n",
       "   'pharm_class_pe': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "    'Increased Respiratory Secretions [PE]'],\n",
       "   'unii': ['495W7451VQ']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '0e136ad4-0fa9-8639-e063-6294a90aa9c7',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220302',\n",
       "  'product_id': '73581-402_0e136ad4-0fa9-8639-e063-6294a90aa9c7',\n",
       "  'application_number': 'ANDA213420',\n",
       "  'brand_name_base': 'MUCUS RELIEF',\n",
       "  'pharm_class': ['Decreased Respiratory Secretion Viscosity [PE]',\n",
       "   'Expectorant [EPC]',\n",
       "   'Increased Respiratory Secretions [PE]']},\n",
       " {'product_ndc': '73581-449',\n",
       "  'generic_name': 'CLOTRIMAZOLE',\n",
       "  'labeler_name': 'YYBA CORP',\n",
       "  'brand_name': 'WELMATE Clotrimazole Topical Solution',\n",
       "  'active_ingredients': [{'name': 'CLOTRIMAZOLE', 'strength': '10 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73581-449-00',\n",
       "    'description': '1 BOTTLE, DROPPER in 1 BOX (73581-449-00)  / 10 mL in 1 BOTTLE, DROPPER',\n",
       "    'marketing_start_date': '20240219',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['YYBA CORP'],\n",
       "   'rxcui': ['309370'],\n",
       "   'spl_set_id': ['dc5bac4a-938c-4678-89ac-a899440c6a3c'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0373581000319'],\n",
       "   'nui': ['N0000175487', 'M0002083'],\n",
       "   'pharm_class_epc': ['Azole Antifungal [EPC]'],\n",
       "   'pharm_class_cs': ['Azoles [CS]'],\n",
       "   'unii': ['G07GZ97H65']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '11e21b4d-1e91-da19-e063-6294a90aae1a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240219',\n",
       "  'product_id': '73581-449_11e21b4d-1e91-da19-e063-6294a90aae1a',\n",
       "  'application_number': 'M005',\n",
       "  'brand_name_base': 'WELMATE Clotrimazole Topical Solution',\n",
       "  'pharm_class': ['Azole Antifungal [EPC]', 'Azoles [CS]']},\n",
       " {'product_ndc': '73590-0001',\n",
       "  'generic_name': 'niacinamide',\n",
       "  'labeler_name': 'NOKSIBCHO cosmetic Co., Ltd.',\n",
       "  'brand_name': 'THE SKINHOUSE WHITE TIGHTENINGCREAM',\n",
       "  'active_ingredients': [{'name': 'NIACINAMIDE', 'strength': '2 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73590-0001-1',\n",
       "    'description': '50 mL in 1 BOTTLE (73590-0001-1)',\n",
       "    'marketing_start_date': '20200122',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['NOKSIBCHO cosmetic Co., Ltd.'],\n",
       "   'spl_set_id': ['9d2a82d1-5ebb-751b-e053-2995a90a1dd0'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['25X51I8RD4']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '9d2a82d1-5ebc-751b-e053-2995a90a1dd0',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200122',\n",
       "  'product_id': '73590-0001_9d2a82d1-5ebc-751b-e053-2995a90a1dd0',\n",
       "  'brand_name_base': 'THE SKINHOUSE WHITE TIGHTENINGCREAM'},\n",
       " {'product_ndc': '73590-0020',\n",
       "  'generic_name': 'Sodium Hyaluronate',\n",
       "  'labeler_name': 'NOKSIBCHO cosmetic Co., Ltd.',\n",
       "  'brand_name': 'THE SKIN HOUSE HYALURONIC 6000 AMPOULE',\n",
       "  'active_ingredients': [{'name': 'HYALURONATE SODIUM',\n",
       "    'strength': '6 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73590-0020-1',\n",
       "    'description': '30 mL in 1 BOTTLE (73590-0020-1)',\n",
       "    'marketing_start_date': '20200314',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['NOKSIBCHO cosmetic Co., Ltd.'],\n",
       "   'spl_set_id': ['a103df05-5067-4324-e053-2995a90accd6'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['8809080823415'],\n",
       "   'unii': ['YSE9PPT4TH']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'a103df89-0437-f1d9-e053-2995a90a1dca',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200314',\n",
       "  'product_id': '73590-0020_a103df89-0437-f1d9-e053-2995a90a1dca',\n",
       "  'brand_name_base': 'THE SKIN HOUSE HYALURONIC 6000 AMPOULE'},\n",
       " {'product_ndc': '73597-012',\n",
       "  'generic_name': 'Petrolatum Jelly',\n",
       "  'labeler_name': 'Mission Series Inc. dba Prestige Beauty Care',\n",
       "  'brand_name': 'Royal Creamy Petroleum Jelly',\n",
       "  'active_ingredients': [{'name': 'PETROLATUM', 'strength': '30 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73597-012-07',\n",
       "    'description': '198 g in 1 TUBE (73597-012-07)',\n",
       "    'marketing_start_date': '20200730',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Mission Series Inc. dba Prestige Beauty Care'],\n",
       "   'rxcui': ['1037285'],\n",
       "   'spl_set_id': ['a903becc-443d-284b-e053-2a95a90a6c75'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['4T6H12BN9U']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'JELLY',\n",
       "  'spl_id': 'a903c855-8679-4f14-e053-2a95a90a5333',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200630',\n",
       "  'product_id': '73597-012_a903c855-8679-4f14-e053-2a95a90a5333',\n",
       "  'application_number': 'part347',\n",
       "  'brand_name_base': 'Royal Creamy Petroleum Jelly'},\n",
       " {'product_ndc': '0591-4920',\n",
       "  'generic_name': 'Amantadine Hydrochloride',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Amantadine Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'AMANTADINE HYDROCHLORIDE',\n",
       "    'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-4920-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE (0591-4920-01)',\n",
       "    'marketing_start_date': '20170103',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0591-4920-05',\n",
       "    'description': '500 TABLET in 1 BOTTLE (0591-4920-05)',\n",
       "    'marketing_start_date': '20170501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['849395'],\n",
       "   'spl_set_id': ['d9c9eaf7-dcc7-49c1-99d4-49f4dac3779f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['M6Q1EO9TD0']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '2731dd72-b146-4869-b95e-61b0ab2a370e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170103',\n",
       "  'product_id': '0591-4920_2731dd72-b146-4869-b95e-61b0ab2a370e',\n",
       "  'application_number': 'ANDA208096',\n",
       "  'brand_name_base': 'Amantadine Hydrochloride',\n",
       "  'pharm_class': ['Influenza A M2 Protein Inhibitor [EPC]',\n",
       "   'M2 Protein Inhibitors [MoA]']},\n",
       " {'product_ndc': '73598-1144',\n",
       "  'generic_name': 'CALCIUM CARBONATE',\n",
       "  'labeler_name': 'JHK Inc dba American Safety & First Aid',\n",
       "  'brand_name': 'MINT ANTACID 250',\n",
       "  'active_ingredients': [{'name': 'CALCIUM CARBONATE',\n",
       "    'strength': '420 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73598-1144-1',\n",
       "    'description': '125 PACKET in 1 BOX (73598-1144-1)  / 2 TABLET, CHEWABLE in 1 PACKET',\n",
       "    'marketing_start_date': '20000202',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['JHK Inc dba American Safety & First Aid'],\n",
       "   'rxcui': ['313884'],\n",
       "   'spl_set_id': ['2496aed6-68ec-44c4-afc9-f7fa41b2147b'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0747200611420'],\n",
       "   'unii': ['H0G9379FGK']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'TABLET, CHEWABLE',\n",
       "  'spl_id': '4e9ffdfd-1537-4b5f-b2da-59b1d035a45f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20000202',\n",
       "  'product_id': '73598-1144_4e9ffdfd-1537-4b5f-b2da-59b1d035a45f',\n",
       "  'application_number': 'M001',\n",
       "  'brand_name_base': 'MINT ANTACID 250'},\n",
       " {'product_ndc': '73606-010',\n",
       "  'generic_name': 'Pegcetacoplan',\n",
       "  'labeler_name': 'Apellis Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Empaveli',\n",
       "  'active_ingredients': [{'name': 'PEGCETACOPLAN',\n",
       "    'strength': '1080 mg/20mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73606-010-01',\n",
       "    'description': '1 VIAL in 1 CARTON (73606-010-01)  / 20 mL in 1 VIAL',\n",
       "    'marketing_start_date': '20210514',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Apellis Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['2557386', '2557391'],\n",
       "   'spl_set_id': ['c23d89e9-b00b-4520-e053-2995a90a95af'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175575', 'N0000175974'],\n",
       "   'pharm_class_epc': ['Complement Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Complement Inhibitors [MoA]'],\n",
       "   'unii': ['TO3JYR3BOU']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'INJECTION, SOLUTION',\n",
       "  'spl_id': 'c774cd91-d1a3-4f46-a2ff-52b94b7ff359',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['SUBCUTANEOUS'],\n",
       "  'marketing_start_date': '20210514',\n",
       "  'product_id': '73606-010_c774cd91-d1a3-4f46-a2ff-52b94b7ff359',\n",
       "  'application_number': 'NDA215014',\n",
       "  'brand_name_base': 'Empaveli',\n",
       "  'pharm_class': ['Complement Inhibitor [EPC]',\n",
       "   'Complement Inhibitors [MoA]']},\n",
       " {'product_ndc': '73607-011',\n",
       "  'generic_name': 'Artesunate',\n",
       "  'labeler_name': 'Amivas, Inc',\n",
       "  'brand_name': 'Artesunate',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73607-011-11',\n",
       "    'description': '2 KIT in 1 CARTON (73607-011-11)  / 1 KIT in 1 KIT *  1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (73607-002-01)  *  1 SOLUTION in 1 VIAL (73607-003-02)',\n",
       "    'marketing_start_date': '20201211',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': '12cf8dd9-2103-4a67-b70c-4d50bee3cac3',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'marketing_start_date': '20201211',\n",
       "  'product_id': '73607-011_12cf8dd9-2103-4a67-b70c-4d50bee3cac3',\n",
       "  'application_number': 'NDA213036',\n",
       "  'brand_name_base': 'Artesunate'},\n",
       " {'product_ndc': '0591-5325',\n",
       "  'generic_name': 'Probenecid and Colchicine',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Probenecid and Colchicine',\n",
       "  'active_ingredients': [{'name': 'COLCHICINE', 'strength': '.5 mg/1'},\n",
       "   {'name': 'PROBENECID', 'strength': '500 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-5325-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE, PLASTIC (0591-5325-01)',\n",
       "    'marketing_start_date': '19821001',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['198153'],\n",
       "   'spl_set_id': ['a0567fe6-132b-463b-bc46-9f5a2a2478fb'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305915325010'],\n",
       "   'nui': ['N0000193949', 'M0000713'],\n",
       "   'pharm_class_epc': ['Alkaloid [EPC]'],\n",
       "   'pharm_class_cs': ['Alkaloids [CS]'],\n",
       "   'unii': ['SML2Y3J35T', 'PO572Z7917']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '08577252-5289-46f0-80b4-06442a22b332',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19821001',\n",
       "  'product_id': '0591-5325_08577252-5289-46f0-80b4-06442a22b332',\n",
       "  'application_number': 'ANDA084279',\n",
       "  'brand_name_base': 'Probenecid and Colchicine',\n",
       "  'pharm_class': ['Alkaloid [EPC]', 'Alkaloids [CS]']},\n",
       " {'product_ndc': '0591-5335',\n",
       "  'generic_name': 'Trihexyphenidyl Hydrochloride',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Trihexyphenidyl Hydrochloride',\n",
       "  'active_ingredients': [{'name': 'TRIHEXYPHENIDYL HYDROCHLORIDE',\n",
       "    'strength': '2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-5335-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE, PLASTIC (0591-5335-01)',\n",
       "    'marketing_start_date': '19871101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0591-5335-10',\n",
       "    'description': '1000 TABLET in 1 BOTTLE, PLASTIC (0591-5335-10)',\n",
       "    'marketing_start_date': '19871101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['905269', '905283'],\n",
       "   'spl_set_id': ['a44d7803-164d-4a67-9356-581c45de8596'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['AO61G82577']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'c4509e62-8781-4169-9c99-75fe1cd677cd',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19871101',\n",
       "  'product_id': '0591-5335_c4509e62-8781-4169-9c99-75fe1cd677cd',\n",
       "  'application_number': 'ANDA084363',\n",
       "  'brand_name_base': 'Trihexyphenidyl Hydrochloride'},\n",
       " {'product_ndc': '73635-5810',\n",
       "  'generic_name': 'Salisylic Acid 17%',\n",
       "  'labeler_name': 'Germa Products, LLC',\n",
       "  'brand_name': 'Verruguin Liquid Wart Remover',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '170 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73635-5810-5',\n",
       "    'description': '1 BOTTLE, WITH APPLICATOR in 1 BOX (73635-5810-5)  / 14.8 mL in 1 BOTTLE, WITH APPLICATOR',\n",
       "    'marketing_start_date': '20190329',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Germa Products, LLC'],\n",
       "   'rxcui': ['312881', '2536143'],\n",
       "   'spl_set_id': ['bf7842a2-9c07-3fc3-e053-2995a90a36c1'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['O414PZ4LPZ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '2486a085-cebe-8c3a-e063-6394a90a171b',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190329',\n",
       "  'product_id': '73635-5810_2486a085-cebe-8c3a-e063-6394a90a171b',\n",
       "  'application_number': 'M028',\n",
       "  'brand_name_base': 'Verruguin Liquid Wart Remover'},\n",
       " {'product_ndc': '73647-400',\n",
       "  'generic_name': 'MENTHOL',\n",
       "  'labeler_name': 'Just Brands LLC',\n",
       "  'brand_name': 'JUST CBD ROLL-ON COOLING',\n",
       "  'active_ingredients': [{'name': 'MENTHOL', 'strength': '4 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73647-400-03',\n",
       "    'description': '89 mL in 1 BOTTLE (73647-400-03)',\n",
       "    'marketing_start_date': '20230314',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Just Brands LLC'],\n",
       "   'spl_set_id': ['f6538e3e-4663-679c-e053-2995a90a87b5'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '180b2939-5ae6-88fb-e063-6394a90aad93',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230314',\n",
       "  'product_id': '73647-400_180b2939-5ae6-88fb-e063-6394a90aad93',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'JUST CBD ROLL-ON COOLING'},\n",
       " {'product_ndc': '73647-602',\n",
       "  'generic_name': 'MENTHOL, CAMPHOR',\n",
       "  'labeler_name': 'Just Brands LLC',\n",
       "  'brand_name': 'JUST CBD ULTRA RELIEF',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (SYNTHETIC)',\n",
       "    'strength': '2 g/100mL'},\n",
       "   {'name': 'MENTHOL', 'strength': '6 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73647-602-04',\n",
       "    'description': '118 mL in 1 BOTTLE, PUMP (73647-602-04)',\n",
       "    'marketing_start_date': '20230314',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Just Brands LLC'],\n",
       "   'spl_set_id': ['f65327b3-9c97-58f3-e053-2995a90a3f55'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0696831876794'],\n",
       "   'unii': ['L7T10EIP3A', '5TJD82A1ET']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '13eef0db-b216-5628-e063-6394a90a20d4',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230314',\n",
       "  'product_id': '73647-602_13eef0db-b216-5628-e063-6394a90a20d4',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'JUST CBD ULTRA RELIEF'},\n",
       " {'product_ndc': '73655-030',\n",
       "  'generic_name': 'Niacinamide, Adenosine',\n",
       "  'labeler_name': 'Celino Inc.',\n",
       "  'brand_name': 'CELONIA SIGNATURE BIO ESSENCE TONER',\n",
       "  'active_ingredients': [{'name': 'ADENOSINE', 'strength': '.06 g/150mL'},\n",
       "   {'name': 'NIACINAMIDE', 'strength': '3 g/150mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73655-030-02',\n",
       "    'description': '1 CONTAINER in 1 CARTON (73655-030-02)  / 150 mL in 1 CONTAINER (73655-030-01)',\n",
       "    'marketing_start_date': '20200201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Celino Inc.'],\n",
       "   'spl_set_id': ['4aed232a-9e91-4b8e-8678-785cd53a65a4'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['8809661470144'],\n",
       "   'nui': ['N0000178375', 'N0000175788'],\n",
       "   'pharm_class_epc': ['Adenosine Receptor Agonist [EPC]'],\n",
       "   'pharm_class_moa': ['Adenosine Receptor Agonists [MoA]'],\n",
       "   'unii': ['K72T3FS567', '25X51I8RD4']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'e3075617-20b8-4e5d-8927-631bbef8e8f7',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200201',\n",
       "  'product_id': '73655-030_e3075617-20b8-4e5d-8927-631bbef8e8f7',\n",
       "  'brand_name_base': 'CELONIA SIGNATURE BIO ESSENCE TONER',\n",
       "  'pharm_class': ['Adenosine Receptor Agonist [EPC]',\n",
       "   'Adenosine Receptor Agonists [MoA]']},\n",
       " {'product_ndc': '73655-100',\n",
       "  'generic_name': 'Zinc Pyrithione, Panthenol, Niacinamide, Biotin',\n",
       "  'labeler_name': 'Celino Inc.',\n",
       "  'brand_name': '574H Cell Care',\n",
       "  'active_ingredients': [{'name': 'BIOTIN', 'strength': '.18 g/300mL'},\n",
       "   {'name': 'NIACINAMIDE', 'strength': '.9 g/300mL'},\n",
       "   {'name': 'PANTHENOL', 'strength': '1.5 g/300mL'},\n",
       "   {'name': 'PYRITHIONE ZINC', 'strength': '3 g/300mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73655-100-02',\n",
       "    'description': '1 BOTTLE in 1 CARTON (73655-100-02)  / 300 mL in 1 BOTTLE (73655-100-01)',\n",
       "    'marketing_start_date': '20200601',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Celino Inc.'],\n",
       "   'rxcui': ['2375032'],\n",
       "   'spl_set_id': ['6b1dab05-16b0-4947-875d-48f8b4a3b1d9'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['8809661470274'],\n",
       "   'unii': ['6SO6U10H04', '25X51I8RD4', 'WV9CM0O67Z', 'R953O2RHZ5']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'SHAMPOO',\n",
       "  'spl_id': '775e178e-17e6-43ab-b13e-733928070e81',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200601',\n",
       "  'product_id': '73655-100_775e178e-17e6-43ab-b13e-733928070e81',\n",
       "  'brand_name_base': '574H Cell Care'},\n",
       " {'product_ndc': '73666-0540',\n",
       "  'generic_name': 'Hydrated Silica, Calcium Glycerophosphate, Sodium Fluoride, Tocopheryl Acetate',\n",
       "  'labeler_name': 'Doctor Choi`s Korea Co., LTD.',\n",
       "  'brand_name': 'DR.CHOIS TOOTHPASTE STEP TWO KIDS',\n",
       "  'active_ingredients': [{'name': '.ALPHA.-TOCOPHEROL ACETATE',\n",
       "    'strength': '.1 g/100g'},\n",
       "   {'name': 'CALCIUM GLYCEROPHOSPHATE', 'strength': '.13 g/100g'},\n",
       "   {'name': 'HYDRATED SILICA', 'strength': '13 g/100g'},\n",
       "   {'name': 'SODIUM FLUORIDE', 'strength': '.11 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73666-0540-2',\n",
       "    'description': '1 TUBE in 1 CARTON (73666-0540-2)  / 60 g in 1 TUBE (73666-0540-1)',\n",
       "    'marketing_start_date': '20220901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Doctor Choi`s Korea Co., LTD.'],\n",
       "   'spl_set_id': ['ea92ca4a-63c5-41ee-9914-cd8a5b028a0a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['9E8X80D2L0', 'XWV9Z12C1C', 'Y6O7T4G8P9', '8ZYQ1474W7']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'PASTE, DENTIFRICE',\n",
       "  'spl_id': '26e9447c-16cd-b180-e063-6394a90aa835',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220901',\n",
       "  'product_id': '73666-0540_26e9447c-16cd-b180-e063-6394a90aa835',\n",
       "  'brand_name_base': 'DR.CHOIS TOOTHPASTE STEP TWO KIDS',\n",
       "  'pharm_class': ['Blood Coagulation Factor [EPC]',\n",
       "   'Calcium [CS]',\n",
       "   'Cations',\n",
       "   'Divalent [CS]',\n",
       "   'Increased Coagulation Factor Activity [PE]',\n",
       "   'Phosphate Binder [EPC]',\n",
       "   'Phosphate Chelating Activity [MoA]']},\n",
       " {'product_ndc': '73666-0560',\n",
       "  'generic_name': 'Sodium Chloride',\n",
       "  'labeler_name': 'Doctor Choi`s Korea Co., LTD.',\n",
       "  'brand_name': 'TID Clean Care',\n",
       "  'active_ingredients': [{'name': 'SODIUM CHLORIDE',\n",
       "    'strength': '.7 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73666-0560-2',\n",
       "    'description': '1 TUBE in 1 CARTON (73666-0560-2)  / 100 mL in 1 TUBE (73666-0560-1)',\n",
       "    'marketing_start_date': '20220901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Doctor Choi`s Korea Co., LTD.'],\n",
       "   'spl_set_id': ['bde071af-6077-4ab7-a831-6148a939be4b'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['8809296110019'],\n",
       "   'unii': ['451W47IQ8X']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'PASTE, DENTIFRICE',\n",
       "  'spl_id': '77d4a67e-4524-410a-8bda-b791075f3fc9',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220901',\n",
       "  'product_id': '73666-0560_77d4a67e-4524-410a-8bda-b791075f3fc9',\n",
       "  'brand_name_base': 'TID Clean Care'},\n",
       " {'product_ndc': '0591-5543',\n",
       "  'generic_name': 'Allopurinol',\n",
       "  'labeler_name': 'Actavis Pharma, Inc.',\n",
       "  'brand_name': 'Allopurinol',\n",
       "  'active_ingredients': [{'name': 'ALLOPURINOL', 'strength': '100 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0591-5543-01',\n",
       "    'description': '100 TABLET in 1 BOTTLE, PLASTIC (0591-5543-01)',\n",
       "    'marketing_start_date': '20090406',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0591-5543-10',\n",
       "    'description': '1000 TABLET in 1 BOTTLE, PLASTIC (0591-5543-10)',\n",
       "    'marketing_start_date': '20090406',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Actavis Pharma, Inc.'],\n",
       "   'rxcui': ['197319', '197320'],\n",
       "   'spl_set_id': ['a80fe56f-8d03-423f-8e2a-7ec8c9e5045b'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0305915544015', '0305915543018'],\n",
       "   'nui': ['N0000175698', 'N0000000206'],\n",
       "   'pharm_class_epc': ['Xanthine Oxidase Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Xanthine Oxidase Inhibitors [MoA]'],\n",
       "   'unii': ['63CZ7GJN5I']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'b7502c6f-ebdf-4d6a-aed2-93de7c6085b4',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20090406',\n",
       "  'product_id': '0591-5543_b7502c6f-ebdf-4d6a-aed2-93de7c6085b4',\n",
       "  'application_number': 'NDA018832',\n",
       "  'brand_name_base': 'Allopurinol',\n",
       "  'pharm_class': ['Xanthine Oxidase Inhibitor [EPC]',\n",
       "   'Xanthine Oxidase Inhibitors [MoA]']},\n",
       " {'product_ndc': '73678-100',\n",
       "  'generic_name': 'Aspirin',\n",
       "  'labeler_name': 'Applied Biological Laboratories Inc.',\n",
       "  'brand_name': 'Natural Aspirin plus Lemon and Honey Dietary Supplement',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73678-100-01',\n",
       "    'description': '1 KIT in 1 KIT (73678-100-01)  *  4 TABLET in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20230425',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Applied Biological Laboratories Inc.'],\n",
       "   'rxcui': ['212033'],\n",
       "   'spl_set_id': ['fa45141d-ac32-ca9b-e053-6394a90a5cbb'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0850013294190']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': 'fa45141d-ac33-ca9b-e053-6394a90a5cbb',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230425',\n",
       "  'product_id': '73678-100_fa45141d-ac33-ca9b-e053-6394a90a5cbb',\n",
       "  'brand_name_base': 'Natural Aspirin plus Lemon and Honey Dietary Supplement'},\n",
       " {'product_ndc': '73715-003',\n",
       "  'generic_name': 'Adapalene Gel 0.1%',\n",
       "  'labeler_name': 'MOHNARK PHARMACEUTICALS INC',\n",
       "  'brand_name': 'Adapalene Gel 0.1%',\n",
       "  'active_ingredients': [{'name': 'ADAPALENE', 'strength': '.1 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73715-003-01',\n",
       "    'description': '30 g in 1 TUBE (73715-003-01)',\n",
       "    'marketing_start_date': '20240930',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['MOHNARK PHARMACEUTICALS INC'],\n",
       "   'rxcui': ['307731'],\n",
       "   'spl_set_id': ['22824b46-53a1-6b19-e063-6394a90a18ad'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0860002324920'],\n",
       "   'nui': ['N0000175607', 'M0018962'],\n",
       "   'pharm_class_epc': ['Retinoid [EPC]'],\n",
       "   'pharm_class_cs': ['Retinoids [CS]'],\n",
       "   'unii': ['1L4806J2QF']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '22824b46-53a2-6b19-e063-6394a90a18ad',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240930',\n",
       "  'product_id': '73715-003_22824b46-53a2-6b19-e063-6394a90a18ad',\n",
       "  'brand_name_base': 'Adapalene Gel 0.1%',\n",
       "  'pharm_class': ['Retinoid [EPC]', 'Retinoids [CS]']},\n",
       " {'product_ndc': '73737-436',\n",
       "  'generic_name': 'Benzalkonium Chloride',\n",
       "  'labeler_name': 'pushclean technology plastik sanayi ve ticaret limited sirketi',\n",
       "  'brand_name': 'Push Clean',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '1.3 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73737-436-10',\n",
       "    'description': '4.5 mL in 1 BOX (73737-436-10)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['pushclean technology plastik sanayi ve ticaret limited sirketi'],\n",
       "   'rxcui': ['1038558'],\n",
       "   'spl_set_id': ['a2405c1e-8c42-0a77-e053-2a95a90a98b3'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CLOTH',\n",
       "  'spl_id': '2540ae39-2215-0f6a-e063-6294a90a5efc',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200330',\n",
       "  'product_id': '73737-436_2540ae39-2215-0f6a-e063-6294a90a5efc',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'Push Clean'},\n",
       " {'product_ndc': '73769-006',\n",
       "  'generic_name': 'ISOPROPANOL',\n",
       "  'labeler_name': \"NATURE'S FUSIONS, LLC\",\n",
       "  'brand_name': 'Antibac on the go',\n",
       "  'active_ingredients': [{'name': 'ISOPROPYL ALCOHOL',\n",
       "    'strength': '70 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73769-006-04',\n",
       "    'description': '118 mL in 1 BOTTLE, SPRAY (73769-006-04)',\n",
       "    'marketing_start_date': '20200826',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73769-006-08',\n",
       "    'description': '236 mL in 1 BOTTLE, SPRAY (73769-006-08)',\n",
       "    'marketing_start_date': '20200826',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': [\"NATURE'S FUSIONS, LLC\"],\n",
       "   'rxcui': ['1014638'],\n",
       "   'spl_set_id': ['a0618307-ad0e-a907-e053-2995a90a4239'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0717932672785',\n",
       "    '0850015333873',\n",
       "    '0717932672655',\n",
       "    '0746175274975',\n",
       "    '0717932672914'],\n",
       "   'unii': ['ND2M416302']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '19c666cf-876a-5e27-e063-6394a90a243a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200826',\n",
       "  'product_id': '73769-006_19c666cf-876a-5e27-e063-6394a90a243a',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'Antibac on the go'},\n",
       " {'product_ndc': '73769-300',\n",
       "  'generic_name': 'Potassium Iodide Tablet',\n",
       "  'labeler_name': \"Nature's Fusions, Llc\",\n",
       "  'brand_name': 'Potassium Iodide',\n",
       "  'active_ingredients': [{'name': 'POTASSIUM IODIDE', 'strength': '65 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73769-300-14',\n",
       "    'description': '14 TABLET in 1 BOTTLE, GLASS (73769-300-14)',\n",
       "    'marketing_start_date': '20230401',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73769-300-40',\n",
       "    'description': '140 TABLET in 1 BOTTLE (73769-300-40)',\n",
       "    'marketing_start_date': '20230401',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73769-300-60',\n",
       "    'description': '60 TABLET in 1 BOTTLE (73769-300-60)',\n",
       "    'marketing_start_date': '20230401',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': [\"Nature's Fusions, Llc\"],\n",
       "   'spl_set_id': ['0bde56be-868f-d1cd-e063-6294a90abe45'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0810102742223'],\n",
       "   'unii': ['1C4QK22F9J']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': '0bde56be-8690-d1cd-e063-6294a90abe45',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230401',\n",
       "  'product_id': '73769-300_0bde56be-8690-d1cd-e063-6294a90abe45',\n",
       "  'brand_name_base': 'Potassium Iodide'},\n",
       " {'product_ndc': '73780-002',\n",
       "  'generic_name': 'Oxycodone hydrochloride',\n",
       "  'labeler_name': 'Ohemo Life Sciences Inc.',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'OXYCODONE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'OXYCODONE HYDROCHLORIDE',\n",
       "    'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73780-002-10',\n",
       "    'description': '100 TABLET, COATED in 1 BOTTLE (73780-002-10)',\n",
       "    'marketing_start_date': '20240909',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Ohemo Life Sciences Inc.'],\n",
       "   'rxcui': ['1944529', '1944538', '1944541', '2693194'],\n",
       "   'spl_set_id': ['1bcc266d-cb6a-8c4a-e063-6394a90a9c5e'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0381140101100', '0381140103104'],\n",
       "   'unii': ['C1ENJ2TE6C']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '2266ec21-6578-1206-e063-6394a90aa882',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240909',\n",
       "  'product_id': '73780-002_2266ec21-6578-1206-e063-6394a90aa882',\n",
       "  'application_number': 'NDA209777',\n",
       "  'brand_name_base': 'OXYCODONE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '73780-004',\n",
       "  'generic_name': 'Oxycodone hydrochloride',\n",
       "  'labeler_name': 'Ohemo Life Sciences Inc.',\n",
       "  'dea_schedule': 'CII',\n",
       "  'brand_name': 'OXYCODONE HYDROCHLORIDE',\n",
       "  'active_ingredients': [{'name': 'OXYCODONE HYDROCHLORIDE',\n",
       "    'strength': '30 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73780-004-10',\n",
       "    'description': '100 TABLET, COATED in 1 BOTTLE (73780-004-10)',\n",
       "    'marketing_start_date': '20240701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Ohemo Life Sciences Inc.'],\n",
       "   'rxcui': ['1944529', '1944538', '1944541', '2693194'],\n",
       "   'spl_set_id': ['1bcc266d-cb6a-8c4a-e063-6394a90a9c5e'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0381140101100', '0381140103104'],\n",
       "   'unii': ['C1ENJ2TE6C']},\n",
       "  'marketing_category': 'NDA AUTHORIZED GENERIC',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '2266ec21-6578-1206-e063-6394a90aa882',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240701',\n",
       "  'product_id': '73780-004_2266ec21-6578-1206-e063-6394a90aa882',\n",
       "  'application_number': 'NDA209777',\n",
       "  'brand_name_base': 'OXYCODONE HYDROCHLORIDE',\n",
       "  'pharm_class': ['Full Opioid Agonists [MoA]', 'Opioid Agonist [EPC]']},\n",
       " {'product_ndc': '73788-002',\n",
       "  'generic_name': 'Ethyl Alcohol',\n",
       "  'labeler_name': 'Hangzhou Huiji Biotechnology Co., Ltd.',\n",
       "  'brand_name': 'hand sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '75 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73788-002-01',\n",
       "    'description': '200 BOTTLE in 1 CARTON (73788-002-01)  / 30 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200321',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-002-02',\n",
       "    'description': '150 BOTTLE in 1 CARTON (73788-002-02)  / 60 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200321',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-002-03',\n",
       "    'description': '100 BOTTLE in 1 CARTON (73788-002-03)  / 100 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200321',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-002-04',\n",
       "    'description': '24 BOTTLE in 1 CARTON (73788-002-04)  / 237 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200321',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-002-05',\n",
       "    'description': '20 BOTTLE in 1 CARTON (73788-002-05)  / 500 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200321',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-002-06',\n",
       "    'description': '18 BOTTLE in 1 CARTON (73788-002-06)  / 1000 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200321',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-002-07',\n",
       "    'description': '4 BOTTLE in 1 CARTON (73788-002-07)  / 3780 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200321',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-002-08',\n",
       "    'description': '4 BOTTLE in 1 CARTON (73788-002-08)  / 5000 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200321',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Hangzhou Huiji Biotechnology Co., Ltd.'],\n",
       "   'spl_set_id': ['a169d3c1-f042-1672-e053-2a95a90a39ac'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6939563201170'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'd8bf30df-8c5f-289b-e053-2a95a90a4992',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200321',\n",
       "  'product_id': '73788-002_d8bf30df-8c5f-289b-e053-2a95a90a4992',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'hand sanitizer'},\n",
       " {'product_ndc': '73788-107',\n",
       "  'generic_name': 'Ethyl Alcohol',\n",
       "  'labeler_name': 'Hangzhou Huiji Biotechnology Co., Ltd.',\n",
       "  'brand_name': 'U.S. Legal Support Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '75 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73788-107-01',\n",
       "    'description': '200 BOTTLE in 1 CARTON (73788-107-01)  / 30 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200812',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-107-02',\n",
       "    'description': '150 BOTTLE in 1 CARTON (73788-107-02)  / 60 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200812',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-107-03',\n",
       "    'description': '100 BOTTLE in 1 CARTON (73788-107-03)  / 100 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200812',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-107-04',\n",
       "    'description': '24 BOTTLE in 1 CARTON (73788-107-04)  / 237 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200812',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-107-05',\n",
       "    'description': '20 BOTTLE in 1 CARTON (73788-107-05)  / 500 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200812',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-107-06',\n",
       "    'description': '6 BOTTLE in 1 CARTON (73788-107-06)  / 1000 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200812',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-107-07',\n",
       "    'description': '4 BOTTLE in 1 CARTON (73788-107-07)  / 4000 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200812',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73788-107-08',\n",
       "    'description': '4 BOTTLE in 1 CARTON (73788-107-08)  / 5000 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20200812',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Hangzhou Huiji Biotechnology Co., Ltd.'],\n",
       "   'rxcui': ['1305100'],\n",
       "   'spl_set_id': ['aca3e336-ce55-3ff1-e053-2a95a90a09d1'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6939563275249'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'd8bfdd5d-1f51-4bab-e053-2995a90ac085',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200812',\n",
       "  'product_id': '73788-107_d8bfdd5d-1f51-4bab-e053-2995a90ac085',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'U.S. Legal Support Hand Sanitizer'},\n",
       " {'product_ndc': '73796-112',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'Prostock LLC',\n",
       "  'brand_name': 'Antibacterial Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '.62 mL/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73796-112-36',\n",
       "    'description': '236 mL in 1 BOTTLE (73796-112-36)',\n",
       "    'marketing_start_date': '20200321',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Prostock LLC'],\n",
       "   'rxcui': ['581660'],\n",
       "   'spl_set_id': ['a185a4b0-a5d3-2487-e053-2995a90a01d3'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '098725d4-ed85-891b-e063-6294a90a051e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200321',\n",
       "  'product_id': '73796-112_098725d4-ed85-891b-e063-6294a90a051e',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Antibacterial Hand Sanitizer'},\n",
       " {'product_ndc': '73796-119',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'Prostock LLC',\n",
       "  'brand_name': 'Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '.62 mL/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73796-119-10',\n",
       "    'description': '10 mL in 1 BOTTLE (73796-119-10)',\n",
       "    'marketing_start_date': '20200930',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73796-119-20',\n",
       "    'description': '20 mL in 1 BOTTLE (73796-119-20)',\n",
       "    'marketing_start_date': '20200930',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Prostock LLC'],\n",
       "   'rxcui': ['1020364'],\n",
       "   'spl_set_id': ['9e7d7912-d594-47e9-bd8a-cc4f8ac85b2c'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '09876f3d-693c-c403-e063-6394a90a502a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200930',\n",
       "  'product_id': '73796-119_09876f3d-693c-c403-e063-6394a90a502a',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Hand Sanitizer'},\n",
       " {'product_ndc': '73881-338',\n",
       "  'marketing_end_date': '20260209',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'Griffin Chemical Company LLC',\n",
       "  'brand_name': 'Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '80 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73881-338-01',\n",
       "    'description': '473 mL in 1 BOTTLE (73881-338-01)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'marketing_end_date': '20260209',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73881-338-02',\n",
       "    'description': '946 mL in 1 BOTTLE (73881-338-02)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'marketing_end_date': '20260209',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73881-338-03',\n",
       "    'description': '3785 mL in 1 BOTTLE (73881-338-03)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'marketing_end_date': '20260209',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73881-338-04',\n",
       "    'description': '59 mL in 1 BOTTLE (73881-338-04)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'marketing_end_date': '20260209',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Griffin Chemical Company LLC'],\n",
       "   'rxcui': ['1039339'],\n",
       "   'spl_set_id': ['a3fb386c-db0e-8a48-e053-2a95a90a361d'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '116f85b8-d5a4-e03e-e063-6294a90a8699',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200330',\n",
       "  'product_id': '73881-338_116f85b8-d5a4-e03e-e063-6294a90a8699',\n",
       "  'brand_name_base': 'Hand Sanitizer'},\n",
       " {'product_ndc': '73898-007',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'Noshinku',\n",
       "  'brand_name': 'Nourishing Hand Sanitizer Vetiver',\n",
       "  'brand_name_suffix': 'Vetiver',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '70 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73898-007-10',\n",
       "    'description': '100 mL in 1 BOTTLE (73898-007-10)',\n",
       "    'marketing_start_date': '20190325',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73898-007-18',\n",
       "    'description': '18 mL in 1 BOTTLE (73898-007-18)',\n",
       "    'marketing_start_date': '20190325',\n",
       "    'marketing_end_date': '20260301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73898-007-20',\n",
       "    'description': '20 mL in 1 BOTTLE (73898-007-20)',\n",
       "    'marketing_start_date': '20240401',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Noshinku'],\n",
       "   'rxcui': ['1041849'],\n",
       "   'spl_set_id': ['d70fb84c-fdbc-6ba8-e053-2995a90ab529'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '1885d507-8aa2-8ccf-e063-6294a90aa45b',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20190325',\n",
       "  'product_id': '73898-007_1885d507-8aa2-8ccf-e063-6294a90aa45b',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'Nourishing Hand Sanitizer'},\n",
       " {'product_ndc': '73926-753',\n",
       "  'generic_name': 'Alcohol',\n",
       "  'labeler_name': 'STERNO PRODUCTS, LLC',\n",
       "  'brand_name': 'EcoChoice Sterno Hand Sanitizer Lemon Zest',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '70 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73926-753-01',\n",
       "    'description': '2 mL in 1 BOTTLE, PLASTIC (73926-753-01)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73926-753-02',\n",
       "    'description': '473 mL in 1 BOTTLE, PLASTIC (73926-753-02)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73926-753-03',\n",
       "    'description': '1000 mL in 1 BOTTLE, PLASTIC (73926-753-03)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73926-753-04',\n",
       "    'description': '59 mL in 1 PACKAGE (73926-753-04)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73926-753-05',\n",
       "    'description': '236 mL in 1 BOTTLE, PLASTIC (73926-753-05)',\n",
       "    'marketing_start_date': '20231130',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['STERNO PRODUCTS, LLC'],\n",
       "   'rxcui': ['582753'],\n",
       "   'spl_set_id': ['576b7579-f44d-4315-a9c6-09d9a6d3f61d'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '0c66b525-7708-cc97-e063-6394a90a2496',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20231130',\n",
       "  'product_id': '73926-753_0c66b525-7708-cc97-e063-6394a90a2496',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'EcoChoice Sterno Hand Sanitizer Lemon Zest'},\n",
       " {'product_ndc': '73928-020',\n",
       "  'generic_name': 'SODIUM FLUORIDE',\n",
       "  'labeler_name': 'Kingkey MBC Life Technology Group co., LTD.',\n",
       "  'brand_name': 'BRUSH BUDDIES BARBIE ANTICAVITY FLUORIDE BUBBLEGUM',\n",
       "  'active_ingredients': [{'name': 'SODIUM FLUORIDE',\n",
       "    'strength': '.03 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73928-020-01',\n",
       "    'description': '355 mL in 1 BOTTLE (73928-020-01)',\n",
       "    'marketing_start_date': '20240510',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Kingkey MBC Life Technology Group co., LTD.'],\n",
       "   'rxcui': ['2682817'],\n",
       "   'spl_set_id': ['1b6f893d-74ac-421e-a78b-f495ac425af0'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['8ZYQ1474W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '190ca093-8dd8-9f82-e063-6394a90a4fd3',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240510',\n",
       "  'product_id': '73928-020_190ca093-8dd8-9f82-e063-6394a90a4fd3',\n",
       "  'application_number': 'M021',\n",
       "  'brand_name_base': 'BRUSH BUDDIES BARBIE ANTICAVITY FLUORIDE BUBBLEGUM'},\n",
       " {'product_ndc': '73928-038',\n",
       "  'generic_name': 'SODIUM FLUORIDE',\n",
       "  'labeler_name': 'Kingkey MBC Life Technology Group Co.,Ltd',\n",
       "  'brand_name': 'BRUSH BUDDIES CRAYOLA ANTICAVITY FLUORIDE STRAWBERRY',\n",
       "  'active_ingredients': [{'name': 'SODIUM FLUORIDE',\n",
       "    'strength': '.05 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73928-038-01',\n",
       "    'description': '355 mL in 1 BOTTLE (73928-038-01)',\n",
       "    'marketing_start_date': '20240501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Kingkey MBC Life Technology Group Co.,Ltd'],\n",
       "   'rxcui': ['240698'],\n",
       "   'spl_set_id': ['1b110db1-fcc0-377f-e063-6394a90a4d44'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0810147881475'],\n",
       "   'unii': ['8ZYQ1474W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '1b4e6469-eaed-81bb-e063-6294a90a89ee',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240501',\n",
       "  'product_id': '73928-038_1b4e6469-eaed-81bb-e063-6294a90a89ee',\n",
       "  'application_number': 'M021',\n",
       "  'brand_name_base': 'BRUSH BUDDIES CRAYOLA ANTICAVITY FLUORIDE STRAWBERRY'},\n",
       " {'product_ndc': '73928-042',\n",
       "  'generic_name': 'SODIUM FLUORIDE',\n",
       "  'labeler_name': 'Kingkey MBC Life Technology Group co., LTD',\n",
       "  'brand_name': 'BRUSH BUDDIES CRAYOLA ANTICAVITY FLUORIDE STRAWBERRY',\n",
       "  'active_ingredients': [{'name': 'SODIUM FLUORIDE',\n",
       "    'strength': '.02 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73928-042-01',\n",
       "    'description': '355 mL in 1 BOTTLE (73928-042-01)',\n",
       "    'marketing_start_date': '20240501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Kingkey MBC Life Technology Group co., LTD'],\n",
       "   'rxcui': ['313029'],\n",
       "   'spl_set_id': ['1ba4a807-d6d5-04a0-e063-6294a90ae04d'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0810147881192'],\n",
       "   'unii': ['8ZYQ1474W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '1ba4944c-44ad-7c58-e063-6394a90ab3e0',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240501',\n",
       "  'product_id': '73928-042_1ba4944c-44ad-7c58-e063-6394a90ab3e0',\n",
       "  'application_number': 'M021',\n",
       "  'brand_name_base': 'BRUSH BUDDIES CRAYOLA ANTICAVITY FLUORIDE STRAWBERRY'},\n",
       " {'product_ndc': '73928-046',\n",
       "  'generic_name': 'SODIUM FLUORIDE',\n",
       "  'labeler_name': 'Kingkey MBC Life Technology Group Co.,Ltd',\n",
       "  'brand_name': 'BRUSH BUDDIES CRAYOLA ANTICAVITY FLUORIDE STRAWBERRY',\n",
       "  'active_ingredients': [{'name': 'SODIUM FLUORIDE',\n",
       "    'strength': '.05 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73928-046-01',\n",
       "    'description': '355 mL in 1 BOTTLE (73928-046-01)',\n",
       "    'marketing_start_date': '20240501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Kingkey MBC Life Technology Group Co.,Ltd'],\n",
       "   'rxcui': ['240698'],\n",
       "   'spl_set_id': ['1b617f4a-b56c-9f75-e063-6294a90a7abe'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0810147881192'],\n",
       "   'unii': ['8ZYQ1474W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '1b6179fb-00a9-182f-e063-6394a90a00b6',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240501',\n",
       "  'product_id': '73928-046_1b6179fb-00a9-182f-e063-6394a90a00b6',\n",
       "  'application_number': 'M021',\n",
       "  'brand_name_base': 'BRUSH BUDDIES CRAYOLA ANTICAVITY FLUORIDE STRAWBERRY'},\n",
       " {'product_ndc': '73931-016',\n",
       "  'generic_name': 'Alcohol',\n",
       "  'labeler_name': 'Guangdong Essence Daily Chemical Co., Ltd',\n",
       "  'brand_name': 'Lifebuoy Hand Sanitizer Professional',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '75 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73931-016-01',\n",
       "    'description': '1000 mL in 1 BOTTLE (73931-016-01)',\n",
       "    'marketing_start_date': '20200827',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73931-016-02',\n",
       "    'description': '5000 mL in 1 BOTTLE (73931-016-02)',\n",
       "    'marketing_start_date': '20200827',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Guangdong Essence Daily Chemical Co., Ltd'],\n",
       "   'rxcui': ['1305100'],\n",
       "   'spl_set_id': ['2b473779-4e94-40d1-938d-b7e46501e4b5'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'a084b642-3789-4e71-b61e-4404feda5013',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200827',\n",
       "  'product_id': '73931-016_a084b642-3789-4e71-b61e-4404feda5013',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'Lifebuoy Hand Sanitizer Professional'},\n",
       " {'product_ndc': '73950-001',\n",
       "  'generic_name': 'ETHYL ALCOHOL',\n",
       "  'labeler_name': 'MINISO DEPOT CA, INC.',\n",
       "  'brand_name': 'Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '62 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73950-001-01',\n",
       "    'description': '29 mL in 1 BOTTLE (73950-001-01)',\n",
       "    'marketing_start_date': '20200525',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['MINISO DEPOT CA, INC.'],\n",
       "   'rxcui': ['581660'],\n",
       "   'spl_set_id': ['a651cb1d-5ca0-a952-e053-2995a90abf22'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0083100007926'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'a651dcde-31cd-b5c7-e053-2995a90ae8ab',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200523',\n",
       "  'product_id': '73950-001_a651dcde-31cd-b5c7-e053-2995a90ae8ab',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'Hand Sanitizer'},\n",
       " {'product_ndc': '73950-002',\n",
       "  'generic_name': 'ETHYL ALCOHOL',\n",
       "  'labeler_name': 'MINISO DEPOT CA, INC.',\n",
       "  'brand_name': 'Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '62 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73950-002-01',\n",
       "    'description': '29 mL in 1 BOTTLE (73950-002-01)',\n",
       "    'marketing_start_date': '20200525',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['MINISO DEPOT CA, INC.'],\n",
       "   'rxcui': ['581660'],\n",
       "   'spl_set_id': ['a682335c-9af5-099a-e053-2a95a90a5c48'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'a682549c-48ee-62d9-e053-2a95a90aca62',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200523',\n",
       "  'product_id': '73950-002_a682549c-48ee-62d9-e053-2a95a90aca62',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'Hand Sanitizer'},\n",
       " {'product_ndc': '73950-008',\n",
       "  'generic_name': 'ETHYL ALCOHOL',\n",
       "  'labeler_name': 'MINISO DEPOT CA, INC.',\n",
       "  'brand_name': 'Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '62 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73950-008-01',\n",
       "    'description': '29 mL in 1 BOTTLE (73950-008-01)',\n",
       "    'marketing_start_date': '20200526',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['MINISO DEPOT CA, INC.'],\n",
       "   'rxcui': ['581660'],\n",
       "   'spl_set_id': ['a684d1a4-556a-c686-e053-2a95a90ae586'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6941501551780'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'a684d6b1-1f77-4151-e053-2a95a90aa981',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200526',\n",
       "  'product_id': '73950-008_a684d6b1-1f77-4151-e053-2a95a90aa981',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'Hand Sanitizer'},\n",
       " {'product_ndc': '73950-053',\n",
       "  'generic_name': 'ETHYL ALCOHOL',\n",
       "  'labeler_name': 'MINISO DEPOT CA, INC.',\n",
       "  'brand_name': 'Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '62 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73950-053-01',\n",
       "    'description': '50 mL in 1 BOTTLE (73950-053-01)',\n",
       "    'marketing_start_date': '20200417',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['MINISO DEPOT CA, INC.'],\n",
       "   'rxcui': ['581660'],\n",
       "   'spl_set_id': ['a3cd13dc-ac71-c2a9-e053-2a95a90a4807'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'a3cd0f3e-90ef-95c7-e053-2995a90a6b1b',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200417',\n",
       "  'product_id': '73950-053_a3cd0f3e-90ef-95c7-e053-2995a90a6b1b',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'Hand Sanitizer'},\n",
       " {'product_ndc': '73978-003',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'Marque of Brands Americas, LLC',\n",
       "  'brand_name': 'b.clean hand sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '70 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73978-003-01',\n",
       "    'description': '59 mL in 1 BOTTLE, PLASTIC (73978-003-01)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73978-003-02',\n",
       "    'description': '236 mL in 1 BOTTLE, PUMP (73978-003-02)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73978-003-03',\n",
       "    'description': '473 mL in 1 BOTTLE, PUMP (73978-003-03)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '73978-003-04',\n",
       "    'description': '946 mL in 1 BOTTLE, PUMP (73978-003-04)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Marque of Brands Americas, LLC'],\n",
       "   'rxcui': ['581662'],\n",
       "   'spl_set_id': ['a5b6452f-961f-efd3-e053-2995a90a71cc'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '1c3b06e9-e848-e975-e063-6394a90a55e0',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200330',\n",
       "  'product_id': '73978-003_1c3b06e9-e848-e975-e063-6394a90a55e0',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'b.clean hand sanitizer'},\n",
       " {'product_ndc': '73978-006',\n",
       "  'generic_name': 'Avobenzone, Homosalate, Octisalate, Octocrylene',\n",
       "  'labeler_name': 'Marque of Brands Americas, LLC',\n",
       "  'brand_name': 'b.tan Sun Safe AF SPF 50',\n",
       "  'brand_name_suffix': 'SPF 50',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '3 g/100mL'},\n",
       "   {'name': 'HOMOSALATE', 'strength': '15 g/100mL'},\n",
       "   {'name': 'OCTISALATE', 'strength': '5 g/100mL'},\n",
       "   {'name': 'OCTOCRYLENE', 'strength': '10 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73978-006-01',\n",
       "    'description': '207 mL in 1 TUBE (73978-006-01)',\n",
       "    'marketing_start_date': '20210316',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Marque of Brands Americas, LLC'],\n",
       "   'spl_set_id': ['bdadeae9-71fa-9375-e053-2995a90a0229'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['9347108007601'],\n",
       "   'unii': ['G63QQF2NOX', 'V06SV4M95S', '4X49Y0596W', '5A68WGF6WM']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOTION',\n",
       "  'spl_id': '1c4012cf-b16b-acd5-e063-6294a90a65de',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210316',\n",
       "  'product_id': '73978-006_1c4012cf-b16b-acd5-e063-6294a90a65de',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'b.tan Sun Safe AF'},\n",
       " {'product_ndc': '73978-009',\n",
       "  'generic_name': 'Avobenzone, Homosalate, Octisalate, Octocrylene',\n",
       "  'labeler_name': 'Marque of Brands Americas, LLC',\n",
       "  'brand_name': 'b.tan Beach Please SPF 7',\n",
       "  'brand_name_suffix': 'SPF 7',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '3 g/100mL'},\n",
       "   {'name': 'HOMOSALATE', 'strength': '6 g/100mL'},\n",
       "   {'name': 'OCTISALATE', 'strength': '5 g/100mL'},\n",
       "   {'name': 'OCTOCRYLENE', 'strength': '8 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '73978-009-01',\n",
       "    'description': '236 mL in 1 BOTTLE, SPRAY (73978-009-01)',\n",
       "    'marketing_start_date': '20210317',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Marque of Brands Americas, LLC'],\n",
       "   'spl_set_id': ['bdc07d83-a34f-5262-e053-2995a90acfc3'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['9347108003078'],\n",
       "   'unii': ['G63QQF2NOX', 'V06SV4M95S', '4X49Y0596W', '5A68WGF6WM']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '1c3bd58e-13c5-7c3e-e063-6394a90aacae',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210317',\n",
       "  'product_id': '73978-009_1c3bd58e-13c5-7c3e-e063-6394a90aacae',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'b.tan Beach Please'},\n",
       " {'product_ndc': '74047-003',\n",
       "  'generic_name': 'Ethanol',\n",
       "  'labeler_name': 'Shantou Kangjie Daily Chemical Industry Co.,Ltd',\n",
       "  'brand_name': 'Denatured Alcohol',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '75 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74047-003-03',\n",
       "    'description': '38 mL in 1 BOTTLE, SPRAY (74047-003-03)',\n",
       "    'marketing_start_date': '20230708',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74047-003-32',\n",
       "    'description': '3780 mL in 1 BOTTLE (74047-003-32)',\n",
       "    'marketing_start_date': '20230606',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Shantou Kangjie Daily Chemical Industry Co.,Ltd'],\n",
       "   'rxcui': ['1047755'],\n",
       "   'spl_set_id': ['fd5f7cfa-0602-ae9a-e053-6294a90aaed1'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0858706006983'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'fff2fe2f-198c-f85f-e053-6294a90a54f5',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230606',\n",
       "  'product_id': '74047-003_fff2fe2f-198c-f85f-e053-6294a90a54f5',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'Denatured Alcohol'},\n",
       " {'product_ndc': '74154-016',\n",
       "  'generic_name': 'Titanium Dioxide',\n",
       "  'labeler_name': 'Windmill Health Products, LLC',\n",
       "  'brand_name': 'Kiss My Face Cool Sport 30 Mineral Sunscreen',\n",
       "  'active_ingredients': [{'name': 'TITANIUM DIOXIDE', 'strength': '78 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74154-016-06',\n",
       "    'description': '177 mL in 1 CAN (74154-016-06)',\n",
       "    'marketing_start_date': '20220222',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Windmill Health Products, LLC'],\n",
       "   'spl_set_id': ['57989817-ddc9-4ccd-ba74-ea04d4e3dd7a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['15FIX9V2JP']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '61819350-ff9c-4db5-a59d-af816a286500',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220222',\n",
       "  'product_id': '74154-016_61819350-ff9c-4db5-a59d-af816a286500',\n",
       "  'application_number': 'part352',\n",
       "  'brand_name_base': 'Kiss My Face Cool Sport 30 Mineral Sunscreen'},\n",
       " {'product_ndc': '74154-319',\n",
       "  'generic_name': 'ZINC OXIDE',\n",
       "  'labeler_name': 'WINDMILL HEALTH PRODUCTS LLC',\n",
       "  'brand_name': 'KISS MY FACE SPF-50 Face Factor Mineral Sunscreen',\n",
       "  'active_ingredients': [{'name': 'ZINC OXIDE', 'strength': '120 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74154-319-00',\n",
       "    'description': '59 mL in 1 TUBE (74154-319-00)',\n",
       "    'marketing_start_date': '20220214',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['WINDMILL HEALTH PRODUCTS LLC'],\n",
       "   'spl_set_id': ['edc2c1e7-e1a8-4b49-96df-8a94eb6a242a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0035046126278'],\n",
       "   'unii': ['SOI2LOH54Z']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '09e2089e-a71c-9d2f-e063-6394a90a2282',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20220214',\n",
       "  'product_id': '74154-319_09e2089e-a71c-9d2f-e063-6394a90a2282',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'KISS MY FACE SPF-50 Face Factor Mineral Sunscreen',\n",
       "  'pharm_class': ['Copper Absorption Inhibitor [EPC]',\n",
       "   'Decreased Copper Ion Absorption [PE]']},\n",
       " {'product_ndc': '74157-006',\n",
       "  'generic_name': 'Amcinonide',\n",
       "  'labeler_name': 'INA PHARMACEUTICS INC.',\n",
       "  'brand_name': 'Amcinonide',\n",
       "  'active_ingredients': [{'name': 'AMCINONIDE', 'strength': '1 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74157-006-60',\n",
       "    'description': '1 TUBE in 1 CARTON (74157-006-60)  / 60 g in 1 TUBE',\n",
       "    'marketing_start_date': '20240509',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['INA PHARMACEUTICS INC.'],\n",
       "   'rxcui': ['197327'],\n",
       "   'spl_set_id': ['e7dc754e-eeff-4c30-a52a-629c72ad2415'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0374157006605'],\n",
       "   'nui': ['N0000175576', 'N0000175450'],\n",
       "   'pharm_class_epc': ['Corticosteroid [EPC]'],\n",
       "   'pharm_class_moa': ['Corticosteroid Hormone Receptor Agonists [MoA]'],\n",
       "   'unii': ['423W026MA9']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '187d0c0d-8817-f8ff-e063-6394a90ab7ef',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240509',\n",
       "  'product_id': '74157-006_187d0c0d-8817-f8ff-e063-6394a90ab7ef',\n",
       "  'application_number': 'ANDA076229',\n",
       "  'brand_name_base': 'Amcinonide',\n",
       "  'pharm_class': ['Corticosteroid Hormone Receptor Agonists [MoA]',\n",
       "   'Corticosteroid [EPC]']},\n",
       " {'product_ndc': '74157-007',\n",
       "  'generic_name': 'diclofenac potassium',\n",
       "  'labeler_name': 'INA Pharmaceutics Inc',\n",
       "  'brand_name': 'Diclofenac Potassium',\n",
       "  'active_ingredients': [{'name': 'DICLOFENAC POTASSIUM',\n",
       "    'strength': '25 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74157-007-60',\n",
       "    'description': '60 TABLET, COATED in 1 BOTTLE (74157-007-60)',\n",
       "    'marketing_start_date': '20210920',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['INA Pharmaceutics Inc'],\n",
       "   'rxcui': ['857702'],\n",
       "   'spl_set_id': ['5ecd99fe-cb74-4a65-9636-2aefd2416ece'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0374157007602'],\n",
       "   'unii': ['L4D5UA6CB4']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'TABLET, COATED',\n",
       "  'spl_id': '2420ef32-1721-c82d-e063-6394a90a0e85',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210920',\n",
       "  'product_id': '74157-007_2420ef32-1721-c82d-e063-6394a90a0e85',\n",
       "  'application_number': 'ANDA075229',\n",
       "  'brand_name_base': 'Diclofenac Potassium',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Decreased Prostaglandin Production [PE]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '74177-043',\n",
       "  'generic_name': 'BENZALKONIUM CHLORIDE',\n",
       "  'labeler_name': 'K7 DESIGN GROUP INC',\n",
       "  'brand_name': 'Vanilla Coconut Scent FOAMING HAND SANITIZER',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '1.3 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74177-043-16',\n",
       "    'description': '473 mL in 1 POUCH (74177-043-16)',\n",
       "    'marketing_start_date': '20210124',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['K7 DESIGN GROUP INC'],\n",
       "   'rxcui': ['1020365'],\n",
       "   'spl_set_id': ['1932ccc6-6b8c-4dc4-bf74-1a155b596f3b'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '0897b5ff-cacc-5ed5-e063-6294a90a92ee',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210124',\n",
       "  'product_id': '74177-043_0897b5ff-cacc-5ed5-e063-6294a90a92ee',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Vanilla Coconut Scent FOAMING HAND SANITIZER'},\n",
       " {'product_ndc': '0597-0035',\n",
       "  'generic_name': 'spesolimab-sbzo',\n",
       "  'labeler_name': 'Boehringer Ingelheim Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'SPEVIGO',\n",
       "  'active_ingredients': [{'name': 'SPESOLIMAB', 'strength': '60 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0597-0035-10',\n",
       "    'description': '2 VIAL, GLASS in 1 CARTON (0597-0035-10)  / 7.5 mL in 1 VIAL, GLASS',\n",
       "    'marketing_start_date': '20220901',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Boehringer Ingelheim Pharmaceuticals, Inc.'],\n",
       "   'spl_set_id': ['41a481ee-3062-45d1-aed5-17e8b105634d'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000194039', 'N0000194040'],\n",
       "   'pharm_class_epc': ['Interleukin-36 Receptor Antagonist [EPC]'],\n",
       "   'pharm_class_moa': ['Interleukin-36 Receptor Antagonists [MoA]'],\n",
       "   'unii': ['5IB2J79MCX']},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'INJECTION',\n",
       "  'spl_id': 'd11c6eb4-aa56-4c59-8769-d8dabf307463',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['INTRAVENOUS'],\n",
       "  'marketing_start_date': '20220901',\n",
       "  'product_id': '0597-0035_d11c6eb4-aa56-4c59-8769-d8dabf307463',\n",
       "  'application_number': 'BLA761244',\n",
       "  'brand_name_base': 'SPEVIGO',\n",
       "  'pharm_class': ['Interleukin-36 Receptor Antagonist [EPC]',\n",
       "   'Interleukin-36 Receptor Antagonists [MoA]']},\n",
       " {'product_ndc': '74246-103',\n",
       "  'marketing_end_date': '20251112',\n",
       "  'generic_name': 'Alcohol',\n",
       "  'labeler_name': 'Frontier Co-op',\n",
       "  'brand_name': 'Aura Cacia Hand Sanitizer Tea Tree Citrus',\n",
       "  'brand_name_suffix': 'Tea Tree Citrus',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '80 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74246-103-02',\n",
       "    'description': '59 mL in 1 BOTTLE, SPRAY (74246-103-02)',\n",
       "    'marketing_start_date': '20200611',\n",
       "    'marketing_end_date': '20251112',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Frontier Co-op'],\n",
       "   'rxcui': ['1039339'],\n",
       "   'spl_set_id': ['a7cdc4c3-2037-4fb7-e053-2a95a90a4435'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0051381903954'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOLUTION',\n",
       "  'spl_id': '0cf79d4b-8751-eaaa-e063-6294a90a1e6d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200611',\n",
       "  'product_id': '74246-103_0cf79d4b-8751-eaaa-e063-6294a90a1e6d',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Aura Cacia Hand Sanitizer'},\n",
       " {'product_ndc': '74446-345',\n",
       "  'generic_name': 'Sofasco Oil',\n",
       "  'labeler_name': 'INDUSTRY SUPPLY INC',\n",
       "  'brand_name': 'So-fas-co oil',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (SYNTHETIC)',\n",
       "    'strength': '1 g/100g'},\n",
       "   {'name': 'CHLOROTHYMOL', 'strength': '.3 g/100g'},\n",
       "   {'name': 'MENTHOL', 'strength': '1 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74446-345-52',\n",
       "    'description': '226.8 g in 1 BOTTLE (74446-345-52)',\n",
       "    'marketing_start_date': '20200330',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['INDUSTRY SUPPLY INC'],\n",
       "   'spl_set_id': ['a2ba8f8a-b618-63dd-e053-2995a90af0b5'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0198715395198'],\n",
       "   'unii': ['5TJD82A1ET', 'LJ25TI0CVT', 'L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '2097bc13-a83a-1f0b-e063-6394a90a9bcd',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200320',\n",
       "  'product_id': '74446-345_2097bc13-a83a-1f0b-e063-6394a90a9bcd',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'So-fas-co oil'},\n",
       " {'product_ndc': '74458-008',\n",
       "  'generic_name': 'ETHYLHEXYL METHOXYCINNAMATE',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd.',\n",
       "  'brand_name': 'MELAO TALLOW SUNSCREEN',\n",
       "  'active_ingredients': [{'name': 'ETHYL METHOXYCINNAMATE',\n",
       "    'strength': '4 g/100g'},\n",
       "   {'name': 'SAURURUS CHINENSIS WHOLE', 'strength': '2 g/100g'},\n",
       "   {'name': 'STEPHANIA TETRANDRA WHOLE', 'strength': '.1 g/100g'},\n",
       "   {'name': 'TARAXACUM OFFICINALE WHOLE', 'strength': '.8 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-008-01',\n",
       "    'description': '60 g in 1 JAR (74458-008-01)',\n",
       "    'marketing_start_date': '20240926',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd.'],\n",
       "   'spl_set_id': ['22fdad80-587c-a7e6-e063-6394a90a5f6e'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6952243219562'],\n",
       "   'unii': ['SD418S06XD', '6DRV3D37XS', '7S7TV2F4XC', '7C42E2D7B0']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '22fdad80-587d-a7e6-e063-6394a90a5f6e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240926',\n",
       "  'product_id': '74458-008_22fdad80-587d-a7e6-e063-6394a90a5f6e',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'MELAO TALLOW SUNSCREEN'},\n",
       " {'product_ndc': '74458-017',\n",
       "  'generic_name': 'Cocos Nucifera (Coconut) Fruit Extract 40% Tocopherol 1%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'MELAO COCONUT MILK BODY SCRUB',\n",
       "  'active_ingredients': [{'name': 'COCOS NUCIFERA (COCONUT) FRUIT EXTRACT',\n",
       "    'strength': '40 g/100g'},\n",
       "   {'name': 'TOCOPHEROL', 'strength': '1 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-017-01',\n",
       "    'description': '340 g in 1 JAR (74458-017-01)',\n",
       "    'marketing_start_date': '20241119',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['278be654-61a2-d73c-e063-6394a90ab39f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3RT3536DHY', 'R0ZB2556P8']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GRANULE',\n",
       "  'spl_id': '278be654-61a3-d73c-e063-6394a90ab39f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20241119',\n",
       "  'product_id': '74458-017_278be654-61a3-d73c-e063-6394a90ab39f',\n",
       "  'application_number': 'M030',\n",
       "  'brand_name_base': 'MELAO COCONUT MILK BODY SCRUB',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Fruit Proteins [EXT]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]']},\n",
       " {'product_ndc': '74458-029',\n",
       "  'generic_name': 'Vanillyl Butyl Ether 3% Caffeine 0.3%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'MELAO Hot Cream',\n",
       "  'active_ingredients': [{'name': 'CAFFEINE', 'strength': '.3 g/100g'},\n",
       "   {'name': 'VANILLYL BUTYL ETHER', 'strength': '3 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-029-01',\n",
       "    'description': '250 g in 1 JAR (74458-029-01)',\n",
       "    'marketing_start_date': '20240822',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['241c7ffe-875a-deac-e063-6394a90a7878'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175739', 'N0000175729', 'N0000175790', 'M0023046'],\n",
       "   'pharm_class_epc': ['Central Nervous System Stimulant [EPC]',\n",
       "    'Methylxanthine [EPC]'],\n",
       "   'pharm_class_pe': ['Central Nervous System Stimulation [PE]'],\n",
       "   'pharm_class_cs': ['Xanthines [CS]'],\n",
       "   'unii': ['3G6A5W338E', 'S2ULN37C9R']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '241c7ffe-875b-deac-e063-6394a90a7878',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240822',\n",
       "  'product_id': '74458-029_241c7ffe-875b-deac-e063-6394a90a7878',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'MELAO Hot Cream',\n",
       "  'pharm_class': ['Central Nervous System Stimulant [EPC]',\n",
       "   'Central Nervous System Stimulation [PE]',\n",
       "   'Methylxanthine [EPC]',\n",
       "   'Xanthines [CS]']},\n",
       " {'product_ndc': '74458-037',\n",
       "  'generic_name': 'Allantoin 0.5% Niacinamide 5%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'GZE Brightenng Exfoliating Gel',\n",
       "  'active_ingredients': [{'name': 'ALLANTOIN', 'strength': '.5 g/100g'},\n",
       "   {'name': 'NIACINAMIDE', 'strength': '5 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-037-01',\n",
       "    'description': '50 g in 1 TUBE (74458-037-01)',\n",
       "    'marketing_start_date': '20241103',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['2763d6e8-e2be-a406-e063-6394a90a6617'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['344S277G0Z', '25X51I8RD4']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '2763d6e8-e2bf-a406-e063-6394a90a6617',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20241103',\n",
       "  'product_id': '74458-037_2763d6e8-e2bf-a406-e063-6394a90a6617',\n",
       "  'application_number': 'M016',\n",
       "  'brand_name_base': 'GZE Brightenng Exfoliating Gel'},\n",
       " {'product_ndc': '74458-050',\n",
       "  'generic_name': 'Salicylic Acid 1.2% Taurine 2% Taurine 2%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'GZE Yellow Peeling Oil',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '1.2 g/100mL'},\n",
       "   {'name': 'SERINE', 'strength': '2 g/100mL'},\n",
       "   {'name': 'TAURINE', 'strength': '2 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-050-01',\n",
       "    'description': '110 mL in 1 BOTTLE, PLASTIC (74458-050-01)',\n",
       "    'marketing_start_date': '20240802',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['269aa921-27d3-e568-e063-6394a90a9d2a'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['O414PZ4LPZ', '452VLY9402', '1EQV5MLY3D']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '269aa921-27d4-e568-e063-6394a90a9d2a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240802',\n",
       "  'product_id': '74458-050_269aa921-27d4-e568-e063-6394a90a9d2a',\n",
       "  'application_number': 'M030',\n",
       "  'brand_name_base': 'GZE Yellow Peeling Oil'},\n",
       " {'product_ndc': '74458-051',\n",
       "  'generic_name': 'Centella Asiatica Extract 0.5% Zingiber Officinale Extract 0.5%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'GZE Sea SaltShampoo',\n",
       "  'active_ingredients': [{'name': 'CENTELLA ASIATICA TRITERPENOIDS',\n",
       "    'strength': '.5 g/100g'},\n",
       "   {'name': 'ZINGIBER OFFICINALE (GINGER) ROOT EXTRACT',\n",
       "    'strength': '.5 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-051-01',\n",
       "    'description': '250 g in 1 JAR (74458-051-01)',\n",
       "    'marketing_start_date': '20240510',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['2678b582-4902-d384-e063-6394a90aef4f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['4YS74Q4G4J', 'C5529G5JPQ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GRANULE',\n",
       "  'spl_id': '2678b3f2-fa61-d337-e063-6394a90a7bc7',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240510',\n",
       "  'product_id': '74458-051_2678b3f2-fa61-d337-e063-6394a90a7bc7',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'GZE Sea SaltShampoo',\n",
       "  'pharm_class': ['Allergens [CS]',\n",
       "   'Cell-mediated Immunity [PE]',\n",
       "   'Dietary Proteins [CS]',\n",
       "   'Food Additives [CS]',\n",
       "   'Increased Histamine Release [PE]',\n",
       "   'Non-Standardized Food Allergenic Extract [EPC]',\n",
       "   'Non-Standardized Plant Allergenic Extract [EPC]',\n",
       "   'Plant Proteins [CS]']},\n",
       " {'product_ndc': '74458-110',\n",
       "  'generic_name': 'Simmondsia Chinensis (Jojoba) Seed Oil 10% Cocos Nucifera (Coconut) Oil 10%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'GZE RICE RAW PULP SOLID CONDITIONER',\n",
       "  'active_ingredients': [{'name': 'COCOS NUCIFERA (COCONUT) OIL',\n",
       "    'strength': '10 g/100g'},\n",
       "   {'name': 'SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL',\n",
       "    'strength': '10 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-110-01',\n",
       "    'description': '60 g in 1 BAG (74458-110-01)',\n",
       "    'marketing_start_date': '20240713',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['255e4fbd-01bd-bf68-e063-6294a90a204f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['Q9L0O73W7L', '724GKU717M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOAP',\n",
       "  'spl_id': '255e4fbd-01be-bf68-e063-6294a90a204f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240713',\n",
       "  'product_id': '74458-110_255e4fbd-01be-bf68-e063-6294a90a204f',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'GZE RICE RAW PULP SOLID CONDITIONER'},\n",
       " {'product_ndc': '0597-0044',\n",
       "  'generic_name': 'telmisartan and hydrochlorothiazide',\n",
       "  'labeler_name': 'Boehringer Ingelheim Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Micardis HCT',\n",
       "  'active_ingredients': [{'name': 'HYDROCHLOROTHIAZIDE',\n",
       "    'strength': '12.5 mg/1'},\n",
       "   {'name': 'TELMISARTAN', 'strength': '80 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0597-0044-37',\n",
       "    'description': '3 BLISTER PACK in 1 CARTON (0597-0044-37)  / 10 TABLET in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20001201',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Boehringer Ingelheim Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['283316', '283317', '477130', '749833', '749837', '749841'],\n",
       "   'spl_set_id': ['b078dae2-664d-4144-847a-3b9d9b557402'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000070',\n",
       "    'N0000175561',\n",
       "    'N0000175359',\n",
       "    'N0000175419',\n",
       "    'M0471776'],\n",
       "   'pharm_class_moa': ['Angiotensin 2 Receptor Antagonists [MoA]'],\n",
       "   'pharm_class_epc': ['Angiotensin 2 Receptor Blocker [EPC]',\n",
       "    'Thiazide Diuretic [EPC]'],\n",
       "   'pharm_class_pe': ['Increased Diuresis [PE]'],\n",
       "   'pharm_class_cs': ['Thiazides [CS]'],\n",
       "   'unii': ['U5SYW473RQ', '0J48LPH2TH']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'c58fc0c9-d4dc-4fc5-9cb5-bfd7f6fe5636',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20001201',\n",
       "  'product_id': '0597-0044_c58fc0c9-d4dc-4fc5-9cb5-bfd7f6fe5636',\n",
       "  'application_number': 'NDA021162',\n",
       "  'brand_name_base': 'Micardis HCT',\n",
       "  'pharm_class': ['Angiotensin 2 Receptor Antagonists [MoA]',\n",
       "   'Angiotensin 2 Receptor Blocker [EPC]',\n",
       "   'Increased Diuresis [PE]',\n",
       "   'Thiazide Diuretic [EPC]',\n",
       "   'Thiazides [CS]']},\n",
       " {'product_ndc': '74458-187',\n",
       "  'generic_name': 'Rosemary 4% Castor Oil 6.5% Rice Bran 8%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'GZE Chebe Rice Water Black Castor Oil HairMask',\n",
       "  'active_ingredients': [{'name': 'CASTOR OIL', 'strength': '6.5 g/100g'},\n",
       "   {'name': 'RICE BRAN', 'strength': '8 g/100g'},\n",
       "   {'name': 'ROSEMARY', 'strength': '4 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-187-01',\n",
       "    'description': '100 g in 1 JAR (74458-187-01)',\n",
       "    'marketing_start_date': '20240912',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['2419a4d2-8ff5-e4f8-e063-6394a90a176b'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['D5340Y2I9G', 'R60QEP13IC', 'IJ67X351P9']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '2419a4d2-8ff6-e4f8-e063-6394a90a176b',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240912',\n",
       "  'product_id': '74458-187_2419a4d2-8ff6-e4f8-e063-6394a90a176b',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'GZE Chebe Rice Water Black Castor Oil HairMask'},\n",
       " {'product_ndc': '74458-206',\n",
       "  'generic_name': 'Kojic Acid 4.4%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'GZE Lemon Turmeric Kojic ScidSoap',\n",
       "  'active_ingredients': [{'name': 'KOJIC ACID', 'strength': '4.4 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-206-01',\n",
       "    'description': '120 g in 1 BAG (74458-206-01)',\n",
       "    'marketing_start_date': '20240918',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['23b8e510-41c3-e655-e063-6394a90ad43d'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['6K23F1TT52']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SOAP',\n",
       "  'spl_id': '23b8e510-41c4-e655-e063-6394a90ad43d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240918',\n",
       "  'product_id': '74458-206_23b8e510-41c4-e655-e063-6394a90ad43d',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'GZE Lemon Turmeric Kojic ScidSoap'},\n",
       " {'product_ndc': '74458-216',\n",
       "  'generic_name': 'Sucrose 15%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'GZE GODDESS SUGAR SCRUB',\n",
       "  'active_ingredients': [{'name': 'SUCROSE', 'strength': '15 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-216-01',\n",
       "    'description': '100 g in 1 JAR (74458-216-01)',\n",
       "    'marketing_start_date': '20240606',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['26a02d13-5558-81ec-e063-6394a90a9fe3'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['C151H8M554']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '26a02d13-5559-81ec-e063-6394a90a9fe3',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240606',\n",
       "  'product_id': '74458-216_26a02d13-5559-81ec-e063-6394a90a9fe3',\n",
       "  'application_number': 'M030',\n",
       "  'brand_name_base': 'GZE GODDESS SUGAR SCRUB'},\n",
       " {'product_ndc': '74458-234',\n",
       "  'generic_name': 'Niacinamide 4.05% Retinol 0.15%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'GZE Fading Cream',\n",
       "  'active_ingredients': [{'name': 'NIACINAMIDE', 'strength': '4.05 g/100g'},\n",
       "   {'name': 'RETINOL', 'strength': '.15 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-234-01',\n",
       "    'description': '100 g in 1 JAR (74458-234-01)',\n",
       "    'marketing_start_date': '20240802',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['25c03d3a-9fc1-ebac-e063-6394a90ac99f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['25X51I8RD4', 'G2SH0XKK91']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '25c03d3a-9fc2-ebac-e063-6394a90ac99f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240802',\n",
       "  'product_id': '74458-234_25c03d3a-9fc2-ebac-e063-6394a90ac99f',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'GZE Fading Cream'},\n",
       " {'product_ndc': '74458-275',\n",
       "  'generic_name': 'Rosemary Oil 10% Biotin 5%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'GZE ROSEMARY MINT HAIR STRONG ROOTS PURE BUTTER',\n",
       "  'active_ingredients': [{'name': 'BIOTIN', 'strength': '5 g/100g'},\n",
       "   {'name': 'ROSEMARY OIL', 'strength': '10 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-275-01',\n",
       "    'description': '100 g in 1 BOTTLE, PLASTIC (74458-275-01)',\n",
       "    'marketing_start_date': '20240913',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['242e5eb9-2bdd-36f5-e063-6294a90aaa1f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['6SO6U10H04', '8LGU7VM393']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '242e5eb9-2bde-36f5-e063-6294a90aaa1f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240913',\n",
       "  'product_id': '74458-275_242e5eb9-2bde-36f5-e063-6294a90aaa1f',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'GZE ROSEMARY MINT HAIR STRONG ROOTS PURE BUTTER'},\n",
       " {'product_ndc': '74458-296',\n",
       "  'generic_name': 'Cocos Nucifera (Coconut) Oil 10% Simmondsia Chinensis (Jojoba) Seed Powder 10%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'GZE LIP SCRUB',\n",
       "  'active_ingredients': [{'name': 'COCOS NUCIFERA (COCONUT) OIL',\n",
       "    'strength': '10 g/100g'},\n",
       "   {'name': 'SIMMONDSIA CHINENSIS SEED', 'strength': '10 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-296-01',\n",
       "    'description': '50 g in 1 JAR (74458-296-01)',\n",
       "    'marketing_start_date': '20240709',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['26aedc39-2fd8-9e2b-e063-6394a90ad381'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['Q9L0O73W7L', 'D24K2Q1F6H']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '26aedc39-2fd9-9e2b-e063-6394a90ad381',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240709',\n",
       "  'product_id': '74458-296_26aedc39-2fd9-9e2b-e063-6394a90ad381',\n",
       "  'application_number': 'M030',\n",
       "  'brand_name_base': 'GZE LIP SCRUB'},\n",
       " {'product_ndc': '74458-333',\n",
       "  'generic_name': 'Ascorbic Acid 2% Coconut Shell 2%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'MELAO SHEA SUGAR SCRUB',\n",
       "  'active_ingredients': [{'name': 'ASCORBIC ACID', 'strength': '2 g/100g'},\n",
       "   {'name': 'COCONUT SHELL', 'strength': '2 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-333-01',\n",
       "    'description': '510 g in 1 JAR (74458-333-01)',\n",
       "    'marketing_start_date': '20240320',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['2675913f-1ad4-2667-e063-6394a90a192d'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000193618', 'M0001797'],\n",
       "   'pharm_class_epc': ['Vitamin C [EPC]'],\n",
       "   'pharm_class_cs': ['Ascorbic Acid [CS]'],\n",
       "   'unii': ['PQ6CK8PD0R', '7O4218UHJ4']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GRANULE',\n",
       "  'spl_id': '2675913f-1ad5-2667-e063-6394a90a192d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240320',\n",
       "  'product_id': '74458-333_2675913f-1ad5-2667-e063-6394a90a192d',\n",
       "  'application_number': 'M030',\n",
       "  'brand_name_base': 'MELAO SHEA SUGAR SCRUB',\n",
       "  'pharm_class': ['Ascorbic Acid [CS]', 'Vitamin C [EPC]']},\n",
       " {'product_ndc': '74458-454',\n",
       "  'generic_name': 'GLYCYRRHIZINATE DIPOTASSIUM 0.5%',\n",
       "  'labeler_name': 'Guangzhou Yilong Cosmetics Co., Ltd',\n",
       "  'brand_name': 'MELAO AFTER SHAVE COLOGNE',\n",
       "  'active_ingredients': [{'name': 'GLYCYRRHIZINATE DIPOTASSIUM',\n",
       "    'strength': '.5 g/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74458-454-01',\n",
       "    'description': '150 mL in 1 BOTTLE, SPRAY (74458-454-01)',\n",
       "    'marketing_start_date': '20240913',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Guangzhou Yilong Cosmetics Co., Ltd'],\n",
       "   'spl_set_id': ['23b6f46a-b88a-09c1-e063-6394a90acfa8'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['CA2Y0FE3FX']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '23b6f46a-b88b-09c1-e063-6394a90acfa8',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240913',\n",
       "  'product_id': '74458-454_23b6f46a-b88b-09c1-e063-6394a90acfa8',\n",
       "  'application_number': 'M028',\n",
       "  'brand_name_base': 'MELAO AFTER SHAVE COLOGNE'},\n",
       " {'product_ndc': '74474-103',\n",
       "  'generic_name': 'Chamomilla, Phosphorus, Platinum Metallicum, Ruta Graveolens, Veratrum Album',\n",
       "  'labeler_name': 'Terravitals LLC',\n",
       "  'brand_name': 'Terravitals LoBak',\n",
       "  'active_ingredients': [{'name': 'CHAMOMILE', 'strength': '6 [hp_C]/1'},\n",
       "   {'name': 'PHOSPHORUS', 'strength': '30 [hp_C]/1'},\n",
       "   {'name': 'PLATINUM', 'strength': '30 [hp_C]/1'},\n",
       "   {'name': 'RUTA GRAVEOLENS FLOWERING TOP', 'strength': '6 [hp_C]/1'},\n",
       "   {'name': 'VERATRUM ALBUM ROOT', 'strength': '30 [hp_C]/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74474-103-01',\n",
       "    'description': '1 BOTTLE, DISPENSING in 1 TUBE (74474-103-01)  / 1 PELLET in 1 BOTTLE, DISPENSING',\n",
       "    'marketing_start_date': '20210615',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Terravitals LLC'],\n",
       "   'spl_set_id': ['c4932c78-3de1-f17c-e053-2a95a90a6c73'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['FGL3685T2X',\n",
       "    '27YLU75U4W',\n",
       "    '49DFR088MY',\n",
       "    'N94C2U587S',\n",
       "    'QNS6W5US1Z']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'PELLET',\n",
       "  'spl_id': 'c4932210-5ba9-3043-e053-2a95a90a8f29',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20210615',\n",
       "  'product_id': '74474-103_c4932210-5ba9-3043-e053-2a95a90a8f29',\n",
       "  'brand_name_base': 'Terravitals LoBak'},\n",
       " {'product_ndc': '74553-007',\n",
       "  'generic_name': 'Salicylic Acid',\n",
       "  'labeler_name': 'Xtreme Tools International, Inc',\n",
       "  'brand_name': 'OKAY Blemish Control Apricot Scrub',\n",
       "  'active_ingredients': [{'name': 'SALICYLIC ACID', 'strength': '2 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74553-007-01',\n",
       "    'description': '170 g in 1 TUBE (74553-007-01)',\n",
       "    'marketing_start_date': '20210421',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Xtreme Tools International, Inc'],\n",
       "   'rxcui': ['562600'],\n",
       "   'spl_set_id': ['b15a0a33-084a-41a2-9963-067308b06623'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0810367017401'],\n",
       "   'unii': ['O414PZ4LPZ']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '06e5b6ce-839c-40cd-b138-586c2bfd951f',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210421',\n",
       "  'product_id': '74553-007_06e5b6ce-839c-40cd-b138-586c2bfd951f',\n",
       "  'application_number': 'part333D',\n",
       "  'brand_name_base': 'OKAY Blemish Control Apricot Scrub'},\n",
       " {'product_ndc': '74683-2001',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'Horizon Tool Inc.',\n",
       "  'brand_name': 'Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '80 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74683-2001-1',\n",
       "    'description': '473 mL in 1 BOTTLE, PLASTIC (74683-2001-1)',\n",
       "    'marketing_start_date': '20230731',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74683-2001-2',\n",
       "    'description': '3785.41 mL in 1 BOTTLE, PLASTIC (74683-2001-2)',\n",
       "    'marketing_start_date': '20230731',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Horizon Tool Inc.'],\n",
       "   'rxcui': ['581662', '1241663', '1489307'],\n",
       "   'spl_set_id': ['a40afa46-a07d-f864-e053-2a95a90aef8a'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0047084225059',\n",
       "    '0047084022542',\n",
       "    '0047084226162',\n",
       "    '0047084226285',\n",
       "    '0047084225165',\n",
       "    '0047084022580'],\n",
       "   'unii': ['3K9958V90M', 'F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '05f48e44-e62d-3bd6-e063-6294a90a1376',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230731',\n",
       "  'product_id': '74683-2001_05f48e44-e62d-3bd6-e063-6294a90a1376',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'Hand Sanitizer'},\n",
       " {'product_ndc': '74690-014',\n",
       "  'generic_name': 'OCTINOXATE',\n",
       "  'labeler_name': 'Farmasi US LLC',\n",
       "  'brand_name': 'Dr. C. Tuna Sun Bronzing Oil SPF 6',\n",
       "  'active_ingredients': [{'name': 'OCTINOXATE', 'strength': '35 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74690-014-01',\n",
       "    'description': '1 BOTTLE in 1 BOX (74690-014-01)  / 115 mL in 1 BOTTLE',\n",
       "    'marketing_start_date': '20210725',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Farmasi US LLC'],\n",
       "   'spl_set_id': ['91b428cc-1c80-4d56-8450-790c66de4133'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['4Y5P7MUD51']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'OIL',\n",
       "  'spl_id': '09735fbf-7779-ca3f-e063-6294a90a9f94',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210725',\n",
       "  'product_id': '74690-014_09735fbf-7779-ca3f-e063-6294a90a9f94',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Dr. C. Tuna Sun Bronzing Oil SPF 6'},\n",
       " {'product_ndc': '74690-051',\n",
       "  'generic_name': 'TITANIUM DIOXIDE',\n",
       "  'labeler_name': 'Farmasi US LLC',\n",
       "  'brand_name': 'Farmasi CC Color Control Cream SPF 25- 06 Deep',\n",
       "  'active_ingredients': [{'name': 'TITANIUM DIOXIDE', 'strength': '40 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74690-051-00',\n",
       "    'description': '1 TUBE in 1 CARTON (74690-051-00)  / 30 mL in 1 TUBE',\n",
       "    'marketing_start_date': '20230701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Farmasi US LLC'],\n",
       "   'spl_set_id': ['c28afa3b-9a8d-4e19-bc6b-39cc8428c9f9'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['15FIX9V2JP']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '0973b548-7ae1-5b98-e063-6394a90af208',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230701',\n",
       "  'product_id': '74690-051_0973b548-7ae1-5b98-e063-6394a90af208',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Farmasi CC Color Control Cream SPF 25- 06 Deep'},\n",
       " {'product_ndc': '0597-0152',\n",
       "  'generic_name': 'Empagliflozin',\n",
       "  'labeler_name': 'Boehringer Ingelheim Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Jardiance',\n",
       "  'active_ingredients': [{'name': 'EMPAGLIFLOZIN', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0597-0152-07',\n",
       "    'description': '1 BOTTLE in 1 CARTON (0597-0152-07)  / 7 TABLET, FILM COATED in 1 BOTTLE',\n",
       "    'marketing_start_date': '20140801',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '0597-0152-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (0597-0152-30)',\n",
       "    'marketing_start_date': '20140801',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0597-0152-37',\n",
       "    'description': '30 BLISTER PACK in 1 CARTON (0597-0152-37)  / 1 TABLET, FILM COATED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20140801',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0597-0152-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (0597-0152-90)',\n",
       "    'marketing_start_date': '20140801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Boehringer Ingelheim Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['1545658', '1545664', '1545666', '1545668'],\n",
       "   'spl_set_id': ['faf3dd6a-9cd0-39c2-0d2e-232cb3f67565'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000187059', 'N0000187058'],\n",
       "   'pharm_class_epc': ['Sodium-Glucose Cotransporter 2 Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Sodium-Glucose Transporter 2 Inhibitors [MoA]'],\n",
       "   'unii': ['HDC1R2M35U']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '691d5f55-2b16-4cf3-9cef-efa755e11127',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20140801',\n",
       "  'product_id': '0597-0152_691d5f55-2b16-4cf3-9cef-efa755e11127',\n",
       "  'application_number': 'NDA204629',\n",
       "  'brand_name_base': 'Jardiance',\n",
       "  'pharm_class': ['Sodium-Glucose Cotransporter 2 Inhibitor [EPC]',\n",
       "   'Sodium-Glucose Transporter 2 Inhibitors [MoA]']},\n",
       " {'product_ndc': '74724-0010',\n",
       "  'generic_name': 'SODIUM MONOFLUOROPHOSPHATE',\n",
       "  'labeler_name': 'K.Boeun Pharmaceutical Co.,Ltd.',\n",
       "  'brand_name': 'Kosette Salt Tooth',\n",
       "  'active_ingredients': [{'name': 'SODIUM MONOFLUOROPHOSPHATE',\n",
       "    'strength': '.76 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74724-0010-1',\n",
       "    'description': '100 g in 1 TUBE (74724-0010-1)',\n",
       "    'marketing_start_date': '20200501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['K.Boeun Pharmaceutical Co.,Ltd.'],\n",
       "   'rxcui': ['545626'],\n",
       "   'spl_set_id': ['a69aa6ef-be27-a4ad-e053-2a95a90aeefb'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['C810JCZ56Q']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'PASTE, DENTIFRICE',\n",
       "  'spl_id': 'a69aa6ef-be28-a4ad-e053-2a95a90aeefb',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['DENTAL'],\n",
       "  'marketing_start_date': '20200501',\n",
       "  'product_id': '74724-0010_a69aa6ef-be28-a4ad-e053-2a95a90aeefb',\n",
       "  'application_number': 'part355',\n",
       "  'brand_name_base': 'Kosette Salt Tooth'},\n",
       " {'product_ndc': '74724-0031',\n",
       "  'generic_name': 'sodium chloride, Precipitated Calcium Carbonate',\n",
       "  'labeler_name': 'K.Boeun Pharmaceutical Co.,Ltd.',\n",
       "  'brand_name': 'SALTRAIN LTOOTHPASTE',\n",
       "  'active_ingredients': [{'name': 'CALCIUM CARBONATE',\n",
       "    'strength': '33 g/100g'},\n",
       "   {'name': 'SODIUM CHLORIDE', 'strength': '3 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74724-0031-1',\n",
       "    'description': '180 g in 1 TUBE (74724-0031-1)',\n",
       "    'marketing_start_date': '20230101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['K.Boeun Pharmaceutical Co.,Ltd.'],\n",
       "   'spl_set_id': ['f126df43-b31a-13c2-e053-2a95a90a523c'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['8809552278941'],\n",
       "   'unii': ['H0G9379FGK', '451W47IQ8X']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'PASTE, DENTIFRICE',\n",
       "  'spl_id': 'f126e30f-5f3a-7bf9-e053-2a95a90a265d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['DENTAL'],\n",
       "  'marketing_start_date': '20230101',\n",
       "  'product_id': '74724-0031_f126e30f-5f3a-7bf9-e053-2a95a90a265d',\n",
       "  'brand_name_base': 'SALTRAIN LTOOTHPASTE',\n",
       "  'pharm_class': ['Blood Coagulation Factor [EPC]',\n",
       "   'Calcium [CS]',\n",
       "   'Cations',\n",
       "   'Divalent [CS]',\n",
       "   'Increased Coagulation Factor Activity [PE]']},\n",
       " {'product_ndc': '74830-546',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'Economy Polymers and Chemicals',\n",
       "  'brand_name': 'PureGel Hand Sanitizer',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '.7 mL/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74830-546-01',\n",
       "    'description': '500 mL in 1 BOTTLE (74830-546-01)',\n",
       "    'marketing_start_date': '20200331',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Economy Polymers and Chemicals'],\n",
       "   'rxcui': ['581662'],\n",
       "   'spl_set_id': ['b4eef112-42ca-a8b5-e053-2a95a90a94ef'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0850019218497'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': 'f89cd0a8-052e-abce-e053-6294a90a2d66',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200331',\n",
       "  'product_id': '74830-546_f89cd0a8-052e-abce-e053-6294a90a2d66',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'PureGel Hand Sanitizer'},\n",
       " {'product_ndc': '74934-002',\n",
       "  'marketing_end_date': '20260131',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'Zhejiang iColor Biotech Co., Ltd',\n",
       "  'brand_name': 'Color Element Advanced Hand Sanitizer with Moisturizers and Vitamin E',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '.7 mL/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74934-002-01',\n",
       "    'description': '1000 mL in 1 BOTTLE (74934-002-01)',\n",
       "    'marketing_start_date': '20200430',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74934-002-10',\n",
       "    'description': '100 mL in 1 BOTTLE (74934-002-10)',\n",
       "    'marketing_start_date': '20200425',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74934-002-12',\n",
       "    'description': '120 mL in 1 BOTTLE (74934-002-12)',\n",
       "    'marketing_start_date': '20200611',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74934-002-25',\n",
       "    'description': '250 mL in 1 BOTTLE (74934-002-25)',\n",
       "    'marketing_start_date': '20200512',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74934-002-30',\n",
       "    'description': '300 mL in 1 BOTTLE (74934-002-30)',\n",
       "    'marketing_start_date': '20200425',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74934-002-31',\n",
       "    'description': '30 mL in 1 BOTTLE (74934-002-31)',\n",
       "    'marketing_start_date': '20200724',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74934-002-38',\n",
       "    'description': '3800 mL in 1 BOTTLE (74934-002-38)',\n",
       "    'marketing_start_date': '20200716',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74934-002-50',\n",
       "    'description': '500 mL in 1 BOTTLE (74934-002-50)',\n",
       "    'marketing_start_date': '20200425',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74934-002-60',\n",
       "    'description': '60 mL in 1 BOTTLE (74934-002-60)',\n",
       "    'marketing_start_date': '20200425',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Zhejiang iColor Biotech Co., Ltd'],\n",
       "   'rxcui': ['581662'],\n",
       "   'spl_set_id': ['056f3e22-94e2-427f-aba6-e89759baf8a1'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6972973040199',\n",
       "    '6972973041523',\n",
       "    '6972973040168',\n",
       "    '6972973041172',\n",
       "    '6972973040212',\n",
       "    '6972973040939',\n",
       "    '6972973040182',\n",
       "    '6972973040175',\n",
       "    '6972973040571'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '0ec37f5d-dd9a-382e-e063-6294a90a5cd8',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200425',\n",
       "  'product_id': '74934-002_0ec37f5d-dd9a-382e-e063-6294a90a5cd8',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Color Element Advanced Hand Sanitizer with Moisturizers and Vitamin E'},\n",
       " {'product_ndc': '0597-0164',\n",
       "  'generic_name': 'empagliflozin and linagliptin',\n",
       "  'labeler_name': 'Boehringer Ingelheim Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Glyxambi',\n",
       "  'active_ingredients': [{'name': 'EMPAGLIFLOZIN', 'strength': '25 mg/1'},\n",
       "   {'name': 'LINAGLIPTIN', 'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0597-0164-07',\n",
       "    'description': '1 BOTTLE in 1 CARTON (0597-0164-07)  / 7 TABLET, FILM COATED in 1 BOTTLE',\n",
       "    'marketing_start_date': '20150130',\n",
       "    'marketing_end_date': '20251031',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0597-0164-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (0597-0164-30)',\n",
       "    'marketing_start_date': '20150130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0597-0164-39',\n",
       "    'description': '30 BLISTER PACK in 1 CARTON (0597-0164-39)  / 1 TABLET, FILM COATED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20150130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0597-0164-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (0597-0164-90)',\n",
       "    'marketing_start_date': '20150130',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Boehringer Ingelheim Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['1602109', '1602115', '1602118', '1602120'],\n",
       "   'spl_set_id': ['ddbab689-f76c-488c-9613-4168d41dd730'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175912', 'N0000175913', 'N0000187059', 'N0000187058'],\n",
       "   'pharm_class_moa': ['Dipeptidyl Peptidase 4 Inhibitors [MoA]',\n",
       "    'Sodium-Glucose Transporter 2 Inhibitors [MoA]'],\n",
       "   'pharm_class_epc': ['Dipeptidyl Peptidase 4 Inhibitor [EPC]',\n",
       "    'Sodium-Glucose Cotransporter 2 Inhibitor [EPC]'],\n",
       "   'unii': ['3X29ZEJ4R2', 'HDC1R2M35U']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '19598884-b178-444f-85f1-9337a4635d3e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20150130',\n",
       "  'product_id': '0597-0164_19598884-b178-444f-85f1-9337a4635d3e',\n",
       "  'application_number': 'NDA206073',\n",
       "  'brand_name_base': 'Glyxambi',\n",
       "  'pharm_class': ['Dipeptidyl Peptidase 4 Inhibitor [EPC]',\n",
       "   'Dipeptidyl Peptidase 4 Inhibitors [MoA]',\n",
       "   'Sodium-Glucose Cotransporter 2 Inhibitor [EPC]',\n",
       "   'Sodium-Glucose Transporter 2 Inhibitors [MoA]']},\n",
       " {'product_ndc': '74934-059',\n",
       "  'marketing_end_date': '20260131',\n",
       "  'generic_name': 'BENZALKONIUM CHLORIDE',\n",
       "  'labeler_name': 'Zhejiang iColor Biotech Co., Ltd',\n",
       "  'brand_name': 'MIOSAIC Antibacterial Wipes Lemon Scent',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '1 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74934-059-01',\n",
       "    'description': '50 PATCH in 1 BAG (74934-059-01)  / 3.78 mL in 1 PATCH',\n",
       "    'marketing_start_date': '20201008',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74934-059-02',\n",
       "    'description': '70 PATCH in 1 CANISTER (74934-059-02)  / 3.49 mL in 1 PATCH',\n",
       "    'marketing_start_date': '20201008',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74934-059-03',\n",
       "    'description': '140 PATCH in 1 CANISTER (74934-059-03)  / 3.9 mL in 1 PATCH',\n",
       "    'marketing_start_date': '20201008',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Zhejiang iColor Biotech Co., Ltd'],\n",
       "   'rxcui': ['1038856'],\n",
       "   'spl_set_id': ['b119f47d-81e7-d9f5-e053-2a95a90a7945'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0843473106578', '0843473106585', '0843473106561'],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CLOTH',\n",
       "  'spl_id': '0fb40715-f0cf-1444-e063-6294a90a492b',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20201008',\n",
       "  'product_id': '74934-059_0fb40715-f0cf-1444-e063-6294a90a492b',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'MIOSAIC Antibacterial Wipes Lemon Scent'},\n",
       " {'product_ndc': '74934-073',\n",
       "  'marketing_end_date': '20260131',\n",
       "  'generic_name': 'ALCOHOL',\n",
       "  'labeler_name': 'Zhejiang iColor Biotech Co., Ltd',\n",
       "  'brand_name': 'Med X Frontline Advanced Hand Sanitizer with Moisturizers and Vitamin E',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '.75 mL/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '74934-073-01',\n",
       "    'description': '236 mL in 1 BOTTLE (74934-073-01)',\n",
       "    'marketing_start_date': '20201205',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74934-073-02',\n",
       "    'description': '3800 mL in 1 BOTTLE (74934-073-02)',\n",
       "    'marketing_start_date': '20201205',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '74934-073-03',\n",
       "    'description': '500 mL in 1 BOTTLE (74934-073-03)',\n",
       "    'marketing_start_date': '20201205',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False}],\n",
       "  'openfda': {'manufacturer_name': ['Zhejiang iColor Biotech Co., Ltd'],\n",
       "   'rxcui': ['1305100'],\n",
       "   'spl_set_id': ['b5577617-e0bb-7381-e053-2a95a90a5568'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '0fb44d72-fdb1-4341-e063-6294a90ae9cf',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20201205',\n",
       "  'product_id': '74934-073_0fb44d72-fdb1-4341-e063-6294a90ae9cf',\n",
       "  'application_number': '505G(a)(3)',\n",
       "  'brand_name_base': 'Med X Frontline Advanced Hand Sanitizer with Moisturizers and Vitamin E'},\n",
       " {'product_ndc': '0597-0182',\n",
       "  'generic_name': 'empagliflozin and linagliptin',\n",
       "  'labeler_name': 'Boehringer Ingelheim Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Glyxambi',\n",
       "  'active_ingredients': [{'name': 'EMPAGLIFLOZIN', 'strength': '10 mg/1'},\n",
       "   {'name': 'LINAGLIPTIN', 'strength': '5 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0597-0182-07',\n",
       "    'description': '1 BOTTLE in 1 CARTON (0597-0182-07)  / 7 TABLET, FILM COATED in 1 BOTTLE',\n",
       "    'marketing_start_date': '20150130',\n",
       "    'marketing_end_date': '20260131',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0597-0182-30',\n",
       "    'description': '30 TABLET, FILM COATED in 1 BOTTLE (0597-0182-30)',\n",
       "    'marketing_start_date': '20150130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0597-0182-39',\n",
       "    'description': '30 BLISTER PACK in 1 CARTON (0597-0182-39)  / 1 TABLET, FILM COATED in 1 BLISTER PACK',\n",
       "    'marketing_start_date': '20150130',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0597-0182-90',\n",
       "    'description': '90 TABLET, FILM COATED in 1 BOTTLE (0597-0182-90)',\n",
       "    'marketing_start_date': '20150130',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Boehringer Ingelheim Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['1602109', '1602115', '1602118', '1602120'],\n",
       "   'spl_set_id': ['ddbab689-f76c-488c-9613-4168d41dd730'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175912', 'N0000175913', 'N0000187059', 'N0000187058'],\n",
       "   'pharm_class_moa': ['Dipeptidyl Peptidase 4 Inhibitors [MoA]',\n",
       "    'Sodium-Glucose Transporter 2 Inhibitors [MoA]'],\n",
       "   'pharm_class_epc': ['Dipeptidyl Peptidase 4 Inhibitor [EPC]',\n",
       "    'Sodium-Glucose Cotransporter 2 Inhibitor [EPC]'],\n",
       "   'unii': ['3X29ZEJ4R2', 'HDC1R2M35U']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET, FILM COATED',\n",
       "  'spl_id': '19598884-b178-444f-85f1-9337a4635d3e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20150130',\n",
       "  'product_id': '0597-0182_19598884-b178-444f-85f1-9337a4635d3e',\n",
       "  'application_number': 'NDA206073',\n",
       "  'brand_name_base': 'Glyxambi',\n",
       "  'pharm_class': ['Dipeptidyl Peptidase 4 Inhibitor [EPC]',\n",
       "   'Dipeptidyl Peptidase 4 Inhibitors [MoA]',\n",
       "   'Sodium-Glucose Cotransporter 2 Inhibitor [EPC]',\n",
       "   'Sodium-Glucose Transporter 2 Inhibitors [MoA]']},\n",
       " {'product_ndc': '75052-001',\n",
       "  'generic_name': 'Hepatitis B Vaccine (Recombinant)',\n",
       "  'labeler_name': 'VBI Vaccines (Delaware) Inc.',\n",
       "  'brand_name': 'PREHEVBRIO',\n",
       "  'active_ingredients': [{'name': 'RECOMBINANT HEPATITIS B SURFACE ANTIGEN (ISOFORM L)',\n",
       "    'strength': '.6 ug/mL'},\n",
       "   {'name': 'RECOMBINANT HEPATITIS B SURFACE ANTIGEN (ISOFORM M)',\n",
       "    'strength': '1.1 ug/mL'},\n",
       "   {'name': 'RECOMBINANT HEPATITIS B SURFACE ANTIGEN (ISOFORM S)',\n",
       "    'strength': '10 ug/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75052-001-10',\n",
       "    'description': '10 VIAL, GLASS in 1 CARTON (75052-001-10)  / 1 mL in 1 VIAL, GLASS (75052-001-01)',\n",
       "    'marketing_start_date': '20220302',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'INJECTION, SUSPENSION',\n",
       "  'spl_id': '101e3333-e418-e216-e063-6394a90a7c2b',\n",
       "  'product_type': 'VACCINE',\n",
       "  'route': ['INTRAMUSCULAR'],\n",
       "  'marketing_start_date': '20220302',\n",
       "  'product_id': '75052-001_101e3333-e418-e216-e063-6394a90a7c2b',\n",
       "  'application_number': 'BLA125737',\n",
       "  'brand_name_base': 'PREHEVBRIO'},\n",
       " {'product_ndc': '75053-0011',\n",
       "  'generic_name': 'Galphimia Glauca, Causticum, Eupatorium Perfoliatum, Ipecacuanha, Aconitum Napellus, Kali Bichromicum, Avena Sativa, Influenzinum (2021-2022), Lobelia Purpurescens, Anas Barbariae, Hepatis ET Cordis Extractum, Echinacea (Angustifolia), Canchalagua',\n",
       "  'labeler_name': 'Nucleic Products, LLC',\n",
       "  'brand_name': 'Influenseg',\n",
       "  'active_ingredients': [{'name': 'ACONITUM NAPELLUS WHOLE',\n",
       "    'strength': '9 [hp_X]/mL'},\n",
       "   {'name': 'AVENA SATIVA FLOWERING TOP', 'strength': '12 [hp_X]/mL'},\n",
       "   {'name': 'CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE',\n",
       "    'strength': '16 [hp_X]/mL'},\n",
       "   {'name': 'CAUSTICUM', 'strength': '6 [hp_X]/mL'},\n",
       "   {'name': 'ECHINACEA ANGUSTIFOLIA WHOLE', 'strength': '3 [hp_C]/mL'},\n",
       "   {'name': 'EUPATORIUM PERFOLIATUM FLOWERING TOP', 'strength': '6 [hp_X]/mL'},\n",
       "   {'name': 'GALPHIMIA GLAUCA FLOWERING TOP', 'strength': '4 [hp_X]/mL'},\n",
       "   {'name': 'INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'strength': '12 [hp_X]/mL'},\n",
       "   {'name': 'INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'strength': '12 [hp_X]/mL'},\n",
       "   {'name': 'INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'strength': '12 [hp_X]/mL'},\n",
       "   {'name': 'INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'strength': '12 [hp_X]/mL'},\n",
       "   {'name': 'IPECAC', 'strength': '6 [hp_X]/mL'},\n",
       "   {'name': 'POTASSIUM DICHROMATE', 'strength': '9 [hp_X]/mL'},\n",
       "   {'name': 'PRATIA PURPURASCENS', 'strength': '16 [hp_X]/mL'},\n",
       "   {'name': 'ZELTNERA VENUSTA WHOLE FLOWERING', 'strength': '30 [hp_C]/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75053-0011-1',\n",
       "    'description': '118 mL in 1 BOTTLE, DROPPER (75053-0011-1)',\n",
       "    'marketing_start_date': '20220620',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Nucleic Products, LLC'],\n",
       "   'spl_set_id': ['48a07004-5b52-4be6-ac88-55725da06931'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['U0NQ8555JD',\n",
       "    'MA9CQJ3F7F',\n",
       "    'RN2HC612GY',\n",
       "    'DD5FO1WKFU',\n",
       "    'VB06AV5US8',\n",
       "    '1W0775VX6E',\n",
       "    '93PH5Q8M7E',\n",
       "    'V529EJB2CX',\n",
       "    'WD5E5VYM2E',\n",
       "    'B93BQX9789',\n",
       "    'VEH9U90EHX',\n",
       "    '62I3C8233L',\n",
       "    'T4423S18FM',\n",
       "    '901NKD188B',\n",
       "    'H93GMC21MW']},\n",
       "  'marketing_category': 'UNAPPROVED HOMEOPATHIC',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': 'df11f289-cd1d-4b8f-90da-3a00ae452e82',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20220620',\n",
       "  'product_id': '75053-0011_df11f289-cd1d-4b8f-90da-3a00ae452e82',\n",
       "  'brand_name_base': 'Influenseg'},\n",
       " {'product_ndc': '75065-019',\n",
       "  'generic_name': 'POTASSIUM NITRATE, SODIUM FLUORIDE',\n",
       "  'labeler_name': 'Made By Dentists, Inc.',\n",
       "  'brand_name': 'Made By Dentists, Inc. Rebuilding',\n",
       "  'active_ingredients': [{'name': 'POTASSIUM NITRATE', 'strength': '5 g/100g'},\n",
       "   {'name': 'SODIUM FLUORIDE', 'strength': '.24 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75065-019-06',\n",
       "    'description': '1 TUBE in 1 CARTON (75065-019-06)  / 120 g in 1 TUBE',\n",
       "    'marketing_start_date': '20230124',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Made By Dentists, Inc.'],\n",
       "   'rxcui': ['1038929'],\n",
       "   'spl_set_id': ['d85f52ca-6339-4ec2-a910-61ddca91a21d'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['RU45X2JN0Z', '8ZYQ1474W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'PASTE',\n",
       "  'spl_id': 'f3834bf9-126a-5d0d-e053-2995a90a9f93',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['DENTAL'],\n",
       "  'marketing_start_date': '20230124',\n",
       "  'product_id': '75065-019_f3834bf9-126a-5d0d-e053-2995a90a9f93',\n",
       "  'application_number': 'part356',\n",
       "  'brand_name_base': 'Made By Dentists, Inc. Rebuilding'},\n",
       " {'product_ndc': '75109-512',\n",
       "  'generic_name': 'Alcohol',\n",
       "  'labeler_name': 'Kangna (Zhejiang) Medical Supplies Co., Ltd.',\n",
       "  'brand_name': 'Digcare Alcohol Wipes',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '75 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75109-512-01',\n",
       "    'description': '50 POUCH in 1 BAG (75109-512-01)  / 270 mL in 1 POUCH',\n",
       "    'marketing_start_date': '20200610',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Kangna (Zhejiang) Medical Supplies Co., Ltd.'],\n",
       "   'rxcui': ['1307051'],\n",
       "   'spl_set_id': ['a9d83763-dd65-5d30-e053-2995a90a1350'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0847432069621'],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'CLOTH',\n",
       "  'spl_id': 'd5877990-9eb3-474d-e053-2995a90aa842',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200610',\n",
       "  'product_id': '75109-512_d5877990-9eb3-474d-e053-2995a90aa842',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'Digcare Alcohol Wipes'},\n",
       " {'product_ndc': '75124-0005',\n",
       "  'generic_name': 'sodium chlorite',\n",
       "  'labeler_name': 'Pure O2',\n",
       "  'brand_name': 'Doctor GuardStick',\n",
       "  'active_ingredients': [{'name': 'SODIUM CHLORITE', 'strength': '5 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75124-0005-1',\n",
       "    'description': '9 g in 1 PACKAGE (75124-0005-1)',\n",
       "    'marketing_start_date': '20200401',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Pure O2'],\n",
       "   'spl_set_id': ['a39b49fd-9eac-73b4-e053-2995a90a180d'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['8809571411749'],\n",
       "   'unii': ['G538EBV4VF']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'LIQUID',\n",
       "  'spl_id': '0a4e3811-94d7-57dd-e063-6394a90af493',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200401',\n",
       "  'product_id': '75124-0005_0a4e3811-94d7-57dd-e063-6394a90af493',\n",
       "  'brand_name_base': 'Doctor GuardStick'},\n",
       " {'product_ndc': '75181-005',\n",
       "  'generic_name': 'SANITIZING WIPES',\n",
       "  'labeler_name': 'Jinhua Aidi Daily Chemical Co., Ltd.',\n",
       "  'brand_name': 'SANITIZING WIPES',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '.13 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75181-005-01',\n",
       "    'description': '30 PATCH in 1 PACKET (75181-005-01)  / 4.3 g in 1 PATCH',\n",
       "    'marketing_start_date': '20200717',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Jinhua Aidi Daily Chemical Co., Ltd.'],\n",
       "   'rxcui': ['1038558'],\n",
       "   'spl_set_id': ['aaa3e7bf-c1d2-5050-e053-2995a90a127e'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CLOTH',\n",
       "  'spl_id': '0f5cb787-b463-b6ae-e063-6394a90a705d',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200717',\n",
       "  'product_id': '75181-005_0f5cb787-b463-b6ae-e063-6394a90a705d',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'SANITIZING WIPES'},\n",
       " {'product_ndc': '75214-120',\n",
       "  'generic_name': 'Benzalkonium Chloride 0.13%',\n",
       "  'labeler_name': 'HANUL CO.,LTD',\n",
       "  'brand_name': 'SAN Skinlab Cloth Wet Wipes',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '.13 mg/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75214-120-01',\n",
       "    'description': '798 mL in 1 CANISTER (75214-120-01)',\n",
       "    'marketing_start_date': '20210412',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['HANUL CO.,LTD'],\n",
       "   'spl_set_id': ['c058d278-3d6d-7e3c-e053-2995a90a6c2f'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['F5UM2KM3W7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CLOTH',\n",
       "  'spl_id': '267ca018-fb82-c44e-e063-6394a90a42c9',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20210412',\n",
       "  'product_id': '75214-120_267ca018-fb82-c44e-e063-6394a90a42c9',\n",
       "  'application_number': 'M016',\n",
       "  'brand_name_base': 'SAN Skinlab Cloth Wet Wipes'},\n",
       " {'product_ndc': '0597-0300',\n",
       "  'generic_name': 'empagliflozin, metformin hydrochloride',\n",
       "  'labeler_name': 'Boehringer Ingelheim Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Synjardy XR',\n",
       "  'brand_name_suffix': 'XR',\n",
       "  'active_ingredients': [{'name': 'EMPAGLIFLOZIN', 'strength': '12.5 mg/1'},\n",
       "   {'name': 'METFORMIN HYDROCHLORIDE', 'strength': '1000 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0597-0300-20',\n",
       "    'description': '1 BOTTLE in 1 CARTON (0597-0300-20)  / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE',\n",
       "    'marketing_start_date': '20161210',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '0597-0300-45',\n",
       "    'description': '60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0300-45)',\n",
       "    'marketing_start_date': '20161210',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0597-0300-93',\n",
       "    'description': '180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0300-93)',\n",
       "    'marketing_start_date': '20161210',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Boehringer Ingelheim Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['1862685',\n",
       "    '1862688',\n",
       "    '1862691',\n",
       "    '1862692',\n",
       "    '1862695',\n",
       "    '1862697',\n",
       "    '1862700',\n",
       "    '1862701'],\n",
       "   'spl_set_id': ['8006ba29-ee3a-f852-a9bb-c8ec9b41cf66'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000187059', 'N0000187058'],\n",
       "   'pharm_class_epc': ['Sodium-Glucose Cotransporter 2 Inhibitor [EPC]'],\n",
       "   'pharm_class_moa': ['Sodium-Glucose Transporter 2 Inhibitors [MoA]'],\n",
       "   'unii': ['786Z46389E', 'HDC1R2M35U']},\n",
       "  'marketing_category': 'NDA',\n",
       "  'dosage_form': 'TABLET, EXTENDED RELEASE',\n",
       "  'spl_id': '988ca94a-e651-428e-bf37-40fd4a52ce57',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20161210',\n",
       "  'product_id': '0597-0300_988ca94a-e651-428e-bf37-40fd4a52ce57',\n",
       "  'application_number': 'NDA208658',\n",
       "  'brand_name_base': 'Synjardy',\n",
       "  'pharm_class': ['Biguanide [EPC]',\n",
       "   'Biguanides [CS]',\n",
       "   'Sodium-Glucose Cotransporter 2 Inhibitor [EPC]',\n",
       "   'Sodium-Glucose Transporter 2 Inhibitors [MoA]']},\n",
       " {'product_ndc': '75262-004',\n",
       "  'generic_name': 'Alcohol',\n",
       "  'labeler_name': 'ZheJiang Eshine Cosmetic Co Ltd',\n",
       "  'brand_name': 'Signature Care Hand Sanitizer Aloe Vera',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '70 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75262-004-01',\n",
       "    'description': '59 mL in 1 BOTTLE, SPRAY (75262-004-01)',\n",
       "    'marketing_start_date': '20200710',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['ZheJiang Eshine Cosmetic Co Ltd'],\n",
       "   'rxcui': ['1041849'],\n",
       "   'spl_set_id': ['a44242b9-82e5-4d16-a3bf-33a0504cd244'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '7bdf567f-1e38-4df9-8c95-a2084d25bc98',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200710',\n",
       "  'product_id': '75262-004_7bdf567f-1e38-4df9-8c95-a2084d25bc98',\n",
       "  'application_number': 'part333E',\n",
       "  'brand_name_base': 'Signature Care Hand Sanitizer Aloe Vera'},\n",
       " {'product_ndc': '75262-011',\n",
       "  'generic_name': 'Alcohol',\n",
       "  'labeler_name': 'ZheJiang Eshine Cosmetic Co Ltd',\n",
       "  'brand_name': 'Primal Elements Moisturizing Hand Sanitizer mist - Aloha Breeze',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '70 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75262-011-01',\n",
       "    'description': '45 mL in 1 BOTTLE, SPRAY (75262-011-01)',\n",
       "    'marketing_start_date': '20240821',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['ZheJiang Eshine Cosmetic Co Ltd'],\n",
       "   'rxcui': ['1041849'],\n",
       "   'spl_set_id': ['557a91d9-a632-4d92-b75d-d1f1182af890'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '202a702f-1bec-9db2-e063-6294a90a13fe',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240821',\n",
       "  'product_id': '75262-011_202a702f-1bec-9db2-e063-6294a90a13fe',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'Primal Elements Moisturizing Hand Sanitizer mist - Aloha Breeze'},\n",
       " {'product_ndc': '75262-012',\n",
       "  'generic_name': 'Alcohol',\n",
       "  'labeler_name': 'ZheJiang Eshine Cosmetic Co Ltd',\n",
       "  'brand_name': 'Primal Elements Moisturizing Hand Sanitizer mist - Coco Cabana',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '70 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75262-012-01',\n",
       "    'description': '45 mL in 1 BOTTLE, SPRAY (75262-012-01)',\n",
       "    'marketing_start_date': '20240821',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['ZheJiang Eshine Cosmetic Co Ltd'],\n",
       "   'rxcui': ['1041849'],\n",
       "   'spl_set_id': ['b30d7dac-91a4-46e7-a2e7-3954b3a9ce6d'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '202aee7e-c899-8312-e063-6294a90acfda',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240821',\n",
       "  'product_id': '75262-012_202aee7e-c899-8312-e063-6294a90acfda',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'Primal Elements Moisturizing Hand Sanitizer mist - Coco Cabana'},\n",
       " {'product_ndc': '0597-0375',\n",
       "  'generic_name': 'adalimumab-adbm',\n",
       "  'labeler_name': 'Boehringer Ingelheim Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Cyltezo',\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0597-0375-16',\n",
       "    'description': '6 KIT in 1 CARTON (0597-0375-16)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE *  2 PACKET in 1 TRAY / 1 mL in 1 PACKET',\n",
       "    'marketing_start_date': '20230701',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0597-0375-23',\n",
       "    'description': '4 KIT in 1 CARTON (0597-0375-23)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE *  2 PACKET in 1 TRAY / 1 mL in 1 PACKET',\n",
       "    'marketing_start_date': '20230701',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0597-0375-48',\n",
       "    'description': '1 KIT in 1 CARTON (0597-0375-48)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE *  2 PACKET in 1 TRAY / 1 mL in 1 PACKET',\n",
       "    'marketing_start_date': '20230701',\n",
       "    'sample': True},\n",
       "   {'package_ndc': '0597-0375-53',\n",
       "    'description': '1 KIT in 1 CARTON (0597-0375-53)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE *  2 PACKET in 1 TRAY / 1 mL in 1 PACKET',\n",
       "    'marketing_start_date': '20230701',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0597-0375-97',\n",
       "    'description': '2 KIT in 1 CARTON (0597-0375-97)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE *  2 PACKET in 1 TRAY / 1 mL in 1 PACKET',\n",
       "    'marketing_start_date': '20230701',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Boehringer Ingelheim Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['797544',\n",
       "    '2640883',\n",
       "    '2640889',\n",
       "    '2640891',\n",
       "    '2640892',\n",
       "    '2640893',\n",
       "    '2640894',\n",
       "    '2640895',\n",
       "    '2640898',\n",
       "    '2640900',\n",
       "    '2640901',\n",
       "    '2640902',\n",
       "    '2640903',\n",
       "    '2680743',\n",
       "    '2680746',\n",
       "    '2680748',\n",
       "    '2680750',\n",
       "    '2680756',\n",
       "    '2680757',\n",
       "    '2680759',\n",
       "    '2680760'],\n",
       "   'spl_set_id': ['115ea79b-7209-7f19-b35d-36ec0828fbf5'],\n",
       "   'is_original_packager': [True]},\n",
       "  'marketing_category': 'BLA',\n",
       "  'dosage_form': 'KIT',\n",
       "  'spl_id': 'b9a21704-58a7-4806-beab-2518b7a3e6fc',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'marketing_start_date': '20230701',\n",
       "  'product_id': '0597-0375_b9a21704-58a7-4806-beab-2518b7a3e6fc',\n",
       "  'application_number': 'BLA761058',\n",
       "  'brand_name_base': 'Cyltezo'},\n",
       " {'product_ndc': '75568-017',\n",
       "  'generic_name': 'LIDOCAINE, MENTHOL',\n",
       "  'labeler_name': 'Planet (Anhui) Pharmaceutical Co., Ltd.',\n",
       "  'brand_name': 'Careland Plantar Fasciitis Hydrogel Pain Patches',\n",
       "  'active_ingredients': [{'name': 'LIDOCAINE', 'strength': '40 mg/g'},\n",
       "   {'name': 'MENTHOL', 'strength': '10 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75568-017-01',\n",
       "    'description': '8 POUCH in 1 BOX (75568-017-01)  / 3 g in 1 POUCH',\n",
       "    'marketing_start_date': '20240810',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Planet (Anhui) Pharmaceutical Co., Ltd.'],\n",
       "   'rxcui': ['1249758'],\n",
       "   'spl_set_id': ['0e2f29c2-2e95-4be0-b7e9-f1761a1321a5'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000175682', 'M0000897', 'N0000175426', 'N0000175976'],\n",
       "   'pharm_class_epc': ['Amide Local Anesthetic [EPC]', 'Antiarrhythmic [EPC]'],\n",
       "   'pharm_class_cs': ['Amides [CS]'],\n",
       "   'pharm_class_pe': ['Local Anesthesia [PE]'],\n",
       "   'unii': ['98PI200987', 'L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'PATCH',\n",
       "  'spl_id': '203098fc-f8d5-c065-e063-6294a90aba56',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240810',\n",
       "  'product_id': '75568-017_203098fc-f8d5-c065-e063-6294a90aba56',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Careland Plantar Fasciitis Hydrogel Pain Patches',\n",
       "  'pharm_class': ['Amide Local Anesthetic [EPC]',\n",
       "   'Amides [CS]',\n",
       "   'Antiarrhythmic [EPC]',\n",
       "   'Local Anesthesia [PE]']},\n",
       " {'product_ndc': '75638-010',\n",
       "  'generic_name': 'MENTHOL, CAMPHOR (SYNTHETIC)',\n",
       "  'labeler_name': 'Dynamic Blending Specialists, Inc.',\n",
       "  'brand_name': 'Doctor Hoys Pain Relief Gel',\n",
       "  'active_ingredients': [{'name': 'CAMPHOR (SYNTHETIC)',\n",
       "    'strength': '50 mg/mL'},\n",
       "   {'name': 'MENTHOL', 'strength': '50 mg/mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75638-010-00',\n",
       "    'description': '89 mL in 1 TUBE (75638-010-00)',\n",
       "    'marketing_start_date': '20230301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '75638-010-01',\n",
       "    'description': '177 mL in 1 TUBE (75638-010-01)',\n",
       "    'marketing_start_date': '20230301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '75638-010-02',\n",
       "    'description': '946 mL in 1 TUBE (75638-010-02)',\n",
       "    'marketing_start_date': '20230301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '75638-010-03',\n",
       "    'description': '1893 mL in 1 TUBE (75638-010-03)',\n",
       "    'marketing_start_date': '20230301',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Dynamic Blending Specialists, Inc.'],\n",
       "   'rxcui': ['797500'],\n",
       "   'spl_set_id': ['50123bb9-d5d8-4ba6-ab94-8ed95fe0f5a8'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['5TJD82A1ET', 'L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '0d0d2163-f953-ccff-e063-6394a90a5d60',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230301',\n",
       "  'product_id': '75638-010_0d0d2163-f953-ccff-e063-6394a90a5d60',\n",
       "  'application_number': 'M017',\n",
       "  'brand_name_base': 'Doctor Hoys Pain Relief Gel'},\n",
       " {'product_ndc': '75670-003',\n",
       "  'generic_name': 'BENZALKONIUM CHLORIDE,Didecyldimonium Chloride',\n",
       "  'labeler_name': 'SHANGHAI SANJUN GENERAL MERCHANDISE CO., LTD.',\n",
       "  'brand_name': 'SANITIZING WIPES',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '.1 g/100g'},\n",
       "   {'name': 'DIDECYLDIMONIUM CHLORIDE', 'strength': '.15 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75670-003-02',\n",
       "    'description': '24 BAG in 1 CARTON (75670-003-02)  / 50 POUCH in 1 BAG / .0078 g in 1 POUCH',\n",
       "    'marketing_start_date': '20200609',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['SHANGHAI SANJUN GENERAL MERCHANDISE CO., LTD.'],\n",
       "   'spl_set_id': ['a7a7ea81-d9f5-6d06-e053-2a95a90a1512'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0852957004996'],\n",
       "   'unii': ['F5UM2KM3W7', 'JXN40O9Y9B']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'CLOTH',\n",
       "  'spl_id': 'd8c0d4f2-21e0-1609-e053-2995a90aed15',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20200609',\n",
       "  'product_id': '75670-003_d8c0d4f2-21e0-1609-e053-2995a90aed15',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': 'SANITIZING WIPES'},\n",
       " {'product_ndc': '75670-010',\n",
       "  'generic_name': 'BENZALKONIUM CHLORIDE',\n",
       "  'labeler_name': 'SHANGHAI SANJUN GENERAL MERCHANDISE CO., LTD.',\n",
       "  'brand_name': '30 soft wipes',\n",
       "  'active_ingredients': [{'name': 'BENZALKONIUM CHLORIDE',\n",
       "    'strength': '.1 g/100g'},\n",
       "   {'name': 'DIDECYLDIMONIUM CHLORIDE', 'strength': '.15 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75670-010-01',\n",
       "    'description': '36 BAG in 1 CARTON (75670-010-01)  / 30 PACKAGE in 1 BAG / .0105 g in 1 PACKAGE',\n",
       "    'marketing_start_date': '20221208',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['SHANGHAI SANJUN GENERAL MERCHANDISE CO., LTD.'],\n",
       "   'spl_set_id': ['ef5d4e16-f8f4-7c59-e053-2995a90ae1ad'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0194359352863'],\n",
       "   'unii': ['F5UM2KM3W7', 'JXN40O9Y9B']},\n",
       "  'marketing_category': 'OTC MONOGRAPH NOT FINAL',\n",
       "  'dosage_form': 'CLOTH',\n",
       "  'spl_id': 'ef5d3884-9b29-8563-e053-2a95a90aeb1a',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20221208',\n",
       "  'product_id': '75670-010_ef5d3884-9b29-8563-e053-2a95a90aeb1a',\n",
       "  'application_number': 'part333A',\n",
       "  'brand_name_base': '30 soft wipes'},\n",
       " {'product_ndc': '75712-021',\n",
       "  'generic_name': 'MENTHOL',\n",
       "  'labeler_name': 'Dollar General Corporation',\n",
       "  'brand_name': 'Cough Drops Dollar General Menthol 80ct',\n",
       "  'active_ingredients': [{'name': 'MENTHOL', 'strength': '5.4 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75712-021-01',\n",
       "    'description': '6 BAG in 1 CARTON (75712-021-01)  / 80 LOZENGE in 1 BAG',\n",
       "    'marketing_start_date': '20230721',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Dollar General Corporation'],\n",
       "   'rxcui': ['485287'],\n",
       "   'spl_set_id': ['773f4ad2-6c91-431f-ad3d-c0e53e7ca918'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0072084068047'],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'LOZENGE',\n",
       "  'spl_id': 'ff21cb2f-fc13-cddd-e053-6294a90a8bdf',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230721',\n",
       "  'product_id': '75712-021_ff21cb2f-fc13-cddd-e053-6294a90a8bdf',\n",
       "  'application_number': 'part341',\n",
       "  'brand_name_base': 'Cough Drops Dollar General Menthol 80ct'},\n",
       " {'product_ndc': '75712-022',\n",
       "  'generic_name': 'MENTHOL',\n",
       "  'labeler_name': 'Dollar General Corporation',\n",
       "  'brand_name': 'Cough Drops Dollar General Strawberry 30ct',\n",
       "  'active_ingredients': [{'name': 'MENTHOL', 'strength': '2.7 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75712-022-01',\n",
       "    'description': '9 BAG in 1 CARTON (75712-022-01)  / 30 LOZENGE in 1 BAG',\n",
       "    'marketing_start_date': '20230721',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Dollar General Corporation'],\n",
       "   'rxcui': ['433196'],\n",
       "   'spl_set_id': ['7d2f3292-bb73-41dc-9729-edb83670be1b'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0072084068030'],\n",
       "   'unii': ['L7T10EIP3A']},\n",
       "  'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       "  'dosage_form': 'LOZENGE',\n",
       "  'spl_id': 'ff3718a6-f55c-70aa-e053-6294a90a541e',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230721',\n",
       "  'product_id': '75712-022_ff3718a6-f55c-70aa-e053-6294a90a541e',\n",
       "  'application_number': 'part341',\n",
       "  'brand_name_base': 'Cough Drops Dollar General Strawberry 30ct'},\n",
       " {'product_ndc': '75712-036',\n",
       "  'generic_name': 'MENTHOL',\n",
       "  'labeler_name': 'Dollar General Corporation',\n",
       "  'brand_name': 'Cough Drops Dollar General Strawberry 30ct',\n",
       "  'active_ingredients': [{'name': 'LEVOMENTHOL', 'strength': '2.7 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75712-036-01',\n",
       "    'description': '9 BAG in 1 CARTON (75712-036-01)  / 30 LOZENGE in 1 BAG',\n",
       "    'marketing_start_date': '20240315',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Dollar General Corporation'],\n",
       "   'spl_set_id': ['2b3fbab9-92b5-42a7-b27b-ff46350ce055'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['BZ1R15MTK7']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'LOZENGE',\n",
       "  'spl_id': '1378c5f5-4afa-7177-e063-6294a90adba6',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240315',\n",
       "  'product_id': '75712-036_1378c5f5-4afa-7177-e063-6294a90adba6',\n",
       "  'application_number': 'M012',\n",
       "  'brand_name_base': 'Cough Drops Dollar General Strawberry 30ct'},\n",
       " {'product_ndc': '75712-944',\n",
       "  'generic_name': 'Avobenzone, Homosalate, Octisalate',\n",
       "  'labeler_name': 'Old East Main Co.',\n",
       "  'brand_name': 'Avobenzone, Homosalate, Octisalate',\n",
       "  'active_ingredients': [{'name': 'AVOBENZONE', 'strength': '30 mg/g'},\n",
       "   {'name': 'HOMOSALATE', 'strength': '120 mg/g'},\n",
       "   {'name': 'OCTISALATE', 'strength': '50 mg/g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75712-944-39',\n",
       "    'description': '312 g in 1 CAN (75712-944-39)',\n",
       "    'marketing_start_date': '20230808',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Old East Main Co.'],\n",
       "   'spl_set_id': ['1a53d8d5-e650-4825-8a3b-7cf42c36e3e5'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['G63QQF2NOX', 'V06SV4M95S', '4X49Y0596W']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'SPRAY',\n",
       "  'spl_id': '24393f7a-5e09-900d-e063-6394a90a04ad',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20230808',\n",
       "  'product_id': '75712-944_24393f7a-5e09-900d-e063-6394a90a04ad',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'Avobenzone, Homosalate, Octisalate'},\n",
       " {'product_ndc': '75742-033',\n",
       "  'generic_name': 'Ethyl Alcohol',\n",
       "  'labeler_name': 'Zhejiang Guoyao Jingyue Aerosol Co., Ltd.',\n",
       "  'brand_name': 'AMORAY 70% ETHYL ALCOHOL HAND SANITIZER FRESH CITRUS',\n",
       "  'active_ingredients': [{'name': 'ALCOHOL', 'strength': '70 mL/100mL'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75742-033-01',\n",
       "    'description': '53 mL in 1 BOTTLE (75742-033-01)',\n",
       "    'marketing_start_date': '20240708',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Zhejiang Guoyao Jingyue Aerosol Co., Ltd.'],\n",
       "   'rxcui': ['581662'],\n",
       "   'spl_set_id': ['1cb4316d-c8c6-3fa2-e063-6394a90a23d2'],\n",
       "   'is_original_packager': [True],\n",
       "   'unii': ['3K9958V90M']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'GEL',\n",
       "  'spl_id': '1cb4316d-c8c7-3fa2-e063-6394a90a23d2',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240708',\n",
       "  'product_id': '75742-033_1cb4316d-c8c7-3fa2-e063-6394a90a23d2',\n",
       "  'application_number': 'M003',\n",
       "  'brand_name_base': 'AMORAY 70% ETHYL ALCOHOL HAND SANITIZER FRESH CITRUS'},\n",
       " {'product_ndc': '75779-007',\n",
       "  'generic_name': 'SUNSCREEN',\n",
       "  'labeler_name': 'GUANG DONG 3 INS TECHNOLOGY Co., Ltd',\n",
       "  'brand_name': 'GHH INVISIBLE PROTECTION DAILY SUNSCREEN',\n",
       "  'active_ingredients': [{'name': 'OCTOCRYLENE', 'strength': '8 g/100g'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75779-007-01',\n",
       "    'description': '50 g in 1 BOTTLE (75779-007-01)',\n",
       "    'marketing_start_date': '20240618',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['GUANG DONG 3 INS TECHNOLOGY Co., Ltd'],\n",
       "   'spl_set_id': ['1b244bdb-a6fa-98e7-e063-6394a90aa653'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['6971690930028'],\n",
       "   'unii': ['5A68WGF6WM']},\n",
       "  'marketing_category': 'OTC MONOGRAPH DRUG',\n",
       "  'dosage_form': 'CREAM',\n",
       "  'spl_id': '1b244bdb-a6fb-98e7-e063-6394a90aa653',\n",
       "  'product_type': 'HUMAN OTC DRUG',\n",
       "  'route': ['TOPICAL'],\n",
       "  'marketing_start_date': '20240618',\n",
       "  'product_id': '75779-007_1b244bdb-a6fb-98e7-e063-6394a90aa653',\n",
       "  'application_number': 'M020',\n",
       "  'brand_name_base': 'GHH INVISIBLE PROTECTION DAILY SUNSCREEN'},\n",
       " {'product_ndc': '75826-137',\n",
       "  'generic_name': 'Phenobarbital',\n",
       "  'labeler_name': 'WINDER LABORATORIES, LLC',\n",
       "  'dea_schedule': 'CIV',\n",
       "  'brand_name': 'Phenobarbital',\n",
       "  'active_ingredients': [{'name': 'PHENOBARBITAL', 'strength': '16.2 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75826-137-00',\n",
       "    'description': '1000 TABLET in 1 BOTTLE, PLASTIC (75826-137-00)',\n",
       "    'marketing_start_date': '20190611',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '75826-137-10',\n",
       "    'description': '100 TABLET in 1 BOTTLE, PLASTIC (75826-137-10)',\n",
       "    'marketing_start_date': '20190611',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['WINDER LABORATORIES, LLC'],\n",
       "   'rxcui': ['198083',\n",
       "    '198086',\n",
       "    '198089',\n",
       "    '199164',\n",
       "    '199167',\n",
       "    '199168',\n",
       "    '312357',\n",
       "    '312362'],\n",
       "   'spl_set_id': ['1805bc08-e870-4373-b290-bed1eed87df6'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0375826140101', '0375826143102'],\n",
       "   'unii': ['YQE403BP4D']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'TABLET',\n",
       "  'spl_id': 'e053b26d-dbad-d075-e053-2995a90afc77',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190611',\n",
       "  'product_id': '75826-137_e053b26d-dbad-d075-e053-2995a90afc77',\n",
       "  'brand_name_base': 'Phenobarbital'},\n",
       " {'product_ndc': '75826-165',\n",
       "  'generic_name': 'Sodium Fluoride',\n",
       "  'labeler_name': 'WINDER LABORATORIES, LLC',\n",
       "  'brand_name': 'Fluoride',\n",
       "  'active_ingredients': [{'name': 'SODIUM FLUORIDE', 'strength': '1 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '75826-165-20',\n",
       "    'description': '120 TABLET, CHEWABLE in 1 BOTTLE (75826-165-20)',\n",
       "    'marketing_start_date': '20240101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['WINDER LABORATORIES, LLC'],\n",
       "   'rxcui': ['198215', '313036', '315213'],\n",
       "   'spl_set_id': ['0df8f1aa-f3ef-9f59-e063-6294a90a0666'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0375826165203', '0375826163209', '0375826164206'],\n",
       "   'unii': ['8ZYQ1474W7']},\n",
       "  'marketing_category': 'UNAPPROVED DRUG OTHER',\n",
       "  'dosage_form': 'TABLET, CHEWABLE',\n",
       "  'spl_id': '0df8f1aa-f3f0-9f59-e063-6294a90a0666',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240101',\n",
       "  'product_id': '75826-165_0df8f1aa-f3f0-9f59-e063-6294a90a0666',\n",
       "  'brand_name_base': 'Fluoride'},\n",
       " ...]"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data[\"results\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'product_ndc': '71335-1999',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-1999-1',\n",
       "    'description': '10 CAPSULE in 1 BOTTLE (71335-1999-1)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-2',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71335-1999-2)',\n",
       "    'marketing_start_date': '20211123',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-3',\n",
       "    'description': '7 CAPSULE in 1 BOTTLE (71335-1999-3)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-4',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71335-1999-4)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-5',\n",
       "    'description': '20 CAPSULE in 1 BOTTLE (71335-1999-5)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-6',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (71335-1999-6)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-7',\n",
       "    'description': '180 CAPSULE in 1 BOTTLE (71335-1999-7)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-1999-8',\n",
       "    'description': '28 CAPSULE in 1 BOTTLE (71335-1999-8)',\n",
       "    'marketing_start_date': '20240403',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198108'],\n",
       "   'spl_set_id': ['99351f77-46b8-4741-9193-1a6d6a7b0b18'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'a3dbc27d-e958-4092-abee-2b77950b342c',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170801',\n",
       "  'product_id': '71335-1999_a3dbc27d-e958-4092-abee-2b77950b342c',\n",
       "  'application_number': 'ANDA208340',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72189-350',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Direct_Rx',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72189-350-60',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (72189-350-60)',\n",
       "    'marketing_start_date': '20230427',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Direct_Rx'],\n",
       "   'rxcui': ['198108'],\n",
       "   'spl_set_id': ['fa56b439-893d-003e-e053-6294a90a865b'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'fa56b439-893e-003e-e053-6294a90a865b',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20230427',\n",
       "  'product_id': '72189-350_fa56b439-893e-003e-e053-6294a90a865b',\n",
       "  'application_number': 'ANDA210347',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '17337-0538',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Olon SpA',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM'}],\n",
       "  'finished': False,\n",
       "  'packaging': [],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'BULK INGREDIENT',\n",
       "  'dosage_form': 'POWDER',\n",
       "  'spl_id': '9e6092e4-3dff-3851-e053-2a95a90a0627',\n",
       "  'product_type': 'BULK INGREDIENT',\n",
       "  'marketing_start_date': '20170405',\n",
       "  'product_id': '17337-0538_9e6092e4-3dff-3851-e053-2a95a90a0627',\n",
       "  'brand_name_base': None},\n",
       " {'product_ndc': '53747-044',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Unichem Laboratories Limited, India',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '1 kg/kg'}],\n",
       "  'finished': False,\n",
       "  'packaging': [{'package_ndc': '53747-044-00',\n",
       "    'description': '1 BAG in 1 DRUM (53747-044-00)  / 50 kg in 1 BAG',\n",
       "    'marketing_start_date': '28-MAR-14'}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'BULK INGREDIENT',\n",
       "  'dosage_form': 'POWDER',\n",
       "  'spl_id': '6e3c28ee-a520-44f5-8acc-2f3dc8113ddd',\n",
       "  'product_type': 'BULK INGREDIENT',\n",
       "  'marketing_start_date': '20140328',\n",
       "  'product_id': '53747-044_6e3c28ee-a520-44f5-8acc-2f3dc8113ddd',\n",
       "  'brand_name_base': None},\n",
       " {'product_ndc': '0093-0756',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Teva Pharmaceuticals USA, Inc.',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0093-0756-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (0093-0756-01)',\n",
       "    'marketing_start_date': '19941019',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Teva Pharmaceuticals USA, Inc.'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['f1123fe1-b79c-430b-8548-08cd6e518482'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '389027d1-0d47-4715-b6c1-2747f4dae8e2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19941019',\n",
       "  'product_id': '0093-0756_389027d1-0d47-4715-b6c1-2747f4dae8e2',\n",
       "  'application_number': 'ANDA074131',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '29300-255',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Unichem Pharmaceuticals (USA), Inc.',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '29300-255-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE, PLASTIC (29300-255-01)',\n",
       "    'marketing_start_date': '20170801',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '29300-255-05',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE, PLASTIC (29300-255-05)',\n",
       "    'marketing_start_date': '20170801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Unichem Pharmaceuticals (USA), Inc.'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['69631088-2645-4cc9-9c64-a36111ab5d21'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0329300255010'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '77ea4fa8-c2a8-4a7f-be81-c56836939005',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170801',\n",
       "  'product_id': '29300-255_77ea4fa8-c2a8-4a7f-be81-c56836939005',\n",
       "  'application_number': 'ANDA208340',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '42543-115',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Vensun Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '42543-115-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE, PLASTIC (42543-115-01)',\n",
       "    'marketing_start_date': '20170928',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '42543-115-05',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE, PLASTIC (42543-115-05)',\n",
       "    'marketing_start_date': '20180723',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Vensun Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['18120467-c024-4d5a-8fcf-105e72a3e671'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0342543115019', '0342543114012'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'bceebd41-54dd-4a1e-b250-f1e460bb903d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170928',\n",
       "  'product_id': '42543-115_bceebd41-54dd-4a1e-b250-f1e460bb903d',\n",
       "  'application_number': 'ANDA206136',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '0093-0757',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Teva Pharmaceuticals USA, Inc.',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '0093-0757-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (0093-0757-01)',\n",
       "    'marketing_start_date': '19940126',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '0093-0757-05',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (0093-0757-05)',\n",
       "    'marketing_start_date': '19940126',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Teva Pharmaceuticals USA, Inc.'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['f1123fe1-b79c-430b-8548-08cd6e518482'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '389027d1-0d47-4715-b6c1-2747f4dae8e2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '19940126',\n",
       "  'product_id': '0093-0757_389027d1-0d47-4715-b6c1-2747f4dae8e2',\n",
       "  'application_number': 'ANDA074131',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '42571-177',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Micro Labs Limited',\n",
       "  'brand_name': 'PIROXICAM',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '42571-177-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (42571-177-01)',\n",
       "    'marketing_start_date': '20180301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '42571-177-05',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (42571-177-05)',\n",
       "    'marketing_start_date': '20180301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '42571-177-10',\n",
       "    'description': '1000 CAPSULE in 1 BOTTLE (42571-177-10)',\n",
       "    'marketing_start_date': '20180301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '42571-177-15',\n",
       "    'description': '15 CAPSULE in 1 BOTTLE (42571-177-15)',\n",
       "    'marketing_start_date': '20180301',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Micro Labs Limited'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['a6335245-7e04-46b9-a505-f47647781e19'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0342571177010', '0342571176013'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '27e24dff-99a8-d5c1-e063-6394a90a936e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180301',\n",
       "  'product_id': '42571-177_27e24dff-99a8-d5c1-e063-6394a90a936e',\n",
       "  'application_number': 'ANDA206152',\n",
       "  'brand_name_base': 'PIROXICAM',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '64380-842',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Strides Pharma Science Limited',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '64380-842-06',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (64380-842-06)',\n",
       "    'marketing_start_date': '20180507',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Strides Pharma Science Limited'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['6039e036-c0aa-4249-af50-115f49ad758a'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'a5f97393-9508-44c8-8510-d8889a98e0f1',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180507',\n",
       "  'product_id': '64380-842_a5f97393-9508-44c8-8510-d8889a98e0f1',\n",
       "  'application_number': 'ANDA210347',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '64380-843',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Strides Pharma Science Limited',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '64380-843-06',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (64380-843-06)',\n",
       "    'marketing_start_date': '20180507',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '64380-843-07',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (64380-843-07)',\n",
       "    'marketing_start_date': '20180509',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Strides Pharma Science Limited'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['6039e036-c0aa-4249-af50-115f49ad758a'],\n",
       "   'is_original_packager': [True],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'a5f97393-9508-44c8-8510-d8889a98e0f1',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180507',\n",
       "  'product_id': '64380-843_a5f97393-9508-44c8-8510-d8889a98e0f1',\n",
       "  'application_number': 'ANDA210347',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '70771-1430',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Zydus Lifesciences Limited',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '70771-1430-0',\n",
       "    'description': '1000 CAPSULE in 1 BOTTLE (70771-1430-0)',\n",
       "    'marketing_start_date': '20190110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '70771-1430-1',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (70771-1430-1)',\n",
       "    'marketing_start_date': '20190110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '70771-1430-3',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (70771-1430-3)',\n",
       "    'marketing_start_date': '20190110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '70771-1430-4',\n",
       "    'description': '10 BLISTER PACK in 1 CARTON (70771-1430-4)  / 10 CAPSULE in 1 BLISTER PACK (70771-1430-2)',\n",
       "    'marketing_start_date': '20190110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '70771-1430-5',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (70771-1430-5)',\n",
       "    'marketing_start_date': '20190110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '70771-1430-9',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (70771-1430-9)',\n",
       "    'marketing_start_date': '20190110',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Zydus Lifesciences Limited'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['5e43b2f2-f3b7-4c07-b1c8-b04f4739d3d2'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0370771142934'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '85b5fc83-a71a-4b26-a788-91f3540456c0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190110',\n",
       "  'product_id': '70771-1430_85b5fc83-a71a-4b26-a788-91f3540456c0',\n",
       "  'application_number': 'ANDA205585',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '46438-0053',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Dipharma Francis Srl',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '1 kg/kg'}],\n",
       "  'finished': False,\n",
       "  'packaging': [{'package_ndc': '46438-0053-1',\n",
       "    'description': '25 kg in 1 DRUM (46438-0053-1)',\n",
       "    'marketing_start_date': '02-FEB-87'}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'BULK INGREDIENT',\n",
       "  'dosage_form': 'POWDER',\n",
       "  'spl_id': '29029196-e3e0-be43-e063-6394a90a304c',\n",
       "  'product_type': 'BULK INGREDIENT',\n",
       "  'marketing_start_date': '19870202',\n",
       "  'product_id': '46438-0053_29029196-e3e0-be43-e063-6394a90a304c',\n",
       "  'brand_name_base': None},\n",
       " {'product_ndc': '42291-674',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'AvKARE',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '42291-674-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (42291-674-01)',\n",
       "    'marketing_start_date': '20130627',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['AvKARE'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['3fa3d666-3154-23a7-1c69-915cd6f6a87c'],\n",
       "   'upc': ['0342291677012', '0342291674011'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '0e99334f-dd18-5853-e063-6294a90ad0f2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20130627',\n",
       "  'product_id': '42291-674_0e99334f-dd18-5853-e063-6294a90ad0f2',\n",
       "  'application_number': 'ANDA074131',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '42543-114',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Vensun Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '42543-114-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE, PLASTIC (42543-114-01)',\n",
       "    'marketing_start_date': '20170928',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Vensun Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['18120467-c024-4d5a-8fcf-105e72a3e671'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0342543115019', '0342543114012'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'bceebd41-54dd-4a1e-b250-f1e460bb903d',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170928',\n",
       "  'product_id': '42543-114_bceebd41-54dd-4a1e-b250-f1e460bb903d',\n",
       "  'application_number': 'ANDA206136',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72789-211',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-211-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE, PLASTIC (72789-211-01)',\n",
       "    'marketing_start_date': '20211027',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['923a81d7-78e7-48e9-901d-e3ce3539aba3'],\n",
       "   'upc': ['0372789211015', '0372789210018'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '240f0b4f-c4e5-9319-e063-6394a90a4680',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180507',\n",
       "  'product_id': '72789-211_240f0b4f-c4e5-9319-e063-6394a90a4680',\n",
       "  'application_number': 'ANDA210347',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '49452-5476',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Spectrum Laboratory Products, Inc.',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '1 g/g'}],\n",
       "  'finished': False,\n",
       "  'packaging': [{'package_ndc': '49452-5476-1',\n",
       "    'description': '5 g in 1 BOTTLE (49452-5476-1)',\n",
       "    'marketing_start_date': '01-MAY-96'},\n",
       "   {'package_ndc': '49452-5476-2',\n",
       "    'description': '25 g in 1 BOTTLE (49452-5476-2)',\n",
       "    'marketing_start_date': '01-MAY-96'},\n",
       "   {'package_ndc': '49452-5476-3',\n",
       "    'description': '100 g in 1 BOTTLE (49452-5476-3)',\n",
       "    'marketing_start_date': '01-MAY-96'},\n",
       "   {'package_ndc': '49452-5476-4',\n",
       "    'description': '1 g in 1 BOTTLE (49452-5476-4)',\n",
       "    'marketing_start_date': '01-MAY-96'},\n",
       "   {'package_ndc': '49452-5476-5',\n",
       "    'description': '1000 g in 1 BOTTLE (49452-5476-5)',\n",
       "    'marketing_start_date': '01-MAY-96'},\n",
       "   {'package_ndc': '49452-5476-6',\n",
       "    'description': '5000 g in 1 PAIL (49452-5476-6)',\n",
       "    'marketing_start_date': '01-MAY-96'}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'BULK INGREDIENT',\n",
       "  'dosage_form': 'POWDER',\n",
       "  'spl_id': '07dc69b9-a678-2134-e063-6394a90a332b',\n",
       "  'product_type': 'BULK INGREDIENT',\n",
       "  'marketing_start_date': '19960501',\n",
       "  'product_id': '49452-5476_07dc69b9-a678-2134-e063-6394a90a332b',\n",
       "  'brand_name_base': None},\n",
       " {'product_ndc': '59348-0014',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Nantong Jinghua Pharmaceutical Co., Ltd.',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '1 kg/kg'}],\n",
       "  'finished': False,\n",
       "  'packaging': [{'package_ndc': '59348-0014-1',\n",
       "    'description': '25 kg in 1 DRUM (59348-0014-1)',\n",
       "    'marketing_start_date': '14-NOV-16'}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'BULK INGREDIENT',\n",
       "  'dosage_form': 'POWDER',\n",
       "  'spl_id': '0ce7ed4a-c4cc-c999-e063-6394a90a9edd',\n",
       "  'product_type': 'BULK INGREDIENT',\n",
       "  'marketing_start_date': '20161114',\n",
       "  'product_id': '59348-0014_0ce7ed4a-c4cc-c999-e063-6394a90a9edd',\n",
       "  'brand_name_base': None},\n",
       " {'product_ndc': '29300-256',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Unichem Pharmaceuticals (USA), Inc.',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '29300-256-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE, PLASTIC (29300-256-01)',\n",
       "    'marketing_start_date': '20170801',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '29300-256-05',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE, PLASTIC (29300-256-05)',\n",
       "    'marketing_start_date': '20170801',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '29300-256-13',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE, PLASTIC (29300-256-13)',\n",
       "    'marketing_start_date': '20170801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {'manufacturer_name': ['Unichem Pharmaceuticals (USA), Inc.'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['69631088-2645-4cc9-9c64-a36111ab5d21'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0329300255010'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '77ea4fa8-c2a8-4a7f-be81-c56836939005',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170801',\n",
       "  'product_id': '29300-256_77ea4fa8-c2a8-4a7f-be81-c56836939005',\n",
       "  'application_number': 'ANDA208340',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '63187-972',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Proficient Rx LP',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '63187-972-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (63187-972-30)',\n",
       "    'marketing_start_date': '20180101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '63187-972-60',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (63187-972-60)',\n",
       "    'marketing_start_date': '20180101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '63187-972-90',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (63187-972-90)',\n",
       "    'marketing_start_date': '20180101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Proficient Rx LP'],\n",
       "   'rxcui': ['198108'],\n",
       "   'spl_set_id': ['4ef7293b-0bf6-48d3-86d5-5b204b2b7243'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': 'f937de38-3c64-4b91-bef4-59ba68dcaa05',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20161219',\n",
       "  'product_id': '63187-972_f937de38-3c64-4b91-bef4-59ba68dcaa05',\n",
       "  'application_number': 'ANDA207938',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '72789-210',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'PD-Rx Pharmaceuticals, Inc.',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '72789-210-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE, PLASTIC (72789-210-01)',\n",
       "    'marketing_start_date': '20211027',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['PD-Rx Pharmaceuticals, Inc.'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['923a81d7-78e7-48e9-901d-e3ce3539aba3'],\n",
       "   'upc': ['0372789211015', '0372789210018'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '240f0b4f-c4e5-9319-e063-6394a90a4680',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180507',\n",
       "  'product_id': '72789-210_240f0b4f-c4e5-9319-e063-6394a90a4680',\n",
       "  'application_number': 'ANDA210347',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '51927-0145',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Professional Compounding Centers of America',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '1 kg/kg'}],\n",
       "  'finished': False,\n",
       "  'packaging': [{'package_ndc': '51927-0145-0',\n",
       "    'description': '1 kg in 1 BOTTLE (51927-0145-0)',\n",
       "    'marketing_start_date': '15-JUN-21'}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING',\n",
       "  'dosage_form': 'POWDER',\n",
       "  'spl_id': '0e8b7f3c-4aee-53ca-e063-6394a90a3dcb',\n",
       "  'product_type': 'BULK INGREDIENT',\n",
       "  'marketing_start_date': '20210615',\n",
       "  'product_id': '51927-0145_0e8b7f3c-4aee-53ca-e063-6394a90a3dcb',\n",
       "  'brand_name_base': None},\n",
       " {'product_ndc': '71335-9622',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'PIROXICAM',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-9622-1',\n",
       "    'description': '10 CAPSULE in 1 BOTTLE (71335-9622-1)',\n",
       "    'marketing_start_date': '20230109',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9622-2',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71335-9622-2)',\n",
       "    'marketing_start_date': '20230109',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9622-3',\n",
       "    'description': '7 CAPSULE in 1 BOTTLE (71335-9622-3)',\n",
       "    'marketing_start_date': '20230109',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9622-4',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71335-9622-4)',\n",
       "    'marketing_start_date': '20230109',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9622-5',\n",
       "    'description': '20 CAPSULE in 1 BOTTLE (71335-9622-5)',\n",
       "    'marketing_start_date': '20230109',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9622-6',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (71335-9622-6)',\n",
       "    'marketing_start_date': '20230109',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9622-7',\n",
       "    'description': '180 CAPSULE in 1 BOTTLE (71335-9622-7)',\n",
       "    'marketing_start_date': '20230109',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-9622-8',\n",
       "    'description': '28 CAPSULE in 1 BOTTLE (71335-9622-8)',\n",
       "    'marketing_start_date': '20230109',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198108'],\n",
       "   'spl_set_id': ['8b8eb243-0efb-4777-b627-b7ae042f8823'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '01fb22ac-f887-431f-9e3c-b1498b5cee46',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180301',\n",
       "  'product_id': '71335-9622_01fb22ac-f887-431f-9e3c-b1498b5cee46',\n",
       "  'application_number': 'ANDA206152',\n",
       "  'brand_name_base': 'PIROXICAM',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '22365-114',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Arch Pharmalabs Limited',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '50 kg/50kg'}],\n",
       "  'finished': False,\n",
       "  'packaging': [{'package_ndc': '22365-114-14',\n",
       "    'description': '50 kg in 1 DRUM (22365-114-14)',\n",
       "    'marketing_start_date': '11-JAN-10'}],\n",
       "  'listing_expiration_date': '20241231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'BULK INGREDIENT',\n",
       "  'dosage_form': 'POWDER',\n",
       "  'spl_id': 'b0a7d056-06fe-4266-bc2f-14697d38b6ed',\n",
       "  'product_type': 'BULK INGREDIENT',\n",
       "  'marketing_start_date': '20100111',\n",
       "  'product_id': '22365-114_b0a7d056-06fe-4266-bc2f-14697d38b6ed',\n",
       "  'brand_name_base': None},\n",
       " {'product_ndc': '38779-0302',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Medisca Inc.',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '1 g/g'}],\n",
       "  'finished': False,\n",
       "  'packaging': [{'package_ndc': '38779-0302-3',\n",
       "    'description': '5 g in 1 BOTTLE, GLASS (38779-0302-3)',\n",
       "    'marketing_start_date': '18-AUG-14'},\n",
       "   {'package_ndc': '38779-0302-4',\n",
       "    'description': '25 g in 1 JAR (38779-0302-4)',\n",
       "    'marketing_start_date': '18-AUG-14'},\n",
       "   {'package_ndc': '38779-0302-5',\n",
       "    'description': '100 g in 1 JAR (38779-0302-5)',\n",
       "    'marketing_start_date': '18-AUG-14'},\n",
       "   {'package_ndc': '38779-0302-8',\n",
       "    'description': '500 g in 1 JAR (38779-0302-8)',\n",
       "    'marketing_start_date': '18-AUG-14'},\n",
       "   {'package_ndc': '38779-0302-9',\n",
       "    'description': '1000 g in 1 JAR (38779-0302-9)',\n",
       "    'marketing_start_date': '18-AUG-14'}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'BULK INGREDIENT',\n",
       "  'dosage_form': 'POWDER',\n",
       "  'spl_id': '25cc0794-f8c8-424c-e063-6294a90aef92',\n",
       "  'product_type': 'BULK INGREDIENT',\n",
       "  'marketing_start_date': '20140818',\n",
       "  'product_id': '38779-0302_25cc0794-f8c8-424c-e063-6294a90aef92',\n",
       "  'brand_name_base': None},\n",
       " {'product_ndc': '71205-203',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Proficient Rx LP',\n",
       "  'brand_name': 'PIROXICAM',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71205-203-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71205-203-30)',\n",
       "    'marketing_start_date': '20190101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71205-203-60',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71205-203-60)',\n",
       "    'marketing_start_date': '20190101',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71205-203-90',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (71205-203-90)',\n",
       "    'marketing_start_date': '20190101',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Proficient Rx LP'],\n",
       "   'rxcui': ['198108'],\n",
       "   'spl_set_id': ['b48a1615-23b5-4db7-bb96-cec551d227f6'],\n",
       "   'upc': ['0371205203306'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '4d359228-d271-4e40-81ad-e8acf35b224a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180301',\n",
       "  'product_id': '71205-203_4d359228-d271-4e40-81ad-e8acf35b224a',\n",
       "  'application_number': 'ANDA206152',\n",
       "  'brand_name_base': 'PIROXICAM',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '62991-1113',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'LETCO MEDICAL, LLC',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '1 g/g'}],\n",
       "  'finished': False,\n",
       "  'packaging': [{'package_ndc': '62991-1113-1',\n",
       "    'description': '5 g in 1 JAR (62991-1113-1)',\n",
       "    'marketing_start_date': '07-APR-11'},\n",
       "   {'package_ndc': '62991-1113-2',\n",
       "    'description': '25 g in 1 JAR (62991-1113-2)',\n",
       "    'marketing_start_date': '07-APR-11'},\n",
       "   {'package_ndc': '62991-1113-3',\n",
       "    'description': '100 g in 1 JAR (62991-1113-3)',\n",
       "    'marketing_start_date': '07-APR-11'},\n",
       "   {'package_ndc': '62991-1113-4',\n",
       "    'description': '500 g in 1 JAR (62991-1113-4)',\n",
       "    'marketing_start_date': '07-APR-11'}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING',\n",
       "  'dosage_form': 'POWDER',\n",
       "  'spl_id': '248846ab-c5b1-460f-9ea0-08b8976e4b1d',\n",
       "  'product_type': 'BULK INGREDIENT',\n",
       "  'marketing_start_date': '20110407',\n",
       "  'product_id': '62991-1113_248846ab-c5b1-460f-9ea0-08b8976e4b1d',\n",
       "  'brand_name_base': None},\n",
       " {'product_ndc': '42291-677',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'AvKARE',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '42291-677-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (42291-677-01)',\n",
       "    'marketing_start_date': '20130627',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '42291-677-50',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (42291-677-50)',\n",
       "    'marketing_start_date': '20130627',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['AvKARE'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['3fa3d666-3154-23a7-1c69-915cd6f6a87c'],\n",
       "   'upc': ['0342291677012', '0342291674011'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '0e99334f-dd18-5853-e063-6294a90ad0f2',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20130627',\n",
       "  'product_id': '42291-677_0e99334f-dd18-5853-e063-6294a90ad0f2',\n",
       "  'application_number': 'ANDA074131',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '42291-954',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'AvKARE',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '42291-954-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (42291-954-01)',\n",
       "    'marketing_start_date': '20240801',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '42291-954-50',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (42291-954-50)',\n",
       "    'marketing_start_date': '20240801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['AvKARE'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['1ea6042e-0090-df18-e063-6394a90a0a0a'],\n",
       "   'upc': ['0342291954014', '0342291953017'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '1ea63be3-2322-b603-e063-6294a90a2891',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240801',\n",
       "  'product_id': '42291-954_1ea63be3-2322-b603-e063-6294a90a2891',\n",
       "  'application_number': 'ANDA210347',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '71205-032',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Proficient Rx LP',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71205-032-30',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE, PLASTIC (71205-032-30)',\n",
       "    'marketing_start_date': '20180501',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71205-032-60',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE, PLASTIC (71205-032-60)',\n",
       "    'marketing_start_date': '20180501',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71205-032-90',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE, PLASTIC (71205-032-90)',\n",
       "    'marketing_start_date': '20180501',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Proficient Rx LP'],\n",
       "   'rxcui': ['198108'],\n",
       "   'spl_set_id': ['23972bf0-e5b8-4f4b-97d0-caa05d6b061c'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '66b45e6d-2ec9-43a9-bbaf-46c0a14fe1a6',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20170928',\n",
       "  'product_id': '71205-032_66b45e6d-2ec9-43a9-bbaf-46c0a14fe1a6',\n",
       "  'application_number': 'ANDA206136',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '42291-953',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'AvKARE',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '42291-953-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (42291-953-01)',\n",
       "    'marketing_start_date': '20240801',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['AvKARE'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['1ea6042e-0090-df18-e063-6394a90a0a0a'],\n",
       "   'upc': ['0342291954014', '0342291953017'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '1ea63be3-2322-b603-e063-6294a90a2891',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20240801',\n",
       "  'product_id': '42291-953_1ea63be3-2322-b603-e063-6294a90a2891',\n",
       "  'application_number': 'ANDA210347',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '70771-1429',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Zydus Lifesciences Limited',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '70771-1429-0',\n",
       "    'description': '1000 CAPSULE in 1 BOTTLE (70771-1429-0)',\n",
       "    'marketing_start_date': '20190110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '70771-1429-1',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (70771-1429-1)',\n",
       "    'marketing_start_date': '20190110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '70771-1429-3',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (70771-1429-3)',\n",
       "    'marketing_start_date': '20190110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '70771-1429-4',\n",
       "    'description': '10 BLISTER PACK in 1 CARTON (70771-1429-4)  / 10 CAPSULE in 1 BLISTER PACK (70771-1429-2)',\n",
       "    'marketing_start_date': '20190110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '70771-1429-5',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (70771-1429-5)',\n",
       "    'marketing_start_date': '20190110',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '70771-1429-9',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (70771-1429-9)',\n",
       "    'marketing_start_date': '20190110',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Zydus Lifesciences Limited'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['5e43b2f2-f3b7-4c07-b1c8-b04f4739d3d2'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0370771142934'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '85b5fc83-a71a-4b26-a788-91f3540456c0',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20190110',\n",
       "  'product_id': '70771-1429_85b5fc83-a71a-4b26-a788-91f3540456c0',\n",
       "  'application_number': 'ANDA205585',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '46438-0639',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Dipharma Francis Srl',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '1 kg/kg'}],\n",
       "  'finished': False,\n",
       "  'packaging': [{'package_ndc': '46438-0639-0',\n",
       "    'description': '25 kg in 1 DRUM (46438-0639-0)',\n",
       "    'marketing_start_date': '01-SEP-16'}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {},\n",
       "  'marketing_category': 'BULK INGREDIENT',\n",
       "  'dosage_form': 'POWDER',\n",
       "  'spl_id': '28fca0af-7689-df1a-e063-6394a90a5e28',\n",
       "  'product_type': 'BULK INGREDIENT',\n",
       "  'marketing_start_date': '20160901',\n",
       "  'product_id': '46438-0639_28fca0af-7689-df1a-e063-6394a90a5e28',\n",
       "  'brand_name_base': None},\n",
       " {'product_ndc': '42571-176',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Micro Labs Limited',\n",
       "  'brand_name': 'PIROXICAM',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '10 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '42571-176-01',\n",
       "    'description': '100 CAPSULE in 1 BOTTLE (42571-176-01)',\n",
       "    'marketing_start_date': '20180301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '42571-176-05',\n",
       "    'description': '500 CAPSULE in 1 BOTTLE (42571-176-05)',\n",
       "    'marketing_start_date': '20180301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '42571-176-10',\n",
       "    'description': '1000 CAPSULE in 1 BOTTLE (42571-176-10)',\n",
       "    'marketing_start_date': '20180301',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '42571-176-15',\n",
       "    'description': '15 CAPSULE in 1 BOTTLE (42571-176-15)',\n",
       "    'marketing_start_date': '20180301',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Micro Labs Limited'],\n",
       "   'rxcui': ['198107', '198108'],\n",
       "   'spl_set_id': ['a6335245-7e04-46b9-a505-f47647781e19'],\n",
       "   'is_original_packager': [True],\n",
       "   'upc': ['0342571177010', '0342571176013'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '27e24dff-99a8-d5c1-e063-6394a90a936e',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180301',\n",
       "  'product_id': '42571-176_27e24dff-99a8-d5c1-e063-6394a90a936e',\n",
       "  'application_number': 'ANDA206152',\n",
       "  'brand_name_base': 'PIROXICAM',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']},\n",
       " {'product_ndc': '71335-2067',\n",
       "  'generic_name': 'Piroxicam',\n",
       "  'labeler_name': 'Bryant Ranch Prepack',\n",
       "  'brand_name': 'Piroxicam',\n",
       "  'active_ingredients': [{'name': 'PIROXICAM', 'strength': '20 mg/1'}],\n",
       "  'finished': True,\n",
       "  'packaging': [{'package_ndc': '71335-2067-1',\n",
       "    'description': '10 CAPSULE in 1 BOTTLE (71335-2067-1)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2067-2',\n",
       "    'description': '30 CAPSULE in 1 BOTTLE (71335-2067-2)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2067-3',\n",
       "    'description': '7 CAPSULE in 1 BOTTLE (71335-2067-3)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2067-4',\n",
       "    'description': '60 CAPSULE in 1 BOTTLE (71335-2067-4)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2067-5',\n",
       "    'description': '20 CAPSULE in 1 BOTTLE (71335-2067-5)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2067-6',\n",
       "    'description': '90 CAPSULE in 1 BOTTLE (71335-2067-6)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2067-7',\n",
       "    'description': '180 CAPSULE in 1 BOTTLE (71335-2067-7)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False},\n",
       "   {'package_ndc': '71335-2067-8',\n",
       "    'description': '28 CAPSULE in 1 BOTTLE (71335-2067-8)',\n",
       "    'marketing_start_date': '20220329',\n",
       "    'sample': False}],\n",
       "  'listing_expiration_date': '20251231',\n",
       "  'openfda': {'manufacturer_name': ['Bryant Ranch Prepack'],\n",
       "   'rxcui': ['198108'],\n",
       "   'spl_set_id': ['7f5ea9e8-3942-4e84-b237-c38517a97a8e'],\n",
       "   'nui': ['N0000000160', 'M0001335', 'N0000175722'],\n",
       "   'pharm_class_moa': ['Cyclooxygenase Inhibitors [MoA]'],\n",
       "   'pharm_class_cs': ['Anti-Inflammatory Agents, Non-Steroidal [CS]'],\n",
       "   'pharm_class_epc': ['Nonsteroidal Anti-inflammatory Drug [EPC]'],\n",
       "   'unii': ['13T4O6VMAM']},\n",
       "  'marketing_category': 'ANDA',\n",
       "  'dosage_form': 'CAPSULE',\n",
       "  'spl_id': '0de24c80-65c2-44ee-8909-576f98e9ab5a',\n",
       "  'product_type': 'HUMAN PRESCRIPTION DRUG',\n",
       "  'route': ['ORAL'],\n",
       "  'marketing_start_date': '20180507',\n",
       "  'product_id': '71335-2067_0de24c80-65c2-44ee-8909-576f98e9ab5a',\n",
       "  'application_number': 'ANDA210347',\n",
       "  'brand_name_base': 'Piroxicam',\n",
       "  'pharm_class': ['Anti-Inflammatory Agents',\n",
       "   'Non-Steroidal [CS]',\n",
       "   'Cyclooxygenase Inhibitors [MoA]',\n",
       "   'Nonsteroidal Anti-inflammatory Drug [EPC]']}]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(filter(lambda x: 'generic_name' in x and x['generic_name'] == \"Piroxicam\", data[\"results\"]))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "manufacturers = data['results']\n",
    "manufacturers = filter(lambda x: 'manufacturer_name' in x['openfda'], manufacturers )\n",
    "manufacturers = list(map(lambda x: x['openfda']['manufacturer_name'][0], manufacturers))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "from collections import Counter\n",
    "\n",
    "c = Counter(manufacturers)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "7788"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(c.most_common())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Teraz bdziemy odpowiadali na pytanie jakie leki s najbardziej wpywowe.\n",
    "Zeby to zobaczy to ciekawe jest czy sa jakies powiznania miedzy tymi lekami.\n",
    "Ponizej mam liste lekw ktore maja taki sam generic name. Czy posortowanie ich\n",
    "w kolejnosci start marketing date da mi odpowiedz."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('Piroxicam',\n",
       "  datetime.datetime(1987, 2, 2, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Dipharma Francis Srl'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(1994, 1, 26, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Teva Pharmaceuticals USA, Inc.'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(1994, 10, 19, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Teva Pharmaceuticals USA, Inc.'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(1996, 5, 1, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Spectrum Laboratory Products, Inc.'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2010, 1, 11, 0, 0),\n",
       "  datetime.datetime(2024, 12, 31, 0, 0),\n",
       "  'Arch Pharmalabs Limited'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2011, 4, 7, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'LETCO MEDICAL, LLC'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2013, 6, 27, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'AvKARE'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2013, 6, 27, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'AvKARE'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2014, 3, 28, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Unichem Laboratories Limited, India'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2014, 8, 18, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Medisca Inc.'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2016, 9, 1, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Dipharma Francis Srl'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2016, 11, 14, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Nantong Jinghua Pharmaceutical Co., Ltd.'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2016, 12, 19, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Proficient Rx LP'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2017, 4, 5, 0, 0),\n",
       "  datetime.datetime(2024, 12, 31, 0, 0),\n",
       "  'Olon SpA'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2017, 8, 1, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Bryant Ranch Prepack'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2017, 8, 1, 0, 0),\n",
       "  datetime.datetime(2024, 12, 31, 0, 0),\n",
       "  'Unichem Pharmaceuticals (USA), Inc.'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2017, 8, 1, 0, 0),\n",
       "  datetime.datetime(2024, 12, 31, 0, 0),\n",
       "  'Unichem Pharmaceuticals (USA), Inc.'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2017, 9, 28, 0, 0),\n",
       "  datetime.datetime(2024, 12, 31, 0, 0),\n",
       "  'Vensun Pharmaceuticals, Inc.'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2017, 9, 28, 0, 0),\n",
       "  datetime.datetime(2024, 12, 31, 0, 0),\n",
       "  'Vensun Pharmaceuticals, Inc.'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2017, 9, 28, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Proficient Rx LP'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2018, 3, 1, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Micro Labs Limited'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2018, 3, 1, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Bryant Ranch Prepack'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2018, 3, 1, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Proficient Rx LP'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2018, 3, 1, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Micro Labs Limited'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2018, 5, 7, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Strides Pharma Science Limited'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2018, 5, 7, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Strides Pharma Science Limited'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2018, 5, 7, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'PD-Rx Pharmaceuticals, Inc.'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2018, 5, 7, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'PD-Rx Pharmaceuticals, Inc.'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2018, 5, 7, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Bryant Ranch Prepack'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2019, 1, 10, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Zydus Lifesciences Limited'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2019, 1, 10, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Zydus Lifesciences Limited'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2021, 6, 15, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'Professional Compounding Centers of America'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2023, 4, 27, 0, 0),\n",
       "  datetime.datetime(2024, 12, 31, 0, 0),\n",
       "  'Direct_Rx'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2024, 8, 1, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'AvKARE'),\n",
       " ('Piroxicam',\n",
       "  datetime.datetime(2024, 8, 1, 0, 0),\n",
       "  datetime.datetime(2025, 12, 31, 0, 0),\n",
       "  'AvKARE')]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(\n",
    "    sorted(\n",
    "        map(\n",
    "            lambda x: \n",
    "                (\n",
    "                    x[\"generic_name\"],\n",
    "                    datetime.strptime(x[\"marketing_start_date\"], '%Y%m%d'),\n",
    "                    datetime.strptime(x[\"listing_expiration_date\"], '%Y%m%d'),\n",
    "                    x[\"labeler_name\"],\n",
    "                  \n",
    "                )\n",
    "            ,\n",
    "            filter(\n",
    "                lambda x: \"generic_name\" in x and x[\"generic_name\"] == \"Piroxicam\",\n",
    "                data[\"results\"],\n",
    "            ),\n",
    "        ),\n",
    "        key= lambda x: (x[1])\n",
    "    )\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(\n",
    "    filter(\n",
    "                lambda x: \"brand_name\" in x and x[\"brand_name\"] == \"Glucosamine Chondroitin\",\n",
    "                data[\"results\"],\n",
    "            )\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Kolejnym pytaniem czy s leki ktre nie s generykami, czyli takie ktre nie maj generic name"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'product_ndc': '0002-2377',\n",
       " 'generic_name': 'galcanezumab-gnlm',\n",
       " 'labeler_name': 'Eli Lilly and Company',\n",
       " 'active_ingredients': [{'name': 'GALCANEZUMAB', 'strength': '120 mg/mL'}],\n",
       " 'finished': False,\n",
       " 'packaging': [{'package_ndc': '0002-2377-00',\n",
       "   'description': '1 mL in 1 SYRINGE (0002-2377-00)',\n",
       "   'marketing_start_date': '27-SEP-18'}],\n",
       " 'listing_expiration_date': '20241231',\n",
       " 'openfda': {},\n",
       " 'marketing_category': 'DRUG FOR FURTHER PROCESSING',\n",
       " 'dosage_form': 'INJECTION, SOLUTION',\n",
       " 'spl_id': '368df5d9-5eeb-49c7-a0dd-8a326ee5d78f',\n",
       " 'product_type': 'DRUG FOR FURTHER PROCESSING',\n",
       " 'marketing_start_date': '20180927',\n",
       " 'product_id': '0002-2377_368df5d9-5eeb-49c7-a0dd-8a326ee5d78f',\n",
       " 'brand_name_base': None}"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "list(filter(\n",
    "                lambda x: \"brand_name\" not in x,\n",
    "                data[\"results\"],\n",
    "            )\n",
    ")[0]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Jaki generyk jest najbardziej popularny?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "generic_counter = Counter(list(\n",
    "    map( lambda x: x['generic_name'],\n",
    "        filter(\n",
    "                    lambda x: \"generic_name\" in x,\n",
    "                    data[\"results\"]\n",
    "                )\n",
    "    )\n",
    "))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('Ibuprofen', 1036),\n",
       " ('Acetaminophen', 972),\n",
       " ('Zinc Oxide', 893),\n",
       " ('Alcohol', 886),\n",
       " ('ALCOHOL', 855),\n",
       " ('Sodium Fluoride', 579),\n",
       " ('Salicylic Acid', 544),\n",
       " ('Benzalkonium Chloride', 521),\n",
       " ('Menthol', 519),\n",
       " ('ZINC OXIDE', 514),\n",
       " ('Nicotine Polacrilex', 436),\n",
       " ('Gabapentin', 428),\n",
       " ('BENZALKONIUM CHLORIDE', 424),\n",
       " ('Oxygen', 415),\n",
       " ('Benzocaine', 401),\n",
       " ('MENTHOL', 346),\n",
       " ('Aspirin', 344),\n",
       " ('Avobenzone, Homosalate, Octisalate, Octocrylene', 335),\n",
       " ('Levothyroxine Sodium', 327),\n",
       " ('Titanium Dioxide', 325),\n",
       " ('Famotidine', 323),\n",
       " ('Ethyl Alcohol', 305),\n",
       " ('Loratadine', 304),\n",
       " ('SALICYLIC ACID', 302),\n",
       " ('Lisinopril', 302),\n",
       " ('Hydrocortisone', 299),\n",
       " ('Diphenhydramine HCl', 298),\n",
       " ('Isopropyl Alcohol', 284),\n",
       " ('Pregabalin', 282),\n",
       " ('Omeprazole', 276),\n",
       " ('Simethicone', 270),\n",
       " ('Lidocaine', 267),\n",
       " ('PREGABALIN', 265),\n",
       " ('Naproxen Sodium', 262),\n",
       " ('Titanium Dioxide, Zinc Oxide', 255),\n",
       " ('Guaifenesin', 254),\n",
       " ('Aripiprazole', 253),\n",
       " ('Amoxicillin', 248),\n",
       " ('Levetiracetam', 244),\n",
       " ('Metformin Hydrochloride', 238),\n",
       " ('TITANIUM DIOXIDE', 237),\n",
       " ('Lamotrigine', 237),\n",
       " ('Calcium Carbonate', 236),\n",
       " ('Olanzapine', 228),\n",
       " ('Aluminum Chlorohydrate', 220),\n",
       " ('OCTINOXATE and TITANIUM DIOXIDE', 220),\n",
       " ('Cetirizine Hydrochloride', 219),\n",
       " ('Pyrithione Zinc', 216),\n",
       " ('Diphenhydramine Hydrochloride', 210),\n",
       " ('levothyroxine sodium', 204),\n",
       " ('Amitriptyline Hydrochloride', 200),\n",
       " ('Tadalafil', 199),\n",
       " ('Diclofenac Sodium', 198),\n",
       " ('SODIUM FLUORIDE', 198),\n",
       " ('AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE', 197),\n",
       " ('Topiramate', 197),\n",
       " ('Celecoxib', 196),\n",
       " ('Minoxidil', 195),\n",
       " ('Prednisone', 194),\n",
       " ('Potassium Chloride', 189),\n",
       " ('Carvedilol', 189),\n",
       " ('nicotine polacrilex', 188),\n",
       " ('Rosuvastatin Calcium', 187),\n",
       " ('Bismuth subsalicylate', 187),\n",
       " ('Cephalexin', 186),\n",
       " ('Amoxicillin and Clavulanate Potassium', 185),\n",
       " ('Titanium Dioxide and Zinc Oxide', 182),\n",
       " ('Hydrocodone Bitartrate and Acetaminophen', 181),\n",
       " ('Lidocaine Hydrochloride', 179),\n",
       " ('Losartan Potassium', 176),\n",
       " ('Quetiapine Fumarate', 175),\n",
       " ('ATORVASTATIN CALCIUM', 173),\n",
       " ('Glipizide', 168),\n",
       " ('Naproxen', 166),\n",
       " ('ETHYL ALCOHOL', 164),\n",
       " ('TITANIUM DIOXIDE, ZINC OXIDE', 163),\n",
       " ('Benzalkonium chloride', 162),\n",
       " ('Methylphenidate Hydrochloride', 161),\n",
       " ('Baclofen', 158),\n",
       " ('Diltiazem Hydrochloride', 158),\n",
       " ('Fluconazole', 158),\n",
       " ('Hydrochlorothiazide', 157),\n",
       " ('Chloroxylenol', 156),\n",
       " ('Clotrimazole', 155),\n",
       " ('Dimethicone', 155),\n",
       " ('Alprazolam', 155),\n",
       " ('Acyclovir', 154),\n",
       " ('LIDOCAINE HYDROCHLORIDE', 152),\n",
       " ('Buspirone Hydrochloride', 151),\n",
       " ('DIPHENHYDRAMINE HYDROCHLORIDE', 151),\n",
       " ('DOCUSATE SODIUM', 149),\n",
       " ('ISOPROPYL ALCOHOL', 143),\n",
       " ('bupropion hydrochloride', 143),\n",
       " ('Labetalol Hydrochloride', 140),\n",
       " ('Trazodone Hydrochloride', 140),\n",
       " ('Sildenafil', 140),\n",
       " ('Estradiol', 139),\n",
       " ('Lansoprazole', 138),\n",
       " ('Glycopyrrolate', 137),\n",
       " ('Ondansetron', 137),\n",
       " ('Venlafaxine Hydrochloride', 136),\n",
       " ('Mirtazapine', 135),\n",
       " ('Lorazepam', 135),\n",
       " ('Glimepiride', 133),\n",
       " ('Metoprolol Tartrate', 132),\n",
       " ('Fenofibrate', 132),\n",
       " ('Benzonatate', 131),\n",
       " ('Bupropion Hydrochloride', 131),\n",
       " ('Levofloxacin', 129),\n",
       " ('Divalproex Sodium', 128),\n",
       " ('Fluoxetine Hydrochloride', 128),\n",
       " ('Triamcinolone Acetonide', 128),\n",
       " ('Esomeprazole Magnesium', 126),\n",
       " ('Risperidone', 126),\n",
       " ('Sennosides', 125),\n",
       " ('ACETAMINOPHEN', 125),\n",
       " ('Atorvastatin Calcium', 124),\n",
       " ('Doxycycline Hyclate', 124),\n",
       " ('Pramipexole Dihydrochloride', 124),\n",
       " ('Cyclobenzaprine Hydrochloride', 122),\n",
       " ('POVIDONE-IODINE', 122),\n",
       " ('Calcium carbonate', 122),\n",
       " ('Aluminum Zirconium Tetrachlorohydrex GLY', 121),\n",
       " ('Azithromycin', 120),\n",
       " ('Miconazole Nitrate', 120),\n",
       " ('Hydralazine Hydrochloride', 120),\n",
       " ('Metronidazole', 120),\n",
       " ('Isopropyl alcohol', 118),\n",
       " ('Methocarbamol', 117),\n",
       " ('alcohol', 117),\n",
       " ('Allopurinol', 116),\n",
       " ('Atenolol', 116),\n",
       " ('Minocycline Hydrochloride', 116),\n",
       " ('ibuprofen', 114),\n",
       " ('Dextromethorphan HBr, Guaifenesin', 114),\n",
       " ('Simvastatin', 113),\n",
       " ('Furosemide', 113),\n",
       " ('IBUPROFEN', 112),\n",
       " ('CHLOROXYLENOL', 112),\n",
       " ('Valsartan', 111),\n",
       " ('Bisacodyl', 111),\n",
       " ('Dexamethasone', 109),\n",
       " ('Sodium fluoride', 109),\n",
       " ('Sulfamethoxazole and Trimethoprim', 109),\n",
       " ('Duloxetine', 109),\n",
       " ('Tolnaftate', 109),\n",
       " ('ASPIRIN', 108),\n",
       " ('Propranolol Hydrochloride', 108),\n",
       " ('Sertraline Hydrochloride', 108),\n",
       " ('Doxepin Hydrochloride', 107),\n",
       " ('Benzoyl Peroxide', 107),\n",
       " ('Etodolac', 106),\n",
       " ('Nitrogen', 104),\n",
       " ('PRAVASTATIN SODIUM', 104),\n",
       " ('Docusate Sodium', 104),\n",
       " ('Zolpidem Tartrate', 104),\n",
       " ('OCTISALATE, TITANIUM DIOXIDE', 104),\n",
       " ('Phentermine Hydrochloride', 103),\n",
       " ('Progesterone', 103),\n",
       " ('OXYGEN', 103),\n",
       " ('Haloperidol', 103),\n",
       " ('Heparin Sodium', 102),\n",
       " ('Tacrolimus', 102),\n",
       " ('GLYCERIN', 102),\n",
       " ('Petrolatum', 101),\n",
       " ('Sodium Chloride', 101),\n",
       " ('Hydroxyzine Hydrochloride', 101),\n",
       " ('Morphine Sulfate', 100),\n",
       " ('Zinc oxide', 100),\n",
       " ('Diazepam', 99),\n",
       " ('LIDOCAINE', 99),\n",
       " ('OCTINOXATE', 99),\n",
       " ('Dicyclomine Hydrochloride', 99),\n",
       " ('Pantoprazole Sodium', 98),\n",
       " ('Oxycodone and Acetaminophen', 98),\n",
       " ('propranolol hydrochloride', 97),\n",
       " ('Lacosamide', 97),\n",
       " ('topiramate', 97),\n",
       " ('Cetirizine HCl', 97),\n",
       " ('Avobenzone, Homosalate, Octisalate', 96),\n",
       " ('Carbamazepine', 96),\n",
       " ('Nifedipine', 95),\n",
       " ('Promethazine Hydrochloride', 95),\n",
       " ('Ciprofloxacin', 95),\n",
       " ('Amlodipine Besylate', 95),\n",
       " ('Fluphenazine Hydrochloride', 94),\n",
       " ('METFORMIN HYDROCHLORIDE', 93),\n",
       " ('Ondansetron Hydrochloride', 93),\n",
       " ('Metoprolol succinate', 92),\n",
       " ('BENZOYL PEROXIDE', 92),\n",
       " ('SODIUM CHLORIDE', 92),\n",
       " ('estradiol', 92),\n",
       " ('Benazepril Hydrochloride', 92),\n",
       " ('Stannous Fluoride', 91),\n",
       " ('Phenobarbital', 90),\n",
       " ('Warfarin Sodium', 90),\n",
       " ('Ciprofloxacin Hydrochloride', 89),\n",
       " ('GABAPENTIN', 89),\n",
       " ('SODIUM MONOFLUOROPHOSPHATE', 89),\n",
       " ('Nortriptyline Hydrochloride', 89),\n",
       " ('diltiazem hydrochloride', 89),\n",
       " ('Ramipril', 89),\n",
       " ('White Petrolatum', 88),\n",
       " ('Docosanol', 88),\n",
       " ('Metoprolol Succinate', 88),\n",
       " ('Ketorolac Tromethamine', 87),\n",
       " ('Sunscreen', 87),\n",
       " ('Quetiapine', 87),\n",
       " ('Fluticasone Propionate', 87),\n",
       " ('POTASSIUM CHLORIDE', 86),\n",
       " ('menthol', 86),\n",
       " ('Citalopram Hydrobromide', 86),\n",
       " ('Enoxaparin Sodium', 85),\n",
       " ('Indomethacin', 85),\n",
       " ('Acetaminophen, Aspirin, Caffeine', 85),\n",
       " ('Doxycycline', 84),\n",
       " ('Aluminum Zirconium Tetrachlorohydrex Gly', 84),\n",
       " ('OCTINOXATE, ZINC OXIDE', 83),\n",
       " ('Clonidine Hydrochloride', 82),\n",
       " ('Meclizine Hydrochloride', 81),\n",
       " ('Terbinafine Hydrochloride', 81),\n",
       " ('dexmethylphenidate hydrochloride', 80),\n",
       " ('furosemide', 80),\n",
       " ('Erythromycin', 80),\n",
       " ('Polyethylene Glycol 3350', 80),\n",
       " ('acetaminophen', 80),\n",
       " ('Finasteride', 80),\n",
       " ('spironolactone', 80),\n",
       " ('PREDNISONE', 79),\n",
       " ('Loperamide Hydrochloride', 78),\n",
       " ('Eucalyptol, menthol, methyl salicylate, thymol', 78),\n",
       " ('Sucralfate', 78),\n",
       " ('Tamsulosin Hydrochloride', 78),\n",
       " ('methylphenidate hydrochloride', 78),\n",
       " ('Oxybutynin Chloride', 77),\n",
       " ('Irbesartan', 77),\n",
       " ('Escitalopram', 77),\n",
       " ('Valsartan and Hydrochlorothiazide', 77),\n",
       " ('Miconazole nitrate', 77),\n",
       " ('Oxycodone Hydrochloride', 76),\n",
       " ('Avobenzone, Homosalate, Octisalate, and Octocrylene', 76),\n",
       " ('Nystatin', 76),\n",
       " ('Budesonide', 76),\n",
       " ('Cefdinir', 76),\n",
       " ('Tizanidine', 75),\n",
       " ('calcium carbonate', 75),\n",
       " ('Hydrogen Peroxide', 75),\n",
       " ('Venlafaxine', 75),\n",
       " ('Colloidal Oatmeal', 74),\n",
       " ('metoprolol succinate', 74),\n",
       " ('hydrocortisone', 73),\n",
       " ('Atomoxetine', 73),\n",
       " ('Capsaicin', 73),\n",
       " ('Torsemide', 73),\n",
       " ('clonazepam', 72),\n",
       " ('Penicillin V Potassium', 72),\n",
       " ('cyclobenzaprine hydrochloride', 72),\n",
       " ('Salicylic acid', 72),\n",
       " ('diclofenac sodium', 71),\n",
       " ('Sumatriptan Succinate', 71),\n",
       " ('Meloxicam', 70),\n",
       " ('Metaxalone', 70),\n",
       " ('Tramadol Hydrochloride', 70),\n",
       " ('Homosalate, Octisalate, Zinc Oxide', 70),\n",
       " ('Lurasidone Hydrochloride', 70),\n",
       " ('gabapentin', 70),\n",
       " ('meloxicam', 70),\n",
       " ('Stannous fluoride', 70),\n",
       " ('Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl', 70),\n",
       " ('Doxazosin', 69),\n",
       " ('Phenylephrine Hydrochloride', 69),\n",
       " ('ALUMINUM CHLOROHYDRATE', 69),\n",
       " ('Magnesium Citrate', 69),\n",
       " ('ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE',\n",
       "  69),\n",
       " ('Triamterene and Hydrochlorothiazide', 69),\n",
       " ('Octinoxate, Titanium Dioxide', 69),\n",
       " ('TRAMADOL HYDROCHLORIDE', 68),\n",
       " ('fenofibrate', 68),\n",
       " ('Enalapril Maleate', 68),\n",
       " ('Clonazepam', 68),\n",
       " ('Eszopiclone', 68),\n",
       " ('Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate',\n",
       "  67),\n",
       " ('phenobarbital', 67),\n",
       " ('Paroxetine', 67),\n",
       " ('ketorolac tromethamine', 67),\n",
       " ('Memantine Hydrochloride', 67),\n",
       " ('Oxcarbazepine', 67),\n",
       " ('Phenazopyridine Hydrochloride', 66),\n",
       " ('Chlorthalidone', 66),\n",
       " ('Olmesartan Medoxomil', 66),\n",
       " ('HYDROCORTISONE', 66),\n",
       " ('benzalkonium chloride', 66),\n",
       " ('Camphor, Menthol', 66),\n",
       " ('Mesalamine', 66),\n",
       " ('Fluoxetine', 65),\n",
       " ('Albuterol Sulfate', 65),\n",
       " ('atorvastatin calcium', 65),\n",
       " ('SPIRONOLACTONE', 64),\n",
       " ('Sodium Monofluorophosphate', 64),\n",
       " ('Bismuth Subsalicylate', 64),\n",
       " ('Bumetanide', 64),\n",
       " ('Donepezil Hydrochloride', 64),\n",
       " ('Acetaminophen, Dextromethorphan HBr, Doxylamine succinate', 64),\n",
       " ('Vancomycin Hydrochloride', 63),\n",
       " ('Sotalol Hydrochloride', 63),\n",
       " ('Glycerin', 63),\n",
       " ('Nabumetone', 63),\n",
       " ('LORATADINE', 63),\n",
       " ('zinc oxide', 63),\n",
       " ('BACLOFEN', 62),\n",
       " ('Deferasirox', 62),\n",
       " ('Montelukast Sodium', 62),\n",
       " ('risperidone', 62),\n",
       " ('Rosuvastatin', 61),\n",
       " ('Ethyl alcohol', 61),\n",
       " ('Escitalopram Oxalate', 61),\n",
       " ('salicylic acid', 61),\n",
       " ('magnesium hydroxide', 61),\n",
       " ('Acetaminophen, Diphenhydramine HCl', 61),\n",
       " ('Octinoxate', 61),\n",
       " ('delandistrogene moxeparvovec-rokl', 61),\n",
       " ('Nicotine', 60),\n",
       " ('Fexofenadine Hydrochloride', 60),\n",
       " ('Ursodiol', 60),\n",
       " ('Felodipine', 60),\n",
       " ('Clarithromycin', 60),\n",
       " ('Carbidopa and Levodopa', 60),\n",
       " ('Mineral Oil', 60),\n",
       " ('Doxorubicin Hydrochloride', 60),\n",
       " ('Lenalidomide', 60),\n",
       " ('tirzepatide', 60),\n",
       " ('Pravastatin Sodium', 60),\n",
       " ('venlafaxine hydrochloride', 60),\n",
       " ('Digoxin', 59),\n",
       " ('temazepam', 59),\n",
       " ('DULOXETINE HYDROCHLORIDE', 59),\n",
       " ('ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE', 59),\n",
       " ('Dexamethasone Sodium Phosphate', 59),\n",
       " ('ARNICA MONTANA', 59),\n",
       " ('Guanfacine', 59),\n",
       " ('TITANIUM DIOXIDE AND ZINC OXIDE', 59),\n",
       " ('Telmisartan', 58),\n",
       " ('doxycycline', 58),\n",
       " ('SIMVASTATIN', 58),\n",
       " ('MENTHOL, UNSPECIFIED FORM', 58),\n",
       " ('Hand Sanitizer', 58),\n",
       " ('Tobramycin', 58),\n",
       " ('Oseltamivir Phosphate', 58),\n",
       " ('Acetazolamide', 58),\n",
       " ('Midodrine Hydrochloride', 58),\n",
       " ('Cream', 58),\n",
       " ('Oil', 58),\n",
       " ('lurasidone hydrochloride', 58),\n",
       " ('omeprazole', 58),\n",
       " ('sodium fluoride', 58),\n",
       " ('buspirone hydrochloride', 58),\n",
       " ('Water', 57),\n",
       " ('Ranolazine', 57),\n",
       " ('Dexmethylphenidate Hydrochloride', 57),\n",
       " ('Spironolactone', 56),\n",
       " ('TOLNAFTATE', 56),\n",
       " ('Aluminum Sesquichlorohydrate', 56),\n",
       " ('Tretinoin', 56),\n",
       " ('oxymetazoline hydrochloride', 56),\n",
       " ('Phenol', 56),\n",
       " ('Amlodipine besylate', 56),\n",
       " ('Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl', 56),\n",
       " ('AMLODIPINE BESYLATE', 55),\n",
       " ('Zolmitriptan', 55),\n",
       " ('Zinc Oxide, Titanium Dioxide', 55),\n",
       " ('Zonisamide', 55),\n",
       " ('Terazosin Hydrochloride', 54),\n",
       " ('Verapamil Hydrochloride', 54),\n",
       " ('clindamycin phosphate', 54),\n",
       " ('Clobetasol Propionate', 54),\n",
       " ('Warfarin', 54),\n",
       " ('ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE', 54),\n",
       " ('Aluminum Zirconium Octachlorohydrex Gly', 54),\n",
       " ('Lovastatin', 54),\n",
       " ('Leuprolide Acetate', 54),\n",
       " ('Clindamycin hydrochloride', 54),\n",
       " ('Witch Hazel', 53),\n",
       " ('verapamil hydrochloride', 53),\n",
       " ('Amiodarone Hydrochloride', 53),\n",
       " ('SENNOSIDES', 53),\n",
       " ('Octinoxate and Zinc Oxide', 53),\n",
       " ('Quetiapine fumarate', 53),\n",
       " ('Fluocinonide', 53),\n",
       " ('AMITRIPTYLINE HYDROCHLORIDE', 53),\n",
       " ('aluminum hydroxide, magnesium hydroxide, dimethicone', 53),\n",
       " ('Nebivolol', 53),\n",
       " ('Avobenzone, Homosalate, Octisalate and Octocrylene', 53),\n",
       " ('Prazosin Hydrochloride', 53),\n",
       " ('PHENYLEPHRINE HYDROCHLORIDE', 52),\n",
       " ('Isotretinoin', 52),\n",
       " ('Avobenzone, Octisalate, Octocrylene', 52),\n",
       " ('Caffeine', 52),\n",
       " ('Ezetimibe', 52),\n",
       " ('olmesartan medoxomil', 52),\n",
       " ('oil', 52),\n",
       " ('Clindamycin Hydrochloride', 52),\n",
       " ('Everolimus', 52),\n",
       " ('Lithium Carbonate', 52),\n",
       " ('Pirfenidone', 52),\n",
       " ('metformin hydrochloride', 51),\n",
       " ('VERAPAMIL HYDROCHLORIDE', 51),\n",
       " ('Valacyclovir Hydrochloride', 51),\n",
       " ('enoxaparin sodium', 51),\n",
       " ('acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride',\n",
       "  51),\n",
       " ('Mometasone Furoate', 51),\n",
       " ('Chlorpromazine Hydrochloride', 51),\n",
       " ('acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride',\n",
       "  51),\n",
       " ('Triamcinolone acetonide', 51),\n",
       " ('Rizatriptan Benzoate', 51),\n",
       " ('Methylprednisolone', 51),\n",
       " ('acyclovir', 50),\n",
       " ('Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate',\n",
       "  50),\n",
       " ('levetiracetam', 50),\n",
       " ('cyclophosphamide', 50),\n",
       " ('Modafinil', 50),\n",
       " ('Colchicine', 50),\n",
       " ('dextromethorphan polistirex', 50),\n",
       " ('Lisinopril and Hydrochlorothiazide', 50),\n",
       " ('Sulfur', 50),\n",
       " ('HEPARIN SODIUM', 50),\n",
       " ('HYDROGEN PEROXIDE', 49),\n",
       " ('memantine hydrochloride', 49),\n",
       " ('Semaglutide', 49),\n",
       " ('Testosterone', 49),\n",
       " ('lisdexamfetamine dimesylate', 49),\n",
       " ('Diphenhydramine HCL', 49),\n",
       " ('dextromethorphan hydrobromide, guaifenesin', 49),\n",
       " ('Losartan Potassium and Hydrochlorothiazide', 49),\n",
       " ('Primidone', 48),\n",
       " ('Paricalcitol', 48),\n",
       " ('methocarbamol', 48),\n",
       " ('Gemfibrozil', 48),\n",
       " ('Atorvastatin calcium', 48),\n",
       " ('docusate sodium and sennosides', 48),\n",
       " ('Skin tag patches', 48),\n",
       " ('Ketoconazole', 48),\n",
       " ('Mupirocin', 48),\n",
       " ('alprazolam', 48),\n",
       " ('Clomipramine Hydrochloride', 48),\n",
       " ('ethyl alcohol', 48),\n",
       " ('Chlorhexidine Gluconate', 48),\n",
       " ('Sodium Bicarbonate', 48),\n",
       " ('baclofen', 48),\n",
       " ('Hydroxyzine Pamoate', 47),\n",
       " ('Rivastigmine Tartrate', 47),\n",
       " ('Oxaliplatin', 47),\n",
       " ('OXCARBAZEPINE', 47),\n",
       " ('zolpidem tartrate', 47),\n",
       " ('ALLANTOIN', 47),\n",
       " ('PHENAZOPYRIDINE HYDROCHLORIDE', 47),\n",
       " ('SIMETHICONE', 47),\n",
       " ('ARIPIPRAZOLE', 47),\n",
       " ('BUPROPION HYDROCHLORIDE', 47),\n",
       " ('Guaifenesin and Dextromethorphan HBr', 47),\n",
       " ('Duloxetine Hydrochloride', 47),\n",
       " ('VANCOMYCIN HYDROCHLORIDE', 47),\n",
       " ('Cefadroxil', 47),\n",
       " ('metronidazole', 47),\n",
       " ('FAMOTIDINE', 46),\n",
       " ('Dofetilide', 46),\n",
       " ('Fexofenadine HCl', 46),\n",
       " ('Tranexamic Acid', 46),\n",
       " ('Pemetrexed disodium', 46),\n",
       " ('loratadine', 46),\n",
       " ('Pioglitazone', 46),\n",
       " ('Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl', 46),\n",
       " ('Levonorgestrel', 45),\n",
       " ('Theophylline', 45),\n",
       " ('TRIAMCINOLONE ACETONIDE', 45),\n",
       " ('GUAIFENESIN', 45),\n",
       " ('Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate', 45),\n",
       " ('Cyclophosphamide', 45),\n",
       " ('MINOXIDIL', 45),\n",
       " ('OCTINOXATE, OXYBENZONE', 45),\n",
       " ('SULFUR', 45),\n",
       " ('levocetirizine dihydrochloride', 45),\n",
       " ('Voriconazole', 45),\n",
       " ('hydroxyzine pamoate', 45),\n",
       " ('Folic Acid', 45),\n",
       " ('Pyrithione zinc', 45),\n",
       " ('SULFACETAMIDE SODIUM, SULFUR', 45),\n",
       " ('Cinacalcet', 45),\n",
       " ('fluticasone propionate', 45),\n",
       " ('potassium chloride', 45),\n",
       " ('KETOROLAC TROMETHAMINE', 45),\n",
       " ('PredniSONE', 45),\n",
       " ('Phenylephrine hydrochloride', 44),\n",
       " ('losartan potassium and hydrochlorothiazide', 44),\n",
       " ('DOXEPIN HYDROCHLORIDE', 44),\n",
       " ('Docetaxel', 44),\n",
       " ('Fentanyl Citrate', 44),\n",
       " ('Azithromycin Dihydrate', 44),\n",
       " ('Methadone Hydrochloride', 44),\n",
       " ('Bupivacaine Hydrochloride', 44),\n",
       " ('Timolol Maleate', 44),\n",
       " ('Abrotanum', 44),\n",
       " ('Methotrexate', 44),\n",
       " ('FENOFIBRATE', 44),\n",
       " ('OCTINOXATE, TITANIUM DIOXIDE', 44),\n",
       " ('Amlodipine and Benazepril Hydrochloride', 44),\n",
       " ('quetiapine fumarate', 44),\n",
       " ('AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE', 44),\n",
       " ('nifedipine', 43),\n",
       " ('Carvedilol Phosphate', 43),\n",
       " ('venlafaxine', 43),\n",
       " ('Adapalene', 43),\n",
       " ('minoxidil', 43),\n",
       " ('Naltrexone Hydrochloride', 43),\n",
       " ('Calcitriol', 43),\n",
       " ('Paclitaxel', 43),\n",
       " ('Ezetimibe and Simvastatin', 43),\n",
       " ('Ofloxacin', 43),\n",
       " ('ropinirole', 43),\n",
       " ('Glyburide', 43),\n",
       " ('Ropivacaine Hydrochloride', 43),\n",
       " ('FENTANYL', 43),\n",
       " ('ACYCLOVIR', 43),\n",
       " ('Bupropion hydrochloride', 43),\n",
       " ('Vasopressin', 42),\n",
       " ('Nitrofurantoin (monohydrate/macrocrystals)', 42),\n",
       " ('Capecitabine', 42),\n",
       " ('Loperamide HCl', 42),\n",
       " ('VENLAFAXINE HYDROCHLORIDE', 42),\n",
       " ('Lisinopril and Hydrochlorothiazide Tablets', 42),\n",
       " ('lidocaine', 42),\n",
       " ('Testosterone Cypionate', 42),\n",
       " ('OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE', 42),\n",
       " ('Dutasteride', 42),\n",
       " ('Bacitracin Zinc', 42),\n",
       " ('Clopidogrel Bisulfate', 42),\n",
       " ('Buprenorphine', 42),\n",
       " ('lansoprazole', 42),\n",
       " ('doxepin hydrochloride', 42),\n",
       " ('acetaminophen and codeine phosphate', 42),\n",
       " ('Hydroxyzine hydrochloride', 41),\n",
       " ('Lidocaine HCl', 41),\n",
       " ('Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride',\n",
       "  41),\n",
       " ('valsartan', 41),\n",
       " ('Anastrozole', 41),\n",
       " ('Atropine Sulfate', 41),\n",
       " ('Aluminum chlorohydrate', 41),\n",
       " ('Betamethasone Dipropionate', 41),\n",
       " ('Naloxone Hydrochloride', 41),\n",
       " ('prazosin hydrochloride', 41),\n",
       " ('Isosorbide Mononitrate', 40),\n",
       " ('DIMETHICONE', 40),\n",
       " ('Carisoprodol', 40),\n",
       " ('morphine sulfate', 40),\n",
       " ('SODIUM BICARBONATE', 40),\n",
       " ('OLOPATADINE HYDROCHLORIDE', 40),\n",
       " ('Propafenone Hydrochloride', 40),\n",
       " ('nitroglycerin', 40),\n",
       " ('MENTHOL, CAMPHOR', 40),\n",
       " ('lacosamide', 40),\n",
       " ('LOPERAMIDE HYDROCHLORIDE', 40),\n",
       " ('Valacyclovir', 40),\n",
       " ('Arnica Montana', 40),\n",
       " ('Pseudoephedrine HCl', 40),\n",
       " ('Paliperidone', 40),\n",
       " ('Mycophenolate Mofetil', 40),\n",
       " ('Dapsone', 40),\n",
       " ('Fluticasone propionate', 40),\n",
       " ('Tirzepatide', 40),\n",
       " ('nicotine', 40),\n",
       " ('Temozolomide', 40),\n",
       " ('simvastatin', 40),\n",
       " ('ESZOPICLONE', 40),\n",
       " ('Ceftriaxone Sodium', 40),\n",
       " ('tramadol hydrochloride', 39),\n",
       " ('Magnesium Sulfate', 39),\n",
       " ('Divalproex sodium', 39),\n",
       " ('Solifenacin Succinate', 39),\n",
       " ('Nadolol', 39),\n",
       " ('Dextroamphetamine Sulfate', 39),\n",
       " ('Phenytoin Sodium', 39),\n",
       " ('Hydromorphone Hydrochloride', 39),\n",
       " ('Meclizine HCl', 39),\n",
       " ('Castor Oil', 39),\n",
       " ('Epinephrine', 39),\n",
       " ('Teriflunomide', 39),\n",
       " ('Tolterodine Tartrate', 39),\n",
       " ('BUPIVACAINE HYDROCHLORIDE', 39),\n",
       " ('CELECOXIB', 39),\n",
       " ('Nicotine polacrilex', 39),\n",
       " ('Potassium Citrate', 39),\n",
       " ('Guaifenesin, Dextromethorphan HBr', 39),\n",
       " ('etranacogene dezaparvovec', 39),\n",
       " ('treprostinil', 38),\n",
       " ('PYRITHIONE ZINC', 38),\n",
       " ('Ramelteon', 38),\n",
       " ('BENZETHONIUM CHLORIDE', 38),\n",
       " ('Epstein-Barr Virus Nosode', 38),\n",
       " ('Linezolid', 38),\n",
       " ('ziprasidone hydrochloride', 38),\n",
       " ('Daptomycin', 38),\n",
       " ('Antacid Tablets', 38),\n",
       " ('Piperonyl butoxide, Pyrethrum extract', 38),\n",
       " ('Octinoxate, Zinc Oxide', 38),\n",
       " ('Captopril', 38),\n",
       " ('Fexofenadine HCL', 38),\n",
       " ('Esomeprazole magnesium', 38),\n",
       " ('Buprenorphine and Naloxone', 38),\n",
       " ('clonidine hydrochloride', 38),\n",
       " ('allopurinol', 38),\n",
       " ('phentermine hydrochloride', 37),\n",
       " ('Temazepam', 37),\n",
       " ('Metolazone', 37),\n",
       " ('Febuxostat', 37),\n",
       " ('glycopyrrolate', 37),\n",
       " ('onasemnogene abeparvovec-xioi', 37),\n",
       " ('Sertraline', 37),\n",
       " ('Insulin lispro', 37),\n",
       " ('temozolomide', 37),\n",
       " ('Neostigmine Methylsulfate', 37),\n",
       " ('NAPROXEN SODIUM', 37),\n",
       " ('Hydrocortisone Acetate', 37),\n",
       " ('Bimatoprost', 37),\n",
       " ('Hydroxychloroquine Sulfate', 37),\n",
       " ('Famciclovir', 37),\n",
       " ('celecoxib', 37),\n",
       " ('Succinylcholine Chloride', 37),\n",
       " ('CARBAMIDE PEROXIDE', 37),\n",
       " ('Pseudoephedrine Hydrochloride', 37),\n",
       " ('lovastatin', 37),\n",
       " ('Levonorgestrel and Ethinyl Estradiol', 37),\n",
       " ('Oxymetazoline Hydrochloride', 37),\n",
       " ('NITROGEN', 37),\n",
       " ('Clindamycin Phosphate', 36),\n",
       " ('Cyclosporine', 36),\n",
       " ('Gentamicin Sulfate', 36),\n",
       " ('PANTOPRAZOLE', 36),\n",
       " ('BENZOCAINE', 36),\n",
       " ('AVOBENZONE, OCTISALATE, OCTOCRYLENE', 36),\n",
       " ('Avobenzone, Homosalate,Octisalate, Octocrylene', 36),\n",
       " ('aripiprazole', 36),\n",
       " ('MICONAZOLE NITRATE', 36),\n",
       " ('Desmopressin Acetate', 36),\n",
       " ('esomeprazole magnesium', 36),\n",
       " ('Dexmethylphenidate hydrochloride', 36),\n",
       " ('ONDANSETRON', 36),\n",
       " ('Oxymetazoline hydrochloride', 36),\n",
       " ('RISPERIDONE', 36),\n",
       " ('Povidone-Iodine', 36),\n",
       " ('triamcinolone acetonide', 36),\n",
       " ('Ziprasidone Hydrochloride', 36),\n",
       " ('Piroxicam', 35),\n",
       " ('Flecainide Acetate', 35),\n",
       " ('paroxetine hydrochloride', 35),\n",
       " ('SERTRALINE HYDROCHLORIDE', 35),\n",
       " ('METHYLPHENIDATE HYDROCHLORIDE', 35),\n",
       " ('Ropinirole', 35),\n",
       " ('Droxidopa', 35),\n",
       " ('Nitrofurantoin', 35),\n",
       " ('Ethanol', 35),\n",
       " ('CARBAMAZEPINE', 35),\n",
       " ('Magnesium Hydroxide', 35),\n",
       " ('LEVETIRACETAM', 35),\n",
       " ('Azathioprine', 35),\n",
       " ('Irbesartan and Hydrochlorothiazide', 35),\n",
       " ('ESTRADIOL', 35),\n",
       " ('ciprofloxacin', 35),\n",
       " ('Nitroglycerin', 35),\n",
       " ('Bartonella Bacilliformis, Bartonella Clarridgeiae, Bartonella Elizabethae, Bartonella Henselae, Bartonella Quintana, Bartonella Vinsonii, Bartonella Washoensis',\n",
       "  35),\n",
       " ('Diltiazem hydrochloride', 34),\n",
       " ('metoprolol tartrate', 34),\n",
       " ('DOXYCYCLINE HYCLATE', 34),\n",
       " ('Argentum Metallicum', 34),\n",
       " ('MORPHINE SULFATE', 34),\n",
       " ('Benzethonium Chloride', 34),\n",
       " ('CLOTRIMAZOLE', 34),\n",
       " ('Niacinamide, Adenosine', 34),\n",
       " ('Armodafinil', 34),\n",
       " ('Risedronate Sodium', 34),\n",
       " ('sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose',\n",
       "  34),\n",
       " ('lamotrigine', 34),\n",
       " ('LAMOTRIGINE', 34),\n",
       " ('Phenylephrine HCl', 34),\n",
       " ('Psyllium Husk', 34),\n",
       " ('deferasirox', 34),\n",
       " ('Leucovorin Calcium', 34),\n",
       " ('quetiapine', 34),\n",
       " ('ropinirole hydrochloride', 34),\n",
       " ('Dimenhydrinate', 34),\n",
       " ('Metoclopramide', 34),\n",
       " ('perphenazine', 34),\n",
       " ('isopropyl alcohol', 34),\n",
       " ('Clobazam', 34),\n",
       " ('tadalafil', 33),\n",
       " ('Metoprolol Succinate ER Tablets', 33),\n",
       " ('Desoximetasone', 33),\n",
       " ('Lisdexamfetamine dimesylate', 33),\n",
       " ('Pectin', 33),\n",
       " ('Diclofenac sodium', 33),\n",
       " ('Prochlorperazine Maleate', 33),\n",
       " ('Amlodipine Besylate and Benazepril Hydrochloride', 33),\n",
       " ('Cetirizine hydrochloride', 33),\n",
       " ('diphenhydramine hydrochloride', 33),\n",
       " ('Air', 33),\n",
       " ('TITANIUM DIOXIDE and ZINC OXIDE', 33),\n",
       " ('atomoxetine', 33),\n",
       " ('paliperidone', 33),\n",
       " ('Citalopram', 33),\n",
       " ('Cefazolin', 33),\n",
       " ('Fluorouracil', 33),\n",
       " ('Sumatriptan', 32),\n",
       " ('Hyoscyamine Sulfate', 32),\n",
       " ('Ivermectin', 32),\n",
       " ('Meropenem', 32),\n",
       " ('GLYCOPYRROLATE', 32),\n",
       " ('diclofenac potassium', 32),\n",
       " ('PETROLATUM', 32),\n",
       " ('PROGESTERONE', 32),\n",
       " ('Silver Sulfadiazine', 32),\n",
       " ('AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE', 32),\n",
       " ('Metformin HCl', 32),\n",
       " ('Bacitracin', 32),\n",
       " ('Posaconazole', 32),\n",
       " ('DEFERASIROX', 32),\n",
       " ('fexofenadine hydrochloride', 32),\n",
       " ('Fexofenadine hydrochloride', 32),\n",
       " ('Nitrous Oxide', 32),\n",
       " ('Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone', 32),\n",
       " ('Metformin hydrochloride', 32),\n",
       " ('Acetaminophen, Guaifenesin, Phenylephrine HCl', 32),\n",
       " ('NAPROXEN', 32),\n",
       " ('albuterol sulfate', 32),\n",
       " ('doxycycline hyclate', 32),\n",
       " ('Aconitum napellus', 32),\n",
       " ('Pancrelipase', 32),\n",
       " ('Olopatadine Hydrochloride Ophthalmic', 32),\n",
       " ('Mexiletine Hydrochloride', 31),\n",
       " ('Tamoxifen Citrate', 31),\n",
       " ('warfarin sodium', 31),\n",
       " ('Perphenazine', 31),\n",
       " ('Liothyronine Sodium', 31),\n",
       " ('pregabalin', 31),\n",
       " ('methylprednisolone', 31),\n",
       " ('famotidine', 31),\n",
       " ('Piperacillin and Tazobactam', 31),\n",
       " ('CAMPHOR', 31),\n",
       " ('Alendronate Sodium', 31),\n",
       " ('Misoprostol', 31),\n",
       " ('vancomycin hydrochloride', 31),\n",
       " ('clobetasol propionate', 31),\n",
       " ('Desvenlafaxine Succinate', 31),\n",
       " ('carbamazepine', 31),\n",
       " ('Midazolam', 31),\n",
       " ('Buspirone hydrochloride', 30),\n",
       " ('Avobenzone, Octisalate Serum', 30),\n",
       " ('Acetaminophen and Diphenhydramine Hydrochloride', 30),\n",
       " ('everolimus', 30),\n",
       " ('hydromorphone hydrochloride', 30),\n",
       " ('amoxicillin and clavulanate potassium', 30),\n",
       " ('Methyl Salicylate', 30),\n",
       " ('Skin Tag Patches', 30),\n",
       " ('Avobenzone, Octinoxate, Octisalate, Oxybenzone', 30),\n",
       " ('azithromycin dihydrate', 30),\n",
       " ('Lisdexamfetamine Dimesylate', 30),\n",
       " ('diazepam', 30),\n",
       " ('Eucalyptol, Menthol, Methyl Salicylate, Thymol', 30),\n",
       " ('DEXAMETHASONE SODIUM PHOSPHATE', 30),\n",
       " ('Chlorhexidine Gluconate 4%', 30),\n",
       " ('oseltamivir phosphate', 30),\n",
       " ('donepezil hydrochloride', 30),\n",
       " ('ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE',\n",
       "  30),\n",
       " ('dexamethasone', 30),\n",
       " ('insulin aspart', 30),\n",
       " ('Carbon Dioxide', 30),\n",
       " ('OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE', 30),\n",
       " ('varenicline tartrate', 30),\n",
       " ('Zinc Oxide and Titanium Dioxide', 30),\n",
       " ('Amlodipine and atorvastatin', 30),\n",
       " ('mesalamine', 30),\n",
       " ('Rosuvastatin calcium', 30),\n",
       " ('Desvenlafaxine', 29),\n",
       " ('Doxazosin Mesylate', 29),\n",
       " ('LOSARTAN POTASSIUM', 29),\n",
       " ('ATROPINE SULFATE', 29),\n",
       " ('guanfacine', 29),\n",
       " ('Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%', 29),\n",
       " ('Chlorpromazine hydrochloride', 29),\n",
       " ('Amantadine Hydrochloride', 29),\n",
       " ('montelukast sodium', 29),\n",
       " ('Homosalate, Zinc Oxide', 29),\n",
       " ('Helicobacter Pylori', 29),\n",
       " ('Ephedrine Sulfate', 29),\n",
       " ('Lamivudine', 29),\n",
       " ('Dimethyl Fumarate', 29),\n",
       " ('Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride',\n",
       "  29),\n",
       " ('fluconazole', 29),\n",
       " ('benzoyl peroxide', 29),\n",
       " ('valsartan and hydrochlorothiazide', 29),\n",
       " ('Amlodipine and Olmesartan Medoxomil', 29),\n",
       " ('Lubiprostone', 29),\n",
       " ('Dexmedetomidine Hydrochloride', 29),\n",
       " ('voriconazole', 29),\n",
       " ('Bortezomib', 29),\n",
       " ('Selenium Sulfide', 29),\n",
       " ('Minoxidil 5%', 29),\n",
       " ('Hydroquinone', 29),\n",
       " ('nitrofurantoin macrocrystals', 28),\n",
       " ('Ipratropium Bromide', 28),\n",
       " ('Cyclobenzaprine hydrochloride', 28),\n",
       " ('Rabeprazole Sodium', 28),\n",
       " ('methotrexate', 28),\n",
       " ('Chlorpheniramine Maleate', 28),\n",
       " ('tizanidine hydrochloride', 28),\n",
       " ('Cetylpyridinium chloride', 28),\n",
       " ('aluminum hydroxide and magnesium carbonate', 28),\n",
       " ('Lidocaine, Menthol', 28),\n",
       " ('Trstay Castor Oil', 28),\n",
       " ('Cetylpyridinium Chloride', 28),\n",
       " ('semaglutide', 28),\n",
       " ('Bisoprolol Fumarate', 28),\n",
       " ('Paroxetine Hydrochloride', 28),\n",
       " ('Decitabine', 28),\n",
       " ('Flucytosine', 28),\n",
       " ('Sevelamer Carbonate', 28),\n",
       " ('Nicotine Transdermal System', 28),\n",
       " ('Fluoride', 28),\n",
       " ('epinephrine', 28),\n",
       " ('Butalbital, Acetaminophen, and Caffeine', 28),\n",
       " ('paroxetine hydrochloride hemihydrate', 28),\n",
       " ('LACOSAMIDE', 28),\n",
       " ('Carboplatin', 28),\n",
       " ('telmisartan', 28),\n",
       " ('Acetaminophen, Caffeine, Pyrilamine maleate', 28),\n",
       " ('Azacitidine', 28),\n",
       " ('SILDENAFIL CITRATE', 28),\n",
       " ('fluocinolone acetonide', 27),\n",
       " ('HYDROCODONE BITARTRATE AND ACETAMINOPHEN', 27),\n",
       " ('Felbamate', 27),\n",
       " ('Lidocaine 4%', 27),\n",
       " ('Empagliflozin', 27),\n",
       " ('Menthol, Camphor', 27),\n",
       " ('loperamide HCl', 27),\n",
       " ('Icosapent Ethyl', 27),\n",
       " ('leuprolide acetate', 27),\n",
       " ('Liraglutide', 27),\n",
       " ('Niacinamide', 27),\n",
       " ('EPINEPHRINE', 27),\n",
       " ('OXYCODONE HYDROCHLORIDE', 27),\n",
       " ('ENALAPRIL MALEATE', 27),\n",
       " ('Mitomycin', 27),\n",
       " ('octinoxate and titanium dioxide', 27),\n",
       " ('Isoproterenol Hydrochloride', 27),\n",
       " ('MAGNESIUM SULFATE HEPTAHYDRATE', 27),\n",
       " ('Acitretin', 27),\n",
       " ('Sildenafil Citrate', 27),\n",
       " ('SODIUM BICARBONATE, SODIUM CHLORIDE', 27),\n",
       " ('Camphor, Eucalyptus Oil, Menthol', 27),\n",
       " ('sodium chloride', 27),\n",
       " ('potassium nitrate and sodium fluoride', 27),\n",
       " ('Docusate sodium', 27),\n",
       " ('Megestrol Acetate', 27),\n",
       " ('NITROGLYCERIN', 27),\n",
       " ('Norgestimate and Ethinyl Estradiol', 27),\n",
       " ('Imatinib Mesylate', 27),\n",
       " ('Telmisartan and Hydrochlorothiazide', 27),\n",
       " ('FUROSEMIDE', 27),\n",
       " ('Absinthium', 27),\n",
       " ('Medroxyprogesterone Acetate', 27),\n",
       " ('Oseltamivir phosphate', 27),\n",
       " ('adenosine', 27),\n",
       " ('Imipramine Hydrochloride', 27),\n",
       " ('Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate', 27),\n",
       " ('Aluminum Zirconium Trichlorohydrex Gly', 27),\n",
       " ('titanium dioxide', 27),\n",
       " ('Methocarbamol Tablets', 27),\n",
       " ('Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl',\n",
       "  27),\n",
       " ('apixaban', 26),\n",
       " ('escitalopram oxalate', 26),\n",
       " ('WITCH HAZEL', 26),\n",
       " ('Nicardipine Hydrochloride', 26),\n",
       " ('CAPSAICIN', 26),\n",
       " ('perampanel', 26),\n",
       " ('Atovaquone', 26),\n",
       " ('Babesia Microti, Borrelia Burgdorferi Nosode, DNA', 26),\n",
       " ('Mycoplasma Pneumoniae', 26),\n",
       " ('Chlamydia Trachomatis', 26),\n",
       " ('OMEPRAZOLE', 26),\n",
       " ('sumatriptan', 26),\n",
       " ('ALUMINUM SESQUICHLOROHYDRATE', 26),\n",
       " ('Povidone Iodine', 26),\n",
       " ('Itraconazole', 26),\n",
       " ('Latanoprost', 26),\n",
       " ('Bethanechol Chloride', 26),\n",
       " ('Rivastigmine', 26),\n",
       " ('Aspirin, Citric Acid, Sodium Bicarbonate', 26),\n",
       " ('Methimazole', 26),\n",
       " ('Doxylamine succinate', 26),\n",
       " ('Avobenzone, Homosalate, Octocrylene', 26),\n",
       " ('Amphetamine Sulfate', 26),\n",
       " ('LISDEXAMFETAMINE DIMESYLATE', 26),\n",
       " ('Cytomegalovirus Nosode', 26),\n",
       " ('Cimetidine', 26),\n",
       " ('Titanium dioxide and Zinc oxide', 26),\n",
       " ('SILDENAFIL', 26),\n",
       " ('promethazine hydrochloride', 26),\n",
       " ('CETIRIZINE HYDROCHLORIDE', 26),\n",
       " ('Menthol, Methyl Salicylate', 26),\n",
       " ('CLOZAPINE', 26),\n",
       " ('atorvastatin calcium, film coated', 26),\n",
       " ('Octinoxate, Titanium Dioixide, Octisalate', 26),\n",
       " ('Acetaminophen and Codeine Phosphate', 26),\n",
       " ('Abies nigra', 26),\n",
       " ('Nitisinone', 26),\n",
       " ('Aminocaproic Acid', 26),\n",
       " ('carbidopa and levodopa', 26),\n",
       " ('Ranitidine', 26),\n",
       " ('Human Herpesvirus 6A, 6B', 26),\n",
       " ('METRONIDAZOLE', 26),\n",
       " ('Phenazopyridine', 26),\n",
       " ('Nystatin and Triamcinolone Acetonide', 25),\n",
       " ('Amlodipine and Atorvastatin', 25),\n",
       " ('LEVOTHYROXINE SODIUM', 25),\n",
       " ('Chlordiazepoxide Hydrochloride', 25),\n",
       " ('aluminum hydroxide, magnesium hydroxide, simethicone', 25),\n",
       " ('Doxycycline hyclate', 25),\n",
       " ('Cyanocobalamin', 25),\n",
       " ('Loxapine', 25),\n",
       " ('OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE', 25),\n",
       " ('escitalopram', 25),\n",
       " ('Dextromethorphan HBr', 25),\n",
       " ('Rivaroxaban', 25),\n",
       " ('Tenofovir Disoproxil Fumarate', 25),\n",
       " ('cetirizine hydrochloride', 25),\n",
       " ('Roflumilast', 25),\n",
       " ('Antihemophilic Factor (Recombinant)', 25),\n",
       " ('Phenytoin', 25),\n",
       " ('Entecavir', 25),\n",
       " ('Abiraterone Acetate', 25),\n",
       " ('Ensulizole', 25),\n",
       " ('dasatinib', 25),\n",
       " ('Mycophenolic Acid', 25),\n",
       " ('Efavirenz', 25),\n",
       " ('Olmesartan Medoxomil and Hydrochlorothiazide', 25),\n",
       " ('Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride',\n",
       "  25),\n",
       " ('tretinoin', 25),\n",
       " ('Dextrose Monohydrate', 25),\n",
       " ('bisoprolol fumarate and hydrochlorothiazide', 25),\n",
       " ('somatropin', 25),\n",
       " ('Albendazole', 25),\n",
       " ('Hydrocodone Bitartrate', 25),\n",
       " ('fluticasone propionate and salmeterol', 25),\n",
       " ('isosorbide dinitrate', 25),\n",
       " ('midodrine hydrochloride', 25),\n",
       " ('Agaricus muscarius', 25),\n",
       " ('ZINC OXIDE, TITANIUM DIOXIDE', 25),\n",
       " ('naloxone hydrochloride', 25),\n",
       " ('AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE', 25),\n",
       " ('Medicated Corn Removers', 25),\n",
       " ('Pelargonium sidoides', 25),\n",
       " ('Clotrimazole and Betamethasone Dipropionate', 25),\n",
       " ('Doxepin hydrochloride', 24),\n",
       " ('CALCIUM CARBONATE', 24),\n",
       " ('Vardenafil Hydrochloride', 24),\n",
       " ('tizanidine', 24),\n",
       " ('HYDROCORTISONE ACETATE', 24),\n",
       " ('Dextromethorphan Hydrobromide, Guaifenesin', 24),\n",
       " ('CARVEDILOL', 24),\n",
       " ('ROPINIROLE HYDROCHLORIDE', 24),\n",
       " ('prednisone', 24),\n",
       " ('Homosalate, Titanium Dioxide, Zinc Oxide', 24),\n",
       " ('Rocuronium Bromide', 24),\n",
       " ('DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE',\n",
       "  24),\n",
       " ('mycophenolate mofetil', 24),\n",
       " ('Ergocalciferol', 24),\n",
       " ('Dronabinol', 24),\n",
       " ('Apixaban', 24),\n",
       " ('Adenosine', 24),\n",
       " ('Human Papilloma Nosode, DNA', 24),\n",
       " ('Rickettsia Nosode (Rickettsia Prowazekii)', 24),\n",
       " ('Dextromethorphan Hydrobromide', 24),\n",
       " ('Zoledronic Acid', 24),\n",
       " ('Sulfasalazine', 24),\n",
       " ('CETYLPYRIDINIUM CHLORIDE', 24),\n",
       " ('Tizanidine Hydrochloride', 24),\n",
       " ('ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY', 24),\n",
       " ('Silodosin', 24),\n",
       " ('imatinib mesylate', 24),\n",
       " ('Thuja Occidentalis', 24),\n",
       " ('Fulvestrant', 24),\n",
       " ('oxycodone hydrochloride', 24),\n",
       " ('Esomeprazole', 24),\n",
       " ('stannous fluoride', 24),\n",
       " ('ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE', 24),\n",
       " ('DEXMEDETOMIDINE HYDROCHLORIDE', 24),\n",
       " ('Actaea Spicata', 24),\n",
       " ('Cefpodoxime Proxetil', 24),\n",
       " ('Levocetirizine Dihydrochloride', 24),\n",
       " ('LENALIDOMIDE', 24),\n",
       " ('Desonide', 24),\n",
       " ('Methazolamide', 24),\n",
       " ('Brucella Melitensis', 24),\n",
       " ...]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "generic_counter.most_common()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Jakie substacje czynne wystpuj w lekach"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'product_ndc': '72705-251',\n",
       " 'generic_name': 'Witch Hazel',\n",
       " 'labeler_name': 'Fridababy, LLC',\n",
       " 'brand_name': 'frida mom Labor and Delivery Plus Postpartum Recovery',\n",
       " 'finished': True,\n",
       " 'packaging': [{'package_ndc': '72705-251-02',\n",
       "   'description': '1 KIT in 1 CARTON (72705-251-02)  *  24 CLOTH in 1 POUCH (72705-100-01)  *  141.75 g in 1 BOTTLE, PUMP (72705-150-01)',\n",
       "   'marketing_start_date': '20190501',\n",
       "   'sample': False}],\n",
       " 'listing_expiration_date': '20241231',\n",
       " 'openfda': {'manufacturer_name': ['Fridababy, LLC'],\n",
       "  'rxcui': ['844379', '2166922'],\n",
       "  'spl_set_id': ['4b5fc312-4c8c-4396-a70c-b1ed129038c7'],\n",
       "  'is_original_packager': [True]},\n",
       " 'marketing_category': 'OTC MONOGRAPH FINAL',\n",
       " 'dosage_form': 'KIT',\n",
       " 'spl_id': '6eb56d87-2690-469c-8901-89030fed550f',\n",
       " 'product_type': 'HUMAN OTC DRUG',\n",
       " 'marketing_start_date': '20190501',\n",
       " 'product_id': '72705-251_6eb56d87-2690-469c-8901-89030fed550f',\n",
       " 'application_number': 'part346',\n",
       " 'brand_name_base': 'frida mom Labor and Delivery Plus Postpartum Recovery'}"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(filter(\n",
    "                lambda x: \"active_ingredients\" not in x,\n",
    "                data[\"results\"],\n",
    "            )\n",
    ")[15]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "fdadata-xDIX1mry-py3.13",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
